form10q.htm



ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

	December 31			September 30
(In millions - unaudited)	2010			2010

ASSETS

CURRENT ASSETS
Cash and cash equivalents	$	374		$	417
Accounts receivable (a)		1,005			1,115
Inventories - Note H		497			447
Deferred income taxes		112			112
Held for sale - Note D (b)		656			693
Other assets		61			49
		2,705			2,833
NONCURRENT ASSETS
Auction rate securities - Note G		22			22
Goodwill - Note I		2,083			2,148
Intangibles - Note I		1,089			1,111
Asbestos insurance receivable (noncurrent portion) - Note M		452			459
Deferred income taxes		336			336
Held for sale - Note D (b)		271			270
Other assets		623			514
		4,876			4,860
PROPERTY, PLANT AND EQUIPMENT
Cost		3,003			3,096
Accumulated depreciation and amortization		(1,235	)		(1,258	)
		1,768			1,838

TOTAL ASSETS	$	9,349		$	9,531

LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES
Short-term debt - Note J	$	77		$	71
Current portion of long-term debt - Note J		39			45
Trade and other payables		640			727
Accrued expenses and other liabilities		404			523
Held for sale - Note D (b)		274			321
		1,434			1,687
NONCURRENT LIABILITIES
Long-term debt (noncurrent portion) - Note J		1,114			1,108
Employee benefit obligations - Note L		1,368			1,372
Asbestos litigation reserve (noncurrent portion) - Note M		826			841
Deferred income taxes		149			145
Other liabilities		581			575
		4,038			4,041

STOCKHOLDERS’ EQUITY		3,877			3,803

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	9,349		$	9,531

(a)	Accounts receivable includes an allowance for doubtful accounts of $29 million and $28 million at December 31, 2010 and September 30, 2010, respectively.

(b)	Primarily relates to assets and liabilities of the Distribution business that have qualified for held for sale classification in accordance with U.S. GAAP due to its expected sale.

SEE NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.



ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
STATEMENTS OF CONSOLIDATED STOCKHOLDERS’ EQUITY

								Accumulated
								other
	Common		Paid-in		Retained			comprehensive
(In millions - unaudited)	stock		capital		earnings			loss			(a)	Total

BALANCE AT SEPTEMBER 30, 2010	$	1	$	665	$	3,482		$	(345	)		$	3,803
Total comprehensive income (loss) (b)						87			(18	)			69
Regular dividend, $.15 per common share						(12	)						(12	)
Common shares issued under stock
incentive and other plans (c)				17									17
BALANCE AT DECEMBER 31, 2010	$	1	$	682	$	3,557		$	(363	)		$	3,877

(a)	At December 31, 2010, the after-tax accumulated other comprehensive loss of $363 million was comprised of pension and postretirement obligations of $620 million for 2010 and net unrealized translation gains of $257 million.

(b)	Reconciliations of net income to total comprehensive (loss) income follow.


	Three months ended
	December 31
(In millions)	2010			2009

Net income	$	87		$	86
Unrealized translation loss, net of tax		(18	)		(19	)
Total comprehensive income	$	69		$	67

(c)	Common shares issued were 231,358 for the three months ended December 31, 2010.

SEE NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.



ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS

	Three months ended
	December 31
(In millions - unaudited)	2010			2009
CASH FLOWS (USED) PROVIDED BY OPERATING ACTIVITIES FROM
CONTINUING OPERATIONS
Net income	$	87		$	86
Income from discontinued operations (net of income taxes)		(25	)		(22	)
Adjustments to reconcile income from continuing operations
to cash flows from operating activities
Depreciation and amortization		73			74
Debt issuance cost amortization		4			6
Deferred income taxes		4			26
Equity income from affiliates		(3	)		(6	)
Distributions from equity affiliates		2			6
Gain from sale of property and equipment		(3	)		(2	)
Stock based compensation expense		4			3
Stock contributions to qualified savings plans		12			9
Net gain on acquisitions and divestitures		(21	)		-
Change in operating assets and liabilities (a)		(172	)		(125	)
		(38	)		55
CASH FLOWS (USED) PROVIDED BY INVESTING ACTIVITIES FROM
CONTINUING OPERATIONS
Additions to property, plant and equipment		(22	)		(21	)
Proceeds from disposal of property, plant and equipment		4			3
Purchase of operations - net of cash acquired		(5	)		-
Proceeds from sale of operations or equity investments		21			-
Proceeds from sales and maturities of available-for-sale securities		-			44
		(2	)		26
CASH FLOWS (USED) PROVIDED BY FINANCING ACTIVITIES FROM
CONTINUING OPERATIONS
Proceeds from issuance of long-term debt		11			-
Repayment of long-term debt		(10	)		(25	)
Proceeds from short-term debt		6			6
Cash dividends paid		(12	)		(6	)
Proceeds from exercise of stock options		1			1
Excess tax benefits related to share-based payments		1			-
		(3	)		(24	)
CASH (USED) PROVIDED BY CONTINUING OPERATIONS		(43	)		57
Cash (used) provided by discontinued operations
Operating cash flows		-			(7	)
Investing cash flows		(1	)		-
Effect of currency exchange rate changes on cash and cash equivalents		1			4
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS		(43	)		54

CASH AND CASH EQUIVALENTS - BEGINNING OF YEAR		417			352

CASH AND CASH EQUIVALENTS - END OF PERIOD	$	374		$	406

(a) Excludes changes resulting from operations acquired or sold.

SEE NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE A – BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial reporting and Securities and Exchange Commission regulations. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. These statements omit certain information and footnote disclosures required for complete annual financial statements and, therefore, should be read in conjunction with Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2010. Results of operations for the period ended December 31, 2010 are not necessarily indicative of results to be expected for the year ending September 30, 2 011. Certain prior period data has been reclassified in the Condensed Consolidated Financial Statements and accompanying footnotes to conform to current period presentation.

Ashland is composed of four reporting segments: Ashland Aqualon Functional Ingredients (Functional Ingredients), Ashland Hercules Water Technologies (Water Technologies), Ashland Performance Materials (Performance Materials) and Ashland Consumer Markets (Consumer Markets). On November 5, 2010, Ashland signed a definitive agreement to sell substantially all of the assets and liabilities of Ashland Distribution (Distribution). As a result of this expected sale, the operating results and assets and liabilities related to Distribution have been reflected as discontinued operations for all periods presented. See Notes D, E and Q for additional information on the Distribution divestiture and reporting segment results.

The preparation of Ashland’s Condensed Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues, expenses and related disclosures of contingent assets and liabilities as well as qualifying subsequent events. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets (including goodwill and intangible assets), employee benefit obligations, income taxes, and liabilities and receivables associated with asbestos litigation, environmental remediation and asset retirement obligations. Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual res ults could differ significantly from the estimates under different assumptions or conditions.

Ashland’s results are affected by domestic and international economic, political, legislative, regulatory and legal actions. Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies, and changes in the prices of hydrocarbon-based products and other raw materials, can have a significant effect on operations. While Ashland maintains reserves for anticipated liabilities and carries various levels of insurance, Ashland could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings relating to asbestos, environmental remediation or other matters.

NOTE B – NEW ACCOUNTING STANDARDS

Changes to estimates of financial statement impacts due to the adoption of new accounting standards and new accounting standards issued during the current fiscal year are included in interim financial reporting. A detailed listing of all new accounting policies material to Ashland is included in the Annual Report on Form 10-K for the fiscal year ended September 30, 2010.

In October 2009, the Financial Accounting Standards Board (FASB) issued accounting guidance related to separating consideration in multiple-deliverable revenue arrangements (ASC 605-25 Revenue Recognition – Multiple-Element Arrangements). Under this guidance, multiple-deliverable arrangements will be accounted for separately (rather than as a combined unit) by selecting the best evidence of selling price among vendor-specific objective evidence, third-party evidence or estimated selling price. Additionally, this guidance eliminates the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement to all deliverables using the relative selling price method. This guidance became effective for Ashland on October 1, 2010. The adoption of this guidance did not have a material impact on the Condensed Consolidated Financial Statements.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE C – ACQUISITIONS

Ara Quimica

In April 2010, Ashland acquired the remaining 50% interest in Ara Quimica S.A. (Ara Quimica), a leading producer of custom unsaturated polyester resin formulations for the composites industry in South America, for $28 million. Prior to the acquisition, Ashland owned a 50% interest in Ara Quimica, which it recorded as an equity method investment within the Performance Materials reporting segment. Ara Quimica recorded sales of approximately $56 million from its most recent fiscal year ended September 30, 2010. As a result of this transaction, Ashland recorded $19 million of current assets and $61 million of long-term assets, which included $55 million of goodwill and intangible assets. In addition, Ashland recorded $18 million of current liabilities and $6 million of noncurrent l iabilities.

Hercules

On November 13, 2008, Ashland completed its acquisition of Hercules Incorporated (Hercules). The total merger consideration for outstanding Hercules Common Stock was $2,594 million, including $2,096 million in cash, $450 million in Ashland Common Stock with the remaining value of the transaction related to cash consideration and value for restricted stock units, stock options and transaction costs. In addition, Ashland inherited $798 million in debt as a part of the transaction. The acquired businesses of Hercules now comprise the Functional Ingredients reporting segment, as well as a significant portion of the Water Technologies reporting segment. The total debt borrowed upon the closing of the merger was approximately $2,300 million with the remaining cash consideration for the tra nsaction paid from Ashland’s existing cash at the date of the transaction.

NOTE D – DIVESTITURES

Ashland Distribution

On November 5, 2010, Ashland signed a definitive agreement with TPG Accolade, LLC (TPG) to sell substantially all of the assets of its global distribution business conducted by the Ashland Distribution (Distribution) segment. The transaction is an asset sale with the total cash proceeds expected to be $930 million, before transaction fees and taxes, subject to post-closing working capital adjustments and certain other adjustments, as specified in the definitive agreement. Ashland anticipates recording a significant gain, which includes a tax valuation allowance release of approximately $60 million to $70 million, upon the closing of the transaction, which is expected at the end of the March 2011 quarter. The closing is subject to regulatory approvals and satisfaction of other customary closing condi tions. Ashland Distribution recorded sales of $3,419 million during the most recently completed fiscal year ended September 30, 2010 and employs approximately 2,000 employees across North America and Europe.

Since this transaction signifies Ashland’s exit from the Distribution business, it qualifies as a discontinued operation. Therefore, the results of operations of Distribution have been classified as discontinued operations for all periods presented. Certain indirect corporate costs previously allocated to the Distribution reporting segment that do not qualify for discontinued operations accounting classification are now reported as costs within the Unallocated and other section of continuing operations, and for the three months ended December 31, 2010 and 2009 were $7 million and $9 million, respectively. Ashland is currently analyzing and developing plans to reduce these costs.

Ashland will retain and has agreed to indemnify TPG for certain liabilities of the Distribution business arising prior to the closing of the sale, which include pension and other postretirement benefits, as well as certain other potential liabilities, including certain litigation and environmental liabilities relating to the pre-closing period, as described in the agreement. Costs related to these expenses were $4 million for the three months ended December 31, 2010 and 2009 and have been included within the Unallocated and other section of continuing operations.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE D – DIVESTITURES (continued)

depending upon the type of service provided, Ashland expects to reduce costs as the transition services are completed. See Note E – Discontinued Operations for further information on the results of operations of Distribution for all periods presented.

As a result of this divestiture, the assets and liabilities of Distribution for prior periods have been reflected as assets and liabilities held for sale within the Condensed Consolidated Balance Sheets and are comprised of the following components:


	December 31		September 30
(In millions - unaudited)	2010		2010
Accounts receivable	$	442	$	494
Inventories		210		197
Other current assets		4		2
Current assets held for sale	$	656	$	693

Property, plant and equipment, net	$	181	$	179
Goodwill and intangible assets		82		82
Noncurrent assets held for sale	$	263	$	261

Trade payables	$	268	$	315
Accrued expenses and other liabilities		6		6
Current liabilities held for sale	$	274	$	321

In addition to the Distribution assets and liabilities identified above as held for sale, Ashland held other noncurrent assets for sale of $8 million and $9 million as of December 31, 2010 and September 30, 2010, respectively, primarily related to non-operational properties and certain Valvoline Instant Oil ChangeTM locations. The noncurrent assets held for sale are required to be measured at carrying value or below this level if an impairment is indicated. The fair values were based on definitive agreements of sale or other market quotes which would be considered significant unobservable market inputs (Level 3) within the fair value hierarchy. See also Note G – Fair Value Measurements for further inf ormation on the fair value hierarchy.

Castings Solutions Joint Venture

During the fifth year of the joint venture’s operations, Ashland will have the option to sell its shares in the expanded global joint venture to Süd-Chemie under mutually agreed terms. If Ashland does not execute this option by the end of the sixth year of the joint venture’s operations, Süd-Chemie will have the option to acquire Ashland’s shares under mutually agreed terms. Under both options, if mutually agreed terms cannot be reached, then the fair market value of the shares will be determined through an appraisal process set forth in the agreement.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE D – DIVESTITURES (continued)

March 2011 quarter, resulting from post-closing activities and measurements set forth in the agreement, which is expected to be approximately $25 million. Ashland recognized a pretax gain of $19 million, attributable to the fair market value of the net assets contributed to the joint venture. For the majority of the valuation of the contributed assets and liabilities, Ashland utilized the discounted cash flow method; however, the adjusted book value method was also used in some areas of the valuation. The gain was included in the net gain on acquisitions and divestitures caption in the Statement of Consolidated Income for the three months ended December 31, 2010. The recorded values of assets and liabilities contributed by Ashland to the expanded joint venture, excluding equity interests were as follows:


	Assets
(In millions)	(liabilities)
Cash	$	9
Accounts receivable		45
Inventories		20
Property, plant and equipment		33
Goodwill		52
Trade and other payables		(24	)
Other noncurrent assets (liabilities) - net		11
	$	146

Ashland’s equity interest in the expanded joint venture qualifies for equity method accounting treatment under U.S. GAAP. As a result, future reported results of the Castings Solutions business will no longer include the sales, cost of sales or selling, general and administrative costs related to this business; however, Ashland will include the financial effects within the equity income caption of the Statements of Consolidated Income. In addition, the expanded joint venture will leave certain stranded costs that Ashland is currently analyzing and developing plans to reduce.

Pinova divestiture

In January 2010, Ashland sold its refined wood rosin and natural wood terpenes business, formerly known as Pinova, a business unit of Functional Ingredients, to TorQuest Partners in a transaction valued at approximately $75 million before tax, which was comprised of $60 million in cash and a $15 million five-year promissory note from TorQuest Partners. The Pinova business, with annual sales of approximately $85 million per year, had approximately 200 employees along with an associated manufacturing facility located in Brunswick, Georgia. As part of this transaction, TorQuest Partners has agreed to continue to manufacture certain products on behalf of Ashland.

NOTE E – DISCONTINUED OPERATIONS

As previously described in Note D, Ashland signed a definitive agreement with TPG on November 5, 2010 to sell substantially all of the assets and liabilities of Distribution. Ashland has determined that this expected sale qualifies as a discontinued operation, in accordance with U.S. GAAP, since the company will not have significant continuing involvement in the distribution business upon closing of the transaction. As a result, the previous operating results related to Distribution have been reflected as discontinued operations in the Statement of Consolidated Income, while assets and liabilities that are to be sold have been classified within the Condensed Consolidated Balance Sheet as held for sale. Sales for the three month periods ended December 31, 2010 and 2009 were $856 million and $729 m illion, respectively. The results of operations for the three month periods ended December 31, 2010 and 2009 are included in the table below.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE E – DISCONTINUED OPERATIONS (continued)

Corporation (Riley), a former subsidiary of Ashland, and from the acquisition of Hercules during fiscal 2009, a wholly owned subsidiary of Ashland. Adjustments to the recorded litigation reserves and related insurance receivables continue periodically and primarily reflect updates to the estimates. See Note M for more information related to the adjustments on asbestos liabilities and receivables.

Ashland’s divestiture of Ashland Paving And Construction (APAC) during 2006 qualified as a discontinued operation. As a result, the previous operating results, assets and liabilities related to APAC have been reflected as discontinued operations in the Condensed Consolidated Financial Statements. Ashland has made subsequent adjustments to the gain on the sale of APAC, primarily relating to the tax effects of the sale, during the three month periods ended December 31, 2010 and 2009. Such adjustments to these and other divested businesses may continue to occur in future periods and are reflected in the period they are determined and recorded in the discontinued operations caption in the Statements of Consolidated Income.

Components of amounts reflected in the Statements of Consolidated Income related to discontinued operations are presented in the following table for the three months ended December 31, 2010 and 2009.


	Three months ended
	December 31
(In millions)	2010		2009
Income from discontinued operations (net of tax)
Distribution (a)	$	23	$	12
Asbestos-related litigation reserves and receivables		1		9
Gain on disposal of discontinued operations (net of tax)
APAC		1		1
Total income from discontinued operations (net of tax)	$	25	$	22

(a)	For the three months ended December 31, 2010 and 2009, the pretax income reported for Distribution was $32 million and $19 million, respectively.

NOTE F – RESTRUCTURING ACTIVITIES

Ashland periodically implements restructuring programs related to acquisitions, divestitures or other cost reduction programs in order to enhance profitability through streamlined operations and an improved overall cost structure for each business. The total restructuring cost incurred for these programs for the three months ended December 31, 2009 was $2 million and was classified within the selling, general and administrative expenses caption. Additional costs from reductions in resources, facilities and business realignment or divestitures may occur in future periods, which could include charges related to additional severance, plant closings, reassessed pension plan valuations or other items.

As of December 31, 2010, the remaining restructuring reserves for these programs principally consisted of severance payments from the Hercules Integration Plan and the recent Performance Materials restructuring, which consisted of several plant closings and operational redesign to eliminate excess capacity that was announced during the prior fiscal year.

The following table details at December 31, 2010 and 2009, the amount of restructuring reserves related to the programs discussed above, and the related activity in these reserves for the three months ended December 31, 2010 and 2009. The reserves are included in accrued expenses and other liabilities in the Condensed Consolidated Balance Sheet and are expected to be fully utilized by the end of fiscal 2011.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE F – RESTRUCTURING ACTIVITIES (continued)


(In millions)	Severance
Balance as of September 30, 2009	$	38
Restructuring reserve		2
Utilization (cash paid or otherwise settled)		(9	)
Balance at December 31, 2009	$	31

Balance as of September 30, 2010	$	26
Utilization (cash paid or otherwise settled)		(5	)
Balance at December 31, 2010	$	21

NOTE G – FAIR VALUE MEASUREMENTS

As required by U.S. GAAP, Ashland uses applicable guidance for defining fair value, the initial recording and periodic remeasurement of certain assets and liabilities measured at fair value and related disclosures for instruments measured at fair value. Fair value accounting guidance establishes a fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). An instrument’s categorization within the fair value hierarchy is based upon the lowest level on input that is significant to the instrument’s fair value measurement. The three levels within the fair value hierarchy are described as follows:

Level 1 — Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3 — Unobservable inputs for the asset or liability for which there is little, if any, market activity at the measurement date. Unobservable inputs reflect Ashland’s own assumptions about what market participants would use to price the asset or liability. The inputs are developed based on the best information available in the circumstances, which might include occasional market quotes or sales of similar instruments or Ashland’s own financial data such as internally developed pricing models, discounted cash flow methodologies, as well as instruments for which the fair value determination requires significant management judgment.

For assets that are measured using quoted prices in active markets (Level 1), the total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs. Assets and liabilities that are measured using significant other observable inputs (Level 2) are primarily valued by reference to quoted prices of similar assets or liabilities in active markets (market approach), adjusted for any terms specific to that asset or liability. For all other assets and liabilities for which unobservable inputs are used (Level 3), fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models that Ashland deems reasonable.

The following table summarizes financial asset instruments subject to recurring fair value measurements as of December 31, 2010. Ashland did not have any financial liability instruments subject to recurring fair value measurements as of December 31, 2010.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE G – FAIR VALUE MEASUREMENTS (continued)


					Quoted prices
					in active		Significant
					markets for		other		Significant
			Total		identical		observable		unobservable
	Carrying		fair		assets		inputs		inputs
(In millions)	value		value		Level 1		Level 2		Level 3
Assets
Cash and cash equivalents	$	374	$	374	$	374	$	-	$	-
Auction rate securities		22		22		-		-		22
Deferred compensation investments (a)		176		176		64		112		-
Investment of captive insurance company (a)		2		2		2		-		-
Total assets at fair value	$	574	$	574	$	440	$	112	$	22

(a) Included in other noncurrent assets in the Condensed Consolidated Balance Sheet.

The following table summarizes financial asset instruments subject to recurring fair value measurements as of September 30, 2010. Ashland did not have any financial liability instruments subject to recurring fair value measurements as of September 30, 2010.


					Quoted prices
					in active		Significant
					markets for		other		Significant
			Total		identical		observable		unobservable
	Carrying		fair		assets		inputs		inputs
(In millions)	value		value		Level 1		Level 2		Level 3
Assets
Cash and cash equivalents	$	417	$	417	$	417	$	-	$	-
Auction rate securities		22		22		-		-		22
Deferred compensation investments (a)		169		169		62		107		-
Investment of captive insurance company (a)		2		2		2		-		-
Total assets at fair value	$	610	$	610	$	481	$	107	$	22

(a) Included in other noncurrent assets in the Condensed Consolidated Balance Sheet.

Level 3 instruments

Auction rate securities

At December 31, 2010 and September 30, 2010, Ashland held at par value $25 million of student loan auction rate securities for which there was not an active market with consistent observable inputs. In February 2008, the auction rate securities market became largely illiquid, as there was not enough demand to purchase all of the securities that holders desired to sell at par value during certain auctions. Since this time, the market for auction rate securities has failed to achieve equilibrium. Due to the uncertainty as to when active trading will resume in the auction rate securities market, Ashland believes the recovery period for certain of these securities may extend beyond a twelve-month period. As a result, these instruments have been classified as noncurrent assets in the Condensed Consolidated Balance Sheet.

During the December 2009 quarter, Ashland liquidated $50 million par value auction rate securities for $44 million in cash proceeds, which approximated book value. The following table provides a reconciliation of the beginning and ending balances of Ashland’s auction rate securities, as these are Ashland’s only assets measured at fair value using significant unobservable inputs (Level 3).

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE G – FAIR VALUE MEASUREMENTS (continued)


(In millions)	Level 3
Balance as of October 1, 2010	$	22
Sales of auction rate securities		-
Balance as of December 31, 2010	$	22

Balance as of October 1, 2009	$	170
Sales of auction rate securities		(44	)
Balance as of December 31, 2009	$	126

Derivative and hedging activities

Currency hedges

Ashland conducts business in a variety of foreign currencies. Accordingly, Ashland regularly uses foreign currency derivative instruments to manage exposure on certain transactions denominated in foreign currencies to curtail the earnings volatility effects of short-term assets and liabilities denominated in currencies other than the functional currency of an entity.

Ashland contracts with counter-parties to buy and sell foreign currencies to offset the impact of exchange rate changes on transactions denominated in non-functional currencies, including short-term inter-company loans. These contracts generally require exchange of one foreign currency for another at a fixed rate at a future date and generally have maturities of less than twelve months. All contracts are marked-to-market with net changes in fair value recorded within the selling, general and administrative expenses caption. For the three months ended December 31, 2010 and 2009, losses of less than $1 million and $1 million, respectively, were recorded in the Statement of Consolidated Income for these contracts. The impacts of these contracts were largely offset by gains and losses resulti ng from the impact of changes in exchange rates on transactions denominated in non-functional currencies.

Ashland’s net loss position on foreign currency derivatives outstanding in the Condensed Consolidated Balance Sheet as of December 31, 2010 was less than $1 million, consisting of a gain of $1 million with a notional amount of $94 million offset by a loss of $1 million with a notional amount of $93 million, and was included in other noncurrent assets and liabilities, respectively. The net gain position on foreign currency derivatives outstanding in the Condensed Consolidated Balance Sheet as of September 30, 2010 was $1 million, consisting of a gain of $2 million with a notional amount of $86 million offset by a loss of $1 million with a notional amount of $41 million, and was included in other noncurrent assets and liabilities, respectively. As of December 31, 2010, there were n o open foreign currency derivatives which qualified for hedge accounting treatment.

Interest rate hedges

During 2009, Ashland purchased a three year interest rate cap on a notional amount of $300 million of variable rate debt. This interest rate cap fixes Ashland’s interest rate on that outstanding variable interest rate debt when LIBOR interest rates equal or exceed 7% on a reset date. This interest rate cap qualifies as an interest rate swap within the provisions of the Senior Credit Agreement. This instrument does not qualify for hedge accounting and therefore gains or losses reflecting changes in fair value, along with the amortization of the upfront premium paid by Ashland to purchase the instrument, are reported in the Statements of Consolidated Income within the net interest and other financing expense caption. As of December 31, 2010 and September 30, 2010, the fair value on th e interest rate cap was less than $1 million and recorded within the other noncurrent assets caption of the Condensed Consolidated Balance Sheet.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE G – FAIR VALUE MEASUREMENTS (continued)

Other financial instruments

At December 31, 2010 and September 30, 2010, Ashland’s long-term debt had a carrying value of $1,153 million compared to a fair value of $1,398 million and $1,402 million, respectively. The fair values of long-term debt are based on quoted market prices or, if market prices are not available, the present values of the underlying cash flows discounted at Ashland’s incremental borrowing rates.

NOTE H – INVENTORIES

Inventories are carried at the lower of cost or market. Certain chemicals, plastics and lubricants are valued at cost using the last-in, first-out (LIFO) method. The remaining inventories are stated at cost using the average cost method. The following table summarizes Ashland’s inventories as of the reported Condensed Consolidated Balance Sheet dates.


	December 31			September 30
(In millions)	2010			2010
Finished products	$	368		$	326
Raw materials, supplies and work in process		180			175
LIFO carrying values		(51	)		(54	)
	$	497		$	447

NOTE I – GOODWILL AND OTHER INTANGIBLES

In accordance with U.S. GAAP, Ashland reviews goodwill and other intangible assets for impairment annually and when events and circumstances indicate an impairment may have occurred. The annual assessment is performed as of July 1 and consists of Ashland determining each reporting unit’s current fair value compared to its current carrying value. Ashland has determined its reporting units for allocation of goodwill include the Functional Ingredients, Water Technologies, Performance Materials and Consumer Markets reportable segments. Prior to its sale to TPG, Distribution was treated as a separate reporting unit for allocation of goodwill. Ashland performed its most recent annual goodwill impairment test as of July 1, 2010, and determined at that time, that no impairment existed.

The following is a progression of goodwill by segment for the period ended December 31, 2010.


	Functional			Water		Performance				Consumer
(In millions)	Ingredients			Technologies		Materials			(a)	Markets		Total
Balance at September 30, 2010	$	1,080		$	620	$	333			$	115	$	2,148
Divestitures		-			-		(52	)			-		(52	)
Currency translation adjustment		(13	)		-		-				-		(13	)
Balance at December 31, 2010	$	1,067		$	620	$	281			$	115	$	2,083

(a)

Within the Performance Materials reportable segment as of September 30, 2010, because further discrete financial information is provided and management regularly reviews this information, this reportable segment was further broken down into the Castings Solutions and Composite Polymers/Specialty Polymers and Adhesives reporting units. Goodwill consisted of $52 million and $281 million, respectively, for the Castings Solutions and Composite Polymers/Specialty Polymers and Adhesives reporting units as of September 30, 2010. The reduction of $52 million of goodwill is related to the contribution of Ashland’s Castings Solutions business to the expanded global joint venture with Süd-Chemie.

Intangible assets principally consist of trademarks and trade names, intellectual property, customer lists and sale contracts. Intangible assets are amortized on a straight-line basis over their estimated useful lives. The cost of trademarks and trade names is amortized principally over 15 to 25 years, intellectual property over 5 to 20 years, customer relationships over 3 to 24 years and other intangibles over 2 to 50 years.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE I – GOODWILL AND OTHER INTANGIBLES (continued)

Certain intangible assets within trademarks and trade names have been classified as indefinite lived and had a balance of $290 million as of December 31, 2010 and September 30, 2010. In accordance with U.S. GAAP, Ashland annually reviews these intangible assets for possible impairment whenever events or changes in circumstances indicate that carrying amounts may not be recoverable. In conjunction with the July 1 annual assessment of indefinite-lived intangible assets, Ashland’s models did not indicate any impairment. Intangible assets were comprised of the following as of December 31, 2010 and September 30, 2010.


	December 31, 2010
	Gross					Net
	carrying		Accumulated			carrying
(In millions)	amount		amortization			amount
Trademarks and trade names	$	353	$	(28	)	$	325
Intellectual property		331		(68	)		263
Customer relationships		579		(87	)		492
Other intangibles		35		(26	)		9
Total intangible assets	$	1,298	$	(209	)	$	1,089


	September 30, 2010
	Gross					Net
	carrying		Accumulated			carrying
(In millions)	amount		amortization			amount
Trademarks and trade names	$	353	$	(27	)	$	326
Intellectual property		331		(63	)		268
Customer relationships		583		(78	)		505
Other intangibles		39		(27	)		12
Total intangible assets	$	1,306	$	(195	)	$	1,111

Amortization expense recognized on intangible assets for the three months ended December 31 was $17 million for 2010 and $18 million for 2009 and is primarily included in the selling, general and administrative expenses caption of the Statements of Consolidated Income. Estimated amortization expense for future periods is $69 million in 2011 (includes three months actual and nine months estimated), $67 million in 2012, $66 million in 2013, $64 million in 2014 and $62 million in 2015.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE J – DEBT

The following table summarizes Ashland’s current and long-term debt as of the reported Condensed Consolidated Balance Sheet dates.


	December 31			September 30
(In millions)	2010			2010
Term Loan A, due 2014 (a)	$	289		$	293
6.60% notes, due 2027		12			12
Accounts receivable securitization		40			40
9.125% notes, due 2017		631			630
Medium-term notes, due 2013-2019, interest at a weighted-
average rate of 8.4% at December 31, 2010 (7.7% to 9.4%)		21			21
8.80% debentures, due 2012		20			20
Hercules Tianpu - term notes, due through 2011		7			14
Hercules Nanjing - term notes, due 2013		45			34
6.50% junior subordinated notes, due 2029		127			126
International revolver agreements, interest at a weighted-
average rate of 5.1% at December 31, 2010 (1.3% to 9.8%)		36			30
Other		2			4
Total debt		1,230			1,224
Short-term debt		(77	)		(71	)
Current portion of long-term debt		(39	)		(45	)
Long-term debt (less current portion)	$	1,114		$	1,108

(a)	Senior credit facilities.

The scheduled aggregate maturities of debt by fiscal year are as follows: $106 million remaining in 2011, $43 million in 2012, $85 million in 2013, $214 million in 2014, $9 million in 2015 and $0 million in 2016. Total borrowing capacity remaining under the $550 million revolving credit facility was $442 million, representing a reduction of $108 million for letters of credit outstanding at December 31, 2010. Additionally, at December 31, 2010, the outstanding amount of accounts receivable sold by Ashland to a wholly-owned “bankruptcy remote” special purpose subsidiary of Ashland was $585 million. As of December 31, 2010, Ashland had drawn $40 million of the approximate $328 million in available funding from qualifying receivables under this accounts receivable s ecuritization facility.

Covenant restrictions

The Senior Credit Facilities include less restrictive covenants than the previous credit facility and no longer contain covenants associated with minimum consolidated net worth and capital expenditure limits. The covenants contain certain usual and customary representations and warranties, and usual and customary affirmative and negative covenants which include financial covenants; limitations on liens, additional indebtedness, further negative pledges, investments, payment of dividends, mergers, sale of assets and restricted payments; and other customary limitations. As of December 31, 2010, Ashland is in compliance with all debt agreement covenant restrictions.

The maximum consolidated leverage ratio permitted under the Senior Credit Facilities are as follows: 3.00 from the period December 31, 2010 through September 30, 2011 and 2.75 from December 31, 2011 and each fiscal quarter thereafter. The permitted consolidated fixed charge coverage ratio under the Senior Credit Facility is 1.50 from December 31, 2010 and for each fiscal quarter thereafter.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE J – DEBT (continued)

1.50. The expected sale of Distribution will cause Ashland to amend its previous calculation of these financial ratios, but will not have a significant affect on the current cushion within the ratio results.

NOTE K – INCOME TAXES

Ashland’s effective tax rate is generally subjected to adjustments related to discrete items and changes within foreign effective tax rates resulting from income or loss fluctuations. The overall effective tax rate of 33.3% for the three months ended December 31, 2010 includes certain discrete items such as a $16 million tax expense from the $19 million pretax gain associated with the fair market value of the Castings Solutions contribution and a $4 million tax benefit associated with research and development tax credits for the 2010 fiscal year. In addition, the effective tax rate during this period was favorably impacted by $3 million from other miscellaneous discrete tax items.

The overall effective tax rate of 25.6% for the three months ended December 31, 2009 includes a benefit of $6 million associated with the reversal of certain foreign tax reserves.

Changes in unrecognized tax benefits are summarized as follows for the three months ended December 31, 2010.


(In millions)
Balance at October 1, 2010	$	116
Increases related to positions taken on items from prior years		5
Increases related to positions taken in the current year		1
Lapse of statute of limitations		(3	)
Balance at December 31, 2010	$	119

It is reasonably possible that the amount of the unrecognized tax benefits may increase or decrease within the next twelve months as the result of settlements from ongoing audits, which may have material affect on the Condensed Consolidated Financial Statements.

NOTE L – EMPLOYEE BENEFIT PLANS

For the three months ended December 31, 2010, Ashland contributed $5 million to the U.S. benefit plans and $3 million to the non-U.S. benefit plans. Ashland expects to make additional contributions to the U.S. plans of approximately $10 million and to the non-U.S. plans of $25 million during the remainder of fiscal year 2011. The following table details the components of pension and other postretirement benefit costs.


							Other postretirement
	Pension benefits						benefits
(In millions)	2010			2009			2010			2009
Three months ended December 31
Service cost	$	13		$	13		$	1		$	1
Interest cost		50			51			4			5
Expected return on plan assets		(57	)		(54	)		-			-
Amortization of prior service credit		(1	)		-			-			-
Amortization of net actuarial loss (gain)		19			13			(1	)		(1	)
	$	24		$	23		$	4		$	5

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE M – LITIGATION, CLAIMS AND CONTINGENCIES

Asbestos litigation

Ashland and Hercules, a wholly owned subsidiary of Ashland, have liabilities from claims alleging personal injury caused by exposure to asbestos. To assist in developing and annually updating independent reserve estimates for future asbestos claims and related costs given various assumptions, Ashland retained Hamilton, Rabinovitz & Associates, Inc. (HR&A). The methodology used by HR&A to project future asbestos costs is based largely on recent experience, including claim-filing and settlement rates, disease mix, enacted legislation, open claims, and litigation defense. The claim experience of Ashland and Hercules are separately compared to the results of previously conducted third party epidemiological studies estimating the number of people likely to develop asbestos-related diseases.&# 160; Those studies were undertaken in connection with national analyses of the population expected to have been exposed to asbestos. Using that information, HR&A estimates a range of the number of future claims that may be filed, as well as the related costs that may be incurred in resolving those claims.

Ashland asbestos-related litigation

The claims alleging personal injury caused by exposure to asbestos asserted against Ashland result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley Stoker Corporation, a former subsidiary.

The amount and timing of settlements and number of open claims can fluctuate significantly from period to period. A summary of Ashland asbestos claims activity, excluding those related to Hercules, follows.


	Three months ended
	December 31					Years ended September 30
(In thousands)		2010		2009		2010		2009		2008
Open claims - beginning of period		83		100		100		115		134
New claims filed		-		1		2		2		4
Claims settled		-		(1	)	(1	)	(1	)	(2	)
Claims dismissed		(4	)	(8	)	(18	)	(16	)	(21	)
Open claims - end of period		79		92		83		100		115

A progression of activity in the asbestos reserve is presented in the following table.


	Three months ended
	December 31						Years ended September 30
(In millions)	2010			2009			2010			2009			2008
Asbestos reserve - beginning of period	$	537		$	543		$	543		$	572		$	610
Reserve adjustment		-			-			28			5			2
Amounts paid		(11	)		(12	)		(34	)		(34	)		(40	)
Asbestos reserve - end of period	$	526		$	531		$	537		$	543		$	572

From the range of estimates, Ashland records the amount it believes to be the best estimate of future payments for litigation defense and claim settlement costs, which generally approximates the mid-point of the estimated range of exposure from model results. Ashland reviews this estimate and related assumptions quarterly and annually updates the results of a non-inflated, non-discounted approximate 50-year model developed with the assistance of HR&A. Total reserves for asbestos claims were $526 million at December 31, 2010 compared to $537 million at September 30, 2010.

Excluding the Hercules asbestos claims further described below, Ashland has insurance coverage for most of the litigation defense and claim settlement costs incurred in connection with its asbestos claims, and coverage-in-place agreements exist with the insurance companies that provide most of the coverage currently being accessed. As a

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE M – LITIGATION, CLAIMS AND CONTINGENCIES (continued)

result, increases in the asbestos reserve have been largely offset by probable insurance recoveries. The amounts not recoverable generally are due from insurers that are insolvent, rather than as a result of uninsured claims or the exhaustion of Ashland’s insurance coverage.

For the Ashland asbestos-related obligations, Ashland has estimated the value of probable insurance recoveries associated with its asbestos reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage, including an assumption that all solvent insurance carriers remain solvent. Approximately 69% of the estimated receivables from insurance companies are expected to be due from domestic insurers, of which approximately 84% have a credit rating of B+ or higher by A. M. Best, as of December 31, 2010. The remainder of the insurance receivable is due from London insurance companies, which generally have lower credit quality ratings, and from Underwriters at Lloyd’s, whose insurance policy obligations have been transferred to a Berkshire Hathaway en tity. During the December 2009 quarter, Ashland entered into a new agreement with a number of London market insurance companies with respect to coverage for asbestos-related insurance claims. As a result, a $12 million increase to the Ashland asbestos receivable was recorded within the Condensed Consolidated Balance Sheet as of December 31, 2009, which had a $9 million (after-tax) effect on the Statement of Consolidated Income for the December 2009 quarter within the discontinued operations caption. As a result of this agreement and other revised estimates, Ashland no longer discounts any portion of the asbestos receivable at this time.

At December 31, 2010, Ashland’s receivable for recoveries of litigation defense and claim settlement costs from insurers amounted to $414 million (excluding the Hercules receivable for asbestos claims), of which $59 million relates to costs previously paid. Receivables from insurers amounted to $421 million at September 30, 2010. During the June 2010 quarter, the model used for purposes of valuing the asbestos reserve described above, and its impact on valuation of future recoveries from insurers, was updated. This model update, along with likely settlement adjustments, caused an additional $24 million net increase in the receivable for probable insurance recoveries.

Hercules asbestos-related litigation

Hercules, a wholly-owned subsidiary of Ashland, has liabilities from claims alleging personal injury caused by exposure to asbestos. Such claims typically arise from alleged exposure to asbestos fibers from resin encapsulated pipe and tank products which were sold by one of Hercules’ former subsidiaries to a limited industrial market. The amount and timing of settlements and number of open claims can fluctuate significantly from period to period. A summary of Hercules’ asbestos claims activity follows.


	Three months ended		Year ended
	December 31		September 30
(In thousands)	2010	2009	2010		2009	(a)
Open claims - beginning of period	20	21	21		27
New claims filed	2	-	-		1
Claims dismissed/settled	-	-	(1	)	(7	)
Open claims - end of period	22	21	20		21

(a) Beginning of period represents acquisition date of November 13, 2008.

A progression of activity in the asbestos reserve is presented in the following table.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE M – LITIGATION, CLAIMS AND CONTINGENCIES (continued)


	Three months ended						Year ended
	December 31						September 30
(In millions)	2010			2009			2010			2009		(a)
Asbestos reserve - beginning of period	$	375		$	484		$	484		$	233
Reserve adjustments (b)		-			(35	)		(93	)		261
Amounts paid		(5	)		(2	)		(16	)		(10	)
Asbestos reserve - end of period	$	370		$	447		$	375		$	484

(a) Beginning of period represents acquisition date of November 13, 2008.

(b) Includes purchase accounting adjustments recorded during 2010 and 2009 as part of purchase price allocations for the Hercules acquisition.

During the December 2009 quarter, Ashland essentially completed the final valuation assessment of the Hercules asbestos claims liability existing as of the acquisition date and underlying claim files as part of transitioning to a standardized claims management approach. This assessment resulted in a $35 million and $22 million reduction to the asbestos liability and receivable, respectively, which was accounted for as an adjustment to Hercules’ opening balance sheet since the adjustment related to claims that had been incurred as of the acquisition date. During the most recent annual update of this estimate, completed during the June 2010 quarter, it was determined that the liability for asbestos claims should be reduced by $58 million. Based upon review of the assumptions underlyin g the asbestos valuation model and the most recent claim filing and settlement trend rates for both pre- and post-acquisition periods, Ashland determined that $14 million of the $58 million adjustment should be recorded to goodwill, which was partially offset by $6 million for an increase in probable insurance recoveries, totalling to a net $8 million adjustment to goodwill. Total reserves for Hercules asbestos claims were $370 million at December 31, 2010 compared to $375 million at September 30, 2010.

For the Hercules asbestos-related obligations, Ashland has estimated the value of probable insurance recoveries associated with its asbestos reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage, including an assumption that all solvent insurance carriers remain solvent. The estimated receivable consists exclusively of domestic insurers, of which approximately 98% have a credit rating of B+ or higher by A.M. Best, as of December 31, 2010.

As of December 31, 2010 and September 30, 2010, the receivables from insurers amounted to $68 million. As previously mentioned, during the June 2010 quarter, the model used for purposes of valuing the asbestos reserve and its impact on valuation of future recoveries from insurers was updated. This model update along with likely settlement adjustments caused a $28 million reduction in the receivable for probable insurance recoveries, $6 million of which was recorded to goodwill. For the Hercules asbestos-related obligations, certain reimbursements pursuant to coverage-in-place agreements with insurance carriers exist. As a result, increases in the asbestos reserve are partially offset by probable insurance recoveries.

Asbestos litigation cost projection

Projecting future asbestos costs is subject to numerous variables that are extremely difficult to predict. In addition to the significant uncertainties surrounding the number of claims that might be received, other variables include the type and severity of the disease alleged by each claimant, the long latency period associated with asbestos exposure, dismissal rates, costs of medical treatment, the impact of bankruptcies of other companies that are co-defendants in claims, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, and the impact of potential changes in legislative or judicial standards. Furthermore, any predictions with respect to these variables are subject to even greater uncertainty as the projection period lengthens. In light of t hese inherent uncertainties, Ashland believes that the asbestos reserves for Ashland and Hercules represent the best estimate within a range of possible outcomes. As a part of the process to develop these estimates of future asbestos costs, a range of long-term cost models was developed. These models are based on national studies that predict the number of people likely to develop asbestos-related diseases and are heavily influenced by assumptions regarding long-term inflation rates for indemnity payments and legal defense costs, as well as other variables mentioned previously.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE M – LITIGATION, CLAIMS AND CONTINGENCIES (continued)

Ashland has currently estimated in various approximate 50-year models that it is reasonably possible that total future litigation defense and claim settlement costs on an inflated and undiscounted basis could range as high as approximately $830 million for the Ashland asbestos-related litigation and approximately $570 million for the Hercules asbestos-related litigation (or approximately $1.4 billion in the aggregate), depending on the combination of assumptions selected in the various models. If actual experience is worse than projected, relative to the number of claims filed, the severity of alleged disease associated with those claims or costs incurred to resolve those claims, Ashland may need to further increase the estimates of the costs associated with asbestos claims and these increases could potentially be materi al over time.

Environmental remediation and asset retirement obligations

Ashland and Hercules are subject to various federal, state and local environmental laws and regulations that require environmental assessment or remediation efforts (collectively environmental remediation) at multiple locations. At December 31, 2010, such locations included 93 waste treatment or disposal sites where Ashland and/or Hercules have been identified as a potentially responsible party under Superfund or similar state laws, 152 current and former operating facilities (including certain operating facilities conveyed to MAP) and about 1,225 service station properties, of which 115 are being actively remediated.

Ashland’s reserves for environmental remediation amounted to $204 million at December 31, 2010 compared to $207 million at September 30, 2010, of which $159 million at December 31, 2010 and $162 million at September 30, 2010 were classified in other noncurrent liabilities on the Condensed Consolidated Balance Sheets.

The following table provides a reconciliation of the changes in the environmental contingencies and asset retirement obligations during the three months ended December 31, 2010 and 2009.


	Three months ended
	December 31
(In millions)	2010			2009
Reserve - beginning of period	$	207		$	221
Inherited Hercules obligations		-			6
Disbursements, net of cost recoveries		(7	)		(7	)
Revised obligation estimates and accretion		4			3
Foreign currency translation		-			(1	)
Reserve - end of period	$	204		$	222

The total reserves for environmental remediation reflect Ashland’s estimates of the most likely costs that will be incurred over an extended period to remediate identified conditions for which the costs are reasonably estimable, without regard to any third-party recoveries. Engineering studies, probability techniques, historical experience and other factors are used to identify and evaluate remediation alternatives and their related costs in determining the estimated reserves for environmental remediation. Ashland continues to discount certain environmental sites and regularly adjusts its reserves as environmental remediation continues. Ashland has estimated the value of its probable insurance recoveries associated with its environmental reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage. At December 31, 2010 and September 30, 2010, Ashland’s recorded receivable for these probable insurance recoveries was $29 million and $30 million, respectively. Environmental remediation expense, included within the selling, general and administrative expenses caption of the Statements of Consolidated Income, amounted to $5 million and $2 million for the three months ended December 31, 2010 and 2009, respectively. Environmental remediation expense, net of receivable activity, was $4 million and $1 million for the three months ended December 31, 2010 and 2009, respectively.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE M – LITIGATION, CLAIMS AND CONTINGENCIES (continued)

Environmental remediation reserves are subject to numerous inherent uncertainties that affect Ashland’s ability to estimate its share of the costs. Such uncertainties involve the nature and extent of contamination at each site, the extent of required cleanup efforts under existing environmental regulations, widely varying costs of alternate cleanup methods, changes in environmental regulations, the potential effect of continuing improvements in remediation technology, and the number and financial strength of other potentially responsible parties at multiparty sites. Although it is not possible to predict with certainty the ultimate costs of environmental remediation, Ashland currently estimates that the upper end of the reasonably possible range of future costs for identified sites could be as high as a pproximately $360 million. No individual remediation location is material, as the largest reserve for any site is less than 10% of the remediation reserve.

Other legal proceedings and claims

Ashland Consumer Markets has established an engine guarantee associated with its ValvolineTM product line. Consumers register their vehicles to qualify for the guarantee. Ashland insures this program with a third party and therefore carries no reserve for this guarantee program.

In addition to the matters described above, there are other various claims, lawsuits and administrative proceedings pending or threatened against Ashland and its current and former subsidiaries. Such actions are with respect to commercial matters, product liability, toxic tort liability, environmental and other matters, which seek remedies or damages, some of which are for substantial amounts. While these actions are being contested, their outcome is not predictable.

NOTE N – EARNINGS PER SHARE

The following is the computation of basic and diluted earnings per share (EPS) from continuing operations. Stock options, SARs and warrants (assumed as part of the Hercules acquisition) available to purchase shares outstanding for each reporting period whose grant price was greater than the average market price of Ashland Common Stock for each applicable period were not included in the computation of income from continuing operations per diluted share because the effect of these instruments would be antidilutive. The total number of these shares outstanding was approximately 2.0 million and 2.1 million as of December 31, 2010 and 2009, respectively.


	Three months ended
	December 31
(In millions except per share data)	2010		2009
Numerator
Numerator for basic and diluted EPS – Income
from continuing operations	$	62	$	64
Denominator
Denominator for basic EPS – Weighted-average
common shares outstanding		79		77
Share based awards convertible to common shares		1		1
Denominator for diluted EPS – Adjusted weighted-
average shares and assumed conversions		80		78

EPS from continuing operations
Basic	$	.79	$	.84
Diluted	$	.78	$	.82

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE O – CAPITAL STOCK

In November 2009, Ashland made a voluntary pension plan contribution of approximately 3.0 million shares of Ashland Common Stock, valued at $100 million on the date of transfer.

NOTE P – STOCK INCENTIVE PLANS

Ashland has stock incentive plans under which key employees or directors are granted stock-settled stock appreciation rights (SARs), performance share awards or nonvested stock awards. Each program is typically a long-term incentive plan designed to link employee compensation with increased shareholder value or reward superior performance and encourage continued employment with Ashland. Ashland recognizes compensation expense for the grant date fair value of stock-based awards over the applicable vesting period. Stock-based compensation expense was $4 million and $3 million for the three months ended December 31, 2010 and 2009, respectively, and is included in the selling, general and administrative expenses caption of the Statements of Consolidated Income.

SARs

SARs are granted to employees or directors at a price equal to the fair market value of the stock on the date of grant and typically become exercisable over periods of one to three years. Unexercised SARs lapse essentially ten years after the date of grant. SARs granted for the three months ended December 31, 2010 and 2009 were 0.6 million. As of December 31, 2010, there was $18 million of total unrecognized compensation costs related to SARs. That cost is expected to be recognized over a weighted-average period of 2.5 years. Ashland estimates the fair value of SARs granted using the Black-Scholes option-pricing model. This model requires several assumptions, which Ashland has developed and updates based on historical trends and current market observations. The accuracy of these assumptions is critical to the estimate of fair value for these equity instruments.

Nonvested stock awards

Nonvested stock awards are granted to employees or directors at a price equal to the fair market value of the stock on the date of grant and are forfeitable until vesting requirements are met, which is generally over a one-to-five-year period. However, such shares are subject to forfeiture upon termination of service before the vesting period ends. Nonvested stock awards entitle employees or directors to vote the shares and to receive any dividends (or dividend equivalents) upon grant. Nonvested stock awards granted for the three months ended December 31, 2010 and 2009 were 12,100 and 30,000 shares, respectively. As of December 31, 2010, there was $6 million of total unrecognized compensation costs related to nonvested stock awards. That cost is expected to be recognized over a weighted-average period of 2.2 years.

Performance shares

Performance share/unit awards are granted to certain key employees and are tied to Ashland’s overall financial performance relative to the financial performance of a selected industry peer group. Ashland believes that the focus on relative performance encourages management to make decisions that create shareholder value. Awards are granted annually, with each award covering a three-year performance cycle. Historically, each performance share/unit is convertible to one share of Ashland Common Stock or cash. As a result, these plans are recorded as a liability in the Condensed Consolidated Balance Sheets within the other noncurrent liabilities caption. Performance measures used to determine the actual number of performance shares issuable upon vesting include an equal weigh ting of Ashland’s total shareholder return (TSR) performance and Ashland’s return on investment (ROI) performance as compared to the performance peer group over the three-year performance cycle. TSR relative to

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE P – STOCK INCENTIVE PLANS (continued)

peers is considered a market condition while ROI is considered a performance condition under applicable U.S. GAAP. Nonvested performance shares/units do not entitle employees to vote the shares or to receive any dividends thereon. Performance shares/units granted for the three months ended December 31, 2010 and 2009 were 0.2 million. As of December 31, 2010, there was $11 million of total unrecognized compensation costs related to performance shares/units. That cost is expected to be recognized over a weighted-average period of 2.4 years.

NOTE Q – SEGMENT INFORMATION

Ashland has recently been comprised of five reporting segments. Following the expected sale of Distribution, Ashland’s businesses will now be managed along four industry segments: Functional Ingredients, Water Technologies, Performance Materials and Consumer Markets.

Functional Ingredients is one of the world’s largest producers of cellulose ethers. It provides specialty additives and functional ingredients that primarily manage the physical properties of water-based systems. Many of its products are derived from renewable and natural raw materials and perform in a wide variety of applications.

Water Technologies is a leading global producer of papermaking chemicals and a leading specialty chemicals supplier to the pulp, paper, commercial and institutional, food and beverage, chemical, mining and municipal markets. Its process, utility and functional chemistries are used to improve operational efficiencies, enhance product quality, protect plant assets, and ensure environmental compliance.

Performance Materials is a global leader in unsaturated polyester resins and vinyl ester resins. In addition, it provides customers with leading technologies in gelcoats, pressure-sensitive and structural adhesives, and metal casting consumables and design services. As previously discussed in Note D, on November 30, 2010 Ashland completed the transaction to expand the global joint venture with Süd-Chemie, serving the foundry chemical sector. As part of the transaction, Ashland transferred its existing Castings Solutions business to the expanded joint venture. Effective December 1, 2010, Ashland’s share of the joint venture’s results of operations are recorded as equity income in the Statements of Consolidated Income. As a result, future reported results will no longer include the sales, cost of sales or selling, general and administrative costs related to this business. Ashland will include the financial effects within the equity income caption of the Statements of Consolidated Income.

Consumer Markets, which includes the ValvolineTM family of products and services, is a leading innovator, marketer and supplier of high-performing automotive lubricants, chemicals and appearance products. ValvolineTM, the world’s first lubricating oil, is the number three passenger car motor oil brand, and Valvoline Instant Oil ChangeTM is the number two quick-lube franchise in the United States.

The following table presents for each segment the net sales and operating income for the three months ended December 31, 2010 and 2009. Results of Ashland’s reportable segments are presented based on its management structure and internal accounting practices. The structure and practices are specific to Ashland; therefore, the financial results of Ashland’s business segments are not necessarily comparable with similar information for other comparable companies. Ashland occasionally modifies its expense allocation methodologies to the reportable segments as internal accounting practices are improved, more refined information becomes available and businesses change. Revisions to Ashland’s methodologies that are deemed insignificant are applied on a prospective basis, while significant changes are applied on a retroactive basis. The unallocated and other caption includes certain specific company-wide restructuring activities that were significant, such as the restructuring plan related to the Hercules acquisition described in Note C, and other costs or adjustments that relate to former businesses that Ashland no longer operates, including the Distribution business.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE Q – SEGMENT INFORMATION


	Three months ended
	December 31
(In millions - unaudited)	2010			2009

SALES
Functional Ingredients	$	216		$	210
Water Technologies		451			443
Performance Materials (a)		326			271
Consumer Markets		440			400
	$	1,433		$	1,324
OPERATING INCOME (LOSS)
Functional Ingredients	$	19		$	27
Water Technologies		24			39
Performance Materials		6			8
Consumer Markets		65			67
Unallocated and other (b)		(15	)		(14	)
	$	99		$	127

(a)	The three months ended December 31, 2010 includes only two months of sales related to the Castings Solutions business, as Ashland contributed this business to its new global joint venture with Süd-Chemie on November 30, 2010.

(b)

Includes $11 million and $13 million of costs for the three months ended December 31, 2010 and 2009, respectively, previously charged to the Distribution business. These costs include former Distribution liabilities that have been retained by Ashland such as pension, postretirement and environmental costs, as well as indirect corporate cost allocations previously charged to this business.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

FORWARD-LOOKING STATEMENTS

This Form 10-Q contains forward-looking statements including, without limitation, statements made under the caption “Management’s Discussion and Analysis” (MD&A), within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. In addition, Ashland may from time to time make forward-looking statements in its other filings with the Securities and Exchange Commission (SEC), press releases and other written and oral communications. These forward-looking statements are based on Ashland’s expectations and assumptions, as of the date such statements are made, regarding Ashland’s future operating performance and financial condition, the economy and other future events or circumstances. Ashland’s expectations and assumptions include, without limitation, those mentioned within the MD&A, internal forecasts and analyses of current and future market conditions and trends, management plans and strategies, operating efficiencies and economic conditions (such as prices, supply and demand, cost of raw materials, and the ability to recover raw material cost increases through price increases), the closing of the sale of the Distribution business and the expected benefits to be realized by Ashland from the sale, weather, and legal proceedings and claims (including environmental and asbestos matters). Various risks and uncertainties may cause actual results to differ materially from those stated, projected or implied by any forward-looking statements, including, without limitation, risks and uncertainties affecting Ashland that are described in Item 1A Risk Factors of its most recent Form 10-K filed with the SEC, which is available on Ashland’s website at http://investor.ashland.com or on the SEC’s we bsite at www.sec.gov. Ashland believes its expectations and assumptions are reasonable, but there can be no assurance that the expectations reflected herein will be achieved. Ashland undertakes no obligation to subsequently update any forward-looking statements made in this Form 10-Q or otherwise except as required by securities or other applicable law.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

The following discussion should be read in conjunction with the Condensed Consolidated Financial Statements and the accompanying Notes to Condensed Consolidated Financial Statements herein.

BUSINESS OVERVIEW

Ashland profile

Ashland is a global specialty chemicals company with approximately 14,500 employees worldwide in more than 100 countries. Ashland provides specialty chemicals, technologies and insights to create new and improved products. Ashland’s chemistry is used in a variety of industries that include automotive, food and beverages, personal care products, pharmaceuticals, paper and tissue to durable goods and infrastructure, including building and construction, energy and water treatment.

Ashland’s sales generated outside of North America were 45% for the three months ended December 31, 2010 and 2009, respectively. Sales by region expressed as a percentage of total consolidated sales for the three months ended December 31 were as follows:


Sales by Geography	2010		2009
North America	55	%	55	%
Europe	24	%	26	%
Asia Pacific	13	%	13	%
Latin America & other	8	%	6	%
	100	%	100	%

Business segments

Ashland’s reporting structure is composed of four reporting segments: Ashland Aqualon Functional Ingredients (Functional Ingredients), Ashland Hercules Water Technologies (Water Technologies), Ashland Performance Materials (Performance Materials) and Ashland Consumer Markets (Consumer Markets).

The contribution to sales by each of the four business segments expressed as a percentage of total consolidated sales for the three months ended December 31 were as follows:


Sales by Business Segment	2010		2009
Functional Ingredients	15	%	16	%
Water Technologies	31	%	33	%
Performance Materials	23	%	21	%
Consumer Markets	31	%	30	%
	100	%	100	%

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

KEY DEVELOPMENTS

During fiscal 2011 and other previous periods, the following operational decisions and economic developments had an impact on Ashland’s current and future cash flows, results of operations and financial position.

Economic environment

Ashland has experienced modest demand increases within each operating segment; however, its current financial performance has been adversely impacted by escalating raw material costs. Ashland continues to emphasize efficient pricing procedures to offset these increased costs, while internally assessing operations for cost reduction opportunities, such as Performance Materials’ recent operational redesign to eliminate excess capacity by closing several plants.

Divestitures/Acquisitions

Distribution divestiture

On November 5, 2010, Ashland signed a definitive agreement with TPG Accolade, LLC (TPG) to sell substantially all of the assets of its global distribution business conducted by the Ashland Distribution (Distribution) segment. The transaction is an asset sale with the total cash proceeds expected to be $930 million, before transaction fees and taxes, subject to post-closing working capital adjustments and certain other adjustments, as specified in the definitive agreement. Ashland anticipates recording a significant gain, which includes a tax valuation allowance release of approximately $60 million to $70 million, upon the closing of the transaction, which is expected at the end of the March 2011 quarter. The closing is subject to regulatory approvals and satisfaction of other customary closing conditi ons. Ashland Distribution recorded sales of $3,419 million during the most recently completed fiscal year ended September 30, 2010 and employs approximately 2,000 employees across North America and Europe.

As part of this pending sale, Ashland expects to receive transition service fees for services to be provided to TPG subsequent to the completion of the sale. While the transition service agreements are expected to vary in duration depending upon the type of service provided, Ashland expects to reduce costs as the transition services are completed. See Notes D and E of Notes to Condensed Consolidated Financial Statements for additional information on the Distribution divestiture.

Süd-Chemie joint venture agreement

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

completed fiscal year. The Foundry-Products and Specialty Resins business unit of Süd-Chemie contributed to the joint venture generated sales of approximately $146 million for its most recently completed fiscal year.

Upon closing of the transaction, the joint venture distributed a $21 million net payment to Ashland in accordance with the agreement. Ashland anticipates receiving an additional cash payment from the joint venture during the March 2011 quarter, resulting from post-closing activities and measurements set forth in the agreement, which is expected to be approximately $25 million. Ashland recognized a pretax gain of $19 million, attributable to the fair market value of the net assets contributed to the joint venture. For the majority of the valuation of the contributed assets and liabilities, Ashland utilized the discounted cash flow method; however, the adjusted book value method was also used in some areas of the valuation. The gain was included in the net gain on acquisitions and divestiture s caption in the Statement of Consolidated Income for the three months ended December 31, 2010.

Ara Quimica acquisition

Pinova divestiture

Hercules acquisition

On November 13, 2008, Ashland completed its acquisition of Hercules Incorporated (Hercules). The total merger consideration for outstanding Hercules Common Stock was $2,594 million, including $2,096 million in cash, $450 million in Ashland Common Stock with the remaining value of the transaction related to cash consideration and value for restricted stock units, stock options and transaction costs. In addition, Ashland inherited $798 million in debt as a part of the transaction. The acquired businesses of Hercules now comprise the Functional Ingredients reporting segment, as well as a significant portion of the Water Technologies reporting segment. The total debt borrowed upon the closing of the merger was approximately $2,300 million with the remaining cash consideration for the tr ansaction paid from Ashland’s existing cash at the date of the transaction.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

Functional Ingredients HEC manufacturing facility

In November 2010, Functional Ingredients’ new Natrosol™ hydroxyethylcellulose (HEC) production facility in Nanjing, China became operational. At $90 million, the new facility represents Ashland’s largest single investment in China and the Asia Pacific region. This manufacturing facility will increase Functional Ingredients’ HEC production capacity by 10,000 metric tons per year and has expanded capabilities to produce up to 20,000 metric tons per year. Ashland is expecting the facility to increase its production throughout fiscal 2011 with a target to produce up to its initial maximum capacity by the end of the 2011 calendar year. Ashland expects that this additional supply will significantly aid in relieving certain capacity constraints in this product line.< /div>

Liquidity and corporate credit ratings

Ashland’s available liquidity position, which includes cash and the revolving credit and accounts receivable securitization facilities, was $1,104 million at December 31, 2010 as compared to $1,155 million at September 30, 2010. In addition to anticipated increases in liquidity from cash flows generated from operations, Ashland expects additional cash proceeds of approximately $825 million, after fees and taxes, from the sale of Distribution, positioning the company for future strategic investment opportunities. In connection with the expected sale of Distribution, Ashland intends to terminate the accounts receivable securitization facility during the upcoming March 2011 quarter.

Ashland’s corporate credit ratings have remained unchanged since its 10-K filing in late November, which were BB+ and Ba1 from Standard & Poor’s and Moody’s Investor Services, respectively, with an outlook of positive from both. Ashland’s ability to access capital markets to provide liquidity has also remained stable. However, the expected increased liquidity from the Distribution sale, along with improvements in the credit markets and Ashland’s financial performance, should continue to allow Ashland to borrow on more favorable terms in the future, including less restrictive covenants and lower interest rates.

RESULTS OF OPERATIONS – CONSOLIDATED REVIEW

Use of non-GAAP measures

Based on January 2010 clarification and interpretive guidance from the Securities and Exchange Commission regarding the use of non-GAAP measures, Ashland has included within this document certain non-GAAP measures which include EBITDA (operating income plus depreciation and amortization), adjusted EBITDA (EBITDA adjusted for key items, which may include pro forma affects for significant acquisitions or divestitures, as applicable), adjusted EBITDA margin (adjusted EBITDA divided by sales, which can include pro forma adjustments) and free cash flow (cash flows by operating activities from continuing operations minus cash dividends paid and additions to property, plant and equipment). Such measurements are not prepared in accordance with U.S. GAAP and should not be construed as an alternative to reported results determined i n accordance with U.S. GAAP. Management believes the use of such non-GAAP measures on a consolidated and business segment basis assists investors in understanding the ongoing operating performance by presenting the financial results between periods on a more comparable basis. In addition, certain financial covenants related to Ashland’s Senior Credit Agreement are based on similar non-GAAP measures. The non-GAAP information provided is unique to Ashland and may not be consistent with the methodologies used by other companies.

Consolidated review

Net income

Ashland’s net income amounted to $87 million and $86 million for the three months ended December 31, 2010 and 2009, respectively, or $1.09 and $1.10 diluted earnings per share. Ashland’s net income is primarily affected by results within operating income, net interest and other financing expense, income taxes, discontinued operations and other significant events or transactions that are unusual or nonrecurring. Income from continuing operations, which excludes results from discontinued operations, amounted to $62 million and $64 million for the three months ended December 31, 2010 and 2009, respectively, or $.78 and $.82 per diluted earnings per share.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

Ashland incurred pretax net interest and other financing expense of $27 million and $41 million for the three months ended December 31, 2010 and 2009, respectively. The decrease in interest expense during 2010 compared to 2009 was primarily attributable to a $364 million reduction in debt and a lower weighted-average rate of borrowing due to Ashland’s refinancing of debt in March of 2010.

During the three months ended December 31, 2010 Ashland reported a nonrecurring gain from the fair market value of the Castings Solutions net assets contributed to the expanded global joint venture with Süd-Chemie exceeding the recorded amounts. This remeasurement resulted in a pretax gain of $19 million, or $3 million, after tax, that was recorded below operating income on the Statement of Consolidated Income in the net gain on acquisitions and divestitures caption.

The effective income tax rates of 33.3% and 25.6% for the three months ended December 31, 2010 and 2009, respectively, were both affected by discrete items discussed in further detail within the income tax expense caption discussion below in the comparative Statement of Consolidated Income analysis.

Discontinued operations, which are reported net of taxes, resulted in $25 million and $22 million of income for the three months ended December 31, 2010 and 2009, respectively. Each period includes the direct operating results of operations for Distribution, while 2009 also includes an income adjustment of $9 million after-tax related to an agreement with a number of London market insurance companies with respect to coverage for asbestos-related insurance claims.

Operating income

Operating income amounted to $99 million and $127 million for the three months ended December 31, 2010 and 2009, respectively. The current period included a $7 million accelerated depreciation charge for plant closure costs associated with capacity reductions in the composites line of business within Performance Materials and a $3 million charge for transaction and start-up costs associated with the expanded global joint venture with Süd-Chemie. Excluding these items, operating income declined in 2010, primarily as a result of gross profit margin decline in all business segments, which primarily resulted from increases in raw material costs that more than offset sale increases.

Operating income for the three months ended December 31, 2010 and 2009 included depreciation and amortization of $73 million (including accelerated depreciation of $7 million) and $74 million, respectively. EBITDA totaled $172 million and $201 million for 2010 and 2009, respectively. Adjusted EBITDA decreased $26 million, from $201 million in 2009 to $175 million in 2010. Adjusted EBITDA margin decreased 3.0 percentage points in 2010 to 12.2% from 15.2% in 2009. A reconciliation of EBITDA and Adjusted EBITDA results for 2010 and 2009 were as follows.


	Three months ended
	December 31
(In millions)	2010		2009
Operating income	$	99	$	127
Depreciation and amortization		73		74
EBITDA		172		201
Castings Solutions transaction and start-up costs		3		-
Adjusted EBITDA	$	175	$	201

Statement of consolidated income – caption review

A comparative analysis of the Statement of Consolidated Income by caption is provided as follows for the three months ended December 31, 2010 and 2009.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS


(In millions)	2010		2009		Change
Sales	$	1,433	$	1,324	$	109

Sales for 2010 increased $109 million, or 8%, compared to 2009 primarily as a result of increases in pricing, implemented to recover the effects of increases in raw material costs, and volume, which improved sales $73 million and $72 million, respectively, or 11%. Unfavorable currency exchange rates and product mix decreased sales $19 million and $8 million, respectively, or 2%. In addition, the net acquisitions and divestitures, attributable to the January 2010 divestiture of Pinova, April 2010 purchase of Ara Quimica and the November 2010 contribution of the Castings Solutions business to the expanded global joint venture with Süd-Chemie, decreased sales by $9 million, or 1%.



(In millions)	2010			2009			Change
Cost of sales	$	1,040		$	906		$	134
Gross profit as a percent of sales		27.4	%		31.6	%

Cost of sales for 2010 increased $134 million, or 15%, compared to 2009 primarily due to escalating raw material costs, increasing cost of sales $123 million, or 14%. Increased volume contributed an additional $35 million, or 4% to cost of sales. Currency exchange, due to the strengthening of the U.S. dollar as compared to 2009, decreased cost of sales by $15 million, or 2%, while the net acquisitions and divestitures impact of Pinova, Ara Quimica and Castings Solutions represented an additional net decline of $6 million, or 1%. Change in product mix decreased cost of sales by $3 million.



(In millions)	2010			2009			Change
Selling, general and administrative expense	$	286		$	284		$	2
As a percent of sales		20.0	%		21.5	%

Selling, general and administrative expenses for 2010 remained essentially flat compared to 2009, however, expenses as a percent of sales decreased 1.5 percentage points, as Ashland was able to leverage 8% sales growth through strict cost management efforts. The currency exchange impact on selling, general and administrative expenses resulted in a $3 million decrease during 2010 as compared to 2009.



(In millions)	2010		2009		Change
Research and development expense	$	20	$	20	$	-

Research and development expenses for 2010 remained unchanged as compared to 2009.



(In millions)	2010		2009		Change
Equity and other income
Equity income	$	3	$	6	$	(3	)
Other income		9		7		2
	$	12	$	13	$	(1	)

Total equity and other income decreased $1 million during 2010 compared to 2009. The decrease in 2010 is primarily due to a $2 million charge for transaction and start-up costs associated with the new global joint venture with Süd-Chemie. The full quarter results from the expanded Süd-Chemie joint venture, which closed on

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

November 30, 2010, will occur in the second quarter of the current fiscal year and will be reported within equity income. See Note D of Notes to Condensed Consolidated Financial Statements for additional information on the expanded Süd-Chemie joint venture.



(In millions)	2010			2009			Change
Net interest and other financing (expense) income
Interest expense	$	(29	)	$	(41	)	$	12
Interest income		3			2			1
Other financing costs		(1	)		(2	)		1
	$	(27	)	$	(41	)	$	14

The combined decrease, excluding interest income, in interest expense and other financing costs of $13 million in 2010 compared to 2009 is a result of the significant decrease in debt outstanding of $364 million compared to 2009 and a lower weighted-average interest rate as a result of the Senior Credit Facility debt refinancing during March 2010.



(In millions)	2010		2009		Change
Net gain on acquisitions and divestitures
Castings Solutions fair market valuation of contribution	$	19	$	-	$	19
MAP Transaction		2		-		2
	$	21	$	-	$	21

Net gain on acquisitions and divestitures during 2010 includes the remeasurement gain from Ashland’s fair market value assessment of the Castings Solutions net assets contributed to the expanded global joint venture with Süd-Chemie exceeding the previously recorded amounts as well as subsequent adjustments to the 2005 transfer of Ashland’s 38% interest in the Marathon Ashland Petroleum joint venture and two other small businesses to Marathon Oil Corporation (Marathon) (MAP Transaction). See Note D of Notes to Condensed Consolidated Financial Statements for additional information on the Süd-Chemie joint venture.



(In millions)	2010			2009			Change
Income tax expense	$	31		$	22		$	9
Effective tax rate		33.3	%		25.6	%

The overall effective tax rate of 33.3% for 2010 includes certain discrete items that include a $16 million tax expense from the $19 million pretax gain associated with the fair market value of the Castings Solutions contribution and a $4 million tax benefit associated with research and development tax credits for the 2010 fiscal year. The overall effective tax rate of 25.6% for 2009 includes a benefit of $6 million associated with the reversal of certain foreign tax reserves. Ashland currently estimates the effective tax rate for fiscal 2011 to be in the low 30% range, excluding key items.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS



(In millions)	2010		2009		Change
Income from discontinued operations (net of income taxes)
Distribution	$	23	$	12	$	11
APAC		1		1		-
Asbestos-related litigation reserves		1		9		(8	)
	$	25	$	22	$	3

As a result of Distribution’s expected sale to TPG and in accordance with U.S. GAAP provisions, the operating results related to Distribution have been reflected as discontinued operations (net of income taxes) for both 2010 and 2009. Distribution sales for 2010 and 2009 included in discontinued operations were $856 million and $729 million, respectively. Gross profit margin, on a comparable basis, was 8.8% in 2010 compared to 9.2% in 2009. The increased sales and stable gross profit margin, along with stable selling, general and administrative costs, resulted in the $11 million increase in 2010 compared to 2009.

During 2009, Ashland entered into a new agreement with a number of London market insurance companies with respect to coverage for asbestos-related insurance claims. As a result, a $12 million increase to the Ashland asbestos receivable was recorded within the Condensed Consolidated Balance Sheet, which had a $9 million (after-tax) affect on the Statement of Consolidated Income within the discontinued operations caption. Additionally, during 2010 and 2009, subsequent tax adjustments were made to the gain on the sale of APAC (divested in 2006). See Notes D and E of Notes to Condensed Consolidated Financial Statements for further information.

RESULTS OF OPERATIONS – BUSINESS SEGMENT REVIEW

Results of Ashland’s business segments are presented based on its management structure and internal accounting practices. The structure and practices are specific to Ashland; therefore, the financial results of Ashland’s business segments are not necessarily comparable with similar information for other comparable companies. Ashland refines its expense allocation methodologies to the reportable segments from time to time as internal accounting practices are improved, more refined information becomes available and businesses change. Revisions to Ashland’s methodologies that are deemed insignificant are applied on a prospective basis.

As previously discussed, Ashland’s businesses are managed along four industry segments: Functional Ingredients, Water Technologies, Performance Materials and Consumer Markets. As a result of Distribution’s announced sale to TPG, the operating results and assets and liabilities related to Distribution have been reflected as discontinued operations for all periods presented. For additional information, see Notes D and Q of Notes to Condensed Consolidated Financial Statements.

The following table shows sales, operating income and statistical operating information by business segment for each of the three months ended December 31, 2010 and 2009.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS


	Three months ended
	December 31
(In millions)	2010			2009
Sales
Functional Ingredients	$	216		$	210
Water Technologies		451			443
Performance Materials		326			271
Consumer Markets		440			400
	$	1,433		$	1,324
Operating income (loss)
Functional Ingredients	$	19		$	27
Water Technologies		24			39
Performance Materials		6			8
Consumer Markets		65			67
Unallocated and other		(15	)		(14	)
	$	99		$	127
Depreciation and amortization
Functional Ingredients	$	24		$	27
Water Technologies		21			24
Performance Materials		18			13
Consumer Markets		9			9
Unallocated and other		1			1
	$	73		$	74
Operating information
Functional Ingredients (a)
Sales per shipping day	$	3.5		$	3.4
Metric tons sold (thousands)		38.5			37.4
Gross profit as a percent of sales		31.2	%		33.7	%
Water Technologies (a)
Sales per shipping day	$	7.3		$	7.2
Gross profit as a percent of sales		31.6	%		36.6	%
Performance Materials (a)
Sales per shipping day	$	5.3			4.4
Pounds sold per shipping day		4.5			4.0
Gross profit as a percent of sales		14.6	%		18.4	%
Consumer Markets (a)
Lubricant sales gallons		40.4			40.3
Premium lubricants (percent of U.S. branded volumes)		30.2	%		28.3	%
Gross profit as a percent of sales		30.9	%		33.9	%

(a)	Sales are defined as sales and operating revenues. Gross profit is defined as sales, less cost of sales.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

The EBITDA and adjusted EBITDA amounts presented below within this business section are provided as a means to enhance the understanding of financial measurements that Ashland has internally determined to be relevant measures of comparison for each segment. Each of these non-GAAP measures is defined as follows: EBITDA (operating income plus depreciation and amortization), adjusted EBITDA (EBITDA adjusted for key items, which may include pro forma affects for significant acquisitions or divestitures, as applicable), and adjusted EBITDA margin (adjusted EBITDA divided by sales, which can include pro forma adjustments).

Functional Ingredients

In January 2010, Ashland sold its refined wood rosin and natural wood terpenes business, formerly known as Pinova, a business unit of Functional Ingredients, to TorQuest Partners in a transaction valued at approximately $75 million before tax. The Pinova business, with annual sales of approximately $85 million a year, had approximately 200 employees along with an associated manufacturing facility located in Brunswick, Georgia.

December 2010 quarter compared to December 2009 quarter

Functional Ingredients’ sales increased 3% to $216 million in 2010 compared to $210 million in 2009. Volume increased sales $30 million, or 14%, as metric tons sold increased 3% to 38.5 thousand, or 16%, excluding the divested Pinova business, which reduced sales by $19 million, or 9%, compared to 2009. Higher product pricing increased sales $8 million, or 4%, while the mix of product sold and foreign currency decreased sales by $8 million and $5 million, respectively, or 6%.

Gross profit decreased $3 million in 2010 compared to 2009. Increasing raw material costs caused a gross profit decline of $18 million, which included production start-up costs of approximately $3 million associated with the new Nanjing production facility described above. The divestiture of Pinova and unfavorable product mix sold also reduced gross profit by an additional $4 million and $5 million, respectively. Increased volume improved gross profit by $25 million, while currency exchange reduced gross profit $1 million. In total, gross profit margin during 2010 decreased 2.5 percentage points to 31.2%.

Selling, general and administrative expenses (which include research and development expenses throughout the business segment discussion and analysis) increased $3 million, or 7%, primarily as a result of increases in salaries, benefits and incentive compensation that totaled to $2 million. Equity and other income decreased by $2 million during 2010 as compared to 2009.

Operating income totaled $19 million in 2010 compared to $27 million in 2009. EBITDA decreased $11 million, from $54 million in 2009 to $43 million in 2010. EBITDA margin decreased 5.8 percentage points in 2010 from 25.7% in 2009 to 19.9% in 2010. There were no unusual or key items that affected comparability for EBITDA during 2010 and 2009.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

Water Technologies

December 2010 quarter compared to December 2009 quarter

Water Technologies’ sales increased 2% to $451 million in 2010 compared to $443 million in 2009. Volume increased sales $13 million, or 3%, but was largely offset by a decline of $10 million, or 2%, in currency exchange. Higher product pricing increased sales $5 million, or 1%.

Gross profit decreased $19 million in 2010 compared to 2009. Increased raw material costs were the primary factor in the gross profit decline as the business was unable to fully recover these increases within the quarter, resulting in a $20 million decrease. Volume increased gross profit by $4 million while currency exchange reduced gross profit by an additional $3 million. In total, gross profit margin during 2010 decreased 5.0 percentage points to 31.6%.

Selling, general and administrative expenses decreased $3 million during 2010, or 2%, primarily as a result of a $3 million decline in foreign currency, as increases in selling expense of $6 million were more than offset by reductions in administrative costs of $7 million. Equity and other income increased by $1 million during 2010 as compared to 2009.

Operating income totaled $24 million in 2010 compared to $39 million during 2009. EBITDA decreased $18 million, from $63 million in 2009 to $45 million in 2010. EBITDA margin decreased 4.2 percentage points in 2010 from 14.2% in 2009 to 10.0% in 2010. There were no unusual or key items that affected comparability for EBITDA during 2010 and 2009.

Performance Materials

In July 2010, Ashland and Süd-Chemie AG (Süd-Chemie) signed an agreement for the formation of an expanded global joint venture serving the foundry chemical sector. The transaction closed on November 30, 2010 and combined three businesses: Ashland’s Castings Solutions business group, the Foundry-Products and Specialty Resins business unit of Süd-Chemie, and Ashland-Südchemie-Kernfest GmbH (ASK), the existing fifty-percent owned European-based joint venture between Ashland and Süd-Chemie, for which Ashland historically only recognized equity income of the joint venture within its consolidated results. Ashland’s Castings Solutions and ASK businesses recorded sales of $279 million and $145 million, respectively, during each businesses’ most recently completed fis cal year. The Foundry-Products and Specialty Resins business unit of Süd-Chemie contributed to the joint venture generated sales of approximately $146 million for its most recently completed fiscal year. Ashland recognized a pretax gain of $19 million, attributable to the fair market value of the net assets contributed to the joint venture. The gain was included in the net gain on acquisitions and divestitures caption on the Statement of Consolidated Income for the three months ended December 31, 2010. Ashland’s equity interest in the expanded joint venture qualifies for equity method accounting treatment under U.S. GAAP. As a result, future reported results of the Castings Solutions business will no longer include the sales, cost of sales or selling, general and administrative costs related to this business; however, Ashland will include the financial effects within the equity income caption of the Statements of Consolidated Income. ; In addition, the expanded joint venture will leave certain stranded costs that Ashland is currently analyzing and developing plans to reduce.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

December 2010 quarter compared to December 2009 quarter

Performance Materials’ sales increased 20% to $326 million compared to $271 million in 2009. Higher product pricing increased sales by $27 million, or 10%, primarily as a result of pricing increases in the composites line of business that were issued to offset increases in raw material costs. Volume increased sales by $23 million, or 9%, as pounds sold per shipping day improved 13% to 4.5 million. The acquisition of Ara Quimica contributed an additional $20 million, or 7%, in sales, while the exclusion of sales for the month of December 2010 related to the contribution of the Castings Solutions business into an expanded global joint venture reduced sales $11 million, or 4%. Foreign currency also reduced sales by an additional $4 million, or 2%.

Gross profit decreased $3 million in 2010 compared to 2009 as the current period included plant closure costs of $7 million from accelerated depreciation. These charges were incurred as part of the previously announced capacity reduction within this business in reaction to a substantial overall decline in industry demand as well as Ashland’s continued overall effort to optimize each business’ cost structure. Higher raw material costs primarily resulted in a $3 million decrease in gross profit, while currency exchange reduced gross profit an additional $1 million. Volume increased gross profit by $7 million, while the acquisition of Ara Quimica contributed an additional $5 million in gross profit. The exclusion of the financial results in December 2010 for the Cast ings Solutions business decreased gross profit by $4 million. In total, gross profit margin during 2010 decreased 3.8 percentage points to 14.6%, as compared to 2009.

Selling, general and administrative expenses decreased $5 million, or 10%, compared to 2009, primarily due to reductions in salaries, benefits and incentive compensation of $3 million. Equity and other income decreased $4 million during 2010 compared to 2009, primarily due to a $2 million charge for transaction and start-up costs associated with the new global joint venture with Süd-Chemie.

Operating income totaled $6 million in 2010 compared to $8 million in 2009. Adjusted EBITDA increased $5 million, from $21 million in 2009 to $26 million in 2010. Adjusted EBITDA margin increased 0.3 percentage points in 2010 from 7.7% in 2009 to 8.0% in 2010. A reconciliation of EBITDA and Adjusted EBITDA results for 2010 and 2009 were as follows.


	Three months ended
	December 31
(In millions)	2010		2009
Operating income	$	6	$	8
Depreciation and amortization (a)		18		13
EBITDA		24		21
Casting Solutions joint venture costs		2		-
Adjusted EBITDA	$	26	$	21

(a)	Includes $7 million of accelerated depreciation during the three months ended December 31, 2010.

Consumer Markets

Consumer Markets, which includes the Valvoline™ family of products and services, is a leading innovator, marketer and supplier of high-performing automotive lubricants, chemicals and appearance products. Valvoline™, the world’s first lubricating oil, is the number three passenger car motor oil brand, and Valvoline Instant Oil Change™ is the number two quick-lube franchise in the United States.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

December 2010 quarter compared to December 2009 quarter

Consumer Markets’ sales increased 10% to $440 million compared to $400 million in 2009. Higher product pricing was the primary factor in sales growth between periods, resulting in a $33 million, or 8%, increase in sales. Volume increased sales by $7 million, or 2%, as lubricant gallons sold were virtually flat with 2009 levels, improving to 40.4 million gallons. A favorable currency exchange increased sales by $1 million, while changes in product mix sold resulted in a $1 million decrease in sales.

Gross profit remained unchanged in 2010 as compared to 2009 as volume and currency exchange increases of $1 million each were offset by raw material cost increases, resulting in a $2 million decline in pricing. In total, gross profit margin declined 3.0 percentage points to 30.9% as trade promotion pricing and mix were factors in the lower gross margin during the quarter compared to the previous year.

Selling, general and administrative expenses increased $1 million, or 1%, during 2010, while equity and other income decreased by $1 million during 2010 compared to 2009.

Operating income totaled $65 million in 2010 as compared to $67 million for 2009. EBITDA decreased $2 million from $76 million in 2009 to $74 million in 2010. EBITDA margin decreased 2.2 percentage points in 2010 from 19.0% in 2009 to 16.8% in 2010. There were no unusual or key items that affected comparability for EBITDA during 2010 and 2009.

Unallocated and other

Unallocated and other recorded costs of $15 million and $14 million for 2010 and 2009, respectively, as both periods included certain costs previously allocated to the Distribution reporting segment that do not qualify for discontinued operations accounting classification of $11 million and $13 million for 2010 and 2009, respectively. In addition, 2010 also included environmental charges of $3 million and transaction costs of $1 million associated with the expanded global joint venture with Süd-Chemie.

FINANCIAL POSITION

Liquidity

Ashland’s cash flows from operating, investing and financing activities, as reflected in the Statements of Condensed Consolidated Cash Flows, are summarized as follows for the three months ended December 31, 2010 and 2009.


(In millions)	2010			2009
Cash provided (used) by:
Operating activities from continuing operations	$	(38	)	$	55
Investing activities from continuing operations		(2	)		26
Financing activities from continuing operations		(3	)		(24	)
Discontinued operations		(1	)		(7	)
Effect of currency exchange rate changes on cash and cash equivalents		1			4
Net decrease in cash and cash equivalents	$	(43	)	$	54

Operating activities

Cash flows generated from operating activities from continuing operations, a major source of Ashland’s liquidity, amounted to a cash outflow of $38 million in 2010 and a cash inflow of $55 million in 2009. The cash results during each period are primarily driven by net income, depreciation and amortization (including debt issuance cost amortization), and changes in working capital, which are fluctuations within accounts receivable, inventory, trade and other payables and accrued expenses and other liabilities. Ashland continues to emphasize working capital management as a high priority and focus within the company.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

In 2010, a working capital outflow of $175 million was primarily a result of increased inventory, resulting from restocking of certain key products that were low or in sold out positions, and reduced trade and other payable balances, primarily the result of incentive compensation payouts to employees during the current quarter and an increase in selected vendor payments due to the end of the calendar year. In 2009, a working capital outflow of $129 million was primarily as a result of reduced trade and other payable balances, mainly the result of incentive compensation payouts to employees during the prior year quarter.

Operating cash flows for 2010 included net income of $87 million (excluding discontinued operations), and noncash adjustments of $73 million for depreciation and amortization, a $19 million gain related to the formation of an expanded global joint venture with Süd-Chemie. Operating cash flows for 2009 included net income of $86 million (excluding discontinued operations), noncash adjustments of $74 million for depreciation and amortization as well as $26 million from deferred income taxes.

Investing activities

Cash used by investing activities was $2 million for 2010 as compared to cash provided by investing activities of $26 million for 2009. The significant cash investing activities for 2010 included cash inflows of $21 million related to the expanded joint venture cash distribution to Ashland, in accordance with the joint venture agreement, and $4 million from proceeds from disposals of property, plant and equipment, offset by cash outflows of $22 million for capital expenditures and $5 million for purchased plant operations in Performance Materials and Consumer Markets. Investing activities during 2009 included cash inflows of $44 million and $3 million from the sale of auction rate securities and proceeds from disposals of property, plant and equipment, respectively, offset by cash outflows of $21 million fo r capital expenditures.

Financing activities

Cash used by financing activities was $3 million for 2010 as compared to cash used by financing activities of $24 million for 2009. Significant cash financing activities for 2010 included repayments of long-term debt of $10 million and cash dividends paid of $.15 per share, for a total of $12 million. These cash outflows were partially offset by proceeds from long- and short-term debt of $11 million and $6 million, respectively. Financing activities for 2010 also included cash inflows of $2 million for proceeds from the exercise of stock options and excess tax benefits related to share-based payments. Significant cash financing activities for 2009 included repayments of long-term debt of $25 million and cash dividends paid of $.075 per share, for a total of $6 milli on. These cash outflows were partially offset by proceeds from short-term debt of $6 million and proceeds from the exercise of stock options of $1 million.

Free cash flow

The following represents Ashland’s calculation of free cash flow for the following periods:


	Three months ended
	December 31
(In millions)	2010			2009
Cash flows provided by operating activities from continuing operations	$	(38	)	$	55
Less:
Additions to property, plant and equipment		(22	)		(21	)
Cash dividends paid		(12	)		(6	)
Free cash flows	$	(72	)	$	28

Cash flow and liquidity metrics

At December 31, 2010, working capital (current assets minus current liabilities, excluding long-term debt due within one year) amounted to $1,310 million, compared to $1,191 million at September 30, 2010. Ashland’s working capital is affected by its use of the LIFO method of inventory valuation that valued inventories below their

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

replacement costs by $51 million at December 31, 2010 and $54 million at September 30, 2010. Liquid assets (cash, cash equivalents and accounts receivable) amounted to 96% of current liabilities at December 31, 2010, compared to 91% at September 30, 2010.

The following summary reflects Ashland’s cash, investment securities and unused borrowing capacity as of December 31, 2010 and September 30, 2010.


	December 31		September 30
(In millions)	2010		2010
Cash and investment securities
Cash and cash equivalents	$	374	$	417
Auction rate securities	$	22	$	22

Unused borrowing capacity
Revolving credit facility	$	442	$	428
Accounts receivable securitization facility	$	288	$	310

Total borrowing capacity remaining under the $550 million revolving credit facility was $442 million, representing a reduction of $108 million for letters of credit outstanding at December 31, 2010. Additionally, at December 31, 2010, the outstanding amount of accounts receivable sold by Ashland to a wholly-owned “bankruptcy remote” special purpose subsidiary of Ashland was $585 million. Ashland had drawn $40 million under this accounts receivable securitization facility as of December 31, 2010 of the approximate $328 million in available funding from qualifying receivables. In total, Ashland’s available liquidity position, which includes cash, the revolving credit and accounts receivable securitization facility, was $1,104 million at December 31, 2010 as compared to $1,155 million at September 30, 2010. In connection with the expected sale of Distribution, Ashland intend s to terminate the accounts receivable securitization facility during the upcoming March 2011 quarter.

Capital resources

Debt

The following summary reflects Ashland’s debt as of December 31, 2010 and September 30, 2010.


	December 31		September 30
(In millions)	2010		2010
Short-term debt	$	77	$	71
Long-term debt (including current portion)		1,153		1,153
Total debt	$	1,230	$	1,224

The current portion of long-term debt was $39 million at December 31, 2010 and $45 million at September 30, 2010. Based on Ashland’s current debt structure included in Note J of Notes to Condensed Consolidated Financial Statements and assuming interest rates remain stable, future annual book interest expense could range from approximately $100 million to $120 million based on applicable fixed and floating interest rates. Debt as a percent of capital employed was 24% at December 31, 2010 and September 30, 2010.

Covenant restrictions

The Senior Credit Facilities, amended during the third quarter of fiscal 2010, include less restrictive covenants than the previous credit facility and no longer contain covenants associated with minimum consolidated net worth and

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

capital expenditure limits. The covenants contain certain usual and customary representations and warranties, and usual and customary affirmative and negative covenants which include financial covenants, limitations on liens, additional indebtedness, further negative pledges, investments, payment of dividends, mergers, sale of assets and restricted payments, and other customary limitations. As of December 31, 2010, Ashland is in compliance with all debt agreement covenant restrictions.

The maximum consolidated leverage ratio permitted under the Senior Credit Facilities are as follows: 3.0 from the period December 31, 2010 through September 30, 2011 and 2.75 from December 31, 2011 and each fiscal quarter thereafter.

The Senior Credit Facilities define the consolidated leverage ratio as the ratio of consolidated indebtedness minus cash and cash equivalents to consolidated EBITDA for any measurement period. In general, the Senior Credit Facilities define consolidated EBITDA as net income plus consolidated interest charges, taxes, depreciation and amortization expense, fees and expenses related to capital market transactions, restructuring and integration charges, noncash stock and equity compensation expense, and any other nonrecurring expenses or losses that do not represent a cash item in such period or any future period; less any noncash gains or other items increasing net income. In general, consolidated indebtedness includes debt plus all purchase money indebtedness, banker’s acceptances and bank guaranties, deferr ed purchase price of property or services, attributable indebtedness, and guaranties.

The permitted consolidated fixed charge coverage ratio under the Senior Credit Facility is 1.5 from December 31, 2010 and for each fiscal quarter thereafter.

The Senior Credit Facilities define the consolidated fixed charge coverage ratio as the ratio of consolidated EBITDA less the aggregate amount of all cash capital expenditures to consolidated fixed charges for any measurement period. In general consolidated fixed charges are defined as the sum of consolidated interest charges, the aggregate principal amount of all regularly scheduled principal payments and the aggregate amount of all restricted payments, which include any dividend or other distribution with respect to any capital stock or other equity interest.

At December 31, 2010, Ashland’s calculation of the consolidated leverage ratio was 0.9 compared to the maximum consolidated leverage ratio permitted under Ashland’s Senior Credit Agreement of 3.0. At December 31, 2010, Ashland’s calculation of the fixed charge coverage ratio was 4.6 compared to the permitted consolidated ratio of 1.5. Any change in consolidated EBITDA of $100 million would have an approximate .1x effect on the consolidated leverage ratio and a .6x effect on the fixed charge coverage ratio. Any change in consolidated indebtedness of $100 million would affect the consolidated leverage ratio by approximately .1x. The expected sale of Distribution will cause Ashland to amend its previous calculation of these financial ratios, but will not have a significant af fect on the current cushion within these ratio results.

Ashland projects that cash flow from operations and other available financial resources such as cash on hand and revolving credit should be sufficient to meet investing and financing requirements to enable Ashland to comply with the covenants and other terms of each respective financing facility. These projections are based on various assumptions that include, but are not limited to: operational results, working capital cash generation, capital expenditures, pension funding requirements and tax payment and receipts.

Stockholders’ equity

Stockholders’ equity increased $74 million to $3,877 million. This increase was primarily due to net income during the period of $87 million and $17 million from common shares issued under stock incentive and other plans offset by regular cash dividends of $12 million and deferred translation losses of $18 million.

During the first quarter of fiscal 2011, the Board of Directors of Ashland announced and paid a quarterly cash dividend of 15 cents per share to eligible shareholders of record. This amount was double the previous quarterly dividend of 7.5 cents per share paid in the first two quarters of fiscal 2010. In conjunction with Ashland’s existing debt facilities, Ashland is subject to various covenants that may restrict certain future payments, which could include quarterly dividend payments, although Ashland does not anticipate that will occur.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

Capital expenditures

Ashland is currently forecasting approximately $215 million (excluding Distribution) of capital expenditures for fiscal 2011 funded primarily from operating cash flows. Capital expenditures, excluding Distribution, were $192 million for 2010 and averaged $179 million during the last three years. Under the senior credit facilities agreement entered into in March 2010, Ashland is no longer subject to a capital expenditure limit, which under the previous financing arrangements was approximately $330 million and $300 million in fiscal year 2011 and 2010, respectively. As of December 31, 2010 total capital expenditures were $22 million, excluding Distribution.

APPLICATION OF CRITICAL ACCOUNTING POLICIES

The preparation of Ashland’s Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, sales and expenses, and the disclosures of contingent assets and liabilities. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets (including goodwill and other intangible assets), employee benefit obligations, income taxes, other liabilities and receivables associated with asbestos litigation and environmental remediation. These accounting policies are discussed in detail in “Management’s Discussion and Analysis – Application of Critical Accounting Policies” in Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2010. Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual results could differ significantly from the estimates under different assumptions or conditions. Management has reviewed the estimates affecting these items with the Audit Committee of Ashland’s Board of Directors. No material changes have been made to the valuation techniques during the three months ended December 31, 2010.

OUTLOOK

Sales growth has continued during the first quarter of fiscal 2011 compared to the previous period within each segment of Ashland’s businesses. In addition, sequential gross profit margins significantly increased in Functional Ingredients and Consumer Markets during the current quarter, while the other businesses were essentially flat on an adjusted basis. However, raw material costs continue to escalate and are expected to continue to be a challenge for each business throughout fiscal 2011. As a result of these rising raw material costs, Ashland’s financial performance in the short term will be directly related to each of the businesses’ ability to maintain its current market position and pass through necessary price increases to offset these escalating costs, while continuing to look fo r opportunities to reduce internal costs.

During the last several years Ashland has been focused on the objective of creating a dynamic, global specialty chemical company. The expected completion of the Distribution sale at the end of the March 2011 quarter will result in Ashland’s remaining business segments having gross profit margins and products that are more reflective of a specialty chemical company. In addition, the proceeds from the sale of Distribution will enhance Ashland’s ability to implement potential growth strategies, such as acquisitions, capital projects, and research and development, with its existing businesses in selected industries, increasing the company’s specialty chemical platform. Ashland is currently assessing these growth opportunities, as well as other potential alternatives to enhance shareholde r value, such as stock buybacks and dividends.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Ashland’s market risk exposure at December 31, 2010 is generally consistent with the types and amounts of market risk exposures presented in Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2010.

ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES

MANAGEMENT’S DISCUSSION AND ANALYSIS

ITEM 4. CONTROLS AND PROCEDURES

(a)

As of the end of the period covered by this quarterly report, Ashland, under the supervision and with the participation of its management, including Ashland’s Chief Executive Officer and its Chief Financial Officer, evaluated the effectiveness of Ashland’s disclosure controls and procedures pursuant to Rule 13a-15(b) and 15d-15(b) promulgated under the Securities Exchange Act of 1934, as amended. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective.

(b)

During the three months ended December 31, 2010, there were no significant changes in Ashland’s internal control over financial reporting, or in other factors, that occurred during the period covered by this quarterly report that have materially affected, or are reasonably likely to materially affect, Ashland’s internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The following is a description of Ashland’s material legal proceedings.

Asbestos-Related Litigation

Ashland is subject to liabilities from claims alleging personal injury caused by exposure to asbestos. Such claims result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley Stoker Corporation (Riley), a former subsidiary. Although Riley was neither a producer nor a manufacturer of asbestos, its industrial boilers contained some asbestos-containing components provided by other companies.

Hercules, a wholly-owned subsidiary of Ashland, is also subject to liabilities from asbestos-related personal injury lawsuits involving claims which typically arise from alleged exposure to asbestos fibers from resin encapsulated pipe and tank products which were sold by one of Hercules’ former subsidiaries to a limited industrial market.

Ashland and Hercules are also defendants in lawsuits alleging exposure to asbestos at facilities formerly or presently owned or operated by Ashland or Hercules.

For additional detailed information regarding liabilities arising from asbestos-related litigation, see Note M of “Notes to Condensed Consolidated Financial Statements” in this quarterly report on Form 10-Q.

Environmental Proceedings

(1) CERCLA and Similar State Law Sites – Under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 and similar state laws, Ashland and Hercules may be subject to joint and several liability for cleanup costs in connection with alleged releases of hazardous substances at sites where it has been identified as a “potentially responsible party” (PRP). As of December 31, 2010, Ashland and Hercules have been identified as a PRP by U.S. federal and state authorities, or by private parties seeking contribution, for the cost of environmental investigation and/or cleanup at 93 waste treatment or disposal sites. These sites are currently subject to ongoing investigation and remedial activities, overseen by the United States Environmental Protection Agency (USEPA) or a state agency, in which Ashland or Hercules is typically participating as a member of a PRP group. Generally, the type of relief sought includes remediation of contaminated soil and/or groundwater, reimbursement for past costs of site cleanup and administrative oversight and/or long-term monitoring of environmental conditions at the sites. The ultimate costs are not predictable with assurance.

(2) Multi-Media Environmental Compliance Investigation – In April 2005, Hercules’ Franklin, Virginia manufacturing facilities were subject to a multi-media environmental compliance investigation by the USEPA and the Virginia Department of Environmental Quality (VADEQ), and in April 2007, Hercules’ Hopewell, Virginia manufacturing facilities were subject to a Clean Air Act (CAA) compliance investigation by USEPA and the VADEQ. In April 2008, the results of both investigations were provided to Hercules. The investigation uncovered areas of potential noncompliance with various environmental requirements. Hercules is engaged in negotiatio ns with USEPA and VADEQ concerning these matters. While it is reasonable to believe that these matters could potentially involve penalties exceeding $100,000, the potential liability with respect to these matters should not be material to Ashland.

(3) Hattiesburg, Mississippi Notice of Violation from MDEQ – In November 2008, the Mississippi Department of Environmental Quality (MDEQ) issued a Notice of Violation to Hercules’ now-closed Hattiesburg, Mississippi manufacturing facility alleging that a storm water retention basin at the facility had been operated as a hazardous waste storage and treatment facility without a permit in violation of the Resource Conservation and Recovery Act. Ashland is working with MDEQ to settle this matter in the context of the shutdown and ongoing remediation of the Hattiesburg facility. MDEQ has proposed to Ashland a settlement penalty in excess of $100,000. While it is reasonable to believe that this matter will involve a penalty exceeding $100,000, the potential liability with respect to this matter should not be material to Ashland.

(4) Louisiana, Missouri Air Inspection and Penalty Assessment – In 2007, the USEPA conducted an inspection of Hercules’ Louisiana, Missouri production facility for compliance with the CAA’s Leak Detection and Repair regulations. Hercules subsequently provided additional information to the USEPA in response to matters identified during the inspection close-out meeting. In July 2010, USEPA issued an offer of settlement and a proposed penalty assessment in excess of $100,000 to address alleged violations. Ashland is working with USEPA to address the allegations. While it is reasonable to believe that this matter could potentia lly involve a penalty exceeding $100,000, the potential liability with respect to this matter should not be material to Ashland.

For additional information regarding environmental matters and reserves, see Note M of “Notes to Condensed Consolidated Financial Statements” in this quarterly report on Form 10-Q.

Other Pending Legal Proceedings

In addition to the matters described, there are various claims, lawsuits and administrative proceedings pending or threatened against Ashland and its current and former subsidiaries. Such actions are with respect to commercial matters, product liability, toxic tort liability, environmental and other matters that seek remedies or damages, some of which are for substantial amounts. While these actions are being contested, their outcome is not predictable with assurance.

ITEM 1A. RISK FACTORS

During the period covered by this report, there were no material changes from the risk factors previously disclosed in Ashland’s Form 10-K for the fiscal year ended September 30, 2010.

ITEM 6. EXHIBITS

(a)		Exhibits
10		Shareholders’ Agreement by and between Süd-Chemie Aktiengesellschaft and Süd-Chemie Finance GmbH and Ashland Inc. and Ashland International Holdings, Inc., effective November 30, 2010 (pursuant to Item 601(b)(2) of Regulation S-K, exhibits and schedules to the Shareholders’ Agreement have been omitted; exhibits and schedules will be supplementally provided to the SEC upon request).

12		Computation of Ratio of Earnings to Fixed Charges.

31.1		Certificate of James J. O’Brien, Chief Executive Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certificate of Lamar M. Chambers, Chief Financial Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32		Certificate of James J. O’Brien, Chief Executive Officer of Ashland, and Lamar M. Chambers, Chief Financial Officer of Ashland pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*		XBRL Instance Document.

101.SCH*		XBRL Taxonomy Extension Schema Document.

101.CAL*		XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF*		XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB*		XBRL Taxonomy Extension Label Linkbase Document.

101.PRE*		XBRL Taxonomy Extension Presentation Linkbase Document.

*Attached as Exhibit 101 to this report are the following documents formatted in XBRL (Extensible Business Reporting Language): (i) Statements of Consolidated Income for the three months ended December 31, 2010 and December 31, 2009; (ii) Condensed Consolidated Balance Sheets at December 31, 2010 and September 30, 2010; (iii) Statements of Consolidated Stockholders’ Equity at December 31, 2010; (iv) Statements of Condensed Consolidated Cash Flows for the three months ended December 31, 2010 and December 31, 2009; and (v) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			Ashland Inc.
			(Registrant)

February 2, 2011			/s/ Lamar M. Chambers
			Lamar M. Chambers
			Senior Vice President and Chief Financial Officer (on behalf of the Registrant and as principal financial officer)

EXHIBIT INDEX

Exhibit No.		Description

10		Shareholders’ Agreement by and between Süd-Chemie Aktiengesellschaft and Süd-Chemie Finance GmbH and Ashland Inc. and Ashland International Holdings, Inc., effective November 30, 2010 (pursuant to Item 601(b)(2) of Regulation S-K, exhibits and schedules to the Shareholders’ Agreement have been omitted; exhibits and schedules will be supplementally provided to the SEC upon request).

12		Computation of Ratio of Earnings to Fixed Charges.

31.1		Certificate of James J. O’Brien, Chief Executive Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certificate of Lamar M. Chambers, Chief Financial Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32		Certificate of James J. O’Brien, Chief Executive Officer of Ashland, and Lamar M. Chambers, Chief Financial Officer of Ashland pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS**		XBRL Instance Document.

101.SCH**		XBRL Taxonomy Extension Schema Document.

101.CAL**		XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF**		XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB**		XBRL Taxonomy Extension Label Linkbase Document.

101.PRE**		XBRL Taxonomy Extension Presentation Linkbase Document.

**Submitted electronically with this report.

EX-10 2 shareagrmt.htm SHAREHOLDERS' AGREEMENT EFFECTIVE NOVEMBER 30, 2010 shareagrmt.htm

Exhibit 10

Beglaubigte Abschrift

- I -

Deed written only single sided

Roll of Deeds No. 228/2010

NEGOTIATED

in Berlin, on November 28, 2010

Today appeared before me, the undersigned

Dr. Markus Jakoby

Notary Public

with office in Schlüterstraße 37, 10629 Berlin, Germany,

1.	Dr. Bernd R. Mayer,

Skadden, Arps, Slate, Meagher and Flom LLP,

born on September 01, 1963,

with business address at Karl-Scharnagl-Ring 7, 80539 Munich,

- II -

not acting on his own behalf but without power of attorney with the provisio of subsequent approval (vorbehaltlich Genehmigung), whereby the approval is seen as communicated and legally effective as of receipt by the officiating notary public, for the following entity:

Süd-Chemie Aktiengesellschaft

with its seat in Munich

business address: Lenbachplatz 6, 80333 Munich

(Commercial Register Munich, HRB 1019)

2.	Frederick von Mallinckrodt,

Skadden, Arps, Slate, Meagher and Flom LLP,

born on November 08, 1974,

with business address at Karl-Scharnagl-Ring 7, 80539 Munich,

Süd-Chemie Finance GmbH

with its seat in Munich

business address: Lenbachplatz 6, 80333 Munich

(Commercial Register Munich, HRB 1064)

The parties hereby release Dr. Bernd R. Mayer, Frederick von Mallinckrodt and Skadden, Arps, Slate, Meagher and Flom LLP from any personal liability and waive the right to assert any claims against Dr. Bernd R. Mayer, Frederick von Mallinckrodt and Skadden, Arps, Slate, Meagher and Flom LLP personally.

3.	Gerald Jörg Schumann,

Baker & McKenzie LLP,

- III -

born on October 24, 1971,

with business address at Neuer Zollhof 2, 40221 Düsseldorf,

not acting on his own behalf but without power of atturney with the provisio of subsequent approval (vorbehaltlich Genehmigung), whereby the approval is seen as communicated and legally effective as of receipt by the officiating notary public, for the following entity:

Ashland Inc.

with its seat in Covington, KY 41012-0391, U.S.A.

business address: 50 East RiverCenter Boulevard,

Covington, KY 41012-0391, U.S.A.

4.	Dr. Michael Bartosch,

Baker & McKenzie,

born on December 27, 1973,

with business address at Theatinerstraße 23, 80333 München,

Ashland International Holdings, Inc.

with its seat in Wilmington, DE 19801, U.S.A.

business address: 1209 Orange Street,

Wilmington, DE 19801, U.S.A.

The parties hereby release Gerald Jörg Schumann und Dr. Michael Bartosch and Baker & McKenzie from any personal liability and waive the right to assert any claims against these persons and Baker & McKenzie personally.

The persons appearing under number 1 is personally known to the notary public. The persons appearing under number 2 to 4 identified themselves through presentation of

- IV -

their identity cards or passport.

The persons appearing requested this Deed to be recorded in the English language. The officiating Notary Public, who has sufficient command of the English language, ascertained that the persons appearing also have sufficient command of the English language. After having been instructed by the officiating Notary Public, the persons appearing waived the right to obtain the assistance of a sworn interpreter and the right to obtain a certified translation of this Deed.

The officiating Notary pointed out that, before the recording, he was required to ask each of those persons appearing whether he or any of his colleagues had already been or was presently active, outside of an official capacity, in the following recorded matter. Those appearing declared that this was not the case.

The persons appearing requested notarization of the following

SHAREHOLDERS' AGREEMENT

Under the Master Formation Agreement dated July 14, 2010 (Roll of Deeds No. M 1542/2010 of the notary public Prof. Dr. Dieter Mayer, Munich) in connection with the deed dated July 13/14, 2010 (Roll of Deeds No. M 1539/2010 of the notary public Prof. Dr. Dieter Mayer, Munich) (the "Reference Deed"), it was agreed that a shareholders' agreement would be certified in accordance with the draft attached to the Reference Deed as Exhibit 5.1-1 and as amended prior to the closing of the contemplated transaction. In order to facilitate, inter alia, the notarization of this Shareholders' Agreement, all exhibits to this Shareholders' Agreement have already been notarized separately in the Reference Deed. Reference was made to the Master Formation Agreement and the Reference Deed pursuant to Section 13a of the German Notarization Act (Beurkundungsgesetz), of which the officiating notary instructed the persons appearing. The persons appearing declared that the Master Formation

- V -

Agreement and the Reference Deed – certified copies of which were available during the notarization – are well known to them. They waved their right to have the Master Formation Agreement and the Reference Deed read aloud by the officiating notary public as well as their right to have the Master Formation Agreement and the Reference Deed attached to this deed.

The draft of the Shareholders Agreement has been completed and will be certified with additional amendments to Exhibit 3.2, 7.4(c) and Exhibit 8.3 of this Shareholders Agreement. Therefore the unchanged Exhibits referenced in the draft Shareholders Agreement of the reference deed are not enclosed to this deed, but enclosed are the Exhibits 3.2, 7.4(c) and 8.3.

II.

- VI -

SHAREHOLDERS' AGREEMENT

in respect of

Ashland-Südchemie-Kernfest GmbH

(in the future: ASK Chemicals GmbH)

by and between

Süd-Chemie Aktiengesellschaft

and

Süd-Chemie Finance GmbH

and

Ashland Inc.

and

Ashland International Holdings, Inc.

Dated as of November 28, 2010

and effective upon approval on November 30, 2010

- VII -

TABLE OF CONTENTS

			Page
ARTICLE I DEFINITIONS			2
ARTICLE II GENERAL PROVISIONS			5
	Section 2.1	Shareholders' Agreement for ASK Chemicals	5
	Section 2.2	Undertaking of Due Performance of Affiliates	5
	Section 2.3	Affiliate Adherence	5
	Section 2.4	Powers of Attorney	7
	Section 2.5	Block Voting	7
	Section 2.6	Applicable Law	7
ARTICLE III ORGANIZATION			7
	Section 3.1	Legal Form	7
	Section 3.2	Articles of Association	8
	Section 3.3	Performance by Subsidiaries	8
	Section 3.4	Tax Elections	8
ARTICLE IV SHARE CAPITAL AND SHAREHOLDINGS			8
	Section 4.1	Share Capital	8
	Section 4.2	Shareholding	8
ARTICLE V CORPORATE BODIES			8
	Section 5.1	Corporate Bodies	8
ARTICLE VI SHAREHOLDERS' MEETING			9
	Section 6.1	Shareholders' Meeting	9
	Section 6.2	Powers and Duties	9
	Section 6.3	Meetings of the Shareholders	9
ARTICLE VII SUPERVISORY BOARD			11
	Section 7.1	Members	11
	Section 7.2	Chairman of the Supervisory Board	11
	Section 7.3	Powers and Duties	11
	Section 7.4	Meetings of the Supervisory Board	11
ARTICLE VIII MANAGEMENT BOARD			14
	Section 8.1	Members	14
	Section 8.2	Powers and Duties	14
	Section 8.3	Major Decisions	14
	Section 8.4	Assertion of Claims under Master Contribution and Sale Agreement	14
	Section 8.5	Additional Management Personnel	15
ARTICLE IX FINANCIAL MATTERS			15
	Section 9.1	Debt Financing	15
	Section 9.2	Dividend Policy	16

- VIII -


	Section 9.3	Financial Information	16
	Section 9.4	Global Business Plan	17
	Section 9.5	Consolidation	18
	Section 9.6	Allowed Capital Expenditures' Level	18
ARTICLE X COMPLIANCE SYSTEM			19
	Section 10.1	Compliance System	19
ARTICLE XI TRANSFER OF SHARES			19
	Section 11.1	General	19
	Section 11.2	Transfer to Subsidiaries	19
	Section 11.3	Offer for Transfer (General Procedure)	19
	Section 11.4	Offer for Transfer (Specific Procedure).	20
	Section 11.5	Treatment of Asserted Claims	22
	Section 11.6	Assignment of Rights and Obligations under this Agreement	23
	Section 11.7	Waiver and cooperation	23
	Section 11.8	Continuation of Services after Exits.	23
	Section 11.9	Sale of Major Projects	23
ARTICLE XII DISSOLUTION AND LIQUIDATION			24
	Section 12.1	Dissolution	24
	Section 12.2	Distribution on Dissolution	24
ARTICLE XIII TERM			25
	Section 13.1	Term and Termination	25
	Section 13.2	Survival	26
ARTICLE XIV NON-COMPETITION OBLIGATION			26
	Section 14.1	Scope of Non-Competition Obligation	26
ARTICLE XV CONFIDENTIALITY			27
	Section 15.1	Confidentiality	27
	Section 15.2	Proprietary Information	27
	Section 15.3	Consented Disclosures	28
	Section 15.4	Mandatory Disclosures	28
	Section 15.5	Termination of Obligations	28
ARTICLE XVI NOTICES			28
	Section 16.1	Notices	28
	Section 16.2	Effectiveness	29
ARTICLE XVII MISCELLANEOUS			29
	Section 17.1	Termination of Previous Shareholder Agreement	29
	Section 17.2	Expenses	29
	Section 17.3	Foreign Currencies	29
	Section 17.4	Language	30
	Section 17.5	Amendments	30
	Section 17.6	Consent Requirements	30
	Section 17.7	Exhibits	30
	Section 17.8	Entire Agreement	30
	Section 17.9	No Third Party Beneficiary	30
	Section 17.10	Assignment	30

- IX -

Section 17.11	Change of Control	30
Section 17.12	Exclusion of Remedies	31
Section 17.13	Interpretation	31
Section 17.14	Invalid Provisions	31
Section 17.15	Governing Law	31
Section 17.16	Arbitration	31

- X -

LIST OF DEFINITIONS


Affiliate	2
Agreement	1
Annual Financial Statements	17
Anti-Corruption Laws	2
Applicable Law	2
Articles of Association	8
Ashland	1
Ashland Notice Date	22
Ashland Supervisory Board Members	11
ASK Chemicals	2
Auction	22
Authority	2
Block Voting	7
Business Day	2
CEO	14
CFO	14
Chairman	11
Change of Control	2
Closing	3
Closing Date	3
Competitor	28
Debt Level	16
Deduction Amount	23
Designated Entities	3
Dispute	33
Distributions	17
EBITDA	3
Exceeding Financing	16
Exclusive Shareholders Actions	10
Exhibits	32
Fair Market Value	3
FCPA	3
Financial Year	8
Foundry Products Business	3
Global Annual Budget	19
Global Business Plan	19
Group	4
Group Companies	4
Group Financing Pledges	16
Guarantee	4
IFRS	4
Initial Global Annual Budget	18

- XI -

Initial Global Business Plan	4
Initial Net Debt Level	16
Investment Banking Firm	23
Local Contribution and Sale Agreement	4
Major Decisions	15
Management Board	9
Master Contribution and Sale Agreement	5
Master Formation Agreement	5
Negotiation Period	21
Net Debt	5
Net Debt Level	5
Parties	5
Partnership Agreement	1
Party	5
Periodic Financial Reports	17
Permitted Transferee	20
Personal Conflict	14
Proprietary Information	29
Request Notice	21
Responsible Party	24
Rules	33
SC	1
SC Finance	1
SC Notice Date	22
SC Supervisory Board Members	11
Share	8
Shareholder Representative	9
Shareholders' Meeting	9
Shareholders' Resolution	10
Shares	8
SPA	22
Subsequent Global Annual Budget	19
Subsequent Global Business Plan	19
Subsidiary	5
Supervisory Board	9
Supervisory Board Members	9
Third Appraisal Value	22
Third Appraiser	21
third party	5
Third Party	5
Transfer	5
Unadjusted Consideration	24
USLP	6
Voting Rights	9

- XII -

LIST OF EXHIBITS

Exhibit 1-1	Net Debt Calculation	4
Exhibit 1-2	EBITDA Calculation	3
Exhibit 3.2	Articles of Association of ASK Chemicals	8
Exhibit 6.2	Exclusive Shareholders Actions	9
Exhibit 7.1	Initial Supervisory Board Members	11
Exhibit 7.4(c)	Supervisory Board Actions	13
Exhibit 8.1	Initial Management Board Members	14
Exhibit 8.2	Reporting Obligations	14
Exhibit 8.3	Major Management Board Actions	14
Exhibit 8.5	Initial Senior Management Team	15
Exhibit 9.4 (a)	Initial Global Business Plan (including Initial Global Annual Budget)	17
Exhibit 11.4(b)	Group Fair Market Value Valuation Principles	20
Exhibit 11.4(d)	SPA	21

- 1 -

SHAREHOLDERS' AGREEMENT

This SHAREHOLDERS' AGREEMENT, (this "Agreement") dated as of November 28, effective upon approval on November 30, 2010 is made and entered into by and between Süd-Chemie Aktiengesellschaft, a publicly listed stock corporation incorporated under the laws of the Federal Republic of Germany with registered number HRB 1019 of the local court in Munich and its registered office at Lenbachplatz 6, 80333 Munich, Germany ("SC"), Süd-Chemie Finance GmbH, a limited liability company incorporated under the laws of the Federal Republic of Germany with registered number HRB 1064 of the local court in Munich and its registered office at Lenbachplatz 6, 80333 Munich, Germany ("SC Finance"), Ashland Inc., a publicly listed company incorporated under the laws of the Commonwealth of Kentucky, U.S.A., and its registered office at 50E. River Center Blvd. Covington, KY 41012-0391, U.S.A. ("Ashland") and Ashland International Holdings, Inc., a company incorporated under the laws of the State of Delaware, U.S.A., with and its registered office at 1209 Orange Street, Wilmington, DE 19801, U.S.A. ("AIHI").

W I T N E S S E T H

WHEREAS, on July 14, 2010, SC, Ashland and ASK Chemicals, have entered into the Master Formation Agreement under which they have determined to combine their respective worldwide businesses related to the foundry industry, by transferring such businesses to ASK Chemicals and USLP;

WHEREAS, SC and Ashland, in each case directly and/or indirectly through SC Finance and AIHI, respectively, hold 50% of the Shares in each of ASK Chemicals and USLP;

WHEREAS, for the purpose of combining their respective worldwide businesses related to the foundry industry as set forth in the first recital, SC and Ashland have entered into the Master Contribution and Sale Agreement under which they contribute or sell to ASK Chemicals and USLP the SC Business and the Ashland Business respectively (as defined in the Master Formation Agreement); and

WHEREAS, the Parties intend to enter into this Agreement to provide for certain matters relating to their respective shareholding in ASK Chemicals. The Parties intend to enter into a similar partnership agreement with respect to USLP (the "Partnership Agreement"), a draft of which is part of the reference deed.

NOW, THEREFORE, the Parties hereto hereby agree as follows:

- 2 -

ARTICLE I

DEFINITIONS

As used in this Agreement, the following capitalized terms have the meanings set forth below:

"Affiliate" means any person that, directly or indirectly through one or more intermediaries, controls, is controlled by or is under common control with the person specified, excluding the Group Companies and USLP and its subsidiaries. For purposes of this definition, control of a person means the power, direct or indirect, to direct or cause the direction of the management and policies of such person whether through ownership of voting securities or ownership interests, by contract or otherwise, provided that the direct or indirect ownership of fifty per cent (50%) or more of the voting share capital of a person is deemed to constitute control of such person, and "controlling" and "controlled" have corresponding meanings.

"Anti-Corruption Laws" means in relation to any person, collectively, the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, the FCPA, German anti-corruption laws, and any other anti-corruption laws and any export control and anti-money laundering laws and laws relating to the proceeds of crime and funding of terrorism, in each case insofar as they apply to that person.

"Applicable Law" means in relation to any person, any and all mandatory laws, common law, statutes, secondary legislation, directives, regulations, resolutions, statutory guidance and codes of practice, civil, criminal or administrative law, notices, judgments, decrees, orders or rulings from any Authority, in each case having the force of mandatory law insofar as they apply to that person.

"ASK Chemicals" means Ashland-Südchemie-Kernfest GmbH (to be renamed to: ASK Chemicals GmbH), Hilden/Germany, a limited liability company (Gesellschaft mit beschränkter Haftung; GmbH) incorporated and existing under the laws of the Federal Republic of Germany and registered with the commercial register of the local court of Düsseldorf under HRB 44968.

"Authority" means, in any jurisdiction, any government, any other supranational, national, state, federal, regional, municipal, city, town or local government, any subdivision, court, arbitral tribunal, central bank, administrative agency or commission or other authority thereof, any state enterprise or state corporation, any other entity controlled by a government, any quasi-governmental body exercising any regulatory, administrative, taxing, excise, customs importing or other governmental or quasi-governmental authority, any stock-exchange or other regulatory or supervisory body or authority, any political party or any public international organization.

"Business Day" means a day other than Saturday, Sunday and public holidays in Munich, Germany and New York, NY, USA.

"Change of Control" means the transfer, issue or redemption of shares in a legal person thereof where the completion of the transfer, issue or redemption would result in a person

- 3 -

who did not previously control that body corporate acquiring control of that legal person. For purposes of this definition, control of a person means the power, direct or indirect, to direct or cause the direction of the management and policies of such person whether through ownership of voting securities or ownership interests, by contract or otherwise.

"Closing" has the meaning given to it in Section 6.8 of the Master Formation Agreement.

"Closing Date" has the meaning given to it in Section 6.8 of the Master Formation Agreement.

"Designated Entities" means any of Dow Chemical Company, Royal DSM N.V., Reichhold Inc., AOC, LLC, Hexion Specialty Chemicals, Inc., Apollo Management L.P., Huntsman Corporation, Interplastic Corporation, Total S.A., Scott Bader Company Limited, Nan Ya Plastics Corporation and any controlling shareholder of any of the foregoing companies or any entity that succeeds to the business of the forgoing companies with respect to the manufacturing of epoxy resins, vinyl ester resins or unsaturated polyester resins. For purposes of this definition, a shareholder is a "controlling" shareholder if such shareholder has the power, direct or indirect, to direct or cause the direction of the management and policies of the entities listed abov e whether through ownership of voting securities or ownership interests, by contract or otherwise, provided that the direct or indirect ownership of fifty per cent (50%) or more of the voting share capital of a person is deemed to constitute control of such entity.

"EBITDA" means the EBITDA to be determined in accordance with the calculation attached hereto as Exhibit 1-2 .

"Fair Market Value" has the meaning given to it in Section 11.4(b).

"Foundry Products Business" means the development, manufacture, marketing and sale of products used in the foundry industry such as resins, coatings, feeders, sleeves, filters, cores and risers and various other additives and/or other products related to the foundry and casting solutions business.

"FCPA" means the U.S. Foreign Corrupt Practices Act of 1977, 15 U.S.C., §§ 78dd-1, et seq.

"General Partner" means ASK Chemicals and/or any other person that becomes a successor or additional General Partner of USLP as provided in the Partnership Agreement.

"GP Interest" means the GP Interest issued and held by ASK Chemicals and/or any other person that becomes a successor or additional General Partner of USLP as provided in the Partnership Agreement, which GP Interest includes, without limitation, all rights and interests of the General Partner to cash distributions made pursuant to the Partnership Agreement.

"Group" means ASK Chemicals, USLP and their respective Subsidiaries, as a whole.

- 4 -

"Group Companies" means ASK Chemicals, USLP and each of their Subsidiaries, and "Group Company" means any of them.

"Guarantee" means any guarantee, indemnity, undertaking, covenant, bond or other form of security given by any Party in its personal capacity in respect of any Group Company's liabilities.

"IFRS" means the International Financial Reporting Standards issued by the International Accounting Standards Board (incorporating International Accounting Standards issued by the former International Accounting Standards Committee) and the final interpretations prepared by the International Financial Reporting Interpretations Committee of the international Accounting Standards Board as approved by the International Accounting Standards Board (including, where applicable, interpretations of International Accounting Standards by the former Standing Interpretations Committee of the International Accounting Standards Committee).

"Initial Global Business Plan" shall have the same meaning as "Pre-Closing Agreed Business Plan" has in the Master Formation Agreement.

"Interest" means the GP Interest and/or LP Interest held by a Partner pursuant to the Partnership Agreement.

"Limited Partner" means each of Ashland and Tecpro Holding Corporation, and/or any other person that becomes a substituted Limited Partner as provided in the Partnership Agreement. "Limited Partners" means all such persons.

"Local Contribution and Sale Agreement" has the meaning given to it in the Master Contribution and Sale Agreement.

"LP Interest" means the LP Interest issued and held by a Limited Partner as set forth in the Partnership Agreement, which LP Interest includes, without limitation, all rights and interests of the Limited Partners to cash distributions made pursuant to the Partnership Agreement.

"Master Contribution and Sale Agreement" means the master contribution and sale agreement between SC and Ashland, dated July 14, 2010, deed no 1543/2010 Notary Public Prof. Dr. Dieter Mayer, Munich, a certified copy of it was available during the notarization.

"Master Formation Agreement" means the formation agreement by and among SC and Ashland, dated July 14, 2010.

"Net Debt" means the net debt to be determined in accordance with the calculation attached hereto as Exhibit 1-1 .

"Net Debt Level" has the meaning given to it in Section 9.1(a).

"Parties" means, collectively, SC, SC Finance, Ashland and AIHI, and "Party" shall mean any of them.

- 5 -

"Partners" means the General Partner and all Limited Partners, where no distinction is required by the context in which the term is used in this Agreement. "Partner" means any one of the Partners.

"Subsidiary" means any person that is directly or indirectly controlled by ASK Chemicals (where, for the purposes of this definition, "control" means the power to direct the management or policies of a person, directly or indirectly, whether through ownership of voting securities or ownership interests, by contract or otherwise, provided that the direct or indirect ownership of fifty per cent (50%) or more of the voting share capital of a person is deemed to constitute control of such person, and "controlling" and "controlled" have corresponding meanings); for the purposes of this Agreement, USLP and its Subsidiaries (if any) shall be deemed to be a Subsidiary of ASK;

"Third Party" or "third party" means a person that is not a Party to this Agreement or an Affiliate of such a Party.

"Transfer" in relation to a Share and, for purposes of Articles XI and XVII, a limited partnership interest in USLP, means: (i) any direct or indirect sale, conveyance, assignment, gift or transfer; (ii) creating or permitting to subsist any pledge, charge, mortgage, lien or other security interest or encumbrance; (iii) creating any trust or conferring any interest; (iv) any agreement, arrangement or understanding in respect of votes or the right to receive dividends or other distributions; (v) any renunciation or assignment of any right to subscribe for or receive a Share or any legal or beneficial interest in a Share; (vi) any agreement to do any of the above, except an agreement to transfer Shares which is conditional on compliance with the terms of this Ag reement; (vii) the transmission by operation of Applicable Laws; and (viii) any transaction which has an analogous economic effect to the foregoing.

"USLP" means ASK Chemicals L.P., a limited partnership formed under the laws of the State of Delaware and with its registered office at 1209 Orange Street, Wilmington, DE 19801, USA.

ARTICLE II

GENERAL PROVISIONS

Section 2.1 Shareholders' Agreement for ASK Chemicals. This Agreement sets forth the corporate governance principles of ASK Chemicals and the relationship between SC and Ashland (and their Affiliates, as the case may be) with respect to ASK Chemicals.

Section 2.2 Undertaking of Due Performance of Affiliates. If and to the extent an Affiliate of SC and/or Ashland is a shareholder of ASK Chemicals, SC, with respect to its Affiliates, and Ashland, with respect to its Affiliates, shall procure, and be responsible to the other, that any such Affiliate exercise its rights and perform its obligations as a shareholder of ASK Chemicals in accordance with this Agreement, as if such Affiliate were SC (if an Affiliate of SC) or Ashland (if an Affiliate of Ashland) and bound by this Agreement accord ingly.

Section 2.3 Affiliate Adherence. SC Finance agrees and acknowledges that if and to the extent an obligation of SC hereunder can be performed by SC Finance as direct

- 6 -

shareholder of ASK Chemicals, SC Finance shall be obliged to perform such obligation as if it was an obligation of SC Finance. AIHI agrees and acknowledges if and to the extent an obligation of Ashland hereunder can be performed by AIHI as direct shareholder of ASK Chemicals, AIHI shall be obliged to perform such obligation as if it was an obligation of AIHI.

- 7 -

Section 2.4 Powers of Attorney.

(a) SC Finance hereby grants an irrevocable power of attorney to SC to represent SC Finance in any respect regarding (i) the entering into, amendment and/or termination of this Agreement, and (ii) the holding and administration of SC Finance's participation in ASK Chemicals (including by exercising all kind of shareholder's voting rights in any shareholders' resolutions of ASK Chemicals, including, without limitation, resolutions (x) provided for in this Agreement, and (y) regarding any amendments of the Articles of Association). SC is in particular authorized to grant and receive waivers, declaration of consents and notices of any kind on behalf of SC Finance; therefore, any notices, invitations, etc. to SC Finance shall be deemed to have been received by SC Finance if they have been received by SC at the address set forth in Section 16.1(b). SC is authorized to represent SC Finance generally within the scope of this power of attorney and in case of doubt; this power of attorney shall be interpreted extensively to realize the purpose of its granting. SC is expressly exempted from the restriction imposed by Section 181 German Civil Code (BGB).

(b) AIHI hereby grants an irrevocable power of attorney to Ashland to represent AIHI in any respect regarding (i) the entering into, amendment and/or termination of this Agreement, and (ii) the holding and administration of AIHI's participation in ASK Chemicals (including by exercising all kind of shareholder's voting rights in any shareholders' resolutions of ASK Chemicals, including, without limitation, resolutions (x) provided for in this Agreement, and (y) regarding any amendments of the Articles of Association). Ashland is in particular authorized to grant and receive waivers, declaration of consents and notices of any kind on behalf of AIHI; therefore, any notices, invitations, etc. to AIHI shall be deemed to have been received by AIHI if they have been received by Ashland a t the address set forth in Section 16.1(a). Ashland is authorized to represent AIHI generally within the scope of this power of attorney and in case of doubt, this power of attorney shall be interpreted extensively to realize the purpose of its granting. Ashland is expressly exempted from the restriction imposed by Section 181 German Civil Code (BGB).

Section 2.5 Block Voting. Ashland and its Affiliates shall be obliged to cast their Voting Rights in ASK Chemicals as a block and SC and its Affiliates shall be obliged to cast their Voting Rights in ASK Chemicals as a block (in each case referred to as the "Block Voting").

Section 2.6 Applicable Law. All terms and provisions of this Agreement and all rights and obligations of the Parties hereunder shall be subject to Applicable Law.

ARTICLE III

ORGANIZATION

Section 3.1 Legal Form. ASK Chemicals is and shall remain a limited liability company (Gesellschaft mit beschränkter Haftung; GmbH) incorporated and existing under the

- 8 -

laws of the Federal Republic of Germany and registered with the commercial register of the local court of Düsseldorf under HRB 44968.

Section 3.2 Articles of Association. The Parties undertake to hold a shareholders' meeting of ASK Chemicals immediately upon execution of this Agreement and resolve the replacement of the current articles of association of ASK Chemicals by the articles attached hereto as Exhibit 3.2 (the "Articles of Association") which include, among others, the new name of ASK Chemicals (i.e., ASK Chemicals GmbH) an d its financial year (i.e., calendar year) (the "Financial Year"). If any provisions of the Articles of Association at any time conflict with any provisions of this Agreement, the provisions of this Agreement shall, as far as legally permitted, prevail, and the Parties shall exercise all powers and rights pertaining to them, including but not limited to their Voting Rights, to procure the amendment of the Articles of Association to the extent necessary to permit ASK Chemicals and its affairs to be administered as provided for in this Agreement.

Section 3.3 Performance by Subsidiaries. ASK Chemicals shall (and SC and Ashland shall exercise all powers and Voting Rights to) procure that (i) any person (including, without limitation any company, partnership, corporation or other legal entity) which is or becomes a Subsidiary at any time after the date of this Agreement shall act in accordance with and comply with the same principles as set forth for ASK Chemicals hereunder, provided that any global decisions for the Group shall be made at the level of ASK Chemicals, and (ii) to the e xtent legally permissible under Applicable Law, any corporate or other organizational documents of such Subsidiaries shall be amended to the extent such amendment may be required to achieve compliance with the foregoing provision (i).

Section 3.4 Tax Elections. The Parties undertake to procure that ASK Chemicals shall not elect to be treated as a partnership for U.S. federal income tax purposes.

ARTICLE IV

SHARE CAPITAL AND SHAREHOLDINGS

Section 4.1 Share Capital. The issued capital of ASK Chemicals shall be increased or contributions into the capital reserves shall be made in accordance with the provisions set forth in the Master Contribution and Sales Agreement (each share in ASK Chemicals a "Share" and collectively the "Shares").

Section 4.2 Shareholding. The Shares in ASK Chemicals shall be held by SC and SC Finance and AIHI, as follows:

(a) SC and SC Finance together shall hold 50% of the Shares; and

(b) AIHI shall hold the remaining 50% of the Shares.

ARTICLE V

CORPORATE BODIES

Section 5.1 Corporate Bodies.

- 9 -

(a) Shareholders' Meeting. ASK Chemicals shall have a shareholders' meeting (the "Shareholders' Meeting") which shall consist of the shareholders of ASK Chemicals and is further described in ARTICLE VI below.

(b) Supervisory Board. ASK Chemicals shall have a voluntary supervisory board (fakultativer Aufsichtsrat) (the "Supervisory Board") which shall be comprised of natural persons (the "Supervisory Board Members") and is further described in ARTICLE VII below.

(c) Management Board. ASK Chemicals shall have a board of executive officers (Geschäftsführer) (the "Management Board") which shall be comprised of natural persons and is further described in ARTICLE VIII below.

(d) If Applicable Law requires the representation of employees in the Corporate Bodies, the Parties shall amend or replace the provisions of this Agreements or any Exhibits hereof or take such other measures as appropriate, to reflect the Parties intention as stipulated herein, in particular to ensure that the balance of respective powers as set forth hereunder stays to the greatest extent possible unaltered.

ARTICLE VI

SHAREHOLDERS' MEETING

Section 6.1 Shareholders' Meeting. Each shareholder shall, subject to the requirement of Block Voting, be entitled to one vote per Share (or fraction thereof, as specified in the Articles of Association) held by such shareholder (the "Voting Rights"). The Voting Rights shall be exercised in the relevant Shareholders' Meeting by one or more representatives designated by each shareholder (each, a "S hareholder Representative"). The shareholders shall authorize their respective Shareholder Representatives by a written power of attorney.

Section 6.2 Powers and Duties. The Shareholders' Meeting shall have the exclusive power and duty to resolve any of the actions listed on Exhibit 6.2 (the "Exclusive Shareholders Actions"). Resolutions on Exclusive Shareholders Actions shall require unanimous vote by all shareholders present or duly represented in a Shareholders’ Meeting having a quorum.

Section 6.3 Meetings of the Shareholders. The Shareholders' Meeting shall be held at least once per year, within four (4) months after the end of each Financial Year. The Shareholders' Meeting shall be held in Hilden, Germany unless otherwise agreed between SC and Ashland. Each shareholder of ASK Chemicals shall have the right to request each member of the Management Board to call subject to the notice requirements set forth herein an extraordinary Shareholders' Meeting of ASK Chemicals at any time. Prior notice for any Sharehol ders' Meeting shall be mailed to (a) each Party, addressed to the address of the Party (in accordance with Section 16.1) at such place by personal delivery, electronic mail or telefax and (b) each Supervisory Board Member by electronic mail to such electronic mail address notified in accordance with Section 7.4. Each such notice must be sent to the relevant address of the respective Party and the relevant electronic mail address of the relevant Supervisory Board Member at least thirty (30) calendar days (in case of an ordinary meeting) and fourteen (14)

- 10 -

calendar days (in case of an extraordinary meeting) before the date on which the respective meeting is to be held. Each such notice shall state the time and place of the meeting and provide for a reasonable detailed agenda. Materials appropriately explaining and providing background information on, the agenda items of the Shareholders' Meeting shall be circulated to each Party at least five (5) Business Days ahead of the meeting.

(a) Quorum. The presence of 100% of the Voting Rights will constitute a quorum for transaction of business at any Shareholders' Meeting. If less than a quorum is present at a meeting, the Shareholder Representatives present at such meeting shall adjourn the meeting by simple majority and give notice (with a notice period of fourteen (14) calendar days) thereof to all relevant shareholders of ASK Chemicals. At the adjourned meeting, the presence of at least 50% of the Voting Rights will constitute a quorum.

(b) Voting. In the Shareholders' Meeting the Shareholders shall act by way of resolutions (each a "Shareholders' Resolution"). All Shareholders' Resolutions shall require the majority of the Voting Rights present in the respective Shareholders' Meeting, unless expressly otherwise stated herein.

(c) Rules and Regulations. The shareholders of ASK Chemicals may establish such rules and regulations for the conduct of the respective Shareholders' Meetings as they deem necessary or advisable, except insofar as any such rules and regulations would be inconsistent with the provisions of Applicable Law, the relevant Articles of Association or this Agreement.

(d) Written consent. Any action required or permitted to be taken at a Shareholders' Meeting may be taken without a meeting if consent in writing, setting forth the actions so taken, shall be signed by all of the relevant shareholders of ASK Chemicals entitled to vote with respect to the subject matter.

(e) Participation of Auditor. Each shareholder of ASK Chemicals shall have the right to request the participation of the relevant auditor of ASK Chemicals in the Shareholders' Meeting which approves the annual financial statements.

(f) Minutes. Insofar as Shareholders' Resolutions do not require notarization, each Shareholders' Resolution shall be set forth in written minutes without undue delay. All minutes shall contain the date and the form of the resolution, the content of the resolution and the votes made thereon. Furthermore, the minutes shall contain a summary of the discussions on the various agenda items. The minutes shall be signed by such number of Management Board members as required for representation purposes. Minutes of resolutions made at the Shareholders' Meeting shall also be signed by the chairman of the Shareholders' Meeting. Minutes shall be sent in copy without delay to each shareholder. The minutes shall serve as evidence and shall not constitute the Shareholders' Resolution.

(g) Objections. Objections to Shareholders' Resolutions by institution of a legal action shall only be allowed if made within a time period of one month after receipt of the copy of the respective minutes. Sections 241 seq. of the German Stock Corporation Law shall apply for the challenge of a resolution.

- 11 -

ARTICLE VII

SUPERVISORY BOARD

Section 7.1 Members. The Supervisory Board shall consist of five (5) members, three (3) of whom shall be appointed by the Shareholders' Meeting pursuant to a nomination by SC (the "SC Supervisory Board Members") and two (2) of whom shall be appointed by the Shareholders' Meeting pursuant to nomination by Ashland (the "Ashland Supervisory Board Members"). Any SC Supervisory Board Member shal l be removed by the Shareholders' Meeting pursuant to a respective request by SC, and any Ashland Supervisory Board Member shall be removed by the Shareholders' Meeting pursuant to a respective request by Ashland. Any vacancy on the Supervisory Board shall be filled pursuant to a nomination by SC, if the vacancy shall be in respect of a SC Supervisory Board Member, or pursuant to a nomination by Ashland, if the vacancy shall be in respect of an Ashland Supervisory Board Member. SC and Ashland shall notify each other of their respective nominations for appointment or requests for removal of Supervisory Board Members as provided in this Section 7.1. The shareholders shall pass all necessary resolutions required to implement a nomination for appointment or request for removal in accordance with this Section 7.1 in a Shareholders' Meeting or by way of written consent. SC undertakes to vote in accordance with the nomination or request, as the case may be, of Ashland, and Ashland undertakes to vote in accordance w ith the nomination or request, as the case may be, of SC. The initial Supervisory Board shall consist of the members as set forth in Exhibit 7.1.

Section 7.2 Chairman of the Supervisory Board. The chairman of the Supervisory Board (the "Chairman") shall be one of the SC Supervisory Board Members and designated by SC. The Chairman shall have the right to nominate a secretary (who shall have the right to participate in all meetings of the Supervisory Board). The Chairman shall preside at all meetings of the Supervisory Board and shall have such other powers and duties as from time to time may be ass igned to him or her by unanimous decision of the Supervisory Board.

Section 7.3 Powers and Duties. Subject to the provisions of this Agreement, the Supervisory Board shall have the power and duty to supervise the Management Board and the management of any Subsidiary, including, inter alia, to resolve any action submitted to it by the Management Board for the approval of the Supervisory Board. Furthermore, the Supervisory Board shall have the right and – upon request of any of its members – the obligation to review the books, records, docu ments, systems and data of any and all Group Companies and to retain, at the cost of the Party who appointed the requesting Supervisory Board Member, external expert counsel for such review. Section 52 para. 1 of the German Limited Liability Act (GmbH-Gesetz; GmbHG) and the provisions of the German Stock Corporation Act (Aktiengesetz; AktG) referred to therein shall, except where expressly stated otherwise in this Agreement, not apply.

Section 7.4 Meetings of the Supervisory Board. Regular meetings of the Supervisory Board shall be held at a frequency, but not less often than twice per calendar year, and, at such time as shall from time to time be determined by the Supervisory Board; if the Supervisory Board at any time is unable to agree or has not agreed on a place and a time of its meeting, the place of the meeting shall be Hilden, Germany, and the time of the meeting shall be determined by the Chairman. Special meetings of the Supervisory Board may be call ed by or at

- 12 -

the request of any Supervisory Board Member. Notice of each Supervisory Board meeting shall be mailed by electronic mail to such electronic mail address notified by the relevant Supervisory Board Member in writing to the Chairman of the Supervisory Board, the CEO and to each of the Parties (to the addresses stated in Section 16.1 or to such other address as notified from time to time in accordance with Sections Section 16.1 and Section 16.2); provided that, for as long as a Supervisory Board Member fails to so notify its electronic mail address any notification obligation vis-à-vis such Supervisory Board Member that may occur from time to time under this Agreement may be satisfied by sending written notice to the Party who appointed such Supervisory Board Member at the address stated in Section 16.1 or to such other address as not ified from time to time in accordance with Sections Section 16.1 and Section 16.2. Each such notice must be sent to the relevant electronic mail address of the respective Supervisory Board Member at least thirty (30) calendar days (in case of an ordinary meeting) and fourteen (14) calendar days (in case of an extraordinary meeting) before the date on which the respective meeting is to be held. Each such notice shall state the time and place of the meeting and the purpose thereof. Materials appropriately explaining, and providing background information on, the agenda items of a Supervisory Board meeting shall be sent to all Supervisory Board at least three (3) Business Days ahead of the meeting (receipt by the Supervisory Board members).Any Supervisory Board Member who is present (in person or by proxy) at a meeting shall be conclusively presumed to have waived notice of such meeting except when such Supervisory Board Member attends for the express purpose of objecting at the beginning of the meeting to the t ransaction of any business because the meeting is not properly called or convened.

(a) Quorum. A number of four (4) Supervisory Board Members present (in person or by proxy) will constitute a quorum for transaction of business at any meeting of the Supervisory Board. If less than a quorum is present at a meeting, the Supervisory Board Members present (in person or by proxy) at such meeting shall adjourn the meeting by simple majority and give notice thereof to all Supervisory Board Members in accordance with the notice provision set forth above, provided that such notice must be given at least fourteen (14) calendar days before the date on which the adjourned meeting is held. At the adjourned meeting the presence of one (1) Supervisory Board Member will constitute a quorum for transaction of busine ss at such adjourned meeting of the Supervisory Board.

(b) Meetings by telephone. Any one or more Supervisory Board Members may participate in and vote at Supervisory Board meetings by means of a conference telephone call which allows all persons participating in the meeting to hear each other. Any Supervisory Board Member so participating in a Supervisory Board meeting shall be deemed to be present in person and shall count towards the quorum. Any resolution taken by the Supervisory Board with any one or more Supervisory Board Member so participating shall only become valid and binding if the wording of the relevant resolution has been sent by the Chairman by electronic mail to the Supervisory Board Members who participated by telephone and all such Supervisory Board Me mbers confirmed vis-à-vis the Chairman by electronic mail that they agree to the wording of the relevant resolution.

(c) Voting. Each Supervisory Board Member (whether present in person or by proxy) shall be entitled to one vote. All decisions of the Supervisory Board shall be taken by a majority of votes of the Supervisory Board Members participating (in person or

- 13 -

by proxy) in the meeting, except with respect to any of the actions listed on Exhibit 7.4(c) which shall require a unanimous decision.

(d) Proxy. Each SC Supervisory Board Member shall have the right to grant a proxy to authorize any of the other SC Supervisory Board Members to represent him or her (including by exercising voting rights) in any meeting of the Supervisory Board, and each Ashland Supervisory Board Member shall have the right to grant a proxy to authorize any of the other Ashland Supervisory Board Members to represent him or her (including by exercising voting rights) in any meeting of the Supervisory Board.

(e) Minutes. Full minutes of every Supervisory Board meeting in English shall be prepared and kept by the Chairman or its secretary (provided however, that the Chairman shall at all times be responsible for the content of the minutes) and shall be circulated without undue delay after the relevant meeting to each Supervisory Board Member for approval. The minutes shall be deemed to have been approved by the Supervisory Board Members unless notice of an objection is given to the Chairman within ten (10) Business Days after the date on which the minutes were received by the respective Supervisory Board Member, provided however, for the avoidance of doubt, that any such objection does not void the underlying resolution i f it has been taken in accordance with the provisions of Section 7.4. If a notice of objection is served, the Chairman shall immediately after the expiration of the ten days objection period circulate the objected minutes to each Supervisory Board Member identifying the objected items thereof which shall be recirculated for approval to the members of the Supervisory Board without undue delay. Any items of the minutes which have not been objected shall be deemed to have been approved.

(f) Observation Right of Management Board. Each member of the Management Board shall have the right to participate in each meeting of the Supervisory Board as observers (with no voting rights), provided however, that each Supervisory Board Member may object such participation at any time from time to time and upon such objection, the relevant member of the Management Board shall not be entitled to participate in such meeting.

(g) Participation of Experts. External experts may participate in meetings of the Supervisory Board at the request of a Supervisory Board Member, provided however, that all other Supervisory Board Members have granted their consent to such participation no later than at the beginning of the meeting.

(h) Written consent. Any action required or permitted to be taken at a meeting of the Supervisory Board may be taken without a meeting if consent in writing, setting forth the actions so taken, shall be signed by all of the relevant Supervisory Board Members entitled (i.e., not conflicted) to vote with respect to the subject matter.

(i) Conflicts. A member of the Supervisory Board shall not be entitled to vote in case of a personal conflict of interests ("Personal Conflict"), and such member of the Supervisory Board shall have the obligation to disclose such Personal Conflict to all other members of the Supervisory Board. In such case of a Personal Conflict the so conflicted member of the Supervisory Board shall be entitled to grant a power of attorney to

- 14 -

another board member (without specific substitution) which shall be entitled to vote in his or her own discretion. Subject to Section 8.4(b) last sentence, the transaction of business between any Group Company on the one hand and Ashland or SC (or any of their respective Affiliates) on the other hand does not constitute a Personal Conflict of the Supervisory Board members nominated by Ashland or, as the case may be, SC.

ARTICLE VIII

MANAGEMENT BOARD

Section 8.1 Members. The Management Board shall consist of at least two members, i.e. a chief executive officer (the "CEO") and a chief financial officer (the "CFO"). The members of the Management Board shall be responsible solely to the Group and shall run the Business of ASK Chemicals with the care of a prudent business man in accordance with Applicable Law (including, but not limited to Section 43 of the German Limited Liability Act), the Articles of Association, the rules of procedure of the Management Board, if any, and their respective service agreement. All members of the Management Board shall be appointed by the Shareholders' Meeting pursuant to a nomination by SC. Any member of the Management Board shall be removed by the Shareholders' Meeting pursuant to a respective request by SC. SC shall notify Ashland of its respective nominations for appointment or requests for removal of Management Board members as provided in this Section 8.1. The shareholders shall pass all necessary resolutions required to implement a nomination for appointment or request for removal in accordance with this Section 8.1 in a Shareholders' Meeting or by way of written consent. Ashland undertakes to vote in accordance with the nomination or request, as the case may be, of SC. The initial Management Board shall consist of the members as set forth in Exhibit 8.1.

Section 8.2 Powers and Duties. Subject to the provisions of this Agreement and except as otherwise required by Applicable Law, the Management Board shall (i) conduct the day-to-day operations of ASK Chemicals and its Subsidiaries in accordance with the Global Business Plan, the Global Annual Budget and the Articles of Association, and (ii) notwithstanding the Management Board's legally unlimited authority to bind ASK Chemicals towards third parties, observe the general and individual instructions which may be issued by the Shareholders' Me eting from time to time. The Management Board shall have the obligation to report to the Supervisory Board in accordance with the matters set forth in Exhibit 8.2.

Section 8.3 Major Decisions. Any of the (i) actions listed on Exhibit 7.4(c) and Exhibit 8.3 may not be taken by the Management Board without the prior approval by the Supervisory Board, and (ii) Exclusive Shareholders Actions (as defined in Section 6.2 above) may not be taken by the Management Board without the prior approval by the Shareholders' Meeting (the actions in (i) and (ii) collectively the "Major Decisions").

Section 8.4 Assertion of Claims under Master Contribution and Sale Agreement.

(a) The Management Board shall have the obligation to immediately and fully inform all members of the Supervisory Board of any and all facts, matters, events, circumstances and / or developments which are reasonably likely to result in a Group

- 15 -

Company having claims (the "Claim") under the Master Contribution and Sale Agreement or Local Contribution and Sale Agreement against Ashland or, as the case may be, SC. In pursuing Claims, the Management Board shall act in good faith and shall treat Ashland and SC fairly and equitably (including decisions with respect to whether to pursue a Claim and the pursuit of such Claim) with respect to all such Claims.

(b) The Management Board shall require prior approval from the Supervisory Board or the Shareholders' Meeting, as the case may be, to pursue such Claims. The shareholder or, as the case may be, the members of the Supervisory Board nominated by the shareholder against whom a Claim or Claims are to be brought shall be entitled to participate in any discussion and deliberation with respect to such Claim or Claims, but shall not be entitled to vote on whether or not such Claim or Claims shall actually be pursued.

Section 8.5 Additional Management Personnel. In addition to the members of the Management Board, SC shall be entitled to approve and/or nominate such members' direct reports. The initial senior management team shall consist of the members as set forth in Exhibit 8.5 .

ARTICLE IX

FINANCIAL MATTERS

Section 9.1 Debt Financing

(a) Debt Level. The Parties agree that the level of Net Debt financing of the Group may be up to 2.5 times EBITDA (the "Initial Net Debt Level"); provided however, that in determining the Initial Net Debt Level, the Parties will take into account various factors such as interest rates, covenants and required security to ensure that the Group is appropriately financed. The Initial Net Debt Level shall be reviewed by the Supervisory Board annually or at such other times as the Supervisory Board Members deem appropriate and adjusted according to operational requirements of the Group and market conditions (such adjusted Initial Net Debt Level and the Initial Net Debt Level, collectively, the "Debt Level").

(b) Stand Alone Financing. Notwithstanding Section 9.1(d) below, neither the Parties nor any of their Affiliates shall be obliged to contribute to the financial requirements of the Group at any time, whether by way of subscription for further shares or by way of loans or subscription for loan notes, or to provide any other form of financial facility nor to provide any Guarantees or other security in respect of the obligations of the Group; provided that, nothing contained herein shall be deemed to prevent a Party or its respective Affiliates, from pledging the Shares as security for any Group financing (the "Group Financing Pledges").< /div>

(c) Additional Debt Financing. The Parties agree that if the Group requires funds which would cause the level of Net Debt financing of the Group to exceed the Debt Level (the "Exceeding Financing") then it may raise additional Net Debt financing from third parties on the most favorable terms available as to interest, fees, repayment and security compatible with its needs, but no third party creditor shall have any right to

- 16 -

participate in the share capital of any of the Group Companies or otherwise in the business thereof, provided however, that the Supervisory Board has, as set forth in Exhibit 7.4(c), granted its prior written unanimous approval to the Exceeding Financing.

(d) Shareholders Financing. SC and/or Ashland (and/or any of their Affiliates) may offer to provide financing to the Group if (i) SC and/or Ashland declares that it has funds available for borrowing to or a Guarantee for the benefit of the Group, (ii) such available financing or such Guarantee, as the case may be, is economically as attractive than third party financing (without such Guarantee), and (iii) approvals that may be required in connection with Major Decisions, if any, have been granted.

Section 9.2 Dividend Policy

(a) Profit Distribution Resolution. The Shareholders' Meetings shall resolve the distribution of ASK Chemicals' profit for a Financial Year as soon as practicably possible following the end of each such Financial Year.

(b) Distribution Policy. The Parties agree that ASK Chemicals shall, to the extent permitted by Applicable Law, make annual dividend distributions of one-third of the net profit (Jahresüberschuss) as defined by IFRS of the respective previous Financial Year (after taking into account debt service; i.e., the payment of interest for and repayment of bank and shareholder loans as per Global Annual Budget and in the absence of such Global Annual Budget as per Global Business Plan and restrictions imposed by lenders, taxes, working capital requirements and projected capital expenditures (as defined in the Global Annual Budget and in the absence of such Global A nnual Budget in the Global Business Plan) of the Group of such Financial Year), provided however, that such annual dividend distributions shall in no event exceed the net profit as calculated in accordance with the German commercial code (Handelsgesetzbuch) (the "Distributions"). Unless consented to in writing by the Party against whom the Claim has been made, ASK Chemicals may not withhold any amount forming part of a Distribution as offset against such Claim.

(c) Dividend Policy Subsidiaries. The Parties agree that the Subsidiaries shall make annual distributions to the largest extent possible under Applicable Law but taking into account reasonable considerations with respect to the relevant Subsidiary’s equity quota.

Section 9.3 Financial Information

(a) Each of the Group Companies shall:

(i) at all times maintain accurate and complete accounting and other financial records in accordance with Applicable Laws and IFRS and shall ensure that those books and records comprise in all material respects complete and accurate records of all information required to be recorded;

(ii) prepare accurate and complete (including a balance sheet, profit and loss accounts, cash flow reports) monthly and quarterly financial reports (the

- 17 -

"Periodic Financial Reports") and annual financial statements (the "Annual Financial Statements") in accordance with IFRS;

(iii) establish, maintain and duly administer an internal control system comprising policies, processes and such other features as are necessary or advisable to ensure:

(1) all Group Companies' effective and efficient operation by enabling it to manage significant business, operational, financial, compliance and other risks;

(2) the quality of all Group Companies' internal and external reporting; and

(3) compliance by all Group Companies with all Applicable Laws;

(iv) furnish all Periodic Financial Reports to each of SC and Ashland no later than on the last day of the respective following calendar month;

(v) furnish all Annual Financial Statements of a specific Financial Year to each of SC and Ashland no later than ninety (90) calendar days following the end of such Financial Year.

(b) ASK Chemicals shall also prepare, and submit to each of SC and Ashland, consolidated Annual Financial Statements of a specific Financial Year in accordance with IFRS no later than ninety (90) calendar days following the end of such Financial Year. Such consolidated Annual Financial Statements shall be audited by Ernst & Young. Furthermore, ASK Chemicals shall, once the appropriate systems have been installed, prepare, and submit to each of SC and Ashland, monthly and quarterly financial reports on a consolidated basis for the Group. The Parties shall procure that the Group Companies use commercially reasonable endeavors to ensure that the appropriate systems be implemented as soon as possible.

Section 9.4 Global Business Plan

(a) Initial Global Business Plan, Initial Global Budget. Attached as Exhibit 9.4(a) is the Initial Global Business Plan specifying as guideline important forecast items for the first four (4) years of the establishment of the Group including projections on capital investments. The Initial Global Business Plan shall include, as an appendix to it, the global annual budget (including balance sheet, profit and loss statement, cash-flow and capital expenditure plans) for the first year of the establishment of the Group (the "Initial Global Annual Budget").

(b) Global Business Plan, Global Budget. After expiration of the first Financial Year, the following shall apply:

(i) In the fourth quarter of every subsequent Financial Year, the Management Board shall prepare an updated global business plan based on the previous

- 18 -

Financial Year's global business plan for the subsequent period of three (3) Financial Years and based in form and structure on the previous Global Business Plan and deliver it to the Supervisory Board for approval (as so approved by the Supervisory Board, the "Subsequent Global Business Plan"; the Initial Global Business Plan and each Subsequent Global Business Plan also the "Global Business Plan").

(ii) Concurrently with the relevant Subsequent Global Business Plan, the Management Board shall prepare an annual budget (including balance sheet, profit and loss statement, cash-flow and capital expenditure plans) for the upcoming Financial Year based on the previous annual budget and based in form and structure on the previous Global Annual Budget and deliver it to the Supervisory Board for approval (as approved by the Supervisory Board, the "Subsequent Global Annual Budget"); the Initial Global Annual Budget and the Subsequent Global Annual Budget also the "Global Annual Budget").

(c) Absence of Approval. If at the beginning of any Financial Year, the adjusted Global Business Plan or the adjusted Global Annual Budget proposed by the Management Board for such Financial Year shall not have been approved by the Supervisory Board, then the Global Business Plan previously approved by the Supervisory Board shall remain in effect, provided, however, that any effect resulting from Major Projects approved since the date of the previously approved Global Business Plan shall be added to all line items in the Global Business Plan in each individual year until a new Global Business Plan has been agreed upon by the Superviso ry Board, and the Management Board shall have the right to form its global annual business plan and global annual budget based thereon with minimal deviations therefrom.

Section 9.5 Consolidation. The governance of ASK Chemicals has been structured such that SC consolidates ASK Chemicals proportionally. In case the IFRS consolidation rules change in a way that such proportional consolidation by SC is no longer possible, Ashland will use reasonable efforts to support SC's intent to fully consolidate ASK Chemicals from then onwards; provided however, in no event shall Ashland be required to relinquish its rights with respect to Exclusive Shareholder Actions or those matters specified as requiring a unanimous decision of Supervisory Board under Exhibit 7.4(c).

Section 9.6 Allowed Capital Expenditures' Level. The range for the allowed capital expenditures level for the Group shall amount to (i) 4% of the projected annual revenues of the Group as set forth in the Global Business Plan for each of ASK Chemicals' Financial Year until December 31, 2012, and (ii) 2.5% to 3.5% of the projected annual revenues for the Group as set forth in the Global Business Plan each of ASK Chemicals' Financial Year after December 31, 2012.

- 19 -

ARTICLE X

COMPLIANCE SYSTEM

Section 10.1 Compliance System. The Parties shall procure that the Group Companies, as soon as reasonably practical following Closing, establish, enforce and improve, a compliance program, a compliance organization and a remediation program at the Group Companies which ensures the conformity of the Group Companies' activities with all Applicable Laws (including Anti-Corruption Laws and anti-trust laws).

ARTICLE XI

TRANSFER OF SHARES

Section 11.1 General. No shareholder may Transfer any of its Shares (for purposes of this Article XI, all references to the term "Shares" shall be deemed to include LP Interests in USLP) otherwise than in accordance with this ARTICLE XI. Any Transfer in accordance with this ARTICLE XI, except for Group Financing Pledges and Transfers in accordance with Section 11.2 below, shall always comprise all Shares held by SC (and any of its Affiliates) or Ashland (and any of its Affiliates) (as the case may be), unless SC and Ashland agree otherwise .

Section 11.2 Transfer to Subsidiaries. Any shareholder may at any time Transfer its Shares to SC or a wholly owned subsidiary of SC (if the shareholder is SC or any of its Affiliates) or to Ashland or a wholly owned subsidiary of Ashland (if the shareholder is Ashland or any of its Affiliates) (each, a "Permitted Transferee") provided, however, that if such Permitted Transferee ceases to be an subsidiary of SC or Ashland (as the case may be), then such Permitted Tr ansferee shall immediately prior to the time at which it ceases to be a subsidiary, transfer, free and clear of any encumbrances or third party rights of whatever kind (except as provided by the Articles of Association) all Shares held by it (i) if Permitted Transferee is a subsidiary of SC, to SC or any of SC's (other) wholly owned subsidiaries designated by SC, and SC shall ensure and be responsible for such timely Transfer, (ii) if Permitted Transferee is a subsidiary of Ashland, to Ashland or any of Ashland's (other) wholly owned subsidiaries designated by Ashland, and Ashland shall ensure and be responsible for such timely Transfer.

Section 11.3 Offer for Transfer (General Procedure). The Parties acknowledge and confirm that they intend to remain shareholders, directly or indirectly, of ASK Chemicals for a minimum period of four (4) years following Closing. Nonetheless, either Party may, at any time following Closing, make a binding offer to the other to acquire the Shares held by such other Party (and its Affiliates). The Party receiving such offer shall inform the offering Party of its decision of whether it accepts or rejects the offer in writing within thirty (30) days from receipt of the offer. For the avoidance of doubt, if the Party receiving such offer rejects the offer, the requesting Party shall, subject to the remaining provisions of this ARTICLE XI, be obliged to remain shareholder, directly or indirectly, of ASK Chemicals.

- 20 -

Section 11.4 Offer for Transfer (Specific Procedure).

(a) Ashland shall

(i) have the right to sell the Shares held by it (and its Affiliates) to SC (or, at the election of SC, to SC's Affiliates) on mutually agreed terms by furnishing a written request to SC (“Request Notice”) from the beginning of the fifth year following Closing; and

(ii) if Ashland has not delivered a Request Notice by the expiration of the sixth year following Closing, it shall sell the Shares held by it (and its Affiliates) to SC (or, at the election of SC, to SC's Affiliates) on mutually agreed terms upon the expiration of the sixth year following Closing.

(b) If mutually agreed terms referred to above cannot be reached within sixty (60) days after the receipt of the Request Notice by SC (in the case of Section 11.4(a)(i) above) or after expiration of the sixth year following Closing (in the case of Section 11.4(a)(ii) above) (the "Negotiation Period"), each Party, at its own cost, shall appoint an independent third party appraiser of international reputation, having a global presence and significant experience in valuing businesses in the chemicals industry, within forty-five (45) days after the end of the Negotiation Period to determine the Group Fair Market Value; provided that if one Party fails to appoint an independent third party appraiser within said period, the Group Fair Market Value will be determined by the independent third party appraiser appointed by the other Party whose appraisal shall constitute the final determination of the Group Fair Market Value and shall be binding upon the Parties (and their Affiliates). Each such independent third party appraiser then will, subject to the further provisions of this Section 11.4(b), determine the fair market value of the Shares (the "Group Fair Market Value") in accordance with the valuation principles set forth in Exhibit 11.4(b).

Each of such appraisers shall submit to the Parties its respective appraisal of the Group Fair Market Value within ninety (90) days after the end of the Negotiation Period. If the discrepancy between the appraised Group Fair Market Values of the appraisals of the two appraisers is not more than 10% of the higher of the two appraisals of Group Fair Market Value, then the final Group Fair Market Value shall be the average of the two appraisals. If the discrepancy between the Group Fair Market Values of the two appraisals exceeds 10% of the higher appraisal and the Parties do not agree on the settlement of the discrepancy within fifteen (15) days after receipt of the appraisals, then the two appraisers shall select a third appraiser having the credentials set forth above who is qualified to make the Group Fair Market Value d etermination and has no material relationship with either Party or any of their Affiliates (the "Third Appraiser"), who shall be afforded access to the first two appraisals. Costs for the Third Appraiser shall be borne by Ashland and SC in equal proportions. The Third Appraiser shall submit to the Parties its appraisal of the Group Fair Market Value (the amount set forth therein as the Group Fair Market Value being hereinafter referred to as the "Third Appraisal Value") within forty-five (45) days of its selection, and upon such submission, the Group Fair Market Value shall be the amount equal to: (A) the sum of (i) the Third Appraisal Value, plus (ii) the Group Fair Market Value set forth in whichever of the two appraisals is closer to the Third Appraisal Value, (B) divided by

- 21 -

two, provided that (C) if the Third Appraisal Value is not equal to or between the Group Fair Market Values set forth in the two initial appraisals, the Group Fair Market Value set forth in whichever of the two appraisals is closer to the Third Appraisal Value shall constitute the final determination of the Group Fair Market Value. In the event the Third Appraisal Value is exactly halfway between the Group Fair Market Values set forth in the two initial appraisals, the Third Appraisal Value shall constitute the final determination of the Group Fair Market Value. Each Party shall procure that any appraisers appointed hereunder shall be instructed to determine the Group Fair Market Value in accordance with Exhibit 11.4(b). Furthermore, the Parties will provide, and will cause ASK Chemicals and all other Group Companies to provide, any a ppraisers appointed hereunder with such financial and other information (including the full set of principles governing the determination of the Group Fair Market Value as agreed between the Parties) concerning the Group as such appraisers may reasonably request. The Parties will also cause ASK Chemicals (and USLP), to make its management and other personnel and appropriate representatives of its independent public accountants and advisors available to such appraisers for discussions and consultations from time to time as such appraisers may reasonably request in connection with such services.

(c) Following the determination of the final Group Fair Market Value in accordance with Section 11.4(b) above, SC shall be entitled to acquire and – if SC exercises such right – Ashland shall be required to sell the Shares, but no Major Project held by Ashland, held by Ashland (and its Affiliates) at their final Group Fair Market Value. If SC, within 15 days following the determination of the final Group Fair Market Value (the "SC Notice Date"), does not notify Ashland in writing that it is willing to so acquire the Shares held by Ashland (and its Affiliates), Ashland shall be entitled to acquire and – if Ashland exercises such right – SC shall be required to sell the Sha res, but no Major Project held by SC, held by SC (and its Affiliates) at their final Group Fair Market Value. If Ashland, within 15 days following the SC Notice Date (the "Ashland Notice Date"), does not notify SC that it is willing to so acquire the Shares held by SC (and its Affiliates), an auction shall be initiated for the purpose of selling all Shares (the "Auction") in accordance with Section 11.4(e) below.

(d) If SC notifies Ashland of its intent to acquire the Shares held by Ashland in accordance with Section 11.4(c) above prior to the SC Notice Date, the Parties shall thereafter negotiate in good faith to reach a definitive agreement for the purchase by SC of said Ashland Shares and if no such Agreement is reached within forty-five (45) days of the SC Notice Date, the Parties shall be obliged to enter into a binding agreement in accordance with the terms of the sample share purchase and transfer agreement attached hereto as Exhibit 11.4(d) (“SPA”) at a purchase price equal to the final Group Fair Market Value of the respective Ash land Shares. In the event SC has not notified Ashland of its intent to acquire the Shares held by Ashland and Ashland thereafter notifies SC of its intent to acquire the Shares held by SC prior to the Ashland Notice Date, the Parties shall thereafter negotiate in good faith to reach a definitive agreement for the purchase by Ashland of said SC Shares and if no such Agreement is reached within forty-five (45) days of the SC Notice Date, the Parties shall be obliged to enter into a binding agreement in accordance with the terms of the SPA at a purchase price equal to the final Group Fair Market Value of the respective SC Shares.

- 22 -

(e) The Parties shall jointly implement and control the Auction. The Parties may, upon joint agreement, appoint an investment banking firm (the "Investment Banking Firm") to assist in the Auction. The Parties will consult with one another in connection with any such appointment and the decision with respect to the choice of Investment Banking Firm shall be taken jointly. The Parties will provide, and will cause ASK Chemicals to provide, the Investment Banking Firm with such financial and other information concerning the Group and the Major Project as the Investment Banking Firm may reasonably request. &# 160;The Parties will also cause ASK Chemicals (and USLP) to make its management and other personnel and appropriate representatives of its independent public accountants and advisors available to the Investment Banking Firm for discussions and consultations from time to time as the Investment Banking Firm may reasonably request. The fees of such Investment Banking Firm and other advisors, such as attorneys and accountants, retained in connection with the Auction shall be borne equally by the Parties.

(f) Upon receipt of the bids solicited in connection with the Auction, the Parties' shall promptly enter into negotiations with the bidder offering the highest price for the Shares and shall thereafter proceed to finalize a definitive agreement with respect to the sales of the Shares and, to the extent applicable, in accordance with Section 11.9, the Major Projects to such bidder, or to an alternate bidder, within 90 days following the date on which said bids are received. If no such definitive agreement is finalized within said 90 day period, the Parties may upon mutual agreement extent the period to complete the sale for an additional 90 days. The Parties are in agreement, that Section 12.2 of the Master Contribution and Sale Agreement (Survival of Rights a nd Obligations in case of a Change of Control) shall remain unaffected by the sale and transfer of the Shares to a bidder, unless otherwise agreed between the Parties. In the event that there is no mutual agreement to extend the Auction process as described above, or if upon expiration of any agreed extension period no definitive agreement has been reached with respect to the sale of the Shares, either Party may request dissolution or liquidation of the Group under the Applicable Laws of Germany and the United States. Each Party shall fully cooperate in connection with such dissolution or liquidation, if any, to give effect to the provisions of this ARTICLE XI.

(g) The rights provided for in this Section 11.4 may not be exercised independently of the rights set forth in Article 9 of the Partnership Agreement and in no event may a Party acquire the Shares under this Section 11.4 without also acquiring the other Party's LP Interests (as defined in Article 1 of the Partnership Agreement) under Article 9 of the Partnership Agreement..

Section 11.5 Treatment of Asserted Claims

. If the Shares are sold in accordance with Section 11.4 (f) to a third party bidder and said bidder has taken into account in its bid a deduction ("Deduction Amount") from the consideration which it would have otherwise paid for the Shares ("Unadjusted Consideration" ) which is based on facts or assumptions which constitute or would constitute a Claim against a Party ("Responsible Party" ) under Articles VI or XIII of the Master Contribution and Sale Agreement (whether said Claim has been asserted by any of the Group Companies or not) and the Deduction Amount has been agreed between the bidder, on the one hand, and both of Ashland and SC, on the other hand, the non-Responsible Party shall receive an amount equaling 50% of the Unadjusted Consideration

- 23 -

and the Responsible Party shall receive an amount equaling 50% of the Unadjusted Consideration minus the Deduction Amount.

Section 11.6 Assignment of Rights and Obligations under this Agreement. Subject to this ARTICLE XI, none of the shareholders shall assign or transfer, or purport to assign or transfer all or any of their rights and obligations under this Agreement or the Partnership Agreement to any party.

Section 11.7 Waiver and cooperation. Each shareholder shall, in accordance with the provisions of the Articles of Association, waive any right of first refusal it may have in relation to the transfer of Shares pursuant to this ARTICLE XI. Each shareholder shall fully cooperate with the other shareholder to give effect to any transfer of Shares allowed under this ARTICLE XI.

Section 11.8 Continuation of Services after Exits.

In case SC and/or its relevant Affiliates or Ashland and/or its relevant Affiliates cease to be a shareholder of ASK Chemicals and a Limited Partner of USLP (each an "Exiting Party" and the termination of the shareholding the "Exit") such Exiting Party and its Affiliates shall - for a period of one (1) year from the date on which the Exit becomes effective - be prohibited from exercising potential termination rights, other than for cause, they may have under Ancillary Agreements (as defined in the Master Formation Agreement).

Section 11.9 Sale of Major Projects.

(a) If a Major Project has not been approved by the Supervisory Board and the Party (and/or its Affiliates) whose Supervisory Board Member consented to the Major Project proceeded with the Major Project on its own behalf (the "Major Project Owner"), is selling its Shares to a Third Party in accordance with the provisions of this Article XI, such Major Project Owner shall, subject to Section 11.7(b), simultaneously be obliged to sell the relevant Major Project to the Third Party as well, provided however, that the Major Project Owner shall receive the Major Project Fair Market Value as compen sation for the sale of the relevant Major Project out of the total aggregate sale proceeds paid by the Third Party for the (i) Major Project Owner's Shares, (ii) other Party's Shares and (iii) Major Project.

(b) The two independent third party appraisers appointed pursuant to Section 11.4(b) shall be instructed to determine separately from the Group Fair Market Value the fair market value of any Major Project(s) (the "Major Project Fair Market Value") in accordance with Exhibit 11.4(b); the Major Project Owner will provide the independent third party appraisers with such financial and other information concerning the Group as such appraisers may reasonably request in connection with the determination of the Major Project Fair Market Value.

(i) If the discrepancy between the appraised Major Project Fair Market Values of the appraisals of the two appraisers is not more than 10% for any Major

- 24 -

Project(s), then the Major Project Owner shall be required to include such Major Project(s) in the sale to the Third Party; and,

(ii) If the discrepancy between the Major Project Fair Market Values of the two appraisals exceeds 10% for any Major Project(s), the Major Project Owner may, but shall not be required to, include such Major Project(s) in the sale to the Third Party.

ARTICLE XII

DISSOLUTION AND LIQUIDATION

Section 12.1 Dissolution. ASK Chemicals shall be dissolved upon the earliest to occur of the following (each, an "Event of Dissolution"):

(a) the unanimous resolution of the shareholders to voluntary wind up, liquidate or dissolute or voluntary file for bankruptcy or insolvency;

(b) if one of the shareholders requests a voluntary wind up, liquidation or dissolution under Section 11.4(f);

(d) the appointment of a trustee, custodian or other similar receiver for ASK Chemicals.

Section 12.2 Distribution on Dissolution.

(a) Upon dissolution of ASK Chemicals, no further business shall be conducted except for the taking of such action as shall be necessary for the winding up of the affairs of ASK Chemicals and the distribution of assets pursuant to the provisions of this Section 12.2.

(b) All assets of ASK Chemicals shall be applied and distributed in the following order:

(i) first, to the payment and discharge of all of ASK Chemicals'debts and liabilities to creditors, including liabilities to shareholders who are creditors, to the extend permitted by Applicable Law;

(ii) second, to establish such reserves as the Management Board may deem reasonably necessary for contingent or unforeseen liabilities or obligations of ASK Chemicals; and

(iii) thereafter, proportionally to the holders of the Shares.

- 25 -

ARTICLE XIII

TERM

Section 13.1 Term and Termination.

(a) Upon being duly executed and provided that Closing has occurred, this Agreement shall become effective.

(b) Subject to Section 13.2 below, this Agreement shall automatically terminate and be of no further force and effect for the future upon the earlier of (i) the transfer of all Shares held, directly or indirectly, by a Party from such Party to the other Party or any designee of the other Party, (ii) the transfer of all Shares by the Parties (and any of their Affiliates) to a third party in accordance with Section 11.4 above, or (iii) the date which is the thirtieth anniversary of this Agreement (but the Parties shall negotiate in good faith on a potential extension of the term of this Agreement).

(i) with regard to (the assets of) the respective other Party (or any of its Affiliates holding Shares) (i) insolvency or similar proceedings are instituted or the institution of such proceedings is applied for by the respective other Party (or any of its Affiliates holding Shares) or refused for reason of the lack of assets, (ii) a decree of judicial dissolution under Applicable Law is entered, or (iii) a trustee, custodian or other similar receiver is appointed (iv) a filing or similar proceeding under the US Bankruptcy Code is initiated, a plan of liquidation or dissolution is adopted or a receiver or trustee in bankruptcy is appointed;

(ii) the respective other Party (or any of its Affiliates) breaches Section 11.1 or Section 14.1 of this Agreement, unless such breach is cured within 30 Business Days after it becomes known to the respective other Party; or

(iii) the Shares of the respective other Party (or any of its Affiliates) become seized or otherwise subject to any enforcement measure by Third Parties and such measure is not lifted within three (3) months.

(d) ASK Chemicals shall have the right to redeem the Shares (the "Redemption Right") and purchase the LP Interests in USLP (the "Purchase Right") of (i) SC and its Affiliates if Ashland terminates the Agreement in accordance with Section 13.1(c) above and (ii) Ashland and its Affiliates if SC terminates the Agreement in accordance with Section 13.1(c) above, at eighty-five percent (85%) of the fair market value of the respective Shares and respective LP Interests in USLP to be agreed on between ASK Chemicals and SC (in the case of (i)) and between ASK Chemicals and Ashland (in case of (ii)), respectively. In case ASK Chemicals and SC or Ashland, respectively, cannot agree on the fair market value of the Shares and LP Interests in USLP within sixty (60) days after the shareholders' of ASK Chemicals have resolved the redemption of the relevant Shares in ASK Chemicals in accordance with Section 12.3 of the Articles of Association (the "Redemption Resolution") the fair market value of the

- 26 -

Shares and LP Interests in USLP shall be determined by applying the provisions of Section 11.4(b) mutatis mutandis, provided however, that (i) the opposing parties shall be ASK Chemicals on the one hand and SC and its Affiliates or Ashland and its Affiliates, respectively, on the other hand, and (ii) for the purposes of the separate processes associated with the implementation of the Redemption Right and the Purchase Right the Group Fair Market Value shall be allocated to the Shares and the LP Interests in USLP. ASK may exercise its Purchase Right for the relevant LP Interests in USLP only after Redemption Resolution has been taken. The Parties shall be obliged to undertake (or cause their Affiliates to undertake) all steps required to implement the Purchase Right on terms substantially similar to those as set forth in the SPA attache d hereto as Exhibit 11.4(d) to the extent such SPA relates to LP Interests in USLP. The Articles of Association shall provide for the Redemption Right.

Section 13.2 Survival. In case of a termination of this Agreement, for whatever reason, the provisions contained in ARTICLE XV, ARTICLE XVI and ARTICLE XVII shall survive, provided that in case of a termination of this Agreement in accordance with Section 13.1(c) above Section 13.1(d) shall survive in addition.

ARTICLE XIV

NON-COMPETITION OBLIGATION

Section 14.1 Scope of Non-Competition Obligation.

(a) SC and Ashland undertake, and undertake to cause their Affiliates, to not compete, directly or indirectly, with the Foundry Products' Business, except as otherwise contemplated in connection with the Transaction (as defined in the Master Formation Agreement), for as long as they are a Party to this Agreement. Such obligation not to compete shall include, without limitation, that SC and Ashland and their Affiliates shall not:

(i) serve or, as the case may be, let any of their employees serve with a Competitor (as defined below) as a director or officer, employee, consultant or otherwise;

(ii) engage, directly or indirectly, in the business of a Competitor or hold, directly or indirectly, an interest in a Competitor, except for shares in publicly listed corporations which represent a capital participation of less than 5%; or

(iii) influence or attempt to influence any customer, supplier, employee, consultant or other third party maintaining a contractual or other business relationship with any Group Company to terminate or discontinue such contractual or other business relationship or to reduce the volume of goods or services provided thereunder.

For purposes of this Agreement, "Competitor" shall mean any individual person or legal entity which is engaged in the Foundry Products Business at any time during the term of the non-compete obligation.

- 27 -

(b) The non-compete obligation under Section 14.1(a) above shall survive with respect to SC for a period of two years from the closing date of any sale of the Shares (and interests in USLP) from SC to Ashland in accordance with Section 11, and the non-compete obligation under Section 14.1(a) above shall survive with respect to Ashland for a period of two years from the closing date of any sale of the Shares (and interests in USLP) from Ashland to SC in accordance with Section 11.

(c) Nothing in this Section 14 shall prevent any of SC, Ashland and/or any of their respective Affiliates from acquiring, directly or indirectly, shares in, or the undertaking or assets of, any company which carries on a Foundry Products' Business (herein "Competing Business") if (i) such Competing Business or interest therein is acquired by the SC, Ashland and/or any of their respective Affiliates as part of a larger acquisition, and the revenues attributable to the Competing Business did not at the date of the acquisition amount to more than fifteen (15 %) of the total revenues of such larger acquisition; and (ii) (a) the Competing Business or interest is offered for sale on reasonable commercial terms within one (1) year from the acquisition, (b) the Group Companies are invited to participate in the sale process at the same time and (c) the Group Companies are treated in the sale process in the same manner as any other interested buyer (irrespective of whether a buyer can or cannot be found)

(d) If a Major Project has not been approved by the Supervisory Board and the Party whose Supervisory Board Member consented to the Major Project proceeded with the Major Project on its own behalf, then Sections 14.1(a) and (b) above shall not apply to such Party (and its Affiliates) to the extent it would prohibit such Party (and its Affiliates) to conduct the business relating to the relevant Major Project.

ARTICLE XV

CONFIDENTIALITY

Section 15.1 Confidentiality. Each Party undertakes to treat, and shall procure that its Affiliates treat, Proprietary Information (as defined in Section 15.2 below) strictly confidential and refrain from disclosing it to any third parties, unless such disclosure is explicitly permitted by this Agreement.

Section 15.2 Proprietary Information. "Proprietary Information" shall mean:

(a) with respect to the confidentiality obligations of either Party: the contents of (i) this Agreement, (ii) any related agreements or documents (whether legally binding or not), and (iii) any accompanying discussions and negotiations;

(b) with respect to the confidentiality obligations of Ashland: any information obtained in connection with the preparation, negotiation, execution or consummation of this Agreement and the transactions contemplated herein about SC, SC's Affiliates and their representatives; and

(c) with respect to the confidentiality obligations of SC: any information obtained in connection with the preparation, negotiation, execution or

- 28 -

consummation of this Agreement and the transactions contemplated herein about Ashland, Ashland's Affiliates and their representatives;

except for information that (i) in the case of items (a), (b) and (c) has come into the public domain or (ii) in the case of items (b) and (c) has been received from an independent source, save in either case where such information has come into the public domain or been received from an independent source following a breach by either Party, its Affiliates or their respective representatives of any confidentiality obligation provided for in this ARTICLE XV.

Section 15.3 Consented Disclosures. Without prejudice to the provisions of Section 11.4, a Party may disclose Proprietary Information to any third party only (i) if the relevant other Party has given its prior written consent to such disclosure, or (ii) if such disclosing Party intends to Transfer Shares in accordance with ARTICLE XI and the third party as potential transferee requests Proprietary Information in connection with its due diligence review, provided however, that the third party is subject to confidentiality obligat ions equivalent to the confidentiality obligations of the disclosing Party under this ARTICLE XV and that the scope of disclosure of Proprietary Information may not exceed the scope of disclosure which is standard for the kind of transactions underlying the third party's request. A disclosing Party shall be obliged to inform the relevant other Party of any disclosure made in accordance with this Section 15.3.

Section 15.4 Mandatory Disclosures. A Party may disclose Proprietary Information if and to the extent that such disclosure is mandatory pursuant to Applicable Law, governmental or court order, stock exchange regulations, accounting principles or required by any governmental, supervisory or regulatory body. Prior to making a mandatory disclosure, the disclosing Party shall inform the relevant other Party in writing of the need to make such disclosure and the circumstances requiring it and the Parties shall discuss and agree in go od faith upon defense measures, if any, or other appropriate means to protect the other Party's interests.

Section 15.5 Termination of Obligations. The obligations under this Section 15 shall remain in force up to five (5) years from the date one of the Parties ceases to be a shareholder, directly and indirectly, of ASK Chemicals, for whatever reason.

ARTICLE XVI

NOTICES

Section 16.1 Notices. Any notice, demand or request provided for in this Agreement, or served, given or made in connection with it, shall be in writing and shall be deemed properly served, given or made if delivered in person or sent by facsimile, electronic mail or registered mail or by a nationally recognized courier service that provides a receipt of delivery, in each case, to the addresses specified below (or to such other addresses, electronic mail addresses or facsimile numbers notified in the future by one Party to the ot her Party):

(a) If to Ashland (and/or any of its Affiliates):

Ashland Inc.

- 29 -

Attn: David L. Hausrath, General Counsel

P.O. Box 391, 50 E. RiverCenter Boulevard,

Covington, KY 41012-0391

USA

Fax: +1-859-815-5053

E-mail: dlhausrath@ashland.com

(b) If to SC (and/or any of its Affiliates):

Süd-Chemie Aktiengesellschaft

Attn: Dr. Ulrich Müller, General Counsel

Lenbachplatz 6

80333 München

Germany

Facsimile: +49-(0)89-5110407

E-mail: ulrich.mueller@sud-chemie.com

Section 16.2 Effectiveness. Notice given by personal delivery, certified mail or courier service shall be effective upon physical receipt. Notice given by facsimile shall be effective as of the date of confirmed delivery if delivered on or before 6:00 P.M. Central European Time on any Business Day at the place of receipt or the next succeeding Business Day if confirmed delivery is after 6:00 P.M. Notice given by electronic mail shall be effective as of the date it has been sent if sent on or before 6:00 P.M. Central European Tim e on any Business Day at the place of receipt or the next succeeding Business Day if it has been sent after 6:00 P.M. Central European Time Eastern Time on any Business Day or during any non-Business Day at the place of receipt.

ARTICLE XVII

MISCELLANEOUS

Section 17.1 Termination of Previous Shareholder Agreement. The Parties hereby terminate, upon this Agreement becoming effective, the previous shareholders' agreement ("Ashland GmbH Shareholders Agreement") entered into between them, dated April 14, 1970, which shall be of no further force and effect for the future except as provided for in its Section 13.

Section 17.2 Expenses. Each Party shall bear its (and its Affiliates') own cost and expenses incurred in anticipation of, relating to and in connection with the negotiation and execution of this Agreement and the transactions contemplated hereunder, it being understood that neither Party shall, directly or indirectly, pass on such costs and expenses to any entity or person which will become part of the Group.

Section 17.3 Foreign Currencies. Except as otherwise agreed herein, any currency conversions shall be determined using the European Central Bank's fixing rates as published on its website (www.ecb.int) shortly after 2.15 p.m. on the Business Day that occurs two (2) Business Days preceding the date on which the respective payment becomes due and payable.

- 30 -

Section 17.4 Language. All notices, communications and statements to be made by either Party under or in connection with this Agreement shall be made in the English language.

Section 17.5 Amendments. Any amendments to this Agreement (including amendments to this clause) shall be valid only, if made in writing, unless mandatory law provides for stricter form requirements.

Section 17.6 Consent Requirements. Except where explicitly stated otherwise herein, whenever in this Agreement any action of a Party is subject to the consent of the other Party, such consent must not be unreasonably withheld or delayed or granted subject only to unreasonable conditions.

Section 17.7 Exhibits. All exhibits and annexes to this Agreement (the "Exhibits") constitute an integral part of this Agreement. In the case of a conflict between any Exhibit and the provisions of this Agreement, the provisions of this Agreement shall prevail.

Section 17.8 Entire Agreement. This Agreement including its Exhibits together with the other transaction documents to be executed hereunder constitutes the entire agreement of the Parties concerning the subject matter hereof and supersedes all prior discussions and agreements among the Parties with respect to the subject matter hereof except as set forth in section 17.1.

Section 17.9 No Third Party Beneficiary. The terms and provisions of this Agreement are intended solely for the benefit of the Parties and their respective successors or permitted assigns, and it is not the intention of the Parties to confer any rights or remedies, neither directly or by way of a contract for the benefit of a third party, upon any person or entity other than the Parties, except as expressly otherwise provided for herein.

Section 17.10 Assignment. Save for Section 11.6, without the written consent of the other Parties, no Party shall be entitled to assign any rights or claims under this Agreement.

Section 17.11 Change of Control.

(a) A Change of Control of Ashland shall not trigger any rights under this Agreement or otherwise, in particular no right to terminate this Agreement and no right to Transfer any Shares.

(b) If a Change of Control of SC results in SC being controlled by a Designated Entity, then Ashland may, at its option at any time after such Change of Control of SC occurs, initiate the procedure set forth in Section 11.4. Any Change of Control of SC that does not result in SC being controlled by a Designated Entity shall not trigger any rights under this Agreement or otherwise, in particular no right to terminate this Agreement and no right to Transfer any Shares, but, however, Ashland shall have the right that two of the SC Supervisory Board Members may not be replaced until the fourth anniversary of the Closing Date, unless they are replaced by either Dr. Günter von Au or Dr. Hans-Joachim Müller.

- 31 -

Section 17.12 Exclusion of Remedies. Except as provided otherwise herein, neither Party shall be entitled (i) to set-off any rights and claims it may have against any rights or claims the other Party may have under this Agreement, or (ii) to refuse to perform any obligation it may have under this Agreement on the grounds that it has a right of retention, unless the rights or claims of the relevant Party claiming a right of set-off or retention have been acknowledged in writing by the relevant other Party or have been confirmed by final deci sion of the competent arbitral tribunal.

Section 17.13 Interpretation. The headings in this Agreement are inserted for convenience only and shall not affect the interpretation of this Agreement. Except as set forth otherwise, all references to "Section" refer to the corresponding Section of this Agreement. The word "including" shall not limit the preceding words or terms.

Section 17.14 Invalid Provisions. In the event that one or more provisions of this Agreement shall, or shall be deemed to, be invalid or unenforceable, the validity and enforceability of the other provisions of this Agreement shall not be affected thereby. In such case, the Parties agree to recognize and give effect to such valid and enforceable provision or provisions which correspond as closely as possible with the original commercial intent of the Parties. The same shall apply in the event that this Agreement contains any gaps or loophol es.

Section 17.15 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of Germany, without giving effect to any conflict or choice of law provision that would result in the imposition of another jurisdiction's law. The UN Convention on Contracts for the International Sale of Goods shall not be applicable.

Section 17.16 Arbitration.

(a) Any dispute, controversy or claim arising out of or relating to this Agreement or the breach, termination or validity thereof ("Dispute") shall be finally settled by arbitration in accordance with the Rules of Arbitration of the International Chamber of Commerce ("Rules") then in effect. The Parties recognize that it is in their best interests to resolve any Dispute as expeditiously as possible.

(b) The place of arbitration shall be Munich, Germany. Any meetings and hearings related to the arbitration shall be held in the English language. There shall be three arbitrators of whom, (i) one shall be nominated by the claimant, (ii) one shall be nominated by the respondent and (iii) one by the two arbitrators so nominated, in accordance with the Rules, which arbitrator shall serve as chairman of the Arbitral Tribunal (as defined in the Rules), within one (1) month following the confirmation of the nomination of the second arbitrator. Where there are multiple parties to the Dispute, whether as claimant or respondent, the multiple claimants, jointly, and the multiple respondents, jointly, shall nominate their respective arbitrator. If any of the arbitrators are not timely nomin ated, then upon request of any Party, any arbitrator(s) not timely nominated shall be appointed by the International Court of Arbitration of the International Chamber of Commerce, within two (2) weeks following receipt of a request in accordance with the Rules, provided, however, that if multiple claimants in their request for arbitration or multiple respondents within 15 days as from receipt of the request for arbitration cannot agree on an arbitrator, the ICC Court of

- 32 -

Arbitration shall appoint each member of the Arbitral Tribunal in accordance with Art. 10 (2) of the ICC Rules.

(c) The Terms of Reference (as defined in the Rules) shall be signed by the Parties as expeditiously as possible, however, no later than one (1) month after the confirmation of the appointment of the third arbitrator. The hearing on the merits shall be held as expeditiously as possible, but no later than three (3) months after the signing of the Terms of Reference unless otherwise decided by the Arbitral Tribunal.

(d) The arbitrators shall be bound by the terms and conditions of this Agreement and shall apply the substantive laws of Germany. If and to the extent that the Arbitral Tribunal should, notwithstanding the choice of law provided for under Section 17.15 hereof, be required to resolve on any conflicts of law, such conflicts shall exclusively be resolved applying the rules on conflicts of law as set forth in Articles 3 to 47 of the Introductory Act to the German Civil Code (Einführungsgesetz zum Bürgerlichen Gesetzbuch). The Arbitral Tribunal is empowered to award damages, declaratory relief and injunctive relief with regard to any Dispute only in accordance with the terms of this Agreement. Any award or final decisio n of the Arbitral Tribunal shall include a decision on costs, including, without limitation, fees of counsel. The Arbitral Tribunal shall order the Parties to bear the costs of the arbitration proceedings pro rata, i.e. to the extent they have prevailed with their claims in the arbitration.

(e) The award shall be rendered within one (1) month following the close of the hearing (and, except if otherwise expressly agreed to by the Parties, specifically excluding any extension of this time limit that may be ordered by the International Court of Arbitration pursuant to the Rules either at the request of the Arbitral Tribunal or upon its own initiative). The award shall be final and binding upon the Parties, and shall be the sole and exclusive remedy among the Parties regarding any claims, counterclaims or other issues presented to the Arbitral Tribunal.

(f) The Parties agree that if an Arbitral Tribunal has been appointed, the same Arbitral Tribunal shall be appointed to resolve any further dispute between the same parties and/or additional Parties governed by this Agreement if, as determined in the discretion of the Arbitral Tribunal, the further dispute is based on substantially similar facts or substantially similar issues or if the Arbitral Tribunal finds that it would be cost-efficient to consolidate such proceedings. Should the Arbitral Tribunal not be prepared to resolve the further dispute, a new tribunal shall be appointed with respect to the new dispute in accordance with Section 17.16(b).

(g) Notwithstanding Section 17.16(a), each Party shall be entitled to request injunctive relief or to initiate attachment proceedings in the competent ordinary courts of any jurisdiction with the exception of courts in the United States of America, provided however, that such exception shall not apply to injunctive relief proceedings in connection with Article XV.

(h) Notwithstanding the provisions of Section 17.16(a), each Party hereto shall be entitled to issue a third party notice ("Streitverkündung") to the other Party in

- 33 -

the event that it has initiated or is otherwise involved in litigation with a third party or third parties before the ordinary courts of any jurisdiction in accordance with the procedural rules of the respective jurisdiction.

EX-12 3 ex12.htm COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES ex12.htm

				EXHIBIT 12
ASHLAND INC.
COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES
(In millions)


	Three months ended
	December 31
	2010			2009
EARNINGS

Income from continuing operations	$	62		$	64
Income tax expense		31			22
Interest expense		25			35
Interest portion of rental expense		5			5
Amortization of deferred debt expense		4			6
Distributions less than earnings of
unconsolidated affiliates		(1	)		-
	$	126		$	132

FIXED CHARGES

Interest expense	$	25		$	35
Interest portion of rental expense		5			5
Amortization of deferred debt expense		4			6
Capitalized interest		-			1
	$	34		$	47

RATIO OF EARNINGS TO FIXED CHARGES		3.71			2.81

EX-31.1 4 ex311.htm CERTIFICATION OF JJ O'BRIEN ex311.htm

EXHIBIT 31.1

CERTIFICATIONS

I, James J. O’Brien, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Ashland Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 2, 2011

	/s/ James J. O’Brien
	James J. O’Brien
	Chairman and Chief Executive Officer
	(Principal Executive Officer)

EX-31.2 5 ex312.htm CERTIFICATION OF LM CHAMBERS ex312.htm

EXHIBIT 31.2

CERTIFICATIONS

I, Lamar M. Chambers, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Ashland Inc.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

5.	The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the Audit Committee of the registrant’s Board of Directors (or persons performing the equivalent functions):

a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 2, 2011

	/s/ Lamar M. Chambers
	Lamar M. Chambers
	Chief Financial Officer
	(Principal Financial Officer)

EX-32 6 ex32.htm SECTION 906 CERTIFICATION OF JJ O'BRIEN AND LM CHAMBERS ex32.htm

EXHIBIT 32

ASHLAND INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Ashland Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, James J. O’Brien, Chief Executive Officer of the Company, and Lamar M. Chambers, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ James J. O'Brien
James J. O'Brien
Chief Executive Officer
February 2, 2011


/s/ Lamar M. Chambers
Lamar M. Chambers
Chief Financial Officer
February 2, 2011

EX-101.INS 7 ash-20101231.xml INSTANCE DOC 0001305014 2009-12-31 0001305014 2009-09-30 0001305014 2010-12-31 0001305014 us-gaap:CommonStockMember 2010-12-31 0001305014 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0001305014 us-gaap:RetainedEarningsMember 2010-12-31 0001305014 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-12-31 0001305014 2010-09-30 0001305014 us-gaap:CommonStockMember 2010-09-30 0001305014 us-gaap:AdditionalPaidInCapitalMember 2010-09-30 0001305014 us-gaap:RetainedEarningsMember 2010-09-30 0001305014 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-09-30 0001305014 2010-10-01 2010-12-31 0001305014 us-gaap:CommonStockMember 2010-10-01 2010-12-31 0001305014 us-gaap:AdditionalPaidInCapitalMember 2010-10-01 2010-12-31 0001305014 us-gaap:RetainedEarningsMember 2010-10-01 2010-12-31 0001305014 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-10-01 2010-12-31 0001305014 2009-10-01 2009-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

No Q1

-43000000

54000000

1000000

6000000

-172000000

-125000000

4000000

3000000

2000000

6000000

19000000

0.31

0.28

1346000000

1210000000

false Ashland Inc.

11000000

4038000000

4041000000

826000000 841000000

1768000000

1838000000

452000000 459000000

1.09

1.10

21000000 0

1040000000

906000000

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block"><div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE O – CAPITAL STOCK</font></div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During the first quarter of fiscal 2011, the Board of Directors of Ashland announced and paid a quarterly cash dividend of 15 cents per share to eligible shareholders of record.  This amount was double the quarterly cash dividend of 7.5 c ents per share paid in the December 2009 quarter.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In November 2009, Ashland made a voluntary pension plan contribution of approximately 3.0 million shares of Ashland Common Stock, valued at $100 million on the date of transfer.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.2pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE A </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold">–</font><font style="DISPLAY: inline; FONT-SIZE: 10pt"> </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">BASIS OF PRESENTATION</font></font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The accompanying unaudited Condensed Consoli dated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial reporting and Securities and Exchange Commission regulations.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.  These statements omit certain information and footnote disclosures required for complete annual financial statements and, therefore, should be read in conjunction with Ashland’s Annual Report on Form 10-K for the fiscal year ended September 30, 2010.  Results of operations for the period ended December 31, 2010 are not necessarily indicative of results to be expected for the year ending September 30, 2011.  Certain prior period data has been reclassified in the Condensed Consolidated Financial Statements and accompanying footnotes to conform to current period presentat ion.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland is composed of four reporting segments:  Ashland Aqualon Functional Ingredients (Functional Ingredients), Ashland Hercules Water Technologies (Water Technologies), Ashland Performance Materials (Performance Materials) and Ashland Consumer Markets (Consumer Markets).  On November 5, 2010, Ashland signed a definitive agreement to sell substantially all of the assets and liabilities of Ashland Distribution (Distribution).  As a result of this expected sale, the operating results and assets and liabilities related to Distribution have been reflected as discontinued operations for all periods presented.&#16 0; See Notes D, E and Q for additional information on the Distribution divestiture and reporting segment results.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The preparation of Ashland’s Condensed Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues, expenses and related disclosures of contingent assets and liabilities as well as qualifying subsequent events.  Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets (including goodwill and intangible assets), employee benefit obligations, income taxes , and liabilities and receivables associated with asbestos litigation, environmental remediation and asset retirement obligations.  Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual results could differ significantly from the estimates under different assumptions or conditions.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland’s results are affected by domestic and international economic, political, legislative, regulatory and legal actions.  Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies, and changes in the prices of hydrocarbon-based products and other raw materials, can have a significant effect on operations.  While Ashland maintains reserves for anticipated liabilities and carries various levels of insurance, Ashland could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings relating to asbestos, environmental remediation or other matters.</font></div>

Yes

22000000

21000000

10-Q 4019982131

44000000

87000000

-18000000

69000000

67000000

374000000

417000000

352000000

406000000

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE E – DISCONTINUED OPERATIONS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 18pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 18pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As previously described in Note D, Ashland signed a definitive agreement with TPG on November 5, 2010 to sell substantially all of the assets and liabilities of Distribution.  Ashland has determined that this expected sale qualifies as a discontinued operation, in accordance with U.S. GAAP, since the company will not have significant conti nuing involvement in the distribution business upon closing of the transaction.  As a result, the previous operating results related to Distribution have been reflected as discontinued operations in the Statement of Consolidated Income, while assets and liabilities that are to be sold have been classified within the Condensed Consolidated Balance Sheet as held for sale.  Sales for the three month periods ended December 31, 2010 and 2009 were $856 million and $729 million, respectively.  The results of operations for the three month periods ended December 31, 2010 and 2009 are included in the table below.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt" >Ashland is subject to liabilities from claims alleging personal injury caused by exposure to asbestos.  Such claims result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley Stoker </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Corporation (Riley), a former subsidiary of Ashland, and from the acquisition of Hercules during fiscal 2009, a wholly owned subsidiary of Ashland.  Adjustments to the recorded litigation reserves and related insurance receivables continue periodically and primarily reflect updates to the estimates.  See Note M for more information related to the adjustments on asbestos liabilities and receivables.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> & lt;/div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland’s divestiture of Ashland Paving And Construction (APAC) during 2006 qualified as a discontinued operation.  As a result, the previous operating results, assets and liabilities related to APAC have been reflected as discontinued operations in the Condensed Consolidated Financial Statements.  Ashland has made subsequent adjustments to the gain on the sale of APAC, primarily relating to the tax effects of the sale, during the three month periods ended December 31, 2010 and 2009.  Such adjustments to these and other divested businesses may continue to occur in future periods and are reflected in the period they are determined and recorded in the discontinued operations caption in the Statements of Consolidated Income.</font></div> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Components of amounts reflected in the Statements of Consolidated Income related to discontinued operations are presented in the following table for the three months ended December 31, 2010 and 2009.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"><div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div><div style="MARGIN-LEFT: 18pt" align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="69%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#1 60;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="69%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" wid th="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="69%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" a lign="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="righ t"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income from discontinued operations (net of tax)</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: t imes new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Distribution <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td valign="bottom " width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>& lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-LEFT: 2%" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos-related litigation reserves and receivables</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-F AMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" no wrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gain on disposal of discontinued operations (net of tax)</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>< ;/td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 2%" valign="bottom" widt h="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">APAC</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times ne w roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total income from discontinued operations (net of tax)</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPL AY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bott om" width="69%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BOR DER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="69%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font>&l t;/td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#1 60;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div></div><div><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt" align="right"><div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)  </font></div></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three months ended December 31, 2010 an d 2009, the pretax income reported for Distribution was $32 million and $19 million, respectively.</font></div></td></tr></table></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div></div> <div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE D – DIVESTITURES</font></div><div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"> </div><div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Ashland Distribution</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">O n November 5, 2010, Ashland signed a definitive agreement with TPG Accolade, LLC (TPG) to sell substantially all of the assets of its global distribution business conducted by the Ashland Distribution (Distribution) segment.  The transaction is an asset sale with the total cash proceeds expected to be $930 million, before transaction fees and taxes, subject to post-closing working capital adjustments and certain other adjustments, as specified in the definitive agreement.  Ashland anticipates recording a significant gain, which includes a tax valuation allowance release of approximately $60 million to $70 million, upon the closing of the transaction, which is expected at the end of the March 2011 quarter.  The closing is subject to regulatory approvals and satisfaction of other customary closing conditions.  Ashland Distribution recorded sales of $3,419 million during the most recently completed fiscal year ended September 30, 2010 and e mploys approximately 2,000 employees across North America and Europe.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Since this transaction signifies Ashland’s exit from the Distribution business, it qualifies as a discontinued operation.  Therefore, the results of operations of Distribution have been classified as discontinued operations for all periods presented.  Certain indirect corporate costs previously allocated to the Distribution reporting segment that do not qualify for discontinued operations accounting classification are now reported as costs within the Unallocated and other section of continuing operations, and for the three months ended December  31, 2010 and 2009 were $7 million and $9 million, respectively.  Ashland is currently analyzing and developing plans to reduce these costs.  </font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland will retain and has agreed to indemnify TPG for certain liabilities of the Distribution business arising prior to the closing of the sale, which include pension and other postretirement benefits, as well as certain other potential liabilities, including certain litigation and environmental liabilities relating to the pre-closing period, as described in the agreement.  Costs related to these expenses were $4 million for the three months ended December 31, 2010 and 2009 and have been included within the Unallocated and other section of continuing operations.  </font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As part of this pending sale, Ashland expects to receive transition service fees for services to be provided to TPG subsequent to the completion of the sale.  While the transition service agreements are expected to vary in duration </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">depending upon the type of service provided, Ashland expects to reduce costs as the transition services are completed.  See Note E – Discontinued Operations for further information on the res ults of operations of Distribution for all periods presented.  </font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"></font> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As a result of this divestiture, the assets and liabilities of Distribution for prior periods have been reflected as assets and liabilities held for sale within the Condensed Consolidated Balance Sheets and are comprised of the following components:</font></div><div style="TEXT-INDENT: 0pt ; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.2pt" align="justify"> </div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block"><div style="MARGIN-LEFT: 18pt" align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZ E: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISP LAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions - unaudited)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width ="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td&g t;<td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">442</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">494</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" ali gn="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventories</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">210</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font sty le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">197</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font></div></td><td style ="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td>&l t;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current assets held for sale</font></div></td>& lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">656</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></t d><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">693</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> ;</td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property, plant and equipment, net</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE : 10pt">181</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bo ttom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill and intangible assets</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="D ISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Noncurrent assets held for sale</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">263</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><fo nt style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">261</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%">&l t;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="botto m" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade payables</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIG N: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">268</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">315</font></td& gt;<td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses and other liabilities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px so lid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td><td style="BORDER-BOT TOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current liabilities held for sale</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: blac k 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">274</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">321</font></td><td style="BOR DER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: i nline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div><div style="MARGIN-LEFT: 18pt" align="left"> </div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" a lign="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In addition to the Distribution assets and liabilities identified above as held for sale, Ashland held other noncurrent assets for sale of $8 million and $9 million as of December 31, 2010 and September 30, 2010, respectively, primarily related to non-operational properties and certain Valvoline Instant Oil Change<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</font> locations.  The noncurrent assets held for sale are required to be measured at carrying value or below this level if an impairment is indicated.  The fair values were based on definitive agreements of sale or other market quotes which would be considered significant unobservable market inputs (Level 3) within the fair value hierarchy.  See also Note G – Fair Value Measurements for further information on the fair value hierarchy.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Castings Solutions Joint Venture</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In July 2010, Ashland and Süd-Chemie AG (Süd-Chemie) signed an agreement for the formation of an expanded global joint venture serving the foundry chemical sector.  The transaction closed on November 30, 2010 and combined three businesses :  Ashland’s Castings Solutions business group, Süd-Chemie’s Foundry-Products and Specialty Resins business unit, and Ashland-Südchemie-Kernfest GmbH (ASK), the existing fifty-percent owned European-based joint venture between Ashland and Süd-Chemie, for which Ashland historically only recognized equity income of the joint venture within its consolidated results.  Ashland’s Castings Solutions and ASK businesses recorded sales of $279 million and $145 million, respectively, during each businesses’ most recently completed fiscal year.  The Foundry-Products and Specialty Resins business unit of Süd-Chemie contributed to the joint venture generated sales of approximately $146 million for its most recently completed fiscal year.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div> ;<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During the fifth year of the joint venture’s operations, Ashland will have the option to sell its shares in the expanded global joint venture to Süd-Chemie under mutually agreed terms.  If Ashland does not execute this option by the end of the sixth year of the joint venture’s operations, Süd-Chemie will have the option to acquire Ashland’s shares under mutually agreed terms.  Under both options, if mutually agreed terms cannot be reached, then the fair market value of the shares will be determined through an appraisal process set forth in the agreement.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"> </div><div style="TEXT-INDENT: 0p t; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Upon closing of the transaction, the joint venture distributed a $21 million net payment to Ashland in accordance with the agreement.  Ashland anticipates receiving an additional cash payment from the joint venture during the </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">March 2011 quarter, resulting from post-closing activities and measurements set forth in the agreement, which is expected to be approximately $25 million.  Ashland recognized a pretax gain of $19 million, attributable to the fair market value of the net assets contributed to the joint venture.  For the majority of the valuation of the contributed assets and liabilities, Ashland utilized the discounted cash flow method; however, the adjusted book value method was also used in some areas of the valuation.  The gain was included in the net gain on acquisitions and divestitures caption in the Statement of Consolidated Income for the three months ended December 31, 2010.  The recorded values of assets and liabilities contributed by Ashland to the expanded joint venture, excluding equity interests were as follows:  </font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="86%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td>& lt;td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assets</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOT TOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(liabilities)</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> Cash</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accoun ts receivable</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT- SIZE: 10pt">Inventories</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new r oman; FONT-SIZE: 10pt">Property, plant and equipment</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: i nline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DI SPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade and other payables</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN- RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other noncurrent assets (liabilities) - net</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></t d></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">146</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&g t; </font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div></div><div style="TEXT-INDENT: 0pt; DISP LAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland’s equity interest in the expanded joint venture qualifies for equity method accounting treatment under U.S. GAAP.  As a result, future reported results of the Castings Solutions business will no longer include the sales, cost of sales or selling, general and administrative costs related to this business; however, Ashland will include the financial effects within the equity income caption of the Statements of Consolidated Income.  In addition, the expanded joint venture will leave certain stranded costs that Ashland is currently analyzing and developing plans to reduce.</font></div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 1 8pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Pinova divestiture</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 18pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In January 2010, Ashland sold its refined wood rosin and natural wood terpenes business, formerly known as Pinova, a business unit of Functional Ingredients, to TorQuest Partners in a transaction valued at approximately $75 million before tax, which was comprised of $60 million in cash and a $15 million five-year promissory note from TorQuest Partners.  The Pinova business, with annual sales of approximately $85 million per year, had approximately 200 employees along with an associated manufacturing facility located in Brunswick, Georgia.  As part of this transaction, TorQuest Partners has agreed to continue to manufacture certain products on behalf of Ashland.  </font></div> Yes 0001305014 -43000000 57000000

1000000

-2000000

26000000

404000000

523000000

112000000

23000000

12000000

93000000 86000000 --09-30 Ashland Inc. 12000000 9000000

4000000

6000000

3877000000

3803000000

1000000

665000000

682000000

3482000000

3557000000

-345000000

-363000000

640000000

727000000

77000000

71000000

0.15

0.075

99000000

127000000

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE M – LITIGATION, CLAIMS AND CONTINGENCIES</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Asbestos litigation</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font s tyle="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland and Hercules, a wholly owned subsidiary of Ashland, have liabilities from claims alleging personal injury caused by exposure to asbestos.  To assist in developing and annually updating independent reserve estimates for future asbestos claims and related costs given various assumptions, Ashland retained Hamilton, Rabinovitz & Associates, Inc. (HR&A).  The methodology used by HR&A to project future asbestos costs is based largely on recent experience, including claim-filing and settlement rates, disease mix, enacted legislation, open claims, and litigation defense.  The claim experience of Ashland and Hercules are separately compared to the results of previously conducted third party epidemiological studies estimating the number of people likely to develop asbestos-related diseases.  Those studies were undertaken in connection with nati onal analyses of the population expected to have been exposed to asbestos.  Using that information, HR&A estimates a range of the number of future claims that may be filed, as well as the related costs that may be incurred in resolving those claims.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland asbestos-related litigation</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The c laims alleging personal injury caused by exposure to asbestos asserted against Ashland result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley Stoker Corporation, a former subsidiary.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The amount and timing of settlements and number of open claims can fluctuate significantly from period to period.  A summary of Ashland asbestos claims activity, excluding those related to Hercules, follows.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div ali gn="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="27%" colspan="7"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" wi dth="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bot tom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" vali gn="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="27%" colspan="7"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%" align="left"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%" align="left"><font style="D ISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" v align="bottom" width="27%" colspan="7"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="37%" colspan="9"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"& gt; </font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years ended September 30</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In thousands)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inli ne; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td&g t;<td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="righ t"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGH T: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new rom an; FONT-SIZE: 10pt">2008</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Open claims - beginning of period</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div st yle="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       83</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     100</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     100</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times ne w roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     115</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&# 160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     134</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">New claims filed&l t;/font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DIS PLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">         1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width ="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">         2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FO NT-FAMILY: times new roman; FONT-SIZE: 10pt">         2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">         4</font> </div></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Claims settled</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DI SPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       (1</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><fon t style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       (1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAM ILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       (1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FA MILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       (2</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Claims dismissed</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       (8</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></t d><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     (18</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT - -ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     (16</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font s tyle="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     (21</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Open claims - end of period</font ></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="l eft"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       92</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style=" DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       83</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FA MILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     100</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">   </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">     115</font></div></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font>< /td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" widt h="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&a mp;#160;</font></td></tr></table></div><div align="left"> </div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">A progression of activity in the asbestos reserve is presented in the following table.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bott om" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: b lack 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&a mp;#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: t imes new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width= "10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: ti mes new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="10"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years ended September 30</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: in line; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"& gt; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2008</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos reserve - beginning of period</font></div></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline ; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">537</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"> ;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">543</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">543</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valig n="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">572</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>< /td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">610</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve adjustment</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#16 0;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FO NT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"& gt;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="TEXT- ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts paid</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9% "><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(12</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" widt h="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALI GN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(40</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos reserve - end of period</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right "><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">526</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" vali gn="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">531</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN : right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">537</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">543</font></td><td style="BORDER-BOTTOM: black 4px dou ble; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">572</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></ tr><tr bgcolor="white"><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#1 60;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font sty le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div><div> </div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">From the range of estimates, Ashland records the amount it believes to be the best estima te of future payments for litigation defense and claim settlement costs, which generally approximates the mid-point of the estimated range of exposure from model results.  Ashland reviews this estimate and related assumptions quarterly and annually updates the results of a non-inflated, non-discounted approximate 50-year model developed with the assistance of HR&A.  Total reserves for asbestos claims were $526 million at December 31, 2010 compared to $537 million at September 30, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Excluding the Hercules asbestos claims further described below, Ashland has insurance coverage for most of the litigation defen se and claim settlement costs incurred in connection with its asbestos claims, and coverage-in-place agreements exist with the insurance companies that provide most of the coverage currently being accessed.  As a </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">result, increases in the asbestos reserve have been largely offset by probable insurance recoveries.  The amounts not recoverable generally are due from insurers that are insolvent, rather than as a result of uninsured claims or the exhaustion of Ashland’s insurance coverage.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">For the Ashland asbestos-related obligations, As hland has estimated the value of probable insurance recoveries associated with its asbestos reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage, including an assumption that all solvent insurance carriers remain solvent.  Approximately 69% of the estimated receivables from insurance companies are expected to be due from domestic insurers, of which approximately 84% have a credit rating of B+ or higher by A. M. Best, as of December 31, 2010.  The remainder of the insurance receivable is due from London insurance companies, which generally have lower credit quality ratings, and from Underwriters at Lloyd’s, whose insurance policy obligations have been transferred to a Berkshire Hathaway entity.  During the December 2009 quarter, Ashland entered into a new agreement with a number of London market insurance companies with respect to coverage for asbestos-related insurance c laims.  As a result, a $12 million increase to the Ashland asbestos receivable was recorded within the Condensed Consolidated Balance Sheet as of December 31, 2009, which had a $9 million (after-tax) effect on the Statement of Consolidated Income for the December 2009 quarter within the discontinued operations caption.  As a result of this agreement and other revised estimates, Ashland no longer discounts any portion of the asbestos receivable at this time.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">At December 31, 2010, Ashland’s receivable for recoveries of litigation defense and claim settlement costs from insurers amounted to $414 million (excluding the He rcules receivable for asbestos claims), of which $59 million relates to costs previously paid.  Receivables from insurers amounted to $421 million at September 30, 2010.  During the June 2010 quarter, the model used for purposes of valuing the asbestos reserve described above, and its impact on valuation of future recoveries from insurers, was updated.  This model update, along with likely settlement adjustments, caused an additional $24 million net increase in the receivable for probable insurance recoveries.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Hercules asbestos-related litigation</font></div><div style="TEXT- INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Hercules, a wholly-owned subsidiary of Ashland, has liabilities from claims alleging personal injury caused by exposure to asbestos.  Such claims typically arise from alleged exposure to asbestos fibers from resin encapsulated pipe and tank products which were sold by one of Hercules’ former subsidiaries to a limited industrial market.  The amount and timing of settlements and number of open claims can fluctuate significantly from period to period.  A summary of Hercules’ asbestos claims activity follows.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&# 160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="23%" colspan="5"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZ E: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" colspan="8"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="23%" colspan="5"><div style="TEXT-INDENT: 0p t; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: center" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: center" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: center" valign="bottom" width="26%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ye<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ar ended</font></font></td></ tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="42%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="23%" colspan="5"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roma n; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="26%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY : inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In thousands)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new rom an; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%">  (a)</td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Open claims - beginning of period</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       20</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td>< ;td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       21</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT- ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TE XT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td></tr><tr bgcolor="white"><td valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">New claims filed</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">& #160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMI LY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td va lign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline ; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Claims dismissed/settled</font></div></td><td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </ font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left">& lt;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><t d style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Open c laims - end of period</font></div></td><td style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4p x" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       21</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width ="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       20</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left">&l t;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">       21</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width ="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bo ttom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td></tr></table></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)      Beginning of period represents acquisition date of November 13, 2008.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font s tyle="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">A progression of activity in the asbestos reserve is presented in the following table.</font></div><br /><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">& amp;#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FO NT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLA Y: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="42%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td styl e="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign= "bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px sol id" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%" colspan="2"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009 </font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  (a) </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos reserve - beginning of period</font></div></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"& gt;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">375</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">484</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td val ign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">484</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font>& lt;/td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">233</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve adjustments <font style="DISPLAY: inline; FONT-SIZE: 10pt">(b)</font></font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="D ISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(35</font></td><td style="TEXT-ALIGN: left" valig n="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(93</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td>&l t;td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">261</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts paid</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: ti mes new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline ; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style ="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap= "nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos reserve - end of period</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-F AMILY: times new roman; FONT-SIZE: 10pt">370</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">447</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">375</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><f ont style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">484</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>& lt;/td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DI SPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font>      Beginning of period represents acquisition date of November 13, 2008.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b)      Includes purchase accounting adjustments recorded during 2010 and 2009 as part of purchase price al locations for the Hercules acquisition.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During the December 2009 quarter, Ashland essentially completed the final valuation assessment of the Hercules asbestos claims liability existing as of the acquisition date and underlying claim files as part of transitioning to a standardized claims management approach.  This assessment resulted in a $35 million and $22 million reduction to the asbestos liability and receivable, respectively, which was accounted for as an adjustment to Hercules’ opening balance sheet since the adjustment related to claims that had been incurred as of the acquisition date.  During the most recen t annual update of this estimate, completed during the June 2010 quarter, it was determined that the liability for asbestos claims should be reduced by $58 million.  Based upon review of the assumptions underlying the asbestos valuation model and the most recent claim filing and settlement trend rates for both pre- and post-acquisition periods, Ashland determined that $14 million of the $58 million adjustment should be recorded to goodwill, which was partially offset by $6 million for an increase in probable insurance recoveries, totalling to a net $8 million adjustment to goodwill.  Total reserves for Hercules asbestos claims were $370 million at December 31, 2010 compared to $375 million at September 30, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIG HT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">For the Hercules asbestos-related obligations, Ashland has estimated the value of probable insurance recoveries associated with its asbestos reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage, including an assumption that all solvent insurance carriers remain solvent.  The estimated receivable consists exclusively of domestic insurers, of which approximately 98% have a credit rating of B+ or higher by A.M. Best, as of December 31, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As of December 31, 2010 and S eptember 30, 2010, the receivables from insurers amounted to $68 million.  As previously mentioned, during the June 2010 quarter, the model used for purposes of valuing the asbestos reserve and its impact on valuation of future recoveries from insurers was updated.  This model update along with likely settlement adjustments caused a $28 million reduction in the receivable for probable insurance recoveries, $6 million of which was recorded to goodwill.  For the Hercules asbestos-related obligations, certain reimbursements pursuant to coverage-in-place agreements with insurance carriers exist.  As a result, increases in the asbestos reserve are partially offset by probable insurance recoveries.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Asbestos litigation cost projection</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Projecting future asbestos costs is subject to numerous variables that are extremely difficult to predict.  In addition to the significant uncertainties surrounding the number of claims that might be received, other variables include the type and severity of the disease alleged by each claimant, the long latency period associated with asbestos exposure, dismissal rates, costs of medical treatment, the impact of bankruptcies of other companies that are co-defendants in claims, uncertainties surround ing the litigation process from jurisdiction to jurisdiction and from case to case, and the impact of potential changes in legislative or judicial standards.  Furthermore, any predictions with respect to these variables are subject to even greater uncertainty as the projection period lengthens.  In light of these inherent uncertainties, Ashland believes that the asbestos reserves for Ashland and Hercules represent the best estimate within a range of possible outcomes.  As a part of the process to develop these estimates of future asbestos costs, a range of long-term cost models was developed.  These models are based on national studies that predict the number of people likely to develop asbestos-related diseases and are heavily influenced by assumptions regarding long-term inflation rates for indemnity payments and legal defense costs, as well as other variables mentioned previously.</font></div><div style="TEXT-INDENT: 0p t; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland has currently estimated in various approximate 50-year models that it is reasonably possible that total future litigation defense and claim settlement costs on an inflated and undiscounted basis could range as high as approximately $830 million for the Ashland asbestos-related litigation and approximately $570 million for the Hercules asbestos-related litigation (or approximately $1.4 billion in the aggregate), depending on the combination of assumptions selected in the various models.  If actual experience is worse than projected, relative to the number of claims filed, the severity of alleged disease associated with those claims or costs incurred to resolve those claims, Ashland may need to furthe r increase the estimates of the costs associated with asbestos claims and these increases could potentially be material over time.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Environmental remediation and asset retirement obligations</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland and Hercules are subject to various federal, state and local environmental laws and regulations that require environment al assessment or remediation efforts (collectively environmental remediation) at multiple locations.  At December 31, 2010, such locations included 93 waste treatment or disposal sites where Ashland and/or Hercules have been identified as a potentially responsible party under Superfund or similar state laws, 152 current and former operating facilities (including certain operating facilities conveyed to MAP) and about 1,225 service station properties, of which 115 are being actively remediated.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland’s reserves for environmental remediation amounted to $204 million at December 31, 2010 compared to $207 million at September 30, 2010, o f which $159 million at December 31, 2010 and $162 million at September 30, 2010 were classified in other noncurrent liabilities on the Condensed Consolidated Balance Sheets.  </font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table provides a reconciliation of the changes in the environmental contingencies and asset retirement obligations during the three months ended December 31, 2010 and 2009.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="left"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td sty le="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td val ign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY : times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt " align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve - beginning of period</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$ </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">207</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">221</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMI LY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 3%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inherited Hercules obligations</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap= "nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-LEFT: 3%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disbursements, net of cost recoveries</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 1 0pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 3%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revised obligation estimates and accretion</font></div></td><td valign="bottom" width="3%" align="right"><font style="D ISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right " valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 3%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font styl e="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" w idth="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve - end of period</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">204</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DI SPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">222</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td& gt;<td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div>< /div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The total reserves for environmental remediation reflect Ashland’s estimates of the most likely costs that will be incurred over an extended period to remediate identified conditions for which the costs are reasonably estimable, without regard to any third-party recoveries.  Engineering studies, probability techniques, historical experience and other factors are used to identify and evaluate remediation alternatives and their related costs in determining the estimated reserves for environmental remediation.  Ashland continues to discount certain environmental sites and regularly adjusts its reserves as environmental remediation continues.  Ashland has estimated the value of its probable insurance recoveries associated with its environmental reserve based on management’s interpretations and estimates surrounding the available or applicable insurance coverage.  At December 31, 2010 and September 30, 2010, Ashland’s recorded receivable for these probable insurance recoveries was $29 million and $30 million, respectively.  Environmental remediation expense, included within the selling, general and administrative expenses caption of the Statements of Consolidated Income, amounted to $5 million and $2 million for the three months ended December 31, 2010 and 2009, respectively.  Environmental remediation expense, net of receivable activity, was $4 million and $1 million for the three months ended December 31, 2010 and 2009, respectively.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="jus tify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Environmental remediation reserves are subject to numerous inherent uncertainties that affect Ashland’s ability to estimate its share of the costs.  Such uncertainties involve the nature and extent of contamination at each site, the extent of required cleanup efforts under existing environmental regulations, widely varying costs of alternate cleanup methods, changes in environmental regulations, the potential effect of continuing improvements in remediation technology, and the number and financial strength of other potentially responsible parties at multiparty sites.  Although it is not possible to predict with certainty the ultimate costs of environmental remediation, Ashland currently estimates that the upper end of the reasonably possible range of future costs for identified sites could be as high as approximately $360 million.  No individual remediati on location is material, as the largest reserve for any site is less than 10% of the remediation reserve.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Other legal proceedings and claims</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland Consumer Markets has established an engine guarantee associated with its Valvoline<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</fo nt> product line.  Consumers register their vehicles to qualify for the guarantee.  Ashland insures this program with a third party and therefore carries no reserve for this guarantee program.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In addition to the matters described above, there are other various claims, lawsuits and administrative proceedings pending or threatened against Ashland and its current and former subsidiaries.  Such actions are with respect to commercial matters, product liability, toxic tort liability, environmental and other matters, which seek remedies or damages, some of which are for substantial amounts.  While these a ctions are being contested, their outcome is not predictable.</font></div>

4000000

26000000

2083000000

2148000000

0.79

0.84

20000000

-1000000

-38000000

55000000

581000000

575000000

1114000000

1108000000

271000000

270000000

25000000

22000000

12000000

13000000

17000000

39000000

45000000

2705000000

2833000000

1005000000

1115000000

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE N </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold">–</font><font style="DISPLAY: inline; FONT-SIZE: 10pt"> </font><font style="DISPLAY: inline; FONT-WEIGHT: bold">EARNINGS PER SHARE</font></font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following is the computation of basic and diluted earnings per share (EPS) from continuing op erations.  Stock options, SARs and warrants (assumed as part of the Hercules acquisition) available to purchase shares outstanding for each reporting period whose grant price was greater than the average market price of Ashland Common Stock for each applicable period were not included in the computation of income from continuing operations per diluted share because the effect of these instruments would be antidilutive.  The total number of these shares outstanding was approximately 2.0 million and 2.1 million as of December 31, 2010 and 2009, respectively.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>< ;/td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARG IN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions except per share data)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px so lid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</fon t></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Numerator</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inlin e; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Numerator for basic and diluted EPS – Income</font></div></td><td valign="bottom" width="3%"><font style="DISP LAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td st yle="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">from continuing operations</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" wid th="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td val ign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Denominator</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Denominator for basic EPS – Weighted-average</font ></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE : 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">common shares outstanding</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style ="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77</font></td><td style="TEXT-ALIGN: left" va lign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Share based awards convertible to common shares</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" vali gn="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-A LIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Denominator for diluted EPS – Adjusted weighted-</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&a mp;#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">average shares and assumed conversions</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">80</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="now rap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="botto m" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EPS from continuing operations</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> < /font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times n ew roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">.79</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">.84</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"& gt;<td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">.78</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td val ign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">.82</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> < /font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times n ew roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div></div>

10000000

25000000

231358

0.78

0.82

1.11

1.13

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE I – GOODWILL AND OTHER INTANGIBLES  </font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In accordance with U.S. GAAP, Ashland reviews goodwill and other intangible assets for impairment annually and when events and circumstances indicate an impairment may have occurred.  The annual assessment is performed as of July 1 and consists of Ashland determining each reporting unit&#8217 ;s current fair value compared to its current carrying value.  Ashland has determined its reporting units for allocation of goodwill include the Functional Ingredients, Water Technologies, Performance Materials and Consumer Markets reportable segments.  Prior to its sale to TPG, Distribution was treated as a separate reporting unit for allocation of goodwill.  Ashland performed its most recent annual goodwill impairment test as of July 1, 2010, and determined at that time, that no impairment existed.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following is a progression of goodwill by segment for the period ended December 31, 2010.</font></div>&l t;div style="TEXT-INDENT: 0pt; DISPLAY: block"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td&g t;<td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new ro man; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="28%" align="left"><font st yle="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Functional</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDEN T: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Water</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performance</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="2%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consumer</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td ><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align ="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ingredients</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Technologies</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Materials</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Markets</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> < ;/font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at September 30, 2010</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,080</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="botto m" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">620</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">333</font></td><td style="TEXT- ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font& gt;</td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,148</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Divestitures</font>< ;/div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roma n; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(52</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&l t;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"&g t;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(52</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Currency translation adjustment</font></div></td ><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>< /td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> < ;/font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>< /td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">( 13</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2010</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="B ORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,067</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">620</font></td& gt;<td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">281</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10 pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,083</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" align="left"><font style="DISPLAY: in line; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" ali gn="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2p x solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td& gt;<td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SI ZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div></div><div style="MARGIN-LEFT: 18pt"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="95%"><tr valign="top"><td style="TEXT-ALIGN: left; WIDTH: 31px"><div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)   </font></div></td><td width="1138"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN- RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Within the Performance Materials reportable segment as of September 30, 2010, because further discrete financial information is provided and management regularly reviews this information, this reportable segment was further broken down into the Castings Solutions and Composite Polymers/Specialty Polymers and Adhesives reporting units.  Goodwill consisted of $52 million and $281 million, respectively, for the Castings Solutions and Composite Polymers/Specialty Polymers and Adhesives reporting units as of September 30, 2010.  The reduction of $52 million of goodwill is related to the contribution of Ashland’s Castings Solutions business to the expanded global joint venture with <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">Süd-Chemie</font>.</font></div></td></tr></table></div><di v style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Intangible assets principally consist of trademarks and trade names, intellectual property, customer lists and sale contracts.  Intangible assets are amortized on a straight-line basis over their estimated useful lives.  The cost of trademarks and trade names is amortized principally over 15 to 25 years, intellectual property over 5 to 20 years, customer relationships over 3 to 24 years and other intangibles over 2 to 50 years.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style=" TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Certain intangible assets within trademarks and trade names have been classified as indefinite lived and had a balance of $290 million as of December 31, 2010 and September 30, 2010.  In accordance with U.S. GAAP, Ashland annually reviews these intangible assets for possible impairment whenever events or changes in circumstances indicate that carrying amounts may not be recoverable.  In conjunction with the July 1 annual assessment of indefinite-lived intangible assets, Ashland’s models did not indicate any impairment.  Intangible assets were comprised of the following as of December 31, 2010 and September 30, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MA RGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td> <td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td&g t;<td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="58%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="10"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31, 2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width= "3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">& lt;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLA Y: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">carrying</font& gt;</div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY : times new roman; FONT-SIZE: 10pt">amount</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amortization</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman ; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amount</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font s tyle="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks and trade names</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">353</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style=" TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(28</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">325</font></td& gt;<td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intellectual property</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33 1</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">263</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relationships</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPL AY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">579</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(87</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">492</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </f ont></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td><td style="BORDER-BOTTOM: black 2px s olid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN- RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total intangible assets</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,298</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADD ING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(209</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER - -BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,089</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1% "><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style= "TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"> </div></div><div st yle="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE : 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="58%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="10"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30, 2010</font></div></td><td style="BORDER - -BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font ></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net</font></div></td><td style="TEXT-ALIGN: left" val ign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width= "3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new r oman; FONT-SIZE: 10pt">carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amount</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amortization</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="D ISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amount</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; M ARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks and trade names</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">353</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">& ;#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">326</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intellectual property</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAM ILY: times new roman; FONT-SIZE: 10pt">331</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(63</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right">&l t;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">268</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relationships</font></div></td><td valign="bottom" width ="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">583</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> </td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(78</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">505</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39</font></td ><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SI ZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0 pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total intangible assets</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,306</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#1 60;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(195</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160 ;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,111</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style ="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&a mp;#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div><div align="left"> </div></ div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Amortization expense recognized on intangible assets for the three months ended December 31 was $17 million for 2010 and $18 million for 2009 and is primarily included in the selling, general and administrative expenses caption of the Statements of Consolidated Income.  Estimated amortization expense for future periods is $69 million in 2011 (includes three months actual and nine months estimated), $67 million in 2012, $66 million in 2013, $64 million in 2014 and $62 million in 2015.</font></div>

2010-12-31

1000000

4000000

-620000000

62000000

64000000

286000000

284000000

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold"><font style="FONT-VARIANT: small-caps; DISPLAY: inline">NOTE P – </font>STOCK INCENTIVE PLANS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland has stock incentive plans under which key employees or directors are granted stock-settled stock appreciation rights (SARs), performance share awards or nonvested stock awards.  Each program is typically a long-term incentive plan d esigned to link employee compensation with increased shareholder value or reward superior performance and encourage continued employment with Ashland.  Ashland recognizes compensation expense for the grant date fair value of stock-based awards over the applicable vesting period.  Stock-based compensation expense was $4 million and $3 million for the three months ended December 31, 2010 and 2009, respectively, and is included in the selling, general and administrative expenses caption of the Statements of Consolidated Income.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">SARs</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0p t; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">SARs are granted to employees or directors at a price equal to the fair market value of the stock on the date of grant and typically become exercisable over periods of one to three years.  Unexercised SARs lapse essentially ten years after the date of grant.  SARs granted for the three months ended December 31, 2010 and 2009 were 0.6 million.  As of December 31, 2010, there was $18 million of total unrecognized compensation costs related to SARs.  That cost is expected to be recognized over a weighted-average period of 2.5 years.  Ashland estimates the fair value of SARs granted using the Black-Scholes option-pricing model.  This mode l requires several assumptions, which Ashland has developed and updates based on historical trends and current market observations.  The accuracy of these assumptions is critical to the estimate of fair value for these equity instruments.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Nonvested stock awards</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Nonvested stock awards are granted to employees or directors at a price equal to the fair market value of the stock on the date of grant and are forfeitable until vesting requirements are met, which is generally over a one-to-five-year period.  However, such shares are subject to forfeiture upon termination of service before the vesting period ends.  Nonvested stock awards entitle employees or directors to vote the shares and to receive any dividends (or dividend equivalents) upon grant.  Nonvested stock awards granted for the three months ended December 31, 2010 and 2009 were 12,100 and 30,000 shares, respectively.  As of December 31, 2010, there was $6 million of total unrecognized compensation costs related to nonvested stock awards.  That cost is expected to be recognized over a weighted-average period of 2.2 years.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">  </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Performance shares</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Performance share/unit awards are granted to certain key employees and are tied to Ashland’s overall financial performance relative to the financial performance of a selected industry peer group.  Ashland believes that the focus on relative performance encourages management to make decisions that create shareholder value.  Awards are granted annually, with each award covering a three-year performance cycle.  Historically, each performance share/unit is convertible to one share of Ashland Common Stock or cash.  As a result, these plans are recorded as a liability in the Condensed Consolidated Balance Sheets within the other noncurrent liabilities caption.  Performance measures used to determine the actual number of performance shares issuable upon vesting include an equal weighting of Ashland’s total shareholder return (TSR) performance and Ashland’s return on investment (ROI) performance as compared to the performance peer group over the three-year performance cycle.  TSR relative to </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">peers is considered a market condition while ROI is considered a performance condition under applicable U.S. GAAP.  Nonvested performance shares/units do not entitle employees to vote the shares or to receive a ny dividends thereon.  Performance shares/units granted for the three months ended December 31, 2010 and 2009 were 0.2 million.  As of December 31, 2010, there was $11 million of total unrecognized compensation costs related to performance shares/units.  That cost is expected to be recognized over a weighted-average period of 2.4 years.</font></div>

-3000000

-24000000

5000000

4876000000

4860000000

623000000

514000000

336000000

1433000000

1324000000

2011

274000000

321000000

3003000000

3096000000

-27000000

-41000000

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE C – ACQUISITIONS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Ara Quimica</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In April 2010, Ashland acquired the re maining 50% interest in Ara Quimica S.A. (Ara Quimica), a leading producer of custom unsaturated polyester resin formulations for the composites industry in South America, for $28 million.  Prior to the acquisition, Ashland owned a 50% interest in Ara Quimica, which it recorded as an equity method investment within the Performance Materials reporting segment.  Ara Quimica recorded sales of approximately $56 million from its most recent fiscal year ended September 30, 2010.  As a result of this transaction, Ashland recorded $19 million of current assets and $61 million of long-term assets, which included $55 million of goodwill and intangible assets.  In addition, Ashland recorded $18 million of current liabilities and $6 million of noncurrent liabilities.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="T EXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Hercules</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">On November 13, 2008, Ashland completed its acquisition of Hercules Incorporated (Hercules).  The total merger consideration for outstanding Hercules Common Stock was $2,594 million, including $2,096 million in cash, $450 million in Ashland Common Stock with the remaining value of the transaction related to cash consideration and value for restricted stock units, stock options and transaction costs.  In addition, Ashland inherited $798 million in debt as a part of the transaction.  The acquired businesses of Hercules now comprise the Functional Ingredients reporting segment, as well as a significant portion of the Water Technologies reporting segment.  The total debt borrowed upon the closing of the merger was approximately $2,300 million with the remaining cash consideration for the transaction paid from Ashland’s existing cash at the date of the transaction.</font></div>

4000000

3000000

-3000000

-2000000

-3000000

-6000000

29000000

28000000

1368000000

1372000000

87000000

86000000

12000000

6000000

-12000000

9349000000

9531000000

22000000

-7000000

21000000

73000000

74000000

257000000

9349000000

9531000000

1235000000

1258000000

1089000000

1111000000

61000000

49000000

656000000

693000000

497000000

447000000

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE G – FAIR VALUE MEASUREMENTS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As required by U.S. GAAP, Ashland uses applicable guidance for defining fair value, the initial recording and periodic remeasurement of certain assets and liabilities measured at fair value and related disclosures for instruments measured at fair value.  Fair value accounting guidance establishes a fair value hierarchy, which pri oritizes the inputs to valuation techniques used to measure fair value into three broad levels.  The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).  An instrument’s categorization within the fair value hierarchy is based upon the lowest level on input that is significant to the instrument’s fair value measurement.  The three levels within the fair value hierarchy are described as follows:</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 1&a mp;#160;</font>— Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 2 </font>— Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.  These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level 3 </font>— Unobservable inputs for the asset or liability for which there is little, if any, market activity at the measurement date.  Unobservable inputs reflect Ashland’s own assumptions about what market participants would use to price the asset or liability.  The inputs are developed based on the best information available in the circumstances, which might include occasional market quotes or sales of similar instruments or Ashland’s own financial data such as internally developed pricing models, discounted cash flow methodologies, as well as instruments for which the fair value determination r equires significant management judgment.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">For assets that are measured using quoted prices in active markets (Level 1), the total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs.  Assets and liabilities that are measured using significant other observable inputs (Level 2) are primarily valued by reference to quoted prices of similar assets or liabilities in active markets (market approach), adjusted for any terms specific to that asset or liability.  For all other assets and liabilities for which unobservable inputs are used (Level 3), fair value is deriv ed through the use of fair value models, such as a discounted cash flow model or other standard pricing models that Ashland deems reasonable.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table summarizes financial asset instruments subject to recurring fair value measurements as of December 31, 2010.  Ashland did not have any financial liability instruments subject to recurring fair value measurements as of December 31, 2010.</font></div><br /><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><div style="MARGIN-LEFT: 18pt" align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspac ing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY : inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIG N: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>& lt;/td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: l eft" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT : 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quoted prices</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10p t"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline ; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">in active</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&# 160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new r oman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">markets for</font></ div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">other</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font> ;</td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-AL IGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" widt h="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">identical</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">observable</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DI SPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">unobservable</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FO NT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">fair</font></div></ td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">assets</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td> ;<td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">inputs</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">inputs</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"& gt;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">value</font></div></td><td style="BORDER- BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">value</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign= "bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"> <div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 2</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&# 160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"& gt; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZ E: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">374</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times ne w roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">374</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">374</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" now rap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="lef t"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Auction rate securities</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>< /td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roma n; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style=" DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred compensation investments <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font> </font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMI LY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" no wrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investment of captive insurance company <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td style="PADDING-BOTTOM: 2px" v align="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTO M: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td>& lt;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</fon t></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roma n; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets at fair value</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">574</font></td&g t;<td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">574</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10p t"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">440</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZ E: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: tim es new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2 px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font>&l t;/td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: ti mes new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" colspan="15"><font s tyle="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)     Included in other noncurrent assets in the Condensed Consolidated Balance Sheet.</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FA MILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div></div><div> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table summarizes financial asset instruments subject to recurring fair value measurements as of September 30, 2010.  Ashland did not have any financial liability instruments subject to recurring fair value measurements as of September 30, 2010.</font><br /></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISP LAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman ; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right">< ;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" cols pan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#16 0;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quoted prices</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10 pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style=" DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign=" bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">in active</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><f ont style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td va lign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman ; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">markets for</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">other</font></div></td><td style="TE XT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></ td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div></td><td style=" TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">identical</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="b ottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">observable</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">unobservable</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">< font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font sty le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">fair</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">assets</font ></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">inputs</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> &l t;/font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">inputs</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt" > </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">value</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style= "DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">value</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT- FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 2</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">& #160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: ti mes new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&am p;#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">417</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inlin e; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">417</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">417</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="r ight"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIG N: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Auction rate securities</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td> ;<td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new ro man; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPL AY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bo ttom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred compensation investments <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: ti mes new roman; FONT-SIZE: 10pt">169</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">169</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style= "TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">107</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE : 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investment of captive insurance company <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inl ine; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap" ><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" ali gn="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIG N: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets at fair value</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right "><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">610</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" val ign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">610</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALI GN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">481</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">107</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td>&l t;/tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAM ILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left">&l t;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-A LIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td s tyle="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" colspan="13" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)     Included in other noncurrent assets in the Condensed Consolidated Balance Sheet.</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline ; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" vali gn="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Level 3 instruments</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Tim es New Roman; FONT-SIZE: 11pt">Auction rate securities</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">At December 31, 2010 and September 30, 2010, Ashland held at par value $25 million of student loan auction rate securities for which there was not an active market with consistent observable inputs.  In February 2008, the auction rate securities market became largely illiquid, as there was not enough demand to purchase all of the securities that holders desired to sell at par value during certain auctions.  Since this time, the market for auction rate securities has failed to achieve equilibrium.  Due to the uncertainty as to when active trading will resume in t he auction rate securities market, Ashland believes the recovery period for certain of these securities may extend beyond a twelve-month period.  As a result, these instruments have been classified as noncurrent assets in the Condensed Consolidated Balance Sheet.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During the December 2009 quarter, Ashland liquidated $50 million par value auction rate securities for $44 million in cash proceeds, which approximated book value.  The following table provides a reconciliation of the beginning and ending balances of Ashland’s auction rate securities, as these are Ashland’s only assets measured at fair value using significan t unobservable inputs (Level 3).</font></div><br /><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"></font> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 1 0pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of October 1, 2010</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline ; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sales of auction rate securities</font></div></td><td style="PADDING-BOTTOM: 2 px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"& gt;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of December 31, 2010</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white">& lt;td valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MAR GIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of October 1, 2009</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">170</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="86%" align="left"><div style="TEXT-I NDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sales of auction rate securities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(44</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-S IZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of December 31, 2009</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">126</font></td><td st yle="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">  </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISP LAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"> </font></td></tr></table></div><div align="left"> </div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Derivative and hedging activities</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Currency hedges</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN- LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland conducts business in a variety of foreign currencies.  Accordingly, Ashland regularly uses foreign currency derivative instruments to manage exposure on certain transactions denominated in foreign currencies to curtail the earnings volatility effects of short-term assets and liabilities denominated in currencies other than the functional currency of an entity.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland contracts with counter-parties to buy and sell foreign currencies to offset the impact of exchange rate changes on transactions denominated in non - -functional currencies, including short-term inter-company loans.  These contracts generally require exchange of one foreign currency for another at a fixed rate at a future date and generally have maturities of less than twelve months.  All contracts are marked-to-market with net changes in fair value recorded within the selling, general and administrative expenses caption.  For the three months ended December 31, 2010 and 2009, losses of less than $1 million and $1 million, respectively, were recorded in the Statement of Consolidated Income for these contracts.  The impacts of these contracts were largely offset by gains and losses resulting from the impact of changes in exchange rates on transactions denominated in non-functional currencies.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: blo ck; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland’s net loss position on foreign currency derivatives outstanding in the Condensed Consolidated Balance Sheet as of December 31, 2010 was less than $1 million, consisting of a gain of $1 million with a notional amount of $94 million offset by a loss of $1 million with a notional amount of $93 million, and was included in other noncurrent assets and liabilities, respectively.  The net gain position on foreign currency derivatives outstanding in the Condensed Consolidated Balance Sheet as of September 30, 2010 was $1 million, consisting of a gain of $2 million with a notional amount of $86 million offset by a loss of $1 million with a notional amount of $41 million, and was included in other noncurrent assets and liabilities, respectively.  As of December 31, 2010, there were no open foreign currency derivatives which qualified for hedge accounting treatment.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Interest rate hedges</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During 2009, Ashland purchased a three year interest rate cap on a notional amount of $300 million of variable rate debt.  This interest rate cap fixes Ashland’s interest rate o n that outstanding variable interest rate debt when LIBOR interest rates equal or exceed 7% on a reset date.  This interest rate cap qualifies as an interest rate swap within the provisions of the Senior Credit Agreement.  This instrument does not qualify for hedge accounting and therefore gains or losses reflecting changes in fair value, along with the amortization of the upfront premium paid by Ashland to purchase the instrument, are reported in the Statements of Consolidated Income within the net interest and other financing expense caption.  As of December 31, 2010 and September 30, 2010, the fair value on the interest rate cap was less than $1 million and recorded within the other noncurrent assets caption of the Condensed Consolidated Balance Sheet.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: b lock; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Other financial instruments</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"> </div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">At December 31, 2010 and September 30, 2010, Ashland’s long-term debt had a carrying value of $1,153 million compared to a fair value of $1,398 million and $1,402 million, respectively.  The fair values of long-term debt are based on quoted market prices or, if market prices are not available, the present values of the underlying cash flows discounted at Ashland’s incremental borrowing rates.</font></div> Large Accelerated Filer 79040152

-18000000

-19000000

-363000000

149000000

145000000

1434000000

1687000000

0.32

0.29

31000000

22000000

Includes a gain of $19 million for the three months ended December 31, 2010 related to the formation of an expanded global joint venture with Sud-Chemie AG. The gain is primarily attributable to the fair market value of the additional Castings Solutions net assets contributed to the expanded global joint venture exceeding the recorded values. Includes income of $23 million and $12 million for the three months ended December 31, 2010 and 2009, respectively, related to the direct operating results of the Distribution business. Due to its expected sale, the direct operating results of this business have been presented as discontinued operations for each period presented in accordance with U.S. GAAP. Accounts receivable includes an allowance for doubtful accounts of $29 million and $28 million at December 31, 2010 and September 30, 2010, respectively. Primarily relates to assets and liabilities of the Distribution business that have qualified for held for sale classification in accordance with U.S. GAAP due to its expected sale. At December 31, 2010, the after-tax accumulated other comprehensive loss of $363 million was comprised of pension and postretirement obligations of $620 million for 2010 and net unrealized translation gains of $257 million. Common shares issued were 231,358 for the three months ended December 31, 2010. Reconciliations of net income to total comprehensive (loss) income follow. See parenthetical data statements of consolidated stockholders' equity for reconciliation data. Excludes changes resulting from operations acquired or sold.

%UR%-PDA7).H78SG-C!UM@+VKQ!%5FDTH(])S0YH2$GO"8K
MJ%PA7=+2KTT3=:%*M@J!60"&7=\@@N$O[JK5'0,#7*/QEJ:LQZ+,H3PM*%.9
M>4AAI/L,L4`,@YB+3H$MS#<:.='YY_/CT^_!-@`&$'Y#(-"F5N9'-T
M7!E+T]B:E-T;3X^M*'$/+DDL206RW8,-%8Q-C($2079V^F[Y>25`P9`0(Z"@*4@0
MR#8!LLVA"@**\I.#4TNB]0-GJZ7W>_;KS]6[WMQ$\_O?UP<7TII/CYY_/+BS^-WOXR46+1CLZK
MT=NJTD*):CY2>28U9*0(JUQG1GA?9MZ)ZGXDQ0)_U93^/8X2D59?1DH.1^1P
M1.>9,W0BR&B?Y=(:,5:9*DG5Y?YP6?2'L7UV3^NKR:L.>CSIASTY;T^S_IN/E80K3Z2GLNKF\G5,XU_O;XY
MN[FX/GLO)A5>?+BZJ2:]S?K09IL/T!Q$:\!'`CX7`=)DQ75$,\,59G+RYPT(*"FUU`$#=ZSBD])==>(^6:UVCPNUPO1
MU;>K1K2[^[3(5!+^UZE.MLL_FE:K>CW[=SJV22NFN^VV67<";\1JLUZ,
MNR;]K7HWTC9S%B;+<*57+MRT#>H$3F,`
M(#Z2P#=FJ+^GT2RSTLL@BZ7SPAB=%4XX*KB^>AA/3K4(Z&4S;>Y3C;@FM\U6
MY`I>*JE4,FD>NOU.B@Q)L"VC4WF9J3S7Y)0VI(N=TBXZU6O_G%ROTY)@9$TZ
M6:8@@V2%=_B_W(3--G5X_)RR:AAM?*GZ>$C+-68RJW6,C)8J=8D4FOZKWJ+^
MW%.+\L%AU6<0_(-(TJ0ZRRG*H">3B/>I*K(RV6`W\TF]3I'P>2+.4F7Q^C15
MY,1L%UXW0LO48`&>X-N+3!J$EK"GI75"@46`CY,ZLP6A3S;8(60$39V."UP=
M_7X9/B+6SS[`Q
M=L"F"#8A#/(-0DUI[Q)@H!B0I$LI\9LT1Z@*K`B.(L"A&`R=VL2'\`%-:8L0
MOCU'1J>51@WYHDQ4.G:P/5@7C[!UKK=.^IA+.AQ%))#.R70*BPP6.]BIR<8<
MGG8MBG':++_R2P`+@=L@MTHIH&`)"AT6TW!PN^R6?]3=,FI;IV-=.FO@NDDI
M/20;ZK%E@H1D8^6K&"*AM7U#9@'%_P%"(*A\7P&EW#-2#'I$T.6(#-"SVGNH
M<;D:(A`N2R"`Y(;
M;>K9`;8_-4$3N:#RJ`C+$ANG(ES%2@Z4-T%#>"/J_E<\ICFQ`\F$@PLZ>'=P
M>C9F;Q%18U^4NAI\-<'7^BOS#)&73[9(BC*I%^&5V()AP>,I
M($R>;!(#,?I(C*?DH12?$VB+8MT&M1K/H(S'"I,&Z!F)37XH3B$+MJ.'1++!^B(K4(R.4$;(T8":=4AA2B7-J+-;Q&644QIX4SK1"8Z&!I7G
MREM*/)V272&IB;AT2)OJSWRE4['6BI@EOZ(\$?XF'7LXLJ66@,=I>-RMJ!%B
MMQ4@4TW,N`QOZB"P3N'L`_,LI.E!C$47#SU5>9^JDH*_WD3QIV+M*7$DY]F!
MMKC9J[P#2';0V"O:+>X"-RM/,XD[7DZ`"6'2QDL*M&=\0.L@51.#%4\_)2A"-4*$FQ35CXUWT@5$*'G?HK`A*&NH)N&>*[5A)J,BLC$);)*;XYPV]$RM
M^KY@N2\83L4OE!R<@'3C.OS`$=RPV0I*Q:+?O-UL9V$'8G2^3IFN^57#ZYF(
M&N!53.Y^*Z@Z377?>TD#MQMT.VT=&J2FEF(AZYD2"W[A^MP^F"#CB/Z)!A)/
M)C3;L.A[@$_B,YNQ0C_YRL]QP`2@$%IM&Z('219%C2WXCON1(>U-VQ&-
M$*L!_)*2-J-X4TL)&N[",6X$S2Q<\__B-QOX3?T(OR$8A_Q6O.2WG/G-#?R6
M!WZ3W^*W%W/`QPY%2Y"@&_1C0REM['G(KI(K+-&&/_/Z7:C,E=Y_?O6TI8O]
M;&<#!UCBDGHEP)OQH>^MRNB#Z5(=3B>G.D])%CQIK":O00YP[#2E04UK,_1:
M5O(:@T^`N>?^A1]\*3!OS)%#UEL4B@`0\9>3:BP7R]ORU^
MMH!@@7<8O3TW'Q5$3M%<<[Q<2S`'PF]V]JN#Q+_A[A\!_$8BB>!2H
MR0_BTV]X,QLIL12CWX7BSP0EC`5!%OBADA/3>WY]/S(JX]19C2:COX](".5D
M\/GH(8L]+;+2EF4)CAO-CZ@#IN6KZ@!NJ8^HZ_,6:W/?T`:KK7E-&P*$SY%!W=[X`W7:T>;W
MD6>AXD>0[]5]%_E>W;>0[_>_@7S<_F'D\Q*#8O$*5GF)1NV.875>H8U)'532
M`@!.$"]&%(F&N>^17L4*/D<.!M57D86\UQ
MCQIZ!ZL-&B&@!P$+\NC)5`Y,J/GC,IDTZR5&E^D6'T>=F-?3Y0J?ATV;"<&:
M0`/1N+`*UB&3D9FP;C]F@&XC]U=WC:#&8Y)V>M?,=JMF%I_KQ6+;+*@]A^?[
MM.#1&9]8NRU?&SH$AA3H]^OV>8I4M;`1'AYYJR^C("?I&ZL*L
M3NTBJ@U*]*DXP,*N;,\#*@%B;V/.*V6\\P
M*'4([(FU4@2!`>6OF]57DGJ:1+W61T3IQ&!$.#QUBF,/&!2;=42`[$N6)_MK9@CB5=-A^FS18/N3=GLNK;[+^'5LMNX$03O
M!O8?>-B##=@"'Y)((B?#V-QRRP^,J9$U")=D^)",?$:2#T[U8_@2-WNR+%+3
M/5W5U=4H*E^9(L"/1LEQVHC"U,=2S$=[F"V\(=KA]803$%M\
MB(^S)%B82[1CGH\[6/C,=9UG:K[S3EL/54]W,45!'SN4K+#N:MY+&W1U>=+N
M@%]Y[2XE40>F%:;[4FN&R>-+?:O0??^\F^J/=FCZPO^""2-(QS+5,SCW?X/[
M]2$)C^J9NL86#@QKAK:I.^0PO'?NY$SKFQ2Y^DP8]`/WAV](J3]<"/'2UU\I
MBB!*T;JB4C.&6EF8QQ,=HLI];<*E]X#;`L?'20ULZ]7?ZZ1X/EF":L
M09EG$:(2&*9IVOK3R2/#/A6:]36)A739K'?-U;@2D,CM<&`:IQ.[!.\P2Q5O
MJQ0^#X+TN:T%@N#/P93NK/"XI_`13R>\N[$#73?Q06^L05=4V_OESS?1Q!U;
ML-K^9;BIYNV:/;+NT[D8(7L9(9#)>!>G2>R/UF+R]3!"WNJKK0RX2HM?Z[A5
MNV`UA_)=2DY^&E2S^?>B#W$#=,;Z!G&63'-%Q]6;M/>OX[@"%$4YG"PTH.NF
M1*XV*#0[W_[),9P`TBTJEF$(BBL^_<54XTN&H2!8Z^0DHD"&VF2?B,@737U6BY'BU\<_V%R`=NO-"V0>2$7\<6
M^9W].TI>E^[$[U:V#VYDVK7CTCS-UE<^'I22%TX9D\#1]+"?C04U,8Y12FX`
ML+'O^"28KRR?%4\%`HDKQ\`=PFC*?WG]A$P8KKVZ_E'L0Z@H%[;EWPP=.D)R
M&[H>;0)S]*A:@T5F'!]&XQF<B64%&%J6^0&RCSS_U,8.0?(DI$)
ME]E%>:KS83,9=3?GLVOU$5./N4!^A_[1&D0PL,E=#7+/PV1-@=O%%9>1W6>'
M;UF$Z0V?\0(5Q3ZK0:L_!>6C1(NUTT09^[X/*.]XX26"7-U''7R6]JZYH6JF>?:)QA+2?@\9H
MC?6)3,23N[H3>(H7YK]HT7+XJC,0.9J;76>]2M)8(&E97RE4@A!47C7001K6
M.U3+):1W:K[K$YLG80(;S'$$\A.I=336>B=?SR84I;*M`OR!,EK,P!],0$>Z
M!RK0&PUI0>E`#QOEAQG?#SX
MT,KQ_O\FP]VBD.`(F;PT\,1"L,I[>#C8RD#LO6SJ;9&MJT^C1TD7"&%.M_7P
M<4%233]_'O+S2/@PB@[F`G0QN;,-1\].&)##S"OXH/$\:,3\M`9JHP^Z:N+0?<%A;=!"=%B=1\$
M46[7"^"GY6(30V]90?9H=PAG=1C]#T?[23]M=1*7C#:'K;+-*Q',%L:-'D@2
M755>QWT`/-[LV;]15-@,!"J&4@R8FDY?U9$2L(WK.00S%/D]Y;Z#R'2'NYP%
M@521)('5R?)JT'.#\GABN:06I?\&>4W^F;&%XB^*ZK>6GW:>_Z3I_JLT<:W8H+KZI7@%UG`'4QK0J]--.R)_@KWL;H@P`@%_/Y;+=!
MY+57U+):<3'XX\T#&J?9G7G"XJG4`79(3<0<:#2BFW/L
M5@*Y0$'B(<.G*$Q8U3R,''5VV[7Y_O;[PY>';[^]?7GX3X`!`)+7AAD-"F5N
M9'-T7!E+T]B:E-T;3X^M*'$/+DDL206RW8,-%8Q-C($2079V^F[Y>25`P9`0(Z"@
M*4@0R#8!LLVA;',%(P,3J.*`HOSDX-22:/T`%S?]D-2*DE@[.X```P#TV!GM
M#0IE;F1S=')E86T-96YD;V)J#30V(#`@;V)J#3P\+T-O;G1E;G1S(#0W(#`@
M4B]#%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH--#<@,"!O8FH-/#PO
M1FEL=&5R+T9L871E1&5C;V1E+TQE;F=T:"`S-#QC>1A>HJUW/7<[?7[HAO8#S^\?G>]O&$^^_''JYOKO\Q>_[3B
M[+&?7>6SUWDN&&?Y9L8#SQ>XXS.]"H07LB3)O"1F^9>9SQ[QEY?T\SQSF)M_
MFG%_?.*/3T3@Q2&]T'=$X@5^%+(Y]WA&I&ZFQUEJ'V,5^-SS4R9B+XQ]3@0\
MWQ<)L71X0B_F(L19EK$X\4(_#(F6$DD37.2S`)18$G.($46">0G/LH1UKGV\O[V[8\N[:8[2X
MOK];W=\N;R[SQ0U;_7*U6MXL+_^^7*P494TO";.17F#I)8K>W7V.J_D]T;E9
MW*T6)Q3?+.\N[ZZ7E[=LE6/CW>(N7UF9Q:',43":YL!;HWU\F"\V!A(DQ1\:
M*,X23_RI?0[-XV>C.NPM^XW=+*YR]M$IVV:HFKUW&0!400_@TM
MP5@1Y$$2$L$/#O=+`>Y-I]]44O6;MA-U0]=];`?
MJK9ASU5=L[+8]Y)=]MNZ<'_-W\X`V"P-8FAMV*:6K=!LFS4;6E9\<5./.Q)?
MU="S72>?JG;?@UQ=[NM"T0>_82M!?5,U15-61XO
M&(34$C;MP+;%DV0%ZZO'IMI49=$,K-ALH"$#GV&K(BCSPC0.M.".9.6^ZR3N
ME?M^J[4=MA5=EDRQ@)_[?3WTGC%_K%P-)/CDYC`<(_T8-Y/'7\:'\+U4`41A
MFEM,1]IX"@5_!0H0)??O%BR__(<[!RMGX7K"69$H9*'?@<)HJ5#[)$L235:Y
MKUG_IV=26:6"M8;B*RDJ6=4S-_(BYU$VLM-.YI&71B*:G)P8@CJ6/SAU_-R#1.HPR,W*;=$\RM[Z2*,DH!S)@V.4\(1KDINVDT##"PKWQK-5
M\\@V74O2LJHIVTELUG:L;ON>;>I]J5$?>B)"XE-R0]Z]0C!A0X44F:]]@O4`
M1_5AN6JEH4>2I9,U,^UUSDVD'C@#,1$$7O"=BQ^'00D%2*-PC##C_#0LM&_\
MB/*8,N:VDSK,(X=T0B+9]N8;\6AB/G)N9"GI_$%V9B?@%V8E?.Z34>K]&O8J
M93<4L/NQCU+EH8P@4&Y9T2/^7O&8T0'"DD**M*)$TU",&TN/ZN3?']K"CPRR
M7@%BH^S`O"&%!$+4'DF,HN];9`L"%0%"D=P45QE
M+X6A\3EI\X"(VU3#F4+`IRPZ,BJ8K>63K-N=0B?2%;TKNQ&4OA`6E')-F=9"
M1GEP`XV4-WCM^^E#72G*0Z,T*5Y-1PI1NN<#R;1.>6.Q1-?-UH3'54
M^*G1E"+I#E`3FMBE
MX*2P%!0I8T`6(W3`?51&,7H9=FJAPNLH0%^*)%1JV:$?(-(V\&TR54H#G-V3
M[$<[^J<&-)I=FZ2-]_NFDV6+VOQOJA,3\J%))Y$_=,+7OX5*^YVZ2CAJ;0@G
MF0C/NB&!G7&[L$GP2Y=T5LM
MZ\3
MK59HGVU@%:#*G0>$"'W7W*#7.[UCSBWC#IF3VD;*G+T[%U$:4L&+#KT3\U-$
M\O1`ZW#2.CO1.K9:QU;K>-(Z=O1K$C^S6H=*:WM$/&)>2@4
MSVCMV3OVX5?LK&><56SV+_3EJN>G)().-TR$E\:L_*)VO\PB+CRE=3U;S?XV
MLY?@)6:.D%(H:Z@Q\XQ:!%R&?T8M0L2G$[DHR[(S>&
MFE"?H8],@7_\E)HY#S+T6_$?G2,MA>/YI-Q5?IQP@Y2L8!.NSK6G0Y2^&$,B
MDVAML@DS@]GE8/K'RC:]%(!M8WN1D**M[ZN'FLH$<$+UPHRK[;X9;",XUBQ;
M?T*T!%/]"4S7;?/[666C:A:K:A8YBG&FQ@P21M*`L99F?3!X-O+K,+61BN%)
M/3?:QK:>#\^R?M+=ONY&^4&_'SHHH+JFT\!#FO5R&&K36TAT0S2A'?14S6-+
MS5RQ7]L.,P'WTSD0[$V.@Z(7['E;H5>EMJ)0V<:.AMOB21YL#V@.T584JH5B
MK=;XND5=QGRPGII/Q?&\C5$M!=KQMJ[6JF-Y4S5%4Q+)%3*,-`UR?U;,`T&0
M"7POCE^JYJ_S/$1`Y)LSK.F'?NPE(]AL%\S5K.7<+=LM^8XMW[V_O_[E8
ML*O%W>+-,F?O;R_O5B2)YB`,!P^3@9I8XRR+C@L'FCO<@4_/1EYSR^RE
MD0$CJVG1T,N[^`+0]"QPS*!IF_DY$WC3JD639`FXCNI1RZG5X\*.CR`V38^A
MZHP"Y[,TFW;P`6;TQN%HUQ^IJE6WS9QEI@LS9G3RD%4%>'3Z@`2G_V8"5&LE!EH`
M_07,<$\O]2_-.4K9_/L79[%-2SVVFO4*2IYKB=F@U@FF-!EDUS84@Z3`#F&M
M,DB#"_%+),>VR%BT0#-Z<5.G-6`D@9T&17Y]WSN2HNQ(=A>;XIVHQ^/=
M\3W>+__%UBTN4(WSM)*AB:WK$T1?0:@"&."F%1H(3"`NX,\$!IZAR10I4T@P
MY/]1W%]2LO`[KA\3*Y*5OFBQF(7E-ZS!54'JN%&&"TGI24^5$/K%CSR"ATQD
MSX?L^)+^0$U=['ORG.H?IOP3\5JBL>FHP@EM=Q($PQ8QDBQ($N1N:Q0H"CN#
M)H_:2C1VK7QL)P]I"M!1;_FM@T0*1&ZIO;4]#.Q32'%F+6
M6"J,-%9G"UW-U7?P;M1`;MDX09`"6@#HD)ULH:"#R7?HH3@Q7NC;.193]36LC]8DJ3J9URL\8`G7@C8('*8$O
M6XRBU?BD*Q]:YMKG^K=_*8G0,-#2.>H;7$.HKI;2YT^R[1_3/[A"'CRW_.!.
MG-9E>*KQGDFHO$][EX^6CZ"3ALDP9+Y"A6&2P%Z
MSB'&=:8&2?>E2635\;%564:R#)[VTAKZYHURYU&4$V62;&[QO-_B5F<7(4;>
M@?M7<=G>HWON-S_3NPBKBL:PI:P:)1!['*@BH*Y`)&AW-#.`[BKH(WVZ')>+
MJ?B5X%"NR_ZX]UV;OE%-*N2[HJS(A&B]+5EY83IS!>;DZ#6EPR
MX=)J].GG5RO@$3#\%?`U%H,]3!@+U/JRGK9/R=6";/;E8I]ZN08!;`.HM+$?
MS"@(3LE^2Q2*$T3<@B8ULUB*Z/GLR;A&V7,>FHJ>03@/36$=-+1SV!R8C;IP
MVN)SYK2+?2[F@WTJYI_N*,DZ72091D+UHLF*3*A>8GDHRNNKVR^?KZ_^"3``
M"XLQ?@T*96YDP``@P`Y^$7
M7PT*96YD%LP(#`@-C$R(#K+V9*63.2)RE-.
M`I(T%06IC'A))Q9"X9O6+"\2E2I%LJQ)3N#UZDQ"$BMR#C.R3+"DX%H7K#=G
M6_+U&XW6PPR&S>P%(,H!DEJ;RU22G@6,23-2A@>N+087=V_>7MQ7-9<+H
MX?+VYN[V[?+J8G5]Q>[^?'VWO%I>O%]>WUG)3EZA]"1/!GF%E7=SN\+6U2W)
MN;J^N;L^D?B/Y7RXBV[6V'AW?7-ZB[8+.8V9W*"9A:M"9\4\.4>($%6
M_!"@7!>)^#E\M`T&N4$[M96$:,E$E2PO52*48](4LE.%>49L.VZ-WLT%%3E%
M:O;U11E%F2@QW_7?N8Q2)OK_RRCS1,QED'?F:C>,_MZ8
M?GUHS'#.*O;TT#7-O^,%$B=BW5-K-BS^U^J/,YZCN*$LI"3P0S0<[H=Z4U?]
MM'7+O,AS]E`]&IA6W==DGSNNDDQQ=WKFD*+21N:8@<6+#(*V??G/8N>HZF&A5K:O#
M`*_N@^7FZ[X;#KUA8\AGH8H8EMS*-INKWS18A$%&4Q.<.],V7!
MG0:8Z:!M#Y4%,R<;#_L-(H5O<8;7NMV8O7'8H&JH<@:.\/)DD+
MP,)`($-N5R-@VW9]3EJ?O..L'!.2MM>QC)V^#J-TC#\MXTD+UAZVX8
M![:K'TW+'JN^[@Y#0$#GA?`6@Z<>6A]#X'8@B?MX(2(B)Y@5^-:;L:J)56\J
MVE(W8]>>L_?@2ML]UN-_V"_>FZ!C[@T7/+!WZ-8U^7_.ENTZ81^C-^]_N?@8
M4^`>#"-\=&3@41F-#]VF:[J=C7<>.?@M!>S3_;-UDN)<1"+J4GL7.<\R[R)8
MLN^[3V8]LF^0M'#5`[NO2'Q3]3O3!/&4HLXQ+_F98[*03GYOUA1L!R2H:?K:
MM&MS[E?J=MT<-I9%]CT$;[%%KDVK!+1[&LPX-H9V&!M>XI&#;5,/!F8R&X5X
MD8CHZSDS;;6FP%.R#8TM+.>LVR/\SUER;FEB_5G]'0Q0W)-K5I`V9FO:P?B(
MN/,4%7;T:E8U6.5@ETE6JF-N^<%!H,+Z5+".(5"^9OG7"G%P3X/95^2B`Q[J
MUAWIS2T;"9L>_B&((XQ"2AT:A`QF^-AX]<]3B+N$%*7R0=KWYI&2P>J(O.)U
MUVX.%CWW/C[4_8;!F-'M,OMZ0Y&@Y"<^UFM4L6%$-(/G*K6-PGNN@])\*I$N
M]4O$RE42\J$]N)5[TY,?>]/M&ZJ^GST"TE+6%["CFU;72:5P6'.1^QX1B+T(
M];#L"<#_`^H4_U8?09;ZM;YI!*=Y?)8*;V"-']6+X!MD7=
M&YAJR[];G%7_/P>';S6&X/!4'QWQ\S&7GO9P&'68>%9&/FNHDDRUNG2UND+R
MM3M#I49%1#KZ3R[9!XHD;:5(3CM"O*SZ%^,%6/FSRAY2+;?)BLY#;C"W4MF5
MD!KWAJ%N&+3LBF+8-/3?)49H`%/'*W5^=+\,\X@/)-4]KZ5,.+2(*+17Z$#1
M.O24=NBD2+FN>73@$H-\7<&A`8>`O',9DXQVD\PB**>1*'57BF-.NFYI1R)?
M1DXY.ZM([*4A*>.:G[A5<._6L7`%`W\XB,#;T^'"-I5IPCAR2H]Z!C*EEVX&[O/+A^RZ++K]UWO\\NN5.Z?S3TJ@B;,0L&HDXSQ3?SY]"J/
MM$M/6>9YQ.I[<7P,5P^,7LP-=_17V6%@FL+GW?Q[TR6"CS'/G\#`
M\37,,ZX5@$ERT]S15V(272:$S'^"/48Q401%>QKP`-FV<$W2Q+'D>C7&F
M\.DAUL*&/M:4+`.2A?Y7L:2]K?NZB5-\*4C4QQ@[M)*4D2*U`GGJ=C%A7_U;
MJITVX5\A@L^_X][K5((*=CUL3$NW/B.Q*)0O:YR'/J$]_6_W<8Y<099+>S-9
M-S$G&H)XG.CY!9.2MIY)2Z$%^4'2%Z3T/J:+%E%Y@=]=G&6)G2`+=##WTOH=
M7IQ?W?E5+Z8C&[;0!,%[;XF):6,?YX4[;3/,?]L`1"%3C:722Y(A3U)];$["
M5?$T3!@..:^4&+3(@`U""V@SB_)"%/BUQ**J)<(=]]F9`AH1-[]Y(7#5G`[Q
M,IO4*V[+^0)7AG!]H_,^/`MG#>1I3E3B/"YQ/LJ">BVG(<.S.[`#L:464U-.*-`C
MI_KC@KDE;@--_PU,XI8;=(!"IK4JL;Z(\YSZX1Q^,@?)R\N\^)[I4P`F'R;_
MD9`0*+X)P3'FL_"YAVD]*S%49-/A(^H6XTG;="X<^!;M9_B>Z/LNW@AI**O2
MPWT9`T4-^%+4$:HG.1!-*1,5C82HGBB>]M?XS^/HV=2$%<`M>(I<$X!;4??W
M6"F=4EM";5L@H3FQV!8R%*:_$`,LH#%::92,/HV\K)^+!/$_+4&"HQ#*JTG&
M#P("Y/`8SHE3Y3\,S(\"(G)?)3/IQ[#+QE);4D!L[:[].X*2%W8>I`+(-O;5
M?A8$\Q"^A_T8X;R$36@$TGJ0$8,5E3EAFX32>7G\4-JTXW\Y2IG*M(_Z$>+R
M?ZQ76V_;R!5^%[#_81Z"0BQB@P[BGV28VX4VXP+
MLZ"`%W2EB+XSPM*5.XK=5H&_#?I:Y:?A]@TBG;QY$V$K2!#@3*PO!:X$J
MQD,5A\?^%E#P;`7X;&('/B0,-#9[*$]&J#A(#3`.[Q/B?\D
M%WN'V:Q5CG'G&+?N.0;<4]W]@3OF%&+K;^T)B4`92@:^Z%:B!`Y,S.F,I>6#
M1VR:BVV_6'*BP>H&+C0U,5/!P7T5$=35DX(3]T9^W2#_D)0?`QVCNMWG@[L,
MA(K\@K,(&CMG&7^IYP:E?3+$!,L\\OEPAS#]`W__0O`^*6RCZD7I4/VD?OTO
MONPW6M5J\[O2#*>UBO)H9X"DH5JBJL_\]?-&AP#YA+B;SLVRZLL;)F8T,CQ(Q&W]G9]$N2;Q+"OR34V?H1`FN,ZD_]*0LTSLSI?)ZJ
M1B^YO>&Z>[VA.#6T;,G+PPD7UB[.`0.^8D%,3?$K%J01U\ZK*3G=6
ME^GT2ES^.35>5P;X>Q&Z#3
M8/MGJ^H!A'AO1[OWEQZZINE>ZO91C>5]8W=^V)SH'^78*U?U!P3/PICOXM5@
MC`(3D1>C#/;,-FAO@]OP:+K0$'D*:&/M>:K`J0E/%?38EK^/`75NN3/PIJNL
MG.QA@0R.70H$SW,C@2(R-R(_%$,_%'D>(ER8A[9'/-#0BSC%E/C%EOT04+,G
MU@6:_=X&A$7WZJ,]C"=4H1O#P*Q%EIW)!*Z"3.@>12Y,OVW_V=)R1T,PSJ(4
M$"DB8%,'`J(H@?$0#&5DHC)08IH!R@C(U1!6\/)UPWB#9A`S`)QY(8:$B
M+*+XC]^0,*SIW9])L<1A5/C>K4ZW@29Q`SRI89D\1Q*KMYW\HISA%XL08!`^
M!\A/S$6"=A&=W]N`IOVC?`=DP\=6?K0KW]P]1GY,?[`]`Q*Y15@/1B:P\AVA
M/E/`3VF0@"3.V!9X+M4F/]EQL")@K1("2IHT$4"'B5X4N<=4(4K4.\#,:$RP
M!['()A;)*@M>/K,9WCM*(^1(8[UDD$43@WBAPT40)@NRW=(&H\,U&R(/*%T%
M"3D*\`;@.]62B\;G8CQ9[%O&SX@681_T+4+ITSL%EL):[C]1\S#;(]+.7QD1
M@(2R-G:W6SX<"0IR%]X2T*>.0ZA6&]I*%E\2@WZ=;Z.9Q
M)I21HWQ++J5Y(GM>G*Q0)Y3?D#\LD@B3<%WA;TD<;:)+,?'_
MKU>@L8))AI:Z+/^Y\G48(PG/"S\RA+XY_HL2CV5CB<-=A@X^^^<\<[BXBI1H
M'#5HLPO73A>+Y<6I"61)IM]>P[X'P'%I9.909(OAR3'`#G&*ZI-(1=B*HM,%
MX137P]0(>PA@"9T1\L"YT24=?1,[PX1K[*+%YL"@[2H[YPM=Q#O4@S]/)U`WG5-`
M+H_%]JO4_GB=V)EZE7HZOT(NIETG]^?KY`O<'+(??`XQ%@OA]
MV3Y:6A.P#=3TM1SM\%[=#D]-V>ZA2=7U^T%6!CKNCNVHZI$@'L].P-T>%%CO5C.=+ZL[;6O[LFG^\.B@H'D^6>B6E3CV?1Z#%E.V/&#O^D(2T.[+(-J.
M5MPF7VK@<^P--X>NACQ83$?.YT1`6]<4"V>NDWQFKE]?C!MF]LNA&\AY#Q36
M#`8I>71[V]#X/3;C@-5M#NES;5](-ZQ\H@';&>\PA.:A:=PR1@$2LH:5+(?A
M2+X[8`!ORV8?R*2`7'0][RBYOGA-X:IX6ZS"_
M13SGJ-C`RZQJN_:F;A]8F??\:U\/%:4E*3<'(:8@["@,RMN7)?DBCJF3E+DX
MIN$-:XNT*WMV82XNW".#F^X`]B_U^"2E,`SU,)9M9//__I=J>"
MS+#-WDR6>Q9%R:(XRIWTNVXL.5JVIWJAI"\'JI5N\)F+-!F05^K%(MCO"#RX
MU&H:RO5R5++)"ABC1?:];'Y5)Q\1,LKWLH+#EZHY[NOVD2LI
MY9#_:/OJV,`19T[(>/^@S0$MH\?-'N$9JKZ^ATV^)R6[/#;:8[BF>YG[V5,Y
MJ+I%N7#LJNX9E8Z:(W>[HD%:DZ.G&IUJD7F>1'%JJ-_1<3A=N.W(:]U6Q]X%
MAGZY"SYUDUAG/G43]'D6V[6MK5@J)V8]7K@K9V<5V_>BCS,7]7-S:,K*SBG*
M_,]2U`6Z7!E+T]B:E-T;3X^M*'$/+DDL206RW8,-%8Q-C($2079V^F[Y>25`P9`0(Z"@
M*4@0R#8!LLVA;$L%(P,SJ.*`HOSDX-22:/T`%S?]D-2*DE@[.X```P#RHQGJ
M#0IE;F1S=')E86T-96YD;V)J#34R(#`@;V)J#3P\+T-O;G1E;G1S(#4S(#`@
M4B]#%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH--3,@,"!O8FH-/#PO
M1FEL=&5R+T9L871E1&5C;V1E+TQE;F=T:"`T,#(V/CYS=')E86T-"DB)C%?)
MDMM&$KTS8OZA#G($.&Y"J,(>X7`$>[%$1ZLU8<(G]1R*9+$)"08X6)J:W_!A
MOM>955D`"-(:':0&L>3R\N7+K+?_DG7+?OKI[8>[U3WSV,\_W][?_6/V]MV:
MLY=F=IO-WF:98)QE^QGW74_`.QXS5[YP`Q;'J1M'+/MCYK$7^)=M\;_3S&'S
M[/.,>_TG7O^)\-THP"_,.R)V?2\,V(*[/$53]\/':6(_ABO?XZZ7,!&Y0>1Q
M-.!ZGHC1I<-3_&(A`GB6IBR*W<`+`K2E0S(&'[*9#Y98''$((PP%IC&K
MU6R/N5YXU!F&$-@H7@`D,(!X.N;$\]'/`H+Q0G0&%SS5&"S7[Q^73_=L]73G
M,KRX^_BT_OBXNE]F#_=L_?OM>G6_6OZV>EAKR\9>'*2]/=_:B[6]IX\9O)I]
M1#OW#T_KAXG%7U9/RZ>[U?*1K3.X\>'A*5O;F,4XYM#OH1E5J\?'`_@B`DA@
M%-\$*$IC5WP?/JDN!J:!;Z;:$E3+=X.$14G@BL`PJ2_9U&$4(MN&5YT/8T-Q
MA)4:/;UJ(T[<0(S?^M_81N*[Z?^WD42N&-O`[+@.^W&5K=XML]7'IYNQ61Y&
M;O1].?(P<9-D8IRLWSTN5Q_68\/"$^YW@B>\$!MH8MC4!-AY9E5`#,%WFO6A
MRE,PR"S0,UL]O7L`5CZU#J_K?"8@/+1^-@T'[IN^?G6U5MGG9J=WS_,Q^
MXKF33WS?N+CN`]Y,_R:>H7L6T!]:8(#8\$<+#`8C3)\*'YOIDU.KIBO:&Y:7
MVUK)1C5PQ=J#8O/0#1S9;%335HWY!>^J^I4>'>3\W]FO,QZYJ+V(T<5NWWC6K9QOX^UM5&;@H%SINNEN5601]OJU=5
MYZIQ&G"W*6,O>-DGYR5`EX
MUA)`K-%`R63#)#-`0^:L*XW]'=L6,C=9-7..H52UP5YG9AV=I\:I@+J2((?J
MZT%V39M7)=I>-H="EKL_&V+.$*75>\_H_0"T`>9%`5T<;1\ZLLH&*0\#>9,P"I'4PX0HB$QHELFFJ;F^@7H1LZI[P]T&4.
MC#-7?4/87MA`S^P8@(\!)HZ$.L9."7":W\K\;DVBOAN&<3`D&IL(`BBRCN%/
M=,(U&5)D8:OJ8ZU:@R%#Y`P4"0+1,$BXAG;8Y>6+!D6^RKS08%#>Y&^2MY8[
M5T2"O$(QY?%8Y-L)CI886AR*3KN9:Q!*^MLT'03C"N
M-(D(<6M"IZ:SBH)A7T''C/P:7>$089Q,20$&*.JMK*'$-5:"N`&H1@5)?\W$Y6Q(N4(8H_0%9AVA;5B:&E<`Z
ME;\BA(U5DL0HB24Y3[D_S<>S.DFI:Y)M28<`5>'Z`+>FLN%?;5]27X]JJ]NA
M`H6="-B.+C#&[=`%.H*)G'`2["@V@5CMN\$\3X=\>T!V&$@2'`ESC,E"PAV6
M!#^P81A$7`PY)F2;A_TPH#083)M=WJ),(JW`U>V/J'Z'_`5ETPR&P&%+EWUP
MV2WD<8,R"N_=`\X8"7C^24VE;PCU
MLS$%4!PDP%=4)PB0"DI.K[:W%U&C$=#_Z621M]J6[Q#LX`HU1>>"7*R3/;B*+S(-8IHUAZJ9@S>L0)IL4G8F6#H(EQ8"<6%
M'D:>5290/9VV7B%:L-?L58V3LV]I$2?QMX4=^D,"@^HOS2&'[GD/@UF>I&UH
M$`J")79@`MYWM5530S2L,1)-(+`V_R2-Q,7*$Z0T_P'J&A"\Z<>C0B&'H$'0
M,992G9A\J94RHQ_%S\P:O7$-W:J]7"^N9Y,K28`WAK9$,W,/.Y4[]1?5LBGC
M>L4VVJ+=PT1#10$]L0KNHYL^S?Z`1V7NYP/;XP29K@`CE[3E1'JPA0CS$CG.^IDKV!QI['W#'HY46!0\>NKZB&US83V\*V@FGB1Q>[46PW
M.&STD]0?5?4.DD&`]%YL>`M*PT5TT0$QIYY3[`X*H5.0>L8?T8,17BN)*,]7"=K6E"15R5EGY*6-/5-_:.4"$:;3!GG94-6U36WG$"TO&83T'3\VT
M/WNJ:@>3+!/;DU1]Y%VEM_]:O>;(`=K:(&/6%>3C<>FR<\7'CQ@)I`-EL&L56\"'C!S
MD]KI&=8NNPHC[.]5O>T*-1QD](8YT05PY?>G4(O06#,IO42O_L)YGH]VKSN/L)6@A2S4G&^P]#FX2(NRG)8@,G6)A=G1'K=4@`!GJ@3%C`-)/('Z4(;,&%/D7VNU]
M9U@TM9=K?23LKF;[$KL%U5U@7\K=YZYISV]":%NI*P/G2+F#Y11RE@5[(R;-
M9GLJ0!_3KVAZ9^;F37I,SB];"9GV[Y]M/&+Q$XS9X!>"V?V>?8V
MRU(&#_M(XO2Q<;$4C?>N-BI'1*$VIBZ.`II8UAKO/Z5#1@2!R
M%M6I!(M-MVGR72YKNHWL(7F^,!-&X:^&\@_Z-$#U-.1
M1J/+8Q,$10LD19%]"9H^>->SFVF]]L:7W?_H%_>0E#1>QU,WP,8:4:)(ZNB0
M-#XEVZ?A25+=8;GYFQ"[.MZ!4"0)H.?K%6JNI!/=;4O=UKG=QJ1(WN8J02*U
MW>28`ALRR*#Z)WWCF7"1L$O?!56$!>Y:UEQ%#%+:K_"J=P/NGN:6%?6NU&X!H\VA9,?Q50#]PY93G(RH
MCASIGP^Z#';.`TR81P&C_+]D^.XR8.%$N2(ILLZKA1/,(X$,SZ6+!>6MU]N7
M?:GWJ")NE%-=4UME/(@]$,<]@G%@4<.,Q5P4Z^@;68VAZZSJ3.V",NA5C),]
M<,!R(EM@9$SN'W[9H$BA"!U`.7'^5;ZVQTH3#O>(682++>;2PE6UX(:0!%^J
M"L_$-S3F?%XM6F^Z.?C.Z*U]SX5`N""$P@)9,1`('%ID2@=3D"^3)_@V]N_E0M-'<,%:H9HD[.
MM.O*0K8<^.>Q`B$8.,YPT^93`NIDI&]A#_>M45,
MM7/.Y%`SUCG?T"6\Y9BJWDYKBY&7UY(6RY:FZEMBTY;!S.,
M+VTM3N0>R=BF/4^02<_'_J4RI`%@K@BTA&C34"]16<8P(@>V6??P"7IBI"-P
M6*?U?`$9EI`9VD7L.9EH-6K^N7C3B!&NS@ES:ZV31BW&7]"7ZF:6H!N0+VMLD\R_3.40-5RQ\:0*;SU_0TB^C/^?D6<_U+(CNI%@9$_J#_^Q,QJ
MIM6@9M^49H[4"G1$VN/P2^4@YQGM
M'5>P,N7I'FD[#V2[0Y(9BT-3R-S:7&-Q2E^B8/>4PCB_(Z$U5,"_I5YRD^I[
M9!B6#A61*JIK^>QYYU/ZV/=<]-]].P["G;YN?&=ROMFC?=UNU(HJ>*C\N'WN
MN;((1/)4>/(9*+UT^X,D9=21H4[Y.=%QD]V4D?C9QKH;_
MT`;NZ7P*SL=\^]&O;8R%YQ9\6+I(*GJ!R6M^N^5/)@
MYS>S]Q_>O9G]*\``I!Y1:0T*96YDL-"F5N9'-TS$+6\5ZG+KWW&>]_;7:
MM>RGG]Y^.IN>LXS]_/.[\[._C=Z^GW%VTXS>S4=OYW/!.)M?C[A,,X$]&?,C
M*5+%BJ),BYS-[T89N\'??$'_?HS&+)E_&_&L/Y+U1X1,)H9)O)4Y1DG@#3+1$%7CD5&)R9"8:TL65ZD*E.*L)Q(
M'O!B/I)`8D7.(8;6@J4%+\N"[>SHFG1]=*/34$.P@;P@1'E",B>SR23=,X$P
MF:;+,."EX^!T]LO'T\MS-KT\2QD-SCY?SCY_G)Z?SB_.V>R?[V;3\^GI;].+
MF4/V>(4J>SP9\0J'=_EYCJWSSX1S?G$YNSA`_/OT\O3R;'KZDVH&UNKYR4!?'@@2),6S!.5ED8K7\5,Z8Y`:M+-T2+"63)5AN5&I
M4-Z3>I,=7IAK\K;]UO&G(5"1DZ4&JT]B%"958KCK?T,,(]/R90R3IV*(0=IQ
M)_;'Z7SZ_G0^_7QY,H3E.D_SU^G(M4F-.0`/Z&?9D-@D8GTE>2)3%,`
M'0![F\`['Z`*R*!>"2MAY4,R`BS<77Y`&^R=*#(U+Z*YZ^`SO+(_+LHZ=,RR++_178CJRE19J#
M4JE3GH=[E%.=2("+(+B^0,KI.N%(.F-VET!Q/:X3G9;C5?B/I3),;9))FH_#
M[B8QF()B2&Q*260YGK%D(@NA,0;%&)=%D1JW@@\!K04T9+0*/%R8_#[_,#)I
MIDSAY*8AW%\CJR'&]X*3O+I/""1SE4P0*70]01Q579#_!89[S7G0_#3A.=0H
MH,:5];]MHIR>RBE(,T@O?F`3Y)/Q[CZ!3=38LDG"H#56#$]B[A>K]YW3;'?(O+(N4L!_/2!-?BXJ%O70&[?,ZY
M9)ZED)U`5`Q@W=M%!+O`0:1S^&2B)(0M`"TU!0P^T6;@LY3A#B")$@R]9&5M
MD,]@A9R[8R@I.N=_P0BYC!<\R@.(AF(<,L"F\S$.URWPV;KH]P'/MI5/!DL*
M_%(:J.&5,B!-XBO!HNC5I'6>!S45M1"EV`NL@B>0G]%:;1/-=LGP\(IK=0%BPTIX28\O%M0F&XLY8Y0/AE
M(IU7TG2+<1FV-$E.-K-^96F7/OH1=!E)/7EPWV-Z9CB>P]*4;K;D['QL<2-1
M?47"9QXNU0:)]*'LL:F.HO\+(("J=DX8$L4=1?>:L??X^P"6O[$4^>0'BCO[
MQ+[\CIGEB+.:C;XS[JL^N@KC.DJEJ7M9W+GI.Z0)3LU&QE:CV>@?HWZ7HCH9
M%I&B2!K7%3\"U*6FNM@#(B"-.,33I:+TYM?2$M&8/X(S:,%>0@M[7@13"IR)
M%]#Z34?@HNP&?J*>6\\()J[OJ0K2'CT>EH^U9;A\Y$JJE.>0V^I%;>U8Z/*WPTGE!.E2J%X33B(#G
MK>YW'#&Y6SS&N%]\)=VZ4*EY01]=(!\\J1"]/9%H/"(--+7WNL#E?;,^>,G&
M5X#?E7-J[<.[H0SOANIKXK86\1W@!C#WP0%?/RF5J5!`W]F;>KVNUS>H252/
M4(YR]*$")8GY#^LZIFWX:"SU2M7B>UI\X^#:O8>+EC
M#KB@YLN!H,]75`NF[G/M%Q>K;FD;MNUV;G9Q6S462BPV';VW;EBU_-913PA)
MM5-8NI;0[[:+C1\L/1BJQ3(`T5GWCJE\[XV"('AH\2
MX\J?T_1[5^U:NSMAI\WMJH+^MB'7J:'3OZE;UV.VV-")K1<>[4Q9[-N9+#1Z
M961P95OP3E==U^MJQ>ZK5>>H`:<-L._01\`TZY88#1PMNI4-??TD7@`+LVQ55U?UJFZCZ/:/NO&.T\3[!LPZ]X\V*4VY
M[T.S,JH5&RVBIELO[<[3`I=*LC&`@P!D\>N:U/"NX]7;56M_DZ-_PZJH9+CN
M:26E"5HV+6ZM=LOZ/Z#T0%,:5FZXKFZ<2:W_:EFUW>XVU>(V96Q^6P=B$3&"
MG@2]UXEXF8J4>O,8BBR@H$_N5F3+&J9C;Z1F?JU>K9PUP<<;X"72N+YPL)2X
MIYY==HNV_X3R0?4@QX'JH=TJXMO562H:^8%5"V^+'1RYOJ^N5O:$1-U:7'9O
M5V'+23(ADG[/3#T.^8::3?>-D":K5NL^
M_?CW`ZH/T0W5H@__EP[`$S9;ZTS>6]M=?:"R]`(8FB$!KBK$'[))5>X%(D?FAZER%6Y=[:3]T:^NK0)_TZI:1
MW9?`VWEBZK5+7Z!EKV"\XZ&"/+AL'C/?T$LI'3BW>9BGD#<:5PM@Y4VW(MZ9
MBQ1<>A4/OM&FUTV!OZA;$9\U'LA'6QJ<-/R\0VF*?MMM8;2=O:_MC]Z<3=/Y
MTUM?(WW1&B0V,)"`X;WS!AF>-JXLU!/QNL_YP>9+NW)!2[N.N($GB);Z>-7*
M/8F&;'/)0[0@V;H(\Q$+[,:V[-7T
MMFT%P7N`_`<>4D!I995?HLAC4B1`#P4*U+>>*.E)9D*3`DG)_OF=_7JD*-D]
MQ*%H^>W;W=F9V4B%A;'V">]A:J@DS[RM*I5JVP@15^^-$^B5^#XD.X44K-">
M@'#%O7:9NSB.(B7"8]ON7Q!GJ?3YHHKF+0$1W.&`>D\@FP6?R8]<05,F@&C%
M.IJO-Z/O,]E#A9-!1\^_[T[6WBFUNZH<#<)+!591V`[>11@.%";!EJE925',VT;-&WUV
M\GGP[(?==7?H+\XU*',WSZ517NUD=N8K(9$D6`BL<.^[&JTTL4,U9;1#?-HFP
MR-.;32+WAG2@Q2KHV_I"`C&)5G9=)?#%:I84R0VEY+G"SW54_VG!P2MZXDI,
ME/Q\]&*?@"23S8V;T=NM;1)G2!OM*(H!T]\#!^X5M>B]*\UYB=RWN@'A[W><
ME&]X$<8W#BXM="?LD,J2#A!29H__JF:N9#,W.%M-=+;C%51F,BNY'IEJ<8K\
M%\8JS=?%Z6,9@(;W\$4036HC(FI=UJLLNO'M>KNOOP7`QE-U?`+)B"JDB^#+
MZJ]5\!69+M51*M?ALL9V0D8<(:2S-\CX#<7_XFEL1&,:/OC+E1$=F%T9^-+^$(2BYR&7R*!2JQ*37O`%P&\)/1
M8Y:F^9P>DU@*RH9[0CK%3@'9N;0@QJ9;KB=N=+2$
MWF->6R,2?$L@RHH;?D_S33*N#`*]M\W!E2_8N6XHK3X/=OY]J8ZBW'BS$OK?
MGKO>I+;Q*@VP]^<2'9./R,6T[*%J'DYUB2*6Q\Y-_Y(`8RFF"19?GZ)9Z5CK
M.![Q3Q7THR=ZX'UE%UQ3\`8-U*0\099OR%2IE$W
M$PNK>&WE\YF5Q^=W481[RPU^?WPL`H0YW-*V%B$,N<](1R]18VV27J+&6/P0
MZ(<3T`<,3IP93\[,BF*V;F(:E4W^UK_%^"IIC+:[)>VMR/-LZ3N$3Y;XYBS[
MI8,3ZN75I>RJA8[.N7`'WL*\.APKHY3@GDLX=
M=?=/VM'VLBAZO'*`^SR9)#85+;>YKXY-A8,)FN=&D3]4=ZQMT[`I6]M%UW7_6\!@*B[@@*V-KO70GFD?2HC63G
MLCR*7960N5"7"7=A],S#T+@\>5>X4J`FG+41XX
MX/T13%/-&>F(X:OZGG9&LN-+!2DR5C.(7#)\=8=O`&'E,'U-*7(67'?Y#8LL'TT/[OS:=A5HNS2U5TKQ80_)Y$JFVH*]UW[L'<'
MU^Q+HKV1>376+'-5XLU&*V](I"TE7BS_!\83=@`Q[%SOQ3]:^-VOP`3=6.2-
M5OH';%%/X\=+1AMMA!QVENU&C6-8C#CC
M?4N<#=;-%A@CI@UV3V5S%`8'I*L>Z*LN&IK4DO[_@:5I1U_VUFV3F/A'?KWM
M!]RK[/;$P]_/';6071RALFP,S\I"O`DRAD'_)V-"[]GH_%E.B>TXL<\))1HG
MGS`Q856,;Q,<":Y`TMA=O@:\:]G[56]T`9&M-!YMBUF>V#R3R1JC&#U&2388G,7Y(;/60H4-?]RA+W9ZTWE>W
MUGTF2B?>[M_%:-VO51B@-+^2K9+P9H8TRSA7QO#)$54_#`1N1A+;!7DF^R[N
MGIND5R63SY_EYR-?G!^?_=8`6IHO#7&LC913"=[;DAPZL-@P%V$@^P&C:3#1
MT9H(KZRRX\:`,&\X4O.]U#S7GFHW63HVBVGA;VRP:F+/$!-^ZIQGQ30'"H_T5:I3VRP2'$H6S`FFL`RU(^+;;$.
M_3BFL0ZZ80[X<'5-_\^MBXZ).@?
M,C0W5C!0L+'1=ZTH<0\N22Q)!;+=@PT5C$U`$D%V=OIN^7DE0,&0$".@H"E(
M$,@V`;+-H6Q+!2,#,ZCB@*+\Y.#4DFC]`!%LP(#`@-C$R(#QZ]L,/G[[>KNY8R'[\\?/=[=]FG[ZL(_:L
M9I\WLT^;#6<1VQQFD0A"CC,A,T^"!S'+LB+(4K9YF87L&7^;'?WW-O.8O_E]
M%H7#)^'P"1=!&M,7Y@S/`A$F,5M$0520J+O+QT7N/L:3"*,@S!E/@S@-(Q(0
MA"'/2*7'(_IBP6/L%05+LR`.XYAD:9.,P/O-3$`2R]((9B0)9T$6%47&.CD[
MD*_O-&H/$Q@VLA5E<#/*$DY=I>8_?-CBZ^49R
M[NX?U_<3B7]?/2X?;U?+![;>8.'K_>-F[6SF8YL3,81FE*TA/B'"E]H`<;+B
M3P.4%EG`OR\^A4X&N4$G"RT)V1)!G+,TCP,>FTH:4C95F"94;9>CWM>QH"RE
M3(UV/Y21Y4',QZ?^.Y:1BZ#X:QEY&O"Q#/(NTF8_K#:K+\O-ZMOC?"PV2M(@
M_3X?HR0/\GPBW$J_?5BNOJ['@GG(@^\,'@\3:J")8),35.>55`X;XN\4*Y#E
M:3"L6)3G9O7XY1Y5>7]EMD"KBN\,B$#+IV-C2+[I^R=OUS9]U9SE_LF_DI^'
MP>03(8R*CW7@9/%_[+ETSP+]H0$&A8T?#3"#LT%$.^BFW[RE.M9ELV?'4K'=
MN>MDT]?_]A=`.H])U5RV[JCTK5IY.7?N'V_1Y$'F]9$FX
M\/^Y^7G&DR`2:0J+K=+4*HTSHU0K2#U9=LQ?)$'BO?A94'CM7M;*KO3'LF<5
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MM;\``#U3"-VUWI]DMSO74EW;/+'FR8-HGWP?V12134-T8L\@!,KM\?NXD%,HG?XXB.DDDN'FF`J'=74LZ4V_KPZ'8JQIC
MV>"K5C7QU<[CQ*AK#S9_I5)G:H[<._D+G6%(`RG
MR[J6SW`9#058H-Y1[:[21:!S^E;U1Y=2U/[(36Y5\\BV:']L(<"I3[1ZE`;*
MQ[1[U>S.6A1P-RDT.[R.6!39;@=L[BD4G51M35&YDEQHR;DWMZ$1":9Z..WN
M,+9I<"#I&I1$4$\!QPUPHJ$::10>SAW"U)&IG0X'!R*^NY>5,]TL5Y\;(NWVQ.(LQU/JI[G0SS-=#O7%M/]13NY+_.",.E
MQ-,X?E?B-KK"`LV@G'K$**>0*C6L4#,BMN95-Y&+OSQ@A*!2B5;5!(-`HX$@
M#"PD?S^C0Y%G$_47WTF7?M.4QNIZ\AD<-!MG@O3OSWH%=(2SH
ME:JWUO1HJMX(DBX,:1J-P"NQFAW.F"@#3T&K$`)5$6B\`55&'*'9?\*9H2H'
MS[3DCZ1?RR!B%LI,3SWU+6'BE@12GO:Q@@=`/0$-S6Y.Y5=[]9!H(;A
ME:=Y<5V2^$UL97=L?<;X.N`#\DI5CON`:IH.H?*>X^;"'=W5#8=BLB@Q&F!:
MTX?>\0RA-W`';<@-AO^AW%7$0R05I]DUY<8T)>#IGGM:>?5^T8C7+),
M3Q)?;%ZE13NI,4X/@*_+7Z@\*4?;]MRS:,YY@K'9O5:8W^3QB'E8+1./"@=Y
M-E\8\S"5_)C3['@[5JA`RB9AT5:2!^6HW83W0=?(_0"V&O([I/Y<)DXX@<0H=OK8U#06^6+&W91(J:,#@%PB3-L'#&\X>JEV=*Z0X<%0S9N(I#EH1\B7#HF7%T,G/F*=8_\RJ[]H@JZB3!^I^7LC<`$K`#7-MW]U`Z:MS1MX[JPKLJM<^F:8&1.BP8LSS69)=NW
M+;`!=[@]/8%^57M-6SZ7*"JTP/HH9:\".XX73OAU3::6$FX@[X!QTKY1E?>E
MAJ&N?05P$5YU$EU(;6NJ31,K^'6D2YP:+A(Q*)PQ_C?/$O/+I+$U##D$!2#9
MY(FE1[%G"(4M<,TJS!>7JX,6/BDPX>)CO1BSD/VYTZX
M5Z\DM5,RM,P8UQF$\$]*A2/W0X<3T0A9RI(0URF18RJ@]EY(V&[FZ;`709&%
M0A^C1^PGN"'F3,0B@#\X#//YP+ULZ3YYJ\8O@"@PFA/B53XN%5Z--?P/]_2F
M\E.\/OG:%,A+.2B6JYU$#SO07@"V+A[M`5EORL&=1T2YR%TYQ/JJ0`39S;!?
MH8ZT?X^=@OZ>[
MES[5[OV%`'KD$'\#M(E3<,X8C'JSPRR0PRHO+7W@RXJ!1T%YN.Y\Q_)3OKXX(,S[,RB75*@J"31'KUL@BM[KW95GZBPYH[!(YX#)Q"G
M)X\V,R,-Y;:(0=WA^G3]XN8E!='_6*^6W;:-*+H7D'_@P@NKD`62P^_T+.EP@ENC$7%KP_>\^86SD'J$+70D_[:78=R35SD%(^?VNZ)*O>\HM#F3
M8:1`SYP>[?3$/^N(QE@PRJMZR.HA>GUH94O7]*":PC4BNC<-1Q/E18:JO^*2
M`EIPY.ESD9[2X%\MNB`.?0I,,?7TE`-J+>IC@[CGT[/T="(]3>P"<$BM:B@E
M=[K$;8K%@OJ4D2?>AD5F[*_6O%LHC;\@B[KQ;^V04DC'C?P%J@0J%1MZ@
MU2@3>&.@H:"+>E8`H#LY^#K-ZS4JRAH@M6/(&+X
MCP(4(,8$\!BR**@>>/5AEY74(L]6YU-^UG
MV180XOB+O?
M?RWNT_XKRKB90'1N[O652.$KV=S:9QD,Q65>16%B%3LU&2#3@
MZ1&(8+O`_1R%PA%,[5FAB$8S7CN21@M`:T%#F9%[YIT1/(9GS*$T:@BTM6Z$
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M.G$/I$,,+C).7_]/O0FY\7%`OWG/TI"!Z[0CC-&TU5J*(K2.SA7ZT<+)6:-1E_`]AF;TZLP[R5;/)>HO2/+:VG[K;UM^/%,X&
M/Y/K=EAZGJM%K5==8O9]DDY0H)EBA$+;XK`P4UXG?WVX(,%!)_2AO5
MCB-PHEM-[O'WS]Q+);;&@X"T00OXZ(9C;ZG*YPZ#7\.^:M@,M2I_?G)4O2A,
MN,!4)2FJT+[Z2`@AEW#I7[>6F@%>/@@K7H,9VGLG?SGZ:R0L!IN#D&HZU.L!
M/-@*8)VDD6]PYF?NL3U=%FTA*`Y/>Y1+3:5/X;./MFDY"BAA>SBT:/PY)AY1
MR@4A]'Z6A?I)@5,Q0L&#(UO]6W]]'`,A>^2><+U-P`*6?/GB#N-R+]S,0$-V
ME]Y%A6]]>GWC*T."Q=GK:^[+RC6/[`=U)OP<7/!VNI]06Q>PMA:5QDJF;6F4
M\@H'G1XN3/C\C-X8*F1NX63NHN&`40R`DD:*+[=0JM!UP?7S3GT^W>@*A,/=
M@`F#`=D>:S=U41R9\RX*C<^+%"X0@?(\.-RTN]\$]ZY#CEH.O:T9!W$=E!Q@
MOV<<]>:6[42&SLI,RB!*8N7DE3WP994G?$&]^HJ&SJ7E->'5)]3POFUJ[BQ>
M^:.K]G/I;V31/OC:RV%TQD-'+R(3]>T&O#3.Z=;
M`)K=,)<9CSCSYC3ST&>=N`HN>M)G
M2EJR3*TNT>0ESJ>LS==*YT8*^J(7+-U%AWYV.;69VCWS.5;)%7J^0@V2<,S2
MDQ!'IVO/0YPN0QR'VRQ)%@F-O)W_*[:!5W,?5M>?/WU8_2O``+P+L#X-"F5N
M9'-T7!E+T]B:E-T;3X^M*'$/+DDL206RW8,-%8Q-C($2079V^F[Y>25`P9`0(Z"@
M*4@0R#8!LLVA"@**\I.#4TNB]0-/Z>,<5^BKPG5`D2>8DL=A^OW+%`?^V!?UYN9J)^?;G*\\=
M/G&'3_S`B4/Z0K_C)T[@1J&X\1PO(U-WIX^SU'Z,J\#U'#<5?NR$L>N1`<=U
M_81
M;4#IA?3TVZT6Q$[\M
M1R]*G32=&#?6;S\M5O>;L6'?]9TW%L]W(QJ@B6'=$Z#SS*J/&,(WF@W0Y6DQ
MC%G`<[M:?U@"E[K[.S^RGKC/Y
M)`BTB\L^\&;V._&
M3%9=7F*$S*^Y/]NIO%-UA7NM;)YE*_)&BK9__%D6G>AJ4?7FW:;N6S'_S_:G
M*S]R/"^DB(W+V+I,M$M5'64#5Z*O"METN4)98+D[YIW(]WNR/(^<<+9HCV5>
M[?XWOXD2:&Z5K1'2JO>(P8IBKKM6D>(35\CA!0D+^VE'Z\$>0R%%!V--U1@ED#K^MZN0UAV-2,R[.4^-)
M<_R`2)(S&PPW\I=>-7(GBE+F5?\DY'Y?-TBUKW:237JQDP2^;X*-K@_`4
M*E0=A#QA(QRP<>A+#K6]UJ%YD9,%679*/K)!I=K@B]K)DAN6S,1SWIA+;BAJC$P=OQXGO74P\\!*3N,V20@T(N`!,=ZQW"+(XYM4!;5/5
M.)_@=_-!I>,H2G0^NG5/-955X76IX6DZAV&F+!!W-%/:ZE-3/\MQ%)5.$"]4
MIU:R@TE&OL9,8#+20QBQE7`8PTX6QZHNZP,5<7;-:&)P]?KM1]F(7+$(5
MU6.)@D&JT:CD9I)IVM)9/[^ABI2=HN<6$:;-6*QHYW1T#5OYB1E=&@O,)C%"
M-!.+$CWN#T?,L%"MJ.H.<;6/PW\30-`G^Y[IB"=&NA`8#+1Y+T"3S!&
MN;SZLJC[TMQ]E/K_O#WQ+'N8(-A(P,0S$#LJM`8?Y4^8BE^YMO$L!YZC6<>,
M$#O93/PUB%VAGZFR1"E!O>QN7=O!V:EGM>M1>/ZMJQ_S9$2Z_L/>2:/T%41C
MDO`4#^:GK`L]2("+!F4^]X!"<`ZP?DW14GW+O`%E=';K<:WRZARQUMVDPV;9
M,70M8LE;*5ON:(4M_K=3'RF(#*EX"&6R:U$'[>I,IF*"0-N3%%G#0!L_\.R6
M\H!:H>:%Q`!4AY9IHBAS];T5ET0V],$D?M\/3?P6UK>8[=Y$VXC[O/DF`:(C
M"H9"`8FJ/0)%2$]O%]]UDC"U*]'W,D-KU4%54ASZ'*#L)-9AV]:@H`[?\IC2
M-OYG7F*YXCVVE-AS&5^$:>9@#49!<<-\P;PADP.
M#4D+,*XN;4X/&C/3`P,',S/<)^J*+DF-"=1X,38208-/\J8AMJ_JLX'A,$Z=
MM@%1809H,_P25Y\C1X2?6()<01+M=DHOOYH+9#@:W-MU5.&=;(M&/1+Z'K%\
M6361T")%ATO+]T$6A*\46AP/J@?*1)&&Y3D!!;>8R0PKMLQ?VIY@217*=RS6
MYC>TV='7!A/[+,]F;>!_=GA)MGB!9\3W$SB=%`17"Z2.G4MI'+"HP#ZVK]Q;
M!&"6!?_>UP/74ZW<`/HKU5H!AJE56W><'*QR"@,3S/:#%4
MVSX9.1Z=R6QV>GE7#ZTK:MVITZYL6&Q,^G<]&KJ1N`]1^@Y;H\#?YL*SH:^I
MFPZR)(ZMNGFULZEH6MJ\\O^"D83BEO+;9+,#T^C,T%#V='FA!ZF9BAVK^9RQ
M@Q5R;:1*2[5@FL?&T[=(\/*%=D_5IZFA-G6Y5IMLJ^XK/H[\ZV@SCKQ@D*>*
MI,X14S?TD@P]2JVN,7C@GMVU(9^Z[XIQ($8S#0FRXGR,G2T77]:K]8>-
M^+S\(C8?%U^68KI<;_`]H#%9L4:)AYDA@2T=\A@)^[HLZQ<^4O!OU9H#J3E;
M])T6"(#.8]YB-`C4.U7VM#YEWEB`A%X46(!43$JD'_4A]^ML^7GS=2[V3:W/
M=>.33(WW]&&(&**KBV\G<+#1RSO!3EW]9`Y2F\47S99&^.L-US2)9.>1*:B=+/GU'[PWB]D<0R9E&BDQ`;TRK0,.D3^9JTB27#
M*`\(\E(57"V;"&U,X@)5%66_L^[1]&P9KS&"-9@3A%SX1T6'(5"!)O?"5+DO]
MT+:U4QR>8BE/4][5M(FJ7JNR1\0_N$1UPQ%(PTL@-1XGDL*W!&V4S,OYB2OZ
M/^75TMOSO`O(?>,A!++*+Y7.7QZ8QBA1(D,(&>FAZ4"3%=F#)J2PG_27]
MO?WFP96\EAW4@+$BAQS.\YL9GKBB3EPPOF]EW$HZ;G&>^M9--K61<07H&M+!
M,:X^I]:$!F_6R[5@":D4W"OC.]<)7]CEE=$V`H:0@=7-6W10Z#RU"WQ004('
M/4]6D-+V+A0^JS\CP'_PQ@\)X2/3`&JQ9!AAMA\JQ-H^(/)V\*8XU=.21L""
M,+RU#1K],M_BZ['>VX#Q97Y%U()&L`DDL]'+6]E>Z27=78FYJ#/RY"+?4R"0
MS5SP*D_?*X"]L-7SI>-;HQ&CO[RVZ
MV1[6\9'B8K=@7AF"]1&"W>IR5WGY8UXIZ-P27*PA5]0=[RW/CO=VZ/#9<&0%
M"A8R`I[A+P+-\2M\:">>HMZ>']^93VPTL@\?OQ/%KLDOP&+9-$KOI&WE*Y=GC*<>.\_'HC@AP9O/\`]T:YN>VB0-EBCCU7U;#UX-OMW)/);E5
MZD19!9*V#TFZRQX=%ILMEE[-YFMF?+8L]$X^M[9X6!^QBU)AV[)KI[T%!(9-^-.G(1;<]`X#"&3QA0?.8ZHQCC`\;_&-U"9@0F3`@([
MFE!RBYA,E"KLB5M>/!N/>"9Z+46*DDC4HBUOI6R57P*E[E4^G3Z'R$V_@1ASK1
MJM0*IAL&G,0H0<"S5>!1X+S2[0/V542M%^ZM&IOA](Z3+=4E@:)R7.GY:Z%4
M:+]DV2,FTZ*MV,'U&F%]`=/8T[C7J^:]5I/4YA">TGDL*^>$T/D$C'\Z@G'5
MB\K`ZF'967!\?;>`]?'N:E)?EA/[?5/Z6`CWM4RQ]K5.:@U#6R5DK5[F.2_1
M]@DOL1Y'7FI\BDAQ*CU-+!F6TAI\\9,DL5JI]A>2QT[S&"E+`".Y2K&\(?@A
MK"('#)6ZX$LHIO78CAN-3#D6J;.XI<=Q?D>)1-WR2BZBJ=0;^[7R6.D&LHQX
M]$BSC.US2B\A"(#_S-#,S0NS_D)>HJH@RSLI6GO9/6+.5'7I=^51R=>7(M95
M%0JHY1Y=;D2G1\5@2.6I=%L\"@2)IDMQX/K'>;;84@B$,>*,Y9A44DQ78G0$QKTR'IZN'<7W;JP=
MH8:=$PN=29G\0!T1%#E'Y(C[=VQ]BGEN7Z#:T'-2,L@N1RHPD$JI7,*(Q5@:
MN?!X*J!$-\KDJQTC/(X/,*S.1P[*\6Y2GH[@=>R9LCO&J=<+*6]W%*=4.]">
M#!"4`0X5%&6,`0Z<^N)EGGW9HO5.I%=ON20[M'X-:_A20G4\,.`'%[BHX"^;_`Z9+A!Y:!&_UY:C+WEV6!-G).V^_]#LN%'DGGF>'8QBQG3333>
M(SNRP1-H&=HA8HJ:?1Z)A'@CL6`<S\]GOL_%01Z/6:7%<1!\51V+!
MWX2>6G]"VH,H"98TOJ06*#`*DF#Q@R!Z)+;1&Z$P*S]E54T$@8^4*J$M>:J4
MIX\1TK'84[D2LCP^+Q><&6*5ZXA5@O?AA]/>K,2GO'DDAYQ\WE7CH5.NJL2G
M7#723[OJ]<4L\Z/9`,NB@:LB$2\VE,++&;#EX@N%[XO9V;M?7LS^$V``'1@J
MNPT*96YD,C0W53!0L+'1=ZTH<0\N22Q)!;+=@PT5C$V,@1)!=G;Z;OEY)4#!
MD!`CH"!(=1"0;0)DFT,5!!3E)P>GED3K![BXZ8>D5I3$VMD!!!@`Z8\79`T*
M96YD%LP(#`@-C$R(#,#FBR2T&``"@#9LC]$W^M<
MJK"P.1H?9AK$DLO+S/>RWG_,FTY\]]W['^^7#T**[[^_>[C_R\W[OZ^4V+_JTW^-_KC2=FZU]O
ME.P_D?TG.O#C$+_@=W3B!S(*Q4+Y*D-3#\/'6>H^AJM`*E^F0L=^&$N%!GPI
M=8(N/1W@%PL=PK,L$W'BAS(,T1:%Q`8?US''_
M_+1Z_K!\N%T_/HC5SW>KYMLTHM[!C7:3ET)+I>;TQEV=-UM\\E`T9M/5
M38L_;MM#F5=;D5=5?:HV!J^VXI@7<.',E?^9+0`>3VSR]B!F_U[_PV&:1BZT
MC$-+,48,;5NZW)JF)>,P
M+3)+0X#<&H^M<67S1J.00]UL?2'6AZ(5^9=9XF<>I-")6>1'WFO>\L6V/J$3
MND88Z&*26.SQS2&[A8O@:I+<])=))O[;+`G&HB+X'\S&?)FEOO9>X+E&8S8*
M'ZO?@YI('@9L&<5Y!SB+Z&]9B=D"0WVJSV0L]%YFV",>F.0G:'ANKUUM^)MA78U%77%"^G
M#K^#]//CL:E_+]!53*X`;8/XQE`6`7`*?E24)7Y!^%`#6L"MPPO`K3>7R'V-
M1B*/_P?)Z+L',[\4Y)]A0Y3S7#O\T[@^ZZ)J_:W0CTF&8;1E_B
M7$OI6V:?\L0PX5?Y($IB/Z8/%WV?T*CCMQF]#0P=^&$Z>G5$TY=&XP@59GC5
M^S@VE.BIH>LVDO#"QA]C&ZGT];=MI%#'^#*[Q$Z!IFGTF,"`[X%ZE_]Z%!^!
M_U=C5QHD*AYC!-\&P0C@JZZUSH!BKZ(UT.1"Q9!&J"U11E.B#%0231OH`*S0
M8L_`5.*P%F=#3=^*4P7T(UX/Q>8@/AM'>#1DRCN6;BH"G/T+7@(W";NI+9\8
M;.U&;'NB13+80^=UT*7$-13$HC5=5TYN#>-`GB[&@;561:`,Y`^'SFR*G(:P
M*?8'8)]/WNKVI_;3;(X\M*L;),;4RR%=2TKY*^@`Q5?5U=FT&!/[YB&Y.WF/2@.\P@B$EC$`17!K9_505T$%DO[0F0+N!;!SB2/`&.+6>J
M37UJ\KTARBPJ)"HK!"ZSP./?QB45X8XGI\VL`VG5#R5N@6!3/K:UH6JNR5$9
M]U7Q7VA"A@L:&%4B&^'ATB-/5[L,_#D4?T=],-8I9$B$2NW,M+K+BQ[!'??2
MXH4@SE^=H&>Q^I.4N"//ADU#6Y?06BC;V)^XXA#"F.1J9+W7:C(^S<)IIW9:
MS5"$#$4\;8WP(D=:'NCJ76A[AS^VFH(HOPO$Y![BXNJG)$PH)?L+[1S=H8'>
MY=>A"0XM=,46$G`[04@[00"+&JQKDLQ;'7=U(HL7=4H?+7`RT1[,+G1^>4*W=B-I#41>[>=B;RK3P*Z8<_S:3W6D;+&`O.U&ATOB
MEM>L`NP&7E6TH*8TP!8^:+C\Z#8"=+'JH#_X&UJ-!KVW3JX6C;=F]'E?5VU=
M%MAE6[&L7`T-K3*]A$_6;^WK)-"C!8*W;\U:!=3X9M>6E^H1\D=P+.$HZ*LQ
MA>/VBEDE_0BG5SB_@TWKV!3``P8VO1*^ZG7PV`/"+!:T3J/(\6S"\N4
MUWPVW3!A5#Q6BXCWH.EV2T/)CW;\EX=U6+70_P3Z,'22`F7FUN^L"(Y8'A21
MG[T8QRQ0"J^?(=-LBI;FEF:9AY:J7E>T\_?K?9!:VI:/EUS?WG,)L_N+V>(8$G>6N*6Z.*?!Q"D=&,$;\N`[E8I9HCQ^RRW5T(1U
M!SU]JAI'>ED8O3FRR3BV?>4T:6OY%/L':0'H6&,;395Z4[==:Z\;4^9VZ+`0
M=.++NX$:R>]5"9-1U)-_VR$%(D]MK+$7,RBEK2AU+5WE]A1I<*DRVT4.3U##
M7;(@F\&;9,,L8W?<^(@2[,_"+87!>`UH&H@'B1K>"4U^]26B;)97;2%:H"=D);FU/3
M`)?@5`+?XB@1X]8OK6G.U)C<=[";;.#=?&,%=E(G\G213N#TIZX"+IA\`HR@]"
M>^ASKIX_OJW/;KHYU\$*\X551KJV%NV/*PJ>]@J>O%5P)]=1$J1N
MG;NBZF/!IK,6`)I\7;*=")/5J]T/&=K^K*NW@D0-B[E`97>FZ$AO3R"$9;\M
MVV%T`YXDXT-KY(I@?7#0AH*N.C?8Z,"-^/"\2GYP]4:AB368QN
MATV6O%U7H#",+[MTTNNXP'10OV\WXVA["C.5#O6T/1.D=O;/=6=LQ]-BPD/!
M&-I!J-RL@%&P;W"%SRM[%@6?YV*+F8I/'H7`/X<2DO])OCJQAP1L/&AZ7/8_
MS00A[;:HKR"`CUW95"J#-UN33NR@XZ?N]#F
M!;X%&/;%I!BNCZ765I1H%6,$E9XK*=\`&\@Y?&=;=RXNCV9P>($C%/20L&L8
M(P!$#*NYHQJ;A?[Z:A:+_S%>_KIMPT`8WP/D'3S:0U*3M!5[;1"@'8H62<8N
MC,S61%3:D*P7R1/W_E*TY`19`@4FCN3Q[OM^QPLN4%E!-GPSB7UQAC16,8VP
MGCT[(QG#6(%AZ>)+"IBI:,+TM)6W-,J]!=V)N&20>)_,1%$5`U
M!^6VDLCL3-Y`B.S#(?(&@^E8:BCJ_%=HH0[_^01:(8WU2<\R:RE3U`1)EXR\JP[MR<\T:[[:;[1A(83=I2T%0EIEMEIF*9$;]Y!0Y
MN"#7&Q[`SCMZ`-#YV1^0RE3#O#4H`>TZ>@*KXVR555UNNN:;4B6AY*AUYKB3
MI3J_"HYWH:$BT1JSKO"UC>QKY.D!<78]0(Y.KL<`=?2W/?3'@L)?0A/!:I"_
MP=GI-(>Z[P:7QBTN]\Q`R&FXDMY`'C6D^M!C`78%6B;XOP0OS,/PZRO8?>ZA
M=4GF5O;5"X8Z=L2-*O;^I`W6!B0&*B9@_UT0&,2+#_4T--)ZRN%\R:P+6GL^
MI5X]?ST'&HBG_2QX<&DJ5-`**!8T3,\2?2,KH=44R%W)XU:WT4>;E`"B]F9>
M-WAX*H)O&?,;^DF$G0Y!7Y,0F=#=%-#'[EDT(.(X*EU[BHA8\$K`-IQ4+$PM
MH?L#BS#_Q1%66G);E38M0."<;/24,76%+LL?M>_V5)V0/Y"5O@'@8B8WA:"6
MFN16MIPLCG`D?EU4T!8MT6,P3H&#MW;5Q`3&]M9$_Q(;F14<-A)UQOT!+#;A
ML`5?W:&)B*5>%V3@4.6B8LP@7DUF-CB,%,2@&N(I$:9$AGO$
M*"71F.JFWR&OR0`RD'4U[F*N$;,UE7(+>BA&&>KWK1-H*-6B#8#3"?CO^>DQ
M,_5F=3=66Q!!21W0'I=P5L!;P[?!'AGVDLAPH4@0P0O#PJ(0_IX__OR.D3)9
MXYX7R=HL-6_'\4-[[%OAZ05:.0XS.W6;R?+!%Q@U5'S/(%NT5[$B(^@-21`.
M.!\*%Z3QS/869NE@_T&"1T2]Q.V6!!L$%@_/5]=7#S_NKZ_^"S``99SI=`T*
M96YD,C0W4S!0L+'1=ZTH<0\N22Q)!;+=@PT5C$V,@1)!=G;Z;OEY)4#!D!`C
MH*`I2!#(-@&RS:$*`HKRDX-32Z+U`US<]$-2*TIB[>P``@P`Z>4790T*96YD
M%LP(#`@-C$R(#.([3Y=.>R`?[N<_GNYLMAB]_.5
MZPR?.,,GGF]'`7VAWO%BVW?"@*UWZYCW;[O##P_UFMS4Q>].80W\HS:1;0WTC.5EM`MWPX2%B6![04*24/+Y@ZCD-`VOFH]30W%
MWFM#EVW$PQP:D-FYYINA;*FV]WC[=^H]VC#^A_W[`E8
MV+*?K+RN.E'UO/AI,77L)2C6U"8L^?ZD11<#\1)4Q+M63_Q9E\WGQ:)[5I9
ME?.)];["2RP[G4J19\]P]*.]M96'E78AT9R$QE&L6N#&KO+T[N;FR69L4U=G
MWG;P-WA3OMICUO#VNJ]$U[*B9E7=,8[V='#&Z:U3J1(*[31R$Y711ZO^]V(5
MVY'%>N;K)*?ZQN"W%&*:JB-7EI3]/$
MO#2,53YPTO"Z0DI/7TD$A@/KT&0592QO]BJD``94/BY(-QH:I)#KZ?90+@WG
MC'KB6T#KL451"MBZ0R+JUV7S'-#->^5MR601V$O6LC^[+AL_59D%MI]XX="I
MBBQU=9>5@!,:41\J\1^DDM?JP],"(286K]I,8BZO6U2PX65&Q:,.JG2TV5D^
MAO"=U`R0ZHH],
MZ@:[\:!N6WXP(QT'R6>X=DGIR1C4)/,%.:CDG+VMR[)^(4M$R\,,M1EXG9A%
MM%TCGGN:^.4XX=++=,(#S_5>I?G[8A4@&P$/ZLJI?
M:&!5;)F*#9.'E5?6B&M?]PT39KG("FO*JHH>T>F19"C"++V_L$7@.=C%YN_;
MOLHI$U#LC)K#EC@[-3419_S9J!Z#ZK'^5(VJBL*:?(BYV79EW7+]3VG58*0U1U;
M2P>TCUO6`C+(M#-@S@H2)5`1,O5Q*5``LZ+J1"-'+^W]F*F89-K1+C@U0DN?
M1JC!01SZEX4G$2,+<3KJARVD4*E5%@Y2#C:@,]M&8:CY'LF`YSLQP!.%>*$6
MKIXS&L-6VHPM*".ULJA[#UJ@`%]XG>2$*GHW*!3M=I;U<%;1T@M[CT&^H60%
MVS>2!5#&AE?\16HY*F.5=7V#=)KLA:D72&5".!F4&37I.JD_G_]QKU4378=)
M095I+Z*-[(RR\L[,$O+18I+:,4)U93S,$*NY+HVU'SU0LI332=$_"7.1Z;\E
MSPK)9O+N4-;/F6$'`V2*Z90A>CUEO]#[^9&K6^JU`ES&C+$Y,&JH#W$-52'CUY6FI`EEJ:118ZG_B'=]JR*>,1%0M]+&DSFR`813%
MAK[*);@-TH+>?>9*;BQ5E&2.HEPJZ:M_6*!EE29]DL?%]"F$4RY.!O$KX^LB
MC7F^DAZR1!^*<;9AL_)D(X5I2W!S9DFP+DB"N;3YOE.
M,`)>$4G?*KTFU%01IX#14-M,>^#[/=+B52YIEE='R:X#J4@_EY7S@'D]E.S7
M/C.9^-:2,NRPZ]@)VZIC&583;0)*$`JW1X2\.HNFKO1.J4@7SZ1P*2B:+_.X
M/C0FD2[VTUSSJB*,NT+="W.1,3T)A&A`4-!!KY5,($]H]7#D>JUF8^-75T#F
M'%ITKFO`*]C$:E3.HM*/4.C)0\)`I7F'0.FR&'.NY5A2-
MY0&>Z8[#<'935D!B!U[F=48M,!@*$B>=;RSX\(P3P!-M6K5HE]PW,B7@$+V6
M5)D51V1S)MQ(D:3G)="8YQ+SW3@PVN,T-Z@ZW;H\:Z7,QTM7ID/PD^ZP0+)[>,H:K3LI,R>51"8S6-1E`)4>:
M1A$2D$S2$\/#5+2?:X$QD9=G#$/?#'G%3CB'GN/&VBM77=_^KUC=2F*S!#A.
MUDI+3LB[JF@T#C7[2>[#6WE7-]`,^;QBAN6N;R@O]F%FM"1X6A?\J=9W2U4.BX52AIV;8N)>^WS`A?
MLS]4>>%'%]1L56G^LN9,$HUY57@BG/O]'L4AT-_A)*$`_0QDN`H82S:J\!!\
MU:I%T1XE\VI],W`US,^%4>+I.E+(*E+M7%KT+3K"M'V),L'20-@8"#C`X:9N
M*,6LG3`UO%PF:M_,`/^U'_@94V#(5LEY&@L*9MME'1\X6;HG=5V7HI"DN)Y]
M9P\*$$>6B3+2TM.+=0=I:#.=%/9R3[DR=1C`](*R]_W(#"`YH7:5LCX2AF+$)<`D`3&9!W,XDTK-9$@W%/DXA>GG>M[(
M^/\S7C:[;N,P%-X'Z#MXF0))8"NV8V.6MP6Z:0E$XDD@>'GZT+<:;=>/;-*.S?BG@5.4B5)G-N$;WZQ/;D`LM
M76597MV5[-M<6CH((7M;"!D)81X1K!P;SVI5*I&!;&IN9/E-;9%<#[8Y^'(/
M?/^_^GC!9:WA8S>0$EZ:)OR'JM#0.7QZO8*V?\V6>'Y.KT_IEOGKY_>O/V99
MNJHK_HW[2]7X.L<_%78E)A
M*6C;731\=1$1O2KN03%33D?YNO:@6!%SHJ=R!D5DAZ_R>(PW'.S^L)S6"[IK
MG^BS0P!8#@T>B(AA@%2;-;5@P'EN>@7DZ"E"@AJ5C'IGTY&]PQ2/GRO
MYK>*4Q10`.4Y7=&T^)_5*2/^A9D65RR)!:YH.)V<;)&PG>/`'*(E/J[=F]C)6_+-D7#L`O6U^+I$Z0`3)
M`+9F_)CXI[5D`FP2T?HZ;0QO>$+/,3=SU,/;J-;=?Y+RO`[WQJWK7C
M06:[8:@(XY;O?;K:9FDN;.;0@=&2H%+8@5^D\%9D[>LTXR>@R!&L7,KST8<*
M&BH>^KCVO.ZR^)`S1PR27`2PU83`&`%$8+(IN4_UWMRE.P3+-S^.(@JVSL2_
M_&+@U@0`C>EIO]1-`_[DW)]Z`D1'\*0`_POO4[6*UI&U'*]\)?G8<`1'-9Q,
M8[&^TLR5]/U%Q>P-JFJ$0V]F*EWQG!XV/HYIMO;/BN/8+$#G'_+==J,K8!L@
M@MI!HBO1(2XH1#+H7@;-!O.Y
M`U7FZ8QT!T;'4HF2P@(:%\!$$N.AV_F]59C>82(_,H3'MSRO9>;M^EEUAK>U
MR>635&/H70R\7,(,/)^E]1T/?ILSS$([O%]*<6HISM:XU-;L1Q>-$G(H))"`
MA%Y2)F9ZNNDIU&>J]&LGCPGVDHL=>$>8VN&_(8G=[B:U!SURL+L0%P1RS[F9
MWVZ-+$$C30Z0C.CL*UH0@5J3,80N(T=%E%`=$4<$&0AF@0!DG]%
M)[O(AL<;>C/VG98;O.HR+'A^7J^]`.AZ<9MS*VJCO8GDS-WB@3B0)]>B,5";
M;2>Q\>%WA1"'PD8B8O-NY(I=NC[*46%NEWJ^?)\"_'<((7;_<1$WD[GW]A$*LG[9/KF
M3'N3;D`"@^5$(4=-;[HH[AKT)(3ZHEL]F5#7#E36U:-1TC
M,-.S%IA,D*@/M`[:[=EU\K34,91^?)V]FWW\_/)N]EN``0""=(-,#0IE;F1S
M=')E86T-96YD;V)J#38Y(#`@;V)J#3P\+T9I;'1E%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH--S$@,"!O8FH-/#PO1FEL=&5R+T9L
M871E1&5C;V1E+TQE;F=T:"`R,C2N'KR9
M#5[/9H)P,OL\X#)G`FL8B5]2Y(I8ZW)KR.SK@)$[_)LM_'\/`TJRV9
M7SA$18>PP+E@TI\S!!FF_6'XX"[XX'SZMZOSR2493RYRXC\N;B;3FZOQY?EL
M=$FFO[^9CB_'YQ_&HVE`CGA6N0Y/MG@VX$UN9E@ZN_$XEZ/)='2"^'8\.9]<
MC,^OR'2&@>O19#9M.8L^9RT[U_2BU?F'P7TF.4AX%B\ZR#B;BQ_SCPO!\&;X
ME2X@(5HR5P4QA;8>E]+<^D,5P'^AI#&MR?83Q5Q^C$%YD
MW\/`M.QC!.MXX#T=O?..[V-RZ7)A?LQ"KGB.;#B!CBH?3][>?+@^GXUO)GUX
M@8P2O1W8(&4\XG2]@N7TW!\J(X"G`2D\N=170#"WQR291EN464
MBAR[NAQ52<9,>;%]I+-LR$5NZ"KCFN[*DGS-A*#;;"AS3C=9D3O:9!`%%OCO
M.D/*4U)N_/)EN3#<$1A+FD53;4&%JOX]_T[.7>,[#4>G?$81(]!C_<[=)7&1N8<$?H?0(Z0Z1%6UDHQU_QW)D#0VD
M+6W*^#=2%91`H@((-(TOXI_5)EIKHY6"MC_OJOB[K&,(,<;<:0A9/%HA>#IC
MGK$JD%N:*B63+-.^GBQ]]6]5R45$>._9.'"#UW:?D15@L-U!YCQ8E)*(TT5)
MKNHP]099
MNH?)@@8G2(I4OY[O_A&&X"9!FQ\,C`(Y=@@,BW(")V>E"]RXUFFS2D9!C!8J
MX$&#]$QEFDKII0J%F?ZLIF=2J$<)B_*JI/#@$KYK%=MFGK21W7_.+$=]*&Z?'5'.1WGVIRVO5SN5^G_
M;2Z+7#`GGY8,HCG4LC!4NJ3BM/I$Q?_I#$[$+*ID)*;SPME#A3=%Z(?;)?_=
MG'K)048G!QG[DH-$VSG[9M'O^WV3.3@"P5EO%_#`DLS]R))LFPSE!9V!]QZ<
M\GP=@QF"*%2APCQ=R&Y#P!TJ&7FNE&%W'\-#\)CTGRC7R+6ALKZI\C]52CU$
MB4N3,H[K(Z]\C"K'^Z2`\EE4?^B%PHUF<'=3+J*KT(XS\@[_?@6A+R1GACR@
M@R/7Y.,?&%D..*G(X)_(\M"O$:6]Z40;DQ>"++Z&X:^^Y!5>).O!=/#;P"_B
M6`.]$#^#%M]IASB$%C_-:M2MEZ:Y;Q_;:8/HQ>E'5/Q-@(?$BU24Q66B^H>Y
M_F$*UO@P/CN-%]^+5'1H7HTI_*.S8Z+A\T)T5-I%UMN=YOJ&/[+,*'6$QQGN
M5'-BFE'!CV'N&;AT,/IL/%R^PTYR_XCHV#UIK`B>>%D"85'QK`;:Z>=$T,U_
M5P6)SSDP<2UN-4C5IY
M\HZR[9,K?,1EN`%=5XIXN,1\.X6R$3MQ>[BP=2JG/<2C&UU#@^SD3B0]AUAZ#)WA"8&*4FT6Z_VR#%4'[H32S`'=MNCI
MZJK)=K/^$]<#.I#F81O.\-U".&7[F63^ZJ_GZ[*.G[MR'>IW^-%LT]]5?,3A
M82<*\\B4PJ2FIR07\[JI-GD_-ZM9ZW8((?
M6CLA6ZP(M5F2!4CN,@7F5>8+_^W>$VM651TO@"'N#&&+T(KQ@JDC5CYH,CW`
M6@8$]E1-33;E`[E;;V_G:_)E6VT:D8H?L*O?9IYU*I9
MD>F_EL/`\&(5`H5+N"KA<3+9WK<#_M["BC*:0B0[RWS_%&*9QT^2#.)%7E@T
M!GZ#-JKMH(0XO0@-/32.!QT:K5[4(7,A&9)!P=^"M^:,HZIJ\A/G425H7M9K
MA!!W^1*C\F04XEEL:[CS\W:'J/1%C$5!8%&B1>Z4[26`:T]."7`B=MRIK=R#
M^(+FPY?GD8:8.R-MG"PS!QWQV"D+9E/P=V7]K5PTU7V)-%"0T5DF*?FV*^^K
M[;Y.8V01P5!M+,3<@:D6+#EI-=_=>0UN@\%)A2AUDA5)A;&!$+Z'#SLNJ[K9
M5;@1;?BEK;JMUU50(
M8K.:-V0UOR_);5EN4`Z;.4Y>1BOE,4A2`C,)A-S^&?,4[J[WBY7/VV_EI@:1
MLPB`#LAQ^X3/6X1OL`MG5KLR&`3U(\L.,8Q^0[IIRX_\QL(K(>:92$^=1;;[*`-"`E3CM]5(?2EX?2TJ8Y.L57
M@]'UQ:O!OP48`(P[5*`-"F5N9'-T7!E
M+T]B:E-T;3X^M*'$/+DDL206RW8,-%8Q-
MC($2079V^F[Y>25`P9`0(Z"@*4@0R#8!LLVA;',%(P,3J.*`HOSDX-22:/T`
M%S?]D-2*DE@[.X```P#TV1GM#0IE;F1S=')E86T-96YD;V)J#3%LP(#`@-C$R(#7!E+U!A9V4^/@UE
M;F1O8FH--S0@,"!O8FH-/#PO1FEL=&5R+T9L871E1&5C;V1E+TQE;F=T:"`R
M,3(U/CYS=')E86T-"DB)?%?;DN.V$7U7U?X#GE)42N(0X#WE/]PY($Y/OOWR_OWTWN?EA3>>&2Z^8K/!,P]`U=AD!!*_23"!\R2N1\'(:'Z_V8Y
M\0/\+"8>2^P&UZ!I$OII9#!QJ=YGM9F$L(2D<>;'&8FCD/@IP]T:,=DC%1KV
M>X7#7E'L1Z-P@&_T!WS3D/II@LOG$&D0(3Y/#'U9H0A^:R>S,XFOB,]41'B>W90FQA9-G2
M/$\'MC?##Z`,V2VV`9E3GV:F")I;KG/[X?G3/Q>?EO./S\\_/3S]@`_E>M><
MT"CUXX@D6>I3=E&-2W0:Y7[&1FLU!-4/K#>0GL?5TV8]WIVQR,^RT1.H#",-
M3.<(<]S2"FJ$-@F>1Y9R6%.H)`L8+J0G[W-42KRH6Y^F68^]0!A
M_C,IZJKELE)D7S=GWNSF95U_D]6!J):WPJP45:N(K*;_VOQU`KV1A"'RL2"Y
M`TD-2%%V.WA^1LZR/=9=2TJ)NS!/PH:RKF;#SLSL/(W]V#/?^90!WDZ8>UVU
M$XVY;(]P#_'G+@"L;)S%+HS8B#;+0AL&/R$:^?V15_P`<*F?(=QOTWGLAYXB
M2ZF*3BE=KMI"GA0AU+!$66L:Y:Y&'V/+)O:G.3M-)<"-+6HR^6FX6^J*+))V6!
M%=-8%=_$VQIE3J-$PD<-Y!NRER6LLMP-`V$H*]6;V;&,`>B/(%N(`
M1$O(EKGOF:$#$6Q,AH6!0_KU!$HT`>KPN5*=03E-YPQ*I7^:P7VGTQW$0517
M''5(CA!+LW0@E!J;"0.;,RS[$#9^X="V.7C'#*;%`7@BQ2L6U+-^L^_:KK%E
MK4^B@8!QO2.HP5^+4_NZ'P61U28\M#=>&GJ\*H0FNY<57$M=L,IU"W(4\+TV
MB[7-,`^Q(P\?TA=UZRPFC;+DLI)AGEL3U](VP8L7G8"Z(85L"IMD2"$$@]IX
MHWH6X!8Y0,O^L(H8/E01_='\)"OT>W'I]N'@]GT]$P9BO*@G]*%MP&.M3!F%
M+F.%#X,2SX.CHA7/`+`5#7@UJED47)GY8?/8RQ.A+JQ%#\//L,[Z?.1AQV%N
MM!=#US>035-$DUXS_,!\O.:;:(>"FH2TC3#,P/M8D%TZ"WQ:I58[$+MQ#)1H
MYKEYE&NN\+TE)RB4V5:U($5Q`/^9D4&78K^7A12@K&$Z6-R;#AHD&,99\]UI
MDI'7*Q!&<6'OC3A]\70'0E>>&ED@O,:A*=(P\^C/H4J0I>@#6`NH;Q\"W[=NHU@9$!YZQ<0.SYG*+M8;H]^
MFH9N:&`?<#W%#8R)`;3:&)]MCTW='8Z&Z7`?K1M#*TC=QV>CAO.]@8QX)C;?I,[(;FU%!CAF$66F);48D]
M#CC(SE9`@G@I_PO/;G76$J\?RWH(H\`T!D9CJPF]$63L\OP2IFELQZ#@.'YF
MEH<33^R58*DEY*LNA-CIL8J_%26WASNE1S2(R!C"*R]%Q(N261%ES*I45"^R
MJ2OKZ8!D+&.#5$QZ3E.BM8^/*D+&"=^!$O&@["`-&>%ECO
MA"J@(X`$./N#.X*084Z$5ZT6Q_9T01?D$X1$/D"!ZD:?(+`AC-IK/%_`A&_1
M.]#,];N.+@:\Z_R$)T)AIZT^[XWF1?CZ-!.[X@+KK,^51J)]'Y?/:5*/Q#_3(<#\!)0%``K1/YYNDM
M-ZTF61`+M'6698EPO#@BPQV0=B\#89AE5^\]>::E
M[`Z,1+]_MOP;Y`:"K;>E/&@H,MU\G=`(@AJ42JG;PUH:N(7JMDK\NP,E&E,`
M@^Q.^K!KFY8ZEPA!,#F]FFSVT)L'UKW>ZG!S$!X?@HD^-(%<=0MDN@%^UD+"
M0IREPMP5XM3BP&\@2-GTIA)[IA)J]$*J3TF-_=1O*&,KT$7!E+T]B:E-T;3X^M*'$/+DDL
M206RW8,-%8Q-C($2079V^F[Y>25`P9`0(P4C`PN0()!M`F2;0Q4$%.4G!Z>6
M1.L'N+CIAZ16E,3:V0$$&`#I_Q=A#0IE;F1S=')E86T-96YD;V)J#3%LP(#`@-C$R(#7!E+U!A9V4^
M/@UE;F1O8FH--S<@,"!O8FH-/#PO1FEL=&5R+T9L871E1&5C;V1E+TQE;F=T
M:"`R-S@U/CYS=')E86T-"DB)E%?9;MM(%GT7,/]0+SV@&A9#UL)ET&A`L9VT
M&K:2B90.!DD_T!0M,:.0:I**.[^1+YYS:Y$H1;8U`6*1K%MW7\Y]\39K.O;+
M+R]N+R=7+&"__OKRZO(?@Q>O9R%;MH.7\\&+^9RSD,WO!V'@IPEH`F:>!/D(7`.E22;SZUNB
M2C6KE$6@3E@,;M$1GV.!D?1%CQ(L>6PT]?L,8^Y'49_,R&4G><:)'_2(M9[&
M_-OQ=/SZ^O9Z.O\^Z[,/X\"/H[,4#F/ARV/N1INKR>SR_6PV>3/M\^8R\)4\
MBS>7PN?RB'>JZQRCUXR.&D64XOOG/;'+@!L&5S\_B*WCLIX=\
M0Z/HFU<''&%1>)[Q0BH_.3;>Y,*KR70\O9R,;_JL97!>ADG\'+D@Y)K\\LWT
M:C(_"I>,X8/S4D'&<,)Q*IP,EPI"/S[/LRJ0ON0GL_?=]>S]S?P@8DK)@VQ\
MBK&*_3`Z(V8JIAYT7A80H8CA7Z=I8AB^O7XW)L\>5AE,2WL7J"N))^HX#%+T
MH1UY3Y%]_QS%Z(`P@_J2TKW.4%S/!R*@%`U3/X'Q4C`?SVG,FF)P3SWXM#$0
M&?%]']UWRD"+2$P_U:9*TH>'`XIT21
MHD"5GT;(O^$5PX##[9-ZZYH65>?4$?+
M0BJJ4,1[2R(G)3%23BN-)F.47A5-458^A9S8[7-SQ$W(1]SGL>"[?`I=/FDK
MO)?O9Y/I]6S&WOQQ_>Z/R?4'FSPNFK@=Q8E3+G;*Q2:]V]6:O+9IZOMR79S.
MNRA-=RXTY8&:M\8Y!B6\SY;K^@X6MIN"+.VT'Q./Y2MM;^R5>;9NV5#YRB.G
MTR]-.%^G$3ISKO6^#2Q>9)MH/K?)4407(8PUNN*M6;&/1;*
M"Q4$K##'FW5M#PI$]*%NUHN'_0DA[Z!5IO4*IJ[URP;HB7U7UNE[BOL[DLFK+Y:K3
M#I,>$E#_YBBKKC#/5?%@'G3BTT-I6)+0PM;"_.=>X,,D-.J"8K'-NYZFWUNK
MDE>V7:.U5![%=4LIK\,"1^G?S/Q\S6!KYRCUI_K>ADWX\`P_"EL8XY,67U:+
M;:M=1:[N8&N^WB(4V;:K#V+1E5^+"W9?UPOMD[OB:]%DRP+^LM&Q@HZBHXR\
M,+#R-D73UA5R,\\076?\!=NLLH82$66?%]O.AF*3@5[+Z\JVW2(=:M>S8@5L
ML+/*50/J3(MABVV3W:&.EE#81?&^R6`JY&T;F&(LI::I'7:W+=?FS?4M+>&9
MQD6,T58-6_35"U941;.TC4O+?4"6-*RC;#'MK4!QA%[5[3J-KNTX,).J-_J$
M.*SM[Z;;M[;KM]D:45N20-W9ZFW74A4A]-.Z0=V.3647#;S)'M#==AF!?\>%
M+(2-$)/J)\09*J^H_)JB<$59=:L6]BT@ZZK(;2W?P3@17C`L5$&_[ULI1_YS
M+3FRPCA<>H$!135)&68:1N3YPQ'U(#;3-M[9KR!4>_TI9MQX:+`N8:I`8[-^-8;OLD.+.+).N(%@
M)1HOD>;&2SH(I+,9V.V_7`9$&A-$+$J`!Z1*?)7L(%D/8*1^&B->&NX!&D.P
MXK0)2J$(U!K,)[46H]U<^NC-AA'5%=(N\=:P1>@43+Q6!Y#=#25>O@W17U./
MO<:;(ZB70^"4Q&NRS(B9SA$('K@\-O(%RH4G1_(#PT6IGX8C(;$6
M"OVL`^9N'&H@=:%]]*ZW9%WJ-?6F>$(`TE7N>?/H!&^I=M:)`W2`(AZ&J`DX
MG0)09NQMEI?WPU3C&YJ\^?.FA6(OGIZ?,.T'Y]Z0B2&R8$0SK*P>]3#[)]("
M1S6B`(TCY`)=:8QZTN=!(DZKEY!V*>V9GO--Z),FI%JH-/31\QET/!64=?J%
M*(&=`_8:_W\'[\_,1Z=X`$AFM^SCG_BR&(2L9(._F,G^D,D(.!!&ZD6;<>S`;_'FB:"$3<5Q$S9WZJ4CA)`W)W'@<^,N'QM##U`>"D62_/7#[FEA]_&R9.Z`N;XR
M.FBX!D2_W+9EA<'`VF+Y16/ZYV"TA4,\B`XG;0N]-QBB!`AVF($P6&Y1T::F
M\8.)#PZ?BO;;:N+;![9?0RS`#N+W0H_>GU$_,FS=+V/Q$X/2<=3O[PM&HQ5&J/8N(H]BM>AAAQ:JMD!$P,"C[?9P`6X,DOCUBZK#7@U_RTZ
M$G/R.R38&3URO(_`FL7S(K1@;0X4`8`!3'VW)I'E*XU&0*KS
MQR)0F[WZ#;GBT(P@N!D<+7X\LA99D#=$7E-&/0Z.'L$_.T2CQ1R&Q>*84Q#)
MB/T1$]+7_P?M<(4;$4EZ%N]$#N]PS(XH,'=\NV-0/^#<`1Z=*D/T.P`>FF#T
MU`Y3`COD7(`=FFSL)09_:(]*$%;F=4^O[QAV!6:U\I:&`@-3TFBT%SH,/FQT
MM-%JZ(-7S'W/(*`=Q.=Q),BQ(PM*=6(FJ=&9ZM2@W([@/;91\U/3#S3+S.':
M?&43;&4TSU'2]JDP!`N\4BK8Z_9K!0@H'>?V`&E`&T':G(`;/205GD0[0;BS
M1UE[W!KQ`7H('8518@23"_%L]$45S($"0OT5'7>4O>2B$*7FH(G$4>-1Y.@P6K0_^3#<'6@$3U1U`F@X.6R"@`UT`1BA471QGQ$>X,%S_@XJC8=)@4K7
M('D`JO-K'MN!7LG=#)7!E+T]B
M:E-T;3X^M*'$/+DDL206RW8,-%8Q-C($2
M079V^F[Y>25`P9`0(P4C`PN0()!M`F2;0Q4$%.4G!Z>61.L'N+CIAZ16E,3:
MV0$$&`#G4!=9#0IE;F1S=')E86T-96YD;V)J#3%LP(#`@
M-C$R(#7!E+U!A9V4^/@UE;F1O8FH-.#`@
M,"!O8FH-/#PO1FEL=&5R+T9L871E1&5C;V1E+TQE;F=T:"`S-SDR/CYS=')E
M86T-"DB)C%=-;^/($;T;R'_HPQRH0.+P4R21Q0)>V]@X\7@&D3;`8C8'FFI9
MG'!(+9NR)_LS]A?G55((>Q2`Y9U57UZKVJ]Y_*?E#????^P\W]K0K4
M]]__<'OSIZOW/ZY"]6RN?EA?O5^O(Q6J]?8J#/PBQSN!XJLX\A,5Q7X:!?C_
MKU>!>L:_=45_7J\\-5M_H6^"R'V#JSA8JC#TEPE]P*\L_#2(56C_KF^O_(!^
MJRLORL7`I=-L&?M9PC[I56OG;GT5XQ65I;F?YBI-8N5G$5GK]=660GG;5I+[
M<70\#N)-.-Y`+4(_S/E8"YPK2,@;+L+<1GB]^NO#]>.MNG^\\15=W'Q\7'U\
MN+^]7M_=JM5//ZSN;^^O_W%_MU+*VF:+65*,%B-G<6DM?KA^O/[Q[L/=X_KW
ME;J]7]W\M%K=?WRTQO%?#S^O[IVM8UW8:FJ/>9[_,2E!0DGGI(1%D?WOI"R+
MQ(_S_R\I9R'\_>YG=7OWS[N'CY\HCLOCHOIQ$9.995&D4O(P9"MA&)&5S][M
MH:_;9S5;I'[J;6M3E8V*Z+6RW:ANV.E>[7O]4G<'H_:ZK[N-F2L\5MNN:;K7
M>O:O]=^N`,XD2!+$!B^?/=CK\&XYU%T+^AVU[MNUA./1:5:79J2VBX^!"/XBC
M?#QKD#L?7`CDH]?FT.!XW?88N+'E*/QHF>5G<4HU\:UU6K=E6]5(U+XS-7WJ
M'VLI:%@`7#$%M8C\**,V>NLHG[T[SE^,>)$_W;[4?=?R/<6H.'EGD)[`@^S`
M8!@D8E"RA<0;I;\1`'1;Z8WZ.LN0O6ZCS8`R\5TY"_WM6E1OX,+KYSVR1(1R"#[U$
M\$'<3^ZQID[A@_:EBRI/H]0UP:L2ZSC_TAN0.9RQZLQ@4%Z75I0+)@Y(TM`I
M+9YPE/HW?8S'6CV+A^L4+`.7N^VVKFI*R+['!4ZU[SL4"G"VMKOMUNB!>P\6
M,_#3B.>8;:5IQK:$#-#D1BM7Q@V??:Y>=W5#CQ%16SJ#RR@J+AHD385C&DYF
MXJG2`!"FGA*$`9/TUCC::'.HZ)F+O?"3(HO/8T_9?!'G;+[;[[M^.+3H'8T#
MF@-@A&I^&DN<5P=K;?@+-=Y+N$(K>&TVM3/
MK2U=4W,/`(V#1J=4"!,\`M34@PU^Z0EV<%$UG7]=_7JHF6+,T=+R#Z@@<]R2B24S]/73P=9G
MNQ>-)%QZ#W-%M35$)=T3G(3S,>6H)0";25H!;V-
MP[YH53[W6K[4[=AL09Y=%"G*0RF2(L91ZT\_JNNJZIIRH^?JX>%&_>+AV2\S
MKCI*9W_1[XU<'9[,@%P#)XVKU[$3R>5EG2QC.A;#=Z0#))&$=E8%8BQK_KGI
MGDIQM9EFU#YY.@`7A!Q[!W*@?M`B>1$P6^3'-A,I!U=+R(ROT+.^73I/RO;+
M2161!.98=*:>1>B(=O#5+`QB(C@)6IR>!2V4$69"IVMX'/JR-27W;TU:S_$K
M4X(O;#&&'?-%BK8.)X*:.6L2"&QU`[$EZ;#E,;UA^;'90-&>M'I7Q($B@:B;
M!B[G>(9VUU+7R5GL@ZUV0C3.(`MWCM/8.*N`K0-2^8U9Y>D+W)-SR/2P<#W\
MVO7_IE_T>CVXRI:;+PD7B)IZ$2^*/>`
MU;>:)\L2%4J@T+;?/?5N:7%%(XQ%%I7\77;Z;*X.^XY37C5W:(__6`M5/W
M**A-/K6IO1@5B&YJP[\.XO:&F%%&^RQ:3IJU<)/'TF7X^8!!J.LM^T!5;6Y1
M-X:R0?4,%SSB?4;FHZVT)\W,%N850-[QK%Z.QL9AOPBR\V%_7&5B/HD+BGB3
M16X"Y!,>9+#JC>4F2]#OXGD2%MR]W+=2?&9J69)D+)J^UI&299Z1,8)'"E:.
MR',\SJ_N^=5&6TJ?[%LV2)%-B46H7)<]IG@ZZ4KO!\U<_81DQ0'KILVQ/-\W
MG7QFU`3@B05XS``7$@J2(KJ`JB@]!L!HCAMK=C2*!8R:LNH[R-,CYJV=NK;C
M.<;-TI[B[M!CB/+=DK%P;BAH7%AG49X(7E@CS!\T\QKUP/EHL@PEAPG%3>HB'58?*F[@SFV"9,R&+XJ1>$I7V<]2U/^
M<3&<2.LQ-.OV34F(@DS6A6$'>MUTJNU<^9GW*4=_E+\2(^0!ST=*A(,+$0]R
M$5;B("E+)>*%P:3M7B4(KA43,6?-*B-&I+H5]CVROSA[>^J,`@GJI_:8/6I&
MIE2C1XZMW*H6A\O)#!D[.Y9W/([]=#^;6X.4':M.NLG@N^+DV9QZD$060P^A;PDJ\6<+&II'I1CWBSA8GL47)&Y.`VU5A[Z?
M[L$R_1'LUL-9X27YD1OJA!Z%[DBQ23H9P1-G76!%C4,C/O(%CB.YR6@H!MVV&)AE\GZ5
MA1'BZCI9LF!ON/WLY;X;M%TG)P1,_M^.,0R%(R?)G$LX=K89#>0?>,A!!BR-N.A)G%N@<9(9
M8X(@,I"++UHHFP.%=+@H0;X]AZG>'A?%R,$`3=.O^W575U<9&_?/>@Y.\;Y8S`<)*"+.J/V$!\D@8@%Y0,&LF=7>9"#H;"7/4%DO7`K
MD[B_9[-?TQ@?>UD!3#.3E\RBK7(%+8TK;P)*L\?K-/!1"#'@%I+IY"6FQX>K
MV6J9=CT/>45-*7SX(M$;JU#BZ<+%8W)1W#@7&;L$S[`7,G\@1-2>,2J#:-PC
MID9);Y^!>&T,5XFY/[@)A8.I)9*$>4^TU5EUSO>FZHZD1:F=^II/WQ%BRW-^
M$,@0=?F)HU"#-B2I]A:FI\Z^MC3@HD((;5,O]*=>P)-\CTB\:YF-J%3O)Y$G6#2O6?5GE!5?.V%#JILX&-$$\51;.:,
MA;M4<1:)"4+I-ABM#V#(.OA+3`2E*"^0QAI.C@;Z(#5=0*$F/2);60S%#CZO
MRU-^8-9XFQ?;8D^\NVFVC2XXKK;R`'(^B$_LN%DC_%)!RD9FPBQP!!V((P0.
MQ>6V.P#I=9,W;=5YHC_N[UV``3Q>;NZA!YML?AZFZZ?L2YX%_Y4YP'E&ZCA*
MH4-PE6'%D5'O2)>F(XT(\Z!K\^\B^*<]V6HGLNIZ3S\6DRN%P&_>!0^3T"Y:BAG76Z\C:=*16,+8*'NE;('#+W.I7"(?HMR-,
M[3J/IW*'S@W+PZ"D%<8AVN)0F3S;/VD6T.0GYLNR0F/N#=EJ0&GAD?8O@,*S
M\3O)(H@`A4T\UQ7(?"](,M(?H!]02H;HWPGZ^
M3I/I-2CI8U5B^FGPNU6F84>KS)FQTRV\`8%@XHQP@D\9TNAETQ9Y(W9";SI%
M8MP87M,0X@#)]"[SNB6)G%%H51PQ3\$[^7;W'MA\L[E[N+[A7F??J=U+F>6VK;`FM\5TMR5P#"&WRYIOM+XO
M1\FN`0POQJP%?Z,KS\_6#0^'"%@[#'L5."7(^L$M"_^(A5H^%OF/_GTXV(C`
MQ)^N$O6GV'=Y8W,!U5'J>+)KL=TVO*1*$LA?+`6PK($Q2<,+0HZ6:6PB5KA8
MMC:L5WLB\R*_>K2/<"X(9I!L[CK\<:0!$T0F1+H9XHI4Q""TFMF&O$8Z@9:X
MYPM#%*/_=NP,J;XW`"10C/U+R,JVZ$L7BH9THD>4XIOJ1F0EZ1PSAKBG:,PY
MU"HJ-0_D:>&26>R"))XM'#7H"_@;Q9LS^S.S)_8/_+"8SY(@7F+;T;?RQ>W]
MU:NKVW_7KZ[^%V``0P8A=PT*96YD0-"F5N9'-T0C\14GI)A#^@5]9>
M[(="VO_O'^X\'__F=XL@8P/73C=)Z&TB\HFO6CMO]GK%J8BC4'B;
M`*TU^NZ`J=RV%:5>&(SA0+X1Y>N+M?1D2F&M(2X_0F_P(%.;X7;W][?;]P_B
M\?V])_#A_OOWN^_?/CYL]V\>Q.[C-[O'A\?M#X]O=D)8VV1Q$V6#QO'OS?O_;3CP\[NX_[G:/W[^WQN&KM__:/3I;8U_(:FS#G-=_*(H?
M8=&I*#++-G](_R_7&BQ9:-9X0^Y,6W]9]533\\7KIQ8L/35WT>=<*515B
M=]:Y467'+XCEO_?_N`LB+T[2$&*U$02;C!S_H%M3M6*YCL',4P__T&TK^LIT
MHCZ(W7^+]?U)4VQ&B[RNNL8\]1A=5XL.@K'6U\[\99J26^1SEI]J4W7B65==
MWVAQU)5N%)IJ5:E;]*?.YZ;^8M!?N%#+P`L6G2YM(L%"O))1(N@[4Y:&\@J\
M+$Z&O'P8$O:9DL^Z$H>Z$0:*\WFY@=K6RW4`V;0=]#&'4,A\LA#8`WSA3"]<
M]R#A'KB^,=71ENI@#MU)<#9@"C/&SR_*\AL4XHQU
M,775KKAY,+-QEHQ);LB)#Q6W3K;MJ<364QM?H#K\>%+/VOJHSV@0F]9J^!;+
MT9Y4`V4WU;2/[&G61YXU*27YTU_.X`[*`@`841@_AV^2CEYQ@[UC"+JB;J&;B'U7/9+VGY]M+]YJJ%(%`ZD
M9@X#2UUDX,?L-V/@X82FZ,I2P^!J!@U\IQ6YJK#-3QH&7>4G7:RP#X3V@S+-
M2%W6Y^V,+:&09TP`.&G1_*RACZKL]=!RJH9M"+@K])`PT"G$=&KJ_GCB%*67
MII-Q<"GZ/C.RJBP-*@.L*(`.%QMNI0I(&I"2FS^DI30-CK9
M.$A]/`,,\K)ND9LXBZY15:MR;,GJ&K&B,&WG,LB"*Y0E,`KD75.=V`
MZ*0GPB@]WT3J2KR<#`1N'.$X]S?)-MALAH6CH[^.A7RYJ6ROKE0DAHR"N"KM3%W\2I?M'/."P6F\6GOD7K
M3W7],Q=[_I-1&5FOL_2<,@HU.,!@X^Z-(45_(\5'3R!
MK;/D&T5F7HI7+D_C@;$)ZU-36P)0\]VI1;4%1AZ`J^G3)Q`4H5PA&_KC*G3F
M;NGS4<8Y`;1<1U8U:"C)@'Z8*`VEZ%Q:@^Z]'C:X\V)_PJ*9ZV#DQ!?0=&D.
MR+V8V>@']L*T%A9SN.P`]_9R`,1TTQ?`,>FNC][.&W>A=3_K4N3.3$[VN^WV
M@V='`^]"^V?;\H/B];$2A]ZNID:?@P#4.>Q.K8
MBEU=]H2PX;RT0JFJ15E71\B#<4Q2"D_!%=`+%'U8@];)+#7:4C)V0P_!\1G9
MV!,'2K?B$[.TV%8%+2&S7$.V%:@9/+*>M?6%F[]4CEZB(`GFG92QN^@&SC5C
M2A-><41FDYRF-O"(-3]+ARXZN8G9R<%4('4,Q*X/!UA]6#3PR#`1FN4T0Q#*Z2BG)6+-=CJM#Q)]-+8S:(Y`("Z#5-$EV>'L7R$TP
M.R,O-9&M7*GQLLEUTR%98;/LF]2L[J0ZEQE,V(3MAIN'7?`><$UA90(+M&\:
M<$>:`0A(@8#CYU\A.5CU5@,")4)7R_J,_SR#B19;/R1I?=_L)#W`Y=GHHL^U
M926X+5_O]XF`&`]W_IR7`O<[&_EBVRCQS]Y\-KF:\O1H)YC8@4;.%$40.B1!
MB[;GQI26'4=X\@%(>[;1H^XP%>8:^W]=AG,*=#'1:0.!+1$F.V_KT=-/-FK[
M.'WMI^6*/N3OH+6%U;M81O_V9I&PQ"A^4'I8P081G<.V9@@"![8*X&*1:<76
MN2Z93R%<>-]^"*%#X$O6IO33?IQTF817]"7=)4.LY=8085^"&^B$QNU;0#2-
M.W7!RZ[N0?QNZ37=0.8K^^MA\*VWF="=`_95D(HEK+%L00+>25A"+O_YT!B,
MBH3?!!UC>^L7O#P5]A%"VD?B]/0;?`0(:
M(,IV4(>;))XG&29\2-!20_2U^GAYS>"9,,M[S)9WRV%L)GJY*>:!W3G%R9E"
ML^6.%,#+JS@12W@5X,J#8AOM+C>@)`-$1X_U,:
M+#,YUR#`@:27=OK<3063/P@FT`!J&!=8]?2,R=(U,SW6K(>;&):!$X-(UBW>
MFE-$#J7$FVJ*;1IL2\?"R0IK?;ZN`G]S=4.\2B2KI]$8RHHU@(*)@M[FHXUP
MO"2DL7P>=(;U.LLMI"%)?#>?P*O+Q(>NH/G$N1TV)CT"Q2!'-U^>PJM,LN5IHB1]=Z-5I.?]'>;7L-FJ%X7VD>0<67G@JUP*;Z[:C
MZ4UJ.U4M=3,;8A,;A8(%.)[GZ!/W^V]P($11-5*"Q^3\Y[]]E_3-H;:`F$*A[NB)UP*]QR%[I==QNDE7+EC-%%/)WV*DKA"4
MH^IC>%=%U!KY",<]UT!@9;W.G;!7RZ.S'4M8*A:?^\V4PEB>_L4ZPQM9`$^E_RMH=6)EI#;&>!
MV:02W/?>`&>,O0+<"FCQ>IPMCK7,A>WA.V>8=X'9*L'LM<"5YB\<),^*-)'+,7OBF.W(,L"^%5KP$;B)(LD;FO@5!*#O
M(.^-=\D=&.0++5(;8"AYG]H$\W:^KT\J+J]58X15#*:3L%J?I2B*E_:`/L`%
MD<8;0]6W)\SFK246QQ.AD(6NFB._C+[_T$(AWLOC\\;[J6C:9CIVE3(\"D%^Q)=_CIB-2RS9%L<70!_&\;A'+?\.%:,
M%GQW+XG"#)B$TM2M/!4(RND"CPQ)TX'WV.\/-/BG*R$^\^5??'&UPXB1QZ#_6"`8USXQ_
MJ]TFRD*>FTQ7>N.)GJ%`^-K/XLG7)GGD-V'B9APA#CE)+4TTHU48^0Y2IPZP
M6OLDFU2_UVR>!>-&#@ZNN.$B(>!W?*AN8H[I+_I6^L=
MW,V8C"U$$`1VOMU9,CDV':E`=783+6BU+>L+S`W=895DHO.BH:/6/HXZ0X#$
M\%IS*PU13\5C/X`K.)$A#\6=E569BW<+`H.X2Y+$8M!-?`=J.)`ER0PG5FF8
M=V@A7G(RB5AR\CQ$V1S3$32.EK'D--HB&06!:;71U"E1DK4CMBB(+7K3#[F1
MY[VHJOG_Y5Y7GNOR":X/ZI;/$SRA2_Y-'M,[%,=+W53-F>3TS$B.T;1R@BE2
M[9%Q=.0B-4J/3=LV=V(-OL/M.LP&13U6$*L(H)<0EBB8)1B:"`D6Z5\ZM=^F
M<9J]&LPA8?S\8\?(G\;
M>OMLBQ'Z!UR&*_K,??SJY\/#AX?/OWWZ\/"?``,`X5KX9PT*96YD,K0P4C!0
ML+'1=ZTH<0\N22Q)!;+=@PT5C$V,@1)!=G;Z;OEY)4#!D!`C!2,#"Y`@D&T"
M9)M#V69`MB54<4!1?G)P:DFT?H"+FWY(:D5)K)T=0(`!`/(@&>4-"F5N9'-T
MA8$;B2!TX\##^Z>!)[;XM\KHO^>!(X:K+_2-
M%]AOL`J]L?!]=QS1!WK+R(V]4/C\_VHV<#WZFPV1%9P\)/.,+I\OWM]&XF%G+^SL^'*]N_[E?Z[I'@1)5TGQ4_3R?]/RCB-W#"YE!34+DS#?F8HC+$)P].)^>E0
M9FU>E;(0BW);JW6NRK81[^^78QJG:6PL^#Y;
M\,?P'!9^<1:EN*N.ZFF8N)'S.*3=CJH%H.A=BWR1I"=U)&P
MDSB7D$0QC!WQC$Q8][):R<8XVT,&_^[#@X)$I?@Y095C6/VE!S\OF1CX]0J=
MR3UL:\N^(Q[M`D!$K$(C5`T#-W3:&O&T5=D(E%"8C4K60NI2(:BHPR.L!M;J
M6%M%>G:R$>KK'IE2:S;]2&'GJL&Y!GY*'/841>S@$?\-M"N\)G]B]B?2_IA2
M&=MGI9IH#])4._#2]YA\)PAJE(B<75-("PI"=>P7)7;(0QLGDV`7IS$2=GBP
M)6/8Y0"B7O6RWN[JZK#=58=6;/(F0ST#JM)SWNZ$%"WAM.T,CJS%?G2!%\3]
M8EISE#Q>T->=`WF)+,.*+J?DW#5Z/SLA
MD@5`M;7,2TZQ=M]4611YJ5Q2!CK[I$`C:V84N,&$I/L%5'D!#;K-?SOD:](6
M2E)6U?L*K*E$1OW>"F+091Y(1]!AH4U:!*U
MKQK.[)5XWN79#N%EQ6%M$^5-_%.>#"'&@:^-H)LSV>PZ/JS5L2ITLK7W]$)F
M676@O-4J4_F1?3"5U\=?5I@H,I$T*@-UMOF_95^OP"1P&"3SQK_R`9*^K@@`
M;`9C^MDC:"#TKUAR!3[(*OU\3]V0.!*>4@/2.2C6^3E+M6][!S$UA9#N"Z0;
M)@8^9`F`@/1;U)(!@#//\CUJ2\#4S,%@>E$0-&"7>BC/>>Z],#1&-G6E-<:,
M`%P(O=P4U7,CMJHD_86UT]9.DI&\\[X\U83LGA4EL?!ZW8YL&+V0*;5NP!I"
M[O%+-!`?ETUB-PVCZ)PRX8-1Y?90,H(U2,`MI=)JP;+`
M!,Q%0>TX5(I25\>=Z)4MR)GE%_DV,"^)::5([B?D0N9/[
MIOA!9.2],3CK-S0_N-RJMO9K/0&1N<,^,Y7E,M@AC,V>Z4!HZ=+7-P]9@Z-8
M;GX[X$ZH:K=_:<'](7WIML\WCCXE-M]GV9T\$HN=H`MJ7^M)"P/93I9;944Q
M2OWD584-+ZYI\(10DR#[WNAOD/Z"`J5F)ZOF1D#W`0S*M67>9U6KDRBR@4NB
MB"P9'%U?_]5@F"JL5]?2-RO3/:%C?B];2>J\%G\6'ZNJMM(`_))N1(.ANJ")";I:'A07UTIGXJ>3
M,_[ZQ2D@BQT=8O=C5==X@KSH?J^(^U%^N@\<00_$:X8J"4HFQDXFV<;%&Z,V
M";+2PG%E1BIB@(+`AZZ@&PV#/4,V$:/)$3R$%A)5TQZB)18)YC?X1H3C"5[$
MGAN)<)*Z*<:D)Y`?#'MLU`Z*9@S%*&*_XU48T(?QV"5`/0U&AEK9;9]G"^?3
M?/GY=K44]S^)^X_S3]/5XOYN*?XC;O#G_G8QFZ[F,_%I_O?%_!^GN30QYMQQ
M2"0.WHC]R.:E,\!4['QN6-/*JAR]FTX_BB?@&(GZXRG7PM0++`-R`VA^0R%_
MEB5$P0[M//%EA:SY;L`=8)6PWM?J1#:HYGB,6^PY8K9H*P*;.`TB!(&ED3DS
ML$<>)
MD5NM:=J:;@`EYM>+U6PJ'APSB+(FVE$`=(+;2'&`0PKER7(;#JMO/'PQ##Y?K+H2&V["R;11<*'WYYGIJD@9UVS2E&6*%Q>O6KLEC+
M[2VA8=JSDMZGPFZK20:85)PXS9(7A#^<]*`86U],%3<;GM;)A]ZU%[H&#="3
M+8;P6JQSDNR\U2B136^NH.,OJFHX]DWM,,(7.!<,2$DT4G"6RIY@;@&8A_X&
MVU5QW+_"I-:*&9/X&#B:$RP?;7I(I!J;/\3VO7QU/<5&+O94D$1IOX*F=UB&
M0;D/0X;-IE9*WV+HXH1`NG5CO!KSS)+($V*8;G2O@D#A[R=PT,OT
M0^ZEBC@G``XE\!*]$&M*92X$-.09)<]9*=2@UZX?<0%SPS.A,9N/P0&M)%Y1
MZW93ZDJ=5*4TE67)G_%+'#%2T<5%%%"$,Y%K!Z:=$(6D&`*U0/X`DBBMVIJ<
MI*H"JOQD38%[`E*<"R#+8Z?6J+78KVQ2:3F+143II=\Z8<[!99UF
MX.1\`T:EDF1#GNC%][JKWXP[DTI;DO\\F[:!E+1+UK"A:5K%::7S+8PF12%S
M>Q?P"5BYBGT+)J0J4)'/$^P-"1EKWOC7C`*X@G1/0MWG!^45YKFVC?7V!31I
M64<2:O4#JZVINYC!DFGQ7`@MVH?E"78D34]ALNG;62HJEHJRQ'"@&#IKNM$?
M-ZO+T-9@/>C050)@;KFW&7\9TU&8IK](C;8*TG/:S;VIG9KDE-&_W[NPH4&.
MGW2:[T:H*&3'`R_/=YZ5H]_Q[%2F6V#"$5Y5M-Q`C/2LLE],UQ"9N?E#)W2R
MA1N_W2=O0)Z=R/_R!MB4[2;4&#@]!""?T;@O&FBOM7+QL&!CES=<6I7/:*I\
M,$_N4?1Z-?,132>=+83VE^[LXCXUXMVF#K;(S#[.M58";G+4*_O!0TY1@7ZDDVRPW/T!O/R\W>#`_&_-KEMK%!U([
M]V,_RE9AT9!@]O)%F)>I=Z5:H"FCC`%!NQE_.:&TQ"F*M)]W+;Z;WM
M7&1Z<%//O_@GZ/ZLS+-MHY7.A1`9!Q'1O-],9\TQA,XX-)3D6`=DS%`TX8AW
M4I>7QHH8(\2:M=C,Q+N&^_J7WJ?1Y=V]ET(<%$R83.,WU)TE'4@'C]?:@:1G
M8YT7>]PKO32>(`4G@'S/^#F0X1R0+'.'R[+@+-$WD9?%!_+R.+,RA[ROJ93*
M]J[-O+/PMH$>9R7[0?V.;I\U[_.>H)LA0_9;#R1Y(G5U6'VU7^U2
M5OM_Z#M1VN.9M&^-`WG``88`"G]OH4M>9^W6.?:.0!4^PP/D.E\]KC2O\X<[
M;F+!48`":<7!E+T]B:E-T;3X^M*'$/+DDL206RW8,-%8Q-0!)!=G;Z;OEY)4#!
MD!`C!2,#"Y`@D&T"9)M#V69`MB64;:%@9&@`U1A0E)\0?^@'#T`%%H?-.X'%`A[+V"B8\2PB[4.PDX>V
MU)*YX9`*28TG^8S]WCSD5%/C=S=L?5E+LNYMWZYNWZW4HI%CO;F3@%SF>"02?HM"/11CY21C@
M]\\W@=CC;[VAC]<;3\S6O]`[0>C>P2D*4B&EG\;T`C\R]Y,@$M)\KA)*V`2Z59&OE9S#KI42/G<7T3X1&1);F?Y"*)(^%G(4EK]'CT^KC^^7
MB_OUXT*L?GJW6BZ6]W]:/JZ$,+)98A87@\3024R-Q`_W3_<_/'YX?%K_NA*+
MY>KAI]5J^?')",=/[_^\6CI98UY8:F+,/(__$)0@IJ!S4&119-\.2EK$?I2/
M04'&HB)B/7EBTR2-[3)+0M+WLW??O52JWHJRWAS;5F_%H=6]^BIJW>.NUZWN
M>D$/-/V+;L6NK-7L+^L_WH32CXJ\@`56;L2"TR)AP?6FK/=B-D_\V--?#[KN
MM/W6[.SA-LSLZ?,L]U.OK*JRJ8VVVUB*R>6N:04LP%^K(8A,F#L;SCQD%X,H
MDFP)R8'6NG_IA*ZW\'&A-YIOG^%3).\$JB$PBH&]X@YQ[@YZTY=?=/7WV3SS
MI>?/YG[D"=8$ZONV?#[V
MZKE",!NAQ&T$C/&#-M;0>H3S[&J">D1R!U<+IS%EC0UY!V>?&29*5,TK@OJJ
MS>M$&U$TP@1,8EX/C4\6T[]V\(0`"RB:>DB0H7QT11I;7$5#$"1`M7$%+GU0[>:%
M+B@UOBW@N1,"DU">Q30JJ&<+@`6G=D0L!3B\"L)P"D)CO$-9%.7Y:"_KB+/"
M5MC65$_BM?K0M+UV7Y6HF[K55,]DPU[!F5U+J"($DTD[5;:"OZM9"`O:OZ+<
M!Z`9K=.86X0C[3DK_Z*JXT5!DVP^/:BNA_).K)KJV`-4G6$4U76Z[\0&<3`H
M=/!&0XK",#YS%=J2`=8D&]6C3.SV5?.L*O%+@\(27W3='ULM7LO^1:S^N9T_
MO&AVKAR8PLH_Y6C7)`OQO)6%31#7Y)T`_]U&
M9W=J!UJQ+LIS;K#>P6U;J9!_!\=4;]AA\.Y9HV)%H2B
M47;F5^'*WX##4YN_'%F]FBRL.1N?5N
MQ^3O8@%+I5^@=I`A8JB.4A0!4V^X9R1^^L8".613@RE7H6AMW4S[V/_0FFQH
MK)ZST$2N#Q4.@-,^5GAW,WK%`S^C8I[1U`$B\I:`8!]!`#NT+A!Q2=G,T(0[
M^)_P#T>4\-9A0<:A/&\-T!ZQ=LKL[MB:P6$+>)>5J5&;;X>ST.!`5[/1
M8^I'_":45:TXT"%"1C=E9Y#'%`A[(^0KXM2JB\$Z\O)=H1
M)@)AZ-XTM-1/\U.PV?2'F;-XZ`E47$,Y(M"ZNYL0T&V8B,LA+`RGEWC792TU
M+@,3#M".A=BD:T,GBL$"8P1_=!7\T7\ZEX5F+HL]X6:5/(W&+N+X/;`$*!X5
M0HB8EHT9>*OC%J5,QF]+T&%_0H(N>49
MXN8[I!1#F)G75-4UHTF*9BI78W&66)=^]L[AMOWEV/5G?86Z1R%F&-"0I--^
MP>UB;DA,5P;`-`">%)E1=95M<>,8?H_J>
MT0&:;N[\'')HM%SDT`RBHVF5*ID7B/92;ZA@;&_IR?9V4L53JO`^3INI/E_^
M(#NU97N^^\WY-XA/BV(P,6'Y66KC,2K@0+BJS`T,,L]>*[ZCP<4R04RCU&W!
MPT4^*7:)R(RWPYZ3Q.EY-X,=^3#\_Q\-;=QL2,DD*S*U)?5;^QCU:[.Y`HO3
MRJ9=Y#:;;C;.JRR7\3G8`NEH4VTVNJ(`0\968S+;E*:JQ>9%M19B!VP8/:#2
MT&3G%K>N[T:GC(ZS8K+;3^%:"N;AAH0/V3D!-UJ@VI2]\3?UW%)&W#+I:X5W
M:##]N.DCHD823.JLC8;UO.QPZGK7$O^4;?PB]N]*8,/,*LM04QV
MKQL&#Z/BZJPI(VD5850%`]&DP:.DC?])`'L46Z>,1T9!UZNVGQ\/DU@:$-L8
M#;F#WA&1(2L.$XM(1-+$\+]8%\:,D>3K]"<3.Q_:W0*=78,7'K\2U.S"T-F!
M*;?=7WIW5\;J8=S9Z@WE8CN`LBCBQ!$]$D)E]H+0LVI:,?:`>X[NR+8I2
MN6^;S@;KT#:[LN?SA'WWY0G/&TU7H8D2MQFTYMFI@=[FY;*J[&D`4*?W#$2:
MDG.TH&%:,<;3+X/Q!LAV[,!.ZEQ/4R32N#XG6T)K2VC7/Q(B:9S$6*HZ;2J@
M5:^"[]5,>@Q50;#A42[TB^!D,QMJ7-HVUO$FQ#S?\&38$HLI&G-V'#?RWZT;N)K3BG,C/UJY+6I57:56"5H?:+TZ&'VD'
MR]`-7:W-&U$PGR;#U4B;1'DD;"ABPLPS.]J:_V!]\__SN*9D
MR?E8G[N-C'5]FG$71`\XG9F^,7**QW?+]>(>PT>/W&]/5Y7L8@".G+>6'F46
M7INW8=SDEE#PS1$X17&1/:@.<6^F05AB#4,%&S22X'0B]XYJCR_8[/7O:07)
M+<<9.Q@B]%`V=,\I%1C4\!%#!1_@6'+M524H2#OBA_UJ4U86.,#,XSO&B?0+
M&:87ZY_K+,9:2X*UVZL&;_BK]8F_N!WB(HGB5;=N87):S]@X<0.EX0GT0$BI
ML-,.S$)V!B(52>#'(DQ25"59_/EBH"S\(@ND>9J.0'V"4.L9P4!Z_,L-*OL+$)$*]SA$Z$S/W8SVC(^S8PS<>2':3%66F*\B(C(
M>;DU46#8T*CKGB??TS1U<7>6R/"4(QF^M:&\O?D4]AOQ)L)(C95NV91_,5XM
MO6W#,/ANH/]!1P58/$N6;>F8/C!T0`]#`_10[)`U*9:B3=/'VG^RW[N/#R=V
MXJ8[M'9$2J+)C^1'E%WOXXXIA>)[-':IIKZ41@7^QBX6U#!I/=0>;^#"$I[V
M'#*Q\?6&L9/'%!>GB[7&>S0.;4F4E16\4Z%=RW,NBU0H,8G4]K&S36LF7WHV
MS9XR9Y8FDTBYB+J*!WVC00[5'B#.KLPJ.YX.A-?5,4^84U*!QJ6(@.]7Y'(<
M_6-X5TAE7CH,!MM]NVYK2ECJ&YH0FJ#N0;5+L*Z%_05I*(J$TT?
MY+A8$,60+3I/,COPGL@Y?U3;$UU0:$UPIP/_L'>/6!ZEDDAGR?7<+#K`-G1M`1(R*D/+D5\;O=/ZP..0C8)X?5)3WV3VOE
M%4IAV,BKA%K1DX=$DGWYUAKT*ICA`Y`0MM94J`PA;LQIE1I"*,E`0(>/DX\#
M&ECM-^GO>BEG
M+U_![A_`]HB5@:6]/-XOYTSX>3A:F+_F9K9FVO:\>%LNWI4+P38OMG%%K8M-
M)](NX5RAQ'MBB"W0S+>6F6]&X]?;`D5^)OP^(H\=48T7LH)&,#&+-Y%MO5'C
MI&.EL$C4XQBVO4UG)E<$M<"OW\^+:D86S+_'9&
M0J6/>MW.N!$Z954(]M#LV*`R4E'\TJ>G3#&U=!UE9Q,K0P43!0L+'1=ZTH<0\N22Q)!;+=@PT5C$V,@1)!=G;Z;OEY)4#!D!`C
M!2,#"Y`@D&T"9)M#V69`MB54<4!1?G)P:DFT?H"+FWY(:D5)K)T=0(`!`/+D
M&><-"F5N9'-TLY3]_ONKZ\G?!B_?
MS#A;=8-7\\'+^5PPSN9W`YXF18XU*7,C*1+%A$RT2/'^ZR!E*_R?+^C/TR!B
M\?P+[4E%V(.13`WC/#&*-K@EXT2GDG'[=WX]2%+Z70PB*;R`2+%WASXJYR_*1OSA.?.K#'L
M2A5IPX#GUL.KV3_>7=UO
M9XQ9V4YBIHI>H@@2C97X_NKFZLWK]Z]OYO^=L>OI;/)I-IM^N+'"\>K=OV?3
M(&N?%R=56S-/X]\')544=!<47A39SX-B"I7(?!^4(BDRQ(%6T=`(ID5B&O'H:?([^C*9-7"0\8E]C(1(1U;%,3+3&'/[6&_>RBPT>_XSC
MO^9O!S)+"F,RZ'&EH#G)E$E:F-P)1;&E#&DM6)Q+DZAH$G,#,?\[Q(8=KI.RD4O4MU4M`[KHQ(\HBGA=6&E*7L#?Z_112^
M0)5A3\@->\\^_X69Y8"SF@V^P2";-*;3)$S
MP<=!6*0IQ?X=`D&ILH5P)L[D22Z>$V>RI)?&DR`+167L-D/"4$Q*(VHGI_6T
M[-Q*D>'(^G)*0O7D3D1<^Z,-,LAB/J%V*C?'QM.*'R-3A
MY(CB]`!;Z\>*XH=ZC$8H>!Q_1)_S%PECGQJK3>!VX:;H3[E/MK[XKYL5A6"L(4'9`U<6NX6VY!VJ_>[\VT'<:0"R1-H`:!L``?^=\[A#5,Y[
MYWDP0SLSV!32E\MZ:T52"335EI6+;[NZLY/.X26T=-MZNX/247#4BSYRE'-_
M'9?;;5O?[K8VKJ@X$OVV;'9E:XU%GNQI.A!,11=3_/^HF\UCZ%(L^K8#$?!A>YVU]5-U74A`,XGD4BM
MQ9E/>>9]JKX_P%A4QFJ]N<4I^[*IFRU[Q!&F*#W5VWLV^]]R/+GW?M0X<0?E
MY-SP2D[C].GBLBF@:4]L448-SH5T[5\J=,NJ\,"P>
M%\"&:!-+*OJPKHMYCDL@M'9TE,+V$.NYRI5O[9D(G3VV4G@*(A!4C7ZB<,]Q
M4=#9GL1YBOON/DYQ\Z$ADSZ[;&6756Z.G35^KYX:?T[^N;/AP\^="9--["T?
MJX(NX-@8U"/;V`C(Z`[U6=`-U)&6#`:X^3711@;=;C.0RT1G[(`0:FF('5SV
M"7D=,WGP&,:9H*3SF"NMX,L(@QS+HC3F6A$FJ?`JA87:`D2QGP))H(U&!E89
MNK.'/.R389&Z`$36+(H+`,*%182J]/7_)M;D;HN84RA2YR6:-44*%.%()\OJ!2EJ;/ZL2LVE^2>4I!*K,
M^"^%YR!0T?=;#X'^)M:Z/Z&=)3%W31((VDYQ"']2G;1ENC(UZ,^V,H>`PB%@
M[A`P#@Q&O^[;@D:>",6>".E>H3?+776\J>H6Y;JD9N.>B<[LP`N(!4K!(]I%
M7.S;@`KMS'+<$=I:Z7:"WOHAM>@#7''C(5$GJ99'05#4.*9]J!P@TJ**]>T3
M\^4>0&#N4.IS4>K%(3>F)C1CSV\(R^(P45`[.4`XLT%Z%E9J?`Y
M<1D%F?^(>2@7UCI';J-#^.(]?/5@0@J.W"VDI]$+"-56#U#D/E^.2X7,1S37
M("P/5@`2_-NSK@AY],<9%@Z-+2]]1C@3Q_@V1_C@\4?287Y_MO`J1FE^_T$J
MO?[GS]II)G&1#X^/T&7FDNA$N?@!=`G#`W31T$&7I(^)O$^0J9*[ZVBD"<6EUB%S:(1?OD4M;Y.(6N0AW+'*9
M,^32%KGXSY#+JK?(54@RPKKL#[/(?2G/*HM5!FZ1>QFRO;(`EM/W$[H:OJ#8
MBI0`"?S2A@:<;M76SY2Q$MCA11!>6#YJ8L1K&9M]ARZ]["6]^8JZ,?9[44<-
M!56Z&$J"#82V.)!O#0C3M=/SZ(4%N[R.\/C=;<(UE!].-UY'=8$1BTP?,6*1
MJ4-&%#$W"MTRRHGM\H![N/-=2D28IO>:8J<(0.C2'<(]+K'B`@*2UH,\$0-J
M?TQR#X%7>U(COM(1'+HI>70UQQ1&D2_"/,+RK$6BF>U0BPUCWWH1]>1C0I5((/
M@5]`-)FBJ$U`--<8AG#2<%W5:/7`I<<*
M(/!0-=TARP4&4`>]X[/OI@`IW`ZXWZN..A!P:AT:[QWXR_=][OI^X?K^A99_
MOWFJ'JMV%-J$NM0F4'BN67F_>DO!%^7_*:^:'K=M('H/D/^@PQ:P@=@0*8H4
MC\4BQZ)(FUM/CE=9J_!:7EN.T__>0]\;DI+\M>M>=F6)G!%G1N\CV\JXCWAC
MQ#U,@0F7B?.3N'*1N&S;-ILN'!$&P5LWR)Q(CQ7$OJ2$`D2R7_>K-6MX9.)O
M:Y%+:[X_0U:_Q/S/N_;8K=*)8N2K&D9Y%Y&W6^W:P_.*PJM9=D&S#87>('[X
M5?-7E]7?T:2.:NXK%,MRI.C,9"!\*J1P(N55E6JWC&P^$SH?B91PI]UD^_\U
M-P/!,]_;!-]W#KKEL*9N@9Y8G!-\WT%(TAVEI4QC+R:+,%2N'RK.TX4HD.]#
M@^*-O,8U66#+W$99()=!%NB",BSL(4N:(@D#/P@#$*I(@RI2ODCIEVGA$R$E
M:8"R4!J0V](Z4DXO#/Q\"PR3MHY*J_Z,&-53"!8&GP0]NLENNIF!-9@WT
M708%,G,&'*Y%'L7_LN^'T),//]93S1AMV+2532]332:H111L0FPREHQQ_7-J
M`ZO)?0D26UD)3CR30$5N%/.5OGF@HJ%O$!0DH//&.\F3N;:20L
MJ!4K_/$V03Y@^LK,Y#FZA4IJ<2NC44,.3!GB?KFQ$Y\,.'2\#^RKPKA-'F8"
M^O/2YF4:#^T%-OZ*]2>1>N'Q.`JG?*E+S/%]["5+[7OLQ56Y?8,P-:;$W\G0
M&L;CO7S:C_A7_ERE2YV[>67&E;]-F,KG+'HD3)_@J>S'OEY@RH.9`["OVVVP
MKR28FP3)<2G!Z^?F2FCD&"F3,DMCKH4T#YN`PD\#JI4!U[H<[MCQ>[TJT1$N['9*=W(["10<[8:
MNQU["FJ\D4"-;L=?N!T3W(X5MZ.#VS'7W0[S"\91"P45'9NM3'R)ST"1R2O!
MQ4T.1"U!;E<@9#>U;/H_@GLZZ.QYP1`*8&APW9X10L
M2HH9]RX%`&EW9M8)]IV"&,:\B/AL\^@`"J%1=BTIH,^OF!5ZKD/(VE#(*V(G
M^E'@Q>5NUI`&B-#R<\DNR0N+Y7EA"!HA[-,1V#JY6B
M!2QPD9MA$&<&ZEB'8O:2Q$9-`D\6`OS>R32A<3+I*`C.#:^)I)HE5%JZ9UBB
M)3^#BB64M?"L'/\ZC;USU3#VH6MP/$4519[/'#96G,_(.K."(ZKD#5U51=(B
MEHP.J$!:>2E[9/I)6OV]`DTMA$..-PO0GVJ+#P[@?TA'+X7H-Y%.$SS$"VM"='X:!PL)I(0G&KN])A<
M6[[K,14HPEUZ3.2#T("^DQZE"MS,-UI[JY]?AHC7.YH>W^A(__AZ1\Y9'GKM
M7I)W=N#XR,7*^NCDOK8='$W]>F@Z&J:)<'W;K0#8S291<2U4/7*2#RH+3Y)#
M&1F3M_F;!JWW,W`[LJ79!];*SWUA)*FR5.%MM[LF")#%KEF+P0.L/QW$><(W
M:1A93.$DK(GO!FFQ2Q:74D4NX-8V>[@\+I`;/+9<[+MD&"T45R]B\*W)JQ@?
M!<)BU\T.6[&F>\B6?;ML%G1PQP9F%_7+-O4Q>UZWWU#>O]L&@ND'5--A-W*(
MDF!\8EV9&%VB_/GOT^QQ!:OK2,9UK-[WPWJ=O1Z0'ST*QA$:;->&99*Z3D>H
M2C<<(?9>NRHF^;G%J?'*=+IFTF>3OM;Q[LFK?\J.JP9Z<+EN.06L':()]S.A
MX>1R^.1"9L^8:SR719[[^.'S;X\?/_PGP``E8KR6#0IE;F1S=')E86T-96YD
M;V)J#3DS(#`@;V)J#3P\+T9I;'1EGED3K![BXZ8>D5I3$VMD!!!@`Z/X77@T*96YD%LP(#`@-C$R
M(#?5SU0WLN^]>W8PGURQCWW__^GK\M]&K'Z><+?O1Z]GHU6PF&&>SNQ'/
M4E.")F-N)46JF)!I+C*D9G`HMM$P+Y602J>7S9C:2(&%%7J9YR7(E65H(
MXM;5HSLRY3PO5:92[-2!O6@NOIO]X>W5[S2:W
MXY318OSN=OKN[>3Z:O;FFDU_>3V=7$^N_CEY,V7,\G8<"V6V'$7@J"W'FZO;
MJQ_?W+RYG?TQ9=>3Z?B7Z73R[M8RQ]';?T\G@=?N71S7W*IY[/^M4S)%3G=.
MX<84WW:*-BJ5Y#%II)-3YOZ9,N.4+X4B@1^BV_53_1"7J8@^QB`MH[K#
M@[]DB`_\_]*L5FP]GV\ZUK1LN*]9G*,&T8A+]F-]YWXMY6^S
MGT9"I:7B.33U\DLGORBXDP_67=T.[*[IY]6*_2=."MROJXY5D&#E?ZQA^.X^0U[7S]$!=I$=4Q/!2EC$WKFMVNAYI=
M,^A/JYX-:S:V?+E"8*KBQ(!2Y(XA'%&W/50;K]M^O6H6%>GY0]-6[;R!1=,!
M&P^.ET[S0I9;7IQ[9^C2\8(C>A8GY,&[=>=7U6+1#,VZ!:^FQ3:]%G9IBZW]
MHU@/2&_YD0>DY_WU,SP*U:;_723C^]JQ:6KV:=W`_T^0O>GJE"*5N&D;7IKE
M&846\HUO*\9AM)JTT**PU'Z9RQ1NU[Q,-5V@G"G\,XC"6_IK%"L33>)$%E$+
M.Q4]Y$.L<@1B$RTM/
MPO`NE$D&%NOH:YSKZ+/E'!3N8T29L*?POR-E^\+F0;,'X@S3@LM"0T)]M_[B
MFNO])T.8".W]-8DY97:+UQAB^^;^`;J89W+W":?!BAQ$U!`BYK>_.A]]KL-+
MDCX]N5KC9B)*ZD5Y]`*WH0S%(L\,SH0AFW@N*`KI5$MZ$CHG=12/#8EQ1/"#
MLD0F(W(NK*&^_V@1NL5)Y!_&_%#;!Y.P3)'3W4=OO6WH=6W8-:W+@+D_7_O;
M#W&B"N]BA&(NA'1YD,.K4F\S]4,D!=Z(KG!?*SPU!6XAQ%%WX,87MW?#/420
M#E!-0J,./^03!)KU81,+^_*)-#A%I'&*5^7C#!_(X9(NME8N6MOCB+.&C33H
M6:X1JZR$_ZB1P6EH**X5FJ[SJB#[U9W0/E\[ICO#ZIO(*11$]_NQ=
M[J_^)=URQ,"^7RG`@T:!L4'K"GPY0;4_P1=WE#'F@/,SMN89$.?1'7%DX_^A
M2@XDI8HC5>)G5,GA/WYXQ[H[X8AGH[C+]/T2]N%,22G^0DE1(?0R]B/^?H)R
MGQ@Z&_L"F]D-^_`;=A;.+8\HKQ80,@7(`AKGH?F#W7T8(3)RA=5J-(7%6YH"
M>>&.4F.AK868>\PT=?X39JCB.UZ!Q/*BDWU601)2"\CG5-3V',4YG`.&^D//
MVE\^X1V.W5TZWEY]'"&L)9"+#8X/8YP^F%%]D>GWD19-D!J,Q1UX[GP>/!QA&B\!>N;&>9=F5;:P]K9X"_#M$;
MFF`(TS0M4.ZBGG=UU=8P4+[AD'FX#U*[I
MNH?L08E#R,[]A,D#'J)AS*OCE,D!RW`GCZH.MF)8$=2[FYY5\'6_60TDEB:#
MOEFVS5TSKP#Q@TM(_*+^")K-T`_0G)0E-26F3:-BJ_47^.-+W2SO,1(EU5/=5[?%IJ.?FZJ;WX?1
M"H`JRX]'*\$]<`7,L^V8WLE.4`CE@UA7):?&?'9\,D4F?>,Q&EF#OD.Y@Q2B
M.+!1+WS44Y[Y\6F"^82@(6"VL#,3@=M53#V'GLX>]@"^>CLG%<1^%^\Y]X.2
MT>5>E+FWQ0A#(]88BY2F(L1I@5>-X5`-L&5_:BOR="3R<@A9YEMDJ;:NXCYQ
M;V-E826LC0:VK/"I84;N`3LXK_UO-7^TBXW][TAZQ"7WZR'6V[6_XXZ1E?9K
MX?@L]NX_U:`(=$.\QPO_G"":R4YF%Y4+:YDH>4#XF<_6S!LVKOJA(<'2#H^$
M("4AYBFA=KAQM;&[0^._6YK$5*"ZBPGH$Y#&4=/A?3'LJK#1_6[OU@A;LOG)
M?ODSS[?:8TS?S'\YQDAIMPU#RZAK/KK#$Y4P5RE!7K!PI""HS]V9H1G$Y"!_
M0?.?049$B>.-7.+4D^6Y6]OI2"C-0V87WG4^K&^N8CN]_HRA@1C.B*$=CC!\
M2`K`PDYR!,^K^4!QGL@L!]*2@(F)*DO2*\&C%E8;I11=<*,9@)!%QB6C":3>%R4#KCE2`$-UMP@E>6!K7O48538`V.26C?]
M:'70=>>7KN^AD"PMP:42KT%,8OF";VY&3:N@2*?N#YMQ;+T/0-%,O1+VSZ`E@"V
ML$DMNJL?;'T%Z-ALU[&(6JKWD'_7K=TFN^KO5Y#^!Y2+>G97V<)')Q7(N]])
M;8>7O#Z'?9@0&[3BF?):/56K#4&+ONY[@H9%5+=;2.3J\[)'05YMG.$M!!`U
MX!KJX]`U#H>@8$BY,SZ@!U-ZA/AQ`USC'0I8Y!<0X5;`AK`)%,O5^F.U8I_6
M_V.\;'K;-H(P?#>0_\"#!(A`+5"[_#P6;@KDT#9!`N3B"R6M;;:RZ)*4G?[W
M'OJ^L[,4Q=A(3R*IW9V=[V>`/M$SK@)K1"_-\!!]_G=_[34+PF::95ZS,B^T
MN3RX1RFVC2/8.B?P1IE/G7MNVE-_$`9"_>OI-WM"(>]@>.&AJX_]'<@/]AYU
M$TE3W4RJ"';I>ELNSX"($.&I`+%Z>$"PZM+HHQNZ0(J;U&Q4!6,S+>#MP9TT
MLKP&EZ;G&<-+J\#>:Z1!W>VIQ_#`L*%&>GF5,4-TL941,I/.%>[H*?V/YA#=
MM-U3V[$='Z/;<<%MS)>?/T9?:";?Q&[CM1=F@"`F.S.:3CL0HRX!];KH]Q;<
M_`O-RR>YZDV+0,,AI1'UJ^=>Q.?G`9M@#"8+DA!P
M7>_W4AKP9W/$!_Y9A^DIS2:I86:`*EJWWG\,$F9&D@1>5&;V4%@K2>3J"="RG;!)@E5DQ+?R'
MRK_'%?@I!UV79.L$)K6Y8*\LNI=%SG_['J]5.)TIA8A7X+3D[5]I!GR(+3'E
M&!L>M@/7R7&/?$=E@M!H(,@1I.*,?WW3)2@K_L-3;!))\81VR`G+,`HW7U(Q
M/FZR`I4++6HN'=B
M[A2E(3.^+%?&SLP-O;V"[V/Z!8SM31I^W6Z(A8(15_BM`.QB6C87KG-]7Y[]E"&F(E.!Q3V7(F
M39YJ[T$+\%UNY[J!7.7?]DV_Z]P0:*3QM1VE#-$ULDH]!&2+ZFBQR8E=JP:%
MD+4;MQM[(&\P:R">%Q"-VLG!.^Q!$ZQC]5]L*F4Y/1:@PI.%``%=+7H/>Y7P
M4.B"99':N<*F"MEV1JQ`BL@CJB6DZ.'O;=@;FZ((F;5U)>;2:!_S.+B5K<(-
ML%(:H7!#&K5*I\;:NJ.[:X8WM$(=2&10NT3ITF0C2KNZVSUX#'?/[M`^*66A
M7?)\N!/]&!HP?1DI\B#6X(/$C?\/KD?/'ITG@K]O_Q0OA9KB!1M1W>L.+?G'
MX0K[Y3Y<8SK",.3EB>$4%"Z+:N1+JYD@TT$]V@I'+1AU!0RJIIR;SX\2N$T_
MU4G.OM"I-!H?.#.D`B[HFGOO'AJXPW0#_0))[DY=!^MZ9L[1^Q`M_B[U$)0H
M,%>GED3K![BXZ8>D5I3$VMD!!!@`Z507
M7PT*96YD%LP(#`@-C$R(#GNKIUL[UYL-QD=]?UU*GBA[NR[<6//W[X?#4=BU#\]-/'\=5?!A^N
M9Y'8=(./\\&'^5R*2,S7@R@,BAQG0L&K6`9*R#A(9(C]QT$H-OB;+^GG9>`)
M?_X;W0FENX-5'*8BBH)4T04^,@R2,!:1^9V/!T%(_Y<#+U96P&NE61H'F6*=
M=-3(F)BD6029+6ZL&:7'E;ELJ#6![,@;^*_0W%,`JBG,T:
MPJY0D38LHMQX.)K][=/H9BRF-U>!H,75[-L.IZ.ODPG
M,R&,;):8J6(O43J)J9'X>70SNIY\GMS,O\_$>#J[^CJ;36]OC'!L??K7;.ID
M'?+"4A-CYGG\]T$)%06=@Q(51?;G04D+%<3Y(2A%4&2(`YW",HVD2&20YB)-
M%=W!.?@@4^L,>?4R^.;=>]/:+X+($X^^E('T*C\.4F^+=_BM&M[L_!2/][[_
MZ_R709Q!?)I!#T,AB4AF'(1%FK-0@"T42&LA_"C,"TB]P@)R'OPH"S*OK'T"
MF+?A?]JH%$;X(;5#IP>1DXDLK#:37\I+%+.RJ9][->Q+O&7SZ,>I$2CQ*-8M
MO0A)]LHTNS#MXC^]_2:)>S,+U_G*Z)YXG=MV?NID=#P61(D[NU%
MW8MF+5B0$;ITJJTM??D'A<`)I\LVG$?%BX)))",E34ZB&[*O8S]!%"M204FA
MU,`J_+:5^;?8<43Y);]K_&&@8-90%KF*O0M_&"%1R(F,LA\F
M07Z\$QEC&<=IGMCJB*0Q[YLWNL/1!*I'5PXD:1+G#!(5Y!GGC5:1A1Y$9C*(
MO:&O\EQZ@@$P=#>/%!%>8PM;`2#(T)QC;]?$-'?1`"*?@$9B,_BVZ]XLQI$HA*#WX$CPQ)"
M17%0@".0DE@L'\W;QX&*@IR8?CN8#?Z.)SJ``"G!&R@WX@7#.D>B8!=0^>>B
MZ$S^OC2C*I1DTGN;$;6>-S:MY'@;,;^[%J4I`(D84D]S30>]Q6@)
M"]MSZI6H:E$NETV[*NNE%B]5_R"^!K-`7(]&=^*I;9ZK#MJZ2]$_:/`Z47I5
M;RSM.`6&?0^T8_ME$6>LACWHX`GS"(P\=D4\E,]:++2N<6*]96_*3JPJ]@(=
M.4S3O1>1=.(C%M\MFQI&[7#+&@B#JCNWA?KIA4^T<6B
M@==F99JP]."E9>((77M0)SZ1-GHC`HCTQTC:[:[%4QEWP!=
MI>)SWZ14EN^1GE7UVD%S&=-&7!S=5>XN7Z4@O.A6BXL\2=D]"D/F55N:4>B-
M,N;;%D(33WSN[QXRR@+S(I-F0B%V)W'2BKLDG!(2JV>]_8\_S-`]`G1&M'%Q
MW39=1V!:5[W@2Z5/W;C=5+@(6TK!.9+>$W4C-)C6Q4?)U"(8P5X`XHNRJX#'
M%R`D#_(?",$FQ*\D,-(P2?W`WN.@3:V5>N9JQJXF#K8VK7,`'UEK==G9*NM,
M.KO>F+,YU9HIQ'4>G,I-KI&
MPK=&8;DB!VE$&>*W)K25%&[GE55S!MC(#:\V@8.(G1ZQ\<6NJ7Z_]34*_AS@KM_
M@QJJNMNUAO7.D5-72+%)AXVL57&&%YZN))S;TQP5@'4!AB^;9R1OHPT-E-U"
M8\;JAHX%C_1ORSW5Y5%Q^$JPD(0*FSS"5V?PA9"C1[CN<(G5!`H97EG
MD`_WY&1LN4)F=$U5A577;*N5"I2EDW^!_L7Z[7E*R&X3_KH9K"1M@":`QAG%AEWDRYEZ"3
M4`Z$2YK*`?3PM.)@@<4%Q\6H>8O+B:>7Y1,M**FK547+&Z;T?"%_1]X%UTEES
MED(SKW@SK<5-TZ,XQ\:U">G@%S#B;331_(7()5&;?3("JJB@V=^-@.8+AN=`?+4J^]5Z-A'&
MR*V(BX0&8YX((Q-][\MD]O73?"9N?Q:W=Y,OH_GT]F8F_BL^?IU-;R:SF9A-
MKC]/;N;BR^0?T\D_R2!6)*TBGA&(L8OB_+NPL!G^8NN]$XL=EU5
M:S2X3F\>?>(6@D)BH(`.@+Z'#[^:Y/&E^)W:MUM22PF3BY_I/+)#J`*W7J(C=D_Y6*`J-M
MTVJ>H]=[N+5OAUX>AW[?A(R>MYL0[?`P_#I/[!UYP*NZ<3VJ!I-W7=E6S#5@
M-*(WNHU62+-RV3+-F]&DXJUJ6W(IN&3G*GK%]"!Z&^WC@C'5U)A:XIX;<<\M
MG*+SM]2)3:<[:5I6Y7$D(HQMK@NO*6P&8?1M!$80(--FR1;8TO:EUS\TJV;;
M;"JF#\I+JY^:UF55H>T>W$KL!UJR;R(\IYEH,T%F)MKKMN%7HJ_LGA&_?T#+
M/,:Q>@/'5OF;?2R6>7*&8X/.BDB9/MCTZM(0=(,4(AJ"`[+:LY=-Q6+?O&@.
M/?,SEJY8]=*Z0VJ>2R2?_*9D.'QBXW]TETM/@T`4A?=-_`\LNZBF0*74K:^X
M:**FB6N$L4Q"IJ84_?N>,W.'`6IW!-IYW,>YWRGKPNP5$O6NQ"_RRF%L<8=S
M11])L*_^]E*&ZN)D[UDI+\\6H?3>H"?=798W:9Z?-:*?'F5AW`K%]W>C.7_I
M.Q`Q;UN#9I:
MDL;0KNTHS:P$@G&:WA@R&5/3F^:]N]NCFSIV8H51?N3>/P>JB'N^BZ*DS
MI4.*Z,6`HBO-R;8(9LCN-,F/!"_+I`X^,!:/T4Z5M9&4+*)7=;0EM;:M"F+;
M\D>0-6>0.(8[]Q5_W1;^8NOLUM,Z0;P=HZSK"8=@J_D#78[^['A^U(9X5H-^
M*1U/(*B$C?XN7'QTE8VWNS$V!!+\30"[`U6,B+/#:Z^-0-2$P1<`GL
MO=K%JR34V-3?5('^AT<'OK*^E#)LQP;UQE2W8QX,ZL8MAI=(XE3:9,",UE0T
M380W^E"U810CGD_\UI-D)%0.74GRX>E=LR>QU)0D4Q0"T#CAK;<1;WE$%NCJ
MIBZ4V.;B_#M#X7V94E+D^_+861%&H(=W:
M^!%#@;&W$@[F?,WRS32U\7*3BPLZ(:&ZQ#&'RPD1)EY5K0:D\PDX6==JK2,6MC>-%V,'
MT`?S<3>[FCUN[Z]F?P(,``WVC24-"F5N9'-T7!E+T]B:E-T;3X^M*'$/+DDL206R
MW8,-%8Q-C($2079V^F[Y>25`P9`0(P4C`PN0()!M`F2;0Q4$%.4G!Z>61.L'
MN+CIAZ16E,3:V0$$&`#IJA=@#0IE;F1S=')E86T-96YD;V)J#3$P,"`P(&]B
M:@T\/"]#;VYT96YT\>(`@@2UI'
M@25[ES2"A9V',3F2F:5(AZ1C;#XC7[RG^C*\B90,K.WX@9R9KNKJNIRZ]).7
MS6+%OO_^R>7IQ1GC[(380[&;9>SKL/1D.)1-L>-T3O*H]>#B+
M;TI6FDE5&_TAXN\QZ\*6Z9$)75M"&R]"O#%1/A
M?WC6JS@]1[U"F21@_U!G5>5T/)-8@YSS84^!A3GC*^.9T8I53I*T1=N[)E/N
MEJ5]I>1:'=BKH[V<]44E?%2K#[VXIM/P(GRP\&3PX_.3JS-V<75:,7HY?7$U
M>/'\XNQD>'[&!J^>#B[.+D[^=7$^8"S(CA*=KCN),DNT0>+ER=7)L_/+\ZOA
MGP-V=C$X?3487+RX"L)!>O[OP466M8Y+E&J"FKO^[YS"-3D].D74M3ON%%OK
M2OFU4^JJ=O`#<=&K,,S(RGIF3?!0"#^LD#:90W9][+TNWA07L[*N1,%N2RDK
M64Q*5=EBBC7\3^:1N"PM/M^4Y2_#GWI:54(09"(6C"&1JN)"!ID%P,89PEKO
M1*N?-L(7TI`[HX>%Z#SRNA@T99^.FK;+<-:>#TT7:RN2*;Z.>__Q838J^PZ[
M5V7?0.M)?,SI88M9$XG3N,HNRC[\*8K9S2*]M9%AC$\D0-Z>5F=P@=6OS3#)/I4C]C*U(Y0)F
M^*B'(=U\$=4W!1N6?2GRZHC^WLU@O)#19E/$CYO)QN9E#JE1:C>FR1)M1-E7
MSBF@0VN5M$X[-K1.21*S)2G]DIQ7XR@X;7$=0#5?`&D.LAI:G)4>_Z.673:K
M=C%IX&513!^@E9*VTTHZL:^54YTO46P25&SL@ONS0E=QU\6+]^VB64UF-VPR&\U#0((+8!Q[
M4TSGR])`X_B?TO[;247X-P1_G8L",;9D8ET*9!_E(2]D7G3[B;@!GB^;B+KB
MRKN[P81H][5T'J%7==(Y\7_6--25T3H!7%?.HS=U/%,(@??K**P3L)W.@EU,!6_1+DX7,;J^E`9
M^W^4B&,G"Q%.E@"DWYH)UA`%.ET&HMI`IUM#]G`ID,[8;$>&J5#[4\!UB#:%
M&"L'\MF*=:A<#I79SF<9O>XH(>D1\EFF?`[HIE7*YQK/D,[TTD9RS&:9-Z=5
MRN8ZRUU&I_H*(U.\N-)K#=/A9Z^9\OFZ&/3?B4
M*:LOV]5B,F*K``T5HHNPEAJ19LNT.!UC#D4RV0PA57S8X&OBIG&DQ+70:%'/
M:KRK2/#Q4:'8HI[!`&6DH?$IKKL-LDE&#/\>"GF]VS:?E0J&+A#*NL!X3%;'
M?_9^,;]&4/$Z@1Z$4_IG32(WH2`0-D8M,,#QD3CR-A8YFY(2>THL=>C0&B?T
MI:.1'V,Y8PJ9\9CZAD/A8PJ#Q^-\H7#:Y%N/_N)=*7CO8%8J>(PI5"27*64'"\NQP%L*P1'?T5`"QK66&P
M^D0`K]7]5`"O=^X#V!P&L'Y(=UD/LJ:[X,CDP9?S@-T/$7.S^$"G"#>!FB`:
M'_.P-`V36B0''Y#^HB_Y13_5"7TNDQ0E4!]0#P/E@>-%)^OJ4]VYFH?(<:D3*1``,WH_8"FP$@GC2G/$]K;+JY^'81
M>4:E#('P0=E`6I71_50K,!JN`95);%X24JZCR>P5$.NIAJ"BVC#D(;_?+IJT
M9]R.`SO[/7X3.."3Z1TJMD&9>#+-*,)[)VE616OBW41&Y0,Y6*F(2KZ+Q[]0
M)A%&M^;(^G&&@E-US316K#.YO68`IJ">M2,*J(#8MRB72N0L5+45#".JJO/6
M..@1B'7<.Z3Q$4WV'6R!$]J609(DYZO4ELEL%8JO#YX1I#YK(XF"ELHM9\_P
M^PFP_971F/01599=LM>_8&4<2_%ON+I2>@GT(T,5TE#KLVQT&Y9OR=Z0O=/>
M`+65F!1X/%TB(PENH-L+*O=U)N/&Y.01,N#344U=VTC=5P5CA+A'$VZH'APZ
M2J.;0_QALJ#NO:%*?4`5+0%O?5P7307`WR$MD3DZD#U"=G3",5T,IZ'$>F2%
M7*MB!+6G3I?,I,EPHHDMP_(.P6&F&%*K?,T0%UDM#%%/!D.!6D[O,9)@N<^'N1&D>"0'8,)
MNJ>ZW@W.U,'#U2/,#,T"!=@6+1NWUY-9.T8#2M-$,QNS.?I/H#[80MT*Q,:DBE^;VJCSR)IOERB"<;7Z\F*
M39:=#MTI0G:'\.[N)$-[*;*BWS'\+=EHOERA-\:U"GTOC=&/>N>7IX]Z_Q-@
M`*%NW:Y?MVJLWFZO7FXW'7+;97KF.G29XQV'JRO?L@'F^
M'7H.GG^]66RV^4+?.)[Y!E>^$S'7M:.`/E"O+.S0\9DK_VYN
MKVR'_L^N+#_2!KYW&D>^'0?*)[TJ[=QMKGR\PN(PL<.$A8'/[-@C:XVXVA*4
MR[:"Q/:],1S@#11>ARU+^]OV>K^QF9TIVN;F[9>O?WJQ7MZOE/U9W:\:D;64Q#M+!HF'.&D!X%
MBE6*)UYU$SAD]V(]7)=817Y,&BA,A+:@U`"%NLAJ]?@P6WBV9_&F:)%5]6Q;
M-TSP;(]D[[01((R!T&;LCAXH>(X-HFATICT^DPMDKQ6LJJO%V^7R$R,;\1`(
MJIF+K40'_-NZ1/W;OTJ+8_-YKAW$H3$.3/&$V6<-@#9W=9*5'FC"274)/#M)
M\?5IKEQ%W5`7_L&J#Z+A'=6YJ"@U$`6`ILRP0]E3Q&`L2J^X1^Q6[]1-5_Q'
MWGV8S75:/#MRHFC,2V26,\F("'!U0`2:7?A:1%9*F?12ODLL0I#R\"C1^A9K>4G!J(0!T@7X9%,'
MIGX)Z0'-_3`#^\]HZB/_;NI.R#<1WY&AD138B(4.B:N3VFET:>*<:[%\/4PB
MFIQX?<(EQU$CZ&]])>40DK2J=HW("T$R='%$1&EZEDS7"72]7K"#5JTKP51'
M:[+539E_TTI7\F:'(JL?R&'>*U;X=A('_IDRV$Z::G<9=)6L9J(L^[*&5@@X
M:%HD>-4968?6'ZCERDZ6+[%0EASD>Q*#K&L_EWH;@UN3GIBV'?$5$WRDU'!7
MJ%Z&!BH51M/K.U(!*KY3`^&P_].PWHD<=\3G:9>NYF8+GI>$`ZK2%4)B/7+H
M^N*1MR!D"S>)U:IN#BW"_8%7\B:]6G3MV`O2T\7!I2[(GTP]=2Q-10PMY`B8
M&](Q"\.C$D=J.]ESTJX;V9@?$P")LE-QM"LB;_B1*:'A4F@0.>K02@.`)#N%
MGB*9VF"@5-:91"ASSXZH)'M":D5G-`<(M19();&9;JN%CRTPQMX!M%A84E-/
M7=#0U^Q95>R^?J+)BUGU."-J6Z)A6$.=.;O,Y&\,.6#WO&OJUE`40\-D`+:U
M-M?E?]E>DR!OZF=]"7KJJW+D[(/U[N[F8<9T]FDR;'E6E$5G6*1$NQKI*GU>
M%C;7U2'<\^H+2#IG-]A^.,9_QK42,3VE"!VRMNS8=>HP];`H2]R?2YY68FC#
M,$Z_:T/7396GXTF\DBIZ+VO-CO)-;00M,ZV.-6Q7"H.,)%Y/]QF585Q1M.\S
MK$J^/"?16)$;A9*81:$OVX*S3X@*(P?A[(`)2#>T`DX)6?6('%RE@3W%@$%Y
M1";4&@AQ;[!T"/5K0@SY>\H.`JG*%5!-%8;-3Q/V.7&4G/1:,6Q+&3\@`N7?
MM?2PP078",1,T92FB&]U#5!U-#U12*9?%+QA7!4,O`_3<7-P/>-;MY/>&<7S
M`?E"BY/K1P)/&H-54<6&S?5`O[PQ@%`&$*@`=(6TL\O2DIAE549+0"'P)N:0
M8B8"ZCVVD"'18HYR4!6G)4'#(Q:#SXE'U=&93>+$D$'7JY`'A"'-W;ZI^]V^
M[CMLX"TIJT=EH>,!XZPC8G:#CX5V"_6K
M5]*B?K"7RDQX!9)0;\ULB.(X.E%"4J_4-)U.)GTF80`//N1(:
M!H-TTBNT279(Y/-;GC`BYPT'>>-0CQ1-3&I.V[6VO%P
M=FDAPW?3'&'=RL"=KN&%7"7T04[7E94X`(S*;XQ?5OXX=`?E_Y57/6],\I7F
MFV2U=9G+JC;Z?'&LZYQ!\@N#`$)_#@#6]5Q1B[V9@?);#+X#QN=X_IR/:Z)H
M2@-4"L?O57VL]#FT'7&1RXL+BADFK>7\,IME1["B*S\($BI5KV];*A0(P'!@,"M;M&R-,1BESH1^C$.?0V'VMY
M`:=A_X^=>-!AH9X=RMK81WB\K-%E2LK@NFUK.F0B^5-#+TT[&"[K3+Z.&KYI
M^JH]%MGO<_96U#@2\:&_!V"6!&,+/3!9QH+@5F?CZJ+Y<7MNPST6GTRO7`J\@J.MKW]%7I\N:NEX."B-.TN,
MCPD/>:W[%@HV9S#H1C`EGNET:X;RN-3$YIR2TV&*Z/-=SQWW1;:'CM*XS'4Y
M'H>6P2P;@1C!\5UW;$I=;[C2BD-P$5>*L%XHEBH$>U?L%0P@&U5.<[_7CF6,^D&R8$F7)YBH1086BRK&]P
MJ,HFZA]:N1C*/ZD^73Z>O(8MY,R*X]O72>+'+0E6X4!7N9`#I
M7I*$P._434:5-H2(=;^@[:4_JJLY;T9RQH3ZO`E_+89YQGL*BK/=-%I-!>WE
M;/:8T!%V!>,R=_/-[,SZS4F%49:
M>QX[WV/BW(Q%%A(X$0-F*YAJ4$2L[L0!SE+:'3D!&E6`A<&!=Z/Q[D^^42-M
M=UW>(O^WG&)4#G6_/S<[:NVNN]:BODP)KKBL+&?;B,F%/2X--*FFZH0^:%2'
M]EA=NW.U`Z8F&):)6I'!%HP0KOBI.O6=5R)%O;E1N[I&42).7IEI,A.$M(SV
M6)+2T?H^);CE""Z%<\A=FRVP;*UQ$.?Y_![5O/CW,T=?L@R`/A@BG6DD=A45
MP7ZWD&M'EE>7LE1KX]YU\<88M[5H=6S2GXRE@]B?UY.LN3XWZ4H+'7BOVC<@U&22QU.$=F9XU^]F0+6#Q2_5:3V]%'N*C$RVA"EI
M%P=K9!R`.>A=\Z@DN&3V&?D)JKS`,KJ'8ZA0U4?'&P;I8!08RWXP(^'--J&;
M6!K+#/VLD7K[AGQA\VU#ZPO=,^]A;0]*?UU:K!<.+51B/Q^@&UQ,&Z7X]3P6'NXJ(PHHP[7-N1
MUCVJ!M]#&^FJK$K%5J5R-+>OF/XN[UAH>$+5'*)"!7\8SKU+(?AS$[[],S!]
M9EB&.&AW(:N"T-W$,$Z\0++QLK];:!]A\Y0?LT
MH5;]@CQPGO91O\FIQIY1SQ>K+,2X3;[#QH.+V'[^]O+UD^]1P!'^V?5=FYZE
MHE7'LP16Z4\3SY%/$D\U<;L;R"-9'/MF$B/5V9OBD<94Y[SGVL[]#._0#B$[U/868CUA.
MU+P4#LN_:F8(P+>YU(3H'%P1T30PFJKC$3J(BNA:L^0>+C(%FD8)(NR#'"A+[]Q__A"R"_SJ>W+
MP^/#]ON7QX=_`@P`%DYQ!0T*96YD7!E+T]B:E-T;3X^M*'$/+DDL206RW8,-
M%8Q-C($2079V^F[Y>25`P9`0(P4C`PN0()!M`F2;0]D6"D:&!E#%`47YR<&I
M)='Z`2YN^B&I%26Q=G8``08`]"\9Y@T*96YD%LP(#`@-C$R(#7!E+U!A
M9V4^/@UE;F1O8FH-,3`W(#`@;V)J#3P\+T9I;'1EY_7
M'[.F$]]]]_K]S?)6N.+[[]__5F??5ZO?:$%.O=E72=-(%G
M7,%7ON<$PO.=T'/A]\.2Y^YE>6'VL#+YW&D>_$`?O$1\G.W?K*AT=$'"9.F(@P\(43
M>VBM45<[3.6RK2!Q?.\4#N0;<+ZN6$A')AS6`N)R`_0&%S*A#*]7;]]=/]R*
MY<.-(_#BYL/#ZL.[Y>WU^NY6K'Y^LUK>+J]_6MZMA"#;;#$.TL&B9RQ&9/']
M]R#C\].[?JZ6Q=>H+6PTIS&G]AZ*X`1:=
MBR+3-/[SHD1IX/C)I:)`[_S4'U<&T_!-&I)<_ROK5"/6*C]4=5GO"]5>#CI*
MT]"8B,B$3"*JQ"=MPUZ$3F"=6>);A;G(]&>ILFU1[<6^K#=9*8Y-O>USL%#O
MQ#$[JN;1CIW4RK[@,_E!\=R`/==+;J#$L>^/,XYD+G(ZT<[@9#YO[(]Q[<:
M]$F1%%7;%5W?%765D3.D6$HL0F<2>D7Q5Y<03_Y&]A')[GJ#OD>4'"`>B*VM))K.:+ZEI'
MB&778NESU;9S`3F4Q5!'=+?KJYP2*T=E;;N&^JIS33T_U+F"TY"=RC1@IUFC
M1-^J+1:V0`.)!?Z>E*BAM)FVK78[2$A5\`=AJ.J05;DZ)4<>)LFE&L&N;B#C
MIQ._]9G)P;?FF%NGX/:QS*I.9&T+:5-FJFI["$U53T535UA6SU)5AXG6_.UH
M+[!298'!.$@(C`<8D8P8$4L4F7'J'!N0ZE;EZG$#D`*Y=3&N!@D"UH]0$ZK'
MZ`EXQSSQ5\R3K$$R2L^8-^;<-WL18`O;K(1&%57>J`Q[X+U"M[,@E,*&]S6D
M0ZLH2V@$/,BQ<@5"KD!HF7!G`:C1]`4;88SQ.WS)_W^IRYZ?1+8$UF46:H2Z
M,O8XDU.D'/E,HD,"'3F,Y:46;-7I4&L?5N!_WE"#;F)L,4
MRN'[Z0FF&CY2&IB*KTOTOJR'.)OLF?JFT]JXUF`
MSX*8U0+[GA7PCC2V*?1##903$\76!=8NRSM(55=2>YQ4,C#("0QRR.1^DC)U
M%'""OVWZ%K[!SPB)MDDG(T7IP:-/!YFGJNOL#/2-(QOF8Y"
M;PS=)-+-&@'IK!Y,"4-&""5*?#FAQ"=K%IRA3CP?"BC4'\`>$L6I/7$TY$H.
M)I/7H-35G*>H<-J(;+LM]$"8G0L-#BJH<-WA6#QSQ4]E)#+-GA,#U4Y=C5$L
M_;9OL!.$\1,-0L<5,()R%'U(Y%@7%8`3`.&#VC++<-DUULZY9K8?&6I*KQ0$
M6NTA.E7!7./-(-MJ\;(74+0*!R=,/)A]ZNL1Y@]@9\1*?U`J3X[:(HTC:88X
MK+^F-Z/,!HTB5B7$JH*Q"X@`Q&=,+D8F7X/4V7HE,ZI%OB^JM(R-KF"H0#R8
MC6-M'N@&%=_5C2KVYV(967,H0Z(Y#@'1YXE&^BM_MEA.4P_86_UI/:)4BPZD
MKZM)RAV)LP*1UO"=&E4MMDA[`&QZ5FQ,A88*D+?+F(U"O?-![H
MFN`^U!JS6_^=D@F&(\/B>!L\,#H8V'*`2B\M@!NVNT74!0+$2Q6?#$K22]Z@+;YMQ>K8/Z;!LT[:8
M)"L"R3(KU"AB_`I,Y(N11/%WUJFSL:(;J[>I&$*F[*B6.A783"38?#6.'V)T
M7YW"%>L#LH4H0^:K>ACZ7IS$ITD1:T=2TZ&O^A;6;E2@+XH(!7D7'1YFK!86
M`'`.G(/U>[>#71Q2I`9C>SUH;K893AWPVFX\^6)TL'F=:,CS`GA^`E+
M?EYG'1P.S5#PD^24G)Y0@>'U$6+&X]VBA<%0D!AC;J#,(-L]C>UL@K:6C6D@KF,`[T%H:[)9<34L9!V*KFJQQ+LT.+'_K2+&H\V*_;0TGK!/RM_K]=W!R47@>5N+X7GZW)S<^V:(?AF48R
MG@Q/:)?>FO>5VM+FM6^4XC$)6D,YZ*MM8X9P?M!1%#F\U2H\![`P"1BJ`'4:NB(O
M:Q1*N'J`C9S?V/!X![P28'RHFSZ:\AB$);':CN7R!?=0E)!W8,G#]1=KTQV@
M,,/)0;7_$*8;WW!D^58K;KC]K5C!$LY5]QP_]4]'"2D-]W15>'/@+7XXE?!7
M6&[[XYQ*\\]3::2UL"&RCWQ@9&2MCBH'8>CT`Z8=VO=E.H;Z?/$3\WWPW5=`
M9[,-3M`TUTM$M>4+G?\"'LN'ITYSPO=.M`RT5XTVM?A1-=4.5$7<8ZEC:_,6
MT'N]^O&SS2FKKP5S:5?L.+$$,Y=F"HXG`SB:)$D'&,<+(NVO?L86WO5-?519
MM=C0=#V'XD9USTI5)XH9VHRU4QJ[>JZ>T]"G&B%EX*24'QAKQAY].4!2=8.0
M'O9QNE]7Y8OM\X*4XY'.^/I]=RC9MPE3
MF`,#)Q<^C!%/II>!"Z<2O6H`6$9T%%B+!L6HS5!Q<=?VXE1H5/(^ACYF$G:U
M\=TYI@$,PME@Y!;/)Y%E-@F503-/KI#OEC9!1XG4:KO?":^6WK2!('Q'RG_P
MH0=7H@BP(:YZBM*HZJ%2I:2GGC9@8%MD7+.$J+^^WSSV84/;6PS$NS/SO::G
M)^*P15&&,:'E>Y]KDLBSKZF-&WLDD?,^;+S0);1?$/C+2'L/SK*X]2Q#E%5#
MYU:RAO24`4?_C>T1Q.0D`8+\]JL8A)*5`1"NL\\G)\G\$F;;NJDEE83)F+;M
MI`(T;^DK`$U?K<#6,&R=S@.(QM266#41P7+YA4Z4R$;8E0]Y&A5/@ZI/^UXH
MTSPQ6OFI#("_T2EH\7JQGI=5TRI)3(5.RA,\(:/)$#N<>GPW3Z0JD<`O]8SAI12W7?,:F"17:G]:U-\+YO/1S7E->
MI?^GFTF/0,X5).QHHQJL*90Y2Z]&6#2M)(\FVAN]\7HB\^L(MX`7RD=GG%H4
MNP=_B$[=IWKV675S1KJ9A_`CUJ^$;]SNZ)6RP@H:9^>9L51KS6H.1Q^!0IG]
M,R)),1O[)2O&AY(D9"CA"-SDCS84K.?U]]U9&NFPL+K8N=!@Z!=J_C9YG&2?[NZ^\)>C=&?3+L,SN/?OX
MI`'[<*CF^4.SY=V*<J=LG:P"<,4*J>NBBJ
M*-AF+9N'A?44>8.@`-&D=87.(GO;FR"Q-I;T(=L=SO5+W5W$E>]YW!>X[K0.
M5;P&FZ6EV])CO=G4["WT$,.!"LE_8PG:I\#O04S$XB*1R,>>U?*D*250=4Y4
M9G*-PXC_)5
MW3F2,AH6'EN\^4BXZ&ID@SKLE0]/HYO1PY?[F]$?`08`$$E77`T*96YD
M7!E+T]B:E-T;3X^M*'$/+DDL206RW8,-%8Q-C($2079V^F[Y>25`P9`0(P4C
M`PN0()!M`F2;0]D6"D:&!E#%`47YR<&I)='Z`2YN^B&I%26Q=G8``08`\2`9
MW@T*96YD%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,3$P(#`@;V)J
M#3P\+T9I;'1E
MJ4Q_1KZW%W/N)2G++J<7J=`2Q?LZ]YS+5Q_RIA,__?3JW=WR7GCBYY]?W]_]
M;?+JSCUYM5Y+X8OU;N)[;I9BCR?T*I!N*&3@1M+#^R\33^SQ;[VA
M/\\31\S6G^D;3]IOL`J\6/B^&X?T@=XR=R,O$#[_7=]/7(_^WTR<(#4'O#2:
MQ(&;A-HF;>5S'M:3`%M$$J5NE(HH#(2;2#JM49,=A7+]K#!U`WER!_&&.EY/
MS'W73[5;<_CEA60-"S_E"!>K7]XN'N_%\O'.%;2X>_^X>O]V>;]8/]R+U6^O
M5\O[Y>)?RX>5$'RV/C$)L^%$:4^,^<1WB\?%FX=W#X_K[RMQOUS=_;9:+=\_
M\N%X]?8_JZ4]ZU07?6K$;E[F?TB*%U+2=5+\+$O^.BEQ%KI!>DH**A9D@;:3
M1J9,7LK.RR"*R.!'9UF)Q;$I2@%`>+=BT1[*O-J*?/-[7S1J*[J#@MDOL]3U
MG7PFG:(JJKV(O)M9X$I'%%6G&M5V6(A%DXM_]H7>6VQR,8OO/CFT
M@Y?C;9]FM_JA>5>J?$LV9O]=_SI9_YV]SMAK/PY#[?6QJ;?]1C6BWHE-WW8U
MG09W^JK-N[[).WB.PR+G6)?_F\T3-W#@)/;S0S@,=WFYJQO]:5_F;!"]X2-O
M2.U9POPHTY:[HJY:@<\X,YM:AW&LVZ)3+;*PA3<-FPPI.V)5]]U!+/0VU2#>
M6_Z:CPHVLZ=3$^[*\B9LZ',?SH=@<1-$!()NZ
MV=+9K<@KH6"[XQPDC@W4V+E`8\S6@C@VV:7#,T?-?)CH#O76A%947^'$^&75
MB>>B.\`MBO:#:KB0]#ZO-DJ\`P*:(B];88N:Q-%ED$&<:*N-.M9-1YAKU5['
M1U826''%B[A/T;9YB9H#@D,QR+\5&G7H*,"B4Q:D8AIY
M0K_2-6:L%%UK'M:S.47?"HOQO!&J(M>./P"#2TQ$WH**TH&*
MI"NC.+V``+L.3KJ'I2]/Z!UB"/%[#_'!#R#_F#-!U&*T`]_8'59443[7<<2TM&Q8;`<_)+^_G$54%_PBQ9-39O
M!2KC>S>W5"1ZG(-^[59J(-2V[>
MT26#@VW7(JW_KLM^W%(OLL0>/PUL0;^F,M`+TW,F;3HV4Z(,^=-M9[V\X%`=
MM0]N,7W7,IF@N'5?;>V/MBZW]CE57S\\%,^P'C
M+G0CT'(0N[&C7Y.GFG``UR@.7JA(D!C,<">NSWN3"OY"0S=UU37%4T^*!FHU
M3&..OTXU06IX+=]N^6"40_/H5'IF-6Z"6_.L;LPB06Y16:X/LWRI&'3JVZ8$
M=G2$TLWB1%Y&"..IC9#BT36VL>TP4\&=FE4R=IMB,M$:TQ=%TD[
M$@R),IFD[^_REFB]A0J7O59N5OVA`V9:76".5S;!L!B&J6^#"U+#W>K;,6=Z
MW9?U$[+ZN<:WXBN(N&]H3**9Q.)ZZFNJ"<=M/P3$QU\50YU*LA;>`"/_J!M5
M[,%H?=.H:L-]$H,GRK:^,*A;%F#,PJ$JN@L\T_<6S`AS!(UI*$[H-7[*FT$H
MYN9(.(N!-+O(?BH-H-\T-?*)_MAA'M@JV^/3X"P)FF]1:$W0H2;H>"!H%I#<
MJG;LAM)+7T`LE:8<3(2PO,"V"7LF)^!9X1,=7GL:M=C865QI
M:DIFYMWOQ&:^TS*'%A4)G'5`[4!)'>O=L6,1+OX`O^489VV8YFMAQ^0HR495
M"PP4`TL^&,DT>2(8)`^@.\T45B)C#BLZDT@]!/`[.P9DHZ&9K5Z_POF9;\=7
M&A<4@1_%,!WG6Z#:7J2W>VY2.^*@4XVH:HJW^$1_VON/A&*9"$?\`[1!"@YY
MM3^1WG[<_^<$,T"1#[Y@<7.[LJHQ]:&H43\-3M?8L0Z;5AL/6713HT#"Y*7V3FE*"!.C
MNM&("L>>(T;6H+7N\,@Q:EN;FZKE+4`_()'US@G+#V5Z8L5=46&")I!I<'#3
M:KTE?`UZ:X5Y$,JAO=C&U5IYH:'\D:C.SU65?YY$0/_^09E"<5%I&V4:^J7M>?5U@NE6%3K-'C%O^X8&.0[VY!`./T7*=J[/%MSG/.*K
MAJY;.0!_),UOB3HP>,8WLP`&;XFF_D+2!C'U+F1T*)XEDA6X#@XC+%415:&5
MP(%;(SVS.1)5%:`8*,Q7&LB.JJ(Y?"2XT=#'492,)H'`PL2P!CD;_V@"Y.N)
M#BC6`85G`=F[RXFV8J*M;:]HQ]#P[,%5??4S:1_8IXHU17?@DP7&(/K=XX=`N\9+Y!C!V+#3T&)WP]@`R8.D;--1T>-T-
M%T(X4.O/%&-+/QTAW(*)G1A'/"`60)_Y'N!VS@)C@%H;G/#H>L*C02>&=(/S
MY=6S]>"AF[S)D2JMV29`DBJ,%O/^J'^9&6ET<4QM%PQ7J+:FX09NT6#`S%&I
MY^O3,.]8_;F=WQW,E%^H'_:!0:?T4V/J_9$F*LJ,37W,J<=TPGU/2(_%&,,7
MH^49;"U$HLP[:;AI^B)"UE,A<0N)8OT-;,OXS(F/SB0>D]@H7"`H"JOMP>F!H6B+"4W*)&4#_1FYY=_VS%,5]*`V6`O37_YXLMMIQ.Y,\M1&RKT)FFH(:H5#E%)XE^?+(
M_,_(G"45B<\A2SB-<6+HT,8<29D"\9M`)9,")5]5L)R@'>".PY",!VU;N`LEP1EQW5&3
M3X-F;X>M#^F;5PTAO/P5QJG`C=>A=G/H"0QHJ6?[#6,8!2P)4<0?*F<_\0BY*S^%NTBP_KF2LA540W0>IDE9_6BO>4D9#_Q_SF!.F2JV>;)6;B^#BK
M%*XZK0MT2):A?\#5TR#?`^R2B#ZHG*(RSAD_M7OC\XSX@J(F2H0A=E=(KF)#
M!SF^H2IY`9C7%$P=;&TGZ*O*EB^Z&A2,UHZ.J&2)6T$%C%AE"_('6+7Q?H[$
MK_C]!@]\%6B?XDF@='T2-_]@9,,Q>!#2NHB\DZZ,%M*8%>YQ>6^'[ZD(Y50-
MF\4U_)IHO4)%D0:9JP3/81>E`,)V.R,N`\S7;XG+XE4V(\U/:^"Y.6U^/D4Y
MGZ93W/R7QJ#!H'8J337Z8$L*3))-MO@UT0I4D*?FA;F3J5B359,T@X.>G$S%
MR%$M,(?__[4->%_J-VRS"'FR;<[KJ42YFHUA?A!&:_3/Q-!)FPGAJ;170NBG
M7PNAG__)$,H43G\CA#)-2==I"%$4)L2!,!N:D"ETZCG,@=::V]7VQ4(4B?H?
M:]_-&/)0(P-TP(9?UFM)EJYO42!DE,;<4:Q<%HD5:EJ01D?TTA8`$AJ["G#5
MELU^`VYZE@G7?1T@!78KRK)J"$\`IVTJ+DFH:?((G:>30`?/=[UK]!-I(OXQ
M;KFZ0($)NG9D66J5F^0`*:67I5QIVPZH-:@S@FL<-OL:=^[A*;>:9P!/(F'R
M.4_#+8ES2^2=SF^\C^S1KOLS(0T^@O'N[Z'R4]%_JX!/':(\>-AV.6U,^AP7
MJU0Y$L$B0D)0!SGGXFE;EUN"\NQ^&)^@:CM^FZS+V$KP>*AZA_KLH+"&@.BJ8H-T[6V>RS&KC_W:-LI
MFD?;*G.@SG';D!H6'00G.F#Z8;_;-36&8,2VOMLN@46!YQW9A=9B/W;\U1'K
M(WCR6(EF_Z7WU`\HX@"0&,=!>^[`;5T6+?FN)*Y*;1(##9^SV.VJHB_:LIK.
MC]MQ\.CY@?E9'<_/&7%3E48Z9$+A>.KZ9O.=8`\(1=T/H[44*BWA[>K&^I16
MMOM["Z[I;O)-]Y0IR;5+3V1&,0Q5>X+RT\=WB_\$&`"KC/M.#0IE;F1S=')E
M86T-96YD;V)J#3$Q,2`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O1FER
M%LP(#`@-C$R
M(#7!E+U!A9V4^/@UE;F1O8FH-,3$S(#`@
M;V)J#3P\+T9I;'1E@"PL+H<>ZY=][^E+>]^.Z[MY_N%G/AB^^_
M?S>_^\O5VP]+*;;=U;O5U=O5*A!2K#97TO>R%'M\P:LP\)0(0B\*?'Q_NO+%
M%G^K@OZ]7#G"7?U"9_Q@.(-5Z,="2B]6=("WS+S(#X4T_U?S*\^GW^+*"3,K
MX+72)`Z]1+%.VFKDO%]=A=@BDBCUHE1$*A1>$I"T5E]MR)7+LE3JA<%D#OQ5
M[*\O9M*3*9LU@UV^(FU8R-1X>+O\\>/M_5PL[N\\08N[A_OEP\?%_';U?BZ6
MG]\M%_/%[3\6[Y="&-DL,5'9*#$8),9&XJ?;^]L/[S^]OU]]78KY8GGW>;E<
M/-P;X?CT\5_+Q2!KR@M+C8R9Y_$?@^(K"CH'1699\L=!B3/EA>E)4%(+`B\.
ML]!HQ,(FS(^L&WYF5,]UH9\>=2N`#%_\M@?&\%`T3\]YJ]>B;\31#IP9=EST
M+,XR9?5(:?0$?J!(S[^=NZ;N]D]NZBD'Q]U9Y$7.I[S]5??=5W>FO,2Q+[N\
MTIU=EW71ZKR#(?PL_3=V!<.NE?(%2RRKJFQJ,ML\/KMDC#-X<*U\7[@PQ9/.
MR?ZR-DYY0OQ8;GS3MFU>^IUXU/V+UK5XUFW9K+L;Y+?;5SV)
MPM9<7(1C%;.`_FXHB[FA7
M>IDCIF"R.8^#G=<)A(0*>\[4!E`+YZK](US-:QN7`,K#*`(,;5PR3G48V51O
M\ZI"MD775&OQHELM#F7;[_'6:(2QFRKOQ4N)8!A0P1WE5/J@*T3#Z)@-2DY3
M(&T1AJE511&'"\C;@>*'9"L?1<%O;9:M.MK@NRR!'Z
M"WN&4I)Q-GF6#.HR5E?L\GJK_R"2\B1S)DTONQ+JC(M\O.,'2B.[:K6>H2T;
M"C4:X,;8)-\"IW1]YPM'F.$#8Q@]BV0Q!M&K.@LAM0$KJ#*0,T7$E*CX$
MU!-PC@V2SHL=([79;#K=VXRFCFCS%\%;.A5/F
M0J?=EJ."M0@]G^BGT'6?(Y[/35GW'54/=:`W@S-!%*?G>?.#Q,*$$M:W^9J(
MK^&L-3VY,?`B99#?E^X,_[]PA)D5._*26'/TRFC[DQJH&H@0[.0Q+MF[?6LX
M`$*/^M@K5,)+9FM]*)M])RPGZ;S]1F6,/"`3WX9YJ9&Q>GLCMKK6+?!`ON9K
M4_OP-7#JLD-L^O*@@=IG71-6)]8@%-H81\#&B!>+5M.M20T9GQP3L@0A6S>I
M\&X$DXO^;5_V\",FQ)(I34_=;`PM*3DC4C,&F+G&N@3K3+"H7034C0?B6)MB
MB.F5Y99T!.QDBAA.FU`'8ZAM?[T^2LX6Q4IOD].75Q*+`Y\^/(0G3#
MQ4#12F)QG,%AW#`F)>K"-XQUHT7\E>`=C\4[F:B>/``#ZT["@S#P/6D9D2B'IS9-MJ1Q7,;6U\#GFL:+(B=#I]+[
MUGA\-LC(>&@-E\6TNFC:M0E!UYMN=RW/X$^;KZ5Z#7"3DR'Q*(9Z/;SR,SN:
MH!\](\1@*3.9.3>&N^S^CG\?8Z+;/R]IZ
M,K!O-?3VR7O`CA$4X+JJXHD=@T%=8`<'L/B<>+9\W)O&T^KGIC7LT>GM,7E@
MB;GKJ#E6YX(,9>ZQBC?U/8>!];!
M*+3+VRV/8M?A1)OC5'.*/G3%NL,$,'YA/)@E#7.&?>5E,9AENJXI2@.3D;Z8
M6\AXW]
MW>+V(PG(S)%,9."J^&B_4<0ZSB5G(.-7HDT-.C\]+!>KQKR[;,LMP'<.H0%P8)^D9?'P>KYV/)081H.?W/^4_.]F%86AQ
M?]OM*N3LJSNC>RA:>=[M<$UL7CIA6Q;PW`SCP0T0>=!=/XR9F[+.A[:3RNQ5
MVPE#9,95K5P;Y-Z1:S^0:U`./'9[TI0Y_)^N&:G3EO\=+U#@I21\/8BG
M-G*P?]-4'"E0`YG?[UJM[>P-KMIUJ%LJA[DN-+]]1',)I2WQB?](SUG7')LF
MM[OS1GE2+T$,E@DNU4OF);&9!H!,7D8A@2U0_@#E1`T7#.O8SXZK,F?ASL+$
MJ1%'17WBR54176Z)YJ0#:G!G&95PXRHU[L(4D6'3SZ[Q3%$1!^,-5)EJA/9X
M&$4"-P.L'=^-\5_Z_`0OS;-]S%S?4NE4^K-!,DV\J3(A(T]2"X91&
ME=P-B9P[=!Z<=':NF:J?S4^+/1F1('R(L.G`>\LU'*292-OO:SZ$X,Q"*HJ]
M:R3*=-H!O_F;,![0^*XRA.5O@_VV*#&+\Y04*(RJ)CC27G60X608R2',1ZPU
M64A]*.]=21F0!"2$'':&SM:%U9E#E<4?2MITL&?-P_$'[=+NS@T!-C1A*WG0
MT+"P)\Q[]"@HV0$ZA1L'1RHOF;'GDZ^,8S.$F\848//RC_VR)@P2D+)`JHP*
M]!K;XX3LIAR8DZ'=E?(ABK^,8F(/;`[`NEA%_"V:1JD@">Q0J;BF@1U,-[81
MNY*N436[?B##,V'Q0#H@BR^LZ45<.:L<\15A7D$`@9\D>2R0,WU$+`AG0&=QD+^S!;99
MMHQV(!N%&?.'32HZ(:\@)E53#DVH6,G3;SB1Z"8AR\NZ.\HNJQD#628*#"\W
M'5D4+=&E)Z&[1]SR8)/(O:P0^!G?/`:Y'87!K,D-T%1!LG+01`4\^<6)DJ-1N_5MD@VG='5(]9V^G"[W>RX(I7ZAD52R5L@&R?GQ+HOB
M).3\:)_-!8D*B]T@`1=R@6S.M6(M%24'7WLV\]O`2.Z4#5ER'[)D*BQO.<,G
M:\ED.9ZXKA@_D`V!`>>P.?78F#J@U\I6A=>_]1P:6UT\ZDJI
M5,AP'$".RQ2'32\JE%CAS!LO-XD!'U@P8(:._08D4W:`!(604$_&6.>H7+)2
MMDI2+TCX\'%6^5FV)EWPHLM+,`#RFK-Z*HHR,4<-\JB-J>!9>*I@/R?BF+EX
MV="-[C7`?W9L+R*#M((/!%7<(%$.@XL)>8GIQ(AHUCY1[2,V$"SJ]PDT])[U
M>]*G4?ZY[3<)925CT;:A9ZF>
M>/5IE0!;O#2K7U=WJT`2[8`O[^R*/7YHFE>/81?=W_N;2&/%O)O(UO,JM;O8
MP&JXT:0(.72:4!:9MCAKJ8>"GG>!(P*[F#GNT;C:2Y'HC&X6
M(E.H6[PGDFC_7R35_B1PA)EG&R/@$@F^"L"[\A:D[[GB[LSPNC?"]G5WA-UK
M_OCN_K*31Q^RBPM`=Z671P.9:0/Y9H*4HYB1,CVZF(UX;@&+7\(,MQC"_GM8
MS*VVHA_/,^'!M<0&,XU,AXO9<,DW;%:8@KQ,4XB8-#T/B&&$1<73`7$B'LH-
M8QMF-)ZDJ*("D_47S%A#-_45D@B-=C0:TC,,L(-\-OYY\K4?D;IS!/PV#%DJ
M_G+(LCQE[5!6$IWI2")X3^TXSY!CIR^E/BN"0UZ[:21<:$[]!B.\FAR*PT?\NU,G:97J'F\N\<@R=2]&Z9FA%W4LT0Z!:'^+]"+"ZV#]=03
M?*ZLC@80^J[F$??4>\6P]XU"8NK>O[C6/(3OUHV$'9J5MNJ$W#'D6UFN7?!@
MLK?%[,%0B^-86^=3[RK/SA.;B16:R7[T7V7U,TEHIIHTK=W#:/PP3&4+CU;=
M,)X]Q6(N/26-.JY+;A>>L@ONGS=;=@IL;6M]JXYE>\!U!+BO7?\GR:W*DQ_+
M9FM>CQY8$4B/C=A'0V6^L"\/(M6^J1HGN9OFU8]',"VKBJ[*`%=5SK^4#XW;
M0AC0';N>X4W76Q0>=!QC7]8NF*B2WI@H>-K8:CTE.[KQZ'IS*IE9S*%@UQ`S
M",15U4^XJ.ZODVN9MTUW1;[_EQ$VRC3,!HIZN`HM$_'@CM=L^V-73;,C1HJ93HYCOK2HWV6KU#LX`$V5,:%2?UC=?OKX8?6/
M``,`ULUMD0T*96YD7!E+T]B:E-T
M;3X^M*'$/+DDL206RW8,-%8Q-C($2079V
M^F[Y>25`P9`0(P4C`PN0()!M`F2;0]EF0+8EE&VA8&1H`-484)2?')Q:$JT?
MX.*F'Y):41)K9P<08``:FQQJ#0IE;F1S=')E86T-96YD;V)J#3$Q-2`P(&]B
M:@T\/"]#;VYT96YT_.WBQ<_K#E[Z"Y>;BY>;#:"<;;97?`PR#.\$S)S
M%8D@9B(*$A'B^:>+D#W@WZ:D/T\7'O,WO]`WH7#?X"H*)>,\D#%]8%Y9!4D8
M,:[_;FXO@I#^+R^\.+0&3IVF,@K2V/BD5[6=5YN+"*^P-,F")&-)'+$@%62M
M51<[2N6\K3@+(C&&@WQCDV_(5CS@F0EKA;C"F+SA@FW]U>;U[=LO7/+]=WMW?7_[Y[M69,VS86TS@?+`IG46J+;Z[?
M7O_PZLVKMYL_UNSV;GWS\WI]]^ZM-HY'K_^SOG.VQKX8JXD.%YGOYY460>!U$V%@4=B_+(^,D2VR:N8^=A+,C?>^]NSX"$\(H5[*EI/U;[
M!U86AZHO:M8<^UW=/+%FQRYYFK!//HKN575=-7OV5'3LT%;F7M%6]6_^*@V$
M!SNMZHYU3Y]5^[)51:>VN/JL]GW3VK>N_%40>_9-\KEK&V.*^?_=_.MB\W>*
M-4Q-L$F4FF#Q?M^4.DA8+U7;%]6>?53::N(AH&9[+/N.]8]%SYY4JYA.H(5_
M;5>(((MY@KK-JI%$L7'`NJ;>4N+LT'15CT0[5&:_1:0PC#SZMM@J?:?I'U7+
M#H7-J/`%_M[7RB2P1M$/!C;_[HB[VI8(37/+L,L$6,7P\PXRS+C"Q$7-;XK
M6J8-QYXJVH`QC?4P_PK6A[2TC_-II:FMY247.?-3:8,_(J^*((YNJ=;A(-;'=0;:%U
MPU]11F71/=I+ZF+'=G!`LD:OJAP%9H3;,;&)/%Z:@*B?,7
M65FXS%(M?T.'/WCJ"UFF&+955VH['!(@TVRT$SL[5EX:E'U_1#2-20#R\L&_
M&EN_BI)SJ+/YHQ,V_WVSURD7VU^.73]-BIU&S-RV\5)!MNK0JK(R7=,^
M$[Q0F/>:MJ],,5!%GD_DP];@=_T=<>>2YW/C#Z3"K:H+XK2E+1R:=XR[D5?6
M_#1#$3EI@JJH+P?$!D,/=0.(LU^:"M)#T^,(.7^J^D>V_M]V=?.H;`PJ8(/P
MA3*1-G(A\NP<6F*#EBE.`/6OX614!>UBT1^]^P11FEI9O\PD\_&3-`%,?`8S
MSZ!!=\5V>!`$FK\FKRCE%@63]BFR'HG(*%>)4?%'=P'CL17*R%TVX
M'R8ND%PO2'=8)#K=S**$AF%&0US.+E['6V0'&>N+7.2(=1<)3&7B!$-
M2?K62D$D1#R*F'0N;4^NNT=,S^T5K2-%63;MEF:ID1>[94#-913E;@ZKA?/B
MH57*3%[0)!;2HM9(P',(
M1C]?I0\U=7%0=?7KL3J8CTUT=+/9[3K5F^L!;_X@B>8=LPAU[HM9WRS,>)P[
MG`G@C,=!>HHSMUFA=UC%*JI9I^.[3$ZU23L['-ORT3$J$FD^MB^QCD,W)XBZ
M)N51/*F7/ZE63YX4T-<=?0-DM155;B)YUOSY*1O;87T#DT<[!EK8:3^JOM-;
MY!F2V/7&SA)WUHAE/#EKF"D11IF=J%,V.2*1>,<&&CF4@Y)7>J>2*VC
MLS@UA#:M,]?D;PE78.6@J+JJGG]N(3RBU\TP'`!UU1A"-2<>\_@
M]5OFTWQ-]OY9[8&[OSB?EL?0Y7A"HKMS=O5XBDYST7(]](AG2QV$I\P1:7F8
MG(VG20SRF1@&Z1\Z`7]GF<5EGCK=B*$;,D='3[94.Y_6R]ETWKE5BU#P42V<
M3,GYRW\]&KW8SS8WG,G,'050QF-B!9JE
M3[`PPL4D!AN!F?6=G98##9Y4J\:E5KLY?_Z+8ZNY!QS2(*2U6YC,,NUFRFH<
M*L.SY2`#C'6%M<1TC]@E7;$%%=OEC,7EY`P5QDZ^3$LNN:%P.A-).;NWE!$)
M&0O\T&-L).E0`>WTW-3F8EB!S^Q$T,-FL1A-I5S,N3G`-4M/NRK"?.SJHG1&
MYM47U9856CE;M[J^*3_:6P.I/-)6D@@[CW`Z45U'FSF[5WNU
MJT"*R:E.(W-U;T:O9H]>+U/4F_CC9EZ8RF0Q$D3BCBS?3.S3@]DPX[2#LP
8[@<&7XI$N:G?$'=H8H#\X`OFP^LO$YCFG=IC.
MN+UD+79UN5R7`WMO.N#XAN7,L]8@I--QGB.-9@^0.Q"NB1L?S]X=WL_QSJ`8H)SPJO\",RH<0]_
M$;-^V/D2/S_X.J!8!%G*1\@D>O&,@I!GUJA63.%+CXAM&NT^0DU%'NF.K$9-
M1,0U17'A//O`2HZ8'\[OU5W0DL4\_Z^^JK?FE[/_@
MEW=O+G_SN2&%^6F-*%J'8`L=VFL+#\:_%BECTBB5CF?N\I//,[(('Z6]96PX
M6T=CP,>7,^/+$$`#'<',2(?;D56&F.,H$Z<,11,QGU4^M(N)O^(R"O'=!\_G
M8%F4H6$K'DN:A_0TEZ3D"29C8IOBC*(I$>ULIBF:)N^]UPB"_Y_QJFEN&@:B
M=\_T/^C`(6;2C*7(JLVM0&%@Z'28YM9P<&UW(DB3-+';X=_S=B752F@*A\26
M=BWM][XE\W#SV;WC;Y!0.E?Q%W%J2%^?SE.I8)<&DM::<>BI!S$IZ=Y0(3=KM4HHHQT%FP$!*
M/@(D:)T/+F90\#-^7Z'V3P%$()X$BMZEN/F!G2:1PHKD`9V$RK$4VJ#^:8%6
M1Q6YON?M>S)=085TF5PGWQ-B*L$#_RKA2*CCU*ZV;7(7R*J9,GAC4(HG%-&HN29F7!0.5D&)ISO:;$P?ZFF,D2H&%6T7.9$?,GJT7%@,OJXV0/]F-V?Z4<,_WX6
M09+0S/,<07]6DK_T1+W4S9%N9>'TX#=HC4NH&&G?R\/@YI.76Z<#%83"EO:A
MMXWM?HO[MMO:>O=O@..P@0IYBL7A:;W\19*FK
MC260R^!N/JK[[19`R./J'0"HAX'N*!L0=5Y$54.&D=7;ET]7P8<%HP(%XKH)[,&E2ND#CV92!MWMZA'>7&_Y2C2XQVK9
M.US<+6``6D*BP$68Z[:E<(84%M%'>1#-2715I/=A_J!"GR07EQ].DC\"#``7
MCK+\#0IE;F1S=')E86T-96YD;V)J#3$Q-R`P(&]B:@T\/"]&:6QT97(O1FQA
M=&5$96-O9&4O1FERYCI'W@?O_\,]R#5-NH`"W).?SGT_?B;V4_BA]^>/'VU96/";5I$12D>)BK'_<1:+
M._PO*_IYG`4B7/Y.=V+E[^!-QZF0,DH-7>`C\RB)M9#V=WD]BV)Z5K/`2$?@
M*=,LU5%FF"<=M71>+V<:1T26Y%&2B\1H$66*J/7U;$.J/$_+Y)%6!W&@KV%]
M8S&7DWKR)!+Z_>W2[>O;FYOEJ^OA:+
M]R\7-]TX5F
M/GGBW"2M[%)GQ.[7H*]W;5G5'T/8,ZBWHZBZ81S$ZG,XSR(5B(M$"MYLVK;I
MMJ()
M2L2O_/NF^;1OUH[&,-00+/QM^?-L^?WLX%B)T&%=/@15.=Q?"OH5-:X^E"U4
M&JQD955U>_H`-0.UJQK;J[;^$/)*^3',HBR@,_7:.']F0
M^(FQ$T7ZG>@VHMKW/5FO;'-=LBISS^7,2S[$*-:(
M5]61W9)@%^(@K-'7:\M>?A=JV)"83=9-V"\Q,XHH](B5C3B$5.'U22P/E>8I
M\UC>UV+3M6WWV&SOQ+`GB^0!_Y8A[@:]#8LL0!QNVKJ"-:^&^Q;F_3.<)_#J
M(-@#S?:A'D:V(I(>BIU;4:6:F9)Y:A`O`IAOJ&%(9SWX;+_=#]!SU?4]RU25
MN[)J1BL%@J07BA]!2-BJ*,=[N923ZU4YA*AOP3W$@7#D
M`ALW=G$,YQK9`HFI#-7AG`+$"NIV!)^;`L;+<%Q>E:8RQT6;BH1EGR>>/441
M8O:>6".M(&P@*E[T>Y1M>8!JPM^?W+%]$\X--E!@^,7M;T?^Q#V-^E0$%[A@
ML@(IHSE#,D?!A'-5(&;]$?*(<7O2/;-#VFH*9#:CCQLR+.EQ%4H4_V`/_^5!
M-9(_Z4WTY5C;A+*?SDAS+9.$RA!Q+3(=*!)+T4,5DA+]R<:I;R$-N!74^=BN
MTLMC7%5\;Y,VM-UCU2&&B7OO7AY!75-W@$-AKCM>15[SR\X]D>-LKL_/NE5E
MV=0VR1*N_O]2/T#7).CH;A*T#V29-&BV=O7._HH*E9/WFU%L4'Q04,(,>4!5
M1<=9GA[YI(!/<-+P!392CABT^RF9Z[!%C_S@,642GY'3!*+TDTE"7J!K6
M2VG41BQXO4A@G,OY4NZB9%(V:?X"D[F(@DCO).Q=^'OF7=T]LVD\*]%`;-E@[NMVN4]A$M
M^"))8L$'_!#EQA%5)'*JR=+Q]^6TKQ^Z]L%V280X!??D?IN+C^B6%\:HD_GL
M$K+L^GK`[&*E]2.)Y7322A/C]"QQ9;VWA8:Z[X6,&DW7<\C6UN/8]T/
M_$&-VIJ"A>.U_3B,*+Z-GQ1DK(\FA8(U-(6;3R#@T?2I3CHXNO35&H0A0-FV
MG[D<7SY_?AH8++MC+?%2^/Y&(QJY8Q*2V#,A&A))]VFF/(R38NC:M1N?T4[<
M>$2C6LESYN-]-\DW[QZW]9K7_[TJM__L][NQ\G?=H.I8HKI@UU=I[?%
M;GL2W)F?!-G55)9/ACN?/D9GZHE**G'&PWUR=[G;]=T?S7&"HH]>:)6?JM8`
M"CV436N%V^PY/J;\L:S.=,L]\G+*;?J.S2X^[N3%PLQ#>:WF2':8VZ;&>=&XC45UOM,C*V0\2\"J"QF;0I?M^O&^J
M>VA:M?MU[6=[,M*AUDS>M)S/-':`R2AG8I?[)W#LVUR<()=MQ,I+&5N(^12/
MGCG=@CH']RQZ(NRD&#G91>3D42I)AR;CPC5I8H6YEUR4'3&;4$)VCA+@H:K;
M;FLNC8_->,^Y-=ZS=_">YH><\O$0&^>=6M1_(($!/\4`X&H#NAG&OEGMV2D^
MX1I`U.UZ$%Z!N2=]9GX_F4DWF:$84W;01$2SH8WV;W"#Y2&+*"GB)^D3VSYD
MVX)WENUP:U!`=!"+_8ZQ*[&]$V_+'B&E2"9$?0^1)GQU!"`\-\R:*M/3Z.O!
MG+09A`E^UU#/1?_J]GV%"!6VC0NID5Q%I'\`@K7]6H\7'(SIBNMQ1D^
M6T*7#6HW]_5ASW69?ZE.R*#WE;NO-RT<.1REJH%5!K$F?L>UZKR-G0)1]0U`
M5,<`',\.,!:&IA,,S1+`4,S>N5`YZDS*V)6F4FN4"8`J:'`"0(L)@/HM#*#'
M&%3FF._LR/L$@LK_'X)*#'I'Z3)!4)680XN&)&0;/+P\_AZ#)NUN&QLZ%J\X
M=R[`+`/VA%VSH.O'D-#.G`9S#.$A\!>A3H4]Y`Q&!8`4C(]ZD86$H#"#6"]0BL[5L>!72VP*IW='!%KM]2+*29$IG$H)1Z(5QEE,2J.6`E(8>`05D;XL$;GLI@U$87@?*>\P"U8(),6#5M9%MH(_?
M_US&-H:DZF[(.#-S[O^W>$SM/TY#=F/SEJM&QU$)V/==Y???C!9(XZQOI3K3(QK&_=`0+=5N]L"F$L/=[79-OJ,)+/(/
MPV/6\<3->3+PD'CUDGU;M!NDNO[,76.@8&B&R"QJOQ"!)680\!C9`@URLM`E
MU"K-7&6?<*(4(F7)>*5=)[!+-'E*\]_HS#W9D27XX14&R]4`5''O
M!<7;,$WB*W7N!]((5>VU)@BL2%%[2XK:7B?T:,M7740Y2M-A;L(37UV+9,1)
M8Y&20:1XP]D\Z,_C!MF9>PP@^>F!*LYL.NA9U58`);[&_*R1XM_);[1BN;JN
M`815*PH\GN%G6Y?%F^O\7YXA32MFV!ZE^)*)LI4``]WTKI?.=4Q^Z2QGQN22
MX[2054MZC;:)KN(95P0"F;>=:1P]KM%_=P\+5JHPG,2PYZJ$PC6)'*Y7>3,'
M`+*/7%4!Y.F,1J]\7&M\1P6:L3%,H_Y*5>>I)#STCU*5\-ZK7F,@H0#&8APC-
M\O*#5Y\UN*4L-@P,VT+8;,L::'$5`^3DD^IC
M9PXY!#V24--`CYZDP52B(]4VR@2JGP]EK:(<=U.51O;3"!G_2WU[2!FSQ:B)
M3-EB79]R)'-'>`*(8RILKV#CBE`R[[11*WK)JZ)NS!KH6G3F65`+TV)NG#1Z
MX"#L&T%7MR^:-T]8OES!`-%5=!9II"DHO1H^U)%#5L]]V9LR;]O!E!-EJMB'
MPMZ[:JA7OF62HCI?LDCOHB<>FOQ4U$?T&S%KVQ-D2BJ30E'5U!7LC/JNE"(D
METUC.RVDT/>V!L^J.H?Z'9Z'XJ_14JC'G(MN;R2V!31Y5%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,3(R(#`@;V)J#3P\
M+T9I;'1E,87?!5*+Q(R]&+IP_UO-[XXP-\VQW\O
M-PNQW/Z"[_C2O0-7H;\20>"M(GR!'[GS8C\4`?W?/MQX/G[F-XM(6@/73I-5
MZ"41^\1'RT7:/M+V7Q;9DNBM9X0FR/
M6N3U65>J:@U<5:TJ*I'KACZ7_]K^[09::Q4D,9P,_'U9=*8#VZK:B;PS;8VF
M5//OY5T"EB&:4Z.-!BMM45>&'GM130/6"VUNZ3L9O7-6+V))*98@#!*.Y=J;
M%SA_T4*H_;YH[(]M<=:#@P`B#6$@?&)E"[T,O'1!YSXI2N;*W:E:4>_%KC@7.^@;>&#\1G/0#0:$L1M5
M:KZ"Y^E3&:,AGWP]KC0=:39N/PQMW-`W;5/D$*X[4K3@RFHZ)QJL*0&SG<#I
M#_KT>^Q]@!$9``P%(6?F\D3*.JBO8H5%FZI$GP'E^-
MAYT*;`NA#HTFUU@RUXC"I9%S(-@<01-@3_:]Y",,V(PNY>+5YK);PFN9K0*"
M@ZG+8J>P1*4^ZT8=M&@PW>*D&Y=^O-M!XS8]>F1I-IK#V&54LFLHJ4W11E=%
M[;)XWVB8`_OE+RHOR@(A1"B`,67$OB[+^L7\20CH+K%O:NS2="'(FFL[M]O"6-Z:^<2?8<@`9#9U@"V%+,$K^3@,Z:DKRI!MHXKDE7-%3E!B78[1:
MV:+WC0.E1&O\!89J8G:,?X(X:WD'6:HZ,]28_(R3$$1ISX/FR-2!%_K7KC@#
M9"'BM_74T8?WC]N'-315`\];.+1UC0$0,A=)$,G$P2C,G3)`JG2UQ#FI7+MR
M3T'*'RMQT!5DI;RE,*>)M3%8#Q>%C"T1VH1=%V$N`,AFI5ND,CL/>+!D`4P!
M*MD20":MQJQW?P:&,6;TADOF`73I$`O'
M2Y?6K:%1M#]5.<"?P2QP;'H4&_F;U212.G+@02(-`K3HV`:B_\MU$LO9#048"B;\RP;$NFC`!
M&XV\*`Y7KOW'M-N7W(C`BUGIP'"-92<)3EXQ8'7$'79>:M,R`%DB98.I1;Z;
M4QC_@VRPS1N-\_A_RP9,KH/R((GL^*-5IW-MYD6?S7G5L.1=;*Q('&*3W8M\
M2#H\;(?6C65/'FO"'4L1O315!Q#;L':!]D3B@L[O>$_"*25<8F(J11]0EH97
M`Q&BKB.7",J0)0#!:S4R[CDS%B718HB+S,]/@Y3QFR)E1IZ\=0`7D$S2Y%K&
M.QI`7=<_(F#`',
M]6HH6O0]\;V=%7B2WUJW_;(63):U6[$VQQ**@DP(/`B(ED/U*1#(_AA]^I5-
M!H-^M'T&J&`;C8&$X+M?=\=H_@)]#H`K6&QG*.0DG$DU+%71(=]02Q1XKP5_
MZ_@Q_C+:YO`LDT5&^DY1CH>G/PH?@LF+J,M121)*>55@Z?>8RBPT)`O`!-(U
M1>\U=+-=2C7/$R@FJ,TH^\.Z2O#+)>!PW"$F#9"E=JRXE?0+R;6+/#X
MA91<\UP%[CN$7QT<]X".GMOUP.L?`]^'%K/-/(DE((X#!5N6-,AU5^[$49T1
M(H0Z@1[#=DR1VF`Q@D5`"R]X%7J_QU&'-PC87&^2Z=FU1_II\/M-2DN*\%:7
M#@8!$'HK2-!ED<%Z]*82\!A4^?^ZXK)*+TR2R[70=U+4`:3-\65V;257N&/%
MTYBEE&XM&`E\+M)0#83F2=85AWRE?LI>*J392EX)RI[%)YE\=GIPJ"'!2P85
M+-T]J"2,*DHR7/Z(.XPJ1_4DA_-K;-_\$-'#E`M(ZG2P`=@!)D9P&`&L#I0(
MJ^"YJ#LG&D*`@5$I7&A9:&MQ/?\&FZ*"?:0`W
M!:\I#E6Q+W*%2^JD`?,.=AOX->_,T1%>4=F#<,:!E+JR_=V%(DDFX`:9J'\!
M1ZB$5,L2<5_6+U;`8P/B1D2ALY)``G59B\/X&O"2)+220*BS*DK:ET;)TJ:&
M%0T$F^E`$2C#3B&H(XW?L$I9^[,H%I%SD:*/?Z.#MF+@T]?QK]!3L\KJ47J3:0R5=85<>J>L^+,,
M)#Q,B4?Y_ZWLAC%ZM$UOD2+"DK9%&0BX27[XB%PJVW#_*1_**-'&-$F-5[7J
MV1,_B8]S6\9&Q/+36O.5A1C:0#J/)@0LVG:_J'B#0VY`21CTU8?XP="(M/ZD
MK!7MLE!$O,A)#[#B8Z`IK4$PD_9QW#X;M(]X@"/%SZ=H/["GTGOY?H/L^:,.
ME.-/.O>TY,?=;I.@\!IXHZM?*$'Z@T#XI6V`5N%O(FBKDH%?YO)+%H]-48QK
MG6?;A=[A:!4B,WB;8?*&HA0NLJNX7V9NE4CEZC:8D=GR80LANGQ[+E>YGA@!CS,TKZX#"V9Q32YW2_I;#@@!;
M/GXT:=9BPF[6J^K$]`"'JJXZ9M<.SZ"6V;0A5+KP=H0>L6L?;?&):VG475K6
M^3H<^RH>^RJM?1=Z??W[7'8]9;Q'R[/ZE;"GD>8_$`*0!^CWG]NR.R0,$1BE
MONWX.4W/R^.Q/>.$Q9=.I2<^U`T:BX1\?D,6O`$K9KI#V*V3;)W0S04"=[E?
M]I/&/WMR%'Y')TPI)9^OB_7F2BNLWKWX>I1O7GY2B]!*5CC%5T)ELT-/*FX]X(E4
M?KXR&[>));)Q>%69*G*]BNB+@B31Q=GD5)18_%`@SUCD*:%Q;Q8N"M_SFV.8VQ@$QZU1AH%
M0C=3;9*MRJ8';CW+57!E+T]B:E-T;3X^M*'$/+DDL206R
MW8,-%8Q-C($2079V^F[Y>25`P9`0(P4C`PN0()!M`F2;0]EF0+8E5'%`47YR
M<&I)M'Z`BYM^2&I%2:R='4"``0#SJ1GI#0IE;F1S=')E86T-96YD;V)J#3$R
M-"`P(&]B:@T\/"]#;VYT96YT::DO,,*32)*WL;V07^[U[JJMYD:P)@GVP3(ED74Y5
MG3K]ZCY5C?CEEU?O%\MK88M??WU]O?C;Q:MW*T=LZXO7ZXM7Z[4K'+%^NG!L
M*XGQC"WXRG,M7[B>%;@V[G^YL,46?^N,/@X7$S%=?Z9W;+=[!U>>'0K'L4*?
M7N!'9E9@>\+1G^OK"\NF_]G%Q/>,@9=.H]"S(I]]TJ/:SIOUA8='1!3$5A"+
MP/>$%;ED3W\W9OW;V[7WU?B>KE:/*Q6R[M;;1RW;OZQ6G:VAKJPU4"'>8I_#XKM
M$^@,BI,DT8]!"1/?\N(C4$+3!%;H)1Y[C`-3,(H>95BD^[Q)B^/H/,MV[`3F
MN^A.+5INX/A\_PACG83\MI?E)F]:)>L7B<\\RPU='4R8)'TPVH#C:D0_3N;U
MKDC+C9C.`BN8Y+7(6J5DV13_FLXBRYV(ITK)+*V;O-R*=+]7U;?\RQ0],4FG
M+NXWLG_RTG4"P??RHLBG_US_?N'Z:.O(,_$[;I"PVZH4GQ!]5K0;,GR=UXW*
M']LFK\I/4U$]B8S!$D<9(A:AS/GMNTBL)H=E(4*"PNE)3"8")3A73%`T!3^A&=>2W+G+#7V"B)I`PZ:987
M>9.C-CJ%]=]UQ&9L/0-(NH4#"B&8H+,$_I#S1N1E4^%#O$]5MM.17XFN'=&(
M926*JMS*KH\<5U.E`3WN7!@?2M3MXV>9(9U*I.?:1Q2Z`YQ)W@#U70Z?KR6?\ZI%+^9E6F9Z*I1*$2<;EU-W4C:U.*3U>%P<
M&A<>%IV.8[E)X/3I.!&G$X4NN]'SZ$\N/<\VEU^F25=``NC2LVTQ^@TXFJY'
M(4-".E4\`/0T@VOR,[Z/N\P.#;'8L0%4UGO`F3^;`0\GUG1FQ1.!&M&`7LL,
M*4=6,GD$AIYSQ;W75`1[#W^7;1!$`XEU_:'YG7R-9US/PZ7K"FX83N^OQLU,LGT'0\O[^_62[F:^P9
M,I'HEQ*\EECNZ(T1=Y_:=K#1_?C$NJ-98W+W]LBH&V(G_Z15-SD-F$TN/BS7
M"/CFR'#L6;'_DX;C$`-P&BYCL5CFUXGO0/"R!QUH%'S?87F8Y6(X8<2_SL:AS6R!J<@'G?I[0:
M,&/H>L-/WVNQJ$`>90T>PU5=%?DF;?"%&Y[0C@:R"HUASV'#;YD[,""K!F_Q
M&$FB#8QQ5I5@[,2#M;+$N_G\OAME]G,RR48BN&X_R5_;G$:+
M=SQ9CD!'2'U2IEO)WR5_;\Q#(-&73_\IS8\2G3DR9I0`MD*T68I?QPU1("`!GORP8KL\C31[->KD2=%L=;QF;.
M=+QN[U(`FN]K>IZ^D9<-6+&H:LTMI"NJDM8\[2%VHQ_L=DP48>J-5O$H6JZ??-=KE404=QV@SACEF
MD/52U\#&&E8#:EX2+\HK`4+4CLJJX4U'L0""BG-SK9@&IZ=@[G7\-Q1\I9?M
MK`#?;SID/DW8.K'NMJHV!Y"QCJ,"L(KV-_9>_ECTF],X.>G'J--'9H6R]4]3
MD+I.IJATDZ.MI'B4I7R"NJ@>BWRKIPZE1!2DTW2/)L`T_48%U@*D:KJ!\\)P
MV*=\1H)/UV>?%.^HCCH+Z%J9/Z>/U%>(J<)`$F)ZTM+Z$>A7]3!HVOY9918%
M;MI![:D+RIH4I7*T+`\WV7S'?[Q%.SY<+!4Q(E@=K2_$S5G
M*(,D,Y'$()V,!D;9Z-2PDOO&%$NK')M5#FHU+YI=U6YW/>$'21">]I\=16:4
M"?E0TVC0DVZH&SKH2->?/*:U85,?PUN+CF9#9@#DN8/VJ90&E)A.Y;+,Y-"C
M.H:3*L;=H`<#2S[C$$0:EN?8L`HT*GB%"CFF:T4S6>3R67,)KH4Z6T?3F=AU
M!EJ9UE69:G+0L]#V)XHL5UG+K5B#03+-UEG3ZLFHVP*98P**#9H9RT+]J)!F
MM7Z19@QX[CU*.NK7$F]2AHCHQCZ$]R\[0]MBXJ?X\^\::1Y!O/*S_;C-B*)DV-O&!IF?5VE:J,/
M!-`8&;J3CH^WE3#9Z%APWB.QD^WHG%0C^V?J*EG^^-Q[>DK@`P'.48!U(ZD;
M*;OGM&B9;AJ9[>KR/--JM=PR
M3V%Q#JQ)@>N+4=NB:1_;.B\E5B'UXQ(K:\.3"24)/8R1IX[LR-N'Z.>,/TX`
M6XU8544ZA/VAYR9JFX,/7O`,)ASR1('M>.>^;ES5#S%A+T3;@ZP$]<0!!"KK4D''64+9/1:I7;UJ.-!)%<%)$,\5NW.V?
MS>>V)IV%;9=3;7ZK#M@NB$VE!\T:@68-W[`&3W!@A6$8G>Q7T&Y6U
M]"P?]3RGTS.ZRSLTB69(-%30ZF:0:(1(3OR/\FK;4=N*HN\CY1_\Z$AA9(.O
MCS1#)#295!U(WPT033EVV^_H%W?MR_$-JJA/(0P^QWOOM=<%8U?U$PLC
M7!SYPNW\\5I:FKY\1J_X@TH:IPVEV8^RC[81DSQ:#!"9E2^/708=9BKG+P-M
M"%96PRBXG+P&($Z(L2=R7KA0_N1Q--B1_R01$)!`@Z[FS)ZZ8Y8XZ3.(]BI,
M(N46FAZU"[73'3T&]].WQL1&5<]Q1&\'1DGMQP]N]"]XY"5AIVJ\`&Y
M3SL&-VV9)A@^EZ*?F5=!"JPMKNIYP1`E]T.6W]+KU$XIXR@9F/:I!3L>$8#Z
M];/&@9;&JX.3%54D\M+72&CU>R^9?,]^D*V!0P`,J+?O,R]@1\1\RZC6.%:\*\E,4E7N6XVE>.0X5M@/5;7WAJ*KO&W7&A!M!LF#!RH_KJ6M[LNK.9X5
M)EV$Y=OOTG&092Y>'@&E$41`)#KU?#CU+@?HU!.>.IAN["7$W[A$E,5P8-/Z
ML[EJ?+TWYF!U[S6<9/Z-#//@V4\/T,#C-=6).?BN/Y^Y^R<=D+V+0N=U!QP:
M,X>6M$^7,PW?)]*\U(VZ(S60LE;-%4S^5AJK.V=;1^I9%+JJH\#!#"#%@A?[
M/]I2"!7/[8M+V>!<#)IVG&(?Q@Y`&@9UQQTS=^BPE'F4)'+T`=QSKB_ZOI\D
MZ!#MF[_1LB%JP7S`N35G6=%N"1=!,C5*.%Z)J3JTU'@J5,F]\UP\LE20L7#(
MR/Q_Q'_:,;!HM-0H15ZQ%M0
MR;:/A&Z`6G:\"$+G!:B'%(-VC86DJX"/FY1PDZP4
MLO:$?3[5YP..IL1F8,-;P8AMZOT[1L9%+/Q=L7\7/CB4?Y8'4)^]'[?">/$8
M9N2D_W?@"N<>6,J
MYU%XP6@!'&->C$RH$&C6+ZA;;1\^/*Q>/G]X^%>``0`OW==_#0IE;F1S=')E86T-96YD;V)J
M#3$R-B`P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O1FER,K0T4S!0L+'1=ZTH
M<0\N22Q)!;+=@PT5C$V,@1)!=G;Z;OEY)4#!D!`C!2,#"Y`@D&T"9)M#V69`
MMB54<4!1?G)P:DFT?H"+FWY(:D5)K)T=0(`!`/0+&>H-"F5N9'-T%LP
M(#`@-C$R(#0?YA'
MJI#H77)Y`X(`LLBF"FPI,.F'(N[#FEQ);&52Y<5.?R-?W-D+)5EVBAJPM")W
M9\YE9LBKK[SMX>/'J]O%,@$"GSY=)XL/UM7GC,*VLZYSZRK/7:"0;RQ*G#C"
M/03TRG,=!J[G^"[!^T\6@2W^YX7\>+%LF.1_RC/$'<_@RB,!4.H$3![06V:.
M3SR@ZC-/+(?([\*R&3,!WB8-`\\)F>X*#?)GF2V!&'1II6#/$19C,A@L:*8;S[+>;^2J!Y6KA@%PL
MUJML?;-,YGF:0'9_G2V3Y?QNF68`*K:.&++X&-$=(P8JXNU\-?^_9BT#@._UN4(&:.%_T_
M4>A(P5=IEWEZ"\P!*49^M[[)%/BO=^M%FMS?I6_A8S5XL2?#!G'LFQ(@L8I*
MF5+ZF_U@\X<)3&8^H_:\DPO'MYN-6?0[85:B+@$ORPL'T59-"47S+"9_Y%\L
MZB.]F")13/'-;D4)C_],9J'CV;B_ZN#O`7M!M/OQ8BL.3=M/8=[M]ER'0%7P
M3X>0E*E!&1J8=3F%H2Y%JQ!T`V)XKKJJJ8$CL)>JWZD;*MC,C1PWQ-)3[D6&
M.8M]'>J`8*JB.O!>'D=.5=_!TP2+U>83UW'MFF^%_BWT;X1:U2-.9=&($YM.
M><28"5[LA[*JMYI:7?Z0XKEV!XM=)3:0?A?%T%?/`M:;356(5@=%44*L4Z.?
M8B0QZ3._5C6OBXKOQS-3P]+#SO9I_)HE(;Y6CLH.D(C$,]\/O$=3I$!BLQ&%
M1%"+KI/DSX%Z"+2LNF+?=$,KT."Z5ZEP%%&/TC?N$$9UCK;9CZ4CP>O5H6T*
M46*@\=9A:+N!USWT#=P->P'4XS/J/]B/6('JG';/9'OMWIB*^N7Q#&;0/@W[
MK6)XJI`,A6ZKOL+DZ?=BQ^NM@'DQLF&RJ8W.+`41P8IH)]*@G$,&VM1.T#?M'8NYWK1"J,UT;D>XZ
M4+9`(@JAKSZB9AZ=`CXGR52>,3(A.=\++KL44QH/A$9<-]!5V[I"@659ZC+I
ML-??M&]5X_RJT8V3U2CZI4":&8E<9H:!UA=P4+:P.3JJQQ^RG$+3RFR-1`X;
M7O1-VTVU-_U.4W'E$/0O6X^$@1F,Z&]38*W+J5N>M#N;T:=Y3-^;QWC1D#*I
MWI\GGADG&KPN+%5L3Y/0B7!RHLDV!D6".FZ(@TQ5A"@53XZ"MX)W3WPP-;(P5-KX55I_3#L]FGAFW^C(D;%*_)KQ
M^-@ERD7[9^8=J]S!ARP[+_++5X7\E],[PP
M,K0T5S!0L+'1=ZTH<0\N22Q)!;+=@PT5C$V,@1)!=G;Z;OEY)4#!D!`C!2,#
M"Y`@D&T"9)M#%004Y2<'IY9$ZP>XN.F'I%:4Q-K9`008`.H!%V$-"F5N9'-T
M%LP(#`@-C$R(#<>_K-?=YT[(//ND;/G]N*G
MY<6;Y=)GG"TW%SQP/1_?\9A^"GPW9$D$5]>1G"?.YF_CT@OZ*&V21S^:NY^&4ZPO\#.@0)XSHKX@>FNANENJ3Z$''
M#F*7ASHVO6)#VB^J)Y\G;AJSQ(]<7X6E4%Y(+^"!IRK9^\7#DMW>LN_LT_+]
MS0.[_?CVT\/=8GG[Z2-CZM@YQ_L1HLU]-PA1AL[5X_:@0!UTN[RY0X:,?;AY
MM_C`[A\^7=W<7-]^?/=HSN%N'&0!FW.7)V%&IQSW;&RXI[X6!396:F)1I_87
MOSC+K6";NBSKO:R>F6Q9SM:B+1JYZV1=L7K#%NVVS*OU[[-YY+3LVRQUN9//
M?*<3CS4N8K6>)8
MT;)-4^LR6%'F4C^VJ(CE):JA/NR$JL`/W"`E("#4+T[3UA5*E=77OOGW;)ZX
M(0[(^Q;YKNQG\=NN;OM&L%GD1@[BJI^YJ<_5'_7_CWVQU8V:`U>>G^B)1FET
MV"7NQUQ79K/U*5M*OQ%M7W9HOOEUWLA291(XMDA4):NUT(_5#!%21VYDH9M;
MKTK3YY;9BJ.(9[IDUT*3^Q8N/=T^EYV
M6]8!8&U>"H+2@RR%R@]9FLDH@
M?YR3$[K7?8''JJ:/(P>J?I,7'>;=4'FF)'/V44F)A7RB:[*8N&2R:VE&?=LI
M0JUJY-&TU,@NEQ70U=(D'3&#:@&CEBN%K22.N3\.++!Q#&CT*03J0@$B=G9U
M)2K$1%6OJ]*.I@-*#$*#1K2ZM)(Y%&/+8W$0L<(=`SPM:W_)\DA
MVY..-49=0+_0V0G#YP&(08PJSE(P"()4AQS)#XJ5^;[M]?1>Z_)5]?B8HONM
M!,T[\\H.Q"L'BH*NXPSCY+C0(`A]';45TW)(I%#%(#4HW);(-G)%V!F_#8D@
MBEIDJCB'-7*S?H+4"*BHBGP'85&]VLF=8"2G75Z]F,XI-J!L]4D7J`)@2\99
M.)9A=@WJT`?O!;)MZW*BEX`BC=ZBY7=-8'58Z(:A'X^GQ?8T(T53AM/`J0U`
M`-6=.9)RGY!*-P`;GP=Q?-P`RQB3)LTO('ICBLV+Z`;LCWMWBOS0[I_L?=PQJ-."?&DD0$(T&
M7()N-Q8)H1L%*/P\$I1]HG@[H`=2H=\'F#5W<4H-]BAX8)"J,T!6Y$VH>JAV
MCN4VO6M[X@ZN"(K"O6-%L]5J2_&.B:P%=*]64C>A#JM1JL/!1
M)N$XH\S"IX%O:H1QJ3Q?Q+(NBVLT+]ZF'0+!9]T`:NT`__86]T]Z!'WYI_/N+C(1PM7'S>PO%HM*]/#LZ(ZR#_F>/4J:PG=;O@T?
MNUZ,[I[(6FI8R;Z0*5)&Y\H82[4Z,V!LBV'*5\%L<[0W41UZ$"TV<2LNC]_"
M*Q,@4_=/D:-N#TH2*G++&KI65!?8A@`>SU)/J5!K/*XJMU7EDO!<#JS,M?R$
M+N=A>D*9,#.%3@6-N)`K1V(W^$I,5_'76E:=CBY>(1:EWA;E--7(&>5(13XH
MT3=1-Z1::F)%*?*JW]E/==NUQR[TV'W:90F:BKQ%WNC+UCI=#CD?J_5UM;Y=
M@_E_H`]UKVX1:%I5""6QK0+)?DN[3'9L"Z.X$K##<%)5!V>-8'D[F@H5XXCT
MD0&0]4HY^V,'`<#KUAPD:G$3/.0*UGD'[IK?_XF>XZ]/SOW#_=.,+*VJ237W
M6A1":_Y*V(62)7[RUQNY80&_9#[D=P*&Z9BW.0D_X7CJFT*H0Z3<
MD-X7[74K+/Y5KP69($3T),CH5MF6B9&7ON'E,#H*.*V+\\BW+O`5ZF]OJ*CE
M#0)8=`(C,`FX0"#WKA%Y9PY7?A"/,.B6@5Y"^AGBA'B"84FS@
MUOOG;8>F%&6_1NU'$%#CP#OJKFJ63$6.Q<+[X#Z0V.@&W3A=EI8^5%2UWN/E
MYA)A:&4YJQZ0,A!0)-Z!54P+_^"L3)2_J918,U*49&YM\IW-B9<2%P64`[53
M0)94M3:2L0L]&Z6'&Q#YB3]L8,J_!,?F2)Y.A4W4/^I*=A`W3!?I#EICCDW"
M]/1ZXZ=\L&]`/1JK':_:/33?B1C86PWHG`0G=`Z-/3/G]66G[D:)0YC7/201
MJ>H.4@NG5G0Y[1J]-EO<+FCE3>U@;.W8F5N0-I]!&!HJ/SD^&#GC?H2`=Q1[
M?H<8.3MTB7`^.U@"!&*W!W+SG1VY,#]V?1[8,03#[KRM#&`7V!*F!#@89;)=);O<>ORF#431?:3\`XLN0I4@/_`8
MUFFD=D$64=1NNC'@@EL74]N0J)_1+^ZYCQF/;5I%BA0>9NZ<^SCGW,@60]2A
M5Q'^:.VT@271ED0W$I82.]'/[[U]+EX8+TF8QT]>?A;"^?"*&#'FQ'6%\>V%
M;YR#6J#CQVR\T/0P]F-=G>'TM@3>9GZF1!C.P(-=%4-[P5C9G!BI#_QTV!";
MYK;GXF06QL8,"R5-3PN`$"I,$V-QIA@D=7"MKWEFGCIG=4$6?63C!+*&"_J4
MB$#:=R4R]^M4U+D0(PVH06\3O3JU5ZL&]#VK%D9Z5J0R@#OL,EHUT+^'?%>U
MA9_]N]C(QGN1;\)DJ:2,1
MZ*8OO8F-H\4J2,JSICHPYZ/8:])[J%^[%YW1*'9>.`HNTUX0QU2E0ATS`]9R4.7OVYR:`/0O0N#X!:WE:[NRF^KV6<1;6!C-'>C
MW9(W0LZHO*25BJTQOP-HB].NLH*RV3-,$L:U\U/)18I1E\%U%(HA2Y'!'.$D
MNCF"J(]\LY)RJ0(Z#RH:?YU.G[][.A@226L2`GH2..4!/70V)Q(?"LI\KDGZ
MF+64=#BKW:TJYVH:@ZR+:7#3-`7^CL="OWE$%V\\:_BYJ$J9[&]U]7,B/_S`
M;8@V'6OV?!9'Z7*T?L[GL1/O1Q"$9&U-FK8DH]L1VZKHKM2ID-C/0]M)N0G&
MK*)2OHQ5RIVU=;+%HCR4+4.RM6(]PNPW)]IW)YH(3H&SMF&:C*`MK;>UB?)X
M]`]:ZN5N4U8-SNS5P8?9F5HZ?X!)6CX,K'!VK7M!T.P<8/CRG9`'9CN;-+"D
M]$-1'7;<\K+.>>`LP#A-+3YK"\A>9`T83LWH(-(^VV)DL`-"J6M:`V2IV6>_
MLWI+/.W`T=D];&XI>H'%S_F.8%,FP19,U?H6BI8!+S`J1D->G0@<`SF2#:?G
MB0Y%C^7_V8%+%V;JAX`3S*<<>5*,![D'H>7V6+^EN3SDKG%UYX1&@
MEB9A^K%8.50/;+Q0L';'!!V_5/4/*A+S%?4?M4Z3MRWQ\QX/>-RB%9LS+ETU
M(4Z>-L>JS9'GYVA)RU];"ZK9G]IM]2(XL+Q4%%WV.\,V+_$WO-YJR;$NMV::
M)".B&;0)F)#Q[=$<\!M'GH>.*"=JZ\`>811$0RKK/*HD9V!+9<1%7*P-E<\*
MNRF0WC1L,*S>^/)9-)U!YO@7<08FT!+^5T:E;)ZZH+QEZ310_)_M65O)<&G2
MKI(2SF;5P8INWJ";/46,9$PF3@5M-3G>`*42-&ND]MZ<>@_I9!A]C>Q]_4_A
M>WB^NKYZ6-U?7_T58`"""_VF#0IE;F1S=')E86T-96YD;V)J#3$S,B`P(&]B
M:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O1FER%LP(#`@
M-C$R(#?7U\M+DZ9PW[YY>1T\>KH]:]+E]TU1R>KH]>KE<=<
MMMH'C'8>K*]^R`Q5%H^Q%;?3QRV!W^K3+Z>3RRV&3UGR/7Z3^15UX2
M,\^U8X\^4*_8?A)Z;&H[#JR<'N&O3T:L(**G\!YI[XZ=S(PI7$4S\N[%=AR0
M,7SG)/2A[?BSF"+XW;JU@ML)FTS=F6/[UF75B4:D97K,KD335%TMV%S4[*)L
M=CQK156RM,S9-2_3HOV#S9N&-\U'7K;L_VSR[]7;/22\R)Z%<8)85,2NISW[
MRO%%":^A'5B>X\3'K-UR]L_EV?6<9569=UG+<[AB8G`L[4\]I)3$/INZMAO.
M0FU?V:&D=G5%3LCN)LU$(=H_)M,8"+!-52M7GF]'
M03#K$W!"XR-03K+JXR2V9]9N,O5LSRK@(N/L4;1;FWK-3WNZA
M-PGMT+KANU34)BGM:I14K!`+`NVPYG==D9*=QF9]@LI>TZT;_JE#*0J926BI
M^[M:NG!Q[7CQRVJ89*H'D1/D>2[(05H`>D#Q<3*#$>F3M96JDC'X')W8&$R4
M05E+4;*:-SL$S.ES6+/2B6LG5MORNF%P6;9B(^!8`>$#@"`.1T"88#T\D;9S
ME+"\D]'L$20KJH9/JZYE*FK.6[P%I$"UMYV$Q6*>XSK'.@?`[KK[.!:Z@,J;$KEV""5G.]4G5(_`&FHM
MG>ZGZ'J.)FZJ.DK9A$$`R)\RW"*'?W,=YQAA$I0H5$VWTZ+@=W#U("I-#95:
M1'#Y.C77#777V3H=M.ZVH&A%PQZK^I[@E,Q5/;CG@$#6D6N;(Y9&$C0O\EV=
M`D74L_1?6U&@2BTYJGG:@%KK0ELD#GG^`'^B+7D:#$2QYH7@#R#/-FWQ(S3;
M"2`/5/(`$U%)WJ@*=T
MOVJX3_#SG/#1%(5(SZ"G(Q0TOJ9$2M!Z+PSBL.Y5QK44UM0:X*YJ+*$+Y]C!
MS-&R^;LEJ1S(3'V5:;.56995"W">/^8UN8(U75S`;T39#`A(7!AZROIX$`W:
M/?4CVTVBF)*,G2`9]>',TZ4^AU9^33$@6&DML>/E@ZBK4C=FV>)M_2)"#RBS
M7G-]?Q@:3F`\:E6!:!!K@1RO'WASC";D[#U@9E?$@8"47_[]+]ULU#40D7\7
MF"R\;'JU\4(;?/8.SQ(E^.03GS55(?*49M*Y*"'SA/.RQ0U%1"34_(]Z53+T
M4X=]@=>%F2@UWU58((#'N8('K'*=Z3]0GKX^,UT?I)^H#L/%H2(Y7Q@2\@(O
M?0#O:AK0$O9+%*!@UW6E.=RP4:6I3Q*C$V-?4_,4+J,D&;N,33-!7PT+S)`8
M*WW.FZP6:Y[+QJC19OCWD-:BZAH];CU5C+$8QVZDQVV1"B6,#<3VF!7I8].)
M5A$BS=4C,9GBMQ1-6X.":.?=7NX[C4HOQ(GK1<_QI.90\[!&H!`L-##)_EV*
M0=/VJBF5$ZZSKJZYUGW-?>@VFM2P.8;I\08!)YI9F-DB%T"!DU0NNVS+4CG+
M&HG/,Y&0"J>8'/:KA_KE`#JV:LG*/C?I>31'E?LHU,U$X?JR`SU5IF.S%SW7
M*T*[K9Y$AM_ZP+.]YO9U"X5J=4M@%\3F0G4UZP1-
M3%+Y70WZ9JTKLROFSN'@YF+YCIW/%ZL/-TOV0FEZ6_M2HD>^J[$Y58N=JH.<
MH)AI50ZL'B`:.5L;395"JX35*,HC_9B^59%PBV3,S@S/;
MIB6(Q#9UI9Y*):M%#*R?!.TH^<;_`%(M,;)$]K]!JMZ4N^:_7FN4;[^-@W:+'M)\H`
MMAG?/USER`0_&ZHW!>OL:2O6I,[LN5O(7$BOJ'>U&`:)WO7A$Z7`&P!Z
MN84&;*LBAQ)]UFROY$6
MS>BZ*#-[.(::N_(_%Q"DNL3<5!Q*T*E&O.%&+^5RTWL#;&BD'DMSF``X$V5R
MWKY'IVJ_$Z*?M4=/';TVO!^\'P2Z1VZM75/>6NO;R:WE
MW4[H,'3#[SIUXF'+Z;MCLSS+D6Z69VZ80"D"79YW!1I<[RBC*AMD7RX%?2EB1!#?]+0OX#EKP[3@%+WG1S\XTNA^V,`N6`FSAOW[E).=L.1RJ*O_^)AX\D*=+=1@ZG%V
M$?"W3A#+M%ZG)6^F'YX*;JHWQYH%BQX&:H_-`>SW%NYD@,J34`7$M1%4E^FP
M>]?LRB;\ZQK0(TGI&3Q"[""
M'P)+'QG=GEB2NMX,JG.85G%/*U+ZP/H"N5ZB<"S[^E(;(<@C0"XI`MSE7PD^
M/57PZWMD6*9@,O@:*M9PY/Q&(5`#N>)A=XF]>"BI:^SIP2`+E<`Z[!Q&W/T"
MXK1TTL0=03XNH^NX]L7[Y4\`W@M\F@*_G=Q<8E;0/HTI=EIEW;#HENU(&URS
M83K>8&^Y>"/M@9KH'FEOE3Y5I12CT**P+50+Y[5&SH1LR]43.M^`0<9G2#YQ
MXZ77,4SD=3&_5%X#WV0Q>`TL`];@=Y$6F9E+EZ*\7Z?-D&\@??O?F?'IV;GT
MC77JV_F>\HTHQ6&W/Y;RY?SDQU*^3->\^-YDE8_KFS/IPW-HB_X.']`#0IE;F1S=')E86T-96YD;V)J#3$S-2`P
M(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O1FER7!E+T]B:E-T;3X^M*'$/+DDL
M206RW8,-%8Q-C($2079V^F[Y>25`P9`00P,%(T,CD"B08Z1@9&`!99L`V>90
MMAF0;0EE6P#5&T!-"2C*3PY.+8G6#W!QTP])K2B)M;,#"#``?0H?(`T*96YD
M%LP(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-,3,W(#`@;V)J#3P\+T9I
M;'1E&%EM50U2P_)EVZP;@[L%F![,MM$PJ%V/
MQ9&#PO\*GOJV[9^;V9_EQR"*6+K(8X1#RM_";@-U7XT_9CD3H>J,QN#!_9/&
M($+3P1\W#Y_@,5R^&-7I9MTJN!EUTRFMP::<1PF+>);!7#"1YJDO!B\L;5[D
MN:/]8%DU"/E)=IM1;M3C[#?`S,WC#%9&&D7`D:/1/\%MW^F^;6I)/";R289U
MX1Y">(0X=@CW7=53CCA4LP@SP6R>LB1$27Y%U9A6@U+@@OO.;#6HKD:<.U4I
M=W6M!HC%%41<<)!=/8GU'"Z+S2/?HRE/=)2'%V](+XN_?FH,<"7=03B\SK(=[_
MIT\KTU=_;?NV5H/^=S9/6!'"\N^Q,?\X63'ZN(@/LK()9^%P2(T7V]8;]6(8
M%3\)W??7<="C=%E1(=KU4*7$9^6>8F=(U,.(`R7ABY+R/:C-V$K3]!VLYN65
M5XSC>E%@<<\D9]/I]S2I:?>=48.L3/-3P9TT$@6W6#S,=SPG:3#6RKFHAJXW
M\(1AKK4I$WF:3_.Q!G3#CIXTR$[B8-TTV@R.H3YRH@T;>KU3E1F]+>W8<2WS
M22_V3*2%X[\;AUVOD:TS![G:+E:8$_&FZT),`9.W1'2^99IS=O,X-*;9IWU?
M62T"A^85-5-.LQ_=?754&;IVJ$UMC\6>(0&1LO+UL5^2)')*/&,_:M&L;D&&
M06)'E,CDRY=JB\\#!0=FB67F^I%@WC@['QB(Y0>3=!UP[#%=CQ##82U@Q'W#X2EFD!'-WGR3$!*$@*A*B\#M2^F#XZSCK1*'
MKFWU\O6=]=H$**7J0Y)Q/#[GS)FSGET7IH.CH]G5_/(,*!P?GY[-#[S9Q2V#
M=>N=YMXLSSDPR"N/"4(Y]E!PE>!$0A)'1,20;ST*:_SDI?WZ[OD0Y%\]1A\>
M&2J>)<`92;A]P+40D44<0D(IHIQY^"LLB"]3>Q?9Y7%^]/\H\W"Q@AQ@$XR;`=0D98)"S9(-?)"#FU-V*1B5&&U5-B
MP7EL!_KL7_>F[8NF@VX'7:W`J&^]-FH;)"3S5`QI&6JBXV%2PMFS]H&I!91.(TC?;C,(?4-RME1@1L-JIO$-6IC=$K
M*/JNWAG]2ZT(P*AR`ANV@[_3>AZE*7^S+\C`A@-@<^IH$2ED"<=P,FP+$X0C
ML7_2UINB05>P$7VY;$KB&!>YQ^,8(QR+E*`M7$@@D:14XF:]RF;_>>8B2FV_
MI"C5TF__D!B*C`@IQ>,QK#-RU)K)E[6F4>K?^?M-WP5.)$[Z#Q>F#`UYM=#G
M:FGZPDS)X(?`*6.6CZ89);C`63M[5VR#%+D+`U<$YO5XN<2]86?&.(G\9S:A
MSP0YG$TB0SM>MRE*,Y+^OTJ5PF-F\S*OM:K@7#=%4^IB`Q^J"IO,$X;G
MUK_$<.?C(1H/T/AJ>'2@+1,>YWNCD>4>:9[@OY::ZD'9F.R=$_A*GED3K![BXZ8>D5I3$
MVMD!!!@`Y4874PT*96YD%LP
M(#`@-C$R(#7!E+U!A9V4^/@UE;F1O8FH-
M,30S(#`@;V)J#3P\+T9I;'1E&9L;54)DK2$IE"1/%0J^^`D
M$^*M:V=MI[!_H[]W'_;.AYT0`K3=U2)!!L=S[[GGG'O'/OF8E#5Z_?KD0W\T
M0`2]>7,VZ+_JG+R;4'1;=I._^A0TFZQ*Q8KQ"A6S&QPMV`>"X9ZF!"(,NC`)S=!@C`V
MWT+VT&,CVR7W"?UN=%"%T6&/Z:
M6X;3CHR`)QDI+*7A3$F$!8^AA%)WEH;B_=(H@<02ML2PT1+U'_X,=#4OTW6=
M%OF/;C%U<(XC#A(13]7=\ZA\Z93)IO*0<1R_5+D(8[BI+=Q*XM3HA0!`,+$K
M2K`K`K4B4"6L")\#2E`7-A$93%9)J5=%MM!E]1TN"BR"T]M2ZZ]=4";0>>TO
MSO[J]A2F`4KR!9KI^D[K'$VZOT\O.BS$C`M7O5%:-MFDR_;WHM=?04"%XR#5
MZ/1+G>K\5E^WANT"$RN&]++Y9AF4PZ\*M0'3I>>;D
MV*\8L3*9Y4VPWI35)@$UZ@*-:K\724)O@ME-]R9@-UU4+)N"%(.,>Q41T:B/
MKO7M)K/UH$GO/93@VK:RI($D>K')=&52.1&:B`=%D"QV8>N51@_MU!J).B.9
M4E:)8[B.6#*[9T(4)PH*TKO7BMZ?@WJ59!LYLC.-C[@E!
MFW'DC5-MUNML:_8DRQJ?K\OB6[K0"T.#+6W81YLU4%;J/S>ZJF^Z=HS99##F
MF8IW<^T/S!X."?3P85OXX0A]R4Q?AA'!4=`OG,CK3>VD*I;HVJS,8IB4N3&A
M`?4?6`>>JK%!)V_C\$-@\8.1'C=.&""M!PDQCSHZ[).E^D\J;5)=)$X
MZH'?"XRNOI^5T+O'D"W5@.)>SS=@_68**":C5D3:'#C"BAAH=+6$N&!T"-MT
MYJZM)Z:-H$X.9R'<8EF#]H^C>+^=O//%#<'WXT,AI9A!*8%9''PZNQ[#D5G5]J`>%/.-
MGRQ=!N,VKU^>7(_')629],]M%J4$.,@FF2;W1>ZG)S`CX3I8H=9Y94^\^A]$_'#HH=I#\`I>_ZWK0H@U/T<-]_#K)YUB[C7AGA'QF2(&P[>V"'B@!$VKY_0[`":'L=,1>HY
MR1[?<<`I1T>3SS?L/XS!R0H.J>8&%UYQ7G>&'_JO./P(,`*(WP5T-"F5N9'-T
MGED3K![BXZ8>D5I3$VMD!!!@`Y9P75`T*96YD7!E+T]B:E-T;3X^D6-MC*:$([*'WP4I,8'+O8+EO__704RU(N
MSG+IRXI0=#FZ''W?9QV%8H8PHIB;K$P6B'%H2R0TMGVQ%*;4B'`%`V)$*3$_
MQ%AC8J81@A@C9@RAB`F)T>5E-*QG:=&@&(OH.GG^DF;S18,(QCCZE*Y,`S,O
M&N?)O$:,1N.R:$:C\L_#0)K=!HS"EAC#%/EHK>-DF>6O'X95EN0?;<]-LDPC
MV_X^M1V3IDJ;V2*Z*:MEDMNN^]7.W&S\M4GR;#8LYGF*<#1ITN4=TCJ:OCZG
M=B@X5F7/35E%/P.'KZ[,<49)G<*8;KO/Q:Q\RHIY=)\5PZ+.NO8XJ^KF>I%4
M[E1^67,B@/HV^I;X(9.77PUX,*U>4NM*YX]9^JE9U`]4Z4?K1(NICLD>3&6+
M::P#3'FL#::&2D(H8$K9&J;3;)G6Z";]C6[+95($Z%J+,=C^'Y/!"L.CX1X0
MT0*NR(7B]$C0>[TXD06QS@*AY!`:!$9]B3'6U@3VN3])\\F87ZFZ'D5IMXH0
M$N$#D]N+<]Z5OM=(QV;<_JY[QW1L,]C\7%L^[B=@5.9/I\+/N-R`7^"3X`>X
M'&1@A3J4VT=='==3XNGRX`,94+HZ4*3,2I`!)&QK8(D-3'8DM-THTP;:PE5`
MQUUC!VMFN&6M+<$IU]\>H:UIL)BZLW8S@+_`9IT(]("/2FL:WL__Z=3S=>JI
MH$=1#R<#-)3%QPG`GEGR+1%L2J`O^Z]D4Q".3J`94'9LVIT-^LZFV[J3@9MO
M)0$2:6U..IO8AU^O*[N3!1ZZNMIQ.N=3>/+S%0&S_)T"*=88O8?T3Y6_=9@Y
M5NS[[KGM8+,OX/APXP2[ZMD,.O!IA:,ZZ>-PG<."4"A#)U_7'\JRD^^.8`2^
M>`&><9V]"\$>*EL(SF=*U_(='&TKO#N=&)U(_7MJ
MUPW;+]3MN!O:&E^E_^&/T58`!/IIXX#0IE;F1S=')E86T-96YD;V)J#3$T-B`P(&]B:@T\
M/"]&:6QT97(O1FQA=&5$96-O9&4O1FER^(O39@3]_Q2BK>0]3
MKV.2K($Z0RT5,N=SU+43(-50AU`467$56=Z`IDR^&,G6%"RJ^6.FMC.60B/SX*/'@Z>&UP;65T
M82!X;6QN#IX;7!T:STB061O8F4@6$U0
M($-O&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT
M"UD
M969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M(#$P+5$@,3(M,3`@340F86UP.T$N
M9&]C/"]R9&8Z;&D^"B`@("`@("`@("`@(#PO&UP34TZ26YS=&%N8V5)1#YU=6ED.CDQ.&5E-6(P+3!A,3$M-&8U,2TX-#0U
M+3AE.&4U.#5F9F(U9#PO>&UP34TZ26YS=&%N8V5)1#X*("`@("`@/"]R9&8Z
M1&5S8W)I<'1I;VX^"B`@(#PO'!A
M8VME="!E;F0](G(B/SX-"F5N9'-TFMC.60B/SX*/'@Z>&UP;65T82!X;6QN#IX;7!T:STB061O8F4@6$U0($-O&%P+S$N,"\B/@H@("`@("`@("`\>&UP.D-R96%T;W)4;V]L
M/E!38W)I<'0U+F1L;"!697)S:6]N(#4N,BXR/"]X;7`Z0W)E871O&UL;G,Z9&,](FAT='`Z
M+R]P=7)L+F]R9R]D8R]E;&5M96YT"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M
M(#$P+5$@,3(M,3`@1FEN86YC:6%L&UP;65T83X*/#]X<&%C:V5T(&5N9#TB7!E+T]B:E-T;3X^'N*>6(
M>Z!4-"Y2JA[W1-D)[IDR,^Z%,A@BP.$2[RA[\#P##YX7RA$\[RDG\'R@K-_U
MD7(!SX-7P?.9B@,/[Q8&SU?`%3R6"%P*5!%Z(5#)X
M>%8*>/AVJ>"%0M6!%RKNX$5'5?.-3!4Y2!2JF(-$3Q4,B8$J+@&[)O`P]YK!
M@S>U@!?!J^!%\"IX"?XY!V!B"`8Q"01L$KS.#GD*YL<.$Q48P`Y?$CC,#H&2
M,D0&-Q6(`G"J*D#.2JX@XS$S?!/,@[W&(%&.%=^"DYQ@L6"I."4=`=D6*(.<
MU;$,Z.#I=UE509T3M5NMU;:7:7L$?W3Q>C:JZ^NI&U>V@Z51=3]9@76"L
MC%C:#L_5XHI/>(/B$UXW2:TZ(KB\_<$%1[W#8ZP!1(3P.H*+LXYD\J+_809>
M-Y/'9O#J%MX@[[&5[?)!1P#U14=`UHEY!EDGYAGD4'0$5Q0=`3G"EB=/5L^L
MJAR]6%VO#[N[^=5AM[,*^W3H^>[/^=GN`X6Z>O7A_6[UX#5;?=Q_65T#7HST@6:QSQ_>W=\XJV!]@:V&[56K8E7>ZEC5
M4LFJHM6RJF35K"I;/:LJ5M&JEIHVLK.R-LE6V2;%BMNDM_HVN92XR6A5;C)9
MH9O,5NLFBY6[R:7B;?;.BMXD6]V;%"M]D]ZJW^32`$Q&ZP$FD[6!Q47K!":+
M-0.32S\PAYRU!)-L7<&D6&,PZ:TWF%S:@\EH'<)DLB9A,EN?,%FL59A)HOU#]TO%Q@B=I&ZR%V4+CJ9.YD[F3N9.YD[F3N9.YD[F3N9.UDZ63I9&EG[
MQ2*R[R)T$;MXC,E=E"[:)[0/-L%=]$^43BZ=7#JY='+IY-+)I9-K)]=.KH^3
M[^3:R?5QSLM;UDF<%OQ2^ZOKWU!/TFH??62I^Q_OWDYV)NCXLVX&-2^H64'-
M"6I&4/.!F@W47*!F`C4/J%E`S0%J!E#+GUKZU+*GECRUW*FE3BUS:HE3RYM:
MVM2S7EWMYO5V/:^1:U[2?FRG'V7]]&'^?3J&UZY>;P_[]',^WM[?T\^YPCS':?NPV1U.GFX.TZ_KF2[W]_/^]G9WH'KNSAV].7F]O]M.?]R_.3U=
MO=K/M[N3JSUB[Z>W,[V>#ELZ0Q,]^PD]\PR%.0/`SAI>$-8OP1,>F(F+'#S')$3#PB
M9FPR"Q\1$XZ(.<)G?X3/_@B?_1$^^__RN6T(W>SNWYMD+;U)UG86NW[LMS/?
MM0/?M=/>M:/>M7/>M4/>M1/>M>/=-1XW'O??$(W'C<>-QXW'C<>-QXW'C2>-
MUW[4^?Z3KAU]'S?+\O7-,N%'5_C:9ODIY/]NEC_L[]9WF_WZ]OZSEOGW^GL?
MAWN$AQ%AO,_&7W'C$#\.2>.0<56(C$/&ODD9AOBQMWYLKA^[&\;NAK&[8>QN
M&+L;/W7W+P$&`%!&W,@-"F5N9'-T7!E+T]B:E-T;3X^XK,0F$+&!SB1-8V8O[8[03A'3GP&>2P3`IL`A31AJG`N%G%1(8M=(*
M)H>6-'`G/Q#C6QOY?EZM_9(\)8O,29B3]"&W``,`P4XOD`T*96YDG)E4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM
M;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!9&]B92!835`@0V]R
M92`T+C(N,2UC,#0Q(#4R+C,T,CDY-BP@,C`P."\P-2\P-RTR,#HT.#HP,"`@
M("`@("`@(CX*("`@/')D9CI21$8@>&UL;G,Z&UL;G,Z>&UP
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(CX*("`@("`@("`@/'AM
M<#I-;V1I9GE$871E/C(P,3$M,#(M,#%4,34Z,S8Z,S,M,#4Z,#`\+WAM<#I-
M;V1I9GE$871E/@H@("`@("`@("`\>&UP.D-R96%T941A=&4^,C`Q,2TP,2TS
M,50Q-SHR,#HU-2TP-3HP,#PO>&UP.D-R96%T941A=&4^"B`@("`@("`@(#QX
M;7`Z365T861A=&%$871E/C(P,3$M,#(M,#%4,34Z,S8Z,S,M,#4Z,#`\+WAM
M<#I-971A9&%T841A=&4^"B`@("`@("`@(#QX;7`Z0W)E871O&UL.FQA;F<](G@M9&5F875L="(^36EC&UP34TZ26YS=&%N8V5)1#YU=6ED.F4X8SAC
M,3$X+3%D-38M-#$Q-BTY.3=E+3(T.3AD9#-F-F1C-CPO>&UP34TZ26YS=&%N
M8V5)1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@("`@(#QR9&8Z1&5S
M8W)I<'1I;VX@#IX;7!M971A/@H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@"CP_
M>'!A8VME="!E;F0](GV
M",K"U^GE]W.>=L?S?-EN;^G"D:Y(7?<2FI`KB!$%4"KH2`EP-.R.7W//U/7\
M^_\+'7U76?1I'`V-QL-Q!CN#G<'.8>?C=@Z[#+L,NPR[,F`7HRNP*[`KL*NP
MJ[CWBL:&QH;&5H;-A6-<'//B&!BC522-9TJ\#8&D)`E:\`%/O3ZK\-3PU/"T
M^YY_`@P`^!G2_@T*96YD>]`X3M=MS?^XU%1<0PN4F/!RFQ$R]S[$7-3PZM
M1>NMG1R&,(&Y^K34[O2:ASQY,KA7>B[2UA&"<<7H\MQS?JM:@CK6[CCPYGE@P#6!Q>
MP+K!(CS3$I=$L3:3.>G=[EN``0`2I$+=#0IE;F1S=')E86T-96YD;V)J#3$U
M-"`P(&]B:@T\/"]$96-O9&5087)M7!E+UA2968O5ULQ(#,@,5T^/G-T_#J>'7\Z]-TE3&=B/%,'D2B`CMV]5C\-7K0H0
M58:O4J8P`7(+/;!JMN!KR#C2YD3O)3+O"?*:J,IYLPZM]B_"WR$#4AH&>:1,
M\80RCI2^D"!NY]EGC'S?);9@?=F%7>]Z<=6
M^X;@'Y`$47,@]Y11[M?QB`$13U1EGD&:1/22=R[7YQN^X65.X1N4T0,\T_,)
M



XML
17
R19.xml
IDEA: EMPLOYEE BENEFIT PLANS


2.2.0.25falsefalse006120 - Disclosure - EMPLOYEE BENEFIT PLANStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE L &#8211; EMPLOYEE BENEFIT PLANS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">For the three months ended December 31, 2010, Ashland contributed $5 million to the U.S. benefit plans and $3&#160;million to the non-U.S. benefit plans.&#160;&#160;Ashland expects to make additional contributions t
o the U.S. plans of approximately $10 million and to the non-U.S. plans of $25 million during the remainder of fiscal year 2011.&#160;&#160;The following table details the components of pension and other postretirement benefit costs.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="44%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="B
ORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new r
oman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="44%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<
/font></td><td valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: tim
es new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other postretirement</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="44%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspa
n="7"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Pension benefits</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="7"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">benefits</font></div></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="44%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roma
n; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</
font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FO
NT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
 FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="44%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Three months ended December 31</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new
 roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: 
times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="44%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Service cost</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-F
AMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">
;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" v
align="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="44%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest cost</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: le
ft" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">50</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51</font&
gt;</td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: time
s new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="44%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Expected return on plan assets</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPL
AY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(57</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="b
ottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(54</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><
/td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="44%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization of prior servic
e credit</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY
: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap=
"nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="44%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt
; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amortization of net actuarial loss (gain)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>
;</td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">13</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&
lt;/font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10p
t">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="44%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: t
imes new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; F
ONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><fo
nt style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="44%"><fo
nt style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" w
idth="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><t
d style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div>NOTE L &#8211; EMPLOYEE BENEFIT 
PLANS&#160;For the three months ended December 31, 2010, Ashland contributed $5 million to the U.S. benefit plans andfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringDescription containing the entire pension and other postretirement benefits disclosure as a single block of text.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name FASB Staff Position (FSP)
 -Number FAS106-2
 -Paragraph 20, 21, 22

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5, 6, 7, 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 87
 -Paragraph 264

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Implementation Guide (Q and A)
 -Number FAS88
 -Paragraph 63

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 158
 -Paragraph 7, 21, 22

Reference 6: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph b

Reference 7: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 30
 -Paragraph 26

Reference 8: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 106
 -Paragraph 518

Reference 9: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Emerging Issues Task Force (EITF)
 -Number 03-2
 -Paragraph 8

Reference 10: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 8
 -Subparagraph m

Reference 11: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph h

Reference 12: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph a

Reference 13: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph q

falsefalseEMPLOYEE BENEFIT PLANS12EMPLOYEE BENEFIT PLANSUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
18
R11.xml
IDEA: DIVESTITURES


2.2.0.25falsefalse006040 - Disclosure - DIVESTITUREStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0ash_DisposalGroupTextBlockashfalsenadurationDescription of completed or expected disposal(s) group, the gain or loss recognized in the income statement and the income...falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE D &#8211; DIVESTITURES</font></div><div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div><div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Ashland Distribution</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">On November 5, 2010, Ashland signed a definitive agreement with TPG Accolade, LLC (TPG) to sell substantially all of the assets of its global distribution business conducted by the Ashland Distribution (Distribution) segment.&#160;&#160;The transaction is an asset sale with the total cash proceeds expected to be $930 million, before transaction fees and taxes, subject to post-closing working capital adjustments and certain other adjustments, as specified in the definitive agreement.&#160;&#160;Ashland anticipates recording a significant gain, which includes a tax valuation allowance release of approximately $60 million to $70 million, upon the closing of the transaction, which is expected at the end of the March 2011 quarter.&#160;&#160;The closing
 is subject to regulatory approvals and satisfaction of other customary closing conditions.&#160;&#160;Ashland Distribution recorded sales of $3,419 million during the most recently completed fiscal year ended September 30, 2010 and employs approximately 2,000 employees across North America and Europe.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Since this transaction signifies Ashland&#8217;s exit from the Distribution business, it qualifies as a discontinued operation.&#160;&#160;Therefore, the results of operations of Distribution have been classified as discontinued operations for all periods presented.&#160;&#160;Certain indirect corporate costs previously allocated to the Distr
ibution reporting segment that do not qualify for discontinued operations accounting classification are now reported as costs within the Unallocated and other section of continuing operations, and for the three months ended December&#160;31, 2010 and 2009 were $7 million and $9 million, respectively.&#160;&#160;Ashland is currently analyzing and developing plans to reduce these costs.&#160; </font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland will retain and has agreed to indemnify TPG for certain liabilities of the Distribution business arising prior to the closing of the sale, which include pension and other postretirement benefits, as well as certain other potential liabilities, including cer
tain litigation and environmental liabilities relating to the pre-closing period, as described in the agreement.&#160;&#160;Costs related to these expenses were $4 million for the three months ended December 31, 2010 and 2009 and have been included within the Unallocated and other section of continuing operations.&#160;&#160;</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As part of this pending sale, Ashland expects to receive transition service fees for services to be provided to TPG subsequent to the completion of the sale.&#160;&#160;While the transition service agreements are expected to vary in duration&#160;</font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roma
n; FONT-SIZE: 11pt">depending upon the type of service provided, Ashland expects to reduce costs as the transition services are completed.&#160;&#160;See Note E &#8211; Discontinued Operations for further information on the results of operations of Distribution for all periods presented.&#160;&#160;</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"></font>&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As a result of this divestiture, the assets and liabilities of 
Distribution for prior periods have been reflected as assets and liabilities held for sale within the Condensed Consolidated Balance Sheets and are comprised of the following components:</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block"><div style="MARGIN-LEFT: 18pt" align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: tim
es new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" w
idth="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" widt
h="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions - unaudited)</font></div></td><td style="BORDER-BOTTOM: bla
ck 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"
 align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width=
"1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">442</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">494</font></td><td style="TEXT-ALIGN: le
ft" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventories</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">210</font></td><td style="TE
XT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">197</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div sty
le="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE:
 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div 
style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current assets held for sale</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">656</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FON
T-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">693</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman;
 FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMIL
Y: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property, plant and equipment, net</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%">&
lt;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">181</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">179</font></td><td style="TEXT-ALIGN: left" valig
n="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill and intangible assets</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9
%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">82</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign
="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Noncurrent assets held for sale</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom"
 width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">263</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">261</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" 
valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
;Trade payables</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">268</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FON
T-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">315</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accrued expenses and other liabilities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td sty
le="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font
></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current liabilities held for sale</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></
td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">274</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</
font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">321</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="b
ottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</f
ont></td></tr></table></div><div style="MARGIN-LEFT: 18pt" align="left">&#160;</div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In addition to the Distribution assets and liabilities identified above as held for sale, Ashland held other noncurrent assets for sale of $8 million and $9&#160;million as of December 31, 2010 and September 30, 2010, respectively, primarily related to non-operational properties and certain Valvoline Instant Oil Change<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</font> locations.&#160;&#160;The noncurrent assets held for sale are required to be measured at carrying value or below this level if an impairment is indicated.&#160;&#160;The fair values were based on definitive agreements of sale or other market quot
es which would be considered significant unobservable market inputs (Level 3) within the fair value hierarchy.&#160;&#160;See also Note&#160;G&#160;&#8211; Fair Value Measurements for further information on the fair value hierarchy.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Castings Solutions Joint Venture</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In July 2010, Ashland and S&
#252;d-Chemie AG (S&#252;d-Chemie) signed an agreement for the formation of an expanded global joint venture serving the foundry chemical sector.&#160;&#160;The transaction closed on November 30, 2010 and combined three businesses:&#160;&#160;Ashland&#8217;s Castings Solutions business group, S&#252;d-Chemie&#8217;s Foundry-Products and Specialty Resins business unit, and Ashland-S&#252;dchemie-Kernfest GmbH (ASK), the existing fifty-percent owned European-based joint venture between Ashland and S&#252;d-Chemie, for which Ashland historically only recognized equity income of the joint venture within its consolidated results.&#160;&#160;Ashland&#8217;s Castings Solutions and ASK businesses recorded sales of $279 million and $145 million, respectively, during each businesses&#8217; most recently completed fiscal year.&#160;&#160;The Foundry-Products and Specialty Resins business unit of S&#252;d-Chemie contributed to the joint venture generate
d sales of approximately $146&#160;million for its most recently completed fiscal year.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During the fifth year of the joint venture&#8217;s operations, Ashland will have the option to sell its shares in the expanded global joint venture to S&#252;d-Chemie under mutually agreed terms.&#160;&#160;If Ashland does not execute this option by the end of the sixth year of the joint venture&#8217;s operations, S&#252;d-Chemie will have the option to acquire Ashland&#8217;s shares under mutually agreed terms.&#160;&#160;Under both options, if mutually agreed terms cannot be reached, then the fair market value of the shares will be determined 
through an appraisal process set forth in the agreement.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Upon closing of the transaction, the joint venture distributed a $21 million net payment to Ashland in accordance with the agreement.&#160;&#160;Ashland anticipates receiving an additional cash payment from the joint venture during the </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">March 2011 quarter, resulting from post-closing activities and measurements set forth in the agreement, which is expected to be approximately $25 million.&#160;&#160;Ashland recognized a pretax gain of $19 million, attributable to the fair market value of the net assets 
contributed to the joint venture.&#160;&#160;For the majority of the valuation of the contributed assets and liabilities, Ashland utilized the discounted cash flow method; however, the adjusted book value method was also used in some areas of the valuation.&#160;&#160;The gain was included in the net gain on acquisitions and divestitures caption in the Statement of Consolidated Income for the three months ended December 31, 2010.&#160;&#160;The recorded values of assets and liabilities contributed by Ashland to the expanded joint venture, excluding equity interests were as follows:&#160;&#160;</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY:
 block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FON
T-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="86%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assets</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><div style="T
EXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(liabilities)</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceef
f"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white">
<td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr 
bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inventories</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></
tr><tr bgcolor="white"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property, plant and equipment</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">33</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;
</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Goodwill</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">52</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trade and other payables</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(24</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new ro
man; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other noncurrent assets (liabilities) - net</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">11<
/font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roma
n; FONT-SIZE: 10pt">146</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign=
"bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 14.4pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland&#8217;s equity interest in the expanded joint venture qualifies for equity method accounting treatment under U.S. GAAP.&#160;&#160;As a result, future reported results of the Castings Solutions business will no longer include the sales, cost of sales or selling, general and administrative costs related to this business; however, Ashland will include the financial effects within the equity income caption of the Statements of Consolidated Income.&#160;&#160;In addition, the expanded joint venture will leave certain stranded costs that Ashland is currently analyzing and developing plans to redu
ce.</font></div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Pinova divestiture</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 18pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In January 2010, Ashland sold its refined wood rosin and natural wood terpenes business, formerly known as Pinova, a business unit of Functional Ingredients, to TorQuest Partners in a transaction valued at approximately $75&#160;million before tax, which was comprised 
of $60 million in cash and a $15 million five-year promissory note from TorQuest Partners.&#160;&#160;The Pinova business, with annual sales of approximately $85&#160;million per year, had approximately 200 employees along with an associated manufacturing facility located in Brunswick, Georgia.&#160;&#160;As part of this transaction, TorQuest Partners has agreed to continue to manufacture certain products on behalf of Ashland.&#160;&#160;</font></div>NOTE D &#8211; DIVESTITURES&#160;Ashland Distribution&#160;On November 5, 2010, Ashland signed a definitive agreement with TPG Accolade, LLC (TPG) to sellfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringDescription of completed or expected disposal(s) group, the gain or loss recognized in the income statement and the income statement caption that includes that gain or loss, amounts of revenues and pretax profit or loss reported in earnings, the segment in which the disposal group was reported, and the classification and carrying value of the assets and liabilities comprising the disposal group.No authoritative reference available.falsefalseDivestitures12DIVESTITURESUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
19
R10.xml
IDEA: ACQUISITIONS


2.2.0.25falsefalse006030 - Disclosure - ACQUISITIONStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE C &#8211; ACQUISITIONS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Ara Quimica</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><fo
nt style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In April 2010, Ashland acquired the remaining 50% interest in Ara Quimica S.A. (Ara Quimica), a leading producer of custom unsaturated polyester resin formulations for the composites industry in South America, for $28&#160;million.&#160;&#160;Prior to the acquisition, Ashland owned a 50% interest in Ara Quimica, which it recorded as an equity method investment within the Performance Materials reporting segment.&#160;&#160;Ara Quimica recorded sales of approximately $56&#160;million from its most recent fiscal year ended September 30, 2010.&#160;&#160;As a result of this transaction, Ashland recorded $19 million of current assets and $61 million of long-term assets, which included $55 million of goodwill and intangible assets.&#160;&#160;In addition, Ashland recorded $18 million of current liabilities and $6 million of noncurrent liabilities.</font></div><div style="TEXT-INDENT: 
0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Hercules</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">On November 13, 2008, Ashland completed its acquisition of Hercules Incorporated (Hercules).&#160;&#160;The total merger consideration for outstanding Hercules Common Stock was $2,594 million, including $2,096 million in cash, $450&#160;million in Ashland Common Stock with the remaining value of the transaction related to cash consideration and value
 for restricted stock units, stock options and transaction costs.&#160;&#160;In addition, Ashland inherited $798 million in debt as a part of the transaction.&#160;&#160;The acquired businesses of Hercules now comprise the Functional Ingredients reporting segment, as well as a significant portion of the Water Technologies reporting segment.&#160;&#160;The total debt borrowed upon the closing of the merger was approximately $2,300 million with the remaining cash consideration for the transaction paid from Ashland&#8217;s existing cash at the date of the transaction.</font></div>NOTE C &#8211; ACQUISITIONS&#160;Ara Quimica&#160;In April 2010, Ashland acquired the remaining 50% interest in Ara Quimica S.A. (Ara Quimica), a leadingfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringSchedule of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This schedule does not include leveraged buyouts.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 141R
 -Paragraph 68

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 141
 -Paragraph 52

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 141
 -Paragraph 51
 -Subparagraph a

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 141R
 -Paragraph F4
 -Subparagraph e
 -Appendix F

falsefalseAcquisitions12ACQUISITIONSUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
20
R8.xml
IDEA: BASIS OF PRESENTATION


2.2.0.25falsefalse006010 - Disclosure - BASIS OF PRESENTATIONtruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel
1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0.2pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE A </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">BASIS OF PRESENTATION</font></font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="
justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles for interim financial reporting and Securities and Exchange Commission regulations.&#160;&#160;In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included.&#160;&#160;These statements omit certain information and footnote disclosures required for complete annual financial statements and, therefore, should be read in conjunction with Ashland&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended September 30, 2010.&#160;&#160;Results of operations for the period ended December 31, 2010 are not necessarily indicative of results to be expected for the year ending September&#160;30, 2011.&#160;&#160;Certain prior period data
 has been reclassified in the Condensed Consolidated Financial Statements and accompanying footnotes to conform to current period presentation.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland is composed of four reporting segments:&#160;&#160;Ashland Aqualon Functional Ingredients (Functional Ingredients), Ashland Hercules Water Technologies (Water Technologies), Ashland Performance Materials (Performance Materials) and Ashland Consumer Markets (Consumer Markets).&#160;&#160;On November 5, 2010, Ashland signed a definitive agreement to sell substantially all of the assets and liabilities of Ashland Distribution (Distribution).&#160;&#160;As a result of this expected sale, the operating r
esults and assets and liabilities related to Distribution have been reflected as discontinued operations for all periods presented.&#160;&#160;See Notes&#160;D, E and Q for additional information on the Distribution divestiture and reporting segment results.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The preparation of Ashland&#8217;s Condensed Consolidated Financial Statements requires management to make estimates and assumptions that affect the reported amounts of certain assets, liabilities, revenues, expenses and related disclosures of contingent assets and liabilities as well as qualifying subsequent events.&#160;&#160;Significant items that are subject to such estimates and assumption
s include, but are not limited to, long-lived assets (including goodwill and intangible assets), employee benefit obligations, income taxes, and liabilities and receivables associated with asbestos litigation, environmental remediation and asset retirement obligations.&#160;&#160;Although management bases its estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, actual results could differ significantly from the estimates under different assumptions or conditions.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland&#8217;s results are affected by domestic and international economic, political, legislative, regulatory and legal actio
ns.&#160;&#160;Economic conditions, such as recessionary trends, inflation, interest and monetary exchange rates, government fiscal policies, and changes in the prices of hydrocarbon-based products and other raw materials, can have a significant effect on operations.&#160;&#160;While Ashland maintains reserves for anticipated liabilities and carries various levels of insurance, Ashland could be affected by civil, criminal, regulatory or administrative actions, claims or proceedings relating to asbestos, environmental remediation or other matters.</font></div>NOTE A &#8211;&#160;BASIS OF PRESENTATION&#160;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance withfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringDescription containing the entire organization, consolidation and basis of presentation of financial statements disclosure. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the e
nterprise's financial position, financial performance, and cash flows.  Describes procedure if disclosures are provided in more than one note to the financial statements.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name FASB Staff Position (FSP)
 -Number FAS140-4 and FIN46(R)-8
 -Paragraph 8, C1, C7

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 2-6

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Statement of Position (SOP)
 -Number 94-6
 -Paragraph 10

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name FASB Interpretation (FIN)
 -Number 46R
 -Paragraph 4, 14, 15

falsefalseBASIS OF PRESENTATION12BASIS OF PRESENTATIONUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
21
R22.xml
IDEA: CAPITAL STOCK


2.2.0.25falsefalse006150 - Disclosure - CAPITAL STOCKtruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_ScheduleOfStockByClassTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1fa
lsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block"><div style="TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE&#160;O &#8211; CAPITAL STOCK</font></div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During the first quarter of fiscal 2011, the Board of Directors of Ashland announced and paid a quarterly cash dividend of 15 cents per share
 to eligible shareholders of record.&#160;&#160;This amount was double the quarterly cash dividend of 7.5 cents per share paid in the December 2009 quarter.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In November 2009, Ashland made a voluntary pension plan contribution of approximately 3.0 million shares of Ashland Common Stock, valued at $100 million on the date of transfer.</font></div>NOTE&#160;O &#8211; CAPITAL STOCK&#160;During the first quarter of fiscal 2011, the Board of Directors of Ashland announced and paid a quarterly cash dividendfals
efalsefalsefalsefalseOtherus-types:textBlockItemTypestringThis element is used to capture the complete disclosure pertaining to an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation.  Stock by Class includes common, convertible  and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred st
ock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued and outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 29
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 30
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 150
 -Paragraph 9

falsefalseCAPITAL STOCK12CAPITAL STOCKUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
22
R18.xml
IDEA: INCOME TAXES


2.2.0.25falsefalse006110 - Disclosure - INCOME TAXEStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_IncomeTaxDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1false
falsefalse00<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE&#160;K &#8211; INCOME TAXES</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland&#8217;s effective tax rate is generally subjected to adjustments related to discrete items and changes within foreign effective tax rates resulting from income or loss fluctuations.&#160;&#160;The overall effective tax rate of 33.3
% for the three months ended December 31, 2010 includes certain discrete items such as a $16 million tax expense from the $19 million pretax gain associated with the fair market value of the Castings Solutions contribution and a $4&#160;million tax benefit associated with research and development tax credits for the 2010 fiscal year.&#160;&#160;In addition, the effective tax rate during this period was favorably impacted by $3&#160;million from other miscellaneous discrete tax items.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The overall effective tax rate of 25.6% for the three months ended December 31, 2009 includes a benefit of $6&#160;million associated with the reversal of certain fore
ign tax reserves.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Changes in unrecognized tax benefits are summarized as follows for the three months ended December 31, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" wi
dth="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"></font>&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY:
 times new roman; FONT-SIZE: 10pt">Balance at October 1, 2010</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">116</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: in
line; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increases related to positions taken on items from prior years</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt;
 MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Increases related to positions taken in the current year</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="86%"
 align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Lapse of statute of limitations</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(3</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; 
FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2010</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">119
</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap
="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div><div align="left">&#160;</div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">It is reasonably possible that the amount of the unrecognized tax benefits may increase or decrease within the next twelve months as the result of settlements from ongoing audits, which may have material affect on the Condensed Consolidated Financial Statements.</font></div>NOTE&#160;K &#8211; INCOME TAXES&#160;Ashland&#8217;s effective tax rate is generally subjected to adjustments related to discrete items and changes withinfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringDescription containing the entire income tax disclosure. Examples include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables.Reference 1: http://www.xbrl
.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 08
 -Paragraph h
 -Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 136, 172

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 43, 44, 45, 46, 47, 48, 49

falsefalseINCOME TAXES12INCOME TAXESUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
23
R12.xml
IDEA: DISCONTINUED OPERATIONS


2.2.0.25falsefalse006050 - Disclosure - DISCONTINUED OPERATIONStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0ash_DiscontinuedOperationsDisclosureTextBlockashfalsenadurationDescription of activities and amount of cash flows that are expected to continue with the disposal group that is a component...falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE E &#8211; DISCONTINUED OPERATIONS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 18pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 18pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As previously described in Note D, Ashland signed a definitive agreement with TPG on November 5, 2010 to sell subst
antially all of the assets and liabilities of Distribution.&#160;&#160;Ashland has determined that this expected sale qualifies as a discontinued operation, in accordance with U.S. GAAP, since the company will not have significant continuing involvement in the distribution business upon closing of the transaction.&#160;&#160;As a result, the previous operating results related to Distribution have been reflected as discontinued operations in the Statement of Consolidated Income, while assets and liabilities that are to be sold have been classified within the Condensed Consolidated Balance Sheet as held for sale.&#160;&#160;Sales for the three month periods ended December 31, 2010 and 2009 were $856 million and $729&#160;million, respectively.&#160;&#160;The results of operations for the three month periods ended December&#160;31, 2010 and 2009 are included in the table below.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARG
IN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland is subject to liabilities from claims alleging personal injury caused by exposure to asbestos.&#160;&#160;Such claims result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley Stoker </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Corporation (Riley), a former subsidiary of Ashland, and from the acquisition of Hercules during fiscal 2009, a wholly owned subsidiary of Ashland.&#160;&#160;Adjustments to the recorded litigation reserves and related insurance receivables continue periodically and primarily reflect updates to the estimates.&#160;&#160;See Note&#160;M for more information related to the adjustments on asbestos liabilities an
d receivables.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland&#8217;s divestiture of Ashland Paving And Construction (APAC) during 2006 qualified as a discontinued operation.&#160;&#160;As a result, the previous operating results, assets and liabilities related to APAC have been reflected as discontinued operations in the Condensed Consolidated Financial Statements.&#160;&#160;Ashland has made subsequent adjustments to the gain on the sale of APAC, primarily relating to the tax effects of the sale, during the three month periods ended December 31, 2010 and 2009.&#160;&#160;Such adjustments to th
ese and other divested businesses may continue to occur in future periods and are reflected in the period they are determined and recorded in the discontinued operations caption in the Statements of Consolidated Income.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Components of amounts reflected in the Statements of Consolidated Income related to discontinued operations are presented in the following table for the three months ended December 31, 2010 and 2009.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"><div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div><div style="MARGIN-LEFT: 18pt" align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE:
 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="69%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="69%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times ne
w roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="69%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: tim
es new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom
" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div st
yle="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Income from discontinued operations (net of tax)</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"&g
t;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT:
 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Distribution <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">23</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY
: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-LEFT: 2%" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos-related litigation reserves and receivables</font></div></td><td valign="bottom" wi
dth="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>
;</td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Gain on disposal of discontinued operations (net of tax)</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY:
 times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowr
ap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 2%" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">APAC</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inl
ine; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"
><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="69%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Total income from discontinued operations (net of tax)</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&
gt;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">25</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom
" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="69%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new r
oman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="69%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div><div><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="100%"><tr valign="top"><td style="WIDTH: 36pt" align="right"><div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)&#160;&#160;</font></div
></td><td><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For the three months ended December 31, 2010 and 2009, the pretax income reported for Distribution was $32 million and $19 million, respectively.</font></div></td></tr></table></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div></div>NOTE E &#8211; DISCONTINUED OPERATIONS&#160;As previously described in Note D, Ashland signed a definitive agreement with TPG on November 5, 2010 to sellfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringDescription of activities and amount of cash flows that are expected to continue with the disposal group that is a component of the entity (discontinued operation) after it has been sold or otherwise disposed of.No authoritative reference available.falsefalseDISCONTINUED OPERATIONS12DISCONTINUED OPERATIONSUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
24
R3.xml
IDEA: CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)


2.2.0.25falsefalse002000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)truefalseIn Millionsfalse1falsefalseUSDfalsefalse12/31/2010
USD ($)

$c00002http://www.sec.gov/CIK0001305014instant2010-12-31T00:00:000001-01-01T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$<
/CurrencySymbol>2falsefalseUSDfalsefalse9/30/2010
USD ($)
$c00007http://www.sec.gov/CIK0001305014instant2010-09-30T00:00:000001-01-01T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4true0us-gaap_AssetsCurrentAbstractus-gaap<
IsBaseElement>truenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCURRENT ASSETS5false0us-gaa
p_CashAndCashEquivalentsAtCarryingValueus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse374000000374falsetruefalsefalsefalse2truefalsefalse417000000417falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIncludes currency on hand as well as demand deposits with banks or financial institutions. It also includes other ki
nds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not le
gally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7, 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 8, 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7
 -Footnote 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 1
 -Article 5

falsefalseCash and cash equivalents6false0us-gaap_AccountsReceivableNetCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse10050000001005[1]falsefalsefalsefalsefalse2truefalsefalse11150000001115[1]falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 3
 -Subparagraph a(1)
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 4
 -Article 5

falsefalseAccounts receivable7false0us-gaap_InventoryNetus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse497000000497falsefalsefalsefalsefalse2truefalsefalse447000000447falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).No authoritative reference available.falsefalseInventories - Note H8false0us-gaap_DeferredTaxAssetsNetCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse112000000112falsefalsefalsefalsefalse2truefalsefalse112000000112falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be class
ified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating loss carryforward should be presented as a reduction of the related deferred tax asset.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 41, 42, 43

falsefalseDeferred income taxes9false0us-gaap_AssetsHeldForSaleCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse656000000656[2]falsefalsefalsefalsefalse2truefalsefalse693000000693[2]falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCurrent assets (normally turning over within one year or one business cycle if longer) that are held for sale apart from normal operations and anticipated to be sold within one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 46

falsefalseHeld for sale - Note D10false0us-gaap_OtherAssetsCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse6100000061falsefalsefalsefalsefalse2truefalsefalse4900000049falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of current assets not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 8
 -Article 5

falsefalseOther assets11false0us-gaap_AssetsCurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse27050000002705falsefalsefalsefalsefalse2truefalsefalse28330000002833falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 9
 -Article 5

truefalseTotal current assets12true0us-gaap_AssetsNoncurrentAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNONCURRENT ASSETS13false0us-gaap_AvailableForSaleSecuritiesNoncurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse
1truefalsefalse2200000022falsefalsefalsefalsefalse2truefalsefalse2200000022falsefalsefalsefalsefalse<
/Cells>Monetaryxbrli:monetaryItemTypemonetaryInvestments in debt and equity securities which are categorized neither as held-to-maturity nor trading and which are intended to be sold or mature more than one year from the balance sheet date or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 115
 -Paragraph 12
 -Subparagraph b

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 115
 -Paragraph 17

falsefalseAuction rate securities - Note G14false0us-gaap_Goodwillus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse20830000002083falsefalsefalsefalsefalse2truefalsefalse21480000002148falsefalsefalsefalsefalseMonetaryxbrli:monet
aryItemTypemonetaryCarrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of FAS 142 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 142
 -Paragraph 43

falsefalseGoodwill - Note I15false0us-gaap_IntangibleAssetsNetExcludingGoodwillus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse10890000001089falsefalsefalsefalsefalse2truefalsefalse11110000001111falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 142
 -Paragraph 42, 45

falsefalseIntangibles - Note I16false0ash_AsbestosInsuranceReceivableNoncurrentashfalsedebitinstantThe noncurrent portion of the receivable from insurance for reimbursement and payment of asbestos claims.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse452000000452falsefalsefalsefalsefalse2truefalsefalse459000000459falsefalsefalsefalsef
alseMonetaryxbrli:monetaryItemTypemonetaryThe noncurrent portion of the receivable from insurance for reimbursement and payment of asbestos claims.No authoritative reference available.falsefalseAsbestos insurance receivable (noncurrent portion) - Note M17false0us-gaap_DeferredTaxAssetsNetNoncurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse336000000336falsefalsefalsefalsefalse2truefalsefalse336000000336falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and
 assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 41, 42, 43

falsefalseDeferred income taxes18false0us-gaap_AssetsHeldForSaleLongLivedus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse271000000271[2]falsefalsefalsefalsefalse2truefalsefalse270000000270[2]falsefalsefalsefalsefalseMo
netaryxbrli:monetaryItemTypemonetaryLong-lived assets that are held for sale apart from normal operations and anticipated to be sold in less than one year.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 46

falsefalseHeld for sale - Note D19false0us-gaap_OtherAssetsNoncurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse623000000623falsefalsefalsefalsefalse2truefalsefalse514000000514falsefalsefalsefalsefalseMonetaryxbrli:moneta
ryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 17
 -Article 5

falsefalseOther assets20false0us-gaap_AssetsNoncurrentus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefals
e48760000004876falsefalsefalsefalsefalse2truefalsefalse48600000004860falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 18
 -Article 5

truefalseTotal noncurrent assets21true0us-gaap_PropertyPlantAndEquipmentNetAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse
00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemType<
/ElementDataType>stringNo definition available.falsefalsePROPERTY, PLANT AND EQUIPMENT22false0us-gaap_PropertyPlantAndEquipmentGrossus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse30030000003003falsefalsefalsefalsefalse2truefalsefalse30960000003096falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount at the balance sheet date for long-lived physical assets used in the normal conduct of business and not intended for resale. This can include land, physical structures, machinery, vehicles, furniture, computer equipment, construction in progress, and similar items. Amount does not include depreciation.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 5

falsefalseCost23false0us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1truefalsefalse-1235000000-1235falsefalsefalsefalsefalse2truefalsefalse-1258000000-1258falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 5
 -Subparagraph c

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 14
 -Article 5

falsefalseAccumulated depreciation and amortization24false0us-gaap_PropertyPlantAndEquipmentNetus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse17680000001768falsefalsefalsefalsefalse2truefalsefalse18380000001838falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, and production equipment.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 13
 -Subparagraph a
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 12
 -Paragraph 5
 -Subparagraph b, c

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 8
 -Article 7

truefalseProperty, Plant and Equipment, net25false0us-gaap_Assetsus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse93490000009349falsefalsefalsefalsefalse2truefalsefalse95310000009531falsefalsefalsefalsefalseMonetary
xbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Concepts (CON)
 -Number 6
 -Paragraph 25

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 18
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 12
 -Article 7

truefalseTOTAL ASSETS27true0us-gaap_LiabilitiesCurrentAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse<
NumericAmount>00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCURRENT LIABILITIES28false0us-gaap_ShortTermBorrowingsus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1tru
efalsefalse7700000077falsefalsefalsefalsefalse2truefalsefalse7100000071falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryReflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 19
 -Subparagraph a
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 13
 -Subparagraph 2, 3
 -Article 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 16
 -Subparagraph a(1)
 -Article 7

falsefalseShort-term debt - Note J29false0us-gaap_LongTermDebtCurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse3900000039falsefalsefalsefalsefalse2truefalsefalse4500000045falsefalsefalsefalsefalseMonetaryxbrli:monetaryI
temTypemonetaryTotal of the portions of the carrying amounts as of the balance sheet date of long-term debt, which may include notes payable, bonds payable, debentures, mortgage loans, and commercial paper, which are scheduled to be repaid within one year or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 20
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 19
 -Article 5

falsefalseCurrent portion of long-term debt - Note J30false0us-gaap_AccountsPayableCurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalse<
/IsRatio>false640000000640falsefalsefalsefalsefalse2truefalsefalse727000000727falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 19
 -Subparagraph a
 -Article 5

falsefalseTrade and other payables31false0us-gaap_AccruedLiabilitiesCurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse404000000404falsefalsefalsefalsefalse2truefalsefalse523000000523falsefalsefalsefalsefalseMonetaryxbrli
:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 20
 -Article 5

falsefalseAccrued expenses and other liabilities32false0us-gaap_LiabilitiesOfAssetsHeldForSaleus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse274000000274[2]falsefalsefalsefalsefalse2truefalsefalse321000000321[2]falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryLiability (such as a mortgage) related to a disposal group that is held for sale and anticipated to be sold in less than one year. The liability is expected to be discharged as part of the plan of sale for the asset.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 46

falsefalseHeld for sale - Note D33false0us-gaap_LiabilitiesCurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse14340000001434falsefalsefalsefalsefalse2truefalsefalse16870000001687falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 21
 -Article 5

truefalseTotal current liabilities34true0us-gaap_LiabilitiesNoncurrentAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNONCURRENT LIABILITIES35false0us-gaap_LongTermDebtNoncurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse11140000001114falsefalsefalsefalsefalse2truefalsefalse11080000001108falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetarySum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 22
 -Article 5

falsefalseLong-term debt (noncurrent portion) - Note J36false0us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse13680000001368falsefalsefalsefalsefalse2truefalsefalse13720000001372falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis represents the noncurrent liability for underfunded plans recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement defined benefit plans.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph c

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 6

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 3

falsefalseEmployee benefit obligations - Note L37false0ash_LiabilityForAsbestosClaimsGrossNoncurrentashfalsecreditinstantCarrying amount as of the balance sheet date of reserves for the costs of settling insured claims and costs incurred in the...falsefalsefalsefalsefalsefalsefalsefalsefalsefalset
erselabel1truefalsefalse826000000826falsefalsefalsefalsefalse2truefalsefalse841000000841falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date of reserves for the costs of settling insured claims and costs incurred in the claims settlement process attributable to asbestos, before estimated recoveries from reinsurers.No authoritative reference available.falsefalseAsbestos litigation reserve (noncurrent portion) - Note M38false0us-gaap_DeferredTaxLiabilitiesNoncurrentus-gaaptruecreditinstantNo definition available
.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse149000000149falsefalsefalsefalsefalse2truefalsefalse145000000145falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryRepresents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A noncurrent taxable temporary difference is a difference between the tax basis 
and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 41, 42

falsefalseDeferred income taxes39false0us-gaap_OtherLiabilitiesNoncurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse581000000581falsefalsefalsefalsefalse2truefalsefalse575000000575falsefalsefalsefalsefalseMonetaryxbrli:m
onetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet due to materiality considerations. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 24
 -Article 5

falsefalseOther liabilities40false0us-gaap_LiabilitiesNoncurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse40380000004038falsefalsefalsefalsefalse2truefalsefalse40410000004041falsefalsefalsefalsefalseMonetary
xbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 22, 23, 24, 25, 26, 27
 -Article 5

truefalseTotal noncurrent liabilities41false0us-gaap_StockholdersEquityus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse38770000003877falsefalsefalsefalsefalse2truefalsefalse38030000003803falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A3
 -Appendix A

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 4
 -Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 29, 30, 31
 -Article 5

falsefalseSTOCKHOLDERS' EQUITY42false0us-gaap_LiabilitiesAndStockholdersEquityus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse93490000009349falsetruefalsefalsefalse2truefalsefalse95310000009531falsetruefalsefalsefalseMon
etaryxbrli:monetaryItemTypemonetaryTotal of all Liabilities and Stockholders' Equity items.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 32
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 25
 -Article 7

truefalseTOTAL LIABILITIES AND STOCKHOLDERS' EQUITY1Accounts receivable includes an allowance for doubtful accounts of $29 million and $28 million at December 31, 2010 and September 30, 2010, respectively.2Primarily relates to assets and liabilities of the Distribution business that have qualified for held for sale classification in accordance with U.S. GAAP due to its expected sale.238CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue




XML
25
R14.xml
IDEA: FAIR VALUE MEASUREMENTS


2.2.0.25falsefalse006070 - Disclosure - FAIR VALUE MEASUREMENTStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_FairValueMeasurementInputsDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE G &#8211; FAIR VALUE MEASUREMENTS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As required by U.S. GAAP, Ashland uses applicable guidance for defining fair value, the initial recording and periodic remeasurement of certain assets and liabilities measured at fair value and related disclosures for instruments meas
ured at fair value.&#160;&#160;Fair value accounting guidance establishes a fair value hierarchy, which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels.&#160;&#160;The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).&#160;&#160;An instrument&#8217;s categorization within the fair value hierarchy is based upon the lowest level on input that is significant to the instrument&#8217;s fair value measurement.&#160;&#160;The three levels within the fair value hierarchy are described as follows:</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMI
LY: Times New Roman; FONT-SIZE: 11pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level&#160;1&#160;</font>&#8212;&#160;Observable inputs such as unadjusted quoted prices in active markets for identical assets or liabilities.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level&#160;2&#160;</font>&#8212;&#160;Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.&#160;&#160;These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in
 markets that are not active.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="FONT-STYLE: italic; DISPLAY: inline">Level&#160;3&#160;</font>&#8212;&#160;Unobservable inputs for the asset or liability for which there is little, if any, market activity at the measurement date.&#160;&#160;Unobservable inputs reflect Ashland&#8217;s own assumptions about what market participants would use to price the asset or liability.&#160;&#160;The inputs are developed based on the best information available in the circumstances, which might include occasional market quotes or sales of similar instruments or Ashland&#8217;s own financial data such as internally developed 
pricing models, discounted cash flow methodologies, as well as instruments for which the fair value determination requires significant management judgment.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">For assets that are measured using quoted prices in active markets (Level 1), the total fair value is the published market price per unit multiplied by the number of units held without consideration of transaction costs.&#160;&#160;Assets and liabilities that are measured using significant other observable inputs (Level 2) are primarily valued by reference to quoted prices of similar assets or liabilities in active markets (market approach), adjusted for any terms specific to that asset or liability.&#160;&
amp;#160;For all other assets and liabilities for which unobservable inputs are used (Level 3), fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models that Ashland deems reasonable.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table summarizes financial asset instruments subject to recurring fair value measurements as of December 31, 2010.&#160;&#160;Ashland did not have any financial liability instruments subject to recurring fair value measurements as of December 31, 2010.</font></div><br /><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><div
 style="MARGIN-LEFT: 18pt" align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td&g
t;<td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new r
oman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="ri
ght"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inli
ne; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width
="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quoted prices</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign
="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></
td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-
RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">in active</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td vali
gn="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-A
LIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"&
gt;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">markets for</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">other</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="
right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY
: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inli
ne; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">identical</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">observable</font><
/div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">unobservable</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#
160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right">&l
t;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">fair</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">assets</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right">&
lt;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">inputs</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">in
puts</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inlin
e; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">value</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">value</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new
 roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 1</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>
;</td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 2</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-F
AMILY: times new roman; FONT-SIZE: 10pt">Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" widt
h="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bot
tom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" va
lign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">374</font></td><td style="TEX
T-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">374</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&
#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">374</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new
 roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30
%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Auction rate securities</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right
"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td s
tyle="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-S
IZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZ
E: 10pt">Deferred compensation investments <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>
</td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new
 roman; FONT-SIZE: 10pt">64</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font
 style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investment of captive insurance company <font style="DISPLAY: i
nline; FONT-SIZE: 10pt">(a)</font></font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inl
ine; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><
;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign=
"bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIG
N: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets at fair value</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="
9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">574</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">574</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="
bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">440</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" 
valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">112</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: 
black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
;&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="
9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px soli
d; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</fo
nt></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" colspan="15"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)&#160;&#160; &#160; Included in other noncurrent assets in the Condensed Consolidated Balance Sheet.</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>
;</td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div><div>&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table summarizes financial asset instruments subject to recurring fair value measurements as of September 30, 2010.&#160;&#160;Ashland did not have any financial liability instruments subject to recurring fair value measurements as of September 30, 2010.</font><br /></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; 
MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN
: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>&l
t;/td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inlin
e; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAM
ILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" widt
h="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Quoted prices</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign=
"bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
;&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="D
ISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">in active</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant<
/font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font st
yle="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td&
gt;<td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">markets for</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">other</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Significant</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%" align="left"&
gt;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY
: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">identical</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DI
SPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">observable</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">unobservable<
;/font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FO
NT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">fair</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" 
align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">assets</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">inputs</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3
%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">inputs</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="
bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">value</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><
;div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">value</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 1</font></div></td><td style="BORDER-BOTTOM: blac
k 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 2</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" w
idth="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Assets</font></di
v></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FON
T-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" w
idth="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div></td>
;<td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">417</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$&l
t;/font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">417</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">417</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY
: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="
DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Auction rate securities</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%">&
lt;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-AL
IGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&a
mp;#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FON
T-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Deferred compensation investments <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td
><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">169</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">169</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times n
ew roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">62</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style=
"DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">107</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" val
ign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investment of captive insurance company <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td s
tyle="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font>&l
t;/td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT
- -SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new r
oman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets at fair 
value</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">610</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SI
ZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">610</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: ti
mes new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">481</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; F
ONT-FAMILY: times new roman; FONT-SIZE: 10pt">107</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><
font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2
px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;
</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times ne
w roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font s
tyle="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" colspan="13" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)&#160;&#160;&#160;&#160; Included in other noncurrent assets in the Condensed Consolidated Balance Sheet.</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&l
t;/font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Level 3 instruments</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 1
8pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Auction rate securities</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">At December 31, 2010 and September 30, 2010, Ashland held at par value $25 million of student loan auction rate securities for which there was not an active market with consistent observable inputs.&#160;&#160;In February 2008, the auction rate securities market became largely illiquid, as there was not enough demand to purchase all of the securities that holders desired to sell at par value during certain auctions.&#160;&#160;Since this time, the market for auction rate securities has 
failed to achieve equilibrium.&#160;&#160;Due to the uncertainty as to when active trading will resume in the auction rate securities market, Ashland believes the recovery period for certain of these securities may extend beyond a twelve-month period.&#160;&#160;As a result, these instruments have been classified as noncurrent assets in the Condensed Consolidated Balance Sheet.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During the December 2009 quarter, Ashland liquidated $50 million par value auction rate securities for $44 million in cash proceeds, which approximated book value.&#160;&#160;The following table provides a reconciliation of the beginning and ending balances of Ashland&#8
217;s auction rate securities, as these are Ashland&#8217;s only assets measured at fair value using significant unobservable inputs (Level 3).</font></div><br /><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px 
solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"></font>&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" vali
gn="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Level 3</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of October 1, 2010<
;/font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT
- -SIZE: 10pt">Sales of auction rate securities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="86%" 
align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of December 31, 2010</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FA
MILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td
 valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of October 1, 2009</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">170</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgco
lor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sales of auction rate securities</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(44</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" 
valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="86%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of December 31, 2009</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><
font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">126</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="86%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</fo
nt></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div><div align="left">&#160;</div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Derivative and hedging activities</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Currency hedges</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; M
ARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland conducts business in a variety of foreign currencies.&#160;&#160;Accordingly, Ashland regularly uses foreign currency derivative instruments to manage exposure on certain transactions denominated in foreign currencies to curtail the earnings volatility effects of short-term assets and liabilities denominated in currencies other than the functional currency of an entity.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland contracts with counter-parties 
to buy and sell foreign currencies to offset the impact of exchange rate changes on transactions denominated in non-functional currencies, including short-term inter-company loans.&#160;&#160;These contracts generally require exchange of one foreign currency for another at a fixed rate at a future date and generally have maturities of less than twelve months.&#160;&#160;All contracts are marked-to-market with net changes in fair value recorded within the selling, general and administrative expenses caption.&#160;&#160;For the three months ended December 31, 2010 and 2009, losses of less than $1 million and $1 million, respectively, were recorded in the Statement of Consolidated Income for these contracts.&#160;&#160;The impacts of these contracts were largely offset by gains and losses resulting from the impact of changes in exchange rates on transactions denominated in non-functional currencies.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-L
EFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland&#8217;s net loss position on foreign currency derivatives outstanding in the Condensed Consolidated Balance Sheet as of December 31, 2010 was less than $1 million, consisting of a gain of $1 million with a notional amount of $94 million offset by a loss of $1 million with a notional amount of $93 million, and was included in other noncurrent assets and liabilities, respectively.&#160;&#160;The net gain position on foreign currency derivatives outstanding in the Condensed Consolidated Balance Sheet as of September 30, 2010 was $1&#160;million, consisting of a gain of $2&#160;million with a notional amount of $86&#160;million offset by a loss of $1&#160;million with a notional amount of $41&#160;million, and was i
ncluded in other noncurrent assets and liabilities, respectively.&#160;&#160;As of December 31, 2010, there were no open foreign currency derivatives which qualified for hedge accounting treatment.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Interest rate hedges</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During 2009, Ashland purchased a three year interest rate cap on a notional amount of $300
 million of variable rate debt.&#160;&#160;This interest rate cap fixes Ashland&#8217;s interest rate on that outstanding variable interest rate debt when LIBOR interest rates equal or exceed 7% on a reset date.&#160;&#160;This interest rate cap qualifies as an interest rate swap within the provisions of the Senior Credit Agreement.&#160;&#160;This instrument does not qualify for hedge accounting and therefore gains or losses reflecting changes in fair value, along with the amortization of the upfront premium paid by Ashland to purchase the instrument, are reported in the Statements of Consolidated Income within the net interest and other financing expense caption.&#160;&#160;As of December 31, 2010 and September 30, 2010, the fair value on the interest rate cap was less than $1&#160;million and recorded within the other noncurrent assets caption of the Condensed Consolidated Balance Sheet.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN
- -LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Other financial instruments</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">At December 31, 2010 and September 30, 2010, Ashland&#8217;s long-term debt had a carrying value of $1,153 million compared to a fair value of $1,398 million and $1,402 million, respectively.&#160;&#160;The fair values of long-term debt are based on quoted market prices or, if market prices are not available, the present values of the underlying cash flow
s discounted at Ashland&#8217;s incremental borrowing rates.</font></div>NOTE G &#8211; FAIR VALUE MEASUREMENTS&#160;As required by U.S. GAAP, Ashland uses applicable guidance for defining fair value, the initial recording andfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringThis element represents the disclosure related to the fair value measurement of assets and liabilities which includes [financial] instruments measured at fair value that are classified in stockholders' equity. Such assets and liabilities may be measured on
 a recurring or nonrecurring basis. The disclosures which may be required or desired include: (1) for assets and liabilities measured on a recurring basis, disclosure may include: (a) the fair value measurements at the reporting date; (b) the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3); (c) for fair value measurements using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (i) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and a description of where those gains or losses included in earnings (or changes in net assets) are
 reported in the statement of income (or activities); (ii) purchases, sales, issuances, and settlements (net); (iii) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs); (d) the amount of the total gains or losses for the period in subparagraph (c) (i) above included in earnings (or changes in net assets) that are attributable to the change in unrealized gains or losses relating to those assets and liabilities still held at the reporting date and a description of where those unrealized gains or losses are reported in the statement of income (or activities); (e) the valuation technique(s) used to measure fair value and a discussion of changes in valuation techniques, if any, during the period and (2) for assets and liabilities that are measured at fair value on a nonrecurring basis (for example, impaired assets) disclosure may include, in addition to (a) above: (a) the reasons for the fair value measurements recorded; (b) the same as (b)
 above; (c) for fair value measurements using significant unobservable inputs (Level 3), a description of the inputs and the information used to develop the inputs; and (d) the valuation technique(s) used to measure fair value and a discussion of changes, if any, in the valuation technique(s) used to measure similar assets and/or liabilities in prior periods.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 157
 -Paragraph 32

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 157
 -Paragraph 33

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 157
 -Paragraph 6
 -Footnote 4

falsefalseFAIR VALUE MEASUREMENTS12FAIR VALUE MEASUREMENTSUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
26
R15.xml
IDEA: INVENTORIES


2.2.0.25falsefalse006080 - Disclosure - INVENTORIEStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_InventoryDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1false
falsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE H &#8211; INVENTORIES</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Inventories are carried at the lower of cost or market.&#160;&#160;Certain chemicals, plastics and lubricants are valued at cost using the last-in, first-out (LIFO) method.&#160;&#160;The remaining inventories are stated at cost using the average 
cost method.&#160;&#160;The following table summarizes Ashland&#8217;s inventories as of the reported Condensed Consolidated Balance Sheet dates.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right
"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr>
;<td valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" wi
dth="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><
;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new r
oman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Finished products</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%">&
lt;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">368</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">326</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr>&l
t;tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Raw materials, supplies and work in process</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">180</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&am
p;#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">175</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new r
oman; FONT-SIZE: 10pt">LIFO carrying values</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(51</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline;
 FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(54</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><
font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">497</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bott
om" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">447</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times ne
w roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowra
p"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div>NOTE H &#8211; INVENTORIES&#160;Inventories are carried at the lower of cost or market.&#160;&#160;Certain chemicals, plastics and lubricants are valued atfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringThis element represents the complete disclosure related to inventory. This may include, but is not limited to, the basis of stating inventory, the method of determ
ining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 43
 -Chapter 3
 -Section A
 -Paragraph 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 6
 -Subparagraph a, b, c
 -Article 5

falsefalseINVENTORIES12INVENTORIESUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
27
R24.xml
IDEA: SEGMENT INFORMATION


2.2.0.25falsefalse006170 - Disclosure - SEGMENT INFORMATIONtruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_SegmentReportingDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE Q &#8211; SEGMENT INFORMATION</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland has recently been comprised of five reporting segments.&#160;&#160;Following the expected sale of Distribution, Ashland&#8217;s businesses will now be managed along four industry segments:&#160;&
;#160;Functional Ingredients, Water Technologies, Performance Materials and Consumer Markets.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Functional Ingredients is one of the world&#8217;s largest producers of cellulose ethers.&#160;&#160;It provides specialty additives and functional ingredients that primarily manage the physical properties of water-based systems.&#160;&#160;Many of its products are derived from renewable and natural raw materials and perform in a wide variety of applications.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARG
IN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Water Technologies is a leading global producer of papermaking chemicals and a leading specialty chemicals supplier to the pulp, paper, commercial and institutional, food and beverage, chemical, mining and municipal markets.&#160;&#160;Its process, utility and functional chemistries are used to improve operational efficiencies, enhance product quality, protect plant assets, and ensure environmental compliance.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt" color="black"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt" color="black"><font style="DISPL
AY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt" color="black">Performance Materials is a global leader in unsaturated polyester resins and vinyl ester resins.&#160;&#160;In addition, it provides customers with leading technologies in gelcoats, pressure-sensitive and structural adhesives, and metal casting consumables and design services.&#160;&#160;As previously discussed in Note D, on November 30, 2010 Ashland completed the transaction to expand the global joint venture with S&#252;d-Chemie, serving the foundry chemical sector.&#160;&#160;As part of the transaction, Ashland transferred its existing Castings Solutions business to the expanded joint venture.&#160;&#160;Effective December 1, 2010, Ashland&#8217;s share of the joint venture&#8217;s results of operations are recorded as</font> equity income in the Statements of Consolidated Income.&#160;&#160;As a result, future reported results will no longer include the sales, cost of sale
s or selling, general and administrative costs related to this business.&#160;&#160;Ashland will include the financial effects within the equity income caption of the Statements of Consolidated Income.</font></font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Consumer Markets, which includes the Valvoline<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</font> family of products and services, is a leading innovator, marketer and supplier of high-performing automotive lubricants, chemicals and appearance products.&#160;&#160;Valvoline<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</font>, the world&#8217;s first lubricatin
g oil, is the number three passenger car motor oil brand, and Valvoline Instant Oil Change<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</font> is the number two quick-lube franchise in the United States.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table presents for each segment the net sales and operating income for the three months ended December 31, 2010 and 2009.&#160;&#160;Results of Ashland&#8217;s reportable segments are presented based on its management structure and internal accounting practices.&#160;&#160;The structure and practices are specific to Ashland; therefore, the financial results of Ashland&#8217;s business segments 
are not necessarily comparable with similar information for other comparable companies.&#160;&#160;Ashland occasionally modifies its expense allocation methodologies to the reportable segments as internal accounting practices are improved, more refined information becomes available and businesses change.&#160;&#160;Revisions to Ashland&#8217;s methodologies that are deemed insignificant are applied on a prospective basis, while significant changes are applied on a retroactive basis.&#160;&#160;The unallocated and other caption includes certain specific company-wide restructuring activities that were significant, such as the restructuring plan related to the Hercules acquisition described in Note C, and other costs or adjustments that relate to former businesses that Ashland no longer operates, including the Distribution business.</font></div><br /><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><div style="TEXT-INDENT: 
0pt; DISPLAY: block"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><
;td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&am
p;#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black
 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions - unaudited)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 1
0pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><
font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#ccee
ff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SALES</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2">
<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Functional Ingredients</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEX
T-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">216</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">210</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Water Technologies</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">451</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT
- -FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">443</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font styl
e="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performance Materials <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">326</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roma
n; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">271</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consumer Markets</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bot
tom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">440</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black
 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">400</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td&
gt;<td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,433</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</f
ont></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,324</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">OPERATING INCOME (LOSS)</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%">
<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT
- -ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Functional Ingredients</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">19<
/font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" alig
n="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Water Technologies</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">24</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><fon
t style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performance Materials</font></div></td><td valig
n="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160
;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consumer Markets</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: time
s new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">65</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">67</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="now
rap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Unallocated and other <font style="DISPLAY: inline; FONT-SIZE: 10pt">(b)</font></font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid;
 TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(15</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(14</font></td><td style="BORDER-BOTTOM: blac
k 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">99</font></td><td styl
e="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#1
60;</font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font sty
le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" wi
dth="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left
" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div><div style="MARGIN-LEFT: 18pt"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr valign="top"><td style="TEXT-ALIGN: left; WIDTH: 35px"><div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)</font></div></td><td width="1165"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt;
 MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The three months ended December 31, 2010 includes only two months of sales related to the Castings Solutions business, as Ashland contributed this business to its new global joint venture with S&#252;d-Chemie on November 30, 2010.</font></div></td></tr></table></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="MARGIN-LEFT: 18pt"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr valign="top"><td style="TEXT-ALIGN: left; WIDTH: 35px"><div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b)</font></div></td><td width="1169"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0p
t" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Includes $11 million and $13 million of costs for the three months ended December 31, 2010 and 2009, respectively, previously charged to the Distribution business.&#160;&#160;These costs include former Distribution liabilities that have been retained by Ashland such as pension, postretirement and environmental costs, as well as indirect corporate cost allocations previously charged to this business.</font></div></td></tr></table></div>NOTE Q &#8211; SEGMENT INFORMATION&#160;Ashland has recently been comprised of five reporting segments.&#160;&#160;Following the expected sale of Distribution,falsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringThis element may be used to capture the complete disclosure of reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10% or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 131

falsefalseSEGMENT INFORMATION12SEGMENT INFORMATIONUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
28
R20.xml
IDEA: LITIGATION, CLAIMS AND CONTINGENCIES


2.2.0.25falsefalse006130 - Disclosure - LITIGATION, CLAIMS AND CONTINGENCIEStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_CommitmentsAndContingenciesDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="FONT-VARIANT: small-caps; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE M &#8211; LITIGATION, CLAIMS AND CONTINGENCIES</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Asbestos litigation</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><
div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland and Hercules, a wholly owned subsidiary of Ashland, have liabilities from claims alleging personal injury caused by exposure to asbestos.&#160;&#160;To assist in developing and annually updating independent reserve estimates for future asbestos claims and related costs given various assumptions, Ashland retained Hamilton, Rabinovitz &amp; Associates, Inc. (HR&amp;A).&#160;&#160;The methodology used by HR&amp;A to project future asbestos costs is based largely on recent experience, including claim-filing and settlement rates, disease mix, enacted legislation, open claims, and litigation defense.&#160;&#160;The claim experience of Ashland and Hercules are separately compared to the results of previously conducted third party epidemiological studies estimating the number of people li
kely to develop asbestos-related diseases.&#160;&#160;Those studies were undertaken in connection with national analyses of the population expected to have been exposed to asbestos.&#160;&#160;Using that information, HR&amp;A estimates a range of the number of future claims that may be filed, as well as the related costs that may be incurred in resolving those claims.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland asbestos-related litigation</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 
16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The claims alleging personal injury caused by exposure to asbestos asserted against Ashland result primarily from indemnification obligations undertaken in 1990 in connection with the sale of Riley Stoker Corporation, a former subsidiary.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The amount and timing of settlements and number of open claims can fluctuate significantly from period to period.&#160;&#160;A summary of Ashland asbestos claims activity, excluding those related to Hercules, follows.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div><di
v style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="27%" colspan="7"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FON
T-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new rom
an; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="27%" colspan="7"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times n
ew roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SI
ZE: 10pt">&#160; </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: time
s new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="27%" colspan="7"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="
bottom" width="37%" colspan="9"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font> <font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years ended September 30</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In thousands)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><
td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right">
<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&am
p;#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign=
"bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block
; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2008</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Open claims - beginning of period</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 1
0pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;83</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block
; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;100</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;100</font>
;</div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;115</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td vali
gn="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;134</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" al
ign="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">New claims filed</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&a
mp;#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: r
ight; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE
: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;4</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Claims settled</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%" align="right"><di
v style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&a
mp;#160;(1</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE
: 10pt">) </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font>
;</td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(2</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&g
t;Claims dismissed</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(4</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width=
"3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;(8</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"&g
t;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;(18</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times n
ew roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;(16</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font>&
lt;/td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;(21</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><
font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Open claims - end of period</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE:
 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;92</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; <
;/font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;83</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><
;td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;100</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bot
tom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;115</font></div></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%"
><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#1
60;</font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inlin
e; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td 
valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div><div align="left">&#160;</div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">A progression of activity in the asbestos reserve is presented in the following table.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roma
n; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline;
 FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="botto
m" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="30%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DIS
PLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline
; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr>
;<td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAM
ILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="10"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Years ended September 30</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px
 solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align
="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-B
OTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="b
ottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2008</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos reserve - beginning of period&l
t;/font></div></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">537</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new
 roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">543</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">543</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style
="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">572</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" 
width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">610</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve adjustment</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign
="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td&g
t;<td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">28</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman
; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font sty
le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts paid</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160
;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(11</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 
10pt">(12</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: ti
mes new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(34</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(40</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="30%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos reserve - end of p
eriod</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">526</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZ
E: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">531</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: time
s new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">537</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT
- -FAMILY: times new roman; FONT-SIZE: 10pt">543</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">572</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><fon
t style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="30%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valig
n="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></
td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times
 new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div><div>&#160;</div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New R
oman; FONT-SIZE: 11pt">From the range of estimates, Ashland records the amount it believes to be the best estimate of future payments for litigation defense and claim settlement costs, which generally approximates the mid-point of the estimated range of exposure from model results.&#160;&#160;Ashland reviews this estimate and related assumptions quarterly and annually updates the results of a non-inflated, non-discounted approximate 50-year model developed with the assistance of HR&amp;A.&#160;&#160;Total reserves for asbestos claims were $526 million at December 31, 2010 compared to $537&#160;million at September&#160;30, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Excluding th
e Hercules asbestos claims further described below, Ashland has insurance coverage for most of the litigation defense and claim settlement costs incurred in connection with its asbestos claims, and coverage-in-place agreements exist with the insurance companies that provide most of the coverage currently being accessed.&#160;&#160;As a </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">result, increases in the asbestos reserve have been largely offset by probable insurance recoveries.&#160;&#160;The amounts not recoverable generally are due from insurers that are insolvent, rather than as a result of uninsured claims or the exhaustion of Ashland&#8217;s insurance coverage.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="
DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">For the Ashland asbestos-related obligations, Ashland has estimated the value of probable insurance recoveries associated with its asbestos reserve based on management&#8217;s interpretations and estimates surrounding the available or applicable insurance coverage, including an assumption that all solvent insurance carriers remain solvent.&#160;&#160;Approximately 69% of the estimated receivables from insurance companies are expected to be due from domestic insurers, of which approximately 84% have a credit rating of B+ or higher by A. M. Best, as of December 31, 2010.&#160;&#160;The remainder of the insurance receivable is due from London insurance companies, which generally have lower credit quality ratings, and from Underwriters at Lloyd&#8217;s, whose insurance policy obligations have been transferred to a Berkshire Hathaway entity.&#160;&#160;During the December 2009 quarter, Ashland entered into a new agr
eement with a number of London market insurance companies with respect to coverage for asbestos-related insurance claims.&#160;&#160;As a result, a $12&#160;million increase to the Ashland asbestos receivable was recorded within the Condensed Consolidated Balance Sheet as of December 31, 2009, which had a $9 million (after-tax) effect on the Statement of Consolidated Income for the December 2009 quarter within the discontinued operations caption.&#160;&#160;As a result of this agreement and other revised estimates, Ashland no longer discounts any portion of the asbestos receivable at this time.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">At December 31, 2010, Ashland&#8217;s receivable for r
ecoveries of litigation defense and claim settlement costs from insurers amounted to $414 million (excluding the Hercules receivable for asbestos claims), of which $59&#160;million relates to costs previously paid.&#160;&#160;Receivables from insurers amounted to $421 million at September 30, 2010.&#160;&#160;During the June 2010 quarter, the model used for purposes of valuing the asbestos reserve described above, and its impact on valuation of future recoveries from insurers, was updated.&#160;&#160;This model update, along with likely settlement adjustments, caused an additional $24 million net increase in the receivable for probable insurance recoveries.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Tim
es New Roman; FONT-SIZE: 11pt">Hercules asbestos-related litigation</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Hercules, a wholly-owned subsidiary of Ashland, has liabilities from claims alleging personal injury caused by exposure to asbestos.&#160;&#160;Such claims typically arise from alleged exposure to asbestos fibers from resin encapsulated pipe and tank products which were sold by one of Hercules&#8217; former subsidiaries to a limited industrial market.&#160;&#160;The amount and timing of settlements and number of open claims can fluctuate significantly from period to period.&#160;&#160;A summary of Hercules&#8217; asbestos claims activity follows.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid"
 valign="bottom" width="23%" colspan="5"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="30%" colspan="8"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
;&#160;</font></td><td valign="bottom" width="23%" colspan="5"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: center" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: center" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: center" valign="bottom" width="26%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ye<font style="DI
SPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">ar ended</font></font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="42%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="23%" colspan="5"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td sty
le="PADDING-BOTTOM: 2px" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="26%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><div st
yle="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In thousands)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width=
"1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FO
NT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: blac
k 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: center" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%">&#160;&#160;(a)</td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="42%" align="left"
><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Open claims - beginning of period</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;20</font></div></td><td valign="bottom" width="1%"><fo
nt style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;21</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLA
Y: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
;&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">27</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td></tr><tr bgcolor="white"><td valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">New claims filed</font></div></td><td style="TEXT-ALIGN: right" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" val
ign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; T
EXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td valign="bottom" width="1%"><font sty
le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="42%" align="left"><div style="TEX
T-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Claims dismissed/settled</font></div></td><td style="TEXT-ALIGN: right; PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom
" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
;&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font
 style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">) </font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RI
GHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Open claims - end of period</font></div></td><td style="TEXT-ALIGN: right; PADDING-BOTTOM: 4px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">22</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FO
NT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;21</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new rom
an; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;20</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">
&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;21</font></div></td><td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font>
</td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new rom
an; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: ti
mes new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="1%" align="left"><font style="DISPLAY: inline; FONT
- -FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="9%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td></tr></table></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;Beginning of period represents acquisition date of November 13, 2008.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><
div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">A progression of activity in the asbestos reserve is presented in the following table.</font></div><br /><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bott
om" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr>&
lt;td valign="bottom" width="42%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="24%" colspan="6"><div sty
le="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Year ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="42%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: i
nline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10
pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="no
wrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY
: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="10%" colspan="2"><div style="TEXT-ALIGN: right; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT:
 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; (a)&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos reserve - beginning of period</font></div></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times n
ew roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">375</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">484</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font sty
le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">484</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="botto
m" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">233</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve adjustments <font style="DISPLAY: inline; FONT-SIZE: 10pt">(b)</font></font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&g
t;&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline;
 FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(35</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(93</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="left"><
font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">261</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Amounts paid</font></div></td><td style
="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td sty
le="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></
td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(16</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(10</fo
nt></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="42%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Asbestos reserve - end of period</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER
- -BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">370</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">447</font></td><t
d style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">375</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&a
mp;#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">484</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="42%" align="left"><font style="DISPLAY: inline;
 FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="l
eft"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px sol
id; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td&g
t;<td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="3%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;Beginning of period represents acquisition date of November 13, 2008.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(b)&#160;&#160;&#160;&#160;&
;#160;&#160;Includes purchase accounting adjustments recorded during 2010 and 2009 as part of purchase price allocations for the Hercules acquisition.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">During the December 2009 quarter, Ashland essentially completed the final valuation assessment of the Hercules asbestos claims liability existing as of the acquisition date and underlying claim files as part of transitioning to a standardized claims management approach.&#160;&#160;This assessment resulted in a $35 million and $22&#160;million reduction to the asbestos liability and receivable, respectively, which was accounted for as an adjustment to Hercules&#8217; opening balance sheet since the adjus
tment related to claims that had been incurred as of the acquisition date.&#160;&#160;During the most recent annual update of this estimate, completed during the June 2010 quarter, it was determined that the liability for asbestos claims should be reduced by $58&#160;million.&#160;&#160;Based upon review of the assumptions underlying the asbestos valuation model and the most recent claim filing and settlement trend rates for both pre- and post-acquisition periods, Ashland determined that $14&#160;million of the $58 million adjustment should be recorded to goodwill, which was partially offset by $6&#160;million for an increase in probable insurance recoveries, totalling to a net $8 million adjustment to goodwill.&#160;&#160;Total reserves for Hercules asbestos claims were $370 million at December 31, 2010 compared to $375&#160;million at September 30, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" alig
n="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">For the Hercules asbestos-related obligations, Ashland has estimated the value of probable insurance recoveries associated with its asbestos reserve based on management&#8217;s interpretations and estimates surrounding the available or applicable insurance coverage, including an assumption that all solvent insurance carriers remain solvent.&#160;&#160;The estimated receivable consists exclusively of domestic insurers, of which approximately 98% have a credit rating of B+ or higher by A.M. Best, as of December 31, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"&
gt;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As of December 31, 2010 and September 30, 2010, the receivables from insurers amounted to $68 million.&#160;&#160;As previously mentioned, during the June 2010 quarter, the model used for purposes of valuing the asbestos reserve and its impact on valuation of future recoveries from insurers was updated.&#160;&#160;This model update along with likely settlement adjustments caused a $28 million reduction in the receivable for probable insurance recoveries, $6&#160;million of which was recorded to goodwill.&#160;&#160;For the Hercules asbestos-related obligations, certain reimbursements pursuant to coverage-in-place agreements with insurance carriers exist.&#160;&#160;As a result, increases in the asbestos reserve are partially offset by probable insurance recoveries.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"
>&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Asbestos litigation cost projection</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Projecting future asbestos costs is subject to numerous variables that are extremely difficult to predict.&#160;&#160;In addition to the significant uncertainties surrounding the number of claims that might be received, other variables include the type and severity of the disease alleged by each claimant, the long latency period associated with asbestos exposure, dismissal rates, costs of medica
l treatment, the impact of bankruptcies of other companies that are co-defendants in claims, uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, and the impact of potential changes in legislative or judicial standards.&#160;&#160;Furthermore, any predictions with respect to these variables are subject to even greater uncertainty as the projection period lengthens.&#160;&#160;In light of these inherent uncertainties, Ashland believes that the asbestos reserves for Ashland and Hercules represent the best estimate within a range of possible outcomes.&#160;&#160;As a part of the process to develop these estimates of future asbestos costs, a range of long-term cost models was developed.&#160;&#160;These models are based on national studies that predict the number of people likely to develop asbestos-related diseases and are heavily influenced by assumptions regarding long-term inflation rates for indemnity payments and legal def
ense costs, as well as other variables mentioned previously.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland has currently estimated in various approximate 50-year models that it is reasonably possible that total future litigation defense and claim settlement costs on an inflated and undiscounted basis could range as high as approximately $830 million for the Ashland asbestos-related litigation and approximately $570 million for the Hercules asbestos-related litigation (or approximately $1.4 billion in the aggregate), depending on the combination of assumptions selected in the various models.&#160;&#160;If actual experience is worse than projected, relative to the number of claims filed, the severity of
 alleged disease associated with those claims or costs incurred to resolve those claims, Ashland may need to further increase the estimates of the costs associated with asbestos claims and these increases could potentially be material over time.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Environmental remediation and asset retirement obligations</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland and H
ercules are subject to various federal, state and local environmental laws and regulations that require environmental assessment or remediation efforts (collectively environmental remediation) at multiple locations.&#160;&#160;At December 31, 2010, such locations included 93 waste treatment or disposal sites where Ashland and/or Hercules have been identified as a potentially responsible party under Superfund or similar state laws, 152 current and former operating facilities (including certain operating facilities conveyed to MAP) and about 1,225 service station properties, of which 115 are being actively remediated.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland&#8217;s reserves for environmental r
emediation amounted to $204 million at December 31, 2010 compared to $207&#160;million at September 30, 2010, of which $159 million at December 31, 2010 and $162 million at September&#160;30, 2010 were classified in other noncurrent liabilities on the Condensed Consolidated Balance Sheets.&#160;&#160;</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table provides a reconciliation of the changes in the environmental contingencies and asset retirement obligations during the three months ended December 31, 2010 and 2009.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="left"><div align="left"><table style=
"FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="72%" align="left"><font styl
e="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font
 style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDE
R-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%
" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve - beginning of period</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left"
 valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">207</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">221</font></td><t
d style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 3%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Inherited Hercules obligations</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new rom
an; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-LEFT:
 3%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Disbursements, net of cost recoveries</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td vali
gn="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(7</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 3%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revised obligation estimates an
d accretion</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; 
FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px; PADDING-LEFT: 3%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Foreign currency translation</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><
;/td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&
amp;#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Reserve - end of period</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style
="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">204</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
;<td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">222</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%">
;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>&l
t;/tr></table></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The total reserves for environmental remediation reflect Ashland&#8217;s estimates of the most likely costs that will be incurred over an extended period to remediate identified conditions for which the costs are reasonably estimable, without regard to any third-party recoveries.&#160;&#160;Engineering studies, probability techniques, historical experience and other factors are used to identify and evaluate remediation alternatives and their related costs in determining the estimated reserves for environmental remediation.&#160;&#160;Ashland continues to discount certain environmental sites and regularly adjusts its reserves as environmental remediation continues.&#160;&
#160;Ashland has estimated the value of its probable insurance recoveries associated with its environmental reserve based on management&#8217;s interpretations and estimates surrounding the available or applicable insurance coverage.&#160;&#160;At December 31, 2010 and September 30, 2010, Ashland&#8217;s recorded receivable for these probable insurance recoveries was $29 million and $30 million, respectively.&#160;&#160;Environmental remediation expense, included within the selling, general and administrative expenses caption of the Statements of Consolidated Income, amounted to $5 million and $2 million for the three months ended December 31, 2010 and 2009, respectively.&#160;&#160;Environmental remediation expense, net of receivable activity, was $4 million and $1 million for the three months ended December 31, 2010 and 2009, respectively.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#16
0;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Environmental remediation reserves are subject to numerous inherent uncertainties that affect Ashland&#8217;s ability to estimate its share of the costs.&#160;&#160;Such uncertainties involve the nature and extent of contamination at each site, the extent of required cleanup efforts under existing environmental regulations, widely varying costs of alternate cleanup methods, changes in environmental regulations, the potential effect of continuing improvements in remediation technology, and the number and financial strength of other potentially responsible parties at multiparty sites.&#160;&#160;Although it is not possible to predict with certainty the ultimate costs of environmental remediation, Ashland currently estimates that the upper end of the reasonably possible range of future co
sts for identified sites could be as high as approximately $360 million.&#160;&#160;No individual remediation location is material, as the largest reserve for any site is less than 10% of the remediation reserve.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Other legal proceedings and claims</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland Consumer Markets has established an engine guarantee a
ssociated with its Valvoline<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">TM</font> product line.&#160;&#160;Consumers register their vehicles to qualify for the guarantee.&#160;&#160;Ashland insures this program with a third party and therefore carries no reserve for this guarantee program.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In addition to the matters described above, there are other various claims, lawsuits and administrative proceedings pending or threatened against Ashland and its current and former subsidiaries.&#160;&#160;Such actions are with respect to commercial matters, product liability, toxic tort liability, environmental and other m
atters, which seek remedies or damages, some of which are for substantial amounts.&#160;&#160;While these actions are being contested, their outcome is not predictable.</font></div>NOTE M &#8211; LITIGATION, CLAIMS AND CONTINGENCIES&#160;Asbestos litigation&#160;Ashland and Hercules, a wholly owned subsidiary of Ashland, have liabilitiesfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringIncludes disclosure of commitments and contingencies. This element may be used as a single block of text to encapsulate the entire disc
losure including data and tables.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name FASB Interpretation (FIN)
 -Number 14
 -Paragraph 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 5
 -Paragraph 9, 10, 11, 12

falsefalseLITIGATION, CLAIMS AND CONTINGENCIES12LITIGATION, CLAIMS AND CONTINGENCIESUnKnownUnKnownUnKnownUnKnownfalsetrue




ZIP
29
0001305014-11-000010-xbrl.zip
IDEA: XBRL DOCUMENT

begin 644 0001305014-11-000010-xbrl.zip
M4$L#!!0````(`"I(0CXMI:*7/+D``!.("P`0`!P`87-H+3(P,3`Q,C,Q+GAM
M;%54"0`#L&-)3;!C24UU>`L``00E#@``!#D!``#L/6ESXDBRWS=B_T,-VSW1
M$V$P`N/;O8$-[N&-V_0:YGCOQ?M02`54CU!I5)*/^?4OLTH71F"PC19X6A[[O'N[MW=W,
MYOBZ1V7<_'ZB_5U5M3:.CHYVU=NXJ>19#0&LL?O'UZN..60C6GR,#P[/%\"?
MID:A&:R5-TT#W=_7+J"F78J]B',Q"0K>(.@2R.*#4
M'0<>R-WP.?8Y*I:-8M5(L!Y.P[IL5))V%N,34.%9&N+G?_Z#D%-D_+%4++UA
M?:(FXMA_<-E90?*1:R._U+.AQ_IG!1BS&(U5NI=685>#,87CLWN?<.NL8);Q
M?QH^O`)IY/Y#^!?\S2U\TN?,(VI<-L8ORZ>[
M2;<(\.X8Y%.7>5Q8J7'4A/N?%11!2?4YW0QJF$&2L%D'P7[7\
M(H(J*T2047Z%&:HNG2``)=D`[6O\`!YI(W#,[EV;F]S_RD8]&,CBT$Y;\5"=
MCSL^&&3LW?PK`/PNQ,@5#OPIZ_=<%CY'S>#Y2#@=7YA_:EBGNYE#)$CMCF/U
MQGS?VQ"^URV+^]"1VM\HMUK.!76Y3^VUF(/:ALS!#?,I=YC5I)X#(8]<"^;O
M;PCSZR8$CX&-46/;'S(/VWELB-!N60NBT!%;B_DX6"W/]G)7?;@A`O:VGNWE
M?#_:$+Z_GV=[\1P8RU](;*QG>SGSE[_HV2;/]O+Y>/\U&Z#N^0U@9.BL@2IP
MULG3N"%SK%0S[=.C9\^@/%_?P&:IARW
MO^>@/-DEGY_RP.&:[""]XS]B5`8>^QR>=AS_VFF<[D8/-13L.`G"F`"A3G6.
MY9!Z3,X'(PF1+'X+?$M(Q5;7P0B/Q827EODAC!/RM7[S
MI75=O&I>1BW")S>M+S_#(V._5*NY?H%0FP_`1'P/)`CL0^''@7^"@_4!B6BT
M	W;+#>)^2R?=TM7M:_MJ[@81?LC"37[([=UO\T810#1U8/?F_J
M@7O"MM0HU^UND_P7^9&.W)-_'58,`X@`+N'@NSAZA`ER-?K]JBPH3R-?863L
MEU]Q>.,P$YLX0R*/O-&Q`*Q)502T2?@'(C'7.'AN?6%<,#J2?U+"IM;ZCC[
MG-KJI+LS9,PG^$R6)N:XYY'=;9]O'"Q\9;.^'S\/ITJC,3;OOIIW!^;=FYQW
M1:W);%NZU%2W$VV
MOR+!%,Q4Q;TG:IH+Y#;$NR=\7XQBL`>5CX5,DN87[2=)S)C`,>/A6Z]&3C6A
MQN.#X;J38Y2!'E.@?,#+RCK2=D*46M:O6E^NCXD2L:G4`K&.N//P]H;^=SU(
MS*5Q;6A;8VG<35G]M/U?&<-.GIB@=5&2%TG_TJ*AI?*FP4R](5$U9L;VF1JW
MMAJ5R^0JRV2'N7XHE.4M$LII9GY)8?[29&.I/@=`_E`LLKX+Y+.AL"WF%8OX
MYE/+(2-NVQR6MS\M+C5YG+?I5@5WHU];+M8XJ,Q%/Q?]+17],4=+>@.8=>&=
M%?YEFHSU^X44)[;"IW9QW_A*4(?4=X@5,`+BLD?F&^@1J$\TP_7.)W1K9F46
M$?XEH?QA<4PU"Z>A>K0T5"N'1Z_/UI6R*;D$;[@$'U4W7(*G>,6[(??9UOG$
M_=)^^2-,C\]DY!,K![DW6Z(M>`G*[V44C,J&VX1V,Z=76XBQG#>R]A"VB@3D4MR+LF;(:5LAFY#.FP_!'S`S#'
M#[S4&C'CZ#=WADMROK3+]GO7U/F.
M">0F'%_6'B@>#^8^,#<=XW?C:AMN.G))WA))KFZI$]S.I=]^J5;^2+X'#A<>
MD4%/>!:F_V76HX_X,KY#SCW>2J#\?I\^Y>N^7)0W1)3W-UR4\X7?&--:>*W3
MH;K""O'8K;!OF4?HP&.JDH3,;W[FUF+K;\WE,IS+\+K+<'[S\Y5N?M9*QK2;
MGT:I&M[\/,QO?N:FYO%^TJ;'UKDD;XLD;^FEF(Q5XB-W&>4ZK;CW6^(Q50G!
M!7S=,QBVJM;C-?/;KB%)[W8E[^UG9Z6,4ZY$N1*]_)A^RY4H/_M,)_`6/K55
MY<=\T;I"=F05[(2Q4]GX:#\7YNT1YLJ67NK9U@/.SE!X?E+9./=ON4D8P_G3
MP?I>WLDX8L@E>`LE>'V_PY\IP<\\L=R^+=B+P/,80'3!U7'A$-$GMG`&S_)Z
M^<[2*MN;==A9^E2=LU33&NXM/>5Q<^W)M>>%VC/O]U.;ICTO/G+=VQI_?S7F
MW,DGFTE)S/$@X!D5C!=AZ%I9+2"$6"+HV6PES-:<1>L6(N7]=M2,>;\5?]6I
M6:DMMUR%*CYE+R]3OU.IZ;.UL'+J)4OFZ=J1NMACJ
MQ&2V+5UJ^!]+G_8=E4=IA
M*@N'Z3&+^Z0/\VMSGS-9FI?^N21U:7L_8]P9UZQ7&1[5Y_'XQGZILOP),J(+
M@T/06'/(K,!F%J&#@<<&^,7_#TZ-&S&J&.13Z4IX'?+V7AJV]/]H3GB3M$U*1HD?R'%.Z!
M8S&/^,"U#[5:.449IR8AA"P"7_I`G>J=\?%B)F5UL*0Z-8#]L)/9;4<1-09\
MA'6!<62:52)8V!:*1%T.;>2U+S"GP!"DX:$H[AP0)CWZ8:52/NE1YT\O<'U3
ML5+X+'YGG!#I,I,#W]W`XZU"Q_\WM3C]D!\]9&[N&4.A5$P,X;'
ME2;*G/_+\S9A2'"AK=EE'!(`6-,.+$;4(4@\&[>,F.$425`DZB@-!0MZRT4@
M)\PM*KDCU*T)4#P3T`?#G8)`I11@;3`;V!WWAZ#9#A\%(VRI@GJ=)XSYY$YX
M\!K!@1?@Z!?8OZ?V8Y,"\[8/4\_$XP&,2Q_P
MEPH>^"VW@'/P=,0\F!;X(:G-E&>1DOF:XFC&@?]A9T`.7P@U7D)V"N'G.0&.
ML@8L&+DV!WXP+0G@&G6<$Z?,B;DT9AMRX[Q$XS"B]Y/J:+,DEP,7Q&4>"`"^
M2(*QJ49ECBBU6BJ7M1-7EH5Y7%@9.2&B?/$=YOKAJ[)Z92@IK90.:AK*XZ[Z
M/:.@B&'\#,&"YVO,/4;[\'.J)4F('6-)G]_CHR$%?5)BFN+/$UQY0/DW2K5R
M-K9EA2V&GD]AG*O!4M2@GAF=`&/P:6!$TUBH@E6R;3O
M5[2"#P:P&J8C?%@881!!)$@X[W,3G1Z$%X`-Q@1*LL);*>"'AQH;6-7H5YIY
MX",#VU^:>UQ4,3-MP^EN((L#2MWC!GAZX*YI"PGQ7)?=^^G\S/-#<7X7K$'+(1J+N-(;M-`7M31^-VT/.4&=`CW5([T`,IV('$
MC0XU)O0I<@?6!=R#7P)LRJ>KUF7[)XCU_:&PIMJZ]';@.%725R9Y#U'ZE^)USBGMEH_
M=(8,5HSX[/7,WUN+\4R#@J-E':.^Q8G/0?K$9XTOD+S5.??J7T%[FARC#/28
M`N4#7E;6D;8U/AW.I3&7QM61QK$+A2FZ5\:P/W4S<%V4Y$72O[2H?JF\2>T]
M+'`A8W6_PMVX+"E;*)/I_>4M$LII9GY)8?Y:?B[VJ>5$5Q'D,SX+RZ.Y3;<=
MN'W^VG*QQJ%C+OJYZ&^IZ.?)P\:8=LD=+H=XM<03>-UR]@VO]8R5GQ$!+@GE
M.3_J7(5/0JK[BO!FB?#!G=JVU%>6\;,W/O&NXWY9DR<^U9MO9L;@VC
M9>;%?BI/YM)%<,Z<6'DNO97:M%J+7'I[1W-6<]C<3'JY`N4*]`(%VMMZ!7J%
M?>-W=Z'3M7Q%]'H%U'8=]Z^6R>:54L),/C9N.
MCSD9?A-VX/B8WN22V\R3T4?'%N/'NDG<0C?(_-+X6ISN3NT1#]D09J"^S+_4
MR1V^Z907E_!X;-RHG6ZF6ZE&F6/_Q]!C3^T5C_^IT;RX:=8[S9](ZUK_@A_D
MHM[YF=2O&_I'\S^_MGZK7S6ONQ,?8%]0.:P[%O[3_"O@($28+$:/U'),CU')
M&DS_2P*':SP#P+-`+&;R$;7E6:&X7\BDH[A7+:O_)1.YR(#K0.5!X7-M[U6(
M_(8GS>R:5*72!]_!Q>N"IGSF/:HFZ7T*N##=NZ73,$8"T^;<9C
M>IX<8]6(.'A%(N1XLA/W65S6DOS$PTF55B7,5:3CN"L!5I.H@HFH?J:K47D"5TB?2HU(E@QFYS)$Z9XI*]";98UHZ
M0^JQMQ1LM'QF5LW`2VI
MD@EJ!%M`"B;4:SGJE0Z#:X';@
M,TN9J3$F5-),J&2+3KE4-<;0WUKM#!\KX0!_#QHU3%QFUZ&VW207G?';_!%)OU]
M0(/IY?98X\>["O^+^PU$;3C\W^2.PNRL95&..9",4GI787(+8SQNYU(&*BO2
M1/'B62%\*^S5[F--Q.N#
M5>DD17(M?$:^1A10.8R'>+@47@3PPJ9\)+]X8&I?PO;#2FP!%QII/0B$*3M,
M9NQY!(+:@.OR'W;(-UOELP1CAL&+B]9R!Y-\9^BQZJ':H\V.6H/G6WR&C(/]
M"<68-<)J((YN['!2H^="/!8I[D`@J&QGJMC!W$(5@6E%4&YB("\R5+5*6J#F
M&F4=2$/S5CMZ/FDH(UR%?Q,K6.IAAD;1CD_!%P/\HC[S'^"_)#=UKH28IZ^
M>K'TU8W`BU(YJVS1<54)T-:PSH2N"XPGU$C)I[;8?Y_(M5^F2\(`[*YRF",3X8@0&&I
M-1A1>-.22V,M+UT:#8L,Z%N2"N49XQ^4)A%06(E-2)@TFOEI)Z@&J&
MQR06/.X(7BAKOY/*I_X!@JRX6UAK`3.)JQSD$+S+_BQ!2!W.S78HL5=/E2&EA\1DF#6)])HM"Z.$R/,;W,6BF%AL
MC!EF-FG>F_H."II1+J7>K!R$56ZRZ\"UM#$5+G=">PU\H@.F=]&PW!NUD/^:
MQD]8#XA+A0`T=80W4DCA;HE"*FG[DZH=!+[=4[4",=4*N@HDBY(^Y1Y)U_-+
M<2^LPS>U:H4,BU]HC,2(^W'=0.[TA:KUATM=5:!+^`YN+UFQM<6BB6JMILMW
MJ?IVS,?2@`[6#DPXG1H#0.WHHE[0A>W@I:L`Z[KB[A:U=)D\YSM$6GY4\R>S
M?$9=#W&CIA"]V"4@FY!FE(N_*)QTZ)?4$&;JX'RBHEIVA:0;76`(9RI5THD^=X]W56*[:2])[$SMM-SYM,IB(0D=%.DFA<[FE]_UEH`
M;R(E2[)DD1*Z:B:61`(+P+.N`-:*VX_I12PD!&>*R.E:<'.+K0`/0&N:4N`W
M#M@(%#0`:*BO95^*Q"A@P0&A`L(L*'_HS#E(J*+%*-O;DA,9PI
M/(DKY.&2HL_C17Y&[`5B0&M96J0P;J*+A8:1P31/`@JNW0&67%-2K/S[=ZF%
M^YOPK0BE\+\PB11[$-;0]1QO@)+VH/A=YLUOPB<9A`+_:YR!BAV4?OV.`)G:
MOFX0C:#EKU20"%Z:_N9=*=_<9NSTX^DJGEBJ#%4,LP6(-JFJH"9%YP#I@0`1
MC\6D0RRDJA03?!/7>"X]OYBUV'/%UPZRG\JI[094S1NEB.H$ECM7T4V7V$Z.
M4,82AWBWG!Q?.,3S,)P<.:E.`RVI"1@
MF0Y?1MMH0R/(6%0(T1'_$S0G#`8]X@37T4B=6POQEEGN\SE1+!H![%P_.I@/T?-$:009$UG#,CVB!4M1AC$X7J&Q//-]2Y
M$P=8*)$0!^H=)'3@>385<"3=`DK<5=$L]21(;@$6H#<1*"E<$)(@EGJ.WNJG
M>LUT/BWD/^(BT[FYH8E-*]E/%\[FQ>,#T*'[*'W/13R0\3P"_9/:K$07?!M*
M7U<&3U@5
M4Y61+N+1Q^EQI'A48E:9O@'(-IS*M):N)4%OCE"76#1=5AC1$)4(M\ALMB6`
MV\\6T02=DU063NE5K:JG-3P3HLAR=Y5XW3.9^$HU+;,F64X")OH8516)*8!$
M;\)L8!.LC!CSF?#5SAEB#=8*_#2KP<8>,@+@#YA6#&3@D&/1B+U4SU>UZ>$W
MK.-NS0;]E6XR`X.&DB,\((XD[Q<=SM!75=5!!3N:`:7>MZ.^1IXK*(@I8N_9
M1_@U0'`\PAB(G;0WAM1;2;%Y]700^R'@MEA*I`XGMN]9W.]Y;E-=2(CS:65+
MZL6%Y^EX$CXQ5B?X\)2!TE:T#^(E0G2>Y(37U;S"G,*DSI$):3!XW?';Z7.E
M_P*MV?S3]9Y<\(516,(\X*S_\!'XR?5@Z4AX7^+('O4=,:KZ:$<
M;8:2CSM.3DV-DU-3(CZE5#@PI>]Q/7AZ?WOF^:85[IP4+ITLWEN5AW::/1'R
M@J'=7=T_W'V_>/A^=WWSF74O'JY_OWXHJ;-\!ZSA@VRA74-HZ4Z9>5U@KT?B
M[GVOO_PIM[4]:UJ-";'AJ(YRJE'U8TP1@ZZQDY3!+_+PP.>CG$N?/;/4R!U8
M2J4^%3OV!2I9VH>,F\%33SX9IQXHCR&%7^!'L/+U.5E0W3X9ST"%X",<92XF
MH+;1D6#?0]L7;0*,$5"',>6"M*O@8'WT]-&AF2670T^IKNRHJ3&ICAPFL=1`
MI,.(PZM`+/@I8+&$PZ`\B-LZI_WVMYVTUWC;E'*?PV^9$&JF/#W&@8"61KQ!
MH4:>U]F)/VGQL0J%EKDC:=1#W28ATSY9&UH3&+X7^>0B]+F5-4/B^4/W`O&I
M/"`_O^PC#A:%!=.%;?4C6@$=M&FPIZ&$=5`6BO88E62(.<'!@PV7#9/6[:)*Z(P2/ZM\44V)TCHG,OTGD5#!TGB.NEY
MSLJ9OU-,I??:2"#I;2T5<4[PP.*+[*E[F@2&\>S?0,>*4(L3>A4I>(1E1APX
M1UV*U4+GSA02E>,0BR42(+9`1T$?T$&+.T0&1<<'V1.XBH0;5^=OTI-`=GJ\
M2&VT9'::#'@W&5WL>X[C/='D4]3$!K=3`B9@B4IVXF"]U:$;"L.KDU1J_ZT,
MWAG!IE968QR#?1&)+][ST-%.4:I>X,I.G&@O-A`%EEE`Z63HG:GWDF8Q;A!O
M\>H-[<]=JS+\S`OEM2X:XLP&%$@4FJG:]COY\B83UE#7=+8'RG>)X*Q!_0
ME5*Z,AIORSQADN)`A*$C[!4\%5.PK9(RJ!8%VTHLV!WQ=[95KVVW)%?B`!4V
M@)9R?DSYJRIZ3K4H?W7XDH*LNUS]:KF8S,9'8.I?[:>;LX^U@TP(9'Y@M-TR
MT9#MJ__3`RD!LZ-B8'4@PF7J9^\R@7@8I'CA\E89&^EQS_@]S.2C3?_F2]E
MC(].7X'_!H)16NR3X_&P>.E=_4H_SKYEW9I54*=]?G[6:1^VLW?A,RW.*IC*
M'7W'9,3#.'DB9JE]Y-+!66_V/;^)3X&_%&=7G%O4%AZ%:?^J6IO<]KMQ2Y\\
M'W_,)&E<^I;\K"*WB_=9_VG`RAV%:J`OG8VXW-EH[(LAWNQ\%'&JGP-@E@`+
MD^ADQ%3>N)E+35Q,F)]I1Q6)B\O`+3G8P]R:SVEWJ9%\X])N8II*5=RU^,7&
MQG.TD?';&]+QFU_/3HOE#=8SLJX%PC12=_/BJ^W9Y_&Y
MYY_*M;JYF:#JPH4B2.N9BH/>._9_V4+/;6Z`29D7+-M=J)JZ0P/%0KDK8?H"
M0XTJ?Q#\@>E6P-JB*]/_EUUT[W]CW9M+]S+R=)
MAZ(Q?-(Y5^(IHO(R*EOA0)"-$4G/I,)2Q1OEE
MG)F+G"1V5=DQ`JSTEA)2GB5JL?0;`1L*1R6RPK4OSPS,XR(74SE&DO3;SZ4:
M84\"B'][=GS"LBFNWIYVS@O)KS"34X!P!.9Q)O.2E,PIGO`\D9E*!P5JI_.>
M4(N4?*,G'.]IOW+O;*>L0";E=)81*""FTY"";!0#RD0G_$"G;O\C\K%8612H
MI#$@U\AFR*8F+8J,]V,?C"$JJZ&*IP-Z1DIBJ2RF::IGE?XXY']2
M1136/C]OZ4(CKLC4&:'4;2A?`;)WP.P3#%#]">Q2@-.:I_7"\\>>SG]U0#V_
M:V!A%\_'@@6H<*0M,:UNFDA=91]*4FEE\OKA0TEF+9VA*DG(@TF0.(@R#W67
M]X1*IK3Y&=GHTN(U.CF2*EM'*7"G2WKG,Z67%3$.8KTB\AD-*<5ALKA:BH,^
ML;DN+I++;3VWH$#ZS5<2/2./)$=:0&`JV5.V/@_*P#3E^,P\Y:\L;(P4VT@F
M[FS1B$Q%CF_\$?FGJTN*T.80<6GW6_?B7P%)W=0"+UU6G5NT8.0&,ZS<_3*<7C-I(<9_/3>>^KC\2&'=GUVA+*//
M6G4J]1K7VXE;GLZ8N&)&PC7A8Q4UEKS3\]F'9_HO+'_Y\;OZ)NP[.=^UA'WU
M'D#G*)M_ZJ0>H]F54W;/GUQ[?7:I[Q&[)1&^,:L`4S\+?U/3\5#0>\L?D-XY
M[EGABLK):YQ6?(Z95KM:LVU&VXS&J2D_9HS.Y1EQ[]3VKR_BM>[&$PEOM5%DEK6J3L+G*[N7.[K<;)C),9)AH
M.UNFBV3MWAGU/LLM5JG@Y.8.M:PPZ;42;R95^N:V8E]2S6$G4J4;_C'\\P+^
M67`G>'?Y9TG+H#97C1>\[O7RX^OUN3E=">FQB]Z%N5%M^,KP5;W&5"N^6L/.
M]=85KMDV,]MFM=XV,Q@V&*X[AI>J::6#N,GP-Y_HJMUJ93-=);,:>N,WQ57X
MU_7EPV\_L<.3F3=A,]0O/MUS<[%E[\:4)/M;/.J[4)1\Y01XZQ_PIU5RO26I
M*#'CHHR3SXT]'\]:8_:XW"6E)QZPMX>=?/;H]CF;D3-ZP:E>"/);3DN85I%;
MJCA"6G$AS3P:3)59H)-\GWTO&N]C387+J9H*OU_=/UP_?+^[6JZ0PJ8F8N$\
ME2\AH"QSY>LN19S2-MR94=H!9)`=4=K2WH3>+0,).\A^>@>]#Y#*F?4",K4A
M,+\\=Q5%*C%PDI\]5+6]L'K/."["F!3'4,47WIX?ME*]TQ-]S/F=;;TO],T@
MT&PB:&13V8/$#9MQT8HGS_\3_]6%_7*)@*F&$.:4QV/7E`B(>XJ7VG`%P.LU.?Y$T4^#%$M10`##?IZ
M?;'BA"KD!PL"G(85!W1SB%S*DC\_?W4.QTFR957G$UI_>]@X2FV;;.;I$>"'
M+IRYH3.APBJ.('M))>"?".YKP^M>C$-M>;4REI>`-[Q),+4ZG09H>OT;@=?R
M/>##&S#&AJP[$CZ`@5Z_BGQOO+$TSD9`0Y/WNFX.(#,K5#13POMEZ>7%#QFF
MU1HNRZ1J`^3N8I5]9C&-3Z*NH0LSE%5?F:I%5%ZB9DZ:>#3[467$^JJX3@MFRP;U/?1L>:/(RM7J^NRF!:>KW0"0")U,A*>U5
M%^EXWON:5^M&5>8YS7M6,QVK.4(-`&M%OJ]$$XZ'3W-"'OYP:,C819EX2)%XSJO=3,CD0Y#%
M]LA4];&9$@>@+TDKCH&;_9CQII2\*JZ0,S"`_=T@AJ+B!+2;@%)@<^+.GG#!
MV-&&T!.:G3?+52*`.F2
MF')*8!$YN?IP9/C.-<8N2!3DR\0`0Z"5XV*I!\6>1PE[KI177R]O+(R3TE8O
MED"E0S*\N]E:A	*NX!B0LH(30K-HHY6]G(6LQB=@)M3*L"3IB[0(+H)3^%
M"K^I+P+MX*#A*VV%1N3]3)&5F(>5X:F1$;-Q*1C^167M$G,^3T'"&JJH1-;1
M>D2S6I+Q2U";`Z\U3[$MXDE-')-P,B:?)J8[GJ$9,TZ*3>EX'LP8NQIQ8L'/
MK3(U7?XS:X/";8C5GPD0KI>!YP7*USJ$UY44
M^:79@##<^@@S=:T2>9BIL]58HFHJP5Z9*3'P9U2XFM%>KHCFLE4XTT)-5%1>
MXM-:KJ9E=:RDPL]/K\=U*^G7.?N%6Y<'9>_L?#&?TTX=C\[MQ@']=>6'KO38
M:GQ\SJ#1H+$Z:%RR[-3K"_;53W)6"TA[F*O_115P:LM1!I-5QF1VEW*/0+F9
MLDLSM4'=;MNK4Y29LDNLR2*71[8$U]F48#)U:$P))N/4&.@;Z#^G6E<:E3IX.AHUTL=&`3O.(+/CW8`R(WBG1(&!\IY`N7U^NN-07D>2\3V)@M[JBT9TKEX?
M/EK>VS?9D2LI;>J09VE!"WMGXTF&B0P3O=PZW7,F>GF*\25JBNR6`7"14_WY
M<\8O-P1,'N2M!M%JD0?YY/AD"PM3*?EE&,@PT`L8Z'S!HNB[RT!KV97=^`A,
MFM+]C+CM38I'@V&#X;ICV&R)9J;L&Z9C\L-)@_*JA"J#Q5^1'..E^@:\'2[A
M(];,C*V`H*C168GVV8)U[FHK&`R"=QS!I^<[CF"S+[KPA'[V/)OR5U'F,3?D
M[D#B]7RS0VHV=UY9+IWM^^Z.X2+#18:+S![IUHR!&\^US#;I)C<3MNM]U&*7
MIW.R][L\AH$,`[V$@1:,4.TN`YEMTGV)NYDMI@JSH<&PP7#=,6RV23-3]N!S
M+"O`)YC_P%P>K8!%6@59T#DYVW$A8!"\VP@^;!_O.(+-EN@RJ7Y\K`B1E(Y)
MR[AD,M6_/!AJ-G5J-Z2MG7Q__=6IE/0R3&28R#"1V1C=]N71F95J7FX-F)V=
MK7HA]=C9.7U)%HF=V-DQ#&08Z`5^?L=LC9JMT3V)OYEMI0JSH<&PP7#=,9Q1
M)1^HJ&.9\[-D?6\T+:=,7ZO8M5LXW)N46?7Z[.U94AD=WWM[GJY$\KVJ]EI:'#U;?TA]
MW<"*LEC+63X*!^_5^G+$?>E,LC7:@:9F4D.9.U@/&J_A2AUTCTO+_\Z=1P\G
MF5V[08CW-U9`:_2->65&-^)EU]>%HU&K`G`43T
M.)7#=9DM^M*5N"[9NN%8E9NPX&N\P&K]*4+V5^2%V,106D/VY$4PMA[6UW4#
M@"$.(@!.`3!:N"R1Z_6P+C=5>-4-2'<<0?L'7V@PA^]8IJAO2B0;2H"!;PTG
M,RMX]/V.SOU.Q7-==JC,\4]BZG9EYD9V/!K,4*!-=4
M]NDO_G6E^NUYCJVB;!QZ=`<2%55_U]/0J^_P^K!(N[14AR]LAKZWP@$
MLQ+;L>H@L:X&W#GN_&PW+X9B)`7K?F8')=^_(T&`0LU-Q0IQG"J_G?`:23/Q
M8PSMP],#Q^N!X/^#UOE1K3-#$8(R4;T9N;8_81;V8L&C`>@4SY\I]T*?NP&W
MJ"_+\;3,NP$UF5-/2K]XHYY$FL,A$,QZ40"?0(@'/Y6UKBL!+)Q
M*VS@>]&X43:'N28^J0$VO_F>'5E:W=^#YI3<"2?L3D!SF58C$-T->D;3T\QV
M0+,DFO\0OML70<@^CWJ_L8/N_3_>J2KNXH$L7$6H
M?KG;5*HBOR8]$3YA$?=GX-&@)5?:(C%"H$_/Q\4#D'DNF0"6!UKC/T)EV8!A
M2A<60\35VO-=:X4A86ZL;.UW5;*^7#4ON%@TC_?_R"P]T>8C-%$=DEY\VSD]
MSUM'[:/C^(MI.\>.?)Q?P6$"TE8S=+"1!PN#983<$*8"R]$[`H?3EP'B>R+X
M;'2O`!8<01D?PU0J2U/9)<5I'P@7+;/L3/`Q6&@_P)`+8:PX#2=%,Q'7'Y=J
MH6'NDT0_>CV)?JE`2/(3&'U(LUW*7#D&24SQ(%4#E!Q@R,%8Q'>]<>RL!`*^
MQW4.AF#BHD6J![:$WZX70
ML;``R\IPUF3V)HHF/+^CQA[('RO-1AG5LV:&6V3MLS(1I"=KV0%_I^=[8)CK
M?H`D<`M*&P"7PL4)Z:'?`5)(V"3Z,R:N-LRUQZ$G1A%&8X(W;8%MQ;K1BP9#
MTNO`_EP&RE&S4,"`PX,,#W3I]4]4_Z9X>UGFVDG^_C[6U@URN5[!C.'3*)'F
M=AQ80!,-5%H[T6@NK.&83\A>`_C&G`4+RBU4A=RUE`Z>7N#9:A?`$DI+CGDH
MXHIY2"E/XQV`(8L'PZ3CON^-RJA.!5D!3VN>TZ_H[Z%MV`:?E_N`_X:V,,A>
M0OK&H-*:\;3C5#_*)%8QRCJ:L]FBH6TC$%)XOM`*DZC`E&[M)!;&W(G.6%(<
MN%*$_`<;8,P$[9;V>6JE\%`M/[GF6M_/E`8("1W->,Y,**7NDS;[1_P/,/S`
M,-'M8B>)&X!?9%LOCW:EF@A,-H<&BB\"G*D@(WPD'/4Q:#(2X="S?V9#[TD\
MXOK1U-O(C/!YP.
MLH5C$Q]X"@:MXU$:3*6VZA@%IB@
MP9A;@+%?WK34YS$J&/TYWNDY3;=ZUE@E_NQDQ@FW*IXI,96JZS>V73ED\OR6
M]^NSTNKG2ZH%I!>AOYYUVKLK9B;<.6;:D/JJY0'M@VLW=G6"=\MCP^C,79<:
M!QF'9NT`V15-O*$-T26RY,V58!L?VW,GFU:@NU8BPF3/VIQL.'I)"LU=SIZUC,.S
M=0E@\@[MIEMA\@Z]4HZ@5[WJ5W:+=.I"3>'N;?X.W5\14-K'BSQX;TB_JV]`
M<77L@>[8^8*'=.M(W4[]_O[^/?O<[7Z;H
MYB5)H`NGKL<]9FZ(Y:XY9WOO2Y>[>*V>@>LJ\*I])F]-/FE!
M?'U+#S>YOA7,N+]5?J:1*@C\-IQG!X)1TU/JE&'0QZFMS@#ICU,
MO";LO)5TQ^P]V(^]/Y;X!K;4IPX&.^+."N)P\$IH^7?XE]7`Z+
M`N*!O@9!/`9IE(H8RH,R$CYPW9^@,RE[FEK2!@C.0H*.3Y%KZ6O1U^X`N%"B
M_&@@2SYX_C\CE/+?N!^"P*-4"SR7YX9N<%(ZL:E+Q*?'Q?PAS)(/`@SET
MO5"HR](%NF?>1-503Z>.+IMS%U;%F9E[Y*QD:&/0($A0@PVY/?5"I]5B8C1V
MO(G`&]NH;^)^,/;F@:A'"0TXB?HPK>K>.?R%L;B)R@.GKO9^]",W>)+6GPWV
M67C^0/)9"G(,`U=*`:1P[GI^<4V'>!599W'PZ,:M=".ZJ)U2E$K\<9S^A=9S
MR)T^]J.16TK.3.'Q]P^PNC]=RF#LP51_QIQ%#^)'^!%9]=?__B_&_OX_S>85
MD`.S$*?!OR-%CQ.$NBX*FDWUI"WD3^I1_63RH'J.Q@6-WXG^+V^L5JO5[KSY
M]=\B^/N'Y]XL4`*/^,0LMOC!_B$F)22H1^@)>*"T;_SGL'7<:A_E2,B_F?1]
MT;W_C1U\O[^Z?,>^W=W^?GUY=W,<$
MX>S>B!`/EG_SO4<)>OKCY#LPVK5[H589!GF;I!HAB4`T1D#<&U#2%B#8"7YY
MTSQY4SJ&YM%AB_Y3*[E$7U4>V.F;7X]/7SJNJQ^4I`1S(O1`.O=EWB:DG"UV@8'FM+\M
M0D]7)S2;*#KQ)S359(!3BAQE1]J99&:%P60>2[A$!2J^>$&`TK;T$95C[AL8
MKN(V"K\)7WHVT'G;!ZJ7%W=%4&V"KIV?.PI1RM66].
M^WEW8D!!72#FAH]$T;YKSBHP6L)'C
M*#IF0WVD:#8%37/>D.>B876O?O^&/U]DFKE2&GL%IZ"37=C%>JGJ<`"GYR\8
MS:7H8?[[(**DA+0UP$<8*/@/8;I@]F1^N^TG[L$%QBM3:G^0J0#'-=
ML)T7(OG^X?;B'[_=?KF\NKO_/^SJG]^O'_X]32?A:N@YMO"#*[4=LK2-=GAV
M>CI-8+'=UR7K%,EJ%:R1.61]['[IWEQX#N[_Z]G#U]>/579IGO,G`0QUY
MN$L#+22?%%O^7Y9Y^?+J0K_;7N#=M0_\K"3ZL/NC/ESOJ+]Q:3[SDX@CDX*]C0+YB#.X%Q>G33N>^B9BM^]?PT+-#(
MNF>BW0+Q=V2F`D=_#%-Q?+R,@GIN*KJ6%8TB%795(1O:=A-#L''PU((#UOKS
M3VDO]0"??O?\U&V@T[6CK@WNP>'1.H60F>H9J(;OI/W+&]D^PCD_6<;0F77!
MJ2382+E4OJG?5P[AG6B#.Q]I+&EZ.Q2"I7C:*8B'9RB\'X+]W<3D^M`\.`9-
MJFC%_K>PSOC<`SSVT?-][XD\M*4GL,2Z+C:[!=)PYHI6UQS2+J]Q3_+F\IY]
MZUY?LF_`=A>W7[_>WK#[W[IW5],4*HN1D'PI<8_`M8-OPJ=-(]HY`',B1W(G
M2W*GW/MKO6\?I]0NTL5VR#^XI@G6,25WD`:=5@C7
MG4\CHJ395R2)PJH%!II'TY?KA^O/%!!LL(LOW>NO]ZQ[,$36'2DZO?N
MW747NPM@/ITF6.E!IM>U'HN[N7VX8E]9MMK?(M.^1V?GMGUPL1OT!'CN`<.=
MP`$%FLSL;_1L.!D\OPG?BNC`-&=/8+]AJ36JZA9$O4#:$@\XIF?$&JIP4;;*
M`^UZ60Z7(SP>YX@!'0P&*Y!.)4KWCPBK\'$JE=&;X/XSR2:J>*27O/R$'_X>
M2'5,/7/F6!'NJ@)&T=@FJ8J%3<482UFX6#P,"P$*AKOZ(RHEHPIXTE&XN,^$
M9"J&HJQJ=0YZ`,8TGHWTI1<%2$,TBFLGI=53M`_Y&Q]))\2C>7!>W$=C!;W?)K]UW,T\VJE/VGN,-)BR>N.R;.'ECW_M#6&%Q
M7#0(/+5.YW(<[@\$U<_31=7H!(`O05>(ACZYCA-(T]'L2R>>XT"$H:/*B?AJ
M!+8,!+3)1O)'@PF74Q$:7/#`X>I\H@=+H">VH(^VF5F>ENN-.AV=A43U'U_;$J5/-[U,=P,45A)+X#__^`B(?
MHY[2>JE1E5<:TT@W^GK3^CH1CRMK6$H307>L.):6"L*,*D-QF2FS3OHE(
ME>=65Y1ZCE[C8$I2M<'_*I-8\4TLE`EWP/D3W(CY$V3$A>>//5]+%ZZO.V2L
MC?UBZH4=IC7!B(\PRD0*%42Y+@.8JGIE#Z72/*/0L3XDZSN@1",\JI$IWQZ#
M9DRG?L@VH;_*[S?`4H]&>:NR:)2IDYB3;#4P)?@SIX]3RU77`UL;OD]XJ,\3*.``KYK::9=IO+`J!`7KA;RS3<*'N]_R$+0N5#*W)4KZZ
M9%Z1SDKQ]6PR7UV8UF4Z#3P-/"L\G0:>!IXUG'Y
M*X^0;:`KO%.O?4-V+\:A9LH%JQ;6%!O/:)9U;W/6LO#(P36FL/6B@+MV4%+-
MY3D979>`ZF:U=L:@JGY)A*5"JOGA;`SB&YTUO([W:LBNG.MG&-4P:FT8M75N
M&-4PJF'4RC/J=C3J*T'AU3AU)\9C6+7:K+H=G;H3T#:L:ECU55GU;(=9=>%0
MW=Q2P7L1E;O-W,]ILAY>#7/UI1YU!V<)F&QQYV%!8;9XM;QM1Y1?6.%O&HO9
M]_4&Q8OAN?GY><%?9XV@9/M5O+N-V&@0P#&08R#&08R##0
MVABH?6P8R#"08:"5&>CP:/D83WV@,".0\S24H=B[,`XF;M%1',J2M1M1FUH$
M%!.F4<=&'1MUO,XH9:G:-FQFV,RPV:;9K&/8S+"983/#9H;-#)O5
MGLWV,=*SKT=V+E2<1^7<-9$>$^DQD9[:X;UV,M@H[9ILK\%;.N5A#)LPG,*R+<;*^
M,1GC)6.\K/V:>'XEJFC<&%XWO+[KO'[0?M7\#]N*`Q@^-GR\XWQ\8OC8\+'A
MX[KS<6>%_>&Z&]J+G^N:P?]'>Q-'S*=I$JZ]4H*F>;B!N62V%_4+JN;)*+0:$J:%Y*R-63(W?(REEM4/MJYI3]=;["_JAA\TJ,
MP;"Y8?-%_UHJ(:-A<\/FALVKSN;+I;@S/&UXVO!TY7EZJ:Q[NP>F-605VSJ+
M5_CT[-SGV>-`,U`S4#M0K/FH&:@9J!6G4GS4#-0*T"DY9Q:SZ$''RR
M,M\.'=U"K"+??-83G'ISM0WF]EG1(6Z?O.]D-IG_B()0]B-!3P2A%S!X1OB/@LD`7H&_
MW5#8\4-]SW&\)ZR<1=/[?JX3O<1T/;,(KSKQI?A`V..(8S*60S"SA.,$8V[!
MS/WRIJ4^C[EMQY]CUCY-&2CCH;_XEMRL0T)5#&0M=.FOW@/H',%Z6!XB`GX\
MJ<=HECMHQUSOR>?C7]ZH?^LQQ.J$MS"C:#188!7!U;)0E);
M[IF+OTK)L1K+7H,.@PZ#CNJ1:="Q!;MLE;O*53@UM`K=VS?A-A-OK*FE=RDL
M,>H)GQUN^39QI1AU3[%]>);%=KM5=W#_6W!?^R_L7HQ#C?1U'4'?!:0_HY+6
MO4E6RYOT!]8FK3M]\+O)>F(@71>/
M>:^2?Z\FNTDK[,QLB.2WRU.Z\+7^-9-Z?'BZ_FFME'0P`-YM`!^59&@R`#8`
M-@`V`#8`?@T`GY:DPC0`-@"N"X!/RF*H.P7@-:2'VAW_^$Z[Q=S&F\(C`3.V
M3E^X4L&S"@B"EY"\+8G0W'%Y8(!L@&R`O'54&"`OON51LN%AD%P96!@D+^XN
M&R`;(.\"D'<]ZO/B.F_/W9W:'9>Z._(B-PS8F,L5;FE7NC[F8B"O04W#30YI
M6R+HH%UR8VQ'SK[L0K%WPSR59IX%-;AA'L,\51W2UICG\,@PCV$>PSR&>0SS
M&.9Y3>8Y6O"TPJXQSZ*'&&9PV-QR=[L5C2E>`!"NO=+1_U7FLJ)1WJ6JO57[
MT-1F"@:N>Y^C<[*%A:E4!/G%#%1Y=6_X9X,WDN$?PS^&?U:_%K6[_&.JDIO3:U4]O;8W";\-A@V:K-;D5)-E@
MVX+AZTVPP;#!L,+P9IW1N3?F2%E^KC/SQ<>:DP(;KR'^"":52\#YW!P(/
M"0CH;\1#$318-Q@ZW+69+RS/MP-55Y[N>C`9LIYPI'B$+D(/_J8?\>!!T@`V
MUH_"R!=LS">8:"%@?<]GC@SE@(=8M]X6?>$&T"AT8CEXZT9$<32V$V)UIT@3![YPF]+M4T,-^F3+P,+YQ8;3<;+C5G,BN*\)MV'6
M'6\,SSS)<*A6)0AD$'+7HM'^=D`/0F8
MK;?'G9.X[@3C(4MX?\@"H`-XA<%G>([`A\!1"9@0,&O/<4DP-#5J1CZB1+GSC
MNL*B-PG.,BQ0V5!MZ;Z!99ICAP,U?.`+H02+^`'X3_DA2S$`U)7$?@!%X*E'
M:8L<[6O<)G#_8&`,7C]/DP\ZTUPT#U4=9EI09$.HX9Y*1<0B:0'M>N%\>/4
M2$84@XBP(RU4J6WAZWG&G^`;SWF$"6V`(":4P4\@$'#BU,!P!2)7O6G'D/1\
M)<5_##FR".`"GM)P5!2>==JG/Y?!TDB339D)>E%BJ1##KQFK0:_G:/X/\K(C
M5<;X/AB)$:FHN9!$=>99DMXJRH08\3W@!^C894`UK#UEA(HMD
M2&+<,.C5!WPG$I(_`<&P`:^8[#-.ZS+W,?
M1N8C]2,./*R?*)8')CLY_UN)80.*6#XB@4&&^Z8$'O(@&#X@7)5^[F6X
MU?9&V)J5L&T#.U&V%L_U?W;T-R5<.`,99(/A!\RL)&38P-C^K1YI"A1\O`#$O&\,5S;9CUDJ$7K48:
M`2@V:%Z/`HPU4%H3/1JM8ZC=[TC%DR]#7"]8T2^.-\E)'FS>"[(4CCW`RR3+
M!1F!',(S05_XVDSB,$'^G\%0PO+\!G*1/_$)`RP`,:63`79#""'E.>U?$`&9
M%DB0S]::L5;C[&V[4[088V6'798)G2P>GGB@W1,M*[1^O(#!H15BXU]TXIUH
M_,@=HO!^*&#,I1!MGX)%UXG#J/U"]Z
M,S@E)2Z>ZP%W@+/DL]@%08$)IH/GQRIXRNQ(E@`XA'I$)]THX`TIX&Z)\]4H
MM8HR*X.@RVA56,/ES/2\7:?L0>WJ';6/4K80Y;[&%"531OV[C,9Y>WQ>%`-*
MK@1*\"`Y8\2O%P4@SC'31"DKW)4JQB+YG38K<")%*98
M!#GH$3(9#GD<^6,O4%./ID]B;$S;,JG[Q7NP7$H9H=4C018K,8/O\Y@7=5PE
ML[BYP39(+JJX0_D\/2#':FKI,>@2!8"2^8[\$U5_!A!IMDQHW.(T0C1^;%"E
M0!-WV-M.B@B7%(J6XEJP3:'A&9_$B)&B&%%RX>'?7T`PR!!>L#+]K2Y:"K&!
M1*.GTL*LQV;$>CSW:`N!30F6:M-[+A/@*IK-L-)V/PA92_
M#^:#ZI,Z0U.BI$76!TGF:^)`PH$`$"[8+V"?$*S&M\*PR.^0Y$589V53?,]O5Q>^20WS)H1P]D15FAN6)K@"?+$]TYR3+0B>;&L&_
MQ08:Y?XL+EE2=\RX1SVJQ676QJB[,!S#J-5FU-:Y
M853#J(91*\^H1J/N%Z/N@1N]\"7@:9[-OJ^;?#$;;VK^7DMIKU$P+)&+*PY*
ME9SV.>#OYH4'YI::VXM(P&WF@%63]?!0FZM/9:V:P7QQ[JI.-'%QFJLCY?9.
MBI7P]_)_=98Q82H$5EC%*]1O(895)--PPR&
M&0PS&&8PS&"8(3<_:XA/;!UQBV_CK7@=9G?\M0OEJ]DR&$G,L/E!I5M8A]_V
M,]O]RP-UD6+FT,/J*K_ZE[@VG]D>2#',:YC3,61GF-`=[:WFP]V"%RZZ5
M8\>2:VS[R81&0^Z"ACQ89M_TQ6?3-\63:]E5G<&Y\PI#[Y8'GS^D*S#']!J/
MYQ:=^&=*;E=98JQ6FKKB8O#%];9K+`<[RVSJ+C:)=?05GF')^I@IAD%WC$&W
M<(38L+EA<\/FM63S=5T@-FQNV-RP>679_!6U>56/(LP*8]0F+?V.)41XK?V-
M'1C-^6Y!S:02J?)P#.N8Q3&L4X_5,:Q3X<4QK%/EU3&L4U>L9?R[#U36K-2E
MK7F1Q.38`7_W$L?_8S&!%//%&$NO4G$_ZZ](!E+5Q,4J?O#4C?>H_+Y^)F?/BBJH)[8-`;;-<7V_-K]+UF#8!*@=M4(5RL"N%(
M.H[T7%.$<.6-K%96G'1VZE[R)@H.[83"--#??>BOORB>@;Z!?BV@;Z1^K4]3
MK'_;X)GK)%/,,`O^-;J&L67QOPUOBN6/GBSJ6YD2;MWI4QLOK>-6+SFRC&#?
M$,EOEZ=TX;MD:R;U\/1X_=-:-7UI`+R[`#XZ.S(`KI@38Q!L$&Q$\-X`N'-X
MN.9IK?3NS;[7^[K3;@6W\9#UB`[R+];-]'Y/KV279UTNB5&(6RB"L6::2[)"
M[Y]>-$"N/Y`/#NOK93^71]E8=OL`X/-UFW@&P`;`K^FCG)0
MDLSOAGEJ9KX:WMD.[[1/#/,8YC',LQKSE)P_W9'S=G.9QQ1D6OW(W0NK,JV8
M(;[Z=O*L9.K5WF;?3%[XM9_E>XF<6G5A*A4$JTF)!<,_5>2?HZ.2&HN&?PS_
M&/Y9[UERPS^&?PS_K'X0>'T+4Y--3%,[9]=O=)IP52W&5%-E;/C*\%6EQV3X
MJO*C,7Q5PS$9OJK\:`Q?U7!,=74J9Q?L69RRA>KF+-9D2;&=W#AVM/).!2!@/BT\4XSSG;T7Z0O+\VUA,SOR\3?,9<6X:^/T
MGC..1Y#]D%8H;FCL2PN:3X5V?A.^%3DBMW;[51OI^'CS"(F+
M(UVJ!<.)3](UTZ+]%<&2";_!NL'0P:44`;*4A"6;,,L;C1V!U9&H-))TN8-2
M,J*EA/4.X&%$!BYY?DWC$P26P^4H8([D/>E@+2;Q0P8*5T'\5H%YD8S(M87O
M3/!):@-Z5PTG&`M][JJW:&0>XS!?\"KW;?D?(%EW#5/"!X*HY..Q[W%K^+Z,
M"1Z&,L@."41+Y.C"4)R]/3R.D[D2>6\[G?35^`=?V)%%PP!J;$7'6:=]^C/S
MQH)FH\=A+8'Q@J$0`".)?Q-!:0N^<#BMK!?/5#CD(1MRF_6$<&'85N3#B.8L
M5.D\9I`V\H*0!HMS[[H1H"<:Q^(YQ/F&V9$C^**1@9J=-O"_D2N4D$E@*D.:
M'AL>]4?`#+8B&Y].)UE-61Z"P="+'!R;6B9XL3=A;X_/"LM8.JJ/(,P`E&-:
MY4<)S!;/21!$H[$2;1G,YE8_99F19PN',#`]/PG(B3?@@4"$H:-P&_IX_,:'
M>5+B$PR4(58N:]*#8VBEF5T:I1Z#E*6G)^MM^Z@(7CT>F)$4Z"E:LK.G=0``
M9^!Y]A,\G`4NLJ>2'EZ_#X.@:3XI]D=K1##S!6H*8#/@SAX5,)-N$/D$8.SM
M$<8C8#BA%T*[";.[T/;;4F(SE)6S.C84'VY24SI3XLYA8;SP6C:9N'IOOQ3>*Q8#_%2P,O2Z-F.YY_6`$&63I)P"
M-DLBDQ2/(N^2O)H+3A0#GB7IK2<)W"G#H%AOL$="!,5`HI,RPCN`EH%/@:]#
M;2HI=:RH`0$&XAA4@IV(ETT'?/R_./0A.*3`
M4B!FNN^_OF&&5EH%/C7\MB%^ZY;/-T&X*/8:!.`4)R"#P2U.P,#X2-L^
M*$U/$AE?BKTN%?%\E%X4`%R0I^!)83>>L2.4_D5M'`7:R`*G!72IH)$@VQ?T
M>,S'."AD<`DRWPJ1H5,-#^_VHQ"&D94.^=&AEE1VD#W;$M6T*7.).Q[00H+%
MD7\B6V2L@ZR#9G$:#=BKG50SIF:IKG&:85`:]WRU6Z:\$V;%L919!*4#6U(H
M6\(/4?+X0HYZD1\(-498IB#B2LW'$JXIW>;8X>AJ#GRA'U2"N"C0R`69A26N
M#?]&8ID$;%;]6%#XI>;.W`DU(JA,!"F9\O#O+R!4)%AGTLKT]Q*QE#A@H086
M8`:L;EBB/P0QA5F.S6B$;WJ&07!I@9B:UAZ:!!)-FAX^@YSL1B,!Y@TZ2[Y4
M.D$9)_"B^`$>T`C%GBW[?0FR@UX9HSU@E7/R-3H$MLPZXP&,6L+;*#HB5PN7
M4)985D`+:BL0(2!;^T!@?A$%0-^&#R74JS,+.5JAY.QT(X<,GXXB3TL
M6P;D\(#0$`/EA@H.HI3Z`N*4;B*)CT+1M29QP'/:R$PF5/P`Q053W,#&1S((
MT+U!H[&AYQJZ'N%DP?HGUF%]L$[=/_UH'%I2J4`U.')L7)E=#LMK
MVJ(/+BE'*0O"4!"ZK7*?<8)I*@I#9,L`Q@$F&UT%+\`TQ@"Q^)XT1!N9J*?!SZR/.I
MITD,-++):>)UT$8C*Q`9".`$96`-:^^R`4XYS&4Z/Q,T4'$`J1R*%]D1[@!^
M<G4I>D)1XK'>/W*])CR@./G\7^)@DY"[/0BOI;8
M^303%!OS<;[5&@2!)(G'+3BIW2
MR)!T;3%R4=B,^4190=@)\`$,@I@V$,G,87`#7#]TE:;D6&)%9TQK8[=LS'5*
M8P\4MY@0+H&K<$C+!.Y8(%AX`:GO02L*1BODI
M[J49*2..8V`@%2H.F7$OM`)Q5;"NKR"L(_0RB(/4P#(2>1*#A(HA833HF5/H
M.N?1OST[3(-I\6Y0(GVFF25#)OV>;^KXM-C4;.\BT]:!BIEDVVJ_/V(]W59L
M\0\&R'FA>`>:58R%4F:>^A$D7$^ZB=>79==`."#4U=JI()):/[56Y8(=6K!"
M#)&#,D='`;T&F-(GSP]H^=Q85Z#A02-"K:9MFX+%@KLEMM+P6?LCMCD2&V3*
MH@B''@H(U8;GQY9:O!4`O8$ZP$!0[LE4V8SXA+E"/=E7:C2-\(;#*9&N9C$(
MB^&SZ2BLUO>D[F*O3($MT?NPA&";8=L^JGCTMFC7W#=`_]@7H?25:,EX^V:1-JM<^L(7/
MG0::QWH7%K?M02+EEM7A3X'>QAQ$C@Y5DW[QQ5^11'\M]WQVF]C/@4+T068#
M]Q]8GN/$FZ!3;V>>?X=[*"-P_B096O&)@G(CLV23!@86@9^5'D70[IK-S@_1
M3(0Q)\X1D@I"$O0G6G\2!=83VME9,_E#=M^(8M1JX]1&@=27:NN4YR04.@X8
M$D>5C";P1.T9LOL(9'X_PDOV/G0'*@TTNUH&G.X&:Q]W8N-`^42>/T*!#Z^I
M<'B?6[CWB4;J01KMCT-HI<]9GOLH)DI8?^U^>Z>8M`?&.VLW.IUCAMX!'M\(
MPL1M@W:4>Y%$`-OM8V4T"]I>B%TN0UO;Y*WZ)@$<7.0=@\2CR4QBEX[J+82HQMLAS3.`]9ECFPPPLH[L"*EK&C/@^@,$;D\(^Z=FMN0\5C+=(P'UV[L%00K]U;J"_0M6,74_4H!(7_?OY;7`#8`-@*L*8./T+1;C?)1!+G5"YI(-'7RT+#SU^,Q-
M=R,X]D]P+%B?HX)RPSB`!LC94DT[#N25'<#,0;&?V9XJR$^>+Z`3?7W*FJC$
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MW$A7[@!F6E`.'9TJMZ&SX*N"3*&PAJ[\*\+OAS((/9]R46=27>).M4K@U.<6
M_*[HI6H&0(\>I2J?)52U!9'/:.6$PG3+5NR
MR%+/2&FLDL*IK$.14+F,=7;4)`E;ODV55"[-H^?#FJA2#@$5ETC(P9(T,X&7
M]#B7KCEE;;"KY4O;3!.TW?HV"V<`G%F.I#R5FBYK,54N0^4AG3]GF'3Z;2>3
M\@RSFZ5I;_-EWV:PU*PE1Z9Q@Z2HCUX6G04K$%0AJ\$&PL5DCNH$B(V`#T)?
MY8S5#6"UD'$VH=8]YAM42:/AFUQ^M&L7\WDW\GGCIBOB%3+Q+I5*:SUSHL]\
M9I:,,A*"#&JH13G*$]U>+]'S@HR[ENGP-17R[)5/Q60^J6E23Z(\/[ZN9M#O
MS]+:B>;RTHSW*/F"(7:435Y<"M5[S#2:[U&ZCSISLL#$\I3,'@4@:G=]4!E&
M-XI32@-Y5!8"]81*Y)P^J1.M8K9NP=UHG&125=E$DQJ;TV(ZR=>*.M]&^^.1
M^ZK&9EPF(M:C(FE[),`ZP'*"F81[PO2XNH:#3Y42TE(5\Q*MDB*+L\>224/ZMUQS
M.&@.#88ZG;KKA9D\ZDG9$:4,TX(.2"BV3DA)IG.FYDYS9A=SOF=J-43C,2ZH
MVLE0M9N*R=V3"@@ZM;OJG>H!I-:ALC>LN(SC[/3LAR>)GBJ=GAL/RPR`3+6C
M*5Z,,^OBK,6)N!MQI0NP<`:"3N(K8T'5?U3K@"\X5`("\YRW6W]+1UO@]/T2
MLMO-YWU+?*6J1U"5#H'669`6"C!YNS>D\&+A@%88:C+VE?M_BC"(37D0`#(8
M4B4&D`[H?;%!Q$$0A**8U1_UUN_<`?4#SRU&K"+GM/6WG]GO5WL0#HIHFH*:$KSVU1P'^JJ-CFJP%Z@*@L#(0.?CW0Y`>7,ZI3;6JV`S^[Y<5DX%/,YT42-I%.J
MFS/"9T-X+ZG7!1HD1)S8(K!\V1.4F_Q1V4*^*KZ7UJU!2R\N1H$9TR.I2]],
M^3Y9*9;4\_#)Z,=:6]C)`/1Y$.;J(6%C)=G7P=P,)*BGF7$1L@*YKAR%!$]7
MCP*O"AHB>T8/MY%A(6V#8N7C']*"__=SWTZEV4\"*$E+*@(4"/&G5J2"BGK8
M?`1.,_P>@$^7J;OJ*^3CJ$*NS#?E[Y4/[E]#285ET!O.CE$E@D=S#^24+D("
M_*UK0B46E;*BT$6;S51__Q`%S0'GXY\N8**D*G+9=>T++Y/=^5(&ED/ESQY`
M,GU$>/_ZW__%V-__I]F\%'U!L31)#BP+^0\1-)OJ][CM^"'EY#[P'U?*F_P(
M>.A+=!QD>"?ZO[R)6JW6&\"C!;:2$_SRIGGR1HWSA_K=@M_;G3>_'K7HOY3Z
M9WK8)KFG;W[MG*Q*[V==[9,UV0T8W^QZFM;D@:6(:L$<=EIGA]-DQ:UMO'^<
ME/;1V;/]J_G1!>I2_T976P"&F*9'O?`%#/=/\,Y%\LIM\L8WX7_D@;3NR<_,
MDMW)DMTI1U[K_>EY2N^2O55T6*OHT?2H
MXN=!X%RF3VM66%XJ=%K3>)K;027(/EV=[&OW4:@HA,6#(>L[WE,!-Q?PRS>5
MY]_^./D>H,1)WNNJP)V6\#K.;:>+O/P*--O30WD1`94=*G+,NL=X(T(UN@/<
MDWD7EV>@2H6W2769M+GI\J3TP)?T]YNT-,O2]L#Q68%Y9S>_!1)QHD\+,[T`B5^2@IZVZ(7L
M(%._9@P&/]6]TN;-_TY3C^\^P*N7\.9+)K?=;A=LUO*VJT/V*9+=*C#Y,V3_
M)AQ;>3G<$3&!E],$=K%63(#/?O+\>W@26_V"-9^7GELF[5_>R#/0HZ<%`,_N
M9EOTGFIZSY'>@N)?@-ZLZ6AG-$K&>`2LJ$VZK).3@.5JOFU9KJ5`H-WVP4U9
M6DVHT:)Q5F#=9?JMY_#CQ3Z$X7?6,ORK?WZ_?O@WZ]YW7
MPIA(*B;:1L_9TAJ^7:"YK-TMT(:2J>"[SJ7MYNI?K'MQ7]]/$W5M#84>.N.W?B*>N1<=+H#50Y*Z'FXU)?$3MU%V[V6<`;U@X,4BB
M)*6SNO8XYNOM%,_:Q;BY?;AB'UFRO=O^FW4QX5P,RNYNNBKIGMG/U
MX1/<'>96B#79DO+&W/:2DRIX-)(GL,;W7)O[MHKVSOQ1!@&*X4R=M]CJZ(-H
M@_ZIEC;&)I)3-=)5!Y;D*$.F+\BZ<0?E.Q%XO(QCZ66P.95'J(HN3Q,V]AQ)
ME>F2>L4PTF0?(\@10>6Q71)!)[-]
ML;GMBULK]'"NU;$@7)%/"6I2,8R'K#0D/WIXV/+@4_?^X[L8GQF(#")IZV-E
MZ@@C("008Z[]2PM/-]A:$R-,XL*X35LX$L_%TMXV;G&!"E'K@3EC=PU?Y+5E!^C5N]TN7@NYF6WI4RP7DX<-FQK"T?@?G*8/RVYS=Q2T;VI<4\.D)$Y^3TFXW<4=BT/3]SIC+7
M#RED9\>!G-"YWY$H$\]!.IPA3IZHV5(?+A"'1FE`T#Q,:9T'J=P
M@?.IWD1PJ2,E(%M$[MQ?]G4\^POKD%FE@$5!/*%)V?G\1"HR2T?]D!MG3U@<
MS"EU*$CJG=98['DI#[5C<57:8EX?Y&?2EC9M+U$Y9IZ*5Z54GJD"FS)L>A1R
MDUY`,)TX2S28.N$5A&B_X4JZ-(_IYM\8YC(`;R)^&1],/MW3
MIVFC$K^\IM8O23U^HV/FO^,)80J@?\1CO=`"QG<5K):SAP]SX?R9,*S.2!_?KC[JR;
MQ?*A3M1#3CX@NDCL\V+5>.WA^;RPY\54S'.;Q)Z^^?6H$%J;1^P#7;M*#MM0
MQ+$\W+GR['5.6P62K.W;_6_>N$!^\TFH1
M9`7)B)V-IBW19'G$[::8)'U\#B0.D$CG2C,V+=XJU;?ZCFX^G;_;LZQ
MI_(SGF3N*'\T:+#[[IT*13Z16XWA%M`;T0C][X`.(,=N=U*CAUO@S`=2[9FF
MMQ[QJDGD6T,P0F([RXM""FDB671+%2\()2')^'[PT]"#5P;8NW;0\>;;@$ZX
MZO")NE])ER?!1\:3Y?I)H"T]>I[ZC&EOF8N8<7=X&A=][NF@Y=02R.=.E=%*
MQ,NC5@0#!E&@[DRE5XG4F5,\I>M'.GB47&N!=JD)^5@>ADFO=NM;14E[)7/\
M5+@=TWG?RET@[+Q/;Q!R"FEO^[+@"OR(G95E9J/3N3$9RV4I8)9PL."H!=/X
MRYN6^CS&(][ZCZGS>NS
M2WT32"V)\(W9=1A>$?ZFIN.A<`M^KKK:V<0Y93IIF>S%EZ?F-F0\UC(?\L&U&WLH(,E_X-YOQN6U>7U
M^>&T6UD9TYDQMHVA9J-3B)ZKD30&^GL)_=:Y@?X*Q8=V79_.W.[`A!8\]/PE
M4%-=NWM!CM\VF75W,@T&#`;6D.I])P1K7HK29E-QP^[JVWWN:+*Z0V-$KF$W
M(W(-!M9OSI`ICK0LF,YV?OB0(9_#/^\@'_V
MOCJ=\;CFA[(NA>O15<0="6:94DE5G>9*B06#88/ANF/8[--,G9A)-%DFH#@=
M1/R70%@*NZE/PQNE5QF2C<`P2L]@N'K37"D,+^K/305-]BQN:^5NZV=N.*U%
MW54RM&0$QTHTGY:RN[H_]4U0E5GI8_4?8]
MRW/!XPOCHGXY#;F$5ESM:DTEYI-"SQ;,#5!;!*^\6;AG
MBNU2'9<02?+9@VJK8(-EM=^\%T)FQ2828TX
MKCN&,XKD`U5_+#7^]=]I;>6919&3PLIW8LPG6*NS6'U\NL)R\FAPV\]6"E^A
MY'MKN@CTK+:W2"?6`"\4JWZ63E65=>SPY%:_I$+V5*S<#75MUFF29U2\IS4+
MRDO>YT;3SHZF53[IG?UN4A>N4W>
M@-ZU@ZLNA6:'U\D.KU,^O!;X0^G@ENZOLD,[Q:&===8QM!M!M8#A[>>*IU,,
M?>DE:+]OMV?+'FKS=6@Y)5H.%Z7E_NKSUZN;!W9]\^GV[FOWX?KVIL"@8H!<
M?Q>7=+Z4@>5X053I.O.D;G[OWEUWL;L`YLMI6GP<9'HMU5L/I+=NQ*SBWK-.
M&]Q@=?E_YJYRE4SMW/B5J;:^RH)0DW%Y\"$/F"^PZJ$S83TA7*KW[4N\8P^Z
MLR\?1:8T>:"`75Y"_5-2O)WJ?/_`&ME8`IP[5)`.4?%3GK>Y$/X[9A>OQ)0M!/I01%KH6]
M<8==NP-?V!(?;;!_407U!V$-7?"P!U+`=\#K?<^'KBS!ON+O$N0%4P747;Q.
MX,LO!^PUO?0H;:`-*[K#DH<3AM7-L;:[6OU^2I3,$!4..;X,6L67
MP#@*HD3@>#@!;0&/0]-C3$TAB*`GQ%13Y:X()D$H1N4T?>7N!)^7T(D:$?Q!
M)1X!DH_P,ID:O@`_@O3Y$QOEL#M6J`;2&4=G18`'XTL14A=\
M/':`4C("#*@W!.JBK$%`<_`G.6;N8@/'ZRFP$'AQ7<80F+DC!NJM09E1A$^OD,M21=&'48*V0T0JIY-W_>$
MND[62-IML)%$:XA^'H%A9D'H-P-@`=)J1`?P'7`.
MZ0QN#X&01Z$Y922(-7A`YIY%I@_J&44_T`"0`:/+?Y3`W:7$=Y'WQ:/TH@`4
MHPV>3Q0@;P-=-\"?[+(!ZAS^?-2%L%L-AD5J8X-0L:7`*409%OH<)I6$!DH'
M,"KQ&?Q%S_X?GH35?P261@ZG:;E7Q'2..S_;S0N4,R#.B&9MFH()Z=I^*CKA
M1ROT_)G#X7X8FQ\9>A(;5GW9%[Z/PPRQ/+-4\W>AYC%@]YY#LC:U<6,AK48$
M+^8&4DK*5;\/=.(:)F7$VVKRRLUI51I:$YYK/O<80"1R0C)2TK`%R63P"SP?
M:>/YP]],_!6A2%<>.:XL]G`?`O#)&,>FT&K&;"S$#"H(,6M^N28!U%!$JZC\
M#7@O)DU[`Q3)(U:SG,A6YA9Z%P&JMX#6B#XRSX]
M,@O,6T$]&4-M[8;:M)O78$]#:0WC10YHK7[GSJ.'/2Q&@.KBM/6WG]GO5WON;YJ\]'Z%6@+9BX`"BVM=QMY$U(Z;K>(Z;):6BK
M#`9!C\?V(+0SE(-A4WL#9,Q%H$@\X@(GZOD@!G0%.'S;D2",ASZ`D:!1B&)$(O[#,8/@@(>9CT8I*T4
M8#(68#Y,KQNR6WC@`DS.P887?8K@)P\L6VG]V82188`9E@&D4R)MO[L2)00)
M#^.];4HH/)"UD(2UR.-&FXJD-2:E$AQ$A`Y"J>43H59"B":M4(E)U4:!YRL[
M@O`X`FJ'8"^0`9`H]4.MU:D%K&)>RG1WJ=HN4_Y*AQ+!<8R,=+JF'OI3L0C0
M0VBRJ``&C2(V#H5V%$&6$\P<&=OIP'H"D0>//W(8=!PSRL1:
M+1)N,T#V*"E_3&:Q@OX&*31XYP()5$L..H5!`,I(6P
MKH?2N3@'F;<4=4'Q;5^$OL+AK9`9#Y"K#EE`%OE`8F5>/8-L(`'LVL-CT0(S>UJ96D
M(MN"YB/VE;)1^XQI/$_?]'SV86.Z9X6&-W>.>[[BF_7WVA7BW"T^[*WLN+F6
M-B5AF&Q*1IS%C@6_+KO4]XSPD@C?F&>%^_'"W]1T/!2<
MC[GZ?&?/1I;II&6K*VR=F5:@NP*,MAF-4U-^S'C^RS/BWJFY#1F/M;SD>7#M
MLI%T''+1F^CH@N<&;N6[=>-H-S)6/C^<=BLK63HSQK8QK&QT"C&F:.2+@?Y>
M0K]5DMEC;Z&_@@>Y=3NWNK;L@ORT;3+K[K@9#!@,F!R>S^7PO.]^N;I?0M49
MEMISEC(8,!@PJ2(7FR\>\6FR=N2.8<=XRT:*.\$E#NGNVX)OK@^>6>/ZY-/WZM>0A6N
M=K2UDK)EG4=):CBD[9GV+RE$O@M'?0P;&39Z.1NU]IV-5O2@XXDXJNDMDGET
MUTI&P$"8[44]1U1"2"RX*[344+8E'-J-H\,%`VAK79I*R0?#0H:%7L)"AYT%
MZ_;M+@N9LYW/G>V\_79UUWT`X<*N;RYNOUZQ@R^W]_?+W/6J[DD_$X.KZC17
M2D@8#!L,UQW#9C?6G+:MI-2HT5G%MBG4;@!<9P!W3G<-'84&UEA4'RGB#Y<-?--N/;K7S2UJ@](RQR-)L3L@;(.P'DLQT'LG'U-GX4
MU@B*?1`4)\<[+BD,DO<%R7L:WEST0.@^WPCY7EJ.9[&.IN]9]E:^9VE.Q5=9
MAM7A5/Q!>T%U7<-3\25L9;C'<,]:N>A+^?,$-
MHMT]!F_XQ_#/"\[%+7JN:'<9:$G/O#9%*!?4NB\O9E*?FIJ5$!^[:)R;6IN&
MKPQ?U6M,M>*K195TE=U<N]N8BFL&PP7#=,9Q1)!]"#IYK\BF[\Y?Y
M.[-EFML0;9^-4^N,6HH?6XYT9@D'"]-8TAW\\J:E/H^Y;<>?X[4_31/QCYFYP=CV77Z0'&ND-C/1N3A2_+-'MS#W7
M&$/MD^/%MK"7V;+^(PI"V9]L:J0/0\'"0N%TEJG=W&!8816ZL)S(A@8]UYFP
M\,F+7_#Z+.`._.`+AS:_0P]:%.R"`^'N(&#WGA.%5,JW%P5`9A`T&`]8-Q@Z
MN$]N03.^[$7TZE"F3V%#,E2H'#A>CSOL#T_"Z!^%&T:^@'D/A^Q>,53GN/.S
MW;P8BI$40"*[\1[U`%IJ`.\77="%6&]C)Q1RRYT7%8;;-\7M9<=L^3#X#0UM>`(S7]WSBY(7D`[:"]6@;(`>"L;!"^2B<
M28.-??$HO2@`H6$-N3](!<2E#!3C8Z(
M(WE/.C*4,,)PR$,VY(^"]81P@:B00P>#P*0'F+Z+!")O5E3
MD)%UZY-.?_\0!K^V93/1BW_-GS["=`
M2]>UKV%>W($$0KI!(,*@I!.2\/#A3O1_>6.U6JUVY\VO:Q>B[9/WQ\;'73L0>
MXQ8PJ$U7L\AL^/[^_CW[W.U^:R3B`+E4/`5LH-&=.<4G$Y0#SR/,23;*T9A+
M7XL*-P*6G]`[3T,0.`*ME(`^6]*WHE$08N]*8N`I0?@IV\*(3Y2X\BPK\GUA
MSY*$NB\B)`CH78DRC.Z>X=E#,LG^-W(FZ6MMIBVM0*(,A=_C0=LB%/Y(NB`?
MF.`@#_U87+#(E6&"Y].?`T9T07=]H!EU?82R#D;@*X&&MEK\B,5]?X*-T&.E
M0XDI&`+!,170$+:2IT%-=BI0D?QDC6)U@`JE/+=*@Q7OHC=8>54,I&?Z.H.F
M1AE32J26:ZEOOD2%J28"36+\^^';YT9>23W!>$'+J'.BT"4T"E.(@,@/>\ZH
MY\YGB@2D8X3*"!14"M+,W*7H"P7JK`0Y3&OU!LMB!`D.E6)%"[*A_G2];$/B
M!XP5P6M$V49$&0J`O@>H>$*<2,3/V/<`[$$PS1I@Z6B\)I8<8$-Z]BP;;FV+
M5J7YQ\[*3()7]X[6MO?6.:OCYMMNG/%Y?CC319QK.+8:;\`9-!HT&C16=3@&
MC748XFS#P]@=U1V.X:TZ#-&@L39CJS$:<\?0,N.NC$.Y^AFT:@'I1>C?6!1L
MHW.3!EF7V#.M^W$<`\DJ0Y+B^P:-!HV50&-F9\E@HS$N:LL[\=ZK89R=
M`Z0Y";Y>7VY#>XBU3+UU<.W&IQ>#98YRFI#-GNB5U4HM[7J8R'#`_G#`BI58
M#`L8%M@5%EBE)(/!_XI[PO6T(Y>Z]F<$Q]X(CF7SVANQ8="_*^A_\,)5]OIV
M%ON+)SK=B]C+1^[0)1H>LGLQ#O.7KI>`3-2H+&R[T3HK`<-.!6H-
MAG<;PR<=@V"#X#HC^/#P<&\17.W,>H:Y:L]<[47+INP@MNN>Z7\E$$H<1<:J9HITFUF:>YN>.2P`#9`-D`>>NH,$!>?'?ZN%-;
M*#]7>-%X[8:YC)8P6L(`V6B)%^^[:X*6J>*[6X[]!67AM"8L]+D;."I_)+Q0*2+P\L#1O'FLEJF`@S/:BGB,J(:L6/(:VU%"V>)GDY'0+2U,3
M;6]8R+#0VNZR&`8R#&08J.2L]%G;,-!*QG!U8TV&[PW?K^V6C^%[PT"&@4H4
M9Z-U]I(0TTZPT)+!IMK4B5Q0\;X\9U!]RD]50H#L8J3:%/LQ?&7XJEYC,GQ5
M^=$8OJKAF/:+KRI74,:("2,FZC"F_1(3AJ^J."3#5]6)/7T(><\1R:?L69W,
MWYE32KDS2.VS<UF
MGJ&*$=8^/%OL3-DR9\CPLJ#L3S8U#_^2X5"Z+!P*EBF8R)(:#,"\?DF6X0;K"8M'@6#]R(<6?6;+P/)%"%](%]J%!H%4ZH2N0LJ`C7WO
M4=K"9MRU&?3-!X+Z\,4@`B`1'L^\W5#?E-#W!`3&%/1\[T_A
M,MM[@N[`KD/HPYDT&`QZPX3/7-32$3T`+;ZP(ZI`/#T8^#B(1TP+Y'`<
MLIY[F(/0E[TH?K,;#!V@3+5]UFF?_AR4#;,7!8#P((B;$3_&\!8T.W"\'L#J
M#P]6ESW"\D>^`(X,A^Q%W$+,<:^HZAQW?K:;%T,QDOE2HN\7%1(+"?LECJ$F
MTJ#GLP\O;.L%XB@O+-?2/6JSZ?[;)^\[FY>(;2T1K]V0NP.)`H4'@0A11DF0
M76/N@#32+(S(#7UNBQ'W_U2L11^9RZ&+!HH:T)[`P!%@$V3<6/@A\+$%I'O`
MC,R!-M1K`7HR"Y
M(7V&">9&Q(<@G_N1`Q2`%)C)W);WW!B1M5,2LE-$O;:/D5,[QVPBN#]K0M2C
MZLE6_&0R1R0XD/F'4#%#:HYH._D:,REKTR4H7`%`E6@R@*R?68-X5WD*Y@1
MZ5O1*`B1!IH1:0'K0B<\9!;W_0FJ;6"^"%\=\0DX-B',)5!C(?I1PH1K"QP=G]4D"C$O]%7O`4S74ZK%:&H<%#*(,XBKYA`-XBHUFAHC+G?HLCCN
M92[-'U?U9.62-_]K`;G9`SC+,E"[M5@,_"6>M06>@_`W-6UKN$Z]=\R[31-^
M5Q('+ZB?=JFFZ6??"U:HYUM;]IF+QHI25E'[:#-Q1QQD`%EE0'8M*QI%=/[$8-)@LA*8W$,A^4S([P7[@[N3S^_@
MVHU/T`4E&1)?%G':C700R\?R=TENJ/,>)A9IP+^?X,>3AG0>T+"`88']9`$C
M_U;00?=,YJ
MB^`52R\;X.X"<`\["^8KK2!PUYM+<2]LL>NRVV[&#*M0KHQ*"(7#!9.7UU8H
M&"CO"90/3HQA5D$X&`0OGA#[9->=8Q,ORTW:16F>`6.D&;F0H_GX]'S'Y8*!
M\IY`^>!LP7)]%82R,=*J1/*V$'QTWJDM@C=2DF0MMV5K:;[=3B=^6L)R6V'R
MJBI(3!K;+6VEOO[R5$I.&2XR7+2&[=R3G66CYPQ6PSV&>UXVI@7C$C7DG77'
M,V?PVKPZF;ME+#]X(:7>GLJK^'*3V90:W=W3.MMASGFUHYD;IW_UK"\5X>P*,&X==W1,
MVB^#88-A@VX/AUS:&UEB*:V8-D(W6`SD^SL0/34&0U\SP;;+E5RH;[,YN
M+TF31,)H?X:T5;=CG-F2D)
M4B$U4"\#:3`K#(@34D0@\FJ87(/A:0I"6)*
M@IB4\"^<0I,2WH!_G\%O2H(8%MAS%C#RWZ0X-"5!JG7^MTYYZ4U)$(/@6B/X
MH&.2&AK@UA"XAXLF/ZH@<$U)D*6GS)0$,=>P3$D0`^6]@?)!C0LJ&,.L2B1O
MKR1(?8O:F'C9"I-F2H(8N;!(29"S^FHV8Z09*&>-M-/ZJCACI%6)Y*T)XY:I
MK)L;IRD)8DJ"F'3L6PC=[7L^=L-%AHM>;SNWAFQD2H(8[MEPNN,%R^/5D'E,
M39!U'PXT-4%,7O;MY64_;+VD]M=.Y&4W+&18Z`66\%35G7D'%,3I#(N8P48MXY;.B;OE\&PP;#!L,&PP?!K&T/S:X(4PG+;
MJ?O1R80(I\M^+#Z!#S2!-S"!=\4);,?ILC)9%ICX,19N()@O+&_@RO\(F\&W
MA1`BZWL^"X<"_N<+P49`T3!@PK7A^4MAZ4S*;?;$`_:V?1KGN*'7,+DR759^
MVSY+9S?_1.N.'X_,WS\]P]1T!QP
M/O[IL^?93_!:U[6O$^AT"3F7,K`<+X!)>A`_PH_($;_^]W\Q]O?_:38O/2O"
M16'?:/K8%9!R">-M-M4CMI`_Q<^H1^`)?(!90`XT=R?ZO[RQ6BV8@S>_(LZ:
M[4[SL/WW#S/?3/J^ZO>%%2(:K,CWA6M-8%VM(=`.S$!=T-\!LH/%@R'-$_TA
M_HHD2$$$4TQH/`^JT=O^E6[I#AJZ=2_@+9@9_.D`VRWZ+YWV9;JK[,8>B`P12I^$`O-Z
M('G5\?#ID662"])AI`MO-/;%$-MZ%$IV?/&"X%+T@7'MCR":^C+470$Q],ZW
M7&_?'.X&-P+(?^`_EIN,%J"@>=)I3<_'AHE,IO#ZYN+VZQ7[='?[E5V`:KF^
M^7Y]\YG=?KNZZSYVOG@WB\:?#?[Z7
M"HT`\'Q2`/02([A?7`U.CT6_^EF]"`O?S;UVI?7:TBO2.3N9'M!B755V4*-M']D66J`%OQ/$SA?`E<']D/OB
M(P^$_8U/R(I)=&GI>JQ]`_NYPG3KLU#U%_^Z4AWW/,^KU[=]W%006P
ME$X3;+X@,S;5/[U]<_L`T\^4C7/6:;>G`I&E*S5WVWQCYP-R4SO3%ZFU_Q$,
M'63O(?@*08@8!J,80(T\/D:U`[QJ@SOQ-)36D/TIP#X9C1UO(M`F\9D-&LH*
M/1^L9C"\!SYWT4"GAII@<(9._(GQ,2A!2RJCG3SN@!W<=^\",*=!KH+Y#C1:
MX%@@>S'^Q'V;>G`]]Q%,[[0=^J7<0^!`XMCW@(P1&O_A9"PMP.*$<>9X[J`9
M"G\T-3Z0/0',,S0?>@PF\<]D?,#,J0``SSHJ\0]#/(T9ETA
M]+-H.1@Z5JS/94)H7Z]/CT82S_2C4"_!.CDP:^AMXKR#A-7^5"E)]YF62FDA
M'_0H<4')OSG,>:3/.[*-U&M%Y[0!$Q",`7:PALZD$?NJK^RA[I,\VK*Z02FQ
M5_/]BO(?YS8GNT$,SI+P(`FX4OB4#DCTDC^)`#KSFN4+UAX)B(KA?K@*^N[H1
M&`D-S0$S!%H.`I3YU%DH7-4`X_U0"[T<<>6"#AN+YV@EL<6>!$QSZWTQ-C1#
MV"-!A>8:V+&OY6I9"`_GGDX>1FXFC)B3S1::L>H.MEIP'%PI$0]#6'1\'`4L
M"DM+O]'+!REQL3@,$-6ZL)L'\]9M5BQQ2&V(,55`JC<`D0!
MZB5\Z",>&6C>6Z"+$:\DQ9L(4GQ@Y-G"F3$P&!#]#./X*P*,@_DC'I6>"()H
M1`T%#6WW9*TD&QYSO#&J3O@F&MM$L%*!,+G0,'`+`IN!!^_:*C6DBNZ$,9MX
MO4#XC\J7G$$?:&(+WN+61+-3(+*4X8)8O@Q51XH1X^G#%S*3I]$:$-O*$&.Y
MH``I&A?LEQY[';DZ2XW=E%JR9@$VH]C*9WM+J@Y[!3;L"ZFJPT>@C)S$OM82
M2-F;^.A(A+'D`3;7]BNH+BUG01$8JT!7@FT1FZ+
MZB.(>G]@Z!E&IBG#K9-HC&,`-TFZ/#:(453A3/0$/"AHA'G/`%5?N1B;L0BH
MB\$UG#7[0-*C%ZJ>8HI=6BYX0J#=SMT)//\H;1*P!_2V^I2-B[]3PYFMU&>0
MMP8UW^XTVBWUY6&KT8(_U4#ROLO*BO^$O43=+^%2K]$`Z,0&@!%XKZ5QODW'
M58RVV9"V*G:,#/^!!X!%A[X7C2>:Z+WA"-!H:"%
M#I*!>O&LB/8GD^ZSO24Q+S"WN0O_4J@+"!SQ/P4%_@,R9ZDYC*Z%HAA<*Z>H
M.+?<=2-4E`T52Q,8#Z0E`!$&,X<:BRMIGNC-A%!K8CGE'?V66/38,C5:"%BJ
MY4:;'&6K'])I#1@ENJTJH@G3'L_AA3<"9<+NET+!<>*"H7G9)<^.HC=XCJ^Z'`DR0X3_H%C[([
M@&Z(?96X29G&QTJIS&)_)#CNG@3@H2D4VT)9$TJ;ZZ,5;D2J#::D,)'HV`21
M,I)0><>6AH[NP1)KBTSI&OPIG=DLE_TYY:PTRKHT"('F''\7!/F:!1H2'6A`!V!9
MX=AX;/K"=[948?&AA)6"&2D\FAM6\KS:3,C$F+^_OW_//G>[WYXQT(I`(98#
M=QSMF;#$I"RQ(M&>FV5$DG6U`,)SG:\E(%0\[;-Z0*C](L-PUB1OVC0\>LXT
M3'=]7[A#FVP'WR",\1P-":K>A'U2RA+D21>M9_GF>X@:^^/D
M.[Q\[2:OIF^NYW!%\W!ZT_ME%-1H]*6/MIU='9:.$@SW>HK4X6G[^+3/8M0I1)VE9-"
MO[U\EDXZ!1E5VO*KT01S=-PN"([Y-%V*OO!]\H9H(RKD/XKB+W[H@?_0#8GP
M)3-W>%B`U_PNMDCNZ4O(O>]^N2J'?EO/IDILD<6QO:HBT^T*!FK?M-'B/G2:'
MMG`LV-_;]GGRP!B:@&<&V"*H3`_/ST'_%-V:NQ\%IA/.4,#N/2=2QA]*#5_V
MZ),*-K*W)3=1L+^>.I->Z!)F'OPT2]U"T/O@*IX'+\%P;9FYG$3STH=I`,,(
MW;O2Q;@&4FP5&VBH/>SBBMB1KW;[\4*2\AK1V>WS1\_G/;R;-!IS0APX,F\/
M2VXUX=2J\-8(Z!$.@%IX49`N$O9%"[6IW0DC3J#)YSFO<_S^9!G.:YVGG,<3
MV$)#;TMN8)4QD(^;HP$@%)TBS;JQ["'"!.Y^"H.+3>+B0LM^Z>:#51E1%.]9
MC_`ZXG]4T+OO.8[WM.AM2"6HJ[*.L^Z[XGU?BHMF3]8O?".7H6P+0!B"O/SE
M34M]'J.`U9_C*\VGZ9WF3)Z2EY:"/CN9D;^OB@F`3*'N^HUM5_(!;9[C:IDQ
M,S]_&U!U6QS;`5BZVA`)2G*OO:RBO!%AM1G;KHBP58J9[9:TBD]2\)#=6J&'
M5J8V,I=@[YKQ;042_=2H`G6[;2I0[Y%`N-:W0_-'*KQ`JOA;R/\4ZBP1100I
M*#6F>Z)T^,$(#9,=+%]X:S]EQ[Z:$PM)#WU4,][$1<%AY(:1&WFK8S_EQCK*
M]>V61/E"5Y\IW0,/([7!XLB1#-7FZ/)!"%,XJ9)"IPZ%DPX6K.ABZ&49*/)<._XV](%"W;>,+R7SD16X8GX2Z)-C>`I5YF97W>RKC]]1;2=^_"4==G`PXK%Z3W>!ES+9^Z5L73-J_O)'M%A!Z6CBM/[^O;1)^&A/>?O/K8:>0>GQ!PO%R
M9.&REX_WP\()II@.NZZ-N;KI3.]G'T]3+W^KI=4JW,B8W\?KD8>W6%KGA6LL
M"Y*'ET(DM`B,KY+ZJ!/%_>3FY(R4R-?Z'<60.BWQ2K==FIW38JKJ\L:K0C5>
MXSPJX/59JNG6GPY]%V[K6$-A1XZX[&=2N(RL_]768:NS]D_(SF2%M^?*7]M>\YEW;$O'9W+($Z1
M$M]-UJ;6B$L7A=5QZV^I-`,3+;-"[/Y]]ST[R'SSKH%Y402W*5.9[]F1I9*.
M@!4"YC](LH"'D4]6UMAS)IAH`I.$!.H.`)5PH+VW^(`Y)D_`#3DZJJ[3YL"S
M]UZ$B9M'`G/$-.CIMYUB9L[RS!)T`$`G#>&IY$IGPGMR*9_&G*$GN>+"?%(8
M-T[X.!+AT+.S24PR)FXVN<57;9JBA3W&(CLP#TI)"8;ZV^.2.QGJ!A<:XYA(`C-S`'&92T/Z'/^]&(C
MS'],`NYS6&815\\D&\KK[(/-('1S$7[^;>854
M)=3&L+_`MU+'L0UM#U'&\@Q:+*-D4=C;_G^;[WA"E8QCJ"
MA&$>G1`-/VIL(LZF-'&G`3YZ,J$E("D!0'+++K.@8RYMI<)+;XK_D"IWF\HV
M$^9RXQ86[/F(UBJ.7YH1Q_#\D>%[6-OK
MUBWIZ06K5TS6M5A/U1P0Y=]ZX8"NXG3SE*"!1L;[?3`^,8W#_-)NZM6OY+=<
M)V[+6E*H+=11=<:`"U$(62XWAB[>DR;_#H4X[E&'_5.Q#VIEZ0^ZIP74E@MV6=%QT:5ZM8VMJNX$E62V""MC!GO.WPI
M".YYA22G:DYB+MG,WL%+EK1]>%(8^%I(J=]L4"ZHTX+P7.]LW%P]Z#1()6D:
M4_&PO,`\*^PQY!K<,`$P=\7RE>4$7'W]]N7VWU=7[./5S=6GZX?RBHYS9UU/
M=UE9Y.V4FZS^-;\2DV4[S=($KG'WCMX&MD\4T&.*$5,,3#<
M3GU17>-9A)F>M,H>0VU0PA5;A%PZ01KH
M=^/R?^-,J6JU>SI5L#J>-AW?6!.O5&K79_>2U1P=[6JRFAT8S:Q$#_496HW/
M`!LL&BSN$A;K/8#.419^)_4838T1-RM15V7,B-6O/U1*NBE?+F[!M5ENG
MNW1:=X[4^P?)K;'EN=&L?GU7?]E5WTR6WYD^1BWS/)A,N*^6"7=C^-CH%*Z6
M\&-G`Q(&^OL$_59)"A(#?0/]/8"^D?H&^GL*?2/UUYD8>&?\I5GG]A[F'A=;
M`DK5#4,L*`:V36;=(ZX&`P8#!@,&`P8#!@,OS/VY,U87-7DO_$=I"3K3O1:#
MJI+.6`4RD=:IGM."2N.L%+%?WAZK&"XR7%3]
M(54]^E9#+GHN.F>8QS"/89Y5F&?Q;:\9/'94T^3<\^BNE6R`@5`]7$=40C@L
M>$MOJ:%L2RAT%CQ]M-9UJ8EA:OC'\,^S_/,2O\[PC^&?/>I-"D#R_&"
MR!*.1Y]Z'T!*+7!G>B?XO;Z)6J_6&V<*2(^X$O[QIGF!R;S>$/NEW"WYO
M=][\VNZTZ+_,*.;VL#5:3]_\>K(BJ7=B$#G<3ZAML+?OV\=L+'SH!A]GP9#[
M@C79A?Z(KR>?J+'IL:UA1(=O?LV,94TC^(;K(%UF\;$,N5/\8OWC.-K$..Y$
MR('';2:X[TIW$!2_VL!0CM_\VBQRQ)J&U+6L:`3/8F81CRI3PP-C7PQ1;#P*
M.ES[_%/2A<^"'>#3[S8P!2>KKV:P`7(ZRZ_(P^U#]POKWM]?/=Q/4]2E%"[+
MT=`"&LX/C\ZGB5!M;:Y;D'CGQX?M9[KM1A:=U?8!,2P05N3+4((B;+(;#[[Y
M7"#ED4L'==HGS[_GCKA/7KGQ7/C3!X&Z_/QT"DNT2#]5&L3IBP=Q"SS/0Q!,
M(&M!-_8=[ZG`$:@UO_D>HM?^./D>"/O:3=[KPB0\4NMH)`"!THV$K7_VW"7Q
M@ZR3&J[L&&'5FJ?3J[:>H4(+EA!@VO3!GF0!K#[>A_!22CV?B;\B&4Y`
M)C^*("13I&`#Z58^02,@M>`Q&8+M=]O_&`6@S("7@QL1WO:19O4[R/VEU[E3
MD!*K]%N_H9_F(/ZB,5\*4+*65!=?N&LSGKD)4U!LF8?A;T>$RN[/W9Y9>A5/
M#PMZ;H%^*C,"6(S3HQ>-`%8'^O0%>(G_`2R$/G<#1Y&"=XX*",O82N1Q760M
MI6LRE+Z`F03"6X#;>4'RVIH\I,UV[3\BA5X"Q@/_L8+J.RX(H`W0-65F?+GN
M?KS^7[/[A]N(?O]U^N;RZN_\_[.J?WZ\?_CT]6U\D[TF'1!\L
M`-E,0\^QA1]<*5Y>BU7T7"_5&\@,.VOA@60M=GL9'LR\N`B;@'@#"1Q.OCG<
M#>$W)&,\6LE<:W<.C^>`]D74U'9>3G%>CL\V/B_7;LC=@02K,C%PKZ>G('U&
MF?L@!JY^6$YD@P7SV?/L)^DX*RQ[ZZS`KXOTM&W2<67@OQ>13H)8I_"<)IE^
M4VUL[]GOWR___][NKKU4TQ7O*)2_]W
M[D3BJ^`8*D?Y>>V.H]+P>:DMC1'ZM5[`;Y^\/S[.7,)'`TWV)RML5#S01L6-
M>&)WQ8V*]NPRU3>W#U?L,U-;&&>==AL>+)_.XMY&9M]B8VD)_UP:+I3=CW]_?OV>=N]UN#=8.A@V9-!#XFX^.Q(RT,
M&[%!)&WN6H)DEBWZ$@/7K`_PQKVP2#08R&6@",Q,[D#CEN>C]B(3"MA)K56FGP8C*\QT18_Y0MMC"1L%1!HX5Z$?D1L_
MX_7WF25-_OJ4:=VRO,BET%`R:/"P819D,,1)R9(RE,+GOC6<--C34%I#E?<.
MJ/\//*EF!)F=A1Z]H,S&4%A#5_X5P2,PS3;^J$G--BU!YD`36-&]YWL<9D8\
M"B`$>_TK\G`.X2L+GL)UP)B28"/N_XGK
M01-JPUP"")QXD>"[[!H=?$&R6/L=+0OVY'A/TQU%KM?#7(`$)3TE^L7#=Z4C
MZKJ9I4PDQ>G/`;-@W0?0LG;MGV0X!,K#63,@`];C.,O1V'.S]-%T8DITH@=^
M`93`PP'PG^S#@`&AM`!B%B&9[C*PGKD^:BG5(CY+-6ZTV"*P?-E#_.)2.!BB
M_&DW)>+AR;8EXG23ZIF'?W^!AW"[45J9(:ANZ#T"<3HE[5G[\C%P.IGYNRWP
M1!"!".$8.^84.(&U7P./OC>@J31H.LN`1EF/>D<5A)9;0`@ZCO!9BQ@MGI5\
M0[&2D<2('11!A)HL:$"="4D]V&`C6*$S8:1;XT^SA%P@XOZGJ")/1XXD[K*6
MZY$BLE&?%%M)L;Y(DW%;R>A=+]3]&*ZH-E<<+L,5WTL,C-GHII^4O88@%ZCW
MX?O0`3-6]@%X@'^%'(45?(6'U%C6@+7!$BGEA#)J?-%W@'=B`SMG27A/9`)'
MH[':E>(]#RR2)\2L)F/,?0"]''.T:Y^\R"$+'0T48HT9XYQIBVB:E)4!L^Z-
MT1$@,TD;23TTD:0+$S72L0.`YHZTDXCFHSI2B'F*S-9@OH
M>`1$J7U_Y57ES4C@%#Y0D/DCL@?*2MQ)X;-]S_:3EVB#1.8G?B#NG@Z>M:@2
MCT;YM*$',BOGF"F':APIC]!.>)0X$<]+8=2)C2(GE.`_*Q<;WW"C40]^!?7+?><9XT]"TME0LQTS#KO
MJ`$8%8Q/`E_1Z&DP(,L$[O2)HA.98>A%]?Q!+&K'8_!SK2',>V+](MN!.&;(
M8\!48V$A]U,84)6#L8%;K`
MOA<-E)Q`&0TSDO44M2B*Y1:?(93P,1R8(AFEK,W]:8FF)B$.V=A"C%#/\``D
M+I!N9,R&9`Q%6\@?QZ6@<]6PGB-D$PS[I!I*P3.K1H*H]P=:`0!@'X]@^?DH
M6M:\"!`>`)Y+80F2&X?M!NNTVJT9,S;KP@7QF@<40C#FRYB]O6NKSF-MV_#F^T7":7FG(
M7+5=,%G4[/OKK1F)>ZMX?WV!X=3I.O[SPVGCZE@>X@-^[-1Q;#6^TF[0:-!H
MT%C5X1@TUF&(!HVU&9M!8]U6S*"QDFC,I4+*C+LR+MCJ>9"J!:0ZH[^VZ#;X
M,/@P^-A@.'*C<_//[([+W-"K066UZ#12R^##X*-&-GV%S?AMHV%!"&^;S+J#
MUF#`8&!?%%L]S?'D1),QQ0TB*X'(^_24G\&DT91[I"F-B6]`6SO0&@P8#!B#
MJLH&5>:RK3&H#"8K@4FZ&6+0:-!8"33NI\MIW`UC:M8.M$:05EF0/N!UXST2
MH0:-549CDFW%(-(@LA*(3*_F&T@:2%8"DME\$7L$RMUR?@P7;9F++KCO3Z0[
MV",.,H"L,B`Q"8H!HP%C)<"HDE89.!HX5@*.*BN:@:.!HX%CE7RO%V90F'6+
M?6.HV.1=^8-KEXVDXV!*W7?+8\-DH=AUJ4$)#M<-C!KGO##8-]@WV#?8WW7L
MZ_S>!OT&_7N+_HY!OT'_WJ+_T*"_/)3`>@-8>,__Y&`0;
M!!L$&P0;!!L$&P1OAM2FP:_!K\%O9?%K]IURD]:-5*EWGX>"!5B)F]Y
M/W>4+T5?^+ZPF>6-QL(-.'G2TGT403C"G66V6*?3%TAYR;51XXM7C^1M29GV
MZ6&:3\S.M4'R3B"YW=YU-\9`>4^@O.N1I<5WLS5E
MW[J7E]:Q3K)*Q@(L[VH
MYXA*"*P%KU,M-91M":KC16^\KG5A*B6K#`,9!C(,9!C(,-!6&.CHJ&48R#"0
M8:"-GY.Y[6'8T*^%0[Y;G.9
M*B5,#%\9OJK)F`Q?57XTAJ]J.";#5Y4?C>&K&H[)\%7E1V/XJH9CJA5?K2,)
M2E+EI'V\J<'@G:1T/)F03/KGM6LYD2ULZ(5YX5#X,,^N%?D^WI+29V+@)_B%
M77BN+=P`GH6_:`5Y"!\^]5UVY2M,+D5)-E@
M^/4$[H>0]QR1?,J>R,O\'?^9;SW_P(I'%=MGQ;.*[9/WG9CKFE^F5;K!T,'B2K:T`3HA&_)'P?`Z;4J.(WE/.C*<;(*D:?3T?/9A!C(V
M-&47':
MBKV,N52_':S7E1Y;C=T2@T:#1H/&J@['H+$.0S1HK,W8#!KK
MMF(&C95$8RZ0Q>R+RT.V?S>1CL&^P;[!OL[SKVOXA'X;"V0;]!_]ZB
MOZ1PJD&_0?^>H/_0H/^YHC3_CV4)T>^_R
MZR(FS%G<2LV[P8?!A\&'P8?!A\&'P8?!QZO:^TL5H=P%:U\?.@R&#,N/6?B'
M^"N2,&RL&+:#UOX*P-T0R6^7IW1;I1*/VJ<[+@\,@@V"#8(-@@V"#8(-@C=#
M:M/@U^#7X+>R^#5[8+E)ZT96*#V7^3P4+,#BVC*42Y51,=+@-4G>EECHE)PB
MV2FY8)!LD&R0O'U8&"0;4\T`V0#9`+DJJ#!`-K;%,][S?NXH7XJ^\'UA,\L;
MC84;O'LG;DC+MD_,=%S,&R@;*!LH5
MP(6!\L(TG^RZ[6>0O"=(;K?,(0P#Y9V`\JY'EA;?S=:4?>M>7E[??$XNMW;&
M/_8D1]1UXI$/G-16.!A`&T#O%*`SVNY#R'N.2#YECT-F
M_M[8,=`_HB"4_4D9[;O0??NLV'_[Y/WQ\2P:ED+$`R'B!A!Q5T1$>W9%7%U%
M&2]*AWXT>K9@UJY-?V?!V5?3^?#O+S"?,H07K$Q_*ZT(=;-*?O9]78)U3'?(
M+H4E1CTP>@_;#=9IM5M4-.Y>C$/]=4M]W6#=8.C@;T/AV'AT?,SUR7'VMG/,
M1M)Q<.6\/M`'YC30Z7C<9;Q\15G?\QFX$-80#6M?L"<.`MP#@QM>L2A7P8C[
M?XH0]$0X!/_!#6004C:#7B#\1Y3,,/!Q%`;ORZSZ:Y=]$CT_XOX$R&^=-2_1
MZPB',B`-J,:HQX+S.VNX0"@>_'<4#=P:2I!Z5"/0D3U?1J/2WBZ!.G@<^XA<
M35\XH;GQ8"E%LG"ASVT13-$?#/4+=3.LAN``\CS4[8
MT"UG5`','(RO)V"LE@.NH>Q+F$/"Q'H]1B/>UB'>+A4OX3HD8@Z$P3G["^1"
M*/P4;XK1:6G>'K<289:RY3PQ]O;H*'D#EIT*;HY]SQ+"#AI:R/$Q?/-#CJB+
MGN?]J=HMQ>`#T-OW',=[(NI)U,';CQ($!Z$3I*$%K*H2L&IATQ,#Z;KX`HX'
ML(]_]A3,`GQ(#U5U<]9IG_XK]B+=OGN-J>8TU/W^O'QS9Z-X%^"[:G`A*TJP]=RO7B+#%1=C&\+'1
M*=06T[JAL2LBT9A,1I7<2*[#L2N3R>B%*:[GW4#=+;F5-W,*
M&UDO%UOF,N]6K21SF;?.$FO1\Z$HDS9._W,7478N@)<:XZMU8\)302D
M$`%IE91@,Q&0?8R`M$\73*6V:U+!A$!,",2$0"H;`CDX.MK9($C)AJ:)?:P[
M]K&4B6-B'U6TCVH1^VAW3DSPPP0_]L&M,<&/>C#A[#M[I8=H9YX3?TK7?6D)N.+'I;G
MVN#B!ZR'UQ-$0!=U.`@Z7XIP@K9TW_,%4,34?1X+^*'\HI!E>3Z>EG*0H\!X7P@F/@Q]O`N!?/B/ITC42^*U(+#8&G^!-A^Z%".[CK9"`/7H.].Q(&"4X4P+G`._J#3T_
M;(;"'R5%8>@Z#._AH]C>5(^9GE2RC'#(U56G?N02D=Q)!XP1%9?!(*%;<\UI
M\]@&K.#"ZCN3D0L+VQQS/]3`Z$436E^Z=EB.':_?!QC0@LK1&%K#-10_+%AE
MP">%Q=3?>`=H+C9=SVT6,4'7BR2E7*'K02G^)%$;UZ7&RZ/EG/=`%Y/2P0Z$
M*WSN`-/Y>(71%RFY0+KGBB(?TN5(5^&7A\#_??D#B*;1J<]1B%QHTQ&/>)Z1
MS]-K57C]R\=T-?B6DO?)
M\ZG!<.B+>!QXF0RZ*[\HC,&&!BQ6$$S/Q=MV
MA`U`\&I1J(:FKH0B8OM@KDZQ1V:AR
MH%FSNAN6-0J#D*L[EDM<])UU4HFNE9=Q3B.^^(X=H2XE8.)?&>XB><'Q6KI"
M$1^AX*>'SM.+J2FVN1KLXHT$;BE9,?036A?\!!U@I&.K^BA7J-9)H)064=[Z*:^
M?L("953%9GV<6H326)!=-@&G3IG+R;J`48>"LEPR'+9:&3U`SB[='*\X\B"2J#R)?KC[=W^5\#3$P"XP&)
M`,:5@&DX_9L:*CP"(A-%^S+TQT(F0`7`W:DG@B=X)&-94]Z%@&PWG6CA7K@2
M:+GPA2U#UAW`@BB9-)N$V--GMB=4_AA%Q*1"^,0DLZ\1;/"0-Z]/#\
M;"IBT3AJ=O\%D?^I+
M3F8TO/[(I8/ZLZ%U$RA`6)BT.Y6;"PQKAR:",A'U'>\I8+8,5#R0LO24:V_+
M)Q$./-#S?%]E'R(-/%L<_?U#%#0'G(]_^@0#_QT)^:JR`6%+UY3BYQ*Z=BBJ
M_2!^A!\1D;_^]W\Q]O?_:3:O*#+,/DD'UOP"^AIX_J395+_;0OZD'J#?XY\I
M>@,MW8G^+V^L5JO5[KSY]0N&<%C7L@0\20*5WOG[AQF-3%-PX8U&L";W(5#7
M`"$,4QZPV]1T*=*DWJ`7U..9IV$1I*(O`O+>P.);2?GK>.
M6NWC3I;>>1TDY']WP2ERY'\0U1AH%?J(8U==5W[(>V@:Z.(P#6^$>%M_X'_^$8YU:X11`!P8&_Z
M-S<1K>Q$-$^*,X$+V6R?M>B_%%JO1>R.3NHI3NKYUB<5>#,:10[QIC*5K&SO
M*'_03CS`67X'5F8_Q,VEXBQGVIDUAB_01$S513)/EX99(?O#")
MGH?9$-8TV9EF+E:?V\.C:4J+[6Z!-IS$D[/3)6B+MU)P1X,,!/0_(^3/,2I1
M]'JGJ4RQ_@G>NLR\=)N\DQ$('WD@+=)>N<%TLH/IE"N"UOO#3CJ*E?NMP6!/
M<;"=\PT,%G@W<::;[`;L3?:/\D%"2U?JP8_"%7VY)/APP0[;T]";T?3VJ(29
M[G26HA)"/:W^`(?V`_Z*IR,P1=266:%_2;^5H;H(K7CS[Z''X=A
M./[IPX>GIZ?W/WJ^\][S!Q^`BL,/^/,'?/`-=19W!Q9RKA?XS$//CQL%#T`X
MO[R)B6K]?^W_[TO\V]#'L?X_LOWF0Z[)^.%I%OB5D-+S.*^"5X9^1`
M2YA%4KAO?M7%58+.UP.9
M^X&Y$E`_2UP.N2F-8T#'W9BU1V
MS;@S].NT5Y8XC11=LVVI(ZX7G/:&`G;O.9':[W5%&@;"/6=L-AW!?(I5M#-.
M8)M$G)2W]_[O'W(+6[K:73\/).Y;\9JB&)R!H=`KP8!&]N\2//M/Z5K3;]#L
M,Q#13WSH@R793*&"`_*!7=ZWIN"Z'`>TRSB@L_XF#]?`5$N)AF>92IMHM`5Y
M.!6\Z*S&9.FACOPIC2GFLR4`,HQU)P8*Z(!$$H6XQ(,GB'8D(#YK!QRGDXA+
M>!)%OH5-!CR.:,QO569.[:6)N'441.7AGJ'8:0H$M^+4WYF7\/@?'>6CZ"M)
MB>_O[]^SS]WNM_4R67L6D[7KP&2=,HXX6G^3QVM@LLXZF*RK-F1PP\42,LY9
M'6LS%Q/]>T\$&@077F0)^Y$3[^.H#?S.>9XI.YD(XS(QT%SH<:V@[,P"9:<.
MH#PL0]#)^IL\77^39^MO\GS]3;8WL#[M=1BGA^M@\6^)R:>T&QV`G7$,>IY>
MT^4]4"5-'V%QU!^HXI*2$9:R6N=I'F;/T)/KY?[#6=Q_6`?N/RI%U[1.6@5=
M1VM1("427I>AP=AF$]U>_DQ0-#D*=GB2VG>X14V/2=I)ZC-T6V,=,_8`H"*4
MOCX]VW/D0!M!V,Y)IY6S"Q.U@YY*5![WUB<04)\=G\9OKQ>(1[.`>%0'(!Z7
M`G$=[L+Q.H"H][8"M:DE@P"-8SJ;UP%<'AZ?+>4AK'?ACVE
MH)KVB];1YK2EO`I03]/+&UL550)``.P8TE-L&-)375X"P`!!"4.
M```$.0$``.U=67/C-A)^WZK]#UKG6:/QS":;F1MBR(A
M"QN*4`C*EO?7+\!+/'`T*"IJJ?*2B<7N1A\?FD`3QP\_;E?AX)G$G++HT\7E
MF[<7`Q+Y+*#1TZ>+GQ\_#[^_^/&??_W+#W\;#@=?2$1B+R'!8/XZ^+SY+TWX
M9O#K+UX4#*[>7K[[;C`<2M*01K]]E/^9>YP,A/R(?]QR^NEBF23KCZ/1R\O+
MFY?W;UC\-'KW]NWEZ->?[F;^DJR\(8UXXD4^N1@(^H\\_?&.^5Z2*E=AW\[C
ML!#P?E2VI:60?PT+LJ'\:7CY;OC^\LV6!Q>YBO(QH)&"?-NBSVVZ_/#APRA]
M6I(*0=0@NC1;>&\PR/P7LY`\D,5`_OOSPVW)[?%E*!S^QF>KD7PVFB4B(BL2
M)7RZN&819R$-9(QN11174MM47/*Z)I\N.%VMP_*W94P6GRZ$0.&02Q&_S!W?
M6`2.NB@IY`0DXB2H"KSR0FGU;$E(PCLH"A#:2=F&`]IM7`N6SR%[Z:*T@_`^
ME"_%SA+F_[9D82"Z^LWO&YJ\WGNQ(%N2A/I>V"-.;"U5S?)BO[`L_]^J<64O
MH5$R"NAJE-.,`K;R:#1TS:+5D/FUED*9"UFLM"[QMBQB*TIX9N2&CS9\
M^.1Y:VGKAQ$)D_(7:?&'X=O+/`-^D__\GQLOCD3BY_?8[82GD]HM!%*3M?RG2;B*K5-%4U5;EC=
MD3OWARMWW5,5[(WCNM-$ARB:RON&X353]!Z^6:U2:4,JD%CP+X1FMNBR?1U1
M,>7C0-G6(&$#YS98+))-/GIY(?1IF61_8$+/2V<.QU
MD*-$H8NY5ILGY#2I-UB^H,/5"33+)
M5>V<^57\+KF_QH^GMS7C#,W_!G<8^UG.!WX'U-LYB[<`&(F=)'5[$YPJ.O=Q
M43><.K:(\YT@U-U9U<"@\EGNLOHS3+U.E3ZA$-R3NL==*`(.A+>%XZ'```0@R-N_4,&07!P.6
MHE&<`X!A)FU0-%+D'5128\:-'!(.8ZPB85FL20XT)H(UP;20QPAGBY27,Y8V*RJ:)Y6
M`EQ]>KSX:@/(;#;48ML44P2VQHZSJ\Y(*`0_9=^_0V'#.%C1B/)$@O69Y!8U
M4[834Y'$84PXP=#)8BM&H%)Q3J8?""?"KTNA]T2\ID*VEM_^U(@!T>9N,]/B
MQ(>+?5986(3E:'B/"PW39$GBQDNN.1DPD!2S`14)VO<_P"#(&$`M1CT.0!;U
MVR@A,>%Y[22':'N,;R,K:PT:LI.=$`(-[V-6J&\*Y^MC0OF:<2_\$K/-^BM+
ME`7F+QZ-I">F44'>0-:>4G+_=Y5RLKCLQVU]P+:S)C@38IK+OPHQ]72N'A7!
MB*NO1CWQR4+1R0F]E,\L#>;`^O905?V.B!>CP:L-IQ'A_)JMYC1*Z68)68_]
MWS>44_EGMBIQ]RI('\6$/!#B\4VQHE@KE1-FE`H^204CE@05!5FA
MX).0$@H9+`IR;#"]H>0QJI:I^KVE28<=3^)&6SLO-G)X5@I`5&E]4'
M>ZPFV6/Y"/Z/X$ZFNWP.MPG&.>/(;"A7J8_GLM#F-_-,02V3MXXC7S\_:@;^
M3OQ]D*7U@`TA1W7MF//*3I?':\
M_M_P+#-K7>O9&:'LT@T6G-\GY)XA,?*5_\BQ[;,7ROTEX^3:BV,Q\GGZMQ=N
MFM,J)Y[BFQ2(Y]@1;\:7=3-6`8A<0%OW>1(H0%`ZFF;%@%H3U-?\LM&/QJZH.W7Y4COPJCQ"&U*"Z.81U1IQ5
MLPE9$*%P(`:/F?[:3@N@+&JZ!DJ$\84;9@ZW40[.^7]:D#,-R?0$U=HHKL&9
M(L16,\R15;'W6*OL?7C]+Q(&GUDLU[&91MIZLMJ@6T&&,,1`DRPO7:V0/-S?
M80SW5Q;YAC"W']?"6WE\[+"VXZG5W3BSJG+A'"F-GST:RD%=CK,9$0K31,C4
M!].!I0@PA.7805=HSSI9JX#$CC8%!T@FSMF57,[X0L/F1_CFS[DKRI]Q!E>C
MM36`.SZ$)X[<1W\2R-ER9M^M?SPX\Y3L;PH,S^EWLM2=UF%"<\R_5E%$+
M%QBQ80Z.'B!.%EJ189.&
M[NASZY04.Z%NKKXCQ!ETL&6`5X!>4A[^?^`*_WTL%R`EK_>A%R5R#\+O&YIN
M-6@7SB&DN:.,I,<&037T#C9IYOEF"3A+[5J=O\3M%8$P8EO@,^+CA1X4:!,@
M5-;6(&%JP0B47#+.V?[8]SW1A?LRN&D18`PVR"1!KG1R<)PEFVKV@Z7;2J3_KQFH&X/793$6,%@Y.-D,1OD8>S
M=%_16ENZ-]*T08"B=-]Q#`\KY3L.X_$O[:D.6O0P,!(IQGO8@*"NZ8/,TH6_
M7M37B<(YO+\G$<]*+^EGJ'O&DY@D--L'/"$+&I$@W_8K_$RL_,A1E57
MXX&I#BX=YVRHLM("DMB@Y.VE+">7CAQ-A>'%+A3GM"G-BQ"`V`FKBUQ.#A1@
M\V!P,(G#.5&R?M*Q?L2Q?K;!.C^R6N8\.5))-+\F_L#3$QQNID2XV?V>Q)3)
M2Q1CXG$R(=F_#:QV835N?=>P]C4`E+L2Q;_W,7NF(HY7KS]S>5$DX#J3#IR[
M6US`G$<\9K9+)-D^?JD?2.O0O.SX3LWBG#9K3"A/9!W["7W.BH.=X>DHS(Q8
MJ+"C'E#D#$8]AKLYKWF@$50A`ZK!BJ`%>N_77R%`E2L\F-E:"&Z`3>90JC9U
M$A=X_'GXVA^"PAY/:]L3I&Z:G,85)9!EB:V:$)REK`L!6,X!K!U\TS-(81J<
MQ+GYZBL>;N4R69^TWLU`:N/]&3OJ6
M.IYS`&47[QQT**E500U09#LDU=I/J/1-%/!I/)&7=='Y1E4)ZL:_>@:QJRYJ-'^/"\V[.R7D^L7IHK8G2[=;SXVI./D'QG0.J.WDGY[1"M5!
MC=(/N%`Z6WHQN?+2+W0K.:A13=3-1.5.)"71.:`.9'_/*-.UJ:EHOCW4VC&Y
MLD#\._.>Y5:K=!6;5+G(QNJKEMR8BKHWC.D<`-7)/WU7RH$Z:`"'K(;^Y_UV
M.)!]@*ON>IB_=U5*@_U>:N_*;*NX_*B[>;,W85%#\XVRYE"T>:;
MPP-/H8$&9L@JH+L4KZ]X&FE:$^YSJVA"K#_8=!I0L;Q$5K)LKM&K6'[MK6G2
M&F'"&7;5=!O#.0#/V2_]U]&M[6L@B:SN6/T^/UU\%CD[\J45C+=R7<$B+]\S
MLIT#PL#&(MU)(_,DEXF2B%1YLY7&B^'?4J;+Z4+NF,TNR/TE%DZ<+A;RM^RK
MI7QVR_E&'I0L+32`H+\VS@TQ/7J_R!M]X.O/*Z]/]\KK_H"*T:\ES-\C6ZBH
M<7LV^.QI_X&C,//^`Z@P=$CNN/^@F_,.L/\`K`C.0TGNO==T+O7(\B0-/3+6
MG;$X:0+.B`ZLKJAC>_@)@E6@/NDI%`YZ`#9$(,C1Z=I.$J1KFA0?V4W8=>?<
M':@-YCP+]';V5-_P=5$$L!D"`7R;';(85Y-L6T>ZZS-[TKS[H0NK+ON:6,\"
MP=U]=>@,;-0$L&<"60Z>T-05B1CF3Q<*V[+G;3#O(4*1E<$BS@+<^_ON@'D:
MKI$:[`>K?\%*G<1F(XU_
MRD\M?539'(69JVQ08>CZ0\C3SL:Y]G.>'/)!U/O\T`L]&5FYHUY"=`\B`/N@9
M6OI6D1[F4>T+5>7+RWIYS`%X7[QPPP1E4./2MZ?=EPSO=HW29
MQ(,8.L<;7XZ!U>N5NK`VBJ,@UK,`7'=?]8T[)TUP+K[:V5#N2KYFJY5<'L/\
MW[0P-1&W@*DD/B\H`OQQ,/"IVU85CI"]@%--I^E\G]]L2>Q3;JRT&^E5U2`E
M_5D`S]$K!WSA:IK'6;RYV-XL%\9/I0G3AI1<]
MD0'F3W\,Q>"'5K%^?\!/@MJG/:=99E2+MP6:>'
MX3Y]UWO:=5#D)(YUW6\#Q7C.D]CS3=NA>FK@R/L!@_]N\EVU^9$OMP+N_)$]
M$!%ZGX:D=F;Z(P.:#/#?P9L^]MTVY94V[0MY[CUY&].2)%2T?MR+;DJEIXNV
MGH`PPO@17"\E/]N18)*6$[/4F,ZG..B0L[K%[M*./`#8%;7*0I=0.M4U[54>
M;=:,J@:#V"V]+7\@_S,7WA&__!]02P,$%`````@`*DA"/FIET.%@!```!R,`
M`!0`'`!A`L``00E
M#@``!#D!``#56EUSHS84?>],_P-EGS&VTVQK3]R=;)+M>";;["39C[<=&=J48/HXU1\+()"C\*F8K@6>N:&4\=3W5ZO58'4R8/S!'P^'(__;Q^N[
M($01\#`5$M``N8ZRGXKTX34+@$S)%5Y?+SC)`4[\S5R-%OK.R\T\_<@;C;V3
MT6`MH&LHZF&+27)S/8I;[`N^9/8[^"8&H\EDXJ>CN6D\W-@5,4_3.RA=%63'
MR<+,&4&W:.GHOY]OYYOW@`B)TF40L,C78_Z=5,)%B$IQL[Q@5#""H9;R3K+@
M,60$JA2X^B_!\EFQ2*'E1?#-`>!^@3S@
M0<[?7!9=V+B.J?0ACGQCXP-"]G-LT"6/H$600P?1V^&707=%,D+T+1`O$NN99P.R`:*DX\2!;(VX2A0[IUZ$72
M*D$PQ;I>7JO;TKQH+1&%".8S:[:=U(MT^IP`84%I5J++-^.U[DJP9I1%&(G,
MZT3XB?`>`(BU\Q,?$;EYHD,P\88C4[3?F,??-SR5OVBN+D4^%0$+1&9NLX'$
M4D>@QL`_LDM-)7GC4F/-SEUJJ+N[:7+.R\ZI-,[!3$:_<&TN.8M:H\\L'-GR
MG#J[4(YD3AT$X^HNV\P<5\D+%L4JFPA3/[I:T'
M,9J>'%W3E,]ID&+W'7
MLL#O1S6)\GNO$^4N!!R]5TTDU(5,5;&TLST@:]H!+%*H`>"GRR>K0/R_Y&J:
MPF3::3\RK;3UN9'A-L2-F\625>..,;/J;V+L=>DE>T>#8R1^VP.)#>][L-CV
MC-7.IC18[6JRP=?4L7`>8Z=>"VT;T7\7`:,"I5IWM%4AO5;:,'
M?=$7';,TTP6%4=U:H)$%99G:8@[7YD"*6
MJ3=]8(7>9>G`S:F.B46_SJC6ZX92PHG&KDLS.N5JIZX"U\@V`/[_BW\=]
MTKQ\E-V%Z#O^=2%[K#9M7`THY7MT#%!H9#^6]CC;,Y_Z\>U)3V7\2+NQ]M7+
M]GM2U+@6S)SM5$%ZLYS/(4SI`_()8#BG%R#&$I!:6:UL36#:;?LJ]R$>6DF_
M![`W*_H62<48P2O`J6H61:W^[48F+`U&?57G/0=QX$2900_;^N
MM!NL.7*N7_:'OI>7`.OW^IH<+_7ZX_]"\Z
MU),?4$L#!!0````(`"I(0CXJZ(ZU=D```%9!`P`4`!P`87-H+3(P,3`Q,C,Q
M7VQA8BYX;6Q55`D``[!C24VP8TE-=7@+``$$)0X```0Y`0``[7WM<]LXTN?G
MNZK['W"YJMND*DXFDWFNGMW;X5.R+#NZ=22OI61W:FHK18N0S5F:T)*48^]?
M?P#X#@(@0(`O3N;+C"-V-T#VKQL-H-'X\W\]W@?@`4:QC\*?7[Q[\\,+`,,=
M\OSP]N<7G[;G)__YXK^<__'?__P_3T[`!0QAY";0`S=/X/SXFY_$1_#WO[FA
M!TY_>/?C_P$G)X0T\,-__HG\Y\:-(<#RP_A/C['_\XN[)#G\Z>W;KU^_OOGZ
M_@V*;M_^^,,/[][^_>/E9G<'[]T3/XP3-]S!%P#3_RFF/UZBG9O0SE78'V^B
M(!?P_FW1EI""_.LD)SLA/YV\^_'D_;LWC['W(NLB>:S02$[^V*#/WNG='__X
MQ[?T:4&*!?D2T<5KXZ_WW]+/%Z$`7L,](/__=+TLF"GC,7Y[C$]N7??PECQ_
M&[@W,'@;PENB&]PHE9`\'>#/+V+__A#`_+>[".[Y_0BB*)6522'?Z#]/\&=*
MO]'_RH6_+;M(6[W$?]4:A(\)#+VR&T2HY-73_I-O103GDM&N)C,@$$`1]RT2
M]Q&%Z-Z'\1OVV^`&_O@6!DGQ"WFI/Y[\\"Y_J>SG+QLW@/$U?(#A$5X@Y,4K
MF.2-T;?\^86,)/$3\HY0%\3\K@;&:7B\V?WY8]9]]U%M7UZ$:[O#_XSY9WR"C>[A"V
MC$-R4GN=?83N6Y2"5+YC];/\"?`H08*`1,[;$6$[1W&RWM.N;%#@,2`2/,W>
MF'UJ@%-!0V80;0H5HY.E=<@/`.U!3#0V)D!%.D`MWZX.2X:H1*14B4/[4!A@
MP;=IB!#,0F_FW?NA'R4^YGU9A,/*]6MPQ]L6I;$N^L
M)L+)Z%Z#VY02D,#-K=$"F!*/ZM7U0(&Z:8WQ_$J\E;&@`P8'-LAK&$/\M>]P
MY\[PH!6@PST,$[X=*M%F7TQ.:V!U2ITP,[:V)L0V)N=T\L?4I+R28`KVI*9<
MI*6&NO5(64JCT4#.")%4C+N5]27FA%*\QY58JO;8,)CB-64>33%2Y>%4C=C9
MKK>S2S!?;[8;,%N=@<7?KQ:KS;BQOU`GJ.U3-H.K*E4]NNI+K5]^U%%L@A(W
MN.Q'N[@GSI;(!SORA#JPS&F-'CKKZ;?\IG8T/+`/6B=W,%H?R`(;CBR6X0[=
MLUB2D63OS"4Q`*ZL23.?))`L1BZ7P5G\]=-R^PMU2^OMA\4U6*[FZX^+,:$K
M51-2^;)U`/,H2Q"W:WQH(-?[TIC242&)[#W0S?<8:U/84+XM_!R@$GO^`<>HGQVC<::`IK)`E-=2HF(L;
MWV'XO_OAW8\9^/$/7\JISCG^`//4:'%;A=7&IW"/(IC2;=W'Q@Z$@81B9J(O
MP6C2TKG#IO.9+@W+ICKZ\IS:.@XXOUY_!//U"D_W/Y$9?S;W7Z\VX'1QOKY>
MY.L^V]G?Q]U4,8$9LJ!Z=CZE+:@ZU9HZWJTN2TT`]F19*P/R[XA75_[WA?GW
M.ICWT.Y(4@2HL,G"_OT+9WL'`099C`+?H_GQAPCM_00'WB`@JY^8!>!``V`I
M/O+`#961AV4)D?*:_"LXDK3[E!)%I#G@)DGDWQP3]R:@48L;/H$0PQGW#'^B
M@)#GRVUOODL[>O^<[8@$AV1JUZ'!G[0&#QC%,!\\1!/RCI%J=2+^T_W'"7M:X0Q76,6G1"E7Y`-/'DUQ)K2U/3;@UGW269WH(WJSKE;(N2A!:B$Y,L0TE-]U6GS
MJSR\&C6!JA.2!':LA4.N/[*`LW[[PR93=6?&;AO;B-F
M008K4NQYZY3.:K&=3HX\_^LCZ7>K.[P:2>G1^E&=U1E;1PV2P;'4X7-1GFB\
M&E9]6CMG+9%15_6]SQ.\R2_/1GV"+2)]]8TRM]TD."8@NZ"S&U)>8,=?E1=2
MU6:L32KCN%[8L(UY*$]X6YC>Y,E#GN()^#5_]H_Q@QJQYI#BE^9%T0UB-F!N
M@<+(!_`%6&\C$QS(MX'VMJ;M'M!7PKN0R9GV47TQT!7UFR%=1"T^X#T)K"_<
M*/3#V_@*1IL[-X*G;NSO!(!7HLV^BIS6`/I*G3##?UL38B.07,#XX)]!3-
M14`M,!B6VJ+)"#IBUVB:C:B;#KY9RZK-IR[JX@KRSF
MCC_#T0>/QAZW#'W$Z.XI''U@>L+)'>IC6`O(,'3H_\$YZ5X>A(U5E$W,Z7J(+
MX#IMK&N/A1KBNFVXCV\%_8R4HYL`=_2L\E?'3[)GL]X#DC8QV:%T'".QD8K2
MKYE,87%295%293'2^B*DQ2%.)%]SY;&Z00I>DL-_H^8HR%4E7UG46%%L64FT
MKG>KN0R6-/_EQZELCILH7>00IZ%VK1P(S=V&#AI__\+)']"!-1T!Z+-GJW]!
MLH2Y_J>XZIDMTW9>]^3QZZQ\UOC[7CWB=7:HU4^F;<-%I)JT;V`%E`LCO14C
M"1)U5HRJ8C37C$;#\J!KH?T!67,]-&.=VC1N&(0;K8KV@O%IKXPJCW.=)'5;
M'>W'7W1Z@>%72#NZ$3VYW]@JJ8X/,<%QMR4@%:_R'&QBI/72(0S"9,UTHL/M
M>$9C:>6T9[.91K::6I::6G9:#UEI/:ZBEBUHIZ)-?"6555I;HIE6@EEK8ED/
M*.AU3=4`!]-=5]6%@.K:ZI@@Z&F%U43__%76[.FSQH/B6FLW/`Q^@N?^'H6;
M!.W^>>8_^!X,O:)_^NW+]Y@WEZBS%R1X%%J-3/NI=,CWQH]22[/2/@@#G
M;/EY>;98G6W`U6QY1I.XY^N/']>K-)=[W&-!&NI'733$'A=JYZP>'1H?:5:K
MH0P".#)8%P_!@7Q1'+"#'64%,?7<+_T0>"@(W"BF#^FOH\9V_2%1?"=IOU@<
M_J[Q)#KNDF.$AZ4Y[M9MXP8#&4EYLWB3Q.Q"<6&39LY;(%EZ?7B3P:G]"G;I
MS^`E.;5(JJ]LW`"F%_)N+OZW>W_XO[-1K42J0:3RT1NWAC%MX!A8(QO
MX`.,7/QUZ*%2!G#\A]G[,@\-$,UOQ@S+#9EB%#.D3O'O#+O@Y22`*E`&DG_%
M.CCK-"4L9;KL?#_,Z3'V0QC'V,_?^"%=WIKM_G7T8Y_\>0T#4A7JBI:47X;+
M\`&&6.X3@Q`-(7Y32/;V'8480-JLVV;0[]RVV$0ZBG1R/E!A!!5.D+&"E!B=X:E@@`X$.LL0]W('&P5:%:G+]2\IM=E2F$I'C%?%6AJ1+I!)
M>9TK_&YW;DQ'KY-#^BN(,BZZ2.:5?,"])_>G_=L=VVY5`8`T%=5829,QU1;5
M1D*8U:V,'H%&HJON4`,OK^GZU]G8"[5602>*B?J!GR&;<(N65_]XK6D%8DU!?!7MFC^Y3H$%,(ACN\'SWJWN(JX'^=.-[2P#4F-!.
M'8*6[PX>!H7OL]6:RBH-66@)6I%)J*KKFFA?S$JGMCYC"ZKJT\RI0U7K=MXN
MJR@](/4G%7_Y#!9&;*'QIVFC,;]X6*6%_^#"T>@F(M6(NWK[T']\#PC3U,M$
MKAFZV2=+5T096=+4IK,2/@T!NY6VJC9!$@D6NQ'^1S.2_+[JV),=X\[
M.F)'&-(@AACJ&,3C3G#DJD-*'[ON!KFDI=^SB(/J'5Y'!#4C_9LG0G#91X3!+`=3IE>-9`L2E)[K>2!(<\IPND._('+"E'S>[6TC[JI!\FNUN%
MM9+>/0FHZ:WPI(D"F\2-$O&\92#^6SS@5YX0_]8_/73\O/LMGW.?AE,;O^5M$H/&WP+/&HM=R3XG$1>N.C\;T)Z
MN3[[9I$H6,KI'XD#AR.SW0X=<9^NX0[B_MT$<`63.9W\A*$T@>%18JM*5P\0H4?`0ZY0W\#+OUQ3%!+
MU(+:OV4=P$VZ$K=]:]>66S-6+7%BJ7(S[S4!S]5-R2(_9:+FH>?8M"?2`B+#EX:S"@7B[S,]17."G]/3L%+R>.2Q$'M`6,$;QAC(7
M*/-[UJ!M=]50>:AF`K`M*4.9)1,E$PC$6H9GA?!+,"3WHSVK-3\[*I&>9W[&
M:I2[%QU%#NU('EP_(*O&F7/;%+DJ*_QE^/Y%@R5W.RHL)GC6Z)*ADU)K20)[
M%0'.C)\_E,=H%Z/:A8[^41<5,3:DP%DQ+6VH#9UDB9#WU0\"!LCLSWDJ9?ZS
M2?8D(]HP8;*4)LF1S(F<_*\L;AWJPJOSX>!9?`/C!,7+,#[2^GV537-AM*/#4\RR5'B,XG>-
M3IG.RM2:D@7Z*A*_,@CZ!03+5"/P,BP_^(&4>T#AJ]R_?_Q642F>V#Y'7%H^/#P4-.GQ80B:
M^"/G@8M
M9U=4Y6OD5Y1LSR'AIJE#<6Z%2-]%:"VBEV17"*`QB@U(%@6EEF_3>??CM[5<
M=M-;IUOU%7HH[GZ[0XK\#2*O'A]ZL4HY9
M^";LF&Y9;'F*VXY8LQ/?5E_-^'2XK=Y(3Y+;:<2I2`)>111=2)]*B7GKX$5]
M8:=QQMV*]-IY^!'MK5I#RU9/>JQL9JN+3#&T[]9D>E+_1*JN";O8K/"@0MH6
MCAI6@%#I0D^A:%N%""FCDS]]#>AS:C0%Q6L0PFD&J=QZ$AHX:`M0:_4FQ@"-
MU3EZ+]BA]Y9\)^@13>]MXV>4A4?NSB[!;+-9
M;#?C+RF)%I)DBT?LDI&Y$GI8_U/0!5WK>Q;:D"_FR?4Q]!7Q=SBHV\+H_A1%
M$?KJA[>->^+%%/EE\1P*DQOCQ0V:63U?L.3N>`Z]0W\\2?"O>+)PD^3;8O]O
MU-OC)2I""I^5N4>^25BY3+Y-UP/CEVS`D>Z<85WP#QA+*++WYE$8X%?2H!E^
M^8+%^.71._GISDI.9H#I)H9HF=*0PH>N(YI#6"*Z5?LCE>>\P3@XP&&,;F'IH!^4)*/C/X6=2+EC]^P`3YYS0Q4,#)TY%)V9[UO)!:Q08P2
M<1[/R(E-0ANE;EC(?&]M2!+UR%DGF-6FJ%RDIP4F!)+R5**AD;!C*_6]-^#0
MNSE+"K#>Y]/Y6OVI;P='HD6,/I`TGNL5S!G;!A^[\49?@89FA,$++=+DNGQ(
MG4@TH1)&J,8/LL"A;RU;74"_])6^(B+6\+L;CD19XG+3DZP
MO%E["UV*B<$"%N>ROK8E.Q4_F04O6=ZPDK8YRUZ\#&(54`R=M('GKVFV"3UI
M=(7B)(*)']'#X&=P[X?0.X4A_B,AFZ%QQ6"%!F)59IX&8D6FR=:_S91V%.:TZ09/*Q>.Q+A\SI6CGLQ"#*G?.S@1$I;GV4+5=
M2C%#?Z(3\J)"3DH-TE,#TSBHK@^31JRKBS`F`&YE;\;%T\"FU8)-`T.T5KB)
M>*YT_`'XR\#H8<)EFX;`:]N4[?DBUG(IIZ%!2^X'S>ZO)!GQ1WK(,B_G=.,&
MM'A3?`=A`CQ2`Q@_R0`=TZ5V0K;#@SGEB6&2!$02K?L$O:R64WH),R7RTX9)
M<9J4-26@C&E9J$.$=A#[7VHUSC&PPU#@/_EW]/4_@CN
MT`.D-]O1JE,13-N/QJTB-8A=":I)#6=7XU654IDAJI(W*TM9G]>I=L5N=2G]
M*5DK\Z0K3"E.G#1QD5E5&Q>W/-#@0.JAUI1]%#7J355WX*81Q]M'E4+1*:NX
M&J/PE(I7;B>LEJ"R;D#MS5LH1J5O,A*VK"S51'9M%-2'U+\UITI5BQ&HHF*\
MO>?6)239E[".]QZAKH]R`<`;E7PF@G5%F&L@O`7/9!#BHF3PS@Q`3Y>:(F@)>'(EAXF:
MY,YFNY[_YV?DSE%U*"K'"+J6<%Z?NL`
M(Q]YF\2-$K'W,M8V\5NG\-8/0[+T=9JNF3T_98O-Z:%BP:#J'I:F62ILR?.DH,3`WJ
MREKGQ=DJ.&D&W%PN;NP].+#ZFIK9QU=9MN'[0YC"I,XJQ@:?ZKD)W8]=[\_]
M$(J";I322P(KXS^LE6*R83G\9FR4
M9E*R!H;4F4I9(#%ZI7K)<%JG88L%30A[V0D9*00%-#4DLC3&@!0T:@.73=%M
M\&0YG/FGZ^O%:CN9(E8B%2&EC\K#+D/*0EBJ[Y%OSI""64PFN$G#'J3%3=M`
M-5>Z^B4,);97Z]74X"U1FO`R!A60-ZG%5S-,`NJR(I("V.NP*-3'M6$..EWJ
MKUZNDIDH"7"NKM=7B^OM+Z_!U>6,V`V>&).I\-5';$53+7XJ-J4.D,G,2H53
MK23J),RM;>(N,#E=-L4U3ANFI]NU?M<\E4Q068CSW->FQ!;9$5&**U5-R^P&
MQ=$K@+3;HSP"EA!:K1G1FY7I3&TD;,7\IF)1$S&&@@"])6D
M;IRCZ`P=;Y+],<@+:E[#'?0?R*$S80YO5_9\*4&7W62)H6-7#9<>]%N5+$GH
M"G,*#GI`TL?:Q;ST0[C$?S8JX`L)
MV!W*DL#&?F2C.4N[CU6Y"GN-)7EE9_%7\BN@/T]C%[&IF^:>H4A_[`YA0&#,SM'](8)WI%S*`US2`Y8KF*SW6_>1P90"9?859)0&<%;H@!FNY0V(
M`2[CRPOA54GR@ZPO`Q3'K\8$O8I.D<;WKYN!A*&T!V6P#'WRVW_P/1AZ,>[@
M/0KI\@,#2QE)?L*;1V)R&%?2I.'Q6[YDR9%;'H-S#6^/@8OCH/SIJ$=J90I"
M*M^4.3C+H:PV3'RP]LKFK'^V0V.V,:^TB?-$$6#IWK,
MII7'-%-?M5,6#N,H--62Q-\JP2'_I[,&M">C`P8,B.]<_!GR(CUK\'(WZN"@
M!P7425F<$P%MK,PA`3W<3<@"-T3;IVX,/3($XO&O5J5'P1SE`A1L4R"@)T.5
M=[<_JQ6VV\V$!>*<>@B\E
M@U?"J(+U\^6HN0(5F(]^M)46&>`9OYA*>,@UI;)Z,J[6L.WCKKEPG8-Q*4]:
MJ&)T`Y+H2'(NCJ?,JBDTB67GXSA*'VOY:TO6Y$1+7[6'[+)7^M#&DE>M&4O+
M7;E,A:6NE+2ZS$5_F<8*5UT%S=4MGHK8E:UM7BB/RSL)&*9V07P^"O$_X]FC
M+UR0E=&R(.72VL"LK!.6("QH0@'17,X2X*]!=N"HI`"_$III0%ZJWZ8%*,"!
M-0@>"\<^VL$SL+DP'3I#]Z[/SD*D--GWX-,8F(6T43-S$(D6FP&?PV$Q#WY-
MGXP*>KFVD-+WK8.<2UJ"6T'UP^]JY"MP'^']32.R%CXO=S"8YV;[%OS&C'Q0,=3YCI;^-O`DA4`9J_82-#8`'2#*]?WEN'<
M/?B)&W"QJD2;)WM(:4TR.U0Z89C&T=*$)&=#RNF0'T^PO]JE/X^:D*&D2Z3U
MU9E4"QE+):]"'2@#F\8U3%QR.\?"C4B!HYAK$W*B[(L(B`RL0-ZL&?R%LL6X
M%[`X^>\`I@_&1'R+II#:IZUCG$];@EM%\O.=ORY?
M>9NU(I_9[=9ZG3,<(#2:D]Y^K2C%J9!FZ_62-`[PTAUUMTX?*:BS'AL79ZNQ
MUR[2[@+/\:J2*!^[TN)IUB7IY\"55J>L52;I>-1*34*]-DF5\`_Y2M3DJI/H
M'+;J@B-V24K&RBU0,M$S5@K>XI)<&<+/6^S(K3Z0UKC['4YY'>U]4&4:-1I:
M:[):!U@RL+X&[CXA8X?[./'AE8LBG4%6`D/UH;8J1&O`%<-XFN;.W.(HN_"1
M7O%HYAY,6]-S)YU;Z]_]F'Z(0=R502>-W5OGMIV,EN8''6J$U0MFGX$7-#86
M7:]IR3KUO&S71K6]LAUO,$TO?HXBZ-^&Z8GFW=,VPOT/*-!GWF_'.,DJ<1AX
M[BXMZ'EKK1;Z]]!=7G@0KZS9,6-/K-6>@_\"QS"";N#_&\>C24D-;EW_6?C=
M3E#7];4&]J3G7W4:TO:IW6UVC%O.."_!N<2\V?,T"Q8S8%C'F"7]/^-<>FRA
M>J^:Y19,+V3KYX7-_&@_'6NY`LYR>VI1+'`+>7B&'T*ZBC?R%+]/.T`#8(]S
MLYW=AI@K\?HTZ(DX6=XHX>Z2-/R6CAE&GK>O9EO_#1?7V:?AQW#[W5
M]^;6.^%\XH?)Z7+MM)UY;Z;5ZN%[-NH6MV^[]?:QH%]O,I$!HK2$#R@@UW1=
MX*DBF5^LPPW<':.T>F'DQ_A1]6":8$FC[V9:!@#C9GIP^+9>O1\';Z%W^@[=
MN-&J`R=.&\8`NV\_?("I(8*X$#-U?V[-,EK]MV4;;/'7IJVU^V>[QJ[BC]WX
M#OO7=S^\^S'SKOB'ZLG=ZIE=\NOZ0#<\9KM_'?WTPA1)M0H-YN;1>!5F.\?B
M-;II[4B\6IM*Q^%51#EI7924`:0<@+*D>3H@8P)5KM'/\.JCB'<`7A^%1=*.
MC@SNP?=)@5CS6CD8Q?!R>E@F5\ZEF$7IP]?@@=!_/VB57M/[+>%5Z^I?#^V.
M)%`25K,8$;+O7SBDK""((![Q8WH0%T<`8._Z40I>$LU]@-'N&."X+ZZB&V#8
M/<"(I&/Y(599_2$I;SJ+[P*RL)N6.7GS'=F![!+C@>U@&D6,:%F56+..F(!)
M7JR(9;)?H$C0K5Z*$C7;TBY$Q(IP/J/@B+U1]`0.V>X+J2Q$S#F)_)LCP=!K
MILI85J'HI9__,L5:8R*XM-4>DL.L:;H2WM8:0U)T3LE430J.J4A0,>+!2HZI
M=+A'\[97=$PJ+PM.J;'7[9K4PPX3[`Z(C,E:MF&),0U4JMA\QR)CZL@>NH0M
MB0!W/NT(_CN`V>+[[!Y%B?]OGOGKL.0E;E583$K>:G3)L`2N6DN2DK@J`IPJ
M%5UMG`UN;GL81=!+EU>W[N/BD?@!F&5#
M-"Q-B;HP,CFUD7TI=<34M-H:D5F5G-?)"?(#N5B9<-RZTXJZ19HZ8,U'RE2U
M'`WP#&PTE8Q,_.G20XX;VZ>BAOTZ.O/C
M8O&`M>413FU?Z;F"E,+GH;5=D0-,E,G
MKY2=J@RVQETWT`YLV95]?#>`ZWWMAN/B>F/&8/28LF^JR&1@P7K=,K-,NKRINH*ILTC9M@YI::F1FX]%
M[E+$_]^X#Z1T&CW",:]L(V531P9.>DS9VRHR&>!;KUMF>%=N2XQ_11%.1@::=#\KZ,;^'L?
M.^PX`^GH5]WTBT=1GM2S1:3E?*CA0/F^=)#9[+>*3G#O>A#&I9P`+$IR&`/#P:\ZUDT7+<(W5B[$;WF9UD)L+SHH,
MY6IS&X/94K-B=XS7F=O;D2XRM[$[\SO,2RJI`I0_`VX`@_/.+?LA=H+CG;$99//SZ'31T[5H-2GR[AAPG
M)T[S"#P_/J#8#:JY!-.SM`[(009:97R]NH"*L^\*V;&CM--C[(>0U':A!3M(
M])D]\=KB-`564:0F8[49JRETT7*T)F]1(UZ3"7*N\">X(^6UL!FC"^>3@:J&N"
M<=R93Y<3DF.$QRE.[]/GS0'`0`0GLE,682G$T^VRO5A/HV6UH$]9(!/]Y5FD
M%1M%4;[]7=9U&W7!SPAEW"BP(U8YX:"J)'YE(
M6S5,MFH;6R5Q=51DV2U)UB_`:&I="3$2:N4HBS%E#"*87IN'OVU1R\G]=J$G
M+$/V;,!GN[Y8S_A[_\+9WL$TP$?'9!^@KR0Q!Y$#^!AV7_WD#N#XUW_`77R`
M%)0DG0Y&>>TPGY8?"B&M^)S2DSRZ`JR5QL8M(]8'6D7%PGI#Z\B+Q[/0^^@F
MI&;LTWH_>W!]_!(!J0!.'I;59%L6DC6E"!:55:587[+C=Q6;UQM47GE5E
M+>?^#F$D[V*#JADY6RPO14YB1=$"A=)%
M95O*4S>4!]*$)T69K0E/DS>:(9(%Q[>=MF3!WRW'8K+@J+8S>`%2/#TDLY9T
MY?,<3QOCV4V<1.Z.32-1(2U*BDI(C6J'MG?!M$BHM`59-5`)HU,\)=$U>0XH
M`?@U)_G'N"4_%32+=)3`%O$47?L372%[:C-:07LS/35SZB(4068[B3!A,##E%.9H[9H
MGSL=54(,9^;)Y^-/,E5`-K"57<-#MI\OM:TVLNS[",D,[*BM:3/KD4@7VXR0
MR2F>3,LX6M6'5+]VW1!$U"7\[2*BFH2S%"JV=LA!!QW"2WN,4=QH[YP%U8F(5J)
MU4)"M$X7[21$*[;8GA"M),C)J<%Z#PIZ@!D`A5:-!5">*:2A:B&GD17=`7>Y
M/6I(:&9%3PFT>NNP[?D2H\"7++,VLB@.KD_3=I([/_+POR*Z=\=)ER##"0Y(
M_%O<#OGU-?AZY^_N\,,@`#@`]P(AF5T3PWO5#8@K9!NQ35KB(WN"+
M"2HI'/7XC>[:[G"G2;7O8U9-G[+<(\_?^[NT!B$10UCP_^&CGYXG3]EO(YBN
M2)%:+B2*HO?%U:LLN;L['Y)L$5).W/4>7*RQ6SAJ^L=P%BM:-?Z&;%8KQZDE
MP6X<@WU/;I/`<"Z6@G;?SY`BREH:&J`CG9Q;[XMJWG-Z4QXM;2@,#67$C6"0
M2VS%*F7=L!7P"=I0,3DNJT-W++S\$1T1IV%B4J5RC$H!!`TCXO'PS,8>9GB'
MG/CR!SB%QF^866AZM@#1^M037&RJ7D"[>(31SH^EQ\6D]+P$32Z]K51,669(7(:QS>=6DXC26DDAO.[N5A,9!S58+I?:,+O1/+P!VSL_!C#(]U5VP=$CQ[S(
M/L[M;4277L@NT#%-R`FYD6/18%%@_W56$82T1G9]]L48Z1;^>-R++@8R(PKU<+>O_"F<\V'\#5]?KS\FQQAJ=!F\79*W#Z"YBO5]OEZM-R
M=0'65XOKV7:Y7FV^"\R*KFD9%+,#+Z,HGH8Y\^/,D4)/&-19D95]>S-9!E[`
MRDN8A8*F71"["#/)3GEV+1UVR;F/,3V#'<`AJZJO^PXCD:4WL6@-0]^%OM_#
M7;+>+QYW]#ZB:QQ8K4-:[R_TR/](C=<'-X!A(U>P"VM^#[H.J\DMZ!VZ:.8;
M-%N4W("N(\A)J6O%DF#&""(2*Z=_QP"%6>5*DO/D9A?%96)&O2"]"YB0B9Z9
MR]$U)%2N1N^,XQ'"B&:7KFB"''N5%B=JT&6M!`G*K(8Q@6X7S4,`C1;E([ZR
M(&>YFE\O9IL%>'FV2/]Z!98K0*<*L]59^L?BKY^6GV>7B]5VU&E!)]P@$Y4V
MAW95"?61?&J0M;J),0IRR8I0#;(9C'_'KF@A9FCT3B,[0+'.@Z"L@EVA5DH@
MV2C58/>UQBR)I%3^P5(3Z?K9^>7Z;YMR%>WTEWS-;'4!9O/M\O-RNUQLP/GU
M^N.S65CKBF=+)6#D!2KLR+95$&8212]FWF_'K`AY=D/T,H'W\19=0Z)\/X#X
M);%W1O?P$L7X=\47%GC!H9K+]-Y[93!^BEV-OVWKA3:8&8=93+
M);MZY#`4W1SD[@(2\G(A,R4LMO(J.W9C^NC!K`T-#>JZ7^^[U=+C#^M0IA'W
M*EZ&JA?W=A1JY9[P'N/>CJ_52]RKWY>^[D"6Q[WE[O%R]7FQ>=;A;U=86[HN
MN5/XJRG;UN7)4W9YBIF0>BZOHU`K!P-Z='D=7VO,@P(F+D^WB1:7=[YG*=M6YG1WE^=R,ZA1`G&(F37N!D5E3:%C4F;(G4X[@XE#
M4>Z.H;-0:4?B"-K9'4I#8%)0E=50IU+^54/[2%]%C-VU\E5L2A-D`X<(Z^C6
M#?U_4PO&1AVCP/?H/V:A=X7QG2?2^O:5@AWW:?)#7U[3;EK!9_P[.I^?K3
MBJXE;;:SU=GL^FS4R5-/2$;]0HBI[V^UC`::2D11&`CP>XHWQ9'U_&K\`MZ>=K*N/6I65J`9[AQ-5^9#5OLZR,
MN+AFB72,^V#GIAU([MS:$6W\KVH;K[-SVO0ZU`@^P/"8W91ZB"">'I$SVWL_
MJ73I@*(D[1!T(U+2-TY['L/;O,QN6@Z8_)B_9?J*X*M;2GA=]'T7X*]9`II#O/-_G';]L-69LO^U[J?`8FJ]TY,SO5:4YL
MG.I2G"III;+)ED
M<3:17)(AT"@*#I\_'K4*"+5/1X>&Y/OF1+088.GLIJR=5G;3<0
MAB!&`9W%(LP>?25UH-/6"-]^U)G6(/8D*'$TG#T-/,TZ=_WH,YF`?X0NZ16Q
MHF5X.*JD=73BS;ZK'J^!Q^G42;,03;=)L;_1D^2U3I@IGY
MM;0@MC8IHT,.;JRVZ^N1%R.45(ATOG;=7&0P6ASYXI-H94N+P4II#.I^]C6N&&11XEX245'(9>SF%VOEJN+#;C"
MH\OFP^QZ,6HMQE;5(>4/S519%)%72BJJX6'HB^)@&*=[U6NR,'6%XB2"B9_.
MRTYA"/>^2H1G*B:_5JZK&)/;Y@R[;G@)7??6)7?3=17J+#Y>7:Y_62S`Z6*U
M.%]NP=7E;-S5?F-D(5N*9NZSZRBMQ!U(C*.08^KS.?72VWLTNPV:[G?YG&:02Y3CG'"U1`D)E7
M"Q/O`(`":`8VEM)XU_LYNC]@@Z>[%5EJ"+TGF\8"IVX,O?QN65FVA@5IE1P.
M$VF&FY467L0\W\.L$_+M3!/9#C5R4DUVL=HN/R_&'X5M80]9QD!S-]%`:'V/
MT9IQ#%T1'=W?^TEQ[HENE=["<*>4VMF-.:^*KL=L4F2Z4S<-*Z/KMBFI,*TG
MRKE<;I<7-/'F-9A?SI8?TS,B:6+.Q6(U'WGOI"-JD)DZF;K26C(JE:4-0#MT
M[)T>$[BFIP!P+]O-68,CC\$5.$SBSN"")`'B@/E]?
M?QR]>H*.ME$'C3`1>CMC)4K7A95%TPI1F/[+@SYK6OBG+V=9DMLRW*/HGH[S
MPA!<@32/KV6D)L&S0A<,(V-Y"Y*P5\;HY$]!Y?%T,IQ5%(MT=,!$IA*.2MBI
MC)D1S&.+6Q*80_41`W_ZR`+=UXAA$71&I*1B>8W2*?X)
MR+]'+07._?1(^M&8(MM5DDI%;+'>QD!=);%I[A#$ZO1!I$7IG;B(:K+DTS*A=
MI[$P?',;M3..LZ+;!_0Z1SFRI[^#!2D'@Y],89#G*ZLQVLMTR@S[-=+F^"_1
M_(!X7M#C-<(,'/[3/.^&>6J2;<-OR##'IB%4DEG#T#KI#Y.9-HDT@5J^(),\
M4R>JI,S(5#DX'*_AK4]JRH;)RKUG`2,CJ0&3(3%&)[])&Q!M2&[#*<.0@[7\
M&9#?Q\>K0$M(Y.FZ#8@LQPYDK/?`7T`\)/QL2Q2%E+ZO#PT,Z0LG*6:'Q#/'+N
MQSLW^`6Z$3_J;2/+MRY%9":;E"U-&VY'BJ5+-AY%3$[V!*2/`'DVB4"X57](
M]7,SVX4"ZLK&H!(D!O?@?X-!\)<0?0TWT(U1"+UE'!]AQ/7D+;0UCRZB-?;L
M+9VPX>'%3;1Y>A%G[O')\Y-_$@*04X"49'S7WZ9=I*4'WE`@8&&'!"7H#&XH
MGU%P#!,W>CKW`QC%7`,1T-0,@Z4Q-@A!HS8,H2FZS0!8CASXQ>\@?3`^W$6Z
M0DI?EP=OAI2%M53QPT?NZ7!4[*"3JOY'/JKEI/4XGD]J'LY+NV`EJA>UT!K<
M\QF+&#\+A(KG("48WP!:U,I&_"H@J`?^7(Y&_*^`F,&-@UKH'`=GMRCB3VJY
M%#53J%,86P"W01O`9P6WX;U.G\.<_@KRG\<'-U\_2.&;\J!<(V01+%'TX,"]
M.MX$_NX\0"Y[WYKP>0VTU>?&D.4T9@.P=;%M<*U2YV!-?P/TQ_&ARM,):OV2
M/)A6R%B0"A4[?."![N]12`_7T)3W>'U,XL0-/>S\^>&'`D,]")$QF(@U2.E`A'-\XE)3/ABKJ@*D'+!*^1MBBC+$1MNW+
M-:9S_`L;U+=0)?6M>Y;*PN:]H&$[V_=-X>T;^"Q/N85?7;ZDSZ:PB2]27&,;
M7Z[A#/L"XN96OA0)HZ$\33!HQSF'CHOT*ITUK',:MXGVNGA5O%>Y&HC/$@6H%^N;B_L*N0CY0F0,?&QG=D]FRO^N7\L8WM)#A`P6CG%^_>_&#O6H#R]I$52KB5OH
MQS[YYP+_E3PMPP1BL"7D6CW\0P3A-2S+>A+1ZX@(9X!(.D>^8=XB+;<:4"(#@$!(9@'987_9%;
M_[C7`1*D@PK408IUD(,=_P%RN(,JWM.&UA%M:TP_-47[JKC$25J-R/L^8U?P
M3L<7L*7^GZ%/>/?"V>;WP+TD#U\!+.,8T%T<8AGI96MN`-,+[`3E_O$+I0\Y
ME?W?@"6ER6Z%HW>Y9??'T08R%M)@P4,N`-BCJ+AH#L>4,!;=2O<&;.^P?!AD
M=]0%,2JNH'M-F`3W[KF[.Q\^I!W"PFYA=K5<>1V"Z'J\FZ?JC08NN>X@_6KI
MM7;I5\]65/:N'V7WRE&>U#'FRLK?*5<9O?\`!E[^_N09K_.CWG[PNZ_LX%:^
M06?9_9Z>9^@I?WSAK&!^FV4(*D+32U0\_X&(3+"0WP.99V6[()IN>3P-H2WI([:\[3.GWZWSF_4.G\R
M6X2U>=T*[E-,EI%@O`X7CV0&B]_ICG1WO2X]V#UB:THFG5/836
M5ID0E^XDP!H=V-VYT2W$\UI:R)',:3!Y!#\]7S]T=N1O]"5/L\_7Y
MJ6PY*(."W7=049?IL*35'C^>,QHP.H'D_>\@T5+:1+SCS/OM&*M[RW#N'OS$#;;NXV*_A[OD''^BLE9KM9JK;//54@OF^[1V.M*+/[;4
M-\9K+XM54G"3%<$O%V_A(XQVY/)4M`8"B%9>&370Z@,XHAUD:W"8B"DO
M'GYV"Z?%1?^2@S83*ZQV1HUWXNQ&O6(,=%45MU$*X-E3,2>
MW!"YX)#5QIZ*?5K!&VN5IMJ>B"VV1@"G=!_G;Y&?P/5^3W[;PPB'1.39,LO8
M(U=XSMTCP(%`+H1@$)8/,+9\B(ZF'6J1BJ=3!J
MQ[L:ZK>>NG4-R6?"DXQT56.]7\$D#8Q(C[=HB_!`3QQ+!._(-4(/]/?9#2DT
MLV/MKTSQVKCDHI1+Y(:DV/DEQ.ZIP91E72HRF5RWJM4ML_Q;Y;8DUZNJB7`8
MU1&["F&2;_1G>0EXE$R("LDV>*G#=&_^UUS6J*6]-$&#NFFUGN*KQENY:[5W
MC-JQ0^TMY2:`C3LB!K:A:"/`9T]3VN<(=SL`J9N!FT*>X`YCB^O(O3@>]`[??J$)ZC+
MD'LR0!1.&LG(OFTW&0;6:-1I,_OLVK388KM)=`@/.&1,X.41,[TBZ9_\5-=1
MEVS,,(:L:+WN!CJ)*AV#!<`/?8\O^&_`V*`567FI1B-9)O4<
M;;R$8=%'PRY(*D,:278*4K`C3F8?H*^C^@\[@$-65<\4H#016:E2:<\:1@OQ
M\U-8E3-7\>E3Y5_M,;^^B,8D0$.$E5F!?I=M31.T6E:9-V@(=*HTTYA$=,`.
M9U;1&8&-:8:Z)-Z\HRN,[9PREMQ=+2'*"SOPBB\TCX4]
MRCJ5VQU:E(;4OC)3Q8%+6[MY>1`,?.E^WJ='*'PA68L321\VTW[Y?2>J?ZTC
M)>SAV#XA0',2RPNGT)XNF0>0)%>@",#'`]R1O_-$Z)?QJ_0`:WK@4W3,4W#>
ME&:L#&L;_W=]E9
M6/SSSHVB)S(?24^KXK[1DZEQ#).T=X'OWI`D3AS#IGL2>'@DAUP;;8YZ.M70
M"-^/;X1YFO\,_]^;3JI_;V?C)_:>W][Y^-\/R'\S1F@S;VKBMO?"&:\B4Z5S
M94DF$:1&R#E4WWW_8$6#:X($ON+\4S72
M?/W`L0E$FVL73%"@T:N?1-";SS8?P,M/F\79*W!UO?Z\/%N<@=-?P'R]VBY7
MGY:K"["^6ES/MLOU:C,2W#3>LXHB\\_4`,;`XX_UV($!4F_RLY''OOSV8<=Z
MF\.-.=:[+AQP+K(2"/#Q@.-G/*35@JH%")#/F=MUM5K
M;-?R?FQT1@Z:E_2@W.09*_QJZ3\;0:F\KCP&TM"GK6FO
MDU85UXM4W^@2_X7?*O\)_X<`L`
M`00E#@``!#D!``#M75ESY#:2?MZ-V/^@U3RKU6WO>-P.]TZ4KA[%M+LJ)-F>
M?7*P2)2*-HNHX2&5_.L7X%4\<"1`L`B6]-)',9'(XTN<">#'O^\VPCQ_)OW[S^<_^NG+_?N&FV<,S^,$R=TT>D)H?\ASG[\
M@ETGR82K%=\MHZ!D\.UY51>7@O[OK"0[HS^=??CF[-L/[W:Q=UJ(2#\#*BG)
MZ5=?0%_3):?O\"]L\.'CQX_GV==38KW_R,T7X0#=H=4)_?OGN]NJG!.O`V+O
M=R[>G--OYS/WWZD?^]1",:DJ*YR\;->]C?;`-4_K:.T.K3*2E.M/]`G)7K
M_I=&\7.-^B^K^K5Y+CNJX$*=Y/29[WR&@<>&:Q>DU%+\C*4)K*:=+2Z0W$2I6Z2
M1@2D,S?QGTA,:04CCY.6K=$CU?\V7.%HHSMX8S`QX/=NE%R2(CWY5_$,IA@K.B;/#(=Z0Z'W7KH3,(3^>HR#)?J$UQG3:^O'L_8=BVOH7S^\O
M_#6Q1/)R<-%)U=JR!\X2!>J3P`HO;F)\'493S*KA0\;X_>_]M*5[)7`NI
MZ3)&_TZ)AM=/FH/T#@N]V=T3Z2=\TDMH=3*-XK7ZM[49^A?R0X,SVB6(-*V5
M5Z@@9D8I5(!"@@"[C4H#NCZ$HUX@I;^T,5K\_%LN3B7L;$EZ7\=-ROHR.'XZ
ME5`12U)3\*C.1]3O$L<)'=!?[[:T4XPY"LK("@VY9'45ZR":14UUG<@M69)_
M-A#476,K*,ZW&5C.W+4?5.!;17@C]PL&:U87^H<3#M^3!)_P^>&(=(/Y(NN8
M'F\,("_73O2X;R(*;XM("GLP24;RLM2%&*12T\4\IM3';&:6^/<>/:&(SB97\L#-#Z:+$WA6K`_=AF4WCP6QT/=OI0\L-O%VGLARB.+_%FZ8>Y]?9+
M[G(L(KGPP@RY6?EY;/^C$IC*+)Q&(,&#$+'"NZU168^H9NK9':5BB*
MD/>,-X`Q`"FWF,V29\=OU",-K1QTM@/*Y`EI"D,RZ:Q%SL0
MGU\1,H.C*YPNDU4:%"EV\1URD?_D+`/T%8=NKD#;UYK%
M2QBH%A\5(3P5:V!U_!;I#=N.LQ'\C2Y%?<8+B!UPUI_ML
M`TX#!2]0N`=08,P8GD>/3NC_F6?M5F,D&A6A5S=WKI=K)WQ$,9W6[FE\HM$V(.IQ&JEAF)<3
M+K/,)]%`#6I0G>;)M$!CCH4:9S'?6A>SK4NY?E8W\L5+[7_R-D2=1:>E4&`Q
ML?9`VSC]HEZEVMJ&U\%CFW=HYRW,C6>TDM:^2,;:VUD^G^G#@I41"V4QB3`W
M8!R=,->K=LPNG',4_A5'.5,5MIGD0:I(\:6*P;-=^"
MRT1P+5`8YWD]V1!_@8E,*/'SJ7]A;\!8M"^;PEC:;"81N8:,I!/8^E6/&?>-
MFYG?XMUL;D1FU8N7R\")`:E40NI.Q@.;>A)!JJ9ROSP&3@UCAASKML2WR#-U
MF#EO7>G-=QMZ!4CFL&)_.[L<)!MT73@Q\A;.2R:Z:%/4`+?:5FD?;I.(;+,F
MT]U6[27!F"V#]#KPMV;"S,V,FXV?5!FL=0O+A^%ZA:M;')4*3R+F>QE$)\15
M*QRUK^]>X?T6PV;N8LP,>X>V.*+^EP>N0HGJUD9YB4F$J+KJ6H-N2"VC!F/[
M_N>W4#0\WVT9&##GE97HSGNY):81BLJJ]YS_\FNQ_;R@^O,``P5!B,/\?Q[R
M.X\%(/\WABC<.26`M)PPBDB'BG>HJ@^D)HYJ]4\M5;)/(X4IR/)8J$8S$D4,
MLYEH@]$!+J"0^6Y&I/&H1#>!\]AR'O-;>6U$XYOE[A,IHN:_%J?V(:'YDD+3=62>9BE?Y:FDZM\&PSRWEAAO8_$J]Z]"[(OT[IZ5ETK2:
MW":-Y6Z&**;7"+.]-9[-UR+EOF70,;U;
MI[/=OWR=%#W<8%3Z>*2KJ6HO>K_BC!+>A51;'#O!YPBG6T&BM8!HGS_-(II$
MT@=(0F^'&[-MK,V^OS=CDT$O2PM(,>?(7
M?CGVQU
ML$!^H$.;'-@.''*3%G0\MI@(/#B[7`]N0`,HRVF9@-)6;\.U`SI?R)"-!=$;
M\<"IV5CO7]';+1JF:(&'3U!8E4%@*U2DN@`1PN+#!L9WDP5&KMX_4.#=X.B>
MC'4X@P4)66,6P2"S%2I`O:`#!"XW-FS^.G'8B+`B`L@T4&$`"A+_:[PNG>#$
M"6SQ__X93>'*`Y^L@0H&F:7K#U*%8$L0+#:63!MF3XX?T!E.T9#=(R)I]LH(
M_YU;A2*EWR%%1L6`P--82V46,KJ59!@!,;=S&:*\`+@%D?;/2?/.99M=S1$=
M[LX]`UL7"IH7-9/9T/7.#5*::<%QITJ1:F$!4,1B&&BH#(<(C+G!90KF[N\L
M7J(XP?%M&*<1W<6#O'&N4J;J]"%E+,:"CM(*S3^,^[$M5+!69;BP@Q$+%KVF
M`30E->$(D[$]MCEK;3F'BR@A37_Y;F`Y'>D+.JI5*DL#BHB'6K71J*RE:^8"PMV7OE
M"OLYPG$[#QQ&+,-#3CP2$I3\+<('2^4F,B!5"?%25&'G^M?,==--FEU>?(6(
MXJZ?J4W^':#,CZ$WV]"SA7]FOW.5[*;L&&6[3^\QPW8BL!W(C'H`-R<,?UV1
MUS,SK[G)L'8>HD7"4(*Z(JG@F`%=0TWNY),J6F.`?-A"G,ZP)P$
MV#=28PH+VX7LM6AHA_^^^,[2#[*],8+5[+3H&@=$J9CB-GGAC.-5BQ5F!1>;
MR&$)33/H':.`5V;)OEA-8/$I"SEA%S^6G+=01@!64+>)$VA5+:S8>EKC?DV&
M9@\HVES@*,+/](W`%BP$%.7I,0;%^$`0I$?)5>+ZG)$IQ>1FY[2.KG!22:_0
MDI.#+:`HHY]!8;6WY2JI>)O)S0V.3B6#T<2A1,4J)M!T[=$$CIMOCAD-G.W1`ZBFBA\>3GP)AR;AQONKL
ME?''C@+B[OB116PU-)045>I7)(R/+9E!VL9(HV]JK8K1Y@3>CN@<[;%N542:
MJ`^B[0+'GI3]GE-8Q8Q^S5FLQ0G_]7$Y-T-"3,28X(R?+0'S,0;JQD4!.WN"
MQ]/.V:WP+?0KM/)#Y!5/HF?O'S/5;^_+F.19;N`8X6D['H>PG")\#8E@<';/
M3%@OJWTA@[TR:SI_BC?+$>"W9JKE6OV?O)SM&-.U@&HS"*_&W,ZB'W.025#=C=@C&APMX@4"JGOZJ`(OU$>V$
MR$RAF(FCF($S)8PIJFYD'8I3D;D\L(,^$%]=LCQ?,2\CIC,?WJ7&A%H$>$GGWCRXN5GXI3;<+Y%D4-?U)FYB?^4+[_C
MD/R0DM^*C\1SO!O3C3(M;U4WPW3\7#\^5O!`IN-F`'9$H>V/*1$L62TEZMR&
MI!%"7[I'@9C?]GBK?1OK)GRS<,!BE5N7Y!NINT!4O4[^JOHT)_-[W6Z(TZ[\
MV,WM@;R].8@)YJL'9]<"H$[1ZH86A:)'`]\>!AL*W6HB'=WAGYGW>QHGV;B.
M3K&)36])]Q(_X#M$#.'ZV>7+>QL]8*#9>3?5':BZ,K-KZ.J.)C(/[)BAHGEX
M-::\7``Y^=C9*H$7J;9+`$7&.MIU*)AC+=.UCI(-+&R^>0,1TLY,BCMB+.)R
M^HS$%7I"`X?+%:K?`K@'LO]ZKBVGF]WV?'#ZD)YB$]\C-?->XPX5VII%:HO+`<
M5N@5`%W+?(<'.%1,.R\QS5Z^OW"R;>T-'5ZQUD/$1-55`TRB5P!4D'D.#TR>
M6/Q;-LWDS!<*W3M/]+Z%+'N?KF"6;7PQBF]O:RH5JEXM!Q5Z!1#4,M_A(0D5
MDPW1CY/=;FT\R_X5)\P=MWU'4I*W5SCZ<2E7/C2YO((H,F/@$59*=.7F+'&_
M/_#6+K,;N4AC/T0Q:2`V2S_,H>:2X51^[]<=RJZU)(9:^<1\U6NKK9#IQZ1P
MJ":35Q`P1LQ[^'C1%9L3+AJ+ZT\H6F+MG@D:+T6XH\A_(O\G+R-A].10C=(:)NFM_J0%G/(T9*>UG3
M(Q4LQ(E7$PR7@CV2T@$IBT.O('=";UD(YNX%BXE@SEXPE`GF%X(1FD(P*E(E
M&>6-HV#$I/DQ9KDVF'OLP+3*%IP60'3*P/)$:QKR,74.(@W*]8[Z@5AGG9_D
MH3<77:`5CM"OD9^@^6I%?\NUI-]NXSBECU->XIBULV:&[RN(=^-.&'7\9T@3
M3JR)#C58FR=73UNMKL@G(PNB:.?A"1'I*X@%B*E&@[=8.#LOLNYWBJ&]"6B$
MF9'#M\=SR,6H40<\;ME+2'.7+=EQ.PK''OFRA^$S[II,Q6&FRG2:9]S[F<[(
M&7=E$2SI.!;.2]:;/N!BK0#Z4*%ZP?)N3WA!NQI_793A'L8"-?2*@F7W?BH(
MI'[HWO+I<'9(!WE9!C@C65`$>O62^R<)P26/!_;:YAH,]RH2V3G4[X1NN2R,
M\KL"J*6*+YZLS084Y;7:HJ+'`V!]@QVLY1:*I'X,<4)M]Y6?62])(Q+'##/D
MW[M1T(,%HS4'LSB>J.AOP$.T[W#1#)Y@9&[YW:.$:$W#-G^)Q'VY?W;J^W;M
M1'\H?9GS+Z4_&NRIFF8HH`'D.+;WB-IC)S)8^LDAT>4G+_/5[,GQ`_KH6_$<
MTSURZ1>_D^S6DPMG.`WESW1&5M>51:A-=&T9,I6)#_-5
M_A(7(`Q$.(4L*N1UT43UC`.J"%7%*@]O.$)8NNU9=MB_4@(0QE9=5$9
MA^QH(`H*M[K$&:YB7=D'!ZE+IVHLO/V=(JV-E!`18\'?OH&&PR%2B(=V_-Q
M>^VKNY\N\69#3Y)@]P\NW$7$'8`SB8\0T@"C#`]BMA#J:\\3&AYD.LXSY>+K
M'8IG,4S4BJI@&?3D=S2QT-\4YC8>-`]I
ML>^W8UM*O\G5;U]M:DQ[+O8KMX>:*_I#GQ^Q8[:5)>.%V?.4-*_TR0GHH'V!
M(I_>PMN\C*`%4IVBA8.4BEH.TQYF4,.I6D63WWMEJSLCL1I%+R0J?W&"%`9)
M3ADA%MME)@E"L>(FT->I07^,M\V`3,2(DB,&WV_?O%KX=50?!(!;@B*:Q?7I
M]$.?^V!S-%Z'WOA8Y(Q/V(\QJN6=EUU0:"#YLUH*@122Q:&4SW4,D.Y-2@$F1VJA7YB5`/9S7
M,:%>UX(#HEY!)$L.;EZO5L@E_=;USET[X2.Z(SW9/&0/O%JHUBE:OMRD4M3R
MX40/,ZB-(M0JDNQ2_7C>L><7\D/VB?FE86JT2U#H[3?E&L8FDM!+\-ZY>),/
MK"O%8J(9`3\.?(_NW>97(IV._AY?)1]G)"VA:KRYUZ4:M1.C^2+T_'C^>`9O
MJB`C*[L>'ME($2KS"P9KU@Q$#M^LT>?RLZ0]IP+.5Y\Q]N)['+03$#A?:_ZM
M?QW)K5*?89DB37?R^)7^;/"QWL
M9Y/4"E6G=D&%+(:&EMIPQ$#9VWE/!_N):#9^0+3"U\$G@!85)>$@D7`UF$P\
MX&!!,DB0#`YL=KI$%;7NH\GHV"X;I&>AXSN"83)_S;I),E]N]S,"DK)789'8
M.VH$:`0>,;)YV3G,F"=K%%4K=\7TK.EL$4EA&B:)O%!6`S_!#H&.?=\BZVJ^$3;,E9D]E8<3U\0N?V%Y`
M*6FI-J81<.5G_)M)J=[WL#1!G)6BF[_LD=,].+O.S+4'A\;:OAH'>W'2WQX*
M/9Y&56Q$Z;SP;4O:EFLG"DG[2<\L
ME6<[?9>3A@*B+3/(A+3VHD1%1S!J)$SKK[;;T\^P.E>B0"9[IH7R$(=9&CS>
M:98>"4$P>("&0")K-)$EK!0V*FI5!GB.Q^XSLBH]+ART&GPT!DM3!K*^A7I!
M6JE:P+6&=H.;:1Q(7PSI@ZT''$0S13!Q6`(>MIG6X.W*#]($><#A&X>:`YXV
M]72&<&(]M0=Q';9EISKVKB!H-%!(KSV08Y57&K!>FQ83ST!^,'T4X86
ME^WD!WRUZUJK*UQ++;/SKH[?/5($+U*EB@.*V#O^T]!8X7P9A'?9$VOEX#"3
M+#23@V:A5[YA2"1?^F%&=Y^@^J-S]%AJ\K+/?2L>`D5W"#EQ&F4VH*SG$6-G
M@`I'U*@$?*0"ACCQ:@+B4L!'PB4@/'#H%>1.Z"T+`=V]@#$1T-D+B#(!_4)`
M0E,(2$6K)*2\<138O0=AH[4,OA#5ZEMM.,.H:!T2G.`?Z(G/@&B6^2]0=
M\^C&_CQY5TK.'%ZI3'FX`U1FS&YMYKKI)@VHO[)L-GJW:(36*(S])[0?*'+V
MN#5+%]91+3W^;0<`Q^.^5N'>?,"OG':/RI76DE4GEP0$5/8*K4B+[15Y4`OZ
MF:`ES,LL,#$>:8KR5ID^)]\3Y7UK4XL*[=J.+(H,67W8J-,7LC8DF$#`W>`(
M^8]A^<3R0T1T"7)T>;^G<4(5[!=D.C6H!992#4<63#VL.VP`J0EF/-$^TX&^
M'(B\17859G:]9OT1C-JDKCU/TRM&K[(VL
M7.ULQ81T,<_9)P%:`86Z*!45FB`ZX3;HCTIA79:<>Q2*RWZB0@5@8@X0M'$X
M'`7T0-89`H>\BBVYNN=M;5X99[U7ZL'`4ENWGVQGNQ^'Q@]XYGE^OJA+M;L-
M+YVMGS@!/9J5W53)?\^G!5/Z&)`ISE.!IDF=!1>,C/@4TAUR<>CZ@9]O(LQ7
MC;,-#_B!;GDV9D+T=\ZZM!EFU65EO9A-!6)&;:;9+O:5HC*$
M(*7#4?WJ9)RAXE^U-4U$\5:06LNO=(6UNVRT@+SR-6`-]2LV#-V\.)6G*FO-EE@GW_D0KN#V"L6AJI7$I_%JCS9H!W;0H2+9O!J67H;(
MT?_GD(@=^'\B[Q]DB$OO?:YRX.Z1FT;9$Q^SR(_)I_J*$F?_;^AJ).';NYJC
M#5?##CA4>/87FW]GY<]#.;'MF[YQZFL\0EUTMXD:_*TY'+R2JQ<8MKNX)"&
MYFSG=_?W`;1MSS-IQP9"TZ]8334.`#*>#4^S>5GB^)9P5WA#!CDMAPMIRG-L
M3)JQ'2QT(X9IQO$SBW5V?HW-TA)WU[92?T*;)8JZ(S[V]^X.=O%]K(.*0L]A
MN2:M@XDL=JV]YY*-G<]+<+8XF5X&T98YKT):6[VOHB$0"1*6=JZLWJ'$H:O%
MY:E:)AS$1-6^+I/(5@"`=`)ZGL?+SM4V0#XTNU%0+0=/BK<<*[J:0QL..'L[
M%XRJ,0^9\*-;\D_NC*!#T)X&[`G&'AKRQ_X\)<`#_AH#2[H!QI)*VX,\@GK&
M;)-@;`]V_80!BG"\6#&K,EE;3(QE.FSSK-C$B9+Q\QTT@/';-T<#C8XJNN#8
M$I=&Y%\$$'W.X.?0N`Z]\8'Q2C8)Q(C17?AG`T=C,5_CCJ3QCU97.=JUN7,+
M,R*2ZDDJ!HF5*`$H`X$'F\W8VW_'2&*[1,F@#IG-RID^3&
MCOW-MM@1%^97B#,INGRK3`S"^.2D[VFCKSA!\0.^\4,G='TGV&=N@@`
M`'<^```0`!P`87-H+3(P,3`Q,C,Q+GAS9%54"0`#L&-)3;!C24UU>`L``00E
M#@``!#D!``#M6E]SXC@2?]ZKNN_@X^7VJHX`R8RC[CBQZ>H326EXTO*8K)C."H
M88`:5%P\B$`5YX3F!OGBMZUL7#<"U6>#Y6\+Q"0A5K.`LQC6*J.D6
MD`@PNI;)7>U;L$`\+'$IJ0=,6(*Y)&"I1^!;?XA&(8H/U0A(PC1^J0I%>':H
M0D!"*'FA^L1H>J@^0(+C;Z>*XA&`\(;Z,1D[E2E("^*#V^N4)[R9Q:A@,8E4
M4G4@/2]`:1)=-G:LR3;.=UX9ZB/DPW:[;32-1WKU.S`#^]H>!K[A]0W+&_J>
MZ_1@K&PRPAQF+K%DH`*^QAIDZ#.8IUG6]4K0=;+W7B-N9,WW)PM]O61S!!<3^DA*YK$^9%>NWV_#LH#/.
M#SSKYRO/[=EC_Y^&_+N,ZNAYR$N^SZ&J7;[%Q.I1:0
M]&-V+RI-6[=^NS7?[!&E57G7,OTKH^]ZGUY/S,QZ720(&&*TIE=FIJJ)[?9X
MET57CX@P9B+E&#ZZIN]H6XS&M@]V,0/'&QXQU$-\;X8A2ZDD=`Z>2R/$HSPH
MMLS5`7Y:`GQH?S),R_(FP\`9#E1`#'OFN.9F"(>$T-OD2&^,U.%[5L+7
MM.`<\!WEQL>,:8_<82&)!%!R3#=&ZC!]4\*TY]S8?N`$$\@11XVI")D*_A08
M)^J]?.6Q6^;J<'Y;@;,/!R'DA0F<@M[('IO'[L9C<%F>AN"TD'+-4)([HE[@
M,LRW3=:!_JX$.OAT,)Y8X-PJ'YM6X-Q`]CAJ1^\CPF]0G.)KC!1*NA#,,*^>
MJD/\/R7$^Z8S-FY,=V(;U[;I0U;1%>$1`^[0.]"'\4?77A^H`_=]"5QG>`-@
M>N/C]N`!8]$]B6.31A[<_[@#RM$YF<8%P'4+Z@`_+P$^\+S>)\=U#2CD#"^X
MLL=@`ZCJ!D[7/6H;9(_@`7I8.?5JH`;C3OF6DK]Y!^;GHT;47B0Q6V+K;1M=>VCWG<`8N>91UQXN[##7DEDQ(@L!J<+2
M)=X%\O7%A=ICH,N^?QN6:SK7OLXK65DXL(?6<>=U&W$*T(H1
MYOXMXOE_I:71.LS+UQO;'`\!7-^`BMOPK\RQ?<0(6R@A$L7Z#3?_ZV5]I`[9
M\H7&,D=.8+K92^T1@ZJQ@^,/E();^%K>KIJH@[A\?='0J@,2JCZXIA]]UO;Q
M7-U)'#IC?+'V5%HQ7@=T^=;BVP-U30&H^][X^MC?2?UT*O"7%'2R[U:WP]+H
M5HA/.Q6/T?ZDZ]N_3!3*]LV17PE[>"KSIR7UJ\Y7V^6')+L;_.6P^QJV#ZW-
M+L7L>Z.14?4QDD7"N#1HJ=ETK9ESCE"RTF"4+:!L.ZFB
M;N%8/HXT5_Q.'D24]8+M)5"$R1\A#&4T^P)^3Q>F8$GQ7/VOIUB_;[;/Z@3;
M:*^+.<\<-F?07#'84Y*Z3M=])-`DZJM9T"D9SIJ=TZ?+\*;%57_@GMOKU6K3
M-TW0O=,^Q`2E9N`]]RP(U+9O#[=YN;WYF2&A&6YUP[S%6\M4/`2X3(@^9XOL
MNI1"`;]Z..]B.*9QZ04!LN1O3R+.FDIUA_7%@E$L$5\Z$B]4H@'5X=A2_XPH
MZ@%G:5(L);"D85`2QVBJ&D0E3U5/JIZ;9LU'EXV0XXC(8ABD("P*]'Y1FDFT
M#8=N*@C%0EAL,24T2Z6@ET=[P.0.J9)P3?']5G]+32,\?9JB+D%3$A.Y[#-N
MBBD6DHGLN@Q""#%D-$RY:M58:7L`R?B!1'(TVE7\WUJ)=H
M-RW_[:GT/I3N+^/9:V*/<:R.BA%G,P(5>?'8O:SU];WH7Z3W*U\%I7QTIQ\I
MU"5/I2U.IEH2^R%1[34KY?==_R*5];&4V8"EXS-<^OFJOO7OHB51QB
MJ=J?P/WN2(2C[G(B5,MWU5&T9M1#B%ZFVDQB$;`^Q",-B7H0*GK$3)"'HU"N
MN_#NM>M*PAA`L+>**&=2J%BM\G,3%HW@4I4P@6(M0H`?9#=^?!;;EJ:V4V4*
M%[72A2QFGFG90]34X%&13L3K&(8;"#IA6
M%4A[+G]6*EG%V0S%8FN@[(%$5^OAPTK,@ZOL3K!V?6=>U0B3D@X62U$\?@(JNN#<7:
MXXKYEO#_SC+]J8[[]$H7H@ZB#6XJ67+Q9G#0KZZH`0N81#&@DG!\"V4;7-+4
M>/G$?"Z?[W>:ZG>Y[/4`OOX/4$L!`AX#%`````@`*DA"/BVEHI<\N0``$X@+
M`!``&````````0```*2!`````&%S:"TR,#$P,3(S,2YX;6Q55`4``[!C24UU
M>`L``00E#@``!#D!``!02P$"'@,4````"``J2$(^#;JZ0-\/```5X```%``8
M```````!````I(&&N0``87-H+3(P,3`Q,C,Q7V-A;"YX;6Q55`4``[!C24UU
M>`L``00E#@``!#D!``!02P$"'@,4````"``J2$(^:F70X6`$```'(P``%``8
M```````!````I(&SR0``87-H+3(P,3`Q,C,Q7V1E9BYX;6Q55`4``[!C24UU
M>`L``00E#@``!#D!``!02P$"'@,4````"``J2$(^*NB.M79```!600,`%``8
M```````!````I(%AS@``87-H+3(P,3`Q,C,Q7VQA8BYX;6Q55`4``[!C24UU
M>`L``00E#@``!#D!``!02P$"'@,4````"``J2$(^R-DPIV4@```F^@$`%``8
M```````!````I($E#P$`87-H+3(P,3`Q,C,Q7W!R92YX;6Q55`4``[!C24UU
M>`L``00E#@``!#D!``!02P$"'@,4````"``J2$(^>6W.+GH(``!W/@``$``8
M```````!````I('8+P$`87-H+3(P,3`Q,C,Q+GAS9%54!0`#L&-)375X"P`!
@!"4.```$.0$``%!+!08`````!@`&`!0"``"<.`$`````
`
end




XML
30
R4.xml
IDEA: CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)


2.2.0.25falsefalse002010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)truefalseIn Millionsfalse1falsefalseUSDfalsefalse12/31/2010
USD ($)

$c00002http://www.sec.gov/CIK0001305014instant2010-12-31T00:00:000001-01-01T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$<
/CurrencySymbol>2falsefalseUSDfalsefalse9/30/2010
USD ($)
$c00007http://www.sec.gov/CIK0001305014instant2010-09-30T00:00:000001-01-01T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4true0us-gaap_AssetsCurrentAbstractus-gaap<
IsBaseElement>truenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCURRENT ASSETS5false0us-gaa
p_AllowanceForDoubtfulAccountsReceivableNoncurrentus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2900000029<
IsIndependantCurrency>falsetruefalsefalsefalse2truefalsefalse2800000028falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryA valuation allowance for receivables due to an Entity for more than one year from the balance sheet date th
at are expected to be uncollectible.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 4
 -Article 5

falsefalseAllowance for doubtful accounts22CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue




XML
31
R16.xml
IDEA: GOODWILL AND OTHER INTANGIBLES


2.2.0.25falsefalse006090 - Disclosure - GOODWILL AND OTHER INTANGIBLEStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE I &#8211; GOODWILL AND OTHER INTANGIBLES&#160;&#160;</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In accordance with U.S. GAAP, Ashland reviews goodwill and other intangible assets for impairment annually and when events and circumstances indicate an impairment may have occurred.&#160;&#160;The ann
ual assessment is performed as of July&#160;1 and consists of Ashland determining each reporting unit&#8217;s current fair value compared to its current carrying value.&#160;&#160;Ashland has determined its reporting units for allocation of goodwill include the Functional Ingredients, Water Technologies, Performance Materials and Consumer Markets reportable segments.&#160;&#160;Prior to its sale to TPG, Distribution was treated as a separate reporting unit for allocation of goodwill.&#160;&#160;Ashland performed its most recent annual goodwill impairment test as of July 1, 2010, and determined at that time, that no impairment existed.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The f
ollowing is a progression of goodwill by segment for the period ended December 31, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FO
NT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right">
<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" 
valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&a
mp;#160;</font></td></tr><tr><td valign="bottom" width="28%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Functional</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#16
0;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Water</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Performance</font></div></td><td style="TEXT-ALIGN: left" valign="bottom
" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="2%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Consumer</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"&g
t;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;
</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Ingredients</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY
: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Technologies</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Materials</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT
- -FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(a)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Markets</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" 
nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; 
DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at September 30, 2010</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,080</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: t
imes new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">620</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style
="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">333</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap=
"nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,148</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"
><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Divestitures</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td 
style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 1
0pt">(52</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times
 new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(52</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline
; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Currency translation adjustment</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right
"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bot
tom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%
"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"
 valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(13</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="28%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2010</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font
 style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,067</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width=
"9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">620</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">281</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign=
"bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">115</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom
" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,083</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white">&l
t;td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="28%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt
">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-F
AMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="2%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left">
;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEX
T-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div><div style="MARGIN-LEFT: 18pt"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="95%"><tr valign="top"><td style="TEXT-ALIGN: left; WIDTH: 31px"><div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)&#160;&#160;&#160;&l
t;/font></div></td><td width="1138"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Within the Performance Materials reportable segment as of September 30, 2010, because further discrete financial information is provided and management regularly reviews this information, this reportable segment was further broken down into the Castings Solutions and Composite Polymers/Specialty Polymers and Adhesives reporting units.&#160;&#160;Goodwill consisted of $52 million and $281 million, respectively, for the Castings Solutions and Composite Polymers/Specialty Polymers and Adhesives reporting units as of September 30, 2010.&#160;&#160;The reduction of $52 million of goodwill is related to the contribution of Ashland&#8217;s Castings Solutions business to the expanded global joint venture with <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman"&
gt;S&#252;d-Chemie</font>.</font></div></td></tr></table></div><div style="TEXT-INDENT: 0pt; DISPLAY: block"><br /></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Intangible assets principally consist of trademarks and trade names, intellectual property, customer lists and sale contracts.&#160;&#160;Intangible assets are amortized on a straight-line basis over their estimated useful lives.&#160;&#160;The cost of trademarks and trade names is amortized principally over 15 to 25 years, intellectual property over 5 to 20 years, customer relationships over 3 to 24 years and other intangibles over 2 to 50 years.</font></div><div style="TEXT-INDENT:
 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Certain intangible assets within trademarks and trade names have been classified as indefinite lived and had a balance of $290&#160;million as of December 31, 2010 and September 30, 2010.&#160;&#160;In accordance with U.S. GAAP, Ashland annually reviews these intangible assets for possible impairment whenever events or changes in circumstances indicate that carrying amounts may not be recoverable.&#160;&#160;In conjunction with the July 1 annual assessment of indefinite-lived intangible assets, Ashland&#8217;s models did not indicate any impairment.&#160;&#160;Intangible assets were comprised of the following as of December 31, 2010 and September 30, 2010.</font></div><div st
yle="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">&l
t;font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2">
<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="58%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="10"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">De
cember 31, 2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline
; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net
</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 1
0pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" ali
gn="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt;
 DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amount</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amortization</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN
: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amount</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="58%" align="left"&
gt;<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks and trade names</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">353</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="
DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(28</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width=
"9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">325</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intellectual property</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" 
valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">331</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(68</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</f
ont></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">263</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Customer relati
onships</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">579</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FO
NT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(87</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">492</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" now
rap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; F
ONT-FAMILY: times new roman; FONT-SIZE: 10pt">35</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(26</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">
;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" val
ign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total intangible assets</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,298</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISP
LAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(209</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLA
Y: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,089</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new rom
an; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style=
"DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></ta
ble></div><div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valig
n="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" 
valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="58%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="38%" colspan="10"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMI
LY: times new roman; FONT-SIZE: 10pt">September 30, 2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Gross</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap
="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMI
LY: times new roman; FONT-SIZE: 10pt">Net</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline
; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accumulated</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: blo
ck; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">carrying</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align
="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amount</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amortization</font></div></td><td style
="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">amount</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><
td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Trademarks and trade names</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">353</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" 
width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td styl
e="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">326</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Intellectual property</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font>
</td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">331</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(63</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: 
times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">268</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times ne
w roman; FONT-SIZE: 10pt">Customer relationships</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">583</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width
="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(78</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">505</font></td><td style="TEXT
- -ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other intangibles</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" widt
h="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">39</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(27</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" v
align="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#ccee
ff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="58%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total intangible assets</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,306</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width
="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(195</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width
="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,111</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="58%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style
="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" 
valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#1
60;</font></td></tr></table></div><div align="left">&#160;</div></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Amortization expense recognized on intangible assets for the three months ended December 31 was $17 million for 2010 and $18&#160;million for 2009 and is primarily included in the selling, general and administrative expenses caption of the Statements of Consolidated Income.&#160;&#160;Estimated amortization expense for future periods is $69&#160;million in 2011 (includes three months actual and nine months estimated), $67&#160;million in 2012, $66&#160;million in 2013, $64&#160;million in 2014 and $62&#160;million in 2015.</font></div>NOTE I &#8211; GOODWILL AND OTHER INTANGIBLES&#160;&#160;&#160;In ac
cordance with U.S. GAAP, Ashland reviews goodwill and other intangible assets forfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringDiscloses the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of rese
arch and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain or loss on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocate
d amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss. This elemen
t may be used as a single block of text to include the entire intangible asset disclosure including data and tables.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 142
 -Paragraph 42, 43, 44, 45, 46, 47

falsefalseGOODWILL AND OTHER INTANGIBLES12GOODWILL AND OTHER INTANGIBLESUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
32
R9.xml
IDEA: NEW ACCOUNTING STANDARDS


2.2.0.25falsefalse006020 - Disclosure - NEW ACCOUNTING STANDARDStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE B &#8211; NEW ACCOUNTING STANDARDS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Changes to estimates of financial statement impacts due to the adoption of new accounting standards and new accounting standards issued during the current fiscal year are included in interim financial
 reporting.&#160;&#160;A detailed listing of all new accounting policies material to Ashland is included in the Annual Report on Form 10-K for the fiscal year ended September 30, 2010.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">In October 2009, the Financial Accounting Standards Board (FASB) issued accounting guidance related to separating consideration in multiple-deliverable revenue arrangements (ASC 605-25 Revenue Recognition &#8211; Multiple-Element Arrangements).&#160;&#160;Under this guidance, multiple-deliverable arrangements will be accounted for separately (rather than as a combined unit) by selecting the best evidence of selling price among vendor-specific objective evidence, third-pa
rty evidence or estimated selling price.&#160;&#160;Additionally, this guidance eliminates the residual method of allocation and requires that arrangement consideration be allocated at the inception of the arrangement to all deliverables using the relative selling price method.&#160;&#160;This guidance became effective for Ashland on October 1, 2010.&#160;&#160;The adoption of this guidance did not have a material impact on the Condensed Consolidated Financial Statements.</font></div>NOTE B &#8211; NEW ACCOUNTING STANDARDS&#160;Changes to estimates of financial statement impacts due to the adoption of new accounting standards and newfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringRepresents disclosure of any changes in an accounting principle, including a change from one generally accepted accounting principle to another generally accepted accounting principle when there are two or more generally accepted accounting principles that apply or when the accounting principle formerly used is no longer generally accepted. Also disclose any change in the method of applying an accounting principle, or any change in an accounting principle required by a new pronouncement in the unusual instance that a new pronouncement does not include specific transition provisions.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 154
 -Paragraph 2, 17, 18

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 28
 -Paragraph 23, 24

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 01
 -Paragraph b
 -Subparagraph 6
 -Article 10

falsefalseNEW ACCOUNTING STANDARDS12NEW ACCOUNTING STANDARDSUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
33
R6.xml
IDEA: STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited) (Parenthetical)


2.2.0.25falsefalse003010 - Statement - STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited) (Parenthetical)truefalseIn Millions, except Share datafalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse10/1/2009 - 12/31/2009
USD ($)

USD ($) / shares
$c00017http://www.sec.gov/CIK0001305014duration2009-10-01T00:00:002009-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0USDUSD$2true0us-gaap_StatementOfStockholdersEquityAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalse
falsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalse
falsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseStatement of Stockholders' Equity [Abstract]3false0us-gaap_CommonStockDividendsPerShareCashPaidus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse0.150.15falsetruefalsefalsefalse2truefalsefalse0.0750.075falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalAggregate dividends paid during the period for each share of common stock outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

falsetrueDividends paid per common share (in dollars per share)4false0us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse231358231358falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse<
Unit>Sharesxbrli:sharesItemTypesharesNumber of shares issued during the period as a result of any share-based compensation plan other than an employee stock ownership plan (ESOP).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 29, 30
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 10

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 129
 -Paragraph 5

falsefalseStock plan shares issued currnt period5false0us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse-363000000-363falsetruefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAccumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at fiscal year-end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, and unrealized gains and losses on certain investments in debt and equity securities as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 10

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 14, 17, 26

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 31
 -Article 5

falsefalseAccumulated other comprehensive loss, after tax6false0us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTaxus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse
1truefalsefalse-620000000-620falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse
Monetaryxbrli:monetaryItemTypemonetaryThe total of net (gain) loss, prior service cost (credit), and transition assets (obligations), as well as minimum pension liability if still remaining, included in accumulated other comprehensive income associated with a defined benefit pension or other postretirement plan(s) because they have yet to be recognized as components of net periodic benefit cost.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph i

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 158
 -Paragraph 7
 -Subparagraph c

falsefalsePension and postretirement obligations7false0us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTaxus-gaaptruecreditinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse257000000257falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAccumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains (losses).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 52
 -Paragraph 12, 13

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 52
 -Paragraph 31
 -Subparagraph a

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 10

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 17, 18, 19, 22, 23, 24, 25, 26

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 133
 -Paragraph 45

falsefalseNet unrealized translation gains8true0ash_ReconciliationsOfNetIncomeLossToTotalComprehensiveLossAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseReconciliations of net income (loss) to total comprehensive (loss) income9false0us-gaap_NetIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse8700000087falsefalsefalsefalsefalse2truefalsefalse8600000086falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 19
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph d

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A7
 -Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph a

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 20
 -Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 10, 15

Reference 7: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Emerging Issues Task Force (EITF)
 -Number 87-21

Reference 8: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28, 29, 30

falsefalseNet income10false0us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecreaseus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-18000000-18falsefalsefalsefalsefalse2truefalsefalse-19000000-19falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAdjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity, net of tax.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 52
 -Paragraph 13, 20, 31

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph c(3)

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 24
 -Subparagraph b

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 14, 17, 19, 26

falsefalseUnrealized translation loss, net of tax11false0us-gaap_ComprehensiveIncomeNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefal
sefalse6900000069[1]falsetruefalsefalsefalse2truefalsefalse6700000067falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A5
 -Appendix A

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 30

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph c(3)

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 8, 9, 10, 11, 12, 13, 14

falsefalseTotal comprehensive income (loss)1Reconciliations of net income to total comprehensive (loss) income follow.  See parenthetical data statements of consolidated stockholders' equity for reconciliation data.210STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited) (Parenthetical) (USD $)MillionsNoRoundingNoRoundingUnKnownfalsetrue




XML
34
R5.xml
IDEA: STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited)


2.2.0.25truefalse003000 - Statement - STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited)truefalseIn Millionsfalse1falsefalseUSDtruefalse{us-gaap_StatementEquityComponentsAxis} : Common Stock
10/1/2010 - 12/31/2010
USD ($)
$c00013http://www.sec.gov/CIK0001305014na0001-01-01T00:00:000001-01-01T00:00:00falsefalseus-gaap_CommonStockMemberus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CommonStockMemberus-gaap_StatementEquityComponentsAxisexplicitMemberu000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2falsefalseUSDtruefalse{us-gaap_StatementEquityComponentsAxis} : Paid-in capital
10/1/2010 - 12/31/2010
USD ($)
$c00014http://www.sec.gov/CIK0001305014na0001-01-01T00:00:000001-01-01T00:00:00falsefalseus-gaap_AdditionalPaidInCapitalMemberus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_AdditionalPaidInCapitalMemberus-gaap_StatementEquityComponentsAxisexplicitMemberu000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3falsefalseUSDtruefalse{us-gaap_StatementEquityComponentsAxis} : Retained earning
10/1/2010 - 12/31/2010
USD ($)
$c00015http://www.sec.gov/CIK0001305014na0001-01-01T00:00:000001-01-01T00:00:00falsefalseus-gaap_RetainedEarningsMemberus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RetainedEarningsMemberus-gaap_StatementEquityComponentsAxisexplicitMemberu000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4falsefalseUSDtruefalse{us-gaap_StatementEquityComponentsAxis} : Accumulated other comprehensive income (loss) (a)
10/1/2010 - 12/31/2010
USD ($)
$c00016http://www.sec.gov/CIK0001305014na0001-01-01T00:00:000001-01-01T00:00:00falsefalseus-gaap_AccumulatedOtherComprehensiveIncomeMemberus-gaap_StatementEquityComponentsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_AccumulatedOtherComprehensiveIncomeMemberus-gaap_StatementEquityComponentsAxisexplicitMemberu000Standardhttp://www.xbrl.org/2003/iso4
217USDiso42170USDUSD$5falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014na0001-01-01T00:00:000001-01-01T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$1false0us-gaap_StockholdersEquityus-gaaptruecreditinstantNo definition available.falsefalsefalsetruefalsefalsefalsetruefalsefalseperiodstartlabelinstant2010-10-01T00:00:000001-01-01T00:00:001truefalsefalse10000001falsetruefalsetruefalse2tr
uefalsefalse665000000665falsetruefalsetruefalse3truefalsefalse34820000003482falsetruefalsetruefalse4truefalsefalse-345000000-345falsetruefalsetruefalse5truefalsefalse38030000003803falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A3
 -Appendix A

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 4
 -Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 29, 30, 31
 -Article 5

falsefalseBeginning Balance at Sep. 30, 20102false0us-gaap_ComprehensiveIncomeNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00falsefalsefalsetruefalse2truefalsefalse00falsefalsefalsetruefalse3truefalsefalse8700000087falsefalsefalsetruefalse4truefalsefalse-18000000-18falsefalsefalsetruefalse5truefalsefalse6900000069[1]falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions whic
h are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A5
 -Appendix A

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 30

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph c(3)

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 8, 9, 10, 11, 12, 13, 14

falsefalseTotal comprehensive income (loss)3false0us-gaap_DividendsCommonStockus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse00falsefalsefalsetruefalse2truefalsefalse00falsefalsefalsetruefalse3truefalsefalse-12000000-12falsefalsefalsetruefalse4truefalsefalse00falsefalsefalsetruefalse5truefalsefalse-12000000-12falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate cash, stock, and paid-in-kind dividends declared for common shareholders during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

falsefalseRegular dividends4false0us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefal
sefalse00falsefalsefalsetruefalse2truefalsefalse1700000017[2]falsefalsefalsetruefalse3truefalsefalse00falsefalsefalsetruefalse4truefalsefalse00falsefalsefalsetruefalse5truefalsefalse1700000017falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryValue of stock issued during the period as a result of any share-based compensation plan other than an employee stock ownership plan (ESOP).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 29, 30, 31
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 10

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 123R
 -Paragraph 64

falsefalseCommon shares issued under stock incentive and other plans5false0us-gaap_StockholdersEquityus-gaaptruecreditinstantNo definition available.falsefalsefalsetruefalsefalsefalsefalsetruefalseperiodendlabelinstant2010-12-31
T00:00:000001-01-01T00:00:001truefalsefalse10000001falsetruefalsetruefalse2truefalsefalse682000000682falsetruefalsetruefalse3truefalsefalse35570000003557falsetruefalsetruefalse4truefalsefalse-363000000-363[3]falsetruefalsetruefalse5truefalsefalse38770000003877falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the e
conomic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A3
 -Appendix A

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 4
 -Section E

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 29, 30, 31
 -Article 5

falsefalseEnding Balance at Dec. 31, 20101Reconciliations of net income to total comprehensive (loss) income follow.  See parenthetical data statements of consolidated stockholders' equity for reconciliation data.2Common shares issued were 231,358 for the three months ended December 31, 2010.3At December 31, 2010, the after-tax accumulated other comprehensive loss of $363 million was comprised of pension and postretirement obligations of $620 million for 2010 and net unrealized translation gains of $257 million.55STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue




XML
35
R23.xml
IDEA: STOCK INCENTIVE PLANS


2.2.0.25falsefalse006160 - Disclosure - STOCK INCENTIVE PLANStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold"><font style="FONT-VARIANT: small-caps; DISPLAY: inline">NOTE P &#8211; </font>STOCK INCENTIVE PLANS</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland has stock incentive plans under which key employees or directors are granted stock-settled stock appreciation rights (SARs), performanc
e share awards or nonvested stock awards.&#160;&#160;Each program is typically a long-term incentive plan designed to link employee compensation with increased shareholder value or reward superior performance and encourage continued employment with Ashland.&#160;&#160;Ashland recognizes compensation expense for the grant date fair value of stock-based awards over the applicable vesting period.&#160;&#160;Stock-based compensation expense was $4 million and $3 million for the three months ended December 31, 2010 and 2009, respectively, and is included in the selling, general and administrative expenses caption of the Statements of Consolidated Income.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; 
FONT-WEIGHT: bold">SARs</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">SARs are granted to employees or directors at a price equal to the fair market value of the stock on the date of grant and typically become exercisable over periods of one to three years.&#160;&#160;Unexercised SARs lapse essentially ten years after the date of grant.&#160;&#160;SARs granted for the three months ended December 31, 2010 and 2009 were 0.6&#160;million.&#160;&#160;As of December 31, 2010, there was $18&#160;million of total unrecognized compensation costs related to SARs.&#160;&#160;That cost is expected to be recognized over a weighted-average period of 2.5 years.&#160;&#160;Ashland 
estimates the fair value of SARs granted using the Black-Scholes option-pricing model.&#160;&#160;This model requires several assumptions, which Ashland has developed and updates based on historical trends and current market observations.&#160;&#160;The accuracy of these assumptions is critical to the estimate of fair value for these equity instruments.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Nonvested stock awards</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><fo
nt style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Nonvested stock awards are granted to employees or directors at a price equal to the fair market value of the stock on the date of grant and are forfeitable until vesting requirements are met, which is generally over a one-to-five-year period.&#160;&#160;However, such shares are subject to forfeiture upon termination of service before the vesting period ends.&#160;&#160;Nonvested stock awards entitle employees or directors to vote the shares and to receive any dividends (or dividend equivalents) upon grant.&#160;&#160;Nonvested stock awards granted for the three months ended December 31, 2010 and 2009 were 12,100 and 30,000 shares, respectively.&#160;&#160;As of December 31, 2010, there was $6 million of total unrecognized compensation costs related to nonvested stock awards.&#160;&#160;That cost is expected to be recognized over a weighted-average period of 2.2 years.</font></div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Performance shares</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Performance share/unit awards are granted to certain key employees and are tied to Ashland&#8217;s overall financial performance relative to the financial performance of a selected industry peer group.&#160;&#160;Ashland believes that the focus on relative performance encourages management to make decisions th
at create shareholder value.&#160;&#160;Awards are granted annually, with each award covering a three-year performance cycle.&#160;&#160;Historically, each performance share/unit is convertible to one share of Ashland Common Stock or cash.&#160;&#160;As a result, these plans are recorded as a liability in the Condensed Consolidated Balance Sheets within the other noncurrent liabilities caption.&#160;&#160;Performance measures used to determine the actual number of performance shares issuable upon vesting include an equal weighting of Ashland&#8217;s total shareholder return (TSR) performance and Ashland&#8217;s return on investment (ROI) performance as compared to the performance peer group over the three-year performance cycle.&#160;&#160;TSR relative to </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">peers is considered a market condition while ROI is considered a performance condition under applicable U.S. GAAP
.&#160;&#160;Nonvested performance shares/units do not entitle employees to vote the shares or to receive any dividends thereon.&#160;&#160;Performance shares/units granted for the three months ended December 31, 2010 and 2009 were 0.2&#160;million.&#160;&#160;As of December 31, 2010, there was $11 million of total unrecognized compensation costs related to performance shares/units.&#160;&#160;That cost is expected to be recognized over a weighted-average period of 2.4 years.</font></div>NOTE P &#8211; STOCK INCENTIVE PLANS&#160;Ashland has stock incentive plans under which key employees or directors are granted stock-settled stock appreciationfalsefalsefalsefalsefal
seOtherus-types:textBlockItemTypestringDisclosure of compensation-related costs for share-based compensation which may include disclosure of policies, compensation plan details, allocation of stock compensation, incentive distributions, share-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 123R
 -Paragraph 64, 65, A240

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Statement of Position (SOP)
 -Number 93-6
 -Paragraph 53

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 14

falsefalseSTOCK INCENTIVE PLANS12STOCK INCENTIVE PLANSUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
36
defnref.xml
IDEA: XBRL DOCUMENT



  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    Carrying amount as of the balance sheet date of reserves for the costs of settling insured claims and costs incurred in the claims settlement process attributable to asbestos, before estimated recoveries from reinsurers.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    The net cash from (used in) the entity's continuing operations. This element includes the aggregate amount of net cash provided by (used in) operating, investing and financing activities.
    No authoritative reference available.
  
  
    The noncurrent portion of the receivable from insurance for reimbursement and payment of asbestos claims.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    The gain (loss) resulting from the sale of a disposal group that is not a discontinued operation. It is included in income from continuing operations before income taxes in the income statement. This element also includes, in a business combination achieved in stages, the amount of gain or loss recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    The consolidated profit or loss for the period before income taxes, including the portion attributable to any noncontrolling interest.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    Noncash equity contribution made by the entity to qualified saving plan during the period.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    Description of completed or expected disposal(s) group, the gain or loss recognized in the income statement and the income statement caption that includes that gain or loss, amounts of revenues and pretax profit or loss reported in earnings, the segment in which the disposal group was reported, and the classification and carrying value of the assets and liabilities comprising the disposal group.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    Description of activities and amount of cash flows that are expected to continue with the disposal group that is a component of the entity (discontinued operation) after it has been sold or otherwise disposed of.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  
  
    No authoritative reference available.
    No authoritative reference available.
  





XML
37
R21.xml
IDEA: EARNINGS PER SHARE


2.2.0.25falsefalse006140 - Disclosure - EARNINGS PER SHAREtruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_EarningsPerShareTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">NOTE N </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#8211;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt">&#160;</font><font style="DISPLAY: inline; FONT-WEIGHT: bold">EARNINGS PER SHARE</font></font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FO
NT-SIZE: 11pt">The following is the computation of basic and diluted earnings per share (EPS) from continuing operations.&#160;&#160;Stock options, SARs and warrants (assumed as part of the Hercules acquisition) available to purchase shares outstanding for each reporting period whose grant price was greater than the average market price of Ashland Common Stock for each applicable period were not included in the computation of income from continuing operations per diluted share because the effect of these instruments would be antidilutive.&#160;&#160;The total number of these shares outstanding was approximately 2.0 million and 2.1 million as of December 31, 2010 and 2009, respectively.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: bl
ack 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="24%" colspan="6"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3
%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three months ended</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM
: black 2px solid" valign="bottom" width="24%" colspan="6"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(In millions except per share data)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMIL
Y: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0p
t" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2009</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Numerator</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font><
/td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Numerator for basic and diluted 
EPS &#8211; Income</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: time
s new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">from continuing operations</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt
">62</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">64</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: tim
es new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Denominator</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: 
inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline
; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Denominator for basic EPS &#8211; Weighted-average</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-
ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">common shares outstanding</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt
">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">79</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inl
ine; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">77</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Share based awards convertible to common shares</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZ
E: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY:
 times new roman; FONT-SIZE: 10pt">1</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Denominator for diluted EPS &#8211; Adjusted weighted-</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" 
valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#1
60;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px; PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">average shares and assumed conversions</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">80</font>
;</td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">78</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new rom
an; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: in
line; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EPS from continuing operations</font></div></td><td valign="bott
om" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>&
lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Basic</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&
gt;$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">.79</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">.84</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-
FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Diluted</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">.78</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font sty
le="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">.82</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bott
om" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>&
lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div>NOTE N &#8211;&#160;EARNINGS PER SHARE&#160;The following is the computation of basic and diluted earnings per share (EPS) from continuingfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringThis element may be used to capture the complete disclosure pertaining to an entity's earnings per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 40

falsefalseEARNINGS PER SHARE12EARNINGS PER SHAREUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
38
R13.xml
IDEA: RESTRUCTURING ACTIVITIES


2.2.0.25falsefalse006060 - Disclosure - RESTRUCTURING ACTIVITIEStruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE F &#8211; RESTRUCTURING ACTIVITIES</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">Ashland periodically implements restructuring programs related to acquisitions, divestitures or other cost reduction programs in order to enhance profitability through streamlined operations and an improved overall cost struc
ture for each business.&#160;&#160;The total restructuring cost incurred for these programs for the three months ended December 31, 2009 was $2&#160;million and was classified within the selling, general and administrative expenses caption.&#160;&#160;Additional costs from reductions in resources, facilities and business realignment or divestitures may occur in future periods, which could include charges related to additional severance, plant closings, reassessed pension plan valuations or other items.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">As of December 31, 2010, the remaining restructuring reserves for these programs principally consisted of severance payments from the Hercules Integrat
ion Plan and the recent Performance Materials restructuring, which consisted of several plant closings and operational redesign to eliminate excess capacity that was announced during the prior fiscal year.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table details at December 31, 2010 and 2009, the amount of restructuring reserves related to the programs discussed above, and the related activity in these reserves for the three months ended December 31, 2010 and 2009.&#160;&#160;The reserves are included in accrued expenses and other liabilities in the Condensed Consolidated Balance Sheet and are expected to be fully utilized by the end of fiscal 2011.</font></div><div style="TEX
T-INDENT: 0pt; DISPLAY: block">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="83%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom"
 width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="83%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"></font>&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(</font><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td 
style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Severance</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="83%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of September 30, 2009</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 1
0pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">38</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="83%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Restructuring reserve</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; 
FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="83%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Utilization (cash paid or otherwise settled)</font></div></td><td style="PADDING-BOTTOM: 2px" valign
="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(9</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="83%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="D
ISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2009</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">31</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom"
 width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="83%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="
left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance as of September 30, 2010</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">26</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="83%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY
: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Utilization (cash paid or otherwise settled)</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(5</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10p
t">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="83%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Balance at December 31, 2010</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font></td><td style="BORDER-BO
TTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="83%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; F
ONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div>NOTE F &#8211; RESTRUCTURING ACTIVITIES&#160;Ashland periodically implements restructuring programs related to acquisitions, divestitures or other costfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringDescription of restructuring activities including exit and disposal activities, which should include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associate
d with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. This description does not include restructuring costs in connection with a business combination or discontinued operations and long-lived assets (disposal groups) sold or classified as held for sale. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 146
 -Paragraph 20

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 5
 -Section P
 -Subsection 3, 4

falsefalseRESTRUCTURING ACTIVITIES12RESTRUCTURING ACTIVITIESUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
39
R26.xml
IDEA: Entity Information


2.2.0.25falsefalse995400 - Document - Entity Informationtruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2false0dei_EntityTextBlockdeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Ashland Inc.Ashland Inc.falsefalsefalsefalsefalseOtherus-types:textBlockItemType<
/ElementDataType>stringContainer to serve as parent of six Entity related Table concepts.No authoritative reference available.falsefalseEntity [Text Block]3false0dei_EntityRegistrantNamedeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Ashland Inc.Ashland Inc.falsefalsefalsefalsefalseOtherxbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.R
eference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation 12B
 -Number 240
 -Section 12b
 -Subsection 1

falsefalseEntity Registrant Name4false0dei_EntityCentralIndexKeydeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0000013050140001305014falsefalsefalsefalsefalseOtherus-types:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation 12B
 -Number 240
 -Section 12b
 -Subsection 1

falsefalseEntity Central Index Key5false0dei_CurrentFiscalYearEndDatedeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00--09-30--09-30falsefalsefalsefalsefalseOtherxbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No authoritative reference available.falsefalseCurrent Fiscal Year End Date6false0dei_EntityWellKnownSeasonedIssuer<
ElementPrefix>deifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00YesYesfalsefalsefalsefalsefalseOtherus-types:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.No authoritative reference available.falsefalseEntity Well-known Seasoned Issuer7false0dei_EntityVoluntaryFilersdeifalsena
durationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00NoNofalsefalsefalsefalsefalseOtherus-types:yesNoItemTypenaIndicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.No authoritative reference available.falsefalseEntity Voluntary Filers8false0dei_EntityCurrentReportingStatusdeifalsenadurationNo definition available.falsefalsefalse
falsefalsefalsefalsefalsefalsefalse1falsefalsefalse00YesYesfalsefalsefalsefalsefalseOtherus-types:yesNoItemType
naIndicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.No authoritative reference available.falsefalseEntity Current Reporting Status9false0dei_EntityFilerCategorydeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Large Accelerated FilerLarge Accelerated FilerfalsefalsefalsefalsefalseOtherus-types:filerCategoryItemTypenaIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No authoritative reference available.falsefalseEntity Filer Category10false0dei_EntityPublicFloatdeifalsecreditinstant<
/PeriodType>No definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse40199821314019982131falsetruefalsefalse
falseMonetaryxbrli:monetaryItemTypemonetaryState aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.No authoritative reference available.falsefalseEntity Public Float11false0dei_EntityCommonStockSharesOutstandingdeifalsenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse7904015279040152falsefalsefalsefalsefalseSharesxbrli:sharesItemTypesharesIndicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, InstrumentNo authoritative reference available.falsefalseEntity Common Stock, Shares Outstanding12false0dei_DocumentFiscalYearFocusdeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0020112011falsefalsefalsefalsefalseOtherxbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No authoritative reference available.falsefalseDocument Fiscal Year Focus13false0dei_DocumentFiscalPeriodFocusdeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00Q1Q1falsefalsefalsefalsefalseOtherus-types:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No authoritative reference available.falsefalseDocument Fiscal Period Focus112Entity Information (USD $)NoRoundingNoRoundingUnKnownUnKnownfalsetrue




XML
40
R1.xml
IDEA: STATEMENTS OF CONSOLIDATED INCOME (unaudited)


2.2.0.25falsefalse001000 - Statement - STATEMENTS OF CONSOLIDATED INCOME (unaudited)truefalseIn Millions, except Per Share datafalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse10/1/2009 - 12/31/2009
USD ($)

USD ($) / shares
$c00017http://www.sec.gov/CIK0001305014duration2009-10-01T00:00:002009-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0USDUSD$2true0us-gaap_IncomeStatementAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseIncome Statement [Abstract]3false0us-gaap_SalesRevenueGoodsNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse14330000001433falsetruefalsefalsefalse2truefalsefalse13240000001324falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 1
 -Article 5

falsefalseSALES4true0us-gaap_CostsAndExpensesAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCOSTS AND EXPENSES5false0us-gaap_CostOfGoodsSoldus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse10400000001040falsefalsefalsefalsefalse2truefalsefalse906000000906falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryTotal costs related to goods produced and sold during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 2
 -Article 5

falsefalseCost of sales6false0us-gaap_SellingGeneralAndAdministrativeExpenseus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse286000000286falsefalsefalsefalsefalse2truefalsefalse284000000284falsefalsefalsefalsefalseMonetaryxbrl
i:monetaryItemTypemonetaryThe aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 4
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 43
 -Chapter 4
 -Paragraph 5A

falsefalseSelling, general and administrative expense7false0us-gaap_ResearchAndDevelopmentExpenseus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2000000020falsefalsefalsefalsefalse2truefalsefalse2000000020falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.Reference 1: http://
www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 141
 -Paragraph 51
 -Subparagraph g

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 2
 -Paragraph 12, 13

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 86
 -Paragraph 11, 12

falsefalseResearch and development expense8false0us-gaap_CostsAndExpensesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse13460000001346falsefalsefalsefalsefalse2truefalsefalse12100000001210falsefalsefalsefalsefalseMoneta
ryxbrli:monetaryItemTypemonetaryTotal costs of sales and operating expenses for the period.No authoritative reference available.truefalseTotal costs and expenses9false0us-gaap_OtherOperatingIncomeus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1200000012falsefalsefalsefalsefalse2truefalsefalse1300000013falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe total amount of other operating income, not previously categorized, from items that are associated with the entity's normal revenue producing operation.No authoritative reference available.falsefalseEQUITY AND OTHER INCOME10false0us-gaap_OperatingIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse9900000099falsefalsefalsefalsefalse2truefalsefalse127000000127falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net result for the period of deducting operating expenses from operating revenues.No authoritative reference available.truefalseOPERATING INCOME11false0us-gaap_InterestIncomeExpenseNetus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-27000000-27falsefalsefalsefalsefalse2truefalsefalse-41000000-41falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryAmount of net interest income or expense derived from banking operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 10
 -Article 9

falsefalseNet interest and other financing expense12false0ash_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalAndBusinessCombinationStepAcquisitionEquityInterestInAcquireeReeasurementGainOrLossashfalsecreditdurationThe gain (loss) resulting from the sale of a disposal group that is not a discontinued operation. It is included in income...falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse2100000021[1]falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe gain (loss) resulting from the sale of a disposal group that is not a discontinued operation. It is included in income from continuing operations before income taxes in the income statement. This element also includes, in a business combination achieved in stages, the amount of gain or loss recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.No authoritative reference available.falsefalseNet gain on acquisitions and divestitures13false0ash_IncomeLossFromContinuingOperationsBeforeIncomeTaxesashfalsecreditdurationThe consolidated profit or loss for the period before income taxes, including the portion attributable to any noncontrolling...falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse9300000093falsefalsefalsefalsefalse2truefalsefalse8600000086falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe consolidated profit or loss for the period before income taxes, including the portion attributable to any noncontrolling interest.No authoritative reference available.truefalseINCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES14false0us-gaap_IncomeTaxExpenseBenefitus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse3100000031falsefalsefalsefalsefalse2truefalsefalse2200000022falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 08
 -Paragraph h
 -Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 45
 -Subparagraph a, b

falsefalseIncome tax expense - Note K15false0us-gaap_IncomeLossFromContinuingOperationsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefal
sefalse6200000062falsefalsefalsefalsefalse2truefalsefalse6400000064falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the income or loss from continuing operations attributable to the reporting entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items and cumulative effects of changes in accounting principles, but after deduction of those portions of income or loss from continuing operations that are allocable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 29

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 28

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph b(1)

truefalseINCOME FROM CONTINUING OPERATIONS16false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2500000025[2]falsefalsefalsefalsefalse2truefalsefalse2200000022[2]falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items and the cumulative effect of accounting changes before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 13
 -Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 15
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 29

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 43

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 47
 -Subparagraph c

falsefalseIncome from discontinued operations (net of income taxes) - Note E17false0us-gaap_NetIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse8700000087falsetruefalsefalsefalse2truefalsefalse8600000086falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 19
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph d

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A7
 -Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph a

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 20
 -Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 10, 15

Reference 7: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Emerging Issues Task Force (EITF)
 -Number 87-21

Reference 8: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28, 29, 30

truefalseNET INCOME18true0us-gaap_EarningsPerShareBasicAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse
00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseBASIC EARNINGS PER SHARE - Note N19false0us-gaap_IncomeLossFromContinuingOperationsPerBasicShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse0.790.79falsetruefalsefalsefalse2truefalsefalse0.840.84falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalThe amount of income (loss) from continuing operations per each share of common stock outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 21
 -Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 36, 37, 38

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 20
 -Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 18
 -Article 7

falsetrueIncome from continuing operations20false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1true
falsefalse0.320.32falsetruefalsefalsefalse2truefalsefalse0.290.29falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalThe amount of income (loss) from disposition of discontinued operations, net of related tax effect, per each share of common stock outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 8, 9, 10, 36, 37, 38

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 20
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 18
 -Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 21
 -Article 9

falsetrueIncome from discontinued operations21false0us-gaap_EarningsPerShareBasicus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse1.111.11falsetruefalsefalsefalse2truefalsefalse1.131.13falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalThe amount of net income or loss for the period per each share of common stock outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 21
 -Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 36, 37, 38

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 20
 -Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 18
 -Article 7

truetrueNet income22true0us-gaap_EarningsPerShareDilutedAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseDILUTED EARNINGS PER SHARE - Note N23false0us-gaap_IncomeLossFromContinuingOperationsPerDilutedShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel
1truefalsefalse0.780.78falsetruefalsefalsefalse2truefalsefalse0.820.82falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalThe amount of income (loss) from continuing operations available to each share of common stock outstanding during the reporting period and each share that would have been outstanding assuming the issuance of common shares for all dilutive potential common shares outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 21
 -Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 11, 12, 36, 37, 38

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 40
 -Subparagraph a

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 20
 -Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 18
 -Article 7

falsetrueIncome from continuing operations24false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShareus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1tr
uefalsefalse0.310.31falsetruefalsefalsefalse2truefalsefalse0.280.28falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalThe amount of income (loss) from discontinued operations, net of related tax effect, per each diluted share of common stock outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 5
 -Section E
 -Paragraph Question 3

falsetrueIncome from discontinued operations25false0us-gaap_EarningsPerShareDilutedus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse1.091.09falsetruefalsefalsefalse2truefalsefalse1.101.10falsetruefalsefalsefalseEPSus-types:perShareItemTypedecimalThe amount of net income or loss for the period per each share of common stock and dilutive common stock equivalents outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 11, 12, 36

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 20
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 18
 -Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 21
 -Article 9

truetrueNet income26false0us-gaap_CommonStockDividendsPerShareCashPaidus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse0.150.15falsetruefalsefalsefalse2truefalsefalse0.0750.075falsetruefalsefalsefalseEPSus-types:perShareItemType<
/ElementDataType>decimalAggregate dividends paid during the period for each share of common stock outstanding.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

falsetrueDIVIDENDS PAID PER COMMON SHARE1Includes a gain of $19 million for the three months ended December 31, 2010 related to the formation of an expanded global joint venture with Sud-Chemie AG.  The gain is primarily attributable to the fair market value of the additional Castings Solutions net assets contributed to the expanded global joint venture exceeding the recorded values.2Includes income of $23 million and $12 million for the three months ended December 31, 2010 and 2009, respectively, related to the direct operating results of the Distribution business.  Due to its expected sale, the direct operating results of this business have been presented as discontinued operations for each period presented in accordance with U.S. GAAP.225STATEMENTS OF CONSOLIDATED INCOME (unaudited) (USD $)MillionsUnKnownNoRoundingUnKnownfalsetrue




XML
41
R2.xml
IDEA: STATEMENTS OF CONSOLIDATED INCOME (unaudited) (Parenthetical)


2.2.0.25falsefalse001010 - Statement - STATEMENTS OF CONSOLIDATED INCOME (unaudited) (Parenthetical)truefalseIn Millionsfalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse10/1/2009 - 12/31/2009
USD ($)

USD ($) / shares
$c00017http://www.sec.gov/CIK0001305014duration2009-10-01T00:00:002009-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0USDUSD$2true0us-gaap_IncomeStatementAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseIncome Statement [Abstract]3false0us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse1900000019falsetruefalsefalsefalse2truefalsefalse00falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIn a business combination achieved in stages, this element represents the amount of gain or loss recognized by the entity as a result of re measuring to fair value the equity interest in the acquiree it held before the business combination.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 141R
 -Paragraph 48

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 141R
 -Paragraph 68
 -Subparagraph q(2)

falsefalseGain on expanded global joint venture with Sud-Chemie AG4false0us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse2300000023falsetruefalsefalsefalse2truefalsefalse1200000012falsetruefalsefalsefa
lseMonetaryxbrli:monetaryItemTypemonetaryAfter tax income (loss) from operations of a business component (exclusive of any gain or loss on disposal, or provision therefore) during the reporting period, until its disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 43

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 47
 -Subparagraph c

falsefalseDistribution business income from discontinued operations23STATEMENTS OF CONSOLIDATED INCOME (unaudited) (Parenthetical) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue




XML
42
FilingSummary.xml
IDEA: XBRL DOCUMENT




  2.2.0.25
  
  
    
      true
      Sheet
      001000 - Statement - STATEMENTS OF CONSOLIDATED INCOME (unaudited)
      STATEMENTS OF CONSOLIDATED INCOME (unaudited)
      http://ashland.com/role/StatementsOfConsolidatedIncome
      false
      R1.xml
    
    
      false
      Sheet
      001010 - Statement - STATEMENTS OF CONSOLIDATED INCOME (unaudited) (Parenthetical)
      STATEMENTS OF CONSOLIDATED INCOME (unaudited) (Parenthetical)
      http://ashland.com/role/StatementsOfConsolidatedIncomeParenthetical
      false
      R2.xml
    
    
      false
      Sheet
      002000 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)
      CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)
      http://ashland.com/role/CondensedConsolidatedBalanceSheets
      false
      R3.xml
    
    
      false
      Sheet
      002010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)
      CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical)
      http://ashland.com/role/CondensedConsolidatedBalanceSheetsParenthetical
      false
      R4.xml
    
    
      false
      Sheet
      003000 - Statement - STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited)
      STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited)
      http://ashland.com/role/StatementsOfConsolidatedStockholdersEquity
      false
      R5.xml
    
    
      false
      Sheet
      003010 - Statement - STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited) (Parenthetical)
      STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (unaudited) (Parenthetical)
      http://ashland.com/role/StatementsOfConsolidatedStockholdersEquityParenthetical
      false
      R6.xml
    
    
      false
      Sheet
      004000 - Statement - STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS (unaudited)
      STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS (unaudited)
      http://ashland.com/role/StatementsOfCondensedConsolidatedCashFlows
      false
      R7.xml
    
    
      false
      Sheet
      006010 - Disclosure - BASIS OF PRESENTATION
      BASIS OF PRESENTATION
      http://ashland.com/role/BasisOfPresentation
      false
      R8.xml
    
    
      false
      Sheet
      006020 - Disclosure - NEW ACCOUNTING STANDARDS
      NEW ACCOUNTING STANDARDS
      http://ashland.com/role/NewAccountingStandards
      false
      R9.xml
    
    
      false
      Sheet
      006030 - Disclosure - ACQUISITIONS
      ACQUISITIONS
      http://ashland.com/role/Acquisitions
      false
      R10.xml
    
    
      false
      Sheet
      006040 - Disclosure - DIVESTITURES
      DIVESTITURES
      http://ashland.com/role/Divestitures
      false
      R11.xml
    
    
      false
      Sheet
      006050 - Disclosure - DISCONTINUED OPERATIONS
      DISCONTINUED OPERATIONS
      http://ashland.com/role/DiscontinuedOperations
      false
      R12.xml
    
    
      false
      Sheet
      006060 - Disclosure - RESTRUCTURING ACTIVITIES
      RESTRUCTURING ACTIVITIES
      http://ashland.com/role/RestructuringActivities
      false
      R13.xml
    
    
      false
      Sheet
      006070 - Disclosure - FAIR VALUE MEASUREMENTS
      FAIR VALUE MEASUREMENTS
      http://ashland.com/role/FairValueMeasurements
      false
      R14.xml
    
    
      false
      Sheet
      006080 - Disclosure - INVENTORIES
      INVENTORIES
      http://ashland.com/role/Inventories
      false
      R15.xml
    
    
      false
      Sheet
      006090 - Disclosure - GOODWILL AND OTHER INTANGIBLES
      GOODWILL AND OTHER INTANGIBLES
      http://ashland.com/role/GoodwillAndOtherIntangibles
      false
      R16.xml
    
    
      false
      Sheet
      006100 - Disclosure - DEBT
      DEBT
      http://ashland.com/role/Debt
      false
      R17.xml
    
    
      false
      Sheet
      006110 - Disclosure - INCOME TAXES
      INCOME TAXES
      http://ashland.com/role/IncomeTaxes
      false
      R18.xml
    
    
      false
      Sheet
      006120 - Disclosure - EMPLOYEE BENEFIT PLANS
      EMPLOYEE BENEFIT PLANS
      http://ashland.com/role/EmployeeBenefitPlans
      false
      R19.xml
    
    
      false
      Sheet
      006130 - Disclosure - LITIGATION, CLAIMS AND CONTINGENCIES
      LITIGATION, CLAIMS AND CONTINGENCIES
      http://ashland.com/role/LitigationClaimsAndContingencies
      false
      R20.xml
    
    
      false
      Sheet
      006140 - Disclosure - EARNINGS PER SHARE
      EARNINGS PER SHARE
      http://ashland.com/role/EarningsPerShare
      false
      R21.xml
    
    
      false
      Sheet
      006150 - Disclosure - CAPITAL STOCK
      CAPITAL STOCK
      http://ashland.com/role/CapitalStock
      false
      R22.xml
    
    
      false
      Sheet
      006160 - Disclosure - STOCK INCENTIVE PLANS
      STOCK INCENTIVE PLANS
      http://ashland.com/role/StockIncentivePlans
      false
      R23.xml
    
    
      false
      Sheet
      006170 - Disclosure - SEGMENT INFORMATION
      SEGMENT INFORMATION
      http://ashland.com/role/SegmentInformation
      false
      R24.xml
    
    
      false
      Sheet
      995200 - Document - Document Information
      Document Information
      http://xbrl.us/us-gaap/role/document/DocumentInformation
      false
      R25.xml
    
    
      false
      Sheet
      995400 - Document - Entity Information
      Entity Information
      http://xbrl.us/us-gaap/role/document/EntityInformation
      false
      R26.xml
    
    
      false
      Book
      All Reports
      All Reports
      
      false
      
    
  
  1
  18
  4
  0
  3
  125
  true
  false
  
    
      c00002
      39
    
    
      c00007
      34
    
    
      c00016
      3
    
    
      c00009
      1
    
    
      c00011
      1
    
    
      c00001
      1
    
    
      c00008
      1
    
    
      c00017
      53
    
    
      c00012
      86
    
    
      c00014
      3
    
    
      c00003
      1
    
    
      c00015
      3
    
    
      c00004
      1
    
    
      c00013
      3
    
    
      c00006
      1
    
    
      c00000
      1
    
    
      c00010
      1
    
    
      c00005
      1
    
  
  
  true
  true





EXCEL
43
Financial_Report.xls
IDEA: XBRL DOCUMENT

begin 644 Financial_Report.xls
M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O
M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y
M/2(M+2TM/5].97AT4&%R=%]E93@V,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y
M83AA86-D,64B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7
M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX
M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?0D%,04Y#13PO
M>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O
M#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O
M#I7;W)K
M#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DE.5D5.5$]22453/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T
M4V]U#I%>&-E;%=O#I%>&-E;%=O#I.
M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D5-4$Q/
M645%7T)%3D5&251?4$Q!3E,\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I.
M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE
M/D-!4$E404Q?4U1/0TL\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E
M93@V,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y83AA86-D,64-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964X-C(V.69?-S'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@
M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S
M'!E
M;G-E"!E>'!E;G-E("T@
M3F]T92!+/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XS,3QS<&%N
M/CPO2!A='1R:6)U=&%B;&4@
M=&\@=&AE(&9A:7(@;6%R:V5T('9A;'5E(&]F('1H92!A9&1I=&EO;F%L($-A
M'!A;F1E9"!G;&]B86P@:F]I;G0@=F5N='5R92!E>&-E961I;F<@=&AE
M(')E8V]R9&5D('9A;'5E'!E8W1E
M9"!S86QE+"!T:&4@9&ER96-T(&]P97)A=&EN9R!R97-U;'1S(&]F('1H:7,@
M8G5S:6YE'10
M87)T7V5E.#8R-CEF7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT
M4&%R=%]E93@V,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y83AA86-D,64-"D-O
M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964X-C(V.69?-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XS,S8\'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT
M9"!C;&%S'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S6%B
M;&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV-#`\65E
M(&)E;F5F:70@;V)L:6=A=&EO;G,@+2!.;W1E($P\+W1D/@T*("`@("`@("`\
M=&0@8VQA2!R96QA=&5S('1O(&%S'!E8W1E9"!S86QE+CPO=&0^#0H@
M("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-
M"@T*+2TM+2TM/5].97AT4&%R=%]E93@V,C8Y9E\W-S)F7S0P.6-?83,X9E\X
M.6$Y83AA86-D,64-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964X
M-C(V.69?-S'0O:'1M;#L@8VAA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA
M7!E
M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@
M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C
M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA&-E
M<'0@4VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N
M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$#PO=&0^#0H@
M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@
M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$#PO=&0^#0H@("`@("`@(#QT9"!C;&%S2!F;W(@7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S
M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I
M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%SF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S
M/3-$;G5M<#XW,SQS<&%N/CPOF%T:6]N/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M
M<#XT/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S/"]T
M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XT/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`@(#QT9"!C;&%S2!I;F-O;64@9G)O;2!A9F9I;&EA=&5S/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@S*3QS<&%N/CPO2!A;F0@97%U:7!M96YT/"]T9#X-"B`@("`@
M("`@/'1D(&-L87-S/3-$;G5M/B@S*3QS<&%N/CPO2P@<&QA;G0@86YD(&5Q=6EP;65N=#PO=&0^#0H@("`@("`@(#QT9"!C
M;&%S2!I;G9E6UE;G0@
M;V8@;&]N9RUT97)M(&1E8G0\+W1D/@T*("`@("`@("`\=&0@8VQA&5R8VES92!O9B!S=&]C:R!O<'1I;VYS/"]T9#X-
M"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^/"]S<&%N/CPO=&0^
M#0H@("`@("`@(#QT9"!C;&%S"!B96YE9FET6UE;G1S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XQ/'-P86X^
M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S2!E>&-H86YG92!R871E(&-H
M86YG97,@;VX@8V%S:"!A;F0@8V%S:"!E<75I=F%L96YT'!E8W1E
M9"!S86QE+"!T:&4@9&ER96-T(&]P97)A=&EN9R!R97-U;'1S(&]F('1H:7,@
M8G5S:6YE'!A;F1E9"!G
M;&]B86P@:F]I;G0@=F5N='5R92!W:71H(%-U9"U#:&5M:64@04'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$3XF(S$V,#L\+V1I=CX\9&EV
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N
M/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE2!A;&P@;V8@=&AE(&%S'!E8W1E9"!S86QE
M+"!T:&4@;W!E3XF(S$V,#L\+V1I=CX\9&EV
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N
M/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE2!F6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T)SY!2!C:79I;"P@8W)I;6EN86PL
M(')E9W5L871O7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M
M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M
M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T
M.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))
M1TA4.B`Q-BXU-7!T)R!A;&EG;CTS1&IU3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65A'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&
M3TY4+5=%24=(5#H@8F]L9"<^3D]412!#("8C.#(Q,3L@04-154E3251)3TY3
M/"]F;VYT/CPO9&EV/CQD:78@6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y
M/B8C,38P.SPO9&EV/CQD:78@3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE65S=&5R(')E2`F
M;F)S<#LD-38F(S$V,#MM:6QL:6]N(&9R;VT@:71S(&UO6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO
M9&EV/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<^2&5R8W5L97,\+V9O;G0^/"]D:78^
M/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C
M:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N
M/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2`F;F)S<#LD,BPS,#`@;6EL;&EO;B!W:71H
M('1H92!R96UA:6YI;F<@8V%S:"!C;VYS:61E&ES=&EN9R!C
M87-H(&%T('1H92!D871E(&]F('1H92!T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E
M93@V,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y83AA86-D,64-"D-O;G1E;G0M
M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964X-C(V.69?-S'0O:'1M;#L@8VAA6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N
M/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!A;&P@;V8@=&AE(&%S'!E8W1E9"!T;R!B92`F;F)S<#LD.3,P(&UI;&QI;VXL
M(&)E9F]R92!T&EM871E;'D@)FYB'!E8W1E9"!A="!T:&4@96YD(&]F('1H92!-87)C
M:"`R,#$Q('%U87)T97(N)B,Q-C`[)B,Q-C`[5&AE(&-L;W-I;F<@:7,@65A7,@87!P2`R+#`P,"!E;7!L;WEE97,@
M86-R;W-S($YOFEN9R!A;F0@9&5V96QO<&EN9R!P;&%N6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3XF
M(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4
M.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N
M/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE'!E8W1S('1O(')E8V5I=F4@=')A;G-I
M=&EO;B!S97)V:6-E(&9E97,@9F]R('-E2!I;B!D=7)A=&EO;B8C
M,38P.SPO9F]N=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE'!E8W1S('1O(')E9'5C92!C;W-T6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)
M3BU224=(5#H@,'!T)R!A;&EG;CTS1&IU3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#$V+C)P="<@
M86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CPO9&EV/CPO9&EV/CQD:78@
M6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SX\9&EV('-T
M>6QE/3-$)TU!4D=)3BU,1494.B`Q.'!T)R!A;&EG;CTS1&QE9G0^/'1A8FQE
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S(E(&%L
M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY$96-E;6)E6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$P/"]F;VYT/CPO9&EV/CPO
M=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT-#(\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@#L@
M4$%$1$E.1RU,1494.B`R)2<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S(E
M(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY#=7)R96YT(&%S6QE/3-$)U!!1$1)3D6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV.3,\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ.#$\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S
M<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE
M/3-$)U!!1$1)3D6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@#L@4$%$1$E.1RU,1494.B`R)2<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-S(E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.;VYC=7)R96YT(&%S6QE/3-$)U!!1$1)
M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXR-C$\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXV/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M+W1R/CQT6QE/3-$)U!!1$1)3D6QE/3-$)U!!
M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXS,C$\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@2P@<')I;6%R:6QY(')E;&%T960@=&\@;F]N+6]P97)A=&EO;F%L('!R
M;W!E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U325I%
M.B`W,"4[(%9%4E1)0T%,+4%,24=..B!T97AT+71O<"<^5$T\+V9O;G0^(&QO
M8V%T:6]N2X\+V9O;G0^/"]D:78^/&1I=B!S
M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S
M=&EF>3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!C
M:&5M:6-A;"!S96-T;W(N)B,Q-C`[)B,Q-C`[5&AE('1R86YS86-T:6]N(&-L
M;W-E9"!O;B!.;W9E;6)E&ES=&EN9R!F:69T>2UP97)C96YT
M(&]W;F5D($5U2!O;FQY(')E8V]G;FEZ960@97%U:71Y(&EN8V]M92!O
M9B!T:&4@:F]I;G0@=F5N='5R92!W:71H:6X@:71S(&-O;G-O;&ED871E9"!R
M97-U;'1S+B8C,38P.R8C,38P.T%S:&QA;F0F(S@R,3<[65A
M'!A;F1E9"!G;&]B86P@:F]I;G0@=F5N='5R92!T;R!3)B,R
M-3([9"U#:&5M:64@=6YD97(@;75T=6%L;'D@86=R965D('1E2!T:&4@96YD(&]F('1H92!S:7AT:"!Y96%R(&]F('1H92!J;VEN="!V
M96YT=7)E)B,X,C$W.W,@;W!E2!A9W)E960@=&5R;7,N)B,Q-C`[)B,Q
M-C`[56YD97(@8F]T:"!O<'1I;VYS+"!I9B!M=71U86QL>2!A9W)E960@=&5R
M;7,@8V%N;F]T(&)E(')E86-H960L('1H96X@=&AE(&9A:7(@;6%R:V5T('9A
M;'5E(&]F('1H92!S:&%R97,@=VEL;"!B92!D971E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T
M)SY5<&]N(&-L;W-I;F<@;V8@=&AE('1R86YS86-T:6]N+"!T:&4@:F]I;G0@
M=F5N='5R92!D:7-T6UE;G0@9G)O;2!T:&4@:F]I;G0@
M=F5N='5R92!D=7)I;F<@=&AE(#PO9F]N=#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE'!E8W1E
M9"!T;R!B92!A<'!R;WAI;6%T96QY("9N8G-P.R0R-2!M:6QL:6]N+B8C,38P
M.R8C,38P.T%S:&QA;F0@"!G86EN(&]F("9N
M8G-P.R0Q.2!M:6QL:6]N+"!A='1R:6)U=&%B;&4@=&\@=&AE(&9A:7(@;6%R
M:V5T('9A;'5E(&]F('1H92!N970@87-S971S(&-O;G1R:6)U=&5D('1O('1H
M92!J;VEN="!V96YT=7)E+B8C,38P.R8C,38P.T9O2!I;G1E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G
M(&%L:6=N/3-$:G5S=&EF>3X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`Q-"XT<'0G(&%L:6=N/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX\
M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-"XT<'0G(&%L
M:6=N/3-$:G5S=&EF>3X\9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXH;&EA8FEL:71I97,I/"]F;VYT/CPO9&EV/CPO=&0^/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#
M87-H/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#,E(&%L:6=N/3-$6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXR,#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY02P@
M<&QA;G0@86YD(&5Q=6EP;65N=#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0S)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXU,CPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4
M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C0\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,3PO
M9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R
M<'@@"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE'!A;F1E9"!J;VEN="!V96YT=7)E('%U86QI9FEE3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S
M=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@3X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!K;F]W;B!A"P@=VAI8V@@=V%S(&-O;7!R:7-E9"!O9B`F;F)S<#LD-C`@;6EL
M;&EO;B!I;B!C87-H(&%N9"!A("9N8G-P.R0Q-2!M:6QL:6]N(&9I=F4M>65A
M7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\
M:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E
M;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`Q.'!T)R!A;&EG;CTS1&IU2!A;&P@;V8@=&AE(&%S6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T)SY!
M2!E>'!O2!O=VYE9"!S
M=6)S:61I87)Y(&]F($%S:&QA;F0N)B,Q-C`[)B,Q-C`[061J=7-T;65N=',@
M=&\@=&AE(')E8V]R9&5D(&QI=&EG871I;VX@2!A;F0@<')I;6%R:6QY(')E9FQE8W0@=7!D871E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T
M:69Y/B8C,38P.SPO9&EV/CQD:78@"!E
M9F9E8W1S(&]F('1H92!S86QE+"!D=7)I;F<@=&AE('1H6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y
M/B8C,38P.SPO9&EV/CQD:78@3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K)SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K)SX\8G(@+SX\+V1I=CX\9&EV('-T>6QE/3-$)TU!4D=)3BU,
M1494.B`Q.'!T)R!A;&EG;CTS1&QE9G0^/'1A8FQE('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-CDE(&%L:6=N/3-$;&5F=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$"D\+V9O;G0^/"]D:78^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXR,SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ,CPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ/"]F;VYT/CPO=&0^/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&
M3TY4+5=%24=(5#H@8F]L9"<^1V%I;B!O;B!D:7-P;W-A;"!O9B!D:7-C;VYT
M:6YU960@;W!E"D\+V9O;G0^/"]D:78^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@6QE
M/3-$)U!!1$1)3D6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-CDE(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^5&]T
M86P@:6YC;VUE(&9R;VT@9&ES8V]N=&EN=65D(&]P97)A=&EO;G,@*&YE="!O
M9B!T87@I/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CPO
M=&%B;&4^/"]D:78^/"]D:78^/&1I=CX\=&%B;&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXH82DF(S$V,#LF(S$V,#L\+V9O;G0^/"]D:78^/"]T9#X\=&0^/&1I=B!S
M='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&;W(@=&AE('1H"!I
M;F-O;64@3X-"CPO:'1M;#X-"@T*
M+2TM+2TM/5].97AT4&%R=%]E93@V,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y
M83AA86-D,64-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964X-C(V
M.69?-S'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C
M:&%R6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#$V+C4U<'0G(&%L:6=N/3-$:G5S=&EF
M>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@
M3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE2!C;VYS:7-T960@;V8@6UE
M;G1S(&9R;VT@=&AE($AE6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV
M/CQD:78@3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.#,E(&%L
M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$.#,E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SX\+V9O;G0^)B,Q-C`[/"]D:78^/&1I=B!S='EL
M93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$;&5F=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UEF%T:6]N("AC87-H('!A:60@;W(@
M;W1H97)W:7-E('-E='1L960I/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE
M/3-$)U!!1$1)3D6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI
M/"]F;VYT/CPO=&0^/"]T"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"86QA;F-E(&%S(&]F(%-E
M<'1E;6)E6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXR-CPO9F]N=#X\+W1D/CQT9"!S='EL93TS
M1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q
M)2!N;W=R87`],T1N;W=R87`^/&9O;G0@F%T:6]N
M("AC87-H('!A:60@;W(@;W1H97)W:7-E('-E='1L960I/"]F;VYT/CPO9&EV
M/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/"]T"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E93@V
M,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y83AA86-D,64-"D-O;G1E;G0M3&]C
M871I;VXZ(&9I;&4Z+R\O0SHO964X-C(V.69?-S'0O:'1M;#L@8VAA'0^/'-P
M86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S
M/3-$'0^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-0
M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`Q
M-BXU-7!T)R!A;&EG;CTS1&IU6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T
M:69Y/B8C,38P.SPO9&EV/CQD:78@2!5+E,N($=!05`L
M($%S:&QA;F0@=7-EF5S('1H92!I;G!U=',@=&\@=F%L=6%T:6]N('1E8VAN:7%U97,@
M=7-E9"!T;R!M96%S=7)E(&9A:7(@=F%L=64@:6YT;R!T:')E92!B6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,S9P=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S
M=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE2XF(S$V,#LF
M(S$V,#M4:&5S92!I;F-L=61E('%U;W1E9"!P6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@2P@;6%R:V5T(&%C=&EV
M:71Y(&%T('1H92!M96%S=7)E;65N="!D871E+B8C,38P.R8C,38P.U5N;V)S
M97)V86)L92!I;G!U=',@2XF(S$V,#LF
M(S$V,#M4:&4@:6YP=71S(&%R92!D979E;&]P960@8F%S960@;VX@=&AE(&)E
M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T
M:69Y/B8C,38P.SPO9&EV/CQD:78@6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y
M/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N
M/3-$6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L
M:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY3:6=N:69I8V%N
M=#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY#87)R>6EN9SPO
M9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^
M/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SYA6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SYI
M;G!U=',\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SYI;G!U=',\+V9O;G0^
M/"]D:78^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SYV86QU93PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,979E;"`R/"]F
M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-S0\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXM/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M+W1R/CQT6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!=6-T:6]N(')A=&4@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/CPO=&0^/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE2`\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M4TE:13H@,3!P="<^*&$I/"]F;VYT/CPO9F]N=#X\+V1I=CX\+W1D/CQT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0S)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR/"]F;VYT/CPO=&0^
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXU-S0\+V9O;G0^/"]T9#X\=&0@"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXR,CPO9F]N=#X\+W1D/CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M3XF(S$V,#L\+V1I=CX\
M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXU-7!T)R!A
M;&EG;CTS1&IU6QE
M/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S`E(&%L:6=N/3-$
M;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L
M:6=N/3-$6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY1=6]T960@<')I8V5S/"]F;VYT/CPO
M9&EV/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SYI;B!A8W1I=F4\+V9O;G0^/"]D:78^/"]T9#X\
M=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY3:6=N:69I8V%N=#PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#,E(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SYO=&AE6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N
M/3-$6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4;W1A;#PO9F]N
M=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SYU;F]B6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SYV86QU93PO9F]N=#X\+V1I=CX\
M+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY,979E;"`S/"]F;VYT/CPO
M9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^07-S971S/"]F;VYT/CPO
M9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&%L:6=N
M/3-$6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT
M,3<\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/CPO=&0^/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,CPO9F]N=#X\
M+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,CPO9F]N
M=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY$969E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ-CD\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXQ-CD\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXV,CPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT
M"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S`E(&%L:6=N/3-$
M;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY);G9E"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,S`E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4;W1A;"!A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXV,3`\+V9O;G0^/"]T9#X\=&0@"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXQ,#<\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S
M<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M+W1R/CQT6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,S`E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO
M9&EV/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I
M;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@
M8F]L9"<^3&5V96P@,R!I;G-T6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T
M:69Y/B8C,38P.SPO9&EV/CQD:78@2!A2!E>'1E;F0@8F5Y;VYD(&$@='=E;'9E+6UO;G1H('!E3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP
M=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M&EM871E9"!B;V]K('9A;'5E+B8C,38P.R8C,38P.U1H92!F;VQL
M;W=I;F<@=&%B;&4@<')O=FED97,@82!R96-O;F-I;&EA=&EO;B!O9B!T:&4@
M8F5G:6YN:6YG(&%N9"!E;F1I;F<@8F%L86YC97,@;V8@07-H;&%N9"8C.#(Q
M-SMS(&%U8W1I;VX@3X\9&EV(&%L:6=N/3-$;&5F=#X\=&%B
M;&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH26X@;6EL;&EO
M;G,I/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R
M/CQT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R
M/CQT6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY"86QA;F-E(&%S(&]F($]C=&]B97(@,2P@
M,C`P.3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0S)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ-S`\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO
M=&0^/"]T6QE/3-$)U!!
M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ,C8\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CPO=&%B;&4^/"]D:78^/&1I=B!A;&EG;CTS1&QE9G0^)B,Q-C`[
M/"]D:78^/"]D:78^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#$X<'0[($U!4D=)3BU224=(
M5#H@,38N,G!T)R!A;&EG;CTS1&IU3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))
M1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=&
M3TY4+5-464Q%.B!I=&%L:6,[($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T)SY#=7)R96YC
M>2!H961G97,\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1"=415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX\
M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXU-7!T)R!A
M;&EG;CTS1&IU2!O9B!A;B!E;G1I='DN/"]F;VYT/CPO9&EV/CQD:78@2!A;F0@&-H86YG92!O9B!O;F4@9F]R96EG;B!C=7)R96YC
M>2!F;W(@86YO=&AE&5D(')A=&4@870@82!F=71U6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@2!D97)I=F%T
M:79E2!D97)I=F%T:79E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T
M:69Y/B8C,38P.SPO9&EV/CQD:78@2!F;W(@:&5D9V4@
M86-C;W5N=&EN9R!A;F0@=&AEF%T:6]N(&]F('1H92!U<&9R;VYT('!R96UI=6T@<&%I9"!B>2!!
M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T
M:69Y/B8C,38P.SPO9&EV/CQD:78@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#$V+C4U<'0G(&%L
M:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!4:6UE3X\9&EV(&%L:6=N/3-$;&5F
M=#X\=&%B;&4@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L
M:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$-S(E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH26X@;6EL;&EO;G,I/"]F;VYT
M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$P/"]F;VYT/CPO
M9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY&:6YI6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-C@\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ.#`\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ
M-S4\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\+W1R/CQT"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-S(E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY,249/(&-A6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-3$\
M+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT
M/CPO=&0^/"]T"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@3X-
M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E93@V,C8Y9E\W-S)F7S0P
M.6-?83,X9E\X.6$Y83AA86-D,64-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z
M+R\O0SHO964X-C(V.69?-S'0O:'1M
M;#L@8VAA6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#$V+C4U<'0G(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@2!H879E(&]C8W5R3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&=6YC
M=&EO;F%L/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY097)F;W)M86YC93PO9F]N=#X\+V1I=CX\
M+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY#;VYS=6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L
M:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY);F=R961I96YT6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4@86QI9VX],T1L969T/CQD
M:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-87)K971S/"]F;VYT/CPO9&EV
M/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,S,\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,B4^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXM/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXH-3(\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXH,3,\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXM/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[
M(%!!1$1)3D6QE/3-$)U!!1$1)
M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXH,3,\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ+#`V-SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV,C`\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR+#`X,SPO9F]N=#X\+W1D/CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,B4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^
M/"]D:78^/&1I=B!S='EL93TS1"=-05)'24XM3$5&5#H@,3AP="<^/'1A8FQE
M('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE"<^/&1I=B!S='EL93TS1"=415A4
M+4%,24=..B!L969T)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@,'!T)R!A;&EG;CTS
M1&IU6UE6UE'!A;F1E9"!G;&]B86P@:F]I;G0@=F5N='5R
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M3$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P
M<'0G(&%L:6=N/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF
M>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!4:6UE2!O=F5R(#$U('1O(#(U('EE87)S
M+"!I;G1E;&QE8W1U86P@<')O<&5R='D@;W9E6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@2!R979I97=S('1H97-E(&EN=&%N9VEB;&4@87-S971S
M(&9O6EN
M9R!A;6]U;G1S(&UA>2!N;W0@8F4@2`Q(&%N;G5A;"!A6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@
M;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U!!1$1)3D"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970\+V9O
M;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&%L:6=N
M/3-$6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY!8V-U;75L871E9#PO9F]N=#X\+V1I=CX\+W1D
M/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L
M:6=N/3-$6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-3@E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH26X@;6EL;&EO;G,I/"]F
M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L
M:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0S)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-C,\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY#=7-T;VUE6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$-3@E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXS-3PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]4
M5$]-.B!B;&%C:R`R<'@@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXY/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3@E
M(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SY4;W1A;"!I;G1A;F=I8FQE(&%S6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ
M+#(Y.#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B
M;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,C`Y/"]F;VYT/CPO
M=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXQ+#`X.3PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="
M3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L
M969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R
M87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE3X\9&EV(&%L:6=N/3-$;&5F=#X\
M=&%B;&4@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\+W1R/CQT"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-3@E(&%L:6=N/3-$;&5F
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,S@E(&-O;'-P86X],T0Q,#X\9&EV('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P
M86X],T0R(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY.970\
M+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&%L
M:6=N/3-$6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY!8V-U;75L871E9#PO9F]N=#X\+V1I=CX\
M+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-3@E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH26X@;6EL;&EO;G,I
M/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R
M(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0S)2!A;&EG;CTS1')I9VAT/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-C@\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT
M6QE/3-$)U1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY#=7-T;VUE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$-3@E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/=&AE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXS.3PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXQ,CPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$
M15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$
M)U!!1$1)3D"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE2!I;F-L=61E9"!I;B!T:&4@
M7!E.B!T97AT+VAT;6P[
M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@
M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E
M>'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#$V+C4U<'0G
M(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!4:6UE3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S
M=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'
M2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E
M(&%L:6=N/3-$6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY397!T96UB97(@,S`\+V9O;G0^
M/"]D:78^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXR,#$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR.3,\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,CPO9F]N
M=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXT,#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4
M+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R
M87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXV,S$\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXV,S`\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY-961I=6TM=&5R;2!N
M;W1E6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SYA=F5R86=E(')A=&4@;V8F(S$V
M,#LF(S$V,#LX+C0E(&%T($1E8V5M8F5R(#,Q+"`R,#$P("@W+C6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,3PO
M9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR
M,#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY(97)C=6QE6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXT-3PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-CPO9F]N=#X\+W1D/CQT9"!S='EL
M93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@6QE/3-$)U!!
M1$1)3D6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY4;W1A;"!D96)T/"]F
M;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E
M(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#(R-#PO
M9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-S$\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,SD\+V9O;G0^/"]T
M9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/"]T
M6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ+#$Q-#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O
M;G0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ+#$P
M.#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\+W1R/CPO=&%B;&4^/"]D:78^/"]D:78^/&1I=B!S='EL
M93TS1"=-05)'24XM3$5&5#H@,3AP="<^/'1A8FQE('-T>6QE/3-$)T9/3E0M
M1D%-24Q9.B!T:6UE"<^/&1I=B!S='EL93TS1"=415A4+4%,24=..B!L969T)SX\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($U!4D=)3BU,1494.B`P<'0[($U!4D=)3BU224=(5#H@
M,'!T)R!A;&EG;CTS1&IU3XF(S$V,#L\
M+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR
M<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!!3XF(S$V,#L\+V1I=CX\9&EV('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$
M:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@'!E
M;F1I='5R92!L:6UI=',N)B,Q-C`[)B,Q-C`[5&AE(&-O=F5N86YT2!R97!R97-E;G1A=&EO
M;G,@86YD('=A6UE;G0@;V8@9&EV:61E;F1S+"!M97)G
M97)S+"!S86QE(&]F(&%S2!L:6UI=&%T:6]N3XF(S$V,#L\+V1I=CX\9&EV
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N
M/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV
M/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,7!T)SY!="!$96-E;6)E&5D(&-H87)G92!C;W9E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E93@V,C8Y9E\W-S)F
M7S0P.6-?83,X9E\X.6$Y83AA86-D,64-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO964X-C(V.69?-S'0O
M:'1M;#L@8VAA6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0[(%1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L
M:6=N/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP
M=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE
M"!R871E"!R871E(&]F(#,S+C,E
M(&9O"!E>'!E;G-E(&9R;VT@=&AE("9N8G-P.R0Q
M.2!M:6QL:6]N('!R971A>"!G86EN(&%S"!B96YE
M9FET(&%S"!R871E(&1U6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3XF
M(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4
M.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$
M:G5S=&EF>3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%2
M1TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"
M86QA;F-E(&%T($]C=&]B97(@,2P@,C`Q,#PO9F]N=#X\+V1I=CX\+W1D/CQT
M9"!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)2!A;&EG;CTS1')I9VAT/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,38\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU/"]F;VYT/CPO=&0^
M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ/"]F;VYT/CPO=&0^/'1D
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'
M3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$.#8E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY"86QA;F-E(&%T($1E8V5M
M8F5R(#,Q+"`R,#$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)U!!
M1$1)3D6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP
M=#L@34%21TE.+5))1TA4.B`Q-BXU-7!T)R!A;&EG;CTS1&IU2!I;F-R96%S92!O'0@='=E;'9E(&UO;G1H2!H879E
M(&UA=&5R:6%L(&%F9F5C="!O;B!T:&4@0V]N9&5N3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E93@V,C8Y9E\W-S)F
M7S0P.6-?83,X9E\X.6$Y83AA86-D,64-"D-O;G1E;G0M3&]C871I;VXZ(&9I
M;&4Z+R\O0SHO964X-C(V.69?-S'0O
M:'1M;#L@8VAA6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&
M3TY4+5=%24=(5#H@8F]L9"<^3D]412!,("8C.#(Q,3L@14U03$]9144@0D5.
M149)5"!03$%.4SPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV
M/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,7!T)SY&;W(@=&AE('1H3X\9&EV(&%L:6=N/3-$;&5F=#X\
M=&%B;&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X]
M,T0R(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0W/CQD:78@6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,3`E(&-O;'-P86X],T0W/CQD:78@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N
M/3-$6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXR,#$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ,SPO9F]N=#X\+W1D/CQT9"!S
M='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXQ,SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY);G1E6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXU,3PO9F]N=#X\+W1D
M/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXU/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXH-30\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY!;6]R=&EZ871I;VX@;V8@<')I;W(@6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXH,3PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=.
M.B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N
M;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U!!1$1)3D6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXQ,SPO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^
M/"]T6QE/3-$)U!!1$1)
M3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR
M-#PO9F]N=#X\+W1D/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C
M:R`T<'@@9&]U8FQE.R!415A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,SPO9F]N=#X\+W1D/CQT
M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!4
M15A4+4%,24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N
M;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXT/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS
M1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$
M)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E93@V
M,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y83AA86-D,64-"D-O;G1E;G0M3&]C
M871I;VXZ(&9I;&4Z+R\O0SHO964X-C(V.69?-S'0O:'1M;#L@8VAA6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#$V+C4U<'0G(&%L:6=N/3-$:G5S
M=&EF>3X\9F]N="!S='EL93TS1"=&3TY4+59!4DE!3E0Z('-M86QL+6-A<',[
M($1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA
M;CL@1D].5"U325I%.B`Q,7!T.R!&3TY4+5=%24=(5#H@8F]L9"<^3D]412!-
M("8C.#(Q,3L@3$E424=!5$E/3BP@0TQ!24U3($%.1"!#3TY424Y'14Y#2453
M/"]F;VYT/CPO9&EV/CQD:78@2!O=VYE9"!S=6)S:61I87)Y(&]F($%S:&QA;F0L(&AA
M=F4@;&EA8FEL:71I97,@9G)O;2!C;&%I;7,@86QL96=I;F<@<&5R2!E>'!OB`F86UP.R!!2!O;B!R96-E;G0@97AP97)I96YC92P@:6YC;'5D:6YG(&-L86EM+69I
M;&EN9R!A;F0@'!E3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@
M34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!4:6UE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K)SXF
M(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4
M.B`Q-BXU-7!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,S`E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,C6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1L969T/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#(W)2!C;VQS<&%N/3-$-SX\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N
M/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E
M6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^(#QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SY996%R6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S`E(&%L:6=N/3-$
M;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXH26X@=&AO=7-A;F1S*3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS
M1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXR,#`Y/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X\9&EV
M('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@86QI9VX],T1R:6=H=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R
M:6=H=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ
M(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%
M1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LQ,34\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24^/&9O;G0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SY.97<@8VQA:6US(&9I;&5D/"]F;VYT/CPO9&EV/CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F
M;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO
M=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9&EV('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$
M25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4
M.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LQ/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LR/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS
M1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LR/"]F;VYT/CPO9&EV/CPO=&0^/'1D
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LT/"]F;VYT/CPO9&EV
M/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXI(#PO9F]N=#X\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0S)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y
M)3X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V
M,#LH,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-#PO9F]N=#X\+V1I=CX\+W1D
M/CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`R<'@@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!
M1$1)3D6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24^/&9O;G0@"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^
M/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI(#PO9F]N=#X\+W1D/CQT
M9"!S='EL93TS1"=0041$24Y'+4)/5%1/33H@,G!X)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0S)2!A;&EG;CTS1&QE9G0^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LH,C$\+V9O;G0^/"]D
M:78^/"]T9#X\=&0@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#DE(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$
M)U!!1$1)3D"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B
M;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.
M1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@
M34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LX,SPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL93TS1"="3U)$15(M
M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$.24^/&9O;G0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M.24^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K)SXF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9&EV(&%L:6=N/3-$
M;&5F=#X\=&%B;&4@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E
M(&-O;'-P86X],T0V/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N
M/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@;F]W6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E(&-O;'-P86X],T0V/CQD:78@6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L
M969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O
M;'-P86X],T0R(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!
M1$1)3D6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,C0E(&-O;'-P86X],T0V/CQD:78@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,S@E(&-O;'-P
M86X],T0Q,#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,S`E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH26X@;6EL;&EO;G,I/"]F
M;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E
M(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#`Y/"]F;VYT
M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L
M:6=N/3-$6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXR,#`X/"]F;VYT/CPO9&EV/CPO=&0^/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$58
M5"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!
M6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY297-E6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXM/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,S`E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY!;6]U;G1S('!A:60\+V9O;G0^/"]D
M:78^/"]T9#X\=&0@"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,3$\
M+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXH,3(\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH,S0\+V9O
M;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXH,S0\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH-#`\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)U!!1$1)3D6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)U1%6%0M04Q)
M1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&EM871E2!A;F0@86YN
M=6%L;'D@=7!D871E65A6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO
M9&EV/CQD:78@&-L=61I;F<@=&AE($AE2!B96EN9R!A8V-E6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P
M.SPO9&EV/CQD:78@&EM871E;'D@-CDE(&]F('1H92!E'!E8W1E9"!T
M;R!B92!D=64@9G)O;2!D;VUE2`X-"4@:&%V92!A(&-R961I="!R871I;F<@;V8@0BL@;W(@
M:&EG:&5R(&)Y($$N($TN($)E2!R871I;F=S+"!A;F0@9G)O;2!5;F1E60F(S@R
M,3<[2!O8FQI9V%T:6]N2UO=VYE9"!S=6)S:61I87)Y(&]F($%S:&QA;F0L(&AA2!A2!F;VQL
M;W=S+CPO9F]N=#X\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.
M+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3XF(S$V,#L\+V1I=CX\
M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L
M:6=N/3-$:G5S=&EF>3X\9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@
M6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&-E;G1E6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY993QF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SYA"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#(E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C,E(&-O;'-P86X],T0U/CQD
M:78@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O
M;G0@"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXR,#$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T
M>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1R:6=H=#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$.24@86QI9VX],T1R:6=H=#X\9&EV('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^)B,Q-C`[)B,Q-C`[*&$I
M/"]T9#X\+W1R/CQT6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY/<&5N(&-L86EM6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F
M;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\
M9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LR
M,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L@/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$-#(E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SY#;&%I;7,@9&ES;6ES6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%2
M1TE.+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/CPO9&EV/CPO=&0^/'1D
M('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U!!1$1)
M3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!0041$
M24Y'+4)/5%1/33H@-'!X)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0S)3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXR,CPO9F]N=#X\+V1I=CX\+W1D/CQT9"!S
M='EL93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P
M>"!D;W5B;&4G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M/'1D('-T>6QE/3-$)U!!1$1)3D"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Q)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I
M9VAT.R!415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.
M+4Q%1E0Z(#!P=#L@34%21TE.+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#LF(S$V,#LF(S$V,#LF(S$V,#LF
M(S$V,#LF(S$V,#LF(S$V,#LR,3PO9F]N=#X\+V1I=CX\+W1D/CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0S)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX]
M,T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$.24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S
M=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C96YT97(^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1C96YT97(^/&9O;G0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-#(E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$96-E;6)E6QE/3-$)U!!
M1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SY397!T96UB97(@,S`\+V9O;G0^/"]D:78^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXR,#$P/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%21TE.
M+5))1TA4.B`P<'0G/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXR,#`Y/"]F;VYT/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@*&$I)B,Q-C`[
M/"]F;VYT/CPO=&0^/"]T6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS-S4\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXT.#0\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT/CPO
M=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT/CPO=&0^/'1D('-T
M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#,E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U!!
M1$1)3D6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U!!1$1)
M3D6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F
M="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO
M=&0^/'1D('-T>6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,R4@;F]W6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/"]T6QE
M/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,24@;F]W6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@
M5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE2P@=VAI8V@@=V%S(&%C8V]U;G1E9"!F;W(@87,@86X@861J=7-T;65N
M="!T;R!(97)C=6QE2!O9F9S970@
M8GD@)FYB3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))
M1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE3XF(S$V,#L\+V1I=CX\9&EV('-T
M>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$
M:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!4:6UE2!M96YT
M:6]N960L(&1U&ES
M="XF(S$V,#LF(S$V,#M!6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'
M24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T
M:69Y/B8C,38P.SPO9&EV/CQD:78@2!E86-H(&-L86EM86YT+"!T:&4@;&]N9R!L871E;F-Y('!E2!I;F9L=65N8V5D(&)Y(&%S6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@65A
M2`F
M;F)S<#LD.#,P(&UI;&QI;VX@9F]R('1H92!!2`F;F)S<#LD-3&EM871E;'D@)FYB2!O9B!A;&QE9V5D(&1I2!B92!M871E2!R97-P;VYS:6)L92!P87)T>2!U;F1E2!R96UE9&EA=&5D+CPO9F]N=#X\+V1I=CX\
M9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@6QE/3-$)T9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$-S(E(&%L
M:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^
M/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-
M05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1C
M96YT97(^/&9O;G0@"<@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXR,C$\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT
M6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY$
M:7-B=7)S96UE;G1S+"!N970@;V8@8V]S="!R96-O=F5R:65S/"]F;VYT/CPO
M9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&%L:6=N
M/3-$6QE
M/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@]
M,T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXS/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXM/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@
M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U14
M3TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)U!!
M1$1)3D"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F
M;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P
M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^
M/'1D('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
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M93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q
M,7!T)SY4:&4@=&]T86P@2!A9&IU2XF(S$V,#LF
M(S$V,#M%;G9I6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE&ES=&EN9R!E;G9I6EN9R!C;W-T2!E&EM871E;'D@)FYB2!S:71E(&ES(&QE6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U325I%.B`W,"4[(%9%4E1)0T%,+4%,24=..B!T97AT+71O<"<^
M5$T\+V9O;G0^('!R;V1U8W0@;&EN92XF(S$V,#LF(S$V,#M#;VYS=6UE2!F;W(@=&AE(&=U
M87)A;G1E92XF(S$V,#LF(S$V,#M!2!A;F0@=&AE3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE2P@96YV:7)O;FUE;G1A;"!A;F0@;W1H97(@;6%T
M=&5R'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S
M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T
M)SX\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M5T5)1TA4
M.B!B;VQD)SY.3U1%($X@/"]F;VYT/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^
M)B,X,C$Q.SPO9F]N=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U714E'2%0Z(&)O;&0G/D5!4DY)3D=3
M(%!%4B!32$%213PO9F]N=#X\+V9O;G0^/"]D:78^/&1I=B!S='EL93TS1"=4
M15A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z
M(#!P=#L@34%21TE.+5))1TA4.B`P<'0G(&%L:6=N/3-$:G5S=&EF>3XF(S$V
M,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q
M-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\
M9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T)/
M4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,C0E(&-O;'-P86X],T0V/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,C0E(&-O;'-P86X],T0V/CQD:78@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E(&-O;'-P
M86X],T0V/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1R:6=H=#X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T
M:6UE6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T
M=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R(&%L:6=N/3-$6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L
M86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[
M(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E
M(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI
M;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A
M<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)U1%6%0M04Q)
M1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S
M='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SYC;VUM;VX@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXW-SPO9F]N
M=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U!!1$1)
M3D6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXQ/"]F
M;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P
M>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$,24@;F]W6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R
M/CQT#L@4$%$1$E.1RU,1494.B`R)2<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$-S(E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M
M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T
M.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SYA=F5R86=E('-H87)E6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G
M('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\
M+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT
M)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ
M(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXN.#0\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M+W1R/CQT6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SY$:6QU=&5D/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#,E(&%L:6=N/3-$6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXN.#(\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT
M('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M
M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S
M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE
M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA
M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@
M/'1R(&-L87-S/3-$6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P
M="<^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9.B!B
M;&]C:R<^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@,'!T.R!$25-03$%9
M.B!B;&]C:R<^/&9O;G0@3XF(S$V
M,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q
M-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE2!P96YS:6]N('!L86X@
M8V]N=')I8G5T:6]N(&]F(&%P<')O>&EM871E;'D@,RXP(&UI;&QI;VX@'1087)T
M7V5E.#8R-CEF7S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^
M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L
M87-S/3-$3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S
M=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE2!E
M;7!L;WEE97,@;W(@9&ER96-T;W)S(&%R92!G7!I8V%L;'D@82!L;VYG+71E
M6UE;G0@=VET:"!!3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXU-7!T)R!A;&EG;CTS1&IU2!B96-O;64@97AE6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@6QE
M/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM
M3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y
M/B8C,38P.SPO9&EV/CQD:78@65E65E2!D:79I9&5N9',@*&]R
M(&1I=FED96YD(&5Q=6EV86QE;G1S*2!U<&]N(&=R86YT+B8C,38P.R8C,38P
M.TYO;G9E6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P.SPO9&EV/CQD:78@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@1D].5"U325I%.B`Q,7!T.R!&
M3TY4+5=%24=(5#H@8F]L9"<^4&5R9F]R;6%N8V4@65E2!P965R
M(&=R;W5P+B8C,38P.R8C,38P.T%S:&QA;F0@8F5L:65V97,@=&AA="!T:&4@
M9F]C=7,@;VX@2P@=VET:"!E86-H(&%W87)D(&-O=F5R:6YG(&$@=&AR964M>65A6-L92XF(S$V,#LF(S$V,#M(:7-T;W)I8V%L;'DL(&5A
M8V@@<&5R9F]R;6%N8V4@3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R
M=%]E93@V,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y83AA86-D,64-"D-O;G1E
M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964X-C(V.69?-S'0O:'1M;#L@8VAA2!S96=M96YT3XF
M(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4
M.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE7-T96US+B8C,38P.R8C,38P.TUA;GD@;V8@:71S('!R
M;V1U8W1S(&%R92!D97)I=F5D(&9R;VT@6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX],T1J=7-T:69Y/B8C,38P
M.SPO9&EV/CQD:78@2P@<')O=&5C="!P;&%N="!A6QE/3-$
M)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&
M5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF
M>3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[
M($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))
M1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE&ES=&EN9R!#87-T:6YG2!I;F-O;64@8V%P=&EO;B!O9B!T:&4@4W1A
M=&5M96YT3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%
M6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@
M,3AP=#L@34%21TE.+5))1TA4.B`Q-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\
M9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4
M:6UE2!O9B!P'0M=&]P)SY433PO9F]N=#XL('1H92!W;W)L9"8C.#(Q-SMS(&9I3XF(S$V
M,#L\+V1I=CX\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,
M05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,3AP=#L@34%21TE.+5))1TA4.B`Q
M-BXR<'0G(&%L:6=N/3-$:G5S=&EF>3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M24Y$
M14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-
M05)'24XM4DE'2%0Z(#!P="<^/&1I=B!S='EL93TS1"=415A4+4E.1$5.5#H@
M,'!T.R!$25-03$%9.B!B;&]C:R<^/&1I=B!S='EL93TS1"=415A4+4E.1$5.
M5#H@,'!T.R!$25-03$%9.B!B;&]C:SL@34%21TE.+4Q%1E0Z(#!P=#L@34%2
M1TE.+5))1TA4.B`P<'0G/B8C,38P.SPO9&EV/CPO9&EV/CPO9&EV/CQD:78@
M3X\9&EV(&%L:6=N/3-$;&5F=#X\=&%B;&4@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L
M:6=N/3-$8F]T=&]M('=I9'1H/3-$,C0E(&-O;'-P86X],T0V/CQF;VYT('-T
M>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\
M=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L@/"]F;VYT/CPO=&0^/'1D('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#,E/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,C0E(&-O;'-P86X],T0V/CQD:78@6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,C0E(&-O;'-P86X],T0V/CQD:78@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR,#$P/"]F;VYT
M/CPO9&EV/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K
M(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M
M('=I9'1H/3-$,24@;F]W6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,3`E(&-O;'-P86X],T0R/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)
M4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z
M(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^4T%,15,\+V9O;G0^/"]D:78^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T
M:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)
M3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD
M/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V
M86QI9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-0
M3$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY097)F
M;W)M86YC92!-871E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS,C8\+V9O;G0^
M/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@
M=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N
M="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE
M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O
M='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE
M=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXR-S$\+V9O;G0^/"]T9#X\=&0@
M6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT#L@4$%$1$E.1RU,1494.B`R)2<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M-S(E(&%L:6=N/3-$;&5F=#X\9&EV('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`P
M<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM
M4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SY#;VYS=6UE6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\=&0@6QE/3-$)U!!
M1$1)3D6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H
M=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9
M.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P
M>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W
M:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M;F)S<#LD/"]F;VYT/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ
M(&)L86-K(#1P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX]
M,T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@"<@=F%L:6=N
M/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL
M93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D;W5B;&4[(%1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF
M;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF;F)S<#LD/"]F;VYT
M/CPO=&0^/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#1P>"!D
M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@=VED
M=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M
M1D%-24Q9.B!T:6UE6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\+W1R/CQT
M6QE/3-$)U1%6%0M24Y$14Y4
M.B`P<'0[($1)4U!,05DZ(&)L;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'
M24XM4DE'2%0Z(#!P="<@86QI9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T.R!&3TY4+5=%24=(5#H@8F]L9"<^3U!%4D%424Y'
M($E.0T]-12`H3$]34RD\+V9O;G0^/"]D:78^/"]T9#X\=&0@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T
M;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ
M(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO
M=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L;V-K
M.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI9VX]
M,T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY&=6YC
M=&EO;F%L($EN9W)E9&EE;G1S/"]F;VYT/CPO9&EV/CPO=&0^/'1D('9A;&EG
M;CTS1&)O='1O;2!W:61T:#TS1#,E(&%L:6=N/3-$6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M
M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO=W)A
M<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI9VX],T1B;W1T;VT@
M=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I
M;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^
M/"]T9#X\=&0@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R
M:6=H=#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A
M;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXS.3PO9F]N=#X\
M+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI9VX],T1B
M;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`P<'0[($1)4U!,05DZ(&)L
M;V-K.R!-05)'24XM3$5&5#H@,'!T.R!-05)'24XM4DE'2%0Z(#!P="<@86QI
M9VX],T1L969T/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SY0
M97)F;W)M86YC92!-871E6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@
M1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T
M)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV/"]F;VYT/CPO=&0^/'1D('-T>6QE
M/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS
M1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I
M;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE
M9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E/CQF;VYT('-T>6QE/3-$
M)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA
M;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXV-3PO
M9F]N=#X\+W1D/CQT9"!S='EL93TS1"=415A4+4%,24=..B!L969T)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`],T1N;W=R87`^/&9O;G0@
M6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O
M;2!W:61T:#TS1#$E(&YO=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$
M25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].
M5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF
M(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T)/4D1%4BU"
M3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)T1)4U!,
M05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].
M5"U325I%.B`Q,'!T)SXH,34\+V9O;G0^/"]T9#X\=&0@"<@=F%L:6=N/3-$
M8F]T=&]M('=I9'1H/3-$,R4@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS
M1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!
M3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@
M6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S
M;VQI9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H
M/3-$,24@;F]W6QE/3-$)T1)4U!,05DZ
M(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U3
M25I%.B`Q,'!T)SXI/"]F;VYT/CPO=&0^/"]T6QE/3-$)U!!1$1)3D6QE/3-$)T1)4U!,05DZ(&EN;&EN
M93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q
M,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXY.3PO9F]N=#X\+W1D/CQT9"!S='EL
M93TS1"="3U)$15(M0D]45$]-.B!B;&%C:R`T<'@@9&]U8FQE.R!415A4+4%,
M24=..B!L969T)R!V86QI9VX],T1B;W1T;VT@=VED=&@],T0Q)2!N;W=R87`]
M,T1N;W=R87`^/&9O;G0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ
M('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O
M;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXQ,C<\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S
M(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T
M9#X\+W1R/CQT6QE/3-$)T)/4D1%
M4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M('=I
M9'1H/3-$-S(E(&%L:6=N/3-$;&5F=#X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$
M)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI9#L@5$585"U!3$E'3CH@
M;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$,24^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(&)L86-K(#)P>"!S;VQI
M9#L@5$585"U!3$E'3CH@;&5F="<@=F%L:6=N/3-$8F]T=&]M('=I9'1H/3-$
M,24@;F]W6QE/3-$)T1)4U!,05DZ(&EN
M;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%
M.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXF(S$V,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT)R!V86QI
M9VX],T1B;W1T;VT@=VED=&@],T0Y)3X\9F]N="!S='EL93TS1"=$25-03$%9
M.B!I;FQI;F4[($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)U1%
M6%0M04Q)1TXZ(&QE9G0G('9A;&EG;CTS1&)O='1O;2!W:61T:#TS1#$E(&YO
M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[
M($9/3E0M1D%-24Q9.B!T:6UE6QE/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&
M04U)3%DZ('1I;65S(&YE=R!R;VUA;CL@1D].5"U325I%.B`Q,'!T)SXF(S$V
M,#L\+V9O;G0^/"]T9#X\=&0@6QE/3-$)TU!4D=)
M3BU,1494.B`Q.'!T)SX\=&%B;&4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`S-7!X
M)SX\9&EV('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/CQF;VYT('-T>6QE
M/3-$)T1)4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2
M;VUA;CL@1D].5"U325I%.B`Q,'!T)SXH82D\+V9O;G0^/"]D:78^/"]T9#X\
M=&0@=VED=&@],T0Q,38U/CQD:78@3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/
M3E0M1D%-24Q9.B!4:6UE3XF(S$V,#L\+V1I=CX\9&EV('-T>6QE/3-$)TU!4D=)3BU,1494
M.B`Q.'!T)SX\=&%B;&4@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[(%=)1%1(.B`S-7!X)SX\9&EV
M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0G/CQF;VYT('-T>6QE/3-$)T1)
M4U!,05DZ(&EN;&EN93L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@
M1D].5"U325I%.B`Q,'!T)SXH8BD\+V9O;G0^/"]D:78^/"]T9#X\=&0@=VED
M=&@],T0Q,38Y/CQD:78@3X\9F]N="!S='EL93TS1"=$25-03$%9.B!I;FQI;F4[($9/3E0M1D%-
M24Q9.B!4:6UE2!!2!C:&%R9V5D('1O('1H:7,@8G5S:6YE
M7!E.B!T
M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE
M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT
M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^9F%L
M'0^1&5C(#,Q+`T*"0DR,#$P/'-P86X^/"]S<&%N/CPO
M=&0^#0H@("`@("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO
M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E93@V,C8Y9E\W-S)F7S0P.6-?
M83,X9E\X.6$Y83AA86-D,64-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O
M0SHO964X-C(V.69?-S'0O:'1M;#L@
M8VAA'0^
M07-H;&%N9"!);F,N/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*
M("`@("`@/'1R(&-L87-S/3-$2!#
M96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,3,P-3`Q-#QS<&%N/CPO'0^+2TP.2TS,#QS<&%N/CPO
M2!6;VQU;G1A'0^665S/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@
M("`@/'1R(&-L87-S/3-$2!#;VUM;VX@4W1O
M8VLL(%-H87)E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].
M97AT4&%R=%]E93@V,C8Y9E\W-S)F7S0P.6-?83,X9E\X.6$Y83AA86-D,64-
M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO964X-C(V.69?-S&UL
M#0I#;VYT96YT+51R86YS9F5R+45N8V]D:6YG.B!Q=6]T960M<')I;G1A8FQE
M#0I#;VYT96YT+51Y<&4Z('1E>'0O:'1M;#L@8VAA&UL;G,Z;STS1")U


XML
44
R25.xml
IDEA: Document Information


2.2.0.25falsefalse995200 - Document - Document Informationtruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$3false0dei_DocumentTypedeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse0010-Q10-QfalsefalsefalsefalsefalseOtherus-types:SECReportItemTypenaThe type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type should be limited to the same value as the supporting SEC submission type. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, NCSR, N-Q, and Other.No authoritative reference available.falsefalseDocument Type4false0dei_AmendmentFlagdeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalsefalsefalseOtherxbrli:booleanItemTypenaIf the value is true, then the document as an amendment to previously-filed/accepted document.No authoritative reference available.falsefalseAmendment Flag5false0dei_DocumentPeriodEndDatedeifalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsef
alse1falsefalsefalse002010-12-312010-12-31falsefalsetruefalsefalseOtherxbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report.  For all other reports and registration statements this will be the filing date. The format of the date is CCYY-MM-DD.No authoritative reference available.falsefalseDocument Period End Date13Document InformationUnKnownUnKnownUnKnownUnKnownfalsetrue




XML
45
R7.xml
IDEA: STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS (unaudited)


2.2.0.25falsefalse004000 - Statement - STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS (unaudited)truefalseIn Millionsfalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse10/1/2009 - 12/31/2009
USD ($)

USD ($) / shares
$c00017http://www.sec.gov/CIK0001305014duration2009-10-01T00:00:002009-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0USDUSD$3true0us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringCash generated by or used in operating activities of continuing operations; excludes cash flows from discontinued operations.falsefalseCASH FLOWS PROVIDED BY OPERATING ACTIVITIES FROM CONTINUING OPERATIONS4false0us-gaap_NetIncomeLossus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse8700000087falsetruefalsefalsefalse2truefalsefalse8600000086falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 19
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph d

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A7
 -Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph a

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 20
 -Article 9

Reference 6: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 10, 15

Reference 7: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Emerging Issues Task Force (EITF)
 -Number 87-21

Reference 8: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28, 29, 30

falsefalseNet income5false0us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1truefalse
false-25000000-25[1]falsefalsefalsefalsefalse2truefalsefalse-22000000-22[1]falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items and the cumulative effect of accounting changes before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 13
 -Article 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 15
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 29

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 43

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 144
 -Paragraph 47
 -Subparagraph c

falsefalseIncome from discontinued operations (net of income taxes)6true0us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel
1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse<
/hasScenarios>Otherxbrli:stringItemTypestringNo definition available.falsefalseAdjustments to reconcile income from continuing operations to cash flows from operating activities7false0us-gaap_DepreciationDepletionAndAmortizationus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse7300000073falsefalsefalsefalsefalse2truefalsefalse7400000074falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.No authoritative reference available.falsefalseDepreciation and amortization8false0us-gaap_AmortizationOfFinancingCostsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse40000004falsefalsefalsefalse<
/hasSegments>false2truefalsefalse60000006falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe component of interest expense comprised of the periodic charge against earnings over the life of the financing arrangement to which such costs relate.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 8
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 8
 -Article 9

falsefalseDebt issuance cost amortization9false0us-gaap_DeferredIncomeTaxExpenseBenefitus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse40000004falsefalsefalsefalsefalse2truefalsefalse2600000026falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe component of income tax expense for the period representing the net change in the entity's deferred tax assets and liabilities pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 6
 -Section I
 -Subsection 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 45
 -Subparagraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 289

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 08
 -Paragraph h
 -Article 4

falsefalseDeferred income taxes10false0us-gaap_IncomeLossFromEquityMethodInvestmentsus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsef
alse-3000000-3falsefalsefalsefalsefalse2truefalsefalse-6000000-6falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. Such amount typically reflects adjustments similar to those made in preparing consolidated statements, including adjustments to eliminate intercompany gains and losses, and to amortize, if appropriate, any difference between cost and underlying equity in net assets of the investee at the date of investment.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 18
 -Paragraph 19
 -Subparagraph c

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 11
 -Article 7

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 9
 -Article 5

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 18
 -Paragraph 6
 -Subparagraph b

falsefalseEquity income from affiliates11false0us-gaap_EquityMethodInvestmentDividendsOrDistributionsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse20000002falsefalsefalsefalsefalse2truefalsefalse60000006falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis item represents disclosure of the amount of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporation; these investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 13
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 18
 -Paragraph 19

falsefalseDistributions from equity affiliates12false0us-gaap_GainLossOnSaleOfPropertyPlantEquipmentus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-3000000-3falsefalsefalsefalsefalse2truefalsefalse-2000000-2falsefalsefalsefalsefalseMonetary
xbrli:monetaryItemTypemonetaryThe difference between the sale price or salvage price and the book value of a property, plant, and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss).Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

falsefalseGain from sale of property and equipment13false0us-gaap_ShareBasedCompensationus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse40000004falsefalsefalsefalsefalse2truefalsefalse30000003falsefalsefalsefalsefalseMonetary
xbrli:monetaryItemTypemonetaryThe aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock options, amortization of restricted stock, and adjustment for officers compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

falsefalseStock based compensation expense14false0ash_NoncashSavingsPlansContributionExpenseashfalsedebitdurationNoncash equity contribution made by the entity to qualified saving plan during the period.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse1200000012falsefalsefalsefalsefalse2truefalsefalse90000009falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryNoncash equity contribution made by the entity to qualified saving plan during the period.No authoritative reference available.falsefalseStock contributions to qualified savings plans15false0ash_DisposalGroupNotDiscontinuedOperationGainLossOnDisposalAndBusinessCombinationStepAcquisitionEquityInterestInAcquireeReeasurementGainOrLossashfalsecreditdurationThe gain (loss) resulting from the sale of a disposal group that is not a discontinued operation. It is included i
n income...falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1truefalsefalse-21000000-21[2]falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe gain (loss) resulting from the sale of a disposal group that is not a discontinued operation. It is included in income from continuing operations before income taxes in the income statement. This element also includes, in a business combination achieved in stages, the amount of gain or loss reco
gnized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.No authoritative reference available.falsefalseNet gain on acquisitions and divestitures16false0us-gaap_IncreaseDecreaseInOperatingCapitalus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalse<
/IsBeginningBalance>falsefalse1truefalsefalse-172000000-172[3]falsefalsefalsefalsefalse2truefalsefalse-125000000-125[3]f
alsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net change during the reporting period of all current assets and liabilities used in operating activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

falsefalseChange in operating assets and liabilities17false0us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1
truefalsefalse-38000000-38falsefalsefalsefalsefalse2truefalsefalse5500000055falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net cash from (used in) the entity's continuing operations. This element specifically EXCLUDES the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in operating activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26
 -Footnote 10

truefalseNet cash (used) provided by Operating Activities18true0us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1false<
/IsNumeric>falsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringCash generated by or used in investing activities of continuing operations; excludes cash flows from discontinued operations.falsefalseCASH FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES FROM CONTINUING OPERATIONS19false0us-gaap_PaymentsToAcquirePropertyPlantAndEquipmentus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1truefalsefalse-22000000-22falsefalsefalsefalsefalse2truefalsefalse-21000000-21falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 17
 -Subparagraph c

falsefalseAdditions to property, plant and equipment20false0us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipmentus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse40000004falsefalsefalsefalsefalse2truefalsefalse30000003falsefalsefalsefalsefalseMonetary<
/Unit>xbrli:monetaryItemTypemonetaryThe cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 16
 -Subparagraph c

falsefalseProceeds from disposal of property, plant and equipment21false0us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1truefalsefalse-5000000-5falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15, 17

falsefalsePurchase of operations - net of cash acquired22false0us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivestedus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse2100000021falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseM
onetaryxbrli:monetaryItemTypemonetaryThis element represents the cash inflow during the period from the sale of a component of the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15, 16

falsefalseProceeds from sale of operations or equity investments23false0us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecuritiesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalsefalsefalse2truefalsefalse4400000044falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash inflow associated with the sale or maturity (principal being due) of securities not classified as either held-to-maturity securities or trading securities which are classified as available-for-sale securities.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 16
 -Subparagraph a

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 115
 -Paragraph 18

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 16
 -Subparagraph b

falsefalseProceeds from sales and maturities of available-for-sale securities24false0us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse-2000000-2falsefalsefalsefalsefalse2truefalsefalse2600000026falsefalsefalsefalsefalse<
/hasScenarios>Monetaryxbrli:monetaryItemTypemonetaryThe net cash from (used in) the entity's investing activities specifically EXCLUDING the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in investing activities. Such reporting would necessitate the entity to use the Net Cash Provided by (Used in) Discontinued Operations, Total element provided in the taxonomy.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26
 -Footnote 10

truefalseNet cash (used) provided by Investing Activities25true0us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1false<
/IsNumeric>falsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringCash generated by or used in financing activities of continuing operations; excludes cash flows from discontinued operations.falsefalseCASH FLOWS PROVIDED (USED) BY FINANCING ACTIVITIES FROM CONTINUING OPERATIONS26false0us-gaap_ProceedsFromIssuanceOfLongTermDebtus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse1100000011falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 19
 -Subparagraph b

falsefalseProceeds from issuance of long-term debt27false0us-gaap_RepaymentsOfLongTermDebtus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1truefals
efalse-10000000-10falsefalsefalsefalsefalse2truefalsefalse-25000000-25falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 20
 -Subparagraph b

falsefalseRepayment of long-term debt28false0us-gaap_ProceedsFromRepaymentsOfShortTermDebtus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse60000006falsefalsefalsefalsefalse2truefalsefalse60000006falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net cash inflow (outflow) for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

falsefalseProceeds from short-term debt29false0us-gaap_PaymentsOfDividendsCommonStockus-gaaptruecreditdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsetruenegated1truefalsefalse-12000000-12falsefalsefalsefalsefalse2truefalsefalse-6000000-6falsefalsefalsefalsefalseMon
etaryxbrli:monetaryItemTypemonetaryThe cash outflow from the distribution of an entity's earnings in the form of dividends to common shareholders.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 20
 -Subparagraph a

falsefalseCash dividends paid30false0us-gaap_ProceedsFromStockOptionsExercisedus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse10000001falsefalsefalsefalsefalse2truefalsefalse10000001falsefalsefalsefalsefalseMonetaryxbrli:mone
taryItemTypemonetaryThe cash inflow associated with the amount received from holders exercising their stock options.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 123R
 -Paragraph A240
 -Subparagraph i

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 19
 -Subparagraph a

falsefalseProceeds from exercise of stock options31false0us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivitiesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalselabel1truefalsefalse10000001falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryReductions in the entity's income taxes that arise when compensation cost (from non-qualified share-based compensation) recognized on the entity's tax return exceeds compensation cost from share-based compensation recognized in financial statements. This element represents the cash inflow reported in the enterprise's financing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 123R
 -Paragraph A240
 -Subparagraph i

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Emerging Issues Task Force (EITF)
 -Number 00-15
 -Paragraph 3

falsefalseExcess tax benefits related to share-based payments32false0us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel1truefalsefalse-3000000-3falsefalsefalsefalsefalse2truefalsefalse-24000000-24falsefalsefalsefalsefalse
Monetaryxbrli:monetaryItemTypemonetaryThe net cash from (used in) the entity's financing activities specifically EXCLUDING the cash flows derived by the entity from its discontinued operations, if any. This element is only to be used when the entity reports its cash flows attributable to discontinued operations separately from the cash flow provided by or used in financing activities. Such reporting would necessitate the entity to use the Net Cash Provided by (Used in) Discontinued Operations, Total element provided in the taxonomy.No authoritative reference available.truefalseNet cash used by Financing Activities33false0ash_NetCashProvidedByUsedInContinui
ngOperationsashfalsedebitdurationThe net cash from (used in) the entity's continuing operations. This element includes the aggregate amount of net cash...falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-43000000-43falsefalsefalsefalsefalse2truefalsefalse5700000057falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net cash from (
used in) the entity's continuing operations. This element includes the aggregate amount of net cash provided by (used in) operating, investing and financing activities.No authoritative reference available.falsefalseCASH (USED) PROVIDED BY CONTINUING OPERATIONS34true0us-gaap_NetCashProvidedByUsedInDiscontinuedOperationsAbstractus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseCash provided (used) by discontinued operations35false0us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperationsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse00falsefalsefalsefalsefalse2truefalsefalse-7000000-7falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents cash provided by (used in) the operating activities of the entity's discontinued operations during the period. This element should only be used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in operating activities reflect only cash flows attributable to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

falsefalseOperating cash flows36false0us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperationsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse-1000000-1falsefalsefalsefalsefalse2truefalsefalse00falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThis element represents cash provided by (used in) the investing activities of the entity's discontinued operations during the period. This element should only be used by those entities that separately report cash flows attributable to discontinued operations. If using this element, it is an indication that the cash flows of the entity which are detailed in reconciling to cash provided by or used in investing activities reflect only cash flows attributable to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

falsefalseInvesting cash flows37false0us-gaap_EffectOfExchangeRateOnCashAndCashEquivalentsus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1truefalsefalse10000001falsefalsefalsefalsefalse2truefalsefalse40000004falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe effect of exchange rate changes on cash balances held in foreign currencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 25

falsefalseEffect of currency exchange rate changes on cash and cash equivalents38false0us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalsetotallabel<
Id>1truefalsefalse-43000000-43falsefalsefalsefalsefalse2truefalsefalse5400000054falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryThe net change between the beginning and ending balance of cash and cash equivalents.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

truefalse(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS39false0us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsetruefalsefalseperiodstartlabel1tr
uefalsefalse417000000417falsefalsefalsefalsefalse2truefalsefalse352000000352falsefalsefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIncludes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury b
ill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7, 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 8, 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7
 -Footnote 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 1
 -Article 5

falsefalseCASH AND CASH EQUIVALENTS - BEGINNING OF YEAR40false0us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsetruefalseperiodendlabel1truefalsefalse374000000374falsetruefalsefalsefalse2truefalsefalse406000000406falsetruefalsefalsefalseMonetaryxbrli:monetaryItemTypemonetaryIncludes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill an
d a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents.Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7, 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 8, 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7
 -Footnote 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 1
 -Article 5

falsefalseCASH AND CASH EQUIVALENTS - END OF PERIOD1Includes income of $23 million and $12 million for the three months ended December 31, 2010 and 2009, respectively, related to the direct operating results of the Distribution business.  Due to its expected sale, the direct operating results of this business have been presented as discontinued operations for each period presented in accordance with U.S. GAAP.2Includes a gain of $19 million for the three months ended December 31, 2010 related to the formation of an expanded global joint venture with Sud-Chemie AG.  The gain is primarily attributable to the fair market value of the additional Castings Solutions net assets contributed to the expanded global joint venture exceeding the recorded values.3Excludes changes resultin
g from operations acquired or sold.238STATEMENTS OF CONDENSED CONSOLIDATED CASH FLOWS (unaudited) (USD $)MillionsUnKnownUnKnownUnKnownfalsetrue




XML
46
R17.xml
IDEA: DEBT


2.2.0.25falsefalse006100 - Disclosure - DEBTtruefalsefalse1falsefalseUSDfalsefalse10/1/2010 - 12/31/2010
USD ($)

USD ($) / shares

$c00012http://www.sec.gov/CIK0001305014duration2010-10-01T00:00:002010-12-31T00:00:00u000Standardhttp://www.xbrl.org/2003/iso4217USDiso42170u002Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli
0u001Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2true0ash_NotesToFinancialStatementsAbstractashfalsenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalseOtherxbrli:stringItemTypestringNo definition available.falsefalseNotes to Financial Statements [Abstract]3false0us-gaap_DebtDisclosureTextBlockus-gaaptruenadurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 16.55pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">NOTE J &#8211; DEBT</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The following table summarizes Ashland&#8217;s current and long-term debt as of the reported Condensed Consolidated Balance Sheet dates.</font><br /></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MA
RGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><div align="left"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="97%"><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="botto
m" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td valign="bottom" width=
"3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">December 31</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new r
oman; FONT-SIZE: 10pt">September 30</font></div></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><!--efplaceholder-->(In millions)</font></div></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN
- -RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="10%" colspan="2" align="right"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2010</font></div></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"&
gt;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Term Loan A, due 2014 <font style="DISPLAY: inline; FONT-SIZE: 10pt">(a)</font></font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">289</font>&
lt;/td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">293</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDE
NT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.60% notes, due 2027</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FA
MILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">12</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Accounts receivable securitization</font></div></td><td valign="bottom" width="3%" align="right"><
font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEX
T-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">40</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">9.125% notes, due 2017</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></t
d><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">631</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">630</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Medium-term notes, due 2013-2019, interest at a weighted-</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap">
;<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt
" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">average rate of&#160;&#160;8.4% at December 31, 2010 (7.7% to 9.4%)</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: 
times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">21</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">8.80% debentures, due 2012</font></div></td><td valign="bottom" width="3%" align="right"><font style="DI
SPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right
" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">20</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hercules Tianpu - term notes, due through 2011</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font
></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">7</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">14</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY:
 times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Hercules Nanjing - term notes, due&#160;&#160;2013</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">45</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowr
ap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">34</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" ali
gn="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">6.50% junior subordinated notes, due 2029</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">127</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&
amp;#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">126</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">International revolver agreements, interest at a weighted-</font></div></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT
- -FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="
9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="PADDING-LEFT: 2%" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">average rate of&#160;&#160;5.1% at December 31, 2010 (1.3% to 9.8%)</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FO
NT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">30</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><fon
t style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT
- -SIZE: 10pt">2</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FO
NT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total debt</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,230</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLA
Y: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,224</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="#cceeff"><td valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DIS
PLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Short-term debt</font></div></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(77</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: left" va
lign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(71</font></td><td style="TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="white"><td style="PADDING-BOTTOM: 2px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current portion of long-term debt</font></div></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SI
ZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(39</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td><td style="PADDING-BOTTOM: 2px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times 
new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(45</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td></tr><tr bgcolor="#cceeff"><td style="PADDING-BOTTOM: 4px" valign="bottom" width="72%" align="left"><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Long-term debt (less current portion)</font></div></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"&
gt;&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,114</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="PADDING-BOTTOM: 4px" valign="bottom" width="3%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new 
roman; FONT-SIZE: 10pt">$</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,108</font></td><td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr><tr bgcolor="white"><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="72%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" widt
h="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid" valign="bottom" width="3%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px s
olid; TEXT-ALIGN: right" valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td><td style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left" valign="bottom" width="1%" nowrap="nowrap"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td></tr></table></div></div><div style="MARGIN-LEFT: 18pt"><table style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt" cellspacing="0" cellpadding="0" width="99%"><tr valign="top"><td style="TEXT-ALIGN: left; WIDTH: 38px"><div style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(a)</font></div></td><td width="1187"><div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Sen
ior credit facilities.</font></div></td></tr></table></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">The scheduled aggregate maturities of debt by fiscal year are as follows:&#160;&#160;$106 million remaining in 2011, $43&#160;million in 2012, $85 million in 2013, $214 million in 2014, $9 million in 2015 and $0&#160;million in 2016.&#160;&#160;Total borrowing capacity remaining under the $550 million revolving credit facility was $442 million, representing a reduction of $108 million for letters of credit outstanding at December 31, 2010.&#160;&#160;Additionally, at December 31, 2010, the outstanding amount of accounts receivable sold by Ashland to a wholly-owned &#
8220;bankruptcy remote&#8221; special purpose subsidiary of Ashland was $585 million.&#160;&#160;As of December 31, 2010, Ashland had drawn $40&#160;million of the approximate $328 million in available funding from qualifying receivables under this accounts receivable securitization facility.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt; FONT-WEIGHT: bold">Covenant restrictions</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-S
IZE: 11pt">The Senior Credit Facilities include less restrictive covenants than the previous credit facility and no longer contain covenants associated with minimum consolidated net worth and capital expenditure limits.&#160;&#160;The covenants contain certain usual and customary representations and warranties, and usual and customary affirmative and negative covenants which include financial covenants; limitations on liens, additional indebtedness, further negative pledges, investments, payment of dividends, mergers, sale of assets and restricted payments; and other customary limitations.&#160;&#160;As of December 31, 2010, Ashland is in compliance with all debt agreement covenant restrictions.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-F
AMILY: Times New Roman; FONT-SIZE: 11pt">The maximum consolidated leverage ratio permitted under the Senior Credit Facilities are as follows:&#160;&#160;3.00 from the period December 31, 2010 through September 30, 2011 and 2.75 from December 31, 2011 and each fiscal quarter thereafter.&#160;&#160;The permitted consolidated fixed charge coverage ratio under the Senior Credit Facility is 1.50 from December 31, 2010 and for each fiscal quarter thereafter.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">At December 31, 2010, Ashland&#8217;s calculation of the consolidated leverage ratio was 0.9 compared to the maximum consolidated leverage ratio permitted under Ashland&#8217;s Senior Credit Agree
ment of 3.00.&#160;&#160;At December 31, 2010, Ashland&#8217;s calculation of the fixed charge coverage ratio was 4.6 compared to the permitted consolidated ratio of </font><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 11pt">1.50.&#160;&#160;The expected sale of Distribution will cause Ashland to amend its previous calculation of these financial ratios, but will not have a significant affect on the current cushion within the ratio results.</font></div><div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 16.2pt" align="justify">&#160;</div>NOTE J &#8211; DEBT&#160;The following table summarizes Ashland&#8217;s current and long-term debt as of the reported Condensed Consolidated Balance SheetfalsefalsefalsefalsefalseOtherus-types:textBlockItemTypestringInformation about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.Reference 1: http://www.xbrl.org/20
03/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 19, 20, 22
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 129
 -Paragraph 2, 4

falsefalseDEBT12DEBTUnKnownUnKnownUnKnownUnKnownfalsetrue




-----END PRIVACY-ENHANCED MESSAGE-----

Large Accelerated Filer þ	Accelerated Filer o
Non-Accelerated Filer o	Smaller Reporting Company o
(Do not check if a smaller reporting company.)



ASHLAND INC. AND CONSOLIDATED SUBSIDIARIES
STATEMENTS OF CONSOLIDATED INCOME

	Three months ended
	December 31
(In millions except per share data - unaudited)	2010			2009

SALES	$	1,433		$	1,324

COSTS AND EXPENSES
Cost of sales		1,040			906
Selling, general and administrative expense		286			284
Research and development expense		20			20
		1,346			1,210
EQUITY AND OTHER INCOME		12			13

OPERATING INCOME		99			127
Net interest and other financing expense		(27	)		(41	)
Net gain on acquisitions and divestitures (a)		21			-
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES		93			86
Income tax expense - Note K		31			22
INCOME FROM CONTINUING OPERATIONS		62			64
Income from discontinued operations (net of income taxes) - Note E (b)		25			22
NET INCOME	$	87		$	86

BASIC EARNINGS PER SHARE - Note N
Income from continuing operations	$	.79		$	.84
Income from discontinued operations		.32			.29
Net income	$	1.11		$	1.13

DILUTED EARNINGS PER SHARE - Note N
Income from continuing operations	$	.78		$	.82
Income from discontinued operations		.31			.28
Net income	$	1.09		$	1.10

DIVIDENDS PAID PER COMMON SHARE	$	.15		$	.075